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14:00 - 15:30 Room E2 
Interactive Teaching Session 
E³ 120 
Imaging in common clinical problems:  
Soft tissue tumors 
Moderator:
R. Arkun; Izmir/TR 
A‑001 14:00 
Imaging in common clinical problems: Soft tissue tumors 
J.L. Bloem1, A.M.A. de Schepper2; 1Leiden/NL, 2Antwerp/BE (j.l.bloem@lumc.nl) 
Imaging is essential in diagnosis, grading, staging, and therapy monitoring of soft 
tissue tumors. Typically, a patient presents with a clinically detected soft tissue lump. 
In a general practice, benign tumors and tumor-like lesions are 100 times more 
frequent than malignant ones. This makes US a cost-effective first imaging method. 
Normal variants, non-neoplastic lumps (cysts, pos-traumatic lesions, muscle hernia-
tion) and benign lesions (subcutaneous lipoma) can often be diagnosed. US is also 
used to guide needle sampling for cytology or histology. If the lesion does not allow 
a specific US diagnosis, is larger than 3 cm, and/or is located deep to the fascia, 
low threshold MR is indicated. Dynamic Gd-enhanced MR has the highest accuracy 
(80-90%) in differentiating (grading) benign from malignant lesions. Benign lesions 
often have specific signs allowing a tissue specific MR diagnosis with high sensitiv-
ity (75%). A tissue specific diagnosis often cannot be made in malignant lesions 
(sensitivity 37%). Criteria for malignancy are: no tissue specific benign diagnosis 
can be made, size > 3 cm, located deep to fascia, liquefaction, early peripheral 
enhancement, inhomogeneous SI on T1 weighted images. Educational cases will 
be staged during the session, addressing concerns of surgeons. Parameters that 
are useful or worthless in monitoring therapy and detecting recurrences will be 
demonstrated in typical cases. 
Learning Objectives:
1. To know when and how to use US and MR in making a tissue specific 
diagnosis.
2. To be able to use imaging criteria in differentiating benign from potentially 
malignant soft tissue tumors with high accuracy (grading).
3. To learn how to use MR in staging, monitoring therapy and detecting 
recurrence.
16:00 - 17:30 Room B 
Radiology of the Spine in 2010 
CC 216 
Back to basics: Protocols for the spine 
Moderator:
I. Cravo; Lisbon/PT 
A‑002 16:00 
A. The role of the plain films 
J.-L. Drapé; Paris/FR (jean‑luc.drape@cch.aphp.fr) 
Plain films of the spine remain widely performed. Radiologists must be aware of the 
quality criteria, diagnostic value and limitations of spinal plain films. Radiographs are 
most often the first imaging examination in a patient with clinical symptoms (pain, 
radiculalgia) related to the spine. Radiographs still play an important and prelimi-
nary role as an easy screening tool in degenerative disk disease. They are cheap, 
universally available, and offer a good panoramic view of the lumbar spine, adding 
meaningful details on bone structures and the stability of the spine. Functional 
dynamic radiography remains the gold standard for the assessment of lumbar insta-
bility. Because of its simplicity, low cost, and availability, functional flexion-extension 
radiography is the most thoroughly studied and the most widely used method in 
the imaging diagnosis of lumbar intervertebral instability. Full spine radiographs are 
mandatory in patients with scoliosis. In seronegative spondyloarthropathies, spinal 
radiographs remain useful; however, they are unable to detect early inflammatory 
changes of the spinal entheses, which are important for establishing a diagnosis 
and treatment without delay. In a patient with cervical spine trauma, plain films are 
of limited value and the analysis of the craniovertebral junction and upper cervical 
spine is often very difficult. For the diagnosis of myeloma, spinal metastases and 
spinal tumors plain films are complimentary to MRI and CT and basically play a 
much less significant role because of a lack of sensitivity. Radiographs are also of 
limited value in the early diagnosis of a spinal infection. 
Learning Objectives:
1. To be knowledgable about normal and abnormal findings on plain films of 
the spine.
2. To become familiar with the most common “pitfalls” in reading plain films of 
the spine.
A‑003 16:30  
B. CT protocols for the spine 
B. Tins; Oswestry/UK (Bernhard.Tins@rjah.nhs.uk) 
CT is the examination of choice for the assessment of the bone structure of the 
spine. It is fast and tolerated by almost every patient. The choice of imaging pa-
rameters and also the reconstruction algorithm and the mode of display can make 
a significant difference to the perceived image quality and diagnostic accuracy. 
While generally a robust imaging method, artefacts can occur in CT imaging. In 
particular, movement artefact and streak artefact can cause a problem for image 
interpretation. Ways to minimize or limit these artefacts will be discussed. Generally 
improvement in image quality results in an increased radiation dose and longer 
imaging times. Depending on the clinical question, the imaging parameters should 
be varied accordingly. Usually, a common sense approach is all that needed to 
make CT imaging of the spine a relatively simple and highly reliable examination. 
Learning Objectives:
1. To describe state-of-the-art CT protocol for the spine.
2. To become familiar with technical factors (acquisition, reconstruction) and 
parameters for CT examinations of the spine.
3. To recognise artifacts and errors in analysing CT of the spine.
A‑004 17:00 
C. MR protocols for the spine 
J. Hodler; Zurich/CH 
MR imaging of the spine is commonly performed with a number of different indi-
cations. Accordingly, imaging protocols vary. Most protocols include T1- and T2-
weighted spin-echo sequences in the sagittal plane, T2w (often also T1w) images 
in the transverse plane or a plane angled into the disk spaces. Coronal images may 
be obtained for imaging of scoliosis, the atlanto-occipital and the sacral regions. 
Angled sagittal images may assist in the evaluation of the intervertebral foramen in 
the cervical spine. STIR sequences are employed for sensitive detection of radio-
logically occult fractures, screening for metastasis and infection and for grading in 
systemic inflammatory disease. Gradient-echo sequences are most commonly used 
in the cervical spine, often with T2*-weighting, in order to deal with flow artefacts 
and to obtain 3D data sets. Gadolinium-containing contrast is typically indicated 
in infection and neoplasm. Other types of contrast material such as USPIOs are 
not commonly reported but may contribute to the diagnosis in equivocal cases. 
Whole-body MR imaging has become more easily available due to multichannel 
scanners and dedicated software. There is an increasing role for such imaging in 
detection and staging of inflammatory diseases such as ankylosing spondylitis. 
Diffusion-weighted imaging appears to be promising in differentiating neoplastic 
from non-neoplastic fractures. Spectroscopy has rarely been employed for imaging 
of paraspinal muscles and may rather be of scientific interest. 
Learning Objectives:
1. To become familiar with the latest MR techniques in MR imaging of the spine.
2. To implement fast and robust clinical MR protocols for comprehensive 
assessment of the spine.
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16:00 - 17:30 Room C 
Special Focus Session 
SF 2 
Optimal imaging of muscle pathology 
Moderator:
C. Martinoli; Genoa/IT 
A‑005 16:00 
Chairman’s introduction 
C. Martinoli; Genoa/IT (carlo.martinoli@libero.it) 
Muscle imaging is inherently complex and presents unique morphologic challenges 
and continuing integration of dynamic, physiologic and functional capabilities as 
imaging technology progresses. After an overview of the most advanced techniques 
for morphologic and functional imaging of the skeletal muscle, such as whole body 
MR imaging, 23Na MR imaging, metabolite quantification in MR spectroscopy and 
contrast-enhanced ultrasound, this session will be focused on the optimal use of 
modern imaging in a variety of muscle disorders, including sport-related condi-
tions, tumours and non-neoplastic masses, ischemic and inflammatory diseases. 
Speakers will present critical views on the various imaging modalities, to find the 
strengths and the weaknesses of the techniques, and will embrace controversial 
issues regarding the diseases or the technology. In doing so, this session will help to 
understand the appropriate place of modern imaging in the clinical management of 
patients with muscle disease. At the end, a panel discussion will give the occasion 
to draw perspectives and expectations for muscle imaging between morphology 
and function, and to provide an outlook to the future in this field. 
Session Objectives:
1. To provide an overview of the state-of-the-art imaging of muscle pathology.
2. To learn about functional, dynamic, contrast-based and other new techniques 
imaging of muscles.
3. To review the clinically relevant features of muscle imaging.
A‑006 16:03 
Advanced techniques in MRI and functional imaging of muscle, dynamic 
ultrasound and contrast agents 
M.-A. Weber; Heidelberg/DE (MarcAndre.Weber@med.uni‑heidelberg.de) 
Imaging of skeletal muscles has seen considerable advances in recent years 
regarding both morphological as well as functional imaging techniques. Regarding 
morphology, the advent of whole-body MRI has rendered the possibility to screen the 
whole skeletal muscle system for muscles with oedematous changes in suspected 
myositis to which a biopsy should be guided in order to reduce the sampling error. 
Functional MR methods are available that can visualize different aspects of mus-
cular (patho)physiology, such as muscular sodium (Na+) homeostasis using 23Na 
MRI, muscular energy and lipid metabolism using 31P and 1H MR spectroscopy. 31P 
MR spectroscopy also allows for quantification of the myocellular pH value. 23Na 
MRI has demonstrated its usefulness in the diagnostic work-up and management 
of patients with muscular Na+ channelopathies, where a myocellular Na+ overload 
that causes muscle weakness can be quantified. Besides MRI, contrast-enhanced 
ultrasound (CEUS) methods have also been introduced that can quantify muscular 
microcirculation at rest and even during exercise using a second generation contrast 
agent. Using this CEUS method, the influence of different exercise intensities on 
the microcirculation of the exercising muscle becomes detectable. Also, CEUS 
is more efficient in the diagnostic work-up of suspected myositis than classic 
greyscale ultrasonography, because CEUS can detect the inflammatory-induced 
muscular hyperperfusion in acute myositis. It becomes obvious that modern mus-
cular imaging techniques offer deeper insights in muscular (patho)physiology than 
just detecting unspecific myopathic manifestations like oedematous or lipomatous 
changes, hyper- or atrophy. 
Learning Objectives:
1. To learn about recent MRI and US methods for assessing skeletal muscles.
2. To appreciate the abilities of these methods in normal and diseased skeletal 
muscles.
3. To understand the limitations of these methods.
A‑007 16:23 
Sports-related muscle injuries: Temporal changes and when to return to play 
D. Connell; Stanmore/UK (davidconnellrad@gmail.com) 
A thorough understanding of muscle anatomy and basic pathophysiology is es-
sential for imaging interpretation. Muscle fibres (myofibrils) usually tear away from 
connective tissue elements, either the surrounding epimysial fascial covering or 
from the central tendon slip. This may result in a gap or defect within the muscle 
with the formation of oedema and blood fluid products. Recognising muscle injury 
and discriminating central tendon injury from epimysial tears is important. It is also 
important to exclude tendon-bone avulsion from muscle strain. Temporal changes 
following muscle injury follow an orderly pattern and can be observed with both MRI 
and ultrasound. Changes include the resolution of blood fluid products, decrease in 
oedema and the formation of scar tissue. The superior contrast resolution of MRI 
makes it a better modality for detecting the formation of granulation and maturing 
scar tissue. Despite the player becoming rapidly asymptomatic, pathologic changes 
continue for some time. Complications of muscle healing include chronic haematoma 
and myositis ossificans. A weak predictor of return to sporting activity is the amount 
of haematoma. More reliable predictors of return to play include the craniocaudal 
length and cross-sectional area of the muscle tear. Muscles healing involves scar 
formation which in turn limits the ability for the muscle to passively stretch, and 
places additional stress on adjacent muscle fibres predisposing to further injury. 
Risk factors for recurrent injury have been identified and these include a previous 
tear greater than 60 mm in craniocaudal length and a past history of an ACL sprain. 
Learning Objectives:
1. To understand the appearance of muscle injury in US and MR imaging.
2. To provide information on how to assess severity and prognosis.
3. To estimate the time it takes for an athlete to return to play and to modify the 
rehabilitation regimen based on imaging findings.
A‑008 16:43 
Ischemic and inflammatory conditions: What we can see and what is 
important for the clinician 
A. Cotten; Lille/FR (acotten@chru‑lille.fr) 
Inflammatory conditions of muscles are uncommon. These disorders include the 
three main types of chronic, or persistent, inflammatory myopathy: polymyositis, 
dermatomyositis and inclusion body myositis. Myositis can also be found in other 
autoimmune, granulomatous, vasculitic, and systemic disorders. The diagnosis may 
be highly suggested by the clinical and biological features and imaging is therefore 
used for the assessment of the extent and number of lesions, and for determining 
the right site for biopsy. However, the clinical and biological presentation of these 
disorders may be unusual. In these cases, ultrasound and MRI may represent a 
useful complementary diagnostic tool. Other conditions can be associated with 
imaging features that may mimic the appearance of myositis; the usefulness of 
imaging for differentiating these disorders will be presented. Muscle infarction, which 
is a rare complication of diabetes mellitus, will also be described. 
Learning Objectives:
1. To learn about the main ischemic and inflammatory conditions of the 
muscles.
2. To understand the potential and limitations of US and MRI in the assessment 
of such disorders.
3. To consolidate knowledge of the clinically important imaging features.
A‑009 17:03 
Muscle tumors, non-neoplastic masses and mimickers: How to 
differentiate 
K. Wörtler; Munich/DE (woertler@roe.med.tum.de) 
Intramuscular tumors represent a large group of deep soft-tissue masses which 
comprises benign neoplastic and non-neoplastic (tumor-like) lesions as well as 
malignant neoplasms. Lipoma, hemangioma, myositis ossificans, myxoma, and 
intramuscular ganglion represent the most important benign muscle tumors. The dif-
ferential diagnosis of malignant intramuscular masses includes different soft tissue 
sarcomas (myxofibrosarcoma/MFH, fibrosarcoma, liposarcoma, leiomyosarcoma, 
rhabdomyosarcoma, Ewing sarcoma/PNET), metastases, and lymphoma. Hema-
tomas, foreign bodies, parasites, and anatomic variants can mimic intramuscular 
neoplasms. The presentation of patients with a soft-tissue mass is often rather 
unspecific. Clinical features, like sex and history of the patient, previous trauma, 
duration of symptoms, and pain, have not proved to be useful in discrimination of 
benign and malignant lesions. Imaging evaluation is therefore crucial for further 
management. As a general guideline, biopsy should be performed in any mass 
lesion which cannot be specifically diagnosed by imaging. This course reviews the 
Postgraduate Educational Programme
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radiologic appearance of important intramuscular masses with an emphasis on MR 
imaging. Findings which allow for a specific diagnosis will be highlighted on the 
basis of pathologically confirmed cases. 
Learning Objectives:
1. To become familiar with differential diagnosis of intramuscular soft tissue 
masses.
2. To learn about the radiologic approach to the diagnosis of tumors and tumor-
like lesions of muscles.
3. To recognise typical morphologic features of important entities.
4. To understand the importance of biopsy in cases with non-specific imaging 
findings.
Panel discussion:  
An outlook to the future: Muscle imaging between morphology and 
function 17:23 
16:00 - 17:30 Room D 
Imaging in Lung Diseases 
CC 218 
COPD: A disorder of the respiratory and 
cardiovascular systems 
Moderator:
E.E.J.G. Coche; Brussels/BE 
A‑010 16:00 
A. New facets of an old disease 
A.A. Bankier; Boston, MA/US (abankier@bidmc.harvard.edu) 
Chronic Obstructive Pulmonary Disease (COPD) comprises a group of disorders 
whose severity is graded along the decrease of the forced expiratory value in 1 second 
(FEV1), according to the Global Initiative for Obstructive Lung Disease (GOLD) clas-
sification. Although they share this common albeit potentially artificial definition, the 
diseases summarized under the umbrella COPD are heterogeneous in nature, have 
different underlying causes, and require different approaches to diagnosis and therapy. 
This presentation will summarize the historical background of terminology and clas-
sification of COPD. It will further describe the individual diseases and emphasize their 
common and distinguishing factors. The presentation will present imaging algorithms 
for the assessment of both individual diseases and the overall imaging assessment 
of COPD. Finally, the presentation will discuss the importance of phenotyping and 
objective disease quantification in the imaging assessment of COPD. 
Learning Objectives:
1. To learn about evolving comprehension of COPD over the past three 
decades.
2. To understand the lung parenchymal, bronchial, and vascular contributors to 
pathophysiology, imaging and clinical presentation of COPD.
3. To introduce novel integral diagnostic approaches to this complex disease, 
including the imaging contributions to phenotyping patients with COPD.
A‑011 16:30 
B. Morphology and function with CT: Myth or reality? 
M. Rémy-Jardin; Lille/FR (mremy‑jardin@chru‑lille.fr) 
Chronic obstructive pulmonary disease (COPD) is a disease defined by irreversible 
airflow limitation with variable contributions of airway obstruction and parenchymal 
destruction, both accurately evaluated with thin-section volume. The spectrum of 
morphologic and functional evaluation of COPD with CT has recently been enlarged 
to the cardiovascular system, at the level of which specific lesions or functional 
alterations can be depicted, provided that CT examinations have been acquired 
with ECG gating. New options have been recently introduced with dual energy CT 
offering the possibility to generate morphological and functional information from 
the same examination. Because the severity of lung destruction and the distribu-
tion of lung perfusion determine the functional consequences of emphysematous 
changes, great attention has also been directed towards the analysis of lung 
perfusion alterations. As previously achievable with single-source CT, dual energy 
CT can provide thin-collimated high-resolution CT images that can be used to 
detect and characterise emphysema as well as to quantify its severity. From the 
same data set, it is also possible to provide information on the amount of iodine in 
the most peripheral parts of the pulmonary arterial bed, often referred to as «lung 
perfusion imaging», from which it is possible to identify links between the severity 
of parenchymal destruction and the degree of lung perfusion alteration. Moreover, 
dual energy CT can also approach lung ventilation, as recently investigated with the 
inhalation of xenon. The purpose of this lecture is to review the practical approach 
of these combined evaluations in COPD patients, demonstrating the reality of their 
clinical implementations in 2010. 
Learning Objectives:
1. To consolidate knowledge of clinicians’ expectations of functional information 
in the management of respiratory patients.
2. To learn about the most recent technological developments in multidetector-
row CT (MDCT) enabling integration of morphology and function from the 
same examination.
3. To review the practical scanning protocols and the functional parameters that 
can be derived from MDCT examinations.
A‑012 17:00 
C. Functional MRI 
H.-U. Kauczor; Heidelberg/DE (hans‑ulrich.kauczor@med.uni‑heidelberg.de) 
MRI of the lung has significant potential beyond the mere visualization of structure 
by providing comprehensive information about “function”, i.e. ventilation, respiratory 
mechanics, perfusion, and hemodynamics. Regional ventilation can be assessed 
by oxygen-enhanced proton MRI or in a more sophisticated way by the inhalation 
of hyperpolarized noble gases. Oxygen and 129Xe help to assess gas exchange, 
whereas 3He and 129Xe will also address ventilation distribution (“alveolar fill-
ing time”) and pulmonary microstructure. Dynamic proton MRI during tidal and 
forced breathing is well suited to investigate hyperinflation, diaphragmatic and 
rib cage geometry as well as breathing pattern and mechanics. Even paradoxical 
motion and effects of lung volume reduction surgery can be assessed. Dynamic 
contrast-enhanced MR perfusion allows for a high diagnostic accuracy in detecting 
perfusion abnormalities as they occur in COPD due to hypoxic vasoconstriction. 
Delayed, collateral or systemic perfusion can be measured by the “capillary filling 
time”. MR perfusion ratios correlate well with radionuclide perfusion scintigraphy 
ratios and regional analysis can be achieved. Hypoxic vasoconstriction will lead to 
pulmonary hypertension and cor pulmonale. MR-based assessment is important as 
COPD patients with pulmonary hypertension have a poor prognosis and they need 
adequate treatment, including pulmonary vasodilators. MR will identify increased 
right ventricular volumes, decreased right ventricular function, and impaired left 
ventricular diastolic function. The general availability of MRI of the lung for ad-
vanced COPD is envisaged. The clinical impact will grow by increasing options 
for interventional regional treatment. Functional MRI might be complemented by 
structural CT-based phenotyping. 
Learning Objectives:
1. To review the current MRI possibilities in lung functional imaging.
2. To envisage the expected developments and their clinical impact.
3. To describe the complementary roles of MRI and MDCT in providing 
functional information.
16:00 - 17:30 Room E1 
Abdominal and Gastrointestinal 
RC 201 
Gastroesophageal cancer: Is modern imaging 
accurate enough? 
Moderator:
F.‑T. Fork; Malmö/SE 
A‑013 16:00 
A. Role of US, EUS and CEUS 
S. Roberts; Cardiff/UK (Ashley.Roberts@CardiffandVale.wales.nhs.uk) 
The incidence of adenocarcinoma of the oesophagus and gastro-oesophageal 
junction (GOJ) has increased rapidly over the past 20 years, although squamous 
cell carcinoma (SCC) remains the commonest worldwide. Imaging has a major role 
in pre-treatment staging. We perform MDCT primarily to exclude distant metastases, 
then local staging with endoscopic ultrasound (EUS) and PET/CT to further exclude 
metastatic disease. This lecture will mainly focus on EUS with some discussion of the 
role of transcutaneous (US) and contrast enhanced ultrasound (CEUS). T1 -invades 
lamina propria/submucosa; T2 -invades muscularis propria (MP); T3-through MP; T4 
-invades adjacent structures; N0/N1-loco-regional lymph nodes; M1a-distant lymph 
node metastases; M1b-distant metastases; GOJ tumours-Siewert I/II/III (Siewert 








A S9CB D E F G
stenoses. At 5-12 MHz, the five-layered gut wall correlates well with histology. The 
4th (hypoechoic) layer represents MP, and tumour relationship to this provides a 
pre-operative T stage. Malignant nodes are defined by size, structure, margins and 
shape. EUS FNA improves specificity. Surgery has no impact on survival in EUS-
defined T4 disease. Patients who have non-curative surgery have poor quality of 
life. EUS assists radiotherapy and surgical planning. US: Neck US ± FNA can be 
used in SCC. CT PET has diminished this practice, but FNA can confirm malig-
nancy. CEUS: Occasional problem solver for equivocal liver lesions. CE EUS has 
been disappointing. Conclusion: Despite improvements in MDCT, MRI and PET/
CT, EUS with EUS FNA retains a pivotal role in the management of oesophageal 
and gastrooesophageal cancer. 
Learning Objectives:
1. To review the imaging modalities used in the staging of esophageal and 
esophagogastric junction cancer.
2. To discuss pragmatic staging algorithms according to the availability of these 
modalities.
3. To explore the importance of imaging in planning the delivery of treatment.
A‑014 16:30 
B. Role of CT and MRI 
E.J. Rummeny; Munich/DE (rummeny@roe.med.tu‑muenchen.de) 
In general, both multidetector row computed tomography (MDCT) and MR-imaging 
(MRI) may be used for detection and staging of gastroesophageal cancer. However, 
since MDCT is faster and easier to perform it is still the preferred cross-sectional 
imaging technique. During this course, we will discuss the techniques used for 
MDCT and MRI to image patients with suspected cancer of the esophagus and/
or the stomach. We will show how MDCT combined with air and water distension 
improves the capability of local preoperative staging and we will also review data 
for T- and N- staging. New techniques like MPRs may improve accuracy of staging 
even further as compared to transverse images. Furthermore, it can be shown that 
MDCT and MRI provide additional information on tumor depth and extragastric 
tumor spread. It will also be demonstrated how these techniques may be used for 
response evaluation after chemotherapy and radio-chemotherapy. As we could 
show in the literature, volumetry based on MDCT data can help to predict early 
response to treatment 2 weeks after the initiation of neoadjuvant chemotherapy 
in patients with esophageal cancer, while the classic approach of tumor diameter 
measurement shows no correlation with histopathological tumor regression. In 
general, we will discuss if MDCT and /or MRI can be used as primary tools for pre- 
and postoperative staging and follow-up in patients with gastroesophageal cancer. 
Learning Objectives:
1. To describe how CT and MRI should be performed if esophageal and 
esophagogastric junction cancer is suspected.
2. To discuss the accuracy of these imaging modalities for staging.
3. To compare the use of CT and MRI in response evaluation after 
chemotherapy and radiation with other imaging modalities.
A‑015 17:00  
C. Role of PET/CT 
W.L. Wong; Northwood/UK (wailup.wong@stricklandscanner.org.uk) 
Drawing from a survey of the literature, the established role of FDG PET/CT in 
the assessment of patients with gastroeosphageal cancer will be considered. The 
FDG PET/CT appearance of gastroesophageal cancer will be illustrated and the 
strengths and limitations of FDG PET/CT for the evaluation of gastroeosophageal 
cancer will be highlighted. 
Learning Objectives:
1. To demonstrate the typical imaging findings of PET/CT in GOJ cancer.
2. To discuss the accuracy of PET/CT in imaging GOJ cancer.
3. To describe the role of PET/CT in the management of GOJ cancer.
16:00 - 17:30 Room E2 
Interactive Teaching Session 
E³ 220a 
Imaging in common clinical problems: Hematuria 
Moderator:
W. Szmigielski; Doha/QA 
A‑016 16:00 
Imaging in common clinical problems: Hematuria 
J.J. Fütterer1, R.H. Oyen2; 1Nijmegen/NL, 2Leuven/BE (j.futterer@rad.umcn.nl) 
At present, once it is established that haematuria is of non-glomerular origin, the imag-
ing modality of choice for imaging is Multi Detector-row Computerised Tomographic 
Urography (MDCTU). MDCTU has replaced Intravenous Urography (IVU). IVU has a 
limited role only (in young patients< 40 y - with hematuria) as has ultrasonography in 
investigating haematuria because of obvious limitations. MDCTU provides superior 
information on the renal parenchyma of the entire urinary tract in a single examination. 
Although MDCTU offers a unique tool for the investigation of haematuria, optimizing its 
role is still under investigation, particularly as there are several variations of examination 
techniques. These include combinations of phasic acquisitions (ranging from single to 
multiple, as well as low radiation dose and higher dose techniques) and various other 
supportive protocols: compression vs. no compression, saline infusion, administration 
of diuretics, supine and prone acquisitions, timing of acquisitions after intravenous 
contrast administration and split bolus techniques. In addition, postprocessing algo-
rhythms (including the use of maximum and average intensity projection, as well as 
3D-volume-rendered reconstructions), the methods used in analyzing the large number 
of images, and the radiation dose at the time of examination, all contribute to the final 
acceptance of this technique by radiologists, urologists and nephrologists. It is most 
likely that the technique will be more refined and adjusted to the patient and suspected 
underlying disease process (i.e. tailored MDCTU). Thus, the diagnostic accuracy will 
improve at a reasonable patient dose. 
Learning Objectives:
1. To learn about the indications for CTU.
2. To understand the role of CTU in hematuria.
3. To appreciate the decreasing role of IVU.
4. To become familiar with CTU in routine clinical practice.
16:00 - 17:30 Room F1 
Interactive Teaching Session 
E³ 220b 
Commonly missed diagnosis in musculoskeletal 
conditions 
Moderator:
H. Imhof; Vienna/AT 
A‑017 16:00 
Commonly missed diagnosis in musculoskeletal conditions 
F. Kainberger1, K. Bohndorf2; 1Vienna/AT, 2Augsburg/DE 
(franz.kainberger@meduniwien.ac.at) 
Many structures of the musculoskeletal system are prone to overuse and degen-
eration. Thus, stress-related injuries may mask the clinical appearance of many 
other entities. Indications for imaging: documentation of the patient’s history and 
the knowledge of certain laboratory findings are of enormous help to differentiate 
overuse syndromes and arthritis from tumors, infections, vascular diseases, or 
others. Investigation: with standardized imaging protocols all relevant anatomic 
areas have to be included for documenting the effects of biomechanical stress, the 
symmetric manifestation of arthritis, the spread of tumors and infection, or trauma. 
Interpretation: the anatomic distribution of traumatic and stress-related injuries is 
influenced by “kinetic chains”. Bone marrow or soft tissue edema and many other 
imaging findings act as footprint patterns for the differential diagnosis. Likewise in 
inflammatory disorders, the distribution pattern is often characteristic for common 
and uncommon forms of rheumatic diseases or of infections. In tumors, the structure 
(“matrix”) and their borders are important features. Conclusion: a standardized 
diagnostic process bases on the analysis of distinct clinical and anatomic patterns. 
It also includes the recognition of patterns of misinterpretation. 
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Learning Objectives:
1. To learn about the differential diagnosis between stress injuries, 
inflammatory processes, necrosis and tumors.
2. To recognise the importance of insufficient consideration of clinical 
information and symptoms in the interpretation of imaging studies.
3. To recognise the consequences of uncritical imaging requests.
4. To stress the importance of a systematic approach to the interpretation of 
imaging, particularly radiographs.





G. Rizzatto; Gorizia/IT 
A‑018 16:00 
A. Ultrasound and BI-RADS 
H.M. Zonderland; Amsterdam/NL (h.m.zonderland@hccnet.nl) 
The BI-RADS lexicon for Ultrasound (US) dates from 2003. Adherence to its descrip-
tors improves specificity. The descriptors shape, margin, boundary and surround-
ing tissue are most important, but also challenging, sometimes with considerable 
observer variability. The identification of boundary and surrounding tissue effects 
is the result of the soft tissue resolution properties of US, in which it is superior to 
mammography. The effects of a mass on its surroundings such as an echogenic 
halo, obliteration of the tissue planes and thickening of Cooper’s ligaments have a 
high predictive value of malignancy and can avoid false negative results in otherwise 
round, oval or well-defined masses. Recent studies suggest that when a lesion 
is palpable and the US descriptors suggests BI-RADS 3 (probably benign), the 
likelihood is that it is benign and that the lesion may be managed without biopsy, 
similarly to non-palpable BI-RADS 3 lesions. The recommendation of follow-up 
by imaging alone is considered a laudable but difficult goal for many radiologists. 
Others suggest a negative psychological impact for the patient and prefer biopsy. 
Also, the guidance role of the multidisciplinary team cannot be denied. Therefore, 
some choice in recommendations should be acceptable, provided that it is properly 
worded in the report. The use of BI-RADS based-CAD for US is still in its infancy. 
It is a lesion analysis tool rather than a detection tool. Studies show mixed results, 
but even the most experienced reader seems to benefit on occasion from having 
CAD input during the image interpretation process. 
Learning Objectives:
1. To learn how to use BI-RADS lexicon in US.
2. To review the most important pathologic signs.
3. To evaluate the latest advances in US.
A‑019 16:30 
B. The role of ultrasound in premalignant and benign lesions 
I. Leconte; Brussels/BE (Isabelle.Leconte@rdgn.ucl.ac.be) 
Benign lesions can be divided into cystic and solid lesions. Simple cysts, complicated 
cysts are classified Bi-Rads 2. It has been reported that clustered microcysts in 
premenopausal women without any solid component can also be classified Bi-Rads 
2. Benign solid or indeterminate nodules may have specific US findings such as pure 
hyperechogenicity, parallel shape, well-defined margins, and few gentle lobulations. 
However, the predictive negative value of certain findings is less than 98%. The 
association of several findings is necessary as well as the absence of malignant 
finding. Specific benign diagnosis will be reviewed. Frequent premalignant lesions 
include atypical ductal hyperplasia (ADH), lobular carcinoma in situ (LCIs), radial 
scar and papilloma. ADH and LCis are incidental findings; so, their US features 
depend of the underlying lesion. Radial scars contain at least one suspicious 
finding and are classified at least Bi-Rads 4a. Specific premalignant diagnosis will 
be reviewed. To increase US specificity, it is necessary to improve US technique 
by following US guidelines published by ACR. Other technical artifices, like focal 
compression, are useful. The characterization of the lesions is also improved by 
the appropriate use of the compound imaging, tissue harmonic imaging and Color 
Doppler. Elastography seems really promising to reduce the false-positive rate, 
particularly in case of complicated cyts. Finally, care must be taken to correlate 
US findings with mammographic and physical examination findings. Furthermore, 
the final management of the lesion depends on the context, the personal history 
and the anteriority, when available. 
Learning Objectives:
1. To describe the US features.
2. To differentiate between malignant, premalignant and benign lesions on US.
3. To learn how to avoid unnecessary biopsies.
A‑020 17:00 
C. Axillary tail and US 
E.E. Deurloo; Amsterdam/NL (e.e.deurloo@amc.uva.nl) 
Axillary lymph node status is strongly correlated with prognosis in breast cancer 
patients: patients without axillary lymph node metastases have a significant better 
prognosis than patients with axillary lymph node metastases. Nowadays, breast 
cancer patients with a clinically-negative axilla undergo a sentinel lymph node 
biopsy (SLNB) to sample the axillary lymph nodes. Ultrasonography of the axilla 
can be used to detect lymph node metastases prior to surgery in patients with a 
clinically-negative axilla, thereby reducing the number of (time-consuming and 
expensive) SLNBs. In ultrasonography of the axilla, the region that is examined is 
very important: the sentinel node is often located in the lower part of the axilla and 
can be found as low as the level of the nipple. A high frequency probe is required 
and ultrasonography should be combined with fine-needle aspiration (FNA). Charac-
teristics of nodes that might differentiate between benign and malignant are: aspect 
of hilus and cortex, and with less accuracy size or shape. A more reproducible 
characteristic that can be used is cortex thickness. If a cortex thickness of e.g., 
2.3 mm is used as cut-off point to perform FNA, a sensitivity of FNA of 95% can be 
obtained with a specificity of 44%, meaning that most of the ultrasonographically 
visible malignant nodes will be detected, and FNA will be performed in about 25% 
of all patients. Conclusion: Cortex thickness can be used to reduce the number of 
FNAs on benign nodes, while remaining a high sensitivity. 
Learning Objectives:
1. To differentiate between normal and abnormal lymph nodes.
2. To give criteria for abnormal lymph nodes.
3. To describe the best biopsy technique.





M.I. Argyropoulou; Ioannina/GR 
A‑021 16:00 
A. Basic techniques and pattern recognition 
P.M. Parizel; Antwerp/BE (paul.parizel@uza.be) 
Diagnostic neuro-imaging procedures play an essential part in the diagnosis, 
management, treatment and follow-up of patients with lesions of the central 
nervous system (CNS). The purpose of this presentation is to review basic imag-
ing techniques and to illustrate how pattern analysis contributes to the correct 
(differential) diagnosis for CNS lesions. The first step is to identify and outline the 
lesion and to establish its exact topography (anatomical location, intra/extra-axial, 
supra/infra-tentorial). Changes in tissue density (CT) and signal intensity (MRI) 
can provide clues to the histological nature (e.g. fat, fluid, gas, blood, etc). Central 
necrosis and perilesional vasogenic edema are markers of aggressive behavior 
of lesions. Contrast agents can be used to assess lesion vascularity or to detect 
blood-brain-barrier breakdown. Perfusion-weighted imaging provides information 
regarding the microvasculature (angiogenesis) of tissues and tumors, as well capil-
lary permeability. Diffusion-weighted imaging, including diffusion tensor imaging 
and tractrography, provides information about the ultra-structural organisation of 
tissues and lesions at a cellular level. Magnetic resonance spectroscopy yields an 
insight into the biochemical composition of lesions and can be used in diagnosis 
and post-treatment follow-up. At the end of the lecture, we shall provide examples 
of typical disease patterns in CNS diseases, many of which can be associated with 
specific symbols. In summary, thanks to improvements in equipment, both hardware 
and software, a comprehensive multimodal neuro-imaging protocol provides not 
only anatomical images, but also gives information regarding tissue characteristics 
and contributes to the detection and biological characterization of CNS lesions. 
Learning Objectives:
1. To present a comprehensive overview of basic MRI techniques in the 
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2. To illustrate how to correlate MRI signal intensity changes with biochemical 
and pathological findings.
3. To demonstrate how to use anatomic location in CNS lesion characterisation 
(intra vs extra-axial, supra- vs infratentorial).
4. To show how to use an analytic pattern recognition approach for differential 
diagnosis of CNS lesions.
A‑022 16:30 
B. New MR sequences in daily practice 
R. Gasparotti; Brescia/IT (gasparo@med.unibs.it) 
MR imaging of the brain and spine is experiencing continuous progress in the 
development of new sequences, which have significantly improved the diagnostic 
approach in several diseases in daily practice. Demonstration of hemosiderin has 
relied for a long time on T2* gradient echo images, which were characterized by 
low spatial and contrast resolution. Susceptibility-weighted imaging (SWI) is a 
new neuroimaging technique, based on high-spatial resolution 3D gradient-echo 
sequences with phase postprocessing, which uses tissue magnetic susceptibility 
differences to generate a unique contrast, different from that of T1, T2, and T2*. 
Due to its sensitivity in the detection of intravascular venous deoxygenated blood 
as well as extravascular blood products, 3D SWI has been successfully applied to 
stroke, head trauma, vascular malformations, cerebrovascular and neurodegenera-
tive disorders. Diffusion tensor imaging (DTI) has become a research tool in almost 
any field of neurosciences. In daily practice, DTI can be applied to study brain and 
spinal cord tumors and cavernous malformations, where a thorough display of white 
matter fibers is crucial for surgical planning. Conventional MR imaging has not been 
an effective method for imaging the brachial plexus, due to its complex anatomy 
and low contrast resolution between nerves and muscles. A new MR neurography 
technique has been recently developed, consisting of 3D T2 turbo-spin-echo (TSE) 
sequences with short-term inversion recovery (STIR) and variable flip angle RF 
excitations (SPACE), with isotropic voxels, which allow multiplanar reconstructions 
along roots, trunks and cords. Clinical applications are represented by traumatic 
and immune brachial plexopathies, thoracic outlet syndrome. 
Learning Objectives:
1. To become familiar with the new MR sequences for the investigation of brain 
and spine lesions.
2. To learn the essential features of the new MR sequences.
3. To illustrate specific indications for the new MR sequences in brain and spine 
imaging.
4. To discuss the impact of the new MR sequences on the clinical diagnosis.
A‑023 17:00 
C. Diffusion tensor imaging: Basic tool for radiologists? 
S. Lehéricy; Paris/FR (stephane.lehericy@psl.aphp.fr) 
Diffusion-weighted imaging (DWI) is sensitive to the random motion of water 
molecules in the brain. Measures of water diffusivity from DWI provide estimates 
of the microstructural integrity of the brain parenchyma. Diffusion tensor imaging 
(DTI) can also detect the directionality of molecular diffusion in the white matter. The 
directionality dependence of diffusion is called anisotropy and is measured using 
indices such as fractional anisotropy. In the white matter, diffusivity predominates 
along the direction of fiber bundles. By following the main direction of diffusion along 
the tracts, tractography allows the reconstruction of fiber bundles in humans in vivo. 
DTI has several applications in brain pathology, such as preoperative localization 
of fiber bundles, the evaluation of brain damage in patients with traumatic brain 
injury, and the detection of pathology in specific white matter fiber bundles. In this 
presentation, the basics of diffusion tensor imaging and fibre tracking and the main 
clinical applications of DTI in radiological practice will be presented as well as a 
practical guide on how to reconstruct major fibre bundles in the brain. 
Learning Objectives:
1. To understand the basics of diffusion tensor imaging and fibre tracking.
2. To know the main clinical applications of DTI in radiological practice.
3. To learn how to reconstruct major fibre bundles in the brain.
16:00 - 17:30 Room I 
Vascular 
RC 215 
Diseases of the visceral arteries 
Moderator:
M.I. Furmanek; Warsaw/PL 
A‑024 16:00 
A. Renal vascular disease 
D. Vorwerk; Ingolstadt/DE (dierk.vorwerk@klinikum‑ingolstadt.de) 
Renal angioplasty meanwhile has developed into a standardized technique using 
primary stenting in ostial lesions and angioplasty and or stenting in distal lesions. 
Miniaturization of instruments allows a less traumatic single side approach as well 
as transbrachial or transradial access depending on the renal arterial anatomy. 
Technical success is high and acute complications relatively low. However, problems 
of cholesterol embolization following PTRA are still poorly understood. Patients 
with fibromuscular dysplasia usually benefit from renal angioplasty concerning 
their blood pressure. Patients with atherosclerotic disease are not benefitting in the 
same amount, some also will show deteriorated renal function. Actually, discussion 
is running high whether both patients with hypertension and/ or renal insufficiency 
may undergo renal angioplasty as larger randomized studies did not show major 
improvements compared to medication alone. Shortcomings of studies as well as 
intrinsic problems on looking on patients with renal artery disease will be discussed. 
Learning Objectives:
1. To review the different causes of renal artery stenosis.
2. To discuss the role of Doppler US, CTA and MRA in diagnosis of renal artery 
stenosis.
3. To become familiar with optimised treatment planning and treatment selection.
A‑025 16:30 
B. Acute and chronic mesenteric ischemia 
R. Uberoi; Oxford/UK (raman.uberoi@orh.nhs.uk) 
Rapid and accurate diagnosis is vital in mesenteric ischemia and imaging has a major 
to play. Although, angiography remains the gold standard with the advantage that 
it also permits possible therapeutic intervention, include administering intra-arterial 
vasodilators and/or thrombolytic agents and angioplasty with or without stent place-
ment. Imaging has evolved to using non-invasive techniques. Duplex of mesenteric 
arteries was developed in the late 1980s. Its primary application is to identify high-
grade stenoses in mesenteric vessels. A peak systolic velocity of > 275 cm/s in the 
SMA identifies a > 70% SMA stenosis with a sensitivity of 92%, a positive predictive 
value of 80% and a negative predictive value of 99%. CTA and contrast-enhanced 
MRA are excellent non-invasive screening techniques for patients suspected of having 
mesenteric ischemia. CTA has higher spatial resolution and faster acquisition times, 
allowing assessment of the peripheral visceral branches and the inferior mesenteric 
artery with greater accuracy than contrast-enhanced MRA. In addition, in acute 
ischemia CTA is more widely available with good accuracy for the findings of acute 
ischemia including bowel wall thickening, portal venous gas, intramural pneumatosis, 
engorgement of mesenteric veins, loss or increase of bowel wall enhancement, 
and infarction of other abdominal organs. A sensitivity of 93%, specificity of 100%, 
and positive and negative predictive values of 100 and 94%, respectively, can be 
achieved for these CT findings. However, the lack of radiation and iodinated contrast 
agents make MRA the technique of choice for children and patients with azotemia. 
Learning Objectives:
1. To describe the clinical manifestations of acute and chronic mesenteric 
ischemia.
2. To discuss the role of different imaging modalities in diagnosis of acute and 
chronic mesenteric ischemia.
3. To demonstrate potential artifacts and pitfalls in non-invasive diagnosis of 
mesenteric ischemia.
A‑026 17:00 
C. Imaging before and after liver transplantation 
T. Schroeder; Essen/DE (Tobias.Schroeder@uni‑due.de) 
Background: Orthotopic and living donor liver transplantation (OLT, LDLT) are 
routinely used procedures in the treatment of irreversible end-stage liver disease. 
Preoperative imaging is important for exclusion of transplantation contraindications 
in the recipient, assessment of the operation anatomy in living liver donors, and to 
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avoid donor-recipient mismatch. In particular, accurate preoperative knowledge of 
hepatic vascular anatomical variants contributes to reduce the incidence of com-
plications during and following transplantation. The main purpose of postoperative 
imaging is the early detection and characterization of operation complications.
Procedure Details: Earlier pre-harvest evaluation protocols included ultrasound, 
computed tomography (CT) or magnetic resonance imaging (MRI) for assessment 
of parenchymal lesions, tumor staging and liver planimetry, catheter angiography 
(DSA) for the display of the hepatic vascular system, ERCP for assessing the biliary 
anatomy and liver biopsy for the assessment of hepatic-cellular infiltration. To simplify 
and shorten such procedures to a minimum, comprehensive “all-in-one” MRI - and 
Multidetector-CT (MDCT) - protocols have been advocated. Both approaches combine 
the advantage of minimal invasiveness with simultaneous assessment of the hepatic 
parenchymal morphology and a detailed analysis of the biliary and vascular anatomy.
Conclusion: The most versatile imaging modality both for the preoperative evalua-
tion process and the postoperative diagnosis of complications is MDCT. Its specific 
advantages lie in a wide availability and the possibility to evaluate all relevant ana-
tomical components with high reliability within a single diagnostic step. If needed, it 
also offers the possibility of direct CT-guided intervention (e.g., abscess drainage). 
Learning Objectives:
1. To learn about the importance of visualisation of hepatic vasculature prior to 
liver transplantation.
2. To become familiar with anatomical variants of the hepatic vasculature.
3. To become familiar with typical and pathological findings after liver 
transplantation.
4. To learn about the treatment strategies before and after liver transplantation.





A. Abildgaard; Oslo/NO 
A‑027 16:00 
A. Exchange of imaging data with portable media (CD, DVD, USB) 
N.H. Strickland; London/UK 
Exchange of imaging data can be achieved with portable media, but is highly unsatisfac-
tory because it is unreliable, cumbersome and slow. Imaging studies today are mostly 
very large and should include an associated report as well as the images. Unless the 
images are in DICOM format, they cannot be adequately manipulated. A self-launching 
DICOM viewer must be included on the portable media for the average recipient 
(with limited IT skills) to be able to view the images easily on an unsophisticated PC. 
Scrolling through > 1000 images in a single study on portable media via a PC-based 
DICOM viewer is aggravatingly slow. Uploading imaging data from portable media to 
the host PACS and RIS is often fraught with difficulty, and is a labour-intensive manual 
process. Lack of adherence to universal standards for portable media leads to frequent 
incompatibility problems between the host PACS and RIS and the portable media. 
In countries such as England, government-imposed information governance rules 
enforce encryption of imaging studies (for more than four patients) on portable media. 
The encryption and decryption processes, and the human errors often involved, for 
example the loss of passwords or codes, further complicates the use of such portable 
media, and introduces significant clinical risk. The many technical and human problems 
associated with using portable media to exchange imaging data relegate them to use 
as a last resort, best tolerated only for the exchange of low volumes of non-urgent 
data when no more automated direct exchange mechanism is available or feasible. 
Learning Objectives:
1. To learn what are good portable media and how to create them within a PACS.
2. To know about workflow requirements integrating portable media in PACS 
(IHE PDI and IRWF).
3. To implement quality improvement concepts.
A‑028 16:30 
B. Images crossing borders: What about administration and law? 
H.K. Pohjonen; Espoo/FI (hanna.pohjonen@rosalieco.fi) 
eHealth community aims at creating a secure platform for the provision and consumption 
of clinical eServices by developing a new working environment for professionals and 
teams, a shared workspace for cross-border consultations and access to individual 
images and patient records. In this lecture, practical examples of cross-border work-
flow are shown. The cross-border availability and use of professionals as well as the 
possible technical, legal, organizational, semantic and quality assurance issues are 
discussed. Special attention is paid to emerging eMarket places for imaging: customers 
and providers for teleradiology meet via one connection node making the teleradiol-
ogy more controlled and accessible. With one integration to the central platform, the 
whole market with several choices is opened up. The new generation cross-border 
team working reduces waiting times and gives access to a wide professional pool for 
consultations and second opinions increasing the quality of service. It also increases 
radiological effectiveness and gives financial savings. As an example, reporting of an 
extended MRI examination can be even five times less expensive. Cross-border eTeams 
can offer an efficient way to share resources by identifying the need and extra capacity 
for reporting and consultations. Clarifications regarding legal and financial matters and 
EU-level harmonization across different legal environments are still needed in order to 
boost cross-border teleradiology and maintaining the quality of the service. Linguistic 
issues are partly unsolved as well. 
Learning Objectives:
1. To learn about European regulations in telemedicine.
2. To learn concepts for improvement of services for patients.
3. To be able to integrate quality assurance in teleradiology.
4. To be aware of administrative and workflow aspects.
A‑029 17:00 
C. Image compression: Acceptable? Unacceptable? Any decision yet? 
E. Kotter; Freiburg/DE (elmar.kotter@uniklinik‑freiburg.de) 
During the past years, many clinical studies concerning radiological image data 
compression have been published. They all show that loss image compression can 
be used in radiology without loss of relevant image information. They disagree about 
the compression ration that can be used safely. It medical purposes, it should be 
distinguished between the technical loss of information (i.e. irreversible compression 
from a technical viewpoint) and the loss of medical relevant information. In some 
countries (Canady, Germany and UK), official recommendations concerning image 
compression in radiology have been published. These recommendations will be 
presented and compared. We will discuss practical aspects about consequences 
of different implementation models of image compression. 
Learning Objectives:
1. To know that technical and medical lossy compression are different and why.
2. To learn about experiences in clinical studies with compression.
3. To know about legal aspects in different countries.
4. To implement a medical based decision model using lossy compression.
16:00 - 17:30 Room L/M 
Multidisciplinary Sessions: Managing Patients with Cancer 
MS 221 
Carcinoma of the uterus and cervix 
A‑030 16:00 
Chairman’s introduction 
R.H. Reznek; London/UK (r.h.reznek@qmul.ac.uk) 
Imaging has become pivotal in all aspects of the management of patients with can-
cer. At the same time, it is acknowledged that optimal patient care is best achieved 
by a multidisciplinary team approach. The explosion of technological developments 
in imaging over the past years has meant that all members of the multidisciplinary 
team should understand the potential applications, limitations and advantages of 
all the evolving and exciting imaging techniques. Equally, to understand the signifi-
cance of the imaging findings and to contribute actively to management decisions 
and to the development of new clinical applications for imaging, it is critical that 
the radiologist should have sufficient background knowledge of different tumours. 
Thus, the radiologist should understand the pathology, the clinical background, 
the therapeutic options and prognostic indicators of malignancy. This session will 
address these principles in carcinoma of the uterus and cervix. 
Learning Objectives:
1. To become familiar with the factors that influence the decision to operate 
and the nature of the procedure in patients with carcinoma of the uterus and 
cervix.
2. To appreciate the information required from imaging by the oncologist in 
planning radio and chemotherapy.
3. To understand how the imaging has to be optimised and interpreted in order 
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A‑031 16:05 
What the surgeon needs to know 
C. Pomel; Clermont‑Ferrand/FR (christophe.pomel@cjp.fr) 
The treatment of cervical cancer depends on the tumoral volume. Tumors of less 
than 4 cm (FIGO stage 1 b1) are usually treated by surgery alone or followed by 
adjuvant radiotherapy. Tumors superior to 4 cm are actually treated by an association 
of radio-chemotherapy. A conservative treatment can be proposed to women with 
small cervical carcinoma wishing to preserve fertility. MRI allows measuring the 
endocervical extents of the tumor. The clinical examination can correctly predict the 
invasion of parametria. This is well correlated with MRI imaging. The lymph node 
assessment is as crucial. It represents a major prognosis indicator. This assess-
ment has its greater interest in patients with advanced cervical cancer, in whom 
no lymph node assessment will be done. The management of endometrial cancer 
is pending on the infiltration of the myometrium. Stage Ia, Ib grade 1 and 2, there 
is no need for a lymphadenectomy. For all other stages, the lymphadenectomy is 
mandatory. Patients with pelvic recurrence of cervical or endometrial cancer with no 
evidence of metastatic disease may be eligible for pelvic exenteration. As the patient 
presents a clinical suspicious of pelvic relapse, MRI is the ideal tool to diagnose, 
measure the extent and afterwards planify a surgical treatment. The invasion of 
the sciatic fossa as well of the external iliac vessells constitutes in our institution a 
major contra indication for surgery. On the other hand, patients with infiltration of 
the ureter, or the internal iliac vessels may be eligible for surgery. 
Learning Objectives:
1. To learn the factors that are considered in deciding whether or not to treat 
patients surgically in carcinoma of the cervix.
2. To understand what considerations are taken into account in deciding 
whether fertility-sparing surgery is feasible in patients with carcinoma of the 
cervix or endometrium.
3. To appreciate how the decision is made as to whether or not a 
lymphadenectomy is performed in patients with carcinoma of the cervix.
4. To become familiar with the criteria for surgical intervention in patients with 
recurrent endometrial or cervical cancer.
A‑032 16:25 
What the clinical oncologist needs to know 
P.R. Blake; London/UK (peter.blake@rmh.nhs.uk) 
In chemoradiation of cervical cancer, staging is vital to determine the correct treat-
ment protocol and radiotherapy volume. Imaging is now the mainstay of staging, 
rather than invasive investigations, and I will discuss this in terms of both direct 
invasion of tissues and metastasis. The radiotherapy planning process in the UK 
is usually done by clinical oncologists (radiation oncologists who also supervise 
chemotherapy). This has become much more sophisticated and time-consuming 
than was the case with conventional planning using orthogonal films. As a conse-
quence, there are moves towards other groups of staff being used to define normal 
tissue volumes with only tumour volumes being defined by the clinical oncologist, 
with or without radiologists’ help. Using multiple staff groups will require training 
and, possibly, audit by radiologists experienced in cervical cancer imaging. I will 
explain what is meant by gross tumour volume (GTV), clinical tumour volume (CTV) 
and planning tumour volume (PTV) in radiotherapy planning. With image-guided 
brachytherapy (IGBT), these same principles are being applied to the planning 
of brachytherapy. In the UK this is largely by specialist clinical oncologists, but in 
Europe this is often by radiologists. If the clinical oncologists are to do this, then 
they need appropriate training, subspecialisation and continued experience in 
order to maintain their skills. Follow-up is often devolved to local hospitals that are 
not cancer centres. The radiologists there need to be able to distinguish between 
post-radiotherapy effects and recurrent disease. 
Learning Objectives:
1. To understand the basic principles of tumor staging in carcinoma of the 
cervix and uterus.
2. To learn the meaning of the terms GTV, CTV, PTV, treatment volume and 
organs at risk.
3. To appreciate how electronic portal imaging, cone-beam imaging and image-
guided radiotherapy can be used to assure the quality of treatment delivered 
to the patient.
4. To understand the importance and the protocols for the follow-up of patients 
with carcinoma of the cervix and uterus.
A‑033 16:40 
Imaging in carcinoma of the uterus and cervix 
R.H. Reznek; London/UK (r.h.reznek@qmul.ac.uk) 
The purpose of imaging in endometrial cancer is to identify myometrial and cervi-
cal invasion and extra-uterine disease to allow preoperative surgical planning in 
patients who often suffer serious co-morbidity. Overwhelming evidence exists that 
magnetic resonance imaging (MRI) is the imaging technique of choice to provide 
this information. Nevertheless, several pitfalls exist in interpretation of MRI and 
technique is crucial. In cervical cancer, imaging is used to provide answers to several 
clinical questions including detection of parametrial invasion, accurate assessment 
of tumour volume, its proximal extension, early detection of recurrence and nodal 
disease. While computed tomography will accurately detect parametrial invasion, 
MRI has an established role in local staging. By assessing proximal extension of 
tumours in young women, MRI will determine the feasibility of fertility-preserving 
surgery. By accurately showing the volume of tumour, it is used to plan and ad-
minister conformal radiotherapy and for depiction of nodal disease in both cancers. 
For endometrial and cervical cancer, MRI is used for surveillance, detection of 
recurrence and evaluation of complications secondary to treatment. 
Learning Objectives:
1. To understand how imaging is used to decide between surgery and 
chemoradiation in patients with cervical cancer.
2. To learn how imaging is used to decide whether uterus-conserving surgery is 
feasible in early stage cervical cancer.
3. To understand how imaging is used to plan conformal radiotherapy in 
cervical cancer.
4. To understand how imaging is used to determine the most appropriate 
surgical technique in patients with endometrial cancer.
5. To appreciate the pitfalls in the use of imaging to stage patients with 
endometrial and cervical cancer.
Panel discussion and case presentation 17:10 
16:00 - 17:30 Room N/O 




K. Hrabak; Budapest/HU 
A‑034 16:00 
A. Anatomical survival kit 
E. Steiner; St. Pölten/AT (erich.steiner@aon.at) 
Understanding anatomy is the basis for the interpretation of any imaging study. This 
anatomical survival kit aims to provide the anatomical principles of the skull base 
as a foundation for the evaluation of CT and MR imaging studies. On specimen 
photographs and schematic drawings views of the complete skull base from above 
and below are shown. The anatomy of the osseous components such as the frontal, 
ethmoid, sphenoid, temporal and occipital bone is discussed. The topographic 
relationship of the anterior, middle and posterior cranial fossa to the adjacent ex-
tracranial spaces such as the nasal cavity, paranasal sinuses, orbit, pterygopalatine 
fossa, middle ear, infracranial spaces and spinal canal is shown. The foramina and 
the fissures of the skull base including the cribriform plate, optic canal, superior 
orbital fissure, foramen rotundum, ovale and spinosum, foramen lacerum, Vidian 
canal, carotid canal, internal auditory canal, jugular foramen, stylomastoid foramen, 
hypoglossal canal, and foramen magnum are discussed together with the passing 
cranial nerves and vessel. Their significance as pathways for spread of disease 
is emphasized. Special attention is paid to the cavernous sinus and its content. In 
addition, anatomical structures are reviewed on multiplanar CT and MR images. 
Learning Objectives:
1. To review the anatomy of the skull base.
2. To identify normal anatomical structures on CT and MRI studies of the skull 
base.
3. To understand anatomical fundamentals of the spread of disease.
Postgraduate Educational Programme
S14 A B C D E F G
A‑035 16:30 
B. Cranial nerves in cancer imaging 
J.W. Casselman; Bruges/BE (jan.casselman@azbrugge.be) 
Detection of nerve involvement by a head and neck tumor causes a dramatical 
increase in tumor staging (T4). Adenoid cystic carcinoma arising from salivary 
glands, squamous cell carcinoma, basal cell carcinoma, melanoma, lymphoma 
and sarcoma are frequently associated with perineural tumor spread (PNS). This 
PNS can occur in the absence of clinical signs; hence, the radiologist routinely 
has to exclude nerve involvement in all patients with head and neck cancer. Tumor 
spread is most frequent along the maxillary (V2) or mandibular (V3) branches of 
the trigeminal nerve although tumor can less frequently also follow the ophthalmic 
branch (V1). The mastoid segment of the facial nerve is another typical extension 
route and tumors will also follow the connections between the facial and trigeminal 
nerve. Tumor spread along the hypoglossal nerve is less frequent. Involved nerves 
enhance, are thickened and cause enlargement of the foramina, fissures and canals 
they pass through and eventually the tumor will extend intracranially and become 
more difficult to treat or intreatable. PNS can be detected on axial and coronal high 
resolution gadolinium-enhanced T1-weighted images although more and more 
isotropic sub-millimetric gadolinium-enhanced fat suppressed 3D-FFE/VIBE images 
are used. In this refresher course, the typical routes of PNS will be illustrated and 
the signs of PNS will be covered. Attention will be paid to the imaging techniques 
which should be used to detect tumor spread. An overview of the anatomical sites 
where it is easiest to pick up PNS and which should be checked will also be given. 
Learning Objectives:
1. To learn the MR techniques used to depict cranial nerve involvement.
2. To recognise the signs of nerve involvement by tumor.
3. To understand the different routes of perineural tumor spread.
A‑036 17:00 
C. Depiction of dural invasion: How good is MRI? 
A. Borges; Lisbon/PT (borgalexandra@gmail.com) 
Transdural growth of head and neck malignancies has a major impact on treatment 
planning and patient’s prognosis. Whereas tumours remaining extradural can be 
excised through a facial approach, tumours that transgress the dura require a 
combined craniofacial resection including dural resection to obtain free surgical 
margins and often major reconstructive efforts to avoid post-surgical complications. 
Several studies have demonstrated the negative impact of dural invasion in patient’s 
outcome, together with the presence of positive margins and tumour histology. 
Therefore, all efforts should be made to recognize this feature pre-operatively. MR 
has proven to be the most accurate image modality to depict dural invasion and 
perineural spread of tumour. Dural enhancement, although very sensitive for dural 
invasion, has a low specificity as it may result not only from invasion by tumour but 
also from reactive fibrovascular changes and meningeal inflammation. The pattern 
of dural enhancement, thicker than 5 mm or nodular, is more accurate, with higher 
specificity. In addition, loss of the hypointense line which separates tumour from 
the adjacent enhancing dura, (corresponding to the epidural space), and loss of 
continuity of the enhancing dura, best depicted on high resolution MR sequences, 
are helpful imaging signs of dural invasion. During surgery, efforts should be made 
to resect the surgical specimen en bloc with the adjacent dura and, when not at all 
possible, to correctly label the excised fragments of the dura to allow for adequate 
pathologic staging. 
Learning Objectives:
1. To recognise the most common routes of dural invasion by head and neck 
tumors.
2. To understand the impact of transdural growth on treatment planning and 
prognosis.
3. To become familiar with the MR criteria for dural invasion and their accuracy.
4. To understand the limitations of pathology in assessing dural invasion.
16:00 - 17:30 Room P 
Cardiac 
RC 203 
Tips and tricks to improve your image quality 
Moderator:
T. Bader; Vienna/AT 
A‑037 16:00 
A. Sharp CT images with little radiation 
L. Lehmkuhl; Leipzig/DE (lukas.lehmkuhl@med.uni‑leipzig.de) 
In recent years the technological development of cardiac MSCT has increased the 
importance of this procedure for the assessment of coronary heart disease in com-
parison with cardiac catheterization. Computed tomography coronary angiography 
(CTCA) is increasingly performed in the clinical setting. However, successful use 
of CTCA depends on the radiologist‘s knowledge of potential pitfalls. Artifacts and 
suboptimal contrast enhancement can degrade image quality and result in potential 
misinterpretation. Artifacts can have multiple reasons, for example motion-related 
artifacts caused by cardiac, pulmonary or breathing movement, beam-hardening 
effects caused by metallic implants and calcifications, structural artifacts due to 
adjacent contrast enhanced structures and vessels and artifacts that result from 
technical limitations. An optimal contrast enhancement depends mainly from the 
contrast injection protocol. Biphasic contrast injection protocols can be used for 
CTCA, while triphasic injection protocols are more suitable for functional analysis 
and for the assessment of the right ventricle. Furthermore, an optimal contrast 
depends from an appropriate planning of the bolus tracking and from the venous 
access chosen. Moreover, a successful cardiac CT depends on the radiation 
exposure applied. A high radiation dose results in high-resolution images, while a 
lower dose leads to increased image noise and results in unsharp images. There 
are several strategies to reduce the radiation dose during CT examinations without 
compromising the diagnostic value of the examination, for example by the use of 
a prospective gating or lowering the kV. 
Learning Objectives:
1. To eliminate artifacts.
2. To optimise contrast injection.
3. To minimise radiation dose.
A‑038 16:30 
B. Clear MR images without artefacts 
J. Bremerich; Basle/CH (jbremerich@uhbs.ch) 
Introduction: Magnetic Resonance Imaging (MRI) of the heart is a powerful tool, 
but it is also technically demanding. Images, however, can be substantially degraded 
by artefacts. Knowledge of origin, appearance and significance of such artefacts is 
essential to avoid misinterpretation and to improve image quality.
Methods and Material: Cardiac imaging is typically performed on 1.5 or 3 Tesla 
magnets equipped with surface coils using ECG gated sequences. Imaging tech-
niques have evolved from traditional spin-echo and gradient-echo to turbo-spin-
echo, spoiled-gradient-echo, and balanced steady-state-free-precession sequences. 
Most recently developed techniques allow evaluation of morphology, function, 
perfusion, viability, coronary anatomy and flow; some advanced techniques are 
particularly vulnerable to artefacts.
Results: Gating related artefacts may be eliminated by repositioning of the leads, 
acquisition in end-expiration, optimization of sequence parameters or with periph-
eral pulse gating. Insufficient nulling of normal myocardium on late-enhancement 
sequences may be optimized by a dedicated TI scout. In balanced steady-state-
free-precession sequences, dark-band artefacts may occur particularly on 3 Tesla 
systems. Such artefacts can be reduced by frequency shift technique. Some arte-
facts, however, may also be of diagnostic value. In cases when normal myocardium 
cannot be nulled even with long inversion times, amyloidosis may be suspected. 
Moreover, when gradient echo sequences provide low signal of myocardium, iron 
overload may be suspected.
Conclusion: Cardiac MRI is technically demanding and requires profound knowl-
edge of MR physics as well as specific cardiac anatomy and physiology to identify 
artefacts, to avoid misinterpretation and to develop remedies for image improvement. 
Learning Objectives:
1. To improve contrast, spatial and temporal resolution.
2. To discuss usefulness of parallel imaging.
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A‑039 17:00 
C. Rescuing the examination with post-processing 
P.M.A. van Ooijen; Groningen/NL (p.m.a.van.ooyen@rad.umcg.nl) 
Cardiac Computed Tomography (CT) has seen a very fast development over the 
past few years. Although the quality of the examinations has increased due to this 
development, problems such as trigger artefacts, suboptimal contrast bolus and 
respiratory artefacts can still occur. For some of these problems, advanced post-
processing techniques can be utilized to either reduce the resulting artefacts or to 
allow easy recognition of the artefacts. In this refresher course lecture, an overview 
of the current possibilities and impossibilities is given. 
Learning Objectives:
1. To reduce ECG trigger artefacts on CT and MR.
2. To compensate for suboptimal contrast enhancement.
3. To choose appropriate visualisation techniques.
16:00 - 17:30 Room Q 
Interventional Radiology 
RC 209 
The trauma patient 
Moderator:
A.A. Hatzidakis; Iraklion/GR 
A‑040 16:00 
A. Imaging algorithms 
L.S. Fournier; Paris/FR (laure.fournier@egp.aphp.fr) 
Injured patients are considered as multi-trauma victims according to the mechanism 
of injury or the number of lesions, at least one being life-threatening. Initial imag-
ing evaluation of these patients will depend on the techniques available and the 
haemodynamical state of the patient; determining one of two imaging work-ups. 
In the haemodynamically unstable patient, chest and pelvis radiographs are per-
formed as well as a US FAST (Focused Assessment with Sonography in Trauma) 
protocol. This abdominal ultrasound examination provides a quick overview of the 
intraperitoneal cavity to detect free fluid, an indirect sign of acute haemorrhage, 
and injury to visceral organs requiring immediate surgery. It can be performed with 
mobile equipment and by emergency staff, including non-radiologists or surgeons. 
US is highly sensitive (90%) for the detection of free intraperitoneal fluid but less 
(40%) for the identification of organ injuries. In the haemodynamically stable patient, 
whole-body multidetector computed tomography (WBCT) is performed, providing 
rapid and complete assessment of head, cervical spine, chest, abdomen and 
pelvis. WBCT has shown very high positive and negative predictive values > 90% 
for each of the anatomical regions and for detection of active bleeding, with 30% 
of patients presenting lesions in one or more anatomic region than that suspected 
clinically. Lesions to solid organs may be divided in hematomas, lacerations, and 
vascular injuries. CT is the best technique to detect bowel injuries which may be 
occult initially and must be suspected in presence of bowel wall thickening, free 
fluid or air in the peritoneal cavity. 
Learning Objectives:
1. To discuss appropriate triage of trauma patients to imaging.
2. To learn the appropriate imaging techniques.
3. To review imaging appearances.
A‑041 16:30 
B. Principles of embolisation 
J.C. van den Berg; Lugano/CH (jos.vandenberg@eoc.ch) 
In the management of trauma patients, the role of embolisation has become more 
and more important over the last years. With refinement of technique and avail-
ability of new embolic agents and catheters, more patients can be treated minimally 
invasive nowadays. When performing transcatheter, knowledge of proper timing 
of the procedure and knowledge of material is essential. This paper will focus on 
this, and will give an overview of all currently available embolic agents and devices, 
their use, indications and contraindications for their application. Potential pitfals will 
be discussed, and complications will be dealt with. Finally, long-term outcome and 
results will be discussed. 
Learning Objectives:
1. To discuss the indications and timing of embolisation for trauma patients.
2. To learn about principles and techniques of embolisation.
3. To review endpoints and results of embolisation.
A‑042 17:00 
C. Iatrogenic trauma 
P. Haage; Wuppertal/DE (patrick.haage@helios‑kliniken.de) 
Traumatic injuries requiring prompt and effective treatment may in some instances 
be a consequence of iatrogenic procedures. They may be as diverse and individual 
as the triggering trauma itself. Of particular interest to the radiologist regarding 
diagnosis and treatment are vascular traumata. Iatrogenic trauma to the arterial 
and venous systems is quite frequent today, which may partly be attributed to 
the increase in interventional procedure in recent years. Observed injuries to the 
circulation may range from pseudoaneurysms, bleedings and dissections to arte-
rial/deep vein thromboses, arteriovenous fistulae, embolism and occlusion. In this 
presentation, the necessary diagnostic imaging modalities in iatrogenic trauma 
and its interventional radiologic complication management will be presented and 
delivered via “typical” examples. 
Learning Objectives:
1. To review causes and imaging appearances of iatrogenic trauma.
2. To review various IR methods of treatment.
3. To review results and appropriate follow-up strategies.




M. Szczerbo‑Trojanowska; Lublin/PL 
A‑043 18:30 
The two faces of HIV/AIDS in the brain: The face you know - And the one 
you don’t 
A.G. Osborn; Salt Lake City, UT/US (anne.osborn@hsc.utah.edu) 
HIV-induced brain injury is a significant complication of AIDS. CNS symptoms 
(HIV encephalopathy or “HIVE”) are the first complaint in 5-10% of patients. More 
than 25% eventually develop severe cognitive deficits (HIV-associated dementia 
complex). The face of HIV/AIDS that most of us know and recognize is that of 
the disease as managed in a “resource-rich” environment. Questions such as 
“who should be imaged” and “how should they be imaged” presuppose a wealth 
of resources unimaginable in many parts of the world. With the advent of highly-
effective antiviral regimens, HIV/AIDS has become for many infected patients a 
chronic, difficult but manageable disease. This presentation will briefly demonstrate 
the pathology and imaging spectrum of HIV/AIDS as a chronic disorder, including 
examples of the new immune reconstitution inflammatory syndrome (IRIS) in the 
brain. The “other” face of HIV/AIDS, the one that most of us do not know, is that of 
the disease in populations with “resource-poor” environments. AIDS in developing 
countries often presents differently. While the virus is the same, its manifestations 
are quite different. Here AIDS can be an acute, often fulminant disease where co-
infections such as TB create a deadly intersection that magnifies the morbidity and 
lethality of both agents. Imaging in these patients, when available, may show a very 
different disease spectrum from the more familiar patterns seen in resource-rich 
environments. With increased immigration and the rapid emergence of multi-drug 
resistant and extreme drug-resistant TB, this “second face” of HIV/AIDS may be 
the one we will see in the very near future. 
Learning Objectives:
1. To learn about the imaging spectrum of HIV/AIDS in the central nervous 
system in a resource-rich environment where highly effective antiviral 
treatments and supportive therapy are widely available.
2. To identify the imaging manifestations of immune reconstitution inflammatory 
syndrome (IRIS) as seen in the brain.
3. To understand the “deadly intersection” between HIV/AIDS and TB in 
resource-poor environment.
4. To learn about the imaging manifestations of HIV/AIDS when it presents as 
acute, fulminant disease in a resource-poor environment.
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08:30 - 10:00 Room A 
Special Focus Session 
SF 3a 
Diffusion-weighted imaging of the abdomen: 
A new tool for oncologic imaging? 
Moderator:
F. Caseiro‑Alves; Coimbra/PT 
A‑044 08:30 
Chairman’s introduction 
F. Caseiro-Alves; Coimbra/PT (caseiroalves@gmail.com) 
Exploitation of the microscopic movement of water molecules within biological 
tissues by DWI is a new tool for MRI, now becoming more available and wide-
spread for a variety of abdominal applications. In oncology, its role as an imaging 
biomarker is being progressively established for detection, characterization and 
monitor response to therapy. Despite all these features, there are still many open 
issues to be solved such as standard definitions for measurement analysis, imag-
ing protocols for different anatomical locations, reproducibility among vendors, and 
interpretation of the quantitative ADC values. Also, as a measure of diffusivity of 
the extravascular extracellular space, complete understanding at the microscopic 
level is still incomplete and confounding factors may be present contributing to 
change the final imaging appearance. Taking in account all the potential benefits 
of DWI, it is thus essential that radiologists master the technique, understanding 
its physical principles, clinical applications, limitations and pitfalls. It is the purpose 
of this session to provide a comprehensive overview of the technique ranging from 
technical definitions and parametrization options to specific applications in the liver, 
pancreas and for lymph node mapping and/or characterization. 
Session Objectives:
1. To introduce the imaging tools for evaluating tumor components.
2. To address quantification issues and the role of DWI.
3. To recall how to create imaging protocols.
4. To stress the role of DWI in oncologic imaging and future developments.
A‑045 08:34 
Diffusion imaging: From theory to protocol development 
D.-M. Koh; Sutton/UK 
Diffusion-weighted MR imaging (DW-MRI) derives its image contrast from differ-
ences in the mobility of water between tissues. The signal attenuation observed 
on DW-MRI reflects tissues cellularity, the tortuosity of the extracellular space, 
integrity of cell membranes, as well as bulk flow phenomenon such as microcapillary 
perfusion. DW-MRI measurements can be acquired very quickly (typically several 
seconds to a few minutes) without the administration of exogenous contrast media, 
and provides unique qualitative and quantitative information that can aid disease 
detection, disease characterisation and the evaluation of tumour response to treat-
ment. In the body, DW-MRI is most often performed using single-shot echo-plainer 
imaging (EPI) technique. Image acquisition can be performed in breath-hold or 
free-breathing; the latter may be combined with respiratory and/or cardiac trigger-
ing. Each of these techniques has its advantages and disadvantages. DW-MRI in 
the body using EPI technique is prone to a variety of artefacts and careful imaging 
optimisation is therefore critical to success. The DW-MRI acquisition sequences 
should be optimised to maximise signal-to-noise and minimise potential artefacts. 
Adjustment of imaging parameters such as the echo-time, matrix size, partition 
thickness, parallel imaging, fat suppression scheme and the receiver band width are 
important to ensure that high quality DW-MR images can be consistently attained. 
A good apparent diffusion coefficient (ADC) measurement reproducibility can be 
achieve through meticulous technique. Evolving developments of DW-MRI in the 
body include more sophisticated image acquisition and evaluation techniques to 
gain further insights into tissue structure and function. 
Learning Objectives:
1. To describe the principles of DWI and its technical settings
2. To discuss the influence of technical settings for imaging evaluation.
3. To explain the role of quantification obtained by ADC maps and 
measurements and to comment on reproducibility issues.
4. To discuss technique’s pros and cons, trends and future developments.
A‑046 08:53 
Focal liver lesions: What can we expect? 
M. Lewin; Paris/FR (maite.lewin@sat.aphp.fr) 
As a result of rapid technological developments, DW-MRI is now a part of standard 
abdominal imaging practice. It is of special interest for detection and characteriza-
tion of focal hepatic lesions because it improves tumor visualization and provides 
quantitative data (ADC map). This makes it possible to differentiate benign from 
malignant lesions which display higher ADC values due to higher cellularity. How-
ever, an overlap exists. The b value, characterizing the diffusion gradient’s strength, 
is a clue parameter. A minimal b value is needed to avoid perfusion effect but too 
high b values result in signal loss. A series of b values, usually from 200 to 800 
s/mm2, are required to calculate ADC. Benign lesions have ADC values ranging 
from 2.04 to 2.89, HCC from 1.31 to 1.39 and metastasis 0.85 to 1.50 x 10-3 mm2/s. 
An additional interest is the monitoring of treatment response and the prediction of 
treatment outcome for vascular disruptive drugs and apoptosis-inducing therapies. 
Successful treatment is generally reflected by an increase in ADC values because 
of tumor size reduction or tumor necrosis. Correlatively, patients with tumors hav-
ing high ADC levels before treatment may be predicted to have a poor outcome. 
Furthermore, DW-MRI can be used as a pharmacodynamic biomarker that could 
support decision making in the drug development process, the aim being to increase 
the likehood of success in later more coslty trials. However, the major challenge is 
standardization of data acquisition and analysis for multicenter studies. 
Learning Objectives:
1. To present DWI results for focal liver lesion detection and characterisation.
2. To discuss shortcomings, pitfalls and technical details essential for obtaining 
accurate clinical results.
3. To describe the current role of DWI in quantification and tumor response 
evaluation.
A‑047 09:12 
Pancreatic neoplasms: Is DWI helpful? 
C. Matos; Brussels/BE (cmatos@ulb.ac.be) 
Compared to T1-weighted and T2-weighted strategies, diffusion-weighted imag-
ing (DWI) provides another mechanism for developing image contrast that may 
increase the sensitivity and the specificity of MRI of the pancreas. In addition to 
the information on tissue cellularity, on cell membrane integrity and on extracellular 
space turtuosity, apparent diffusion coefficients (ADC) maps of tissue water can 
be generated. For pancreatic DWI, parallel imaging, fat suppression, respiratory 
triggering and multiple b-values (typically 0, 150 and 1000 s/mm2) are used. This 
strategy presents the advantages of exploring a large FOV and has acceptable 
spatial resolution. Moreover, patient cooperation is minimized. Promising results 
have been reported concerning the usefulness of DWI for investigating pancreatic 
adenocarcinoma and mass forming pancreatitis. It has been shown that mean ADC 
values of malignant lesions are significantly lower than those of benign lesions and 
that DWI has similar accuracy to conventional MR imaging in diagnosing pancreatic 
cancer. Our results using DWI to explore the full range of pancreatic diseases did 
not show statistically significant differences in mean ADC values between malignant 
and inflammatory diseases. Using DWI in addition to conventional MRI mainly 
increased the sensitivity and the negative predictive value of the MR examination. 
DWI was a useful non-invasive tool for the follow-up of inflammatory diseases, 
and for detecting a lesion that may be suitable for biopsy in patients with chronic 
pancreatitis or a cystic neoplasm. 
Learning Objectives:
1. To present DWI results in cystic and solid pancreatic lesions, and explain its 
role in detection, characterisation and staging.
2. To discuss which sequence parameters should be used to get consistent 
clinical results.
3. To address the role of quantification, potential shortcomings and pitfalls of 
the technique for this application.
A‑048 09:31 
Pelvic cancers and lymph node imaging: The PET competitor? 
S. Gourtsoyianni; Iraklion/GR (sgty76@gmail.com) 
Identification of metastatic lymph nodes in pelvic malignancies is of paramount 
importance since it modifies treatment strategy and prognosis. In order to avoid 
unnecessary extended lymphadenectomy, non-invasive imaging techniques are 
tried out. Cross-sectional imaging relying on nodal size and morphology and PET 
on metabolic activity for lymph node characterization have not yet produced suf-
ficiently effective staging results due to considerable overlap in imaging features 
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imaging, however, has resulted in higher sensitivity in pelvic cancers lymph node 
characterization but requires long MR scanning time and is not available for routine 
clinical use. Diffusion weighted imaging has been tested with excellent results for 
delineation and characterization of primary pelvic cancers and shows promise for 
lymph node staging. Diffusion weighted whole body imaging with background body 
signal suppression (DWIBS) with inversion of gray scale producing images similar 
to PET and axial single shot EPI DWI with fat suppression demonstrate normal 
lymph nodes with a relative restricted diffusion, while both increase conspicuity 
of small (up to 2 mm) lymph nodes. ADC map produced from the latter sequence 
using a wider range of b values is rendered necessary for quantification and thus 
characterization of lymph nodes. ADC is relatively independent of lesion size and 
various criteria, such as relative ADC value, have been proposed to increase sensi-
tivity of DWI regarding differentiation between metastatic and non-metastatic pelvic 
lymph nodes, with the largest series being those of gynecological malignancies 
due to extensive lymphadenectomy correlation data. 
Learning Objectives:
1. To learn the technical settings (sequence characteristics, b values, necessity 
of ADC map or not, layout of images with or without 3D reconstruction) and 
the optimal compromise for evaluating prostate, rectal and gynecological 
tumors.
2. To review the literature on the Se and Sp of DWI, as compared with PET/CT 
and MRI with tissue-specific contrast media regarding local tumor staging.
Panel discussion:  
Is DWI ready for routine use in oncological practice? 09:50 
08:30 - 10:00 Room B 
Radiology of the Spine in 2010 
CC 316 
Common spinal “problems” 
Moderator:
I.M. Björkman‑Burtscher; Lund/SE 
A‑049 08:30 
A. “Myelopathy”: Easy way to the correct diagnosis 
M.M. Thurnher; Vienna/AT (majda.thurnher@meduniwien.ac.at) 
Myelopathy is a term that actually means “there is something wrong with the spinal 
cord” itself. Increased signal intensity in the spinal cord on T2-weighted magnetic 
resonance images (MR) has been reported in numerous diseases. Causes include 
trauma, primary and secondary tumours, bacterial and viral myelitis, radiation my-
elitis, spinal cord ischemia, compression myelopathy, etc. It is then not surprising 
that the differentiation could be almost impossible based only on imaging findings. 
This lecture will focus on MR imaging findings in the spinal cord diseases and its 
practical value in narrowing the differential diagnosis. The location, extent, multi-
plicity, signal characteristics, and the degree of enhancement of abnormalities will 
be described. A practical schematic approach with integration of imaging features 
and clinical data will be introduced. 
Learning Objectives:
1. To define the term “myelopathy”.
2. To discuss the differential diagnoses of spinal cord diseases.
3. To introduce a “clinically useful” algorithm for myelopathy.
A‑050 09:00 
B. Congenital anomalies made "easy" 
A. Rossi; Genoa/IT (andrearossi@ospedale‑gaslini.ge.it) 
Spinal and spinal cord malformations are collectively named spinal dysraphisms. 
They arise from defects occurring in the early embryological stages of gastrulation 
(weeks 2-3), primary neurulation (weeks 3-4), and secondary neurulation (weeks 
5-6). Spinal dysraphisms are categorized into open spinal dysraphisms, in which 
there is exposure of abnormal nervous tissues through a skin defect, and closed 
spinal dysraphisms, in which there is a continuous skin coverage to the underlying 
malformation. Open spinal dysraphisms basically include myelomeningocele and 
other rare abnormalities such as myelocele and hemimyelo (meningo)cele. Closed 
spinal dysraphisms are further categorized based on the association with low-back 
subcutaneous masses. Closed spinal dysraphisms with mass are represented by 
lipomyelocele, lipomyelomeningocele, meningocele, and myelocystocele. Closed 
spinal dysraphisms without mass comprise simple dysraphic states (tight filum 
terminale, filar and intradural lipomas, persistent terminal ventricle, and dermal 
sinuses) and complex dysraphic states. The latter category further comprises de-
fects of midline notochordal integration (basically represented by diastematomyelia) 
and defects of segmental notochordal formation (represented by caudal agenesis 
and spinal segmental dysgenesis). Magnetic resonance imaging is the preferred 
modality for imaging these complex abnormalities. The use of the aforementioned 
classification scheme is greatly helpful for making the diagnosis. 
Learning Objectives:
1. To become familiar with normal and abnormal embryology of the spine.
2. To review the most common spinal congenital anomalies and their 
pathogenetic background.
3. To describe imaging findings in various spinal anomalies that allow 
differentiation between entities.
A‑051 09:30 
C. Extradural spinal tumors 
P.C. Maly Sundgren; Lund/SE (Pia.Sundgren@med.lu.se) 
Tumors of the spinal canal both the purely extradural tumors and those involving 
the spinal cord are uncommon lesions but may result in significant morbidity. The 
most important imaging tool for evaluating the spinal canal is magnetic resonance 
imaging (MRI). Conventional MRI has the capability to classify tumors of the spinal 
canal in extradural, intradural-extramedullary or intradural intramedullary lesions. 
The differential diagnosis for extradural and intradural-extramedullary spinal tu-
mors are primarily based on location, but also the clinical presentation, age and 
gender of the patient are important factors in determining the diagnosis. The most 
common intradural extramedullary lesions are schwannomas, meningiomas, and 
neurofibromas. Less common lesions include paraganglioma, metastases, and 
rare tumors such as spinal nerve sheath myxoma (neurothekeoma), as well as 
lipoma, sarcomas and vascular tumors. These tumors occur far more commonly 
in the adult population than in children. Purely extradural lesions are rare, includ-
ing lymphoma, metastasis and benign lesions like arachnoid cyst, dermoid, and 
epidermoid. Among the differential diagnosis to primary and secondary tumors, 
we have to consider epidural hematoma and abscesses. This short presentation 
will focus on the current classification and the conventional MRI imaging features 
of the more common extradural and intradural extramedullary spine lesions. The 
role of new MR imaging sequences such as diffusion weighted imaging (DWI) and 
diffusion tensor imaging (DTI) and the use of measurements of apparent diffusion 
coefficient (ADC) and fractional anisotropy (FA) to differentiate spinal neoplasms 
will be discussed. 
Learning Objectives:
1. To review the current classification of tumors in the spinal canal.
2. To summarise key imaging findings in extradural spinal tumors.
3. To become familiar with new techniques used in differentiation of spinal 
neoplasms.
08:30 - 10:00 Room C 
State of the Art Symposium 
SA 3 





A. Rovira-Cañellas; Barcelona/ES (alex.rovira@idi‑cat.org) 
Multiple sclerosis (MS) is a chronic, persistent inflammatory-demyelinating dis-
ease of the CNS that typically presents as an acute clinically isolated syndrome 
attributable to a monofocal or multifocal demyelinating lesion. Conventional MRI 
(cMRI) techniques, such as T2W and gadolinium-enhanced T1W sequences, are 
highly sensitive in detecting MS plaques and provide a quantitative assessment of 
inflammatory activity and lesion load. In fact, MRI is now integrated in the overall 
diagnostic scheme of the disease because of its unique sensitivity to demonstrate 
the spatial and temporal dissemination of demyelinating plaques in the brain and 
spinal cord. However, there is a persisting mismatch between clinical and cMRI 
efficacy of approved treatments, which underlies the fact that cMRI does not suffice 
to explain the entire spectrum of the disease process. In recent years, great effort 
has been dedicated to overcoming this limitation by using non-conventional MR-
derived metrics that can selectively measure the more destructive aspects of MS 
pathology and monitor the reparative mechanisms. These metrics, which include 
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unenhanced T1-weighted imaging, measures of CNS atrophy, MT imaging, MR 
spectroscopy, DW imaging, and functional MRI, provide a better approximation of 
the pathological substrate of the MS plaques, have increased our understanding 
of the pathogenesis of the disease, and have proven useful for studying the natural 
history of MS and monitoring the effects of new treatments. Therefore, MRI not 
only plays an essential role in the diagnosis of MS, but can also serve as a true 
biological marker of the severity of this disease. 
Session Objectives:
1. To introduce the clinical aspects and pathophysiology of MS.
2. To clarify the role of conventional and non-conventional MRI techniques in 
the diagnosis and monitoring of MS.
3. To stress the advantages and limitations of MRI as a biological marker in MS.
A‑053 08:35 
MRI and histopathological studies 
F. Barkhof; Amsterdam/NL (f.barkhof@vumc.nl) 
MRI is often used to diagnose multiple sclerosis (MS). This is due to the very 
high sensitivity of T2-weighted MRI for any alterations occurring in MS, including 
inflammation, demyelination, gliosis and axonal loss; even remyelinated lesion 
appear bright on T2-weighted images. For the same reason, it is hard to predict 
the relationship between the extent of abnormalities on T2-weighted scans and 
relapses or irreversible disability in MS - the so-called clinical-radiological paradox. 
Beyond the shortcomings of clinical scoring systems, MRI factors explaining this 
discrepancy include: a) location of lesions and spinal cord involvement, b) degree 
of tissue damage within lesions, c) abnormalities in the so-called normal appearing 
white matter, and d) grey matter involvement. Even newer techniques like double-
inversion recovery (DIR) fail to identify the vast majority of cortical lesions, and 
only cortical atrophy is a useful predictor of disability in advanced stages of MS. 
Learning Objectives:
1. To understand the clinical-radiological paradox concept in MS.
2. To comprehend the histopathological specificity of the various MR 
sequences based on radiological-pathological correlations.
3. To be aware of the clinical importance of grey matter involvement in MS.
A‑054 08:58 
Update on MRI diagnostic criteria 
T.A. Yousry; London/UK (t.yousry@ion.ucl.ac.uk) 
An early and accurate diagnosis of MS in CIS patients is important to relieve 
uncertainty, provide prognosis counseling and consider MS disease modifying 
treatments that have partial efficacy at this earliest clinical stage of the disease. 
Although, no single clinical feature or diagnostic test is sufficient for the diagnosis 
of MS, MRI has become the most useful investigation to support an MS diagnosis - 
and sometimes identifies alternative diagnoses. Diagnostic MRI criteria have been 
developed based on the demonstration of lesions disseminated in space (DIS) and 
time (DIT) and after exclusion of alternative causes. The most relevant are the 
“McDonald criteria” from 2001, and their revision in 2005. Whilst the new criteria 
are a logical step forward, they are complex. Increasing practical experience and 
the study of different diagnostic approaches have shown potential ways to simplify 
MRI diagnostic prerequisites without relaxing their specificity. A new algorithm is 
proposed by the MAGNIMS group, which takes into consideration both image 
interpretation and the timing of MRI. 
Learning Objectives:
1. To be aware of the clinical importance of early diagnosis of MS.
2. To become familiar with the McDonald MRI-based MS diagnostic criteria.
3. To examine recent data that supports a revision of the McDonald MRI-based 
diagnostic criteria in MS.
A‑055 09:21 
MRI as a biomarker 
M. Filippi; Milan/IT (massimo.filippi@hsr.it) 
MS is a very heterogenous disease, which usually takes several years before 
disability accumulation can be measured clinically. This and the poor reliability of 
clinical scales, has led to the use of MR technology to monitor disease evolution. 
Traditionally, the extent of overall lesion burden, the frequency of occurrence of 
“active” lesions and their changes over time have been the most used MRI out-
comes. These MR metrics, however, lack of pathological specificity and are unable 
to quantify the extent of damage outside focal lesions. Modern, quantitative MR 
techniques have the potential to overcome such limitations and have contributed 
to reshape the picture of MS as a condition which evolves through a balance 
between, on the one side, inflammatory-demyelination and degeneration and, on 
the other, the effectiveness of tissue repair and cortical reorganization. Measures 
of atrophy are increasingly used to quantify the extent of irreversible tissue loss. 
Metrics derived from magnetization transfer and diffusion-weighted MRI enable 
us to quantify the extent of structural changes occurring within T2-visible lesions 
and normal-appearing tissues (including gray matter); proton MR spectroscopy 
adds valuable pieces of information on the biochemical nature of such changes; 
functional MRI discloses the role of cortical adaptive changes in limiting the clinical 
consequences of tissue injury. This new picture of MS has important implications in 
the context of monitoring, since it calls for a multiparametric MR approach, which 
should be tailored according to the disease stage and the mode of action of the 
tested drug (e.g., anti-inflammatory vs. neuroproctective). 
Learning Objectives:
1. To recognise the need for surrogate tools to monitor treatments in MS.
2. To understand the advantages and disadvantages of conventional and non-
conventional MR techniques that can be used as biomarkers of inflammation 
and neurodegeneration in MS.
3. To introduce guidelines for the use of MR techniques in monitoring MS.
Panel discussion:  
How should we use MRI in the diagnosis and monitoring of multiple 
sclerosis? 09:44 
08:30 - 10:00 Room D 
Imaging in Lung Diseases 
CC 318 
Cardiothoracic CT: One-stop-shop procedure? 
Moderator:
P. Herzog; Munich/DE 
A‑056 08:30  
A. How to assess cardiac function from a chest CT angiographic 
examination 
G.W. Gladish; Houston, TX/US (ggladish@mdanderson.org) 
Right heart dysfunction can result from a variety of pathologic processes and can 
be assessed both directly and indirectly using MDCT. Indirect assessment should 
be performed on all contrast enhanced examinations. This includes morphologic 
evaluation of the right cardiac chambers and pulmonary arteries in comparison to 
analogous left heart structures. The right ventricle diameter is normally less than the 
left ventricle. Dilation of the right ventricle indicates pulmonary hypertension or right 
ventricular volume overload and is a poor prognostic sign, particularly in patients with 
acute pulmonary emboli. Optimally performing this evaluation requires multiplanar 
reformatting capabilities, as the ratio of ventricular diameters is best demonstrated 
on images in the short axis of the ventricles. Other morphologic findings include 
straightening or reversal of the interventricular septum as an indication of elevated 
right ventricular pressure. Contrast enhancement patterns can also provide clues to 
right heart function. Significant reflux of contrast material into the inferior vena cava 
and hepatic veins indicates abnormal right heart blood flow due to pulmonary arterial 
hypertension, tricuspid regurgitation, or increased pericardial pressure. These conditions 
may also result in heterogeneous hepatic enhancement due to hepatic congestion. 
Direct assessment of cardiac function requires cardiac gating and optimized contrast 
administration. Right ventricle contrast enhancement must be maintained compared 
to standard coronary CT techniques. Right ventricle function can then be calculated 
using tools developed for left ventricular assessment. The assessment of right heart 
function can add prognostic information to the assessment of diseases affecting the 
pulmonary vasculature, including embolism and fibrosis. 
Learning Objectives:
1. To review the different means of estimating right cardiac function with MDCT.
2. To consolidate knowledge of CT features of right ventricular dysfunction.
3. To understand the clinical usefulness of integrating cardiac functional 
information into the daily routine of a chest radiologist.
A‑057 09:00 
B. Impact in the management of acute pulmonary embolism 
I. Hartmann; Rotterdam/NL (i.hartmann@erasmusmc.nl) 
Pulmonary embolism (PE) is a common and potentially fatal cardiovascular dis-
order. Pressure overload of the right ventricle (RV) secondary to acute pulmonary 
hypertension is thought to play a significant role in PE-related mortality. Massive PE 
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with a poor prognosis and high mortality rates (> 50%). There is general agreement 
that these patients should be treated aggressively (thrombolytic agents, surgery, 
or interventional procedures) whereas more aggressive therapy is generally not 
indicated in normotensive patients without RV dysfunction (RVD). However, up to 
7% of hemodynamically stable patients treated with anticoagulants also eventu-
ally die related to the PE event. Various diagnostic techniques or laboratory tests 
have been proposed to classify patients with PE into groups with high risk and 
low risk of fatal PE, with the ultimate aim of identifying those patients who may 
benefit from more aggressive therapy. There are contradicting results regarding 
the association between the extent of obstruction of the pulmonary arteries at CT 
and immediate outcome. Presence and severity of RV dilatation as assessed by 
either echocardiography or CT have been described as independent predictors of 
mortality within 3 months. Although thrombolytic therapy in normotensive patients 
with RVD is currently controversial, they may also benefit from more aggressive 
treatment. MDCT can be used to assess the degree of vascular obstruction and 
cardiac dysfunction, stratify the patient's risk of death, and, if thrombolytic therapy 
is indicated, can be used as a non-invasive tool for monitoring treatment. 
Learning Objectives:
1. To learn about the current markers of cardiac dysfunction in acute pulmonary 
embolism.
2. To review the prognostic role of MDCT in acute pulmonary embolism.
3. To become familiar with the therapeutic impact in the management of acute 
pulmonary embolism.
A‑058 09:30 
C. Clinical usefulness in chronic thoracic diseases 
G. Bastarrika1, T. Franquet2; 1Pamplona/ES, 2Barcelona/ES (bastarrika@unav.es) 
MDCT was initially limited to the depiction of morphologic changes at the level of 
the thoracic organs. Actually, MDCT examinations offer the possibility of providing 
information on cardiac function by means of the availability of retrospective ECG-
gating techniques and developments in dedicated cardiac analysis software. Chronic 
right ventricular (RV) hypertrophy and increased pulmonary resistance often go 
on to cause RV dilatation and failure. Cor pulmonale is the syndrome of RV hy-
pertrophy, dilatation, and failure resulting from pulmonary hypertension secondary 
to lung disease. MDCT is an accurate and reliable noninvasive technique in the 
assessment of right ventricular (RV) function in the management of patients who 
have a wide variety of acute or chronic respiratory disorders. 
Learning Objectives:
1. To describe the cardiac consequences of chronic thoracic diseases.
2. To discuss the concept of respiratory and cardiovascular disease in specific 
respiratory disorders.
3. To understand how the scanning protocols have to be modified to provide 
such information.
08:30 - 10:00 Room E1 
Abdominal and Gastrointestinal 
RC 301 
Quantification of liver processes: Defining 
biomarkers 
Moderator:
M.A. Bali; Brussels/BE 
A‑059 08:30 
A. Steatosis 
P. Chevallier; Nice/FR (chevallier.p@chu‑nice.fr) 
Hepatic steatosis is the most prevalent liver disorder in the developed world. Non-
alcoholic fatty liver disease (NAFLD) is its most frequent manifestation and has 
been estimated to be as high as 35% in some populations. Currently, liver biopsy 
is still considered the gold standard for the assessment of liver fat, but there is a 
clear need for less invasive diagnostic techniques. Focus has been placed on non-
invasive imaging modalities for liver fat detection and quantification. The rationale, 
performance characteristics, and limitations of these imaging modalities includ-
ing ultrasound, computed tomography, magnetic resonance imaging, magnetic 
resonance spectroscopy and magnetic resonance elastography will be discussed. 
These techniques offer a wide range of anatomical and morphological informa-
tion non-invasively even if none of them is able to assess all features visible using 
histology such as the differentiation between microvesicular and macrovesicular 
steatosis. Nevertheless, non-invasive imaging techniques and especially magnetic 
resonance are particularly useful to diagnose NAFLD in asymptomatic patients or 
to follow disease progression or response to treatment. 
Learning Objectives:
1. To know the general features of the pathology and clinical issues.
2. To know the general imaging findings.
3. To identify the accuracy of each imaging modality to assess hepatic steatosis 
qualitatively and quantitatively.
A‑060 09:00 
B. Iron overload 
J.M. Alústiza; San Sebastián/ES (jmalustiza@osatek.es) 
Quantification of Liver Iron Concentration (LIC) is the definitive parameter for 
diagnosing hereditary hemochromatosis (HH). Values above 71 µmol Fe/g are 
highly suggestive of the disease. In iron overload (IO) secondary to liver disease, 
alcohol abuse, etc. LIC levels are always lower. In secondary hemochromatosis, 
LIC is higher than in HH. Traditionally, LIC quantification requires a biopsy of the 
liver. MRI is considered as the preferred choice for non-invasive quantification 
of the LIC. IO causes a T2 shortening that results in a proportional decrease in 
liver signal. Calculation of relaxation time constants (T2/R2, T2*/R2*) requires 
sequences with multiple TEs and complex post-processing calculations. Results 
have been reproducible in different machines and have shown a high correlation 
with LIC measured on biopsies at all iron overload levels, including the high levels 
found in secondary haemochromatosis. In fact, such calculations are still only 
performed in highly specialised centres. Calculation of LIC from Signal Intensity 
ratios between the liver and the paravertebral muscles is simpler to perform. Several 
different gradient echo (GE) sequences are used to be able to evaluate different 
iron overload levels and may be performed rapidly and easily in a vast majority of 
MRI machines. These calculations have shown a good correlation for LIC levels 
typical of HH, lower than 300-400 µmol Fe/g. However, they saturate with the higher 
overload levels characteristic of secondary hemochromatosis. 
Learning Objectives:
1. To learn the importance of quantifying the liver iron concentration in the 
diagnosis of primary and secondary hemochromatosis.
2. To describe quantification of LIC by MRI. Calculation of T2-R2 vs 
measurement of signal intensity ratio liver/muscle. Advantages and 
disadvantages of each method. Reproducibility, standardisation, availability.
3. To know the indication of the quantification of the LIC by MRI in the diagnosis 
of primary and secondary hemochromatosis.
A‑061 09:30 
C. Fibrosis 
B. Van Beers; Clichy/FR (bernard.van‑beers@bjn.aphp.fr) 
Liver fibrosis is a non-specific cicatrization process that occurs in all chronic insults 
of the liver. Hepatic fibrosis is reversible and can be treated, especially before 
cirrhosis occurs. The diagnosis of fibrosis relies on liver biopsy. However, hepatic 
biopsy is invasive and there is a sampling variability related to the heterogeneity 
of fibrosis and the small size of the biopsies. Scoring systems based on serum 
tests have been developed. These biomarkers only enable differentiation between 
minimal and advanced fibrosis. Anatomical imaging is limited to the detection of 
advanced fibrosis. Functional imaging can be used to stage liver fibrosis. Micro-
circulatory changes that can be detected with perfusion CT or MRI are observed 
in hepatic fibrosis. However, the correlation between the changes of the perfusion 
parameters and the stage of fibrosis is only moderate. At diffusion-weighted MRI, 
there is a decrease of the apparent diffusion coefficient of the liver that correlates 
with increased fibrosis. However, this decrease is mainly related to perfusion 
rather than true extracellular diffusion changes. Elastography is a new method that 
measures the visco-elastic parameters of the liver. Transient and acoustic radiation 
force impulse elastography are ultrasound methods that are increasingly used to 
stage liver fibrosis. With MR elastography, a more accurate and precise assessment 
of the visco-elastic parameters of the liver can be obtained. These visco-elastic 
parameters are currently the most accurate biomarkers of liver fibrosis. However, 
other factors than fibrosis can influence the mechanical properties of the liver, 
including inflammation, bile duct obstruction and stellate cell activation. 
Learning Objectives:
1. To understand the importance of detecting and assessing the severity of liver 
fibrosis.
2. To learn about the value and limitations of different imaging methods for the 
quantification of liver fibrosis.
3. To compare imaging and non-imaging biomarkers of liver fibrosis.
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08:30 - 10:00 Room E2 
Foundation Course: Head and Neck Radiology 
E³ 320a 
Imaging techniques and common pitfalls 
Moderator:
B. Bobek‑Billewicz; Gliwice/PL 
A‑062 08:30 
A. Computed tomography 
R. Maroldi; Brescia/IT (maroldi@med.unibs.it) 
The main advantages of the current CT technology consist of its high spatial and 
temporal resolution. A key issue of spatial resolution is the availability of isotropic 
voxels below 0.30 mm to study very small bony structures as the ossicles in the 
middle ear, or the bony labyrinth. Improvements of temporal resolution permits to 
examine the head and neck in most uncooperative patients, and to better separate 
arterial and venous phases. The combination of high spatial and temporal resolu-
tion enables a precise evaluation of complex structures, as the larynx, minimizing 
artifacts due to patient movement. However, the smaller are the voxels, the more 
the SNR diminishes, thereby often resulting in a poor contrast resolution. The 
radiologist should be aware of this limitation. The choice of the proper slice thick-
ness in MPR or MIP may significantly increase the SNR and the detectability of 
the vascular structures, respectively. In addition, MPR and MIP reconstructions 
provide the power of high resolution in the coronal and the sagittal planes. Specific 
CT protocols have been tailored to achieve the necessary information in the vari-
ous areas of the head and neck and in different diseases (i.e. low mA in sinonasal 
inflammatory lesions, high mA in tumor assessment to maximize lesion detection). 
Though contrast agent administration usually enhances the pattern of the lesions 
(and the adjacent neck “key” vessels), on CT the contrast resolution of tissues is 
poor when compared to MR. 
Learning Objectives:
1. To appreciate the possibilities and limitations of CT in head and neck 
radiology.
2. To become familiar with technical factors affecting image quality, including 
contrast agent administration protocols.
3. To learn how to fully exploit the possibilities of multidetector CT in head and 
neck imaging.
A‑063 09:15 
B. Magnetic resonance imaging 
M.G. Mack; Frankfurt a. Main/DE (m.mack@em.uni‑frankfurt.de) 
Magnetic resonance imaging is the state-of-the-art method for the evaluation of 
head and neck disease. Especially in the head and neck area, the quality of the 
examination depends on the correct selection and adjustment of the MR sequences. 
The goal of this course is to learn how a MRI examination of the head and neck can 
be optimized. The advantages and disadvantages of different MR sequences will 
be discussed. Over the past few years, diffusion-weighted MRI has evolved from a 
technique that is primarily used to evaluate acute cerebral infarction to one that is 
employed to study a variety of head and neck disease. The use of specific contrast 
agent will be evaluated further. This course will reduce the rate of diagnostic errors 
by helping radiologist distinguish pathology from MRI appearance that may simulate 
disease. Tips and tricks of patient positioning and adaption of the sequences will 
be presented. In addition, this course will demonstrate the different artefacts and 
the most common pitfalls of magnetic resonance imaging in the head and neck 
and how to avoid them. 
Learning Objectives:
1. To appreciate the possibilities and limitations of MRI in head and neck 
radiology.
2. To become familiar with technical factors affecting image quality in head and 
neck MRI.
3. To learn about new developments in MRI of head and neck pathology.
08:30 - 10:00 Room F1 
Interactive Teaching Session 
E³ 320b 
Breast cancer: Diagnosis, staging and follow-up 
Moderator:
A. Tardivon; Paris/FR 
A‑064 08:30 
Breast cancer: Diagnosis, staging and follow-up 
K. Kinkel1, J. Camps Herrero2; 1Chêne‑Bougeries/CH, 2Valencia/ES 
(karen.kinkel‑trugli@wanadoo.fr) 
Imaging guided biopsy has replaced surgical biopsy of suspicious breast lesions to 
reduce unnecessary surgery for benign disease and indicate the need for sentinel 
lymph node procedure. Biopsy guidance depends on lesion visibility at sonography, 
mammography or MRI. To minimize false negative results, 9-14G needles and vacuum 
assisted systems are preferred sampling methods for most lesions. Image documenta-
tion of non palpable lesion location and residual amount after biopsy is mandatory for 
preoperative lesion localization planning. A clip is positioned at the site of biopsy when-
ever a suspicious lesion disappears during sampling or neoadjuvant chemotherapy. 
Preoperative lesion localization is usually guided by the imaging modality that has 
been used for biopsy. Specimen radiograph during surgery reduces surgical cancer 
removal with positive tumor margins at postoperative pathology. Breast cancer staging 
encompasses a wide variety of anatomical and pathologic features that have a clear 
impact on treatment: size, extensive intraductal component, extension to the nipple-
areola complex, the pectoralis muscle or the skin and lymph node status. Compared 
to mammography and ultrasound, MRI is the most accurate imaging modality for 
local staging, except for lymph node assessment, where ultrasound and fine-needle 
aspiration biopsy are the techniques of choice. The different follow-up strategies in 
the breast cancer patient depend on the clinical scenario: assessment of response to 
neoadjuvant chemotherapy, follow-up of patients treated with conservative or recon-
structive surgery, confirmation of a suspected recurrence and evaluation of residual 
disease after positive margins at pathology. The role of different imaging modalities 
will be demonstrated in teaching cases. 
Learning Objectives:
1. To obtain adequate lesion samples to allow histological proof prior to 
treatment.
2. To learn how to evaluate the extent of breast cancer.
3. To learn the different follow-up strategies in patients with breast cancer.
08:30 - 10:00 Room F2 





U.G. Mueller-Lisse; Munich/DE (ullrich.mueller‑lisse@med.uni‑muenchen.de) 
Prostate cancer is now estimated to be the most frequently detected cancer in 
men, with the exception of skin cancers (25% of all new cancers in male patients 
in the US). It is the second most common cause of cancer death among men (9% 
of all cancer deaths in male patients in the US). The debate over screening for 
prostate cancer has been active for years. While regional and multinational trials 
continue, there is as yet no nationwide screening project established. Prostate 
specific antigen (PSA) has increased the number of prostate cancers detected 
at an early stage, with curative treatment options and increased post-therapeutic 
survival. With increased numbers of small cancers being detected, there are more 
therapeutic modalities available, both in urological surgery and in radiation oncology. 
Choice demands for selection criteria, including radiological imaging, as an aid to 
decisions. After therapy, patients with prostate cancer are being followed-up, to rule 
out both complications of the respective therapy selected and the development of 
recurrence or metastasis. Findings at follow-up may have to be corroborated and 
treatments planned based on radiological imaging. This multidisciplinary session 
demonstrates and discusses current diagnostic and therapeutic options in prostate 
cancer and the respective role of radiological imaging, with emphasis on commu-
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Learning Objectives:
1. To know which clinical and imaging tests are available to detect and localise 
prostate cancer, and how they are currently being applied in clinical practice.
2. To know which clinical and imaging tests are available to determine the 
extent of prostate cancer and its complications both before and after therapy.
3. To know which therapeutic options are available to treat prostate cancer, and 
what factors influence the selection of treatment modality.
A‑066 08:35 
What the surgeon needs to know 
M. Seitz; Munich/DE (Michael.Seitz@med.uni‑muenchen.de) 
The diagnosis of prostate cancer (PC) is based on a combination of digital rectal 
examination (DRE), serum prostate specific antigen (PSA) testing, and transrectal 
ultrasound (TRUS)-guided biopsy. In prostate cancer diagnosis or staging, neither 
computed tomography (CT) nor magnetic resonance imaging (MRI) are routinely rec-
ommended by European Association of Urology (EAU) guidelines. Nevertheless, MRI, 
PET/CT-scans and other modalities such as contrast-enhanced TRUS, MRI-guided 
biopsy, MRI/TRUS-fusion guided biopsy and elastography are increasingly gaining 
recognition as important tools for the detection and localization in patients suspected 
of prostate cancer. The aim of the lecture is to review the current and future clinical 
status of imaging procedures in the detection and localization of prostate cancer and 
what factors may influence the selection of treatment modality such as radical prosta-
tectomy (RP), radiation (EBRT), hormonal therapy (HT), watchful waiting (WW) and 
active surveillance (AS). Another main issue of the lecture, which is of high interest for 
clinicians, is the diagnostic value of imaging in patients with recurrent PC after definitive 
therapy. We illuminate the advantages and drawbacks of TRUS, MRI and functional 
MRI-techniques as well as choline-based PET/CT-scanning. 
Learning Objectives:
1. To know which tests can be performed to detect and localise prostate cancer, 
and the role diagnostic imaging plays.
2. To know which urologic treatment options there are for prostate cancer, what 
factors influence the selection of treatment modality, and if those factors can 
be evaluated on a clinical basis.
3. To know what information is necessary and what is useful for the surgical 
treatment of prostate cancer.
4. To know how surgical results are evaluated and how complications are 
detected.
5. To know how the patients are followed up.
6. To know how recurrence is detected, analysed, and managed.
A‑067 08:55 
What the oncologist needs to know 
C. Belka; Munich/DE (Claus.Belka@med.uni‑muenchen.de) 
Radical surgery and radiation alone or in combination comprise highly effective 
treatment modalities for prostate cancer. Up to now, only population based data 
indicate that in primary treatment settings surgery and radiation are equally ef-
fective. Due to compliance problems and ethical consideration, no randomized 
trial will address this question in the foreseeable future. In case of a biochemical 
relapse or R1 resection, radiotherapy is the only curative approach currently known. 
Diagnosis and treatment monitoring is still based mainly on PSA determination. 
However, MRI and chlorine-PET may add important information in several clinical 
situations. In this regard, the determination of an exact T stage and N stage is the 
most important question to be addressed by imaging. 
Learning Objectives:
1. To know about clinical staging of prostate cancer and what role there is for 
diagnostic imaging.
2. To know which radiation therapy options there are for prostate cancer, what 
factors decide on the selection of treatment modality, and if those factors can 
be evaluated on a clinical basis.
3. To know how the response to the treatment is evaluated.
4. To know which complications may occur and how complications are detected.
5. To know how the patients are followed up.
6. To know how recurrence is detected, analysed, and managed.
A‑068 09:15 
Imaging in prostate cancer 
U.G. Mueller-Lisse; Munich/DE (ullrich.mueller‑lisse@med.uni‑muenchen.de) 
Digital rectal examination (DRE) and prostate-specific-antigen testing (PSA) rep-
resent the mainstay of prostate cancer (PCA) detection and are of limited use for 
staging. Transrectal ultrasonography (TRUS) guides prostate biopsy when either 
DRE or PSA yields abnormal results. Magnetic resonance imaging (MRI) appears 
to be more accurate than either DRE or TRUS-guided biopsy and can help to detect 
and localize PCA and guide targeted biopsy in patients with suspicious PSA and 
previously negative prostate biopsy results. Studies in small patient populations 
with negative prostate biopsy results concordantly show moderate to high positive 
predictive values (approximately 40-90%) and high negative predictive values 
(approximately 87-100%) for combined MRI and MR spectroscopy. MRI can be 
helpful for the local staging of PCA, including extracapsular extension (ECE) and 
seminal vesical invasion (SVI). MRI findings most indicative of ECE include oblit-
eration of the recto-prostatic angle and asymmetry of the neurovascular bundle. 
While accuracy of MRI varies widely, it appears to improve with maturation of MR 
technology (e.g., combined phased-array-endorectal-coil-systems, faster MRI 
sequences, more powerful gradient coils, and improved image post-processing), 
reader experience (e.g., almost 40% more sensitivity for ECE in experienced read-
ers), and combination of MRI with other MR techniques (e.g., combined dynamic, 
contrast-enhanced MRI with sensitivity/specificity of 85/95% for ECE, respectively). 
For SVI, sensitivity of MRI varies (approximately 25-80%), while specificity is high 
(approximately 80-99%). Data are limited for recurrent PCA, but one study reports 
sensitivity/specificity of 95/100% for local recurrence. PET/CT with choline-markers 
aids in the detection of nodal and distant metastasis of PCA. 
Learning Objectives:
1. To review different diagnostic imaging modalities and their respective 
capabilities in the diagnosis.
2. To summarise diagnostic imaging modalities and their respective test quality 
parameters in tumor detection and localisation.
3. To learn about tumor staging.
4. To learn about challenges in the detection of recurrences.
Panel discussion and case presentation 09:35 
08:30 - 10:00 Room G/H 
Special Focus Session 
SF 3b 
Imaging the polytrauma patient 
Moderator:
A. Palkó; Szeged/HU 
A‑069 08:30 
Chairman’s introduction 
A. Palkó; Szeged/HU (palkoand@gmail.com) 
In the modern trauma management environment, the role of imaging diagnostics is 
paramount. At the same time, the number of available modalities and the special ex-
pertise required for the appropriate treatment of the trauma patient makes it of utmost 
importance to define the optimal, but at the same time sufficiently flexible, diagnostic 
algorithm. The definition is supposed to extend not only to the sequence of available 
modalities in different clinical settings but should also reflect the special attitude required 
from the radiologist in this special emergency environment. Thus, the goal of this session 
is to discuss rather the management and procedural details, the structured diagnostic 
algorithm than the imaging symptoms and techniques, while of course these should 
still play a role in the introduction and discussion of the topic. 
Session Objectives:
1. To introduce the critical role of the radiologist in the care of polytrauma 
patients.
2. To understand the role of imaging and image-guided intervention in reducing 
morbidity and mortality.
3. To explain appropriate diagnostic algorithms in different clinical settings
A‑070 08:35 
Who, when and where: The role of the radiologist in the trauma team 
G. Schueller; Vienna/AT (gerd.schueller@meduniwien.ac.at) 
Trauma induced mortality is approximately as high as of cardiovascular and onco-
logic disease together. During the last decade, the radiologist’s role in dedicated 
trauma centres has been changing considerably. Most often, time is the major 
determinant for the prognosis of the traumatized patient. The radiologist’s expertise 
is needed to rapidly assess life-threatening conditions on the one hand and to pro-
vide adequate information about the extent of organ lesions on the other, thereby 
predicting whether surgery would become necessary or wait and see strategies 
would be of help. Hence, the radiologist is in the very middle of the trauma team, 
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along with trauma surgeons and anesthesiologists. For that purpose, injury severity 
scores are of great help, and the radiologist must be familiar with these scores, as 
well as with the therapeutic consequences associated with them. 
Learning Objectives:
1. To learn about teamwork and evidence-based procedures in the 
management of polytraumatised patients from the radiologist’s point of view.
2. To understand CT-based injury severity scores, and the associated 
therapeutic consequences.
3. To become familiar with the specific requirements regarding equipment, workflow 
and training of technicians and radiologists in an emergency unit environment.
A‑071 08:45 
Front line sonography 
E. Danse; Brussels/BE (danse@rdgn.ucl.ac.be) 
Our aim is to report on the current opinion about the role of US for the manage-
ment of polytraumatized patients. In this specific context, US is used for detection 
of intraperitoneal free fluid, pleural effusion, and indirect signs of pneumothorax. 
In hemodynamically unstable patients, US is followed by an urgent exploratory 
laparotomy or an angiographic procedure depending of US findings. In stable 
patients, negative or positive US is followed by a whole body CT evaluation. Based 
on this presentation, the audience has to be informed to the current opinion about 
the following items: 1. When to do this examination? At the time of accident, during 
the resuscitation process, during the transport or at the initial time of admission 
in the emergency room? 2. Where to do this examination? On the scene of the 
trauma, in the emergency department, in the operating room, in the radiological 
department? 3. Who will do the examination? The more skilled and available opera-
tor, a sonographer or a doctor, including an emergency physician, a surgeon, an 
anesthesiologist, and at the end, a radiologist? 4. Which device has to be used? 
Mobile/portable sonographic machine, high tech device? 5. What do we have to 
look for? a) ascitis and visceral lesions, chest and cardiac abdnormalities? b) which 
findings can help for triage of the patients and definitions of priorities? Wait and see, 
CT without delay, CT with delay, early angiographic procedure or early laparotomy. 
Learning Objectives:
1. To learn about the role and limitations of sonography in the management of 
polytraumatised patients.
2. To be informed about the indications, timing, technical requirements and 
operator skill of US examination of the polytrauma patient.
3. To understand the significance of different findings (visceral, chest and 
cardiac abnormalities, pathologic fluid accumulations, vascular injuries, etc). 
detectable by US.
A‑072 09:05 
MDCT as the single best solution 
U. Linsenmaier; Munich/DE (ulrich.linsenmaier@med.uni‑muenchen.de) 
Diagnosis of trauma-related injuries is a key issue in modern emergency radiology. Fast, 
early and comprehensive, as well as accurate depiction of potentially life-threatening 
injury patterns is crucial. Conventional radiography (CR) and ultrasound (US) are well-
established and still in use for a basic diagnostic work-up; however, many of studies 
have shown a lower detection rate compared to CT. MDCT with its shorter scan time and 
increased accuracy has become the gold standard for all patients after major trauma. 
This lecture will cover the following issues: we will initially present current concepts 
of the so called „whole body CT (WBCT)“ or synonymously used „trauma pan scan“ 
protocols for the initial radiological management of patients with major trauma (syn. 
polytrauma, multiple injured). We discuss also the use of MDCT for the primary patient 
survey (ATLS), integration of MDCT scanners in the emergency room and outcome of 
patients after MDCT. We then focus on comprehensive whole body MDCT scan pro-
tocols for use in different scanner types, from 4, 16, 64 to 128 detector row scanners, 
including, technical aspects, slice and detector collimation, contrast medium injection, 
scan phases and image reconstruction parameters. MDCT delivers higher radiation 
dose, professional optimization of imaging parameters is recommended to minimize 
exposure and maximize diagnostic safety. We then present recent approaches for fast 
volume image data reading (VIR), handling large data sets, as well as handling of a 
larger number of patients as in mass casualties incidences. 
Learning Objectives:
1. To understand the major role of MDCT in the early assessment of 
polytrauma patients and its influence on outcome.
2. To learn about comprehensive whole body protocols for patients with polytrauma 
(for 4-16-64 and > 64*MDCT scanners), technical aspects, contrast medium 
injection, scan phases and image reconstruction parameters.
3. To appreciate approaches for fast volume image data reading, logistics of an 
emergency radiology unit and factors affecting patient throughput.
A‑073 09:25 
The growing importance of interventional radiology 
T. Jargiello; Lublin/PL (tojarg@interia.pl) 
Catheter-based, endovascular techniques had become an integral part of the trauma 
team’s armamentarium. Although recognition of the role of interventional radiology 
in vascular trauma have a significant impact in decreasing morbidity and mortality, 
not all hospitals have possibility to use it as 24-hour service. Transcatheter arte-
rial embolization is the basic IR technique used to control bleeding in polytrauma 
patients. Each case of vascular or solid organ trauma is different, especially when 
it takes multi-organ injury. That is why specialized IR team must have at their own 
disposal all possible catheter equipment (coaxial technique) and all available 
embolization materials. Injuries of main vascular trunks can also be managed with 
covered stents (stentgrafts) - but it is really hard to have all its types and sizes on 
stock. Apart from TEA and stenting, percutaneous drainage procedures are also of 
some importance especially, when there is a need to minimally invasive treatment 
of pathologic blood or other fluid collections. Sometimes, both methods are used 
in particular patient simultaneously. Good results of IR treatment of polytrauma 
patients are strictly depend on patients’ clinical status. Stable patients or those 
with rapid response to fluid resuscitation (SBP > 80 mmHg) have better chance 
for successful minimally-invasive intervention. Injury Severity Score (ISS) is very 
helpful in predicting the final outcome (mortality rate). According statistics, patients 
with ISS less than 50 are almost all to survive after non-surgical treatment and 
those with ISS > 50 may not respond to this type of therapy. 
Learning Objectives:
1. To discuss the role of interventional radiologists in the trauma team.
2. To learn about the possibilities of interventional radiology.
3. To recommend the appropriate methods depending on the clinical status of 
the patient.
Panel discussion:  
Imaging in polytrauma: How can we help most? 09:45 
08:30 - 10:00 Room K 
Special Focus Session 
SF 3c 
Pediatric non-traumatic emergencies:  
What we must know! 
Moderator:
M. Raissaki; Iraklion/GR 
A‑074 08:30 
Chairman’s introduction 
M. Raissaki; Iraklion/GR (mraissaki@yahoo.gr) 
Pediatric non-traumatic emergencies represent a large proportion of all pediatric 
radiology cases and are ideally managed by experienced personnel, familiar with 
the nature of the emergency. It is important to appreciate that certain signs and 
symptoms are indicative of dangerous conditions with significant morbidity and 
mortality if left untreated or if there is delay in diagnosis and treatment. It is equally 
important to realise that conversely, in other cases, imaging could be delayed but 
is usually performed on an emergency basis to alleviate parent’s and/or doctor’s 
anxiety. In some life-threatening conditions, symptoms may be disturbing and 
alarming while in other situations with equally dangerous conditions, symptoms 
may be mild. In all cases, the radiologist should play an active role by keeping a 
high index of suspicion for the devastating pediatric emergencies and by choosing 
the most appropriate test taking under consideration the age of the patient, past 
medical and present history, together with the signs and symptoms. Every test 
should be performed appropriately with a dedicated technique, depending on the 
clinical question especially when considering aspirated foreign bodies and gastro-
intestinal abnormalities. Experienced radiologists prove an invaluable assistance to 
clinicians for the management of these cases guiding towards medical or surgical 
therapy and sometimes offering therapeutic intervention. Paediatric non-traumatic 
emergencies can be divided into four main categories, requiring imaging of the 
brain, chest, abdomen and musculoskeletal system. 
Session Objectives:
1. To discuss the most common non-traumatic pediatric emergencies.
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3. To recommend the most appropriate imaging test depending on age, history 
and symptoms.
4. To understand the importance of appropriate technique when performing 
certain tests on children.
A‑075 08:33 
Neurological emergencies 
C. Garel; Paris/FR (catherine.garel@trs.aphp.fr) 
Some conditions or symptoms may be highly suggestive of brain damage. In neo-
nates, hypoxic-ischaemic encephalopathy, seizures with or without fever, marked 
hypotonia, apnea, marked thrombopenia or thrombophilic disorders prompt rapid 
investigation. In both neonates and older children, intracranial hypertension, con-
sciousness disorders or infectious context with neurological findings require urgent 
cerebral imaging. In older children, acute onset or rapid evolution of neurological 
symptoms or onset of neurological symptoms in a child suffering from sickle cell 
disease, haematological malignancy or solid tumour are also an emergency. In all 
these conditions, cerebral imaging may directly impact on therapeutic manage-
ment. Conversely, in other cases, cerebral imaging could be delayed but is usually 
performed rapidly due to parental and/or medical anxiety. This is particularly true 
in neonates when brain abnormality was diagnosed by prenatal imaging and 
pregnancy was not terminated or when facial malformation or syndrome with pos-
sible brain involvement are discovered at birth and were not diagnosed by prenatal 
ultrasound. Ultrasound is a good screening and monitoring imaging modality in 
neonates but lacks sensitivity and may overlook numerous cerebral lesions. Com-
puted tomography can rapidly detect hydrocephalus or haemorrhage but it also 
lacks sensitivity. Magnetic resonance is the most sensitive current imaging modality 
and has better contrast resolution. Diffusion weighted imaging may be particularly 
useful in the setting of cerebral emergency. 
Learning Objectives:
1. To appreciate alarming symptoms requiring urgent investigation.
2. To differentiate true emergencies for which cerebral imaging may directly 
impact on therapeutic management and “delayed” emergencies related to 
parental and/or medical anxiety.
3. To be aware of the main cerebral non-traumatic emergencies in neonates 
and older children.
4. To learn about the respective contributions of US, CT and MRI.
A‑076 08:51 
Thoracic emergencies 
C.E. de Lange; Oslo/NO (charlotte.eva.delange@rikshospitalet.no) 
In children, non-traumatic thoracic emergencies are very frequent and usually 
present with breathing difficulties. Sometimes, feeding or swallowing problems are 
associated or presenting symptoms. In addition, less specific general symptoms 
like fever, sepsis or chest pain may occur. The emergencies always require a rapid 
diagnosis to establish a medical or surgical intervention plan, and radiological imag-
ing most often plays a key role. Correct interpretation of the radiological findings 
is of great importance to diagnose and monitor the illness and to avoid serious 
complications. Plain radiography with inspiratory and sometimes expiratory films or 
fluoroscopy still remains the most important and frequently used tool to gain informa-
tion on acute pulmonary problems of all kinds. Ultrasonography is the first choice 
for diagnosis and treatment of pleural effusions. Cross-sectional techniques like 
multidetector computed tomography and magnetic resonance imaging are mainly 
used for investigating pulmonary/mediastinal masses and congenital abnormalities 
of the great vessels and the lungs. This lecture will review the imaging characteris-
tics of acquired and congenital causes to non-traumatic thoracic emergencies; the 
common conditions involving the respiratory tract, chest wall and the esophagus, 
as well as the less frequent causes like tumours and manifestations of congenital 
malformations. The choice of imaging modality and the urgency of radiological 
management depending on the clinical presentation and the age of the child will 
be discussed, with the main focus beyond the neonatal period. 
Learning Objectives:
1. To learn about the spectrum of thoracic emergencies in children, including 
foreign bodies, mediastinal tumors, infection, asthma, air leaks and delayed 
manifestations of congenital chest malformations.
2. To consolidate knowledge of the essential role of radiology in making a rapid 
diagnosis, planning treatment and avoiding devastating complications.
3. To understand the different thoracic emergencies depending on age.
4. To recommend the appropriate radiological technique depending on the 
clinical indication and the patient’s age.
A‑077 09:09 
Abdominal emergencies 
S.G.F. Robben; Maastricht/NL (srob@rdia.azm.nl) 
Several pediatric diseases are real abdominal emergencies. Any delay in diagnosis 
and treatment may result in death or severe morbidity. These diseases are highly 
age-dependent. Newborn infants may have congenital diseases as Hirschsprung’s 
disease or meconium ileus or may develop necrotizing enterocolitis, incarcerated 
inguinal herniation and midgut volvulus. Infants and preschool children have 
intussusceptions, urinary tract infections and (rare) hemolytic uremic syndrome. 
Children and adolescents have appendicitis, genito-urinary infections, ovarian tor-
sion and Henoch Schonlein purpura. Considering radiation dose in children and the 
excess value of ultrasonography (US) in small individuals, US plays an important 
role as initial diagnostic modality in pediatric abdominal emergencies. Sensitivity 
and specificity for US in diagnosing intussuception, midgut volvulus, urinary tract 
abnormalities and appendicitis is over 90%. Conventional abdominal radiographs 
or fluoroscopy are valuable in Hirschsprung’s disease, meconium ileus, malrota-
tion and necrotizing enterocolitis. I consider CT as an additional technique when 
the initial techniques (US and conventional radiography) are inconclusive. MRI is 
seldom indicated in pediatric patients with abdominal emergencies because of 
motion artifacts in anxious children and sometimes limited MR capacity. Delay 
in diagnosis of the above-mentioned diseases may be devastating, ranging from 
life-long disability to death. Therefore, it is important to consider these diagnoses 
and to initiate prompt adequate diagnostic work-up. 
Learning Objectives:
1. To discuss the most common and devastating pediatric abdominal 
emergencies.
2. To discuss the appropriate imaging techniques in pediatric abdominal 
emergencies.
3. To understand the consequences of any delay in diagnosis.
A‑078 09:27 
Musculoskeletal emergencies 
K.J. Johnson; Birmingham/UK (karl.johnson@bch.nhs.uk) 
The common non-traumatic paediatric musculoskeletal emergencies which involve 
radiological evaluation in the order of priority are sepsis, slipped capital (upper) 
femoral epiphysis (SCFE) and malignant tumours. This presentation will discuss 
the clinical presentation of these conditions, the role and timing of imaging (and 
its limitations) and the appropriateness of specialist referral in these conditions. A 
septic joint or limb can rapidly cause significant dysfunction and long-term morbidity. 
Fortunately, appropriate rapid treatment will often lead to complete cure. Radiology 
is helpful in confirming the diagnosis, but the imaging features can be non-specific. 
Importantly, normal radiological findings, in particular radiographs and ultrasound, 
cannot exclude the diagnosis and clinical evaluation remains vitally important. The 
radiological features of osteomyelitis and septic arthritis will be demonstrated. 
The value of magnetic resonance imaging in detecting occult infection, assessing 
collections and planning appropriate surgical intervention will be illustrated. SCFE 
can either present as an acute or an acute and chronic problem. It is important that 
both AP and lateral radiographs are obtained to assess the hips. The important 
diagnostic clues in assessing for SCFE will be discussed. The role of MR imaging 
as a complementary investigation will be highlighted. When there is a suspicious 
bone lesion, those features which suggest more rapid and aggressive growth will 
be illustrated. The difficulties in excluding a malignant lesion along with the ap-
propriate use of cross-sectional imaging and the importance of specialist referral 
will be discussed. 
Learning Objectives:
1. To learn about the three commonest musculoskeletal diseases that require 
urgent radiological evaluation and stress the complications of delay in 
diagnosis and treatment.
2. To discuss the complementary role of different imaging modalities in the 
evaluation of musculoskeletal infection, slipped capital femoral epiphysis and 
malignancy.
3. To recommend imaging algorithms.
Panel discussion:  
How to manage the stressed pediatrician 09:45 
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08:30 - 10:00 Room L/M 
Special Focus Session 
SF 3d 
Fetal body MRI 
Moderator:
M. Bekiesinska‑Figatowska; Warsaw/PL 
A‑079 08:30 
Chairman’s introduction 
M. Bekiesinska-Figatowska; Warsaw/PL (m.figatowska@mp.pl) 
Over the last 27 years, much has been written about fetal MRI, an adjunct technique 
to sonography in the detection of prenatal malformations, allowing for confirmation, 
completion and/or correction of sonographic findings. Most publications concerned 
fetal neuroradiology as the assessment of the central nervous system of the fetus 
was the main indication for prenatal MRI. The spectrum of indications has grown 
however and MRI has emerged as a diagnostic tool for global assessment of the 
fetal body because new ultrafast MRI sequences have eliminated artifacts caused 
by fetal motion and provided very good quality of T2-weighted images acquired in 
less than one second. A high contrast between details of fetal body can be obtained 
thanks to the large amounts of water in most of fetal tissues. The purpose of this 
session is to review practical aspects of MR imaging of fetal thorax, abdomen and 
musculoskeletal system. The radiologists should know the normal anatomy of the 
fetal body and be able to recognize the pathologies characteristic for this develop-
mental period. A discussion closing the session should answer the question whether 
this concerns every radiologist or will remain a task for superspecialized radiologists. 
Session Objectives:
1. To understand the role of prenatal body MRI.
2. To learn about the added value of MRI compared to US in prenatal diagnosis 
of the thorax, abdomen and musculoskeletal system.
3. To become familiar with imaging features of pathologies in these areas of the 
fetal body.
A‑080 08:35 
MRI of the thorax 
P. Eliás; Hradec Králové/CZ (elias@fnhk.cz) 
Magnetic resonance imaging (MRI) still suffers from limited temporal resolution and 
is rarely used for fetal cardiac studies. On the contrary, MRI has fewer physical and 
subjective limitations than ultrasonography (US) and offers different information 
using fast T2 and T1-weighted sequences. That is why it is becoming a valuable 
adjunct to US in evaluation of fetal thorax. MRI can aid in three categories: 1) to 
provide more details on abnormalities seen on US, 2) to refine volumetry of the 
lungs, and 3) to provide the data on lung maturation. In congenital diaphragmatic 
hernia, two major prognostic factors can be accurately evaluated: presence of 
intrathoracic liver tissue (T2 hypo- and T1 hyperintense structure) and volume 
of the residual lungs. Estimation of total fetal lung volume on MRI seems to have 
better predictive value than traditionally used lung/head ratio based on US. Con-
genital cystic adenomatoid malformation and pulmonary sequestration present as 
T2 hyperintense and T1 hypointense expansile lesions. MRI is frequently used to 
confirm the diagnosis and for follow-up of possible regression of these abnormali-
ties. Contrary to Doppler US, MRI is not able to differentiate between each other 
and is of limited predictive value. Developing fetal lung shows gradual increase of 
T2 and decrease of T1 signals due to increasing fluid content. Thus, the quantifica-
tion of their relative values with liver serving as a reference organ can be used for 
assessment of pulmonary maturation. Diffusion weighted or spectroscopic MRI 
studies do not seem to be of additional value at present. 
Learning Objectives:
1. To become familiar with the standard US and MR examination techniques for 
imaging of the fetal thorax.
2. To learn the basic aspects of normal imaging anatomy.
3. To cover the most important pathological entities affecting the fetal thorax and to 
show the strengths and weaknesses of US and MR in diagnosing them.
4. To point out currently accepted indications and future perspectives of MRI.
A‑081 08:58 
MRI of the abdomen 
T.A.G.M. Huisman; Baltimore, MD/US (thuisma1@jhmi.edu) 
Fetal MRI has evolved to be a valuable second line imaging modality to confirm, 
correct or complete prenatal ultrasound (US) findings. Fetal MRI has proven to be 
especially helpful for the central nervous system (CNS), but is however less well 
established for fetal abdominal pathologies. With growing fetal imaging expertise, 
increasing acceptance of fetal MRI, and ongoing hard- and software developments, 
fetal MRI is progressively been used for abdominal indications. The fetal radiologist 
should be familiar with the normal abdominal fetal anatomy and embryology to 
understand and identify fetal abdominal pathology. Based upon the normal devel-
opment of the abdominal organs and gastrointestinal (GI) tract, we will review the 
various fetal pathologies that can be identified by fetal MRI. In particular, we will 
review what the added value of fetal MRI is compared to prenatal US, which kind of 
image contrasts should be used and what their respective value is in the examina-
tion of fetal pathology. Many abdominal indications have already been established 
including pathologies of the GI-tract (atresia), the mesenterium (lymphangioma), 
the solid organs (neuroblastoma) and urogenital tract (renal agenesis, cloacal 
malformation). The list of abdominal indications is however continuously growing. 
The importance of evaluating abdominal pathologies in the context of the entire 
fetal anatomy is obvious. Lesions within the abdomen may be related to adjacent 
or distant lesions but may also be part of a syndrome or even related to a possible 
twin fetus. Consequently, a fetus with an abdominal pathology should always receive 
a complete fetal MRI examination. 
Learning Objectives:
1. To learn about fetal abdominal MRI and its current and future indications.
2. To understand the strengths and weaknesses of fetal MRI of the abdomen.
3. To appreciate the added value of fetal MRI compared to US in examining 
fetal abdominal pathologies.
4. To become familiar with the different fetal MRI techniques for studying 
abdominal pathologies.
5. To consolidate knowledge of abdominal pathologies that can be encountered 
intrauterine.
A‑082 09:21 
MRI of the skeleton 
D. Prayer, S.F. Nemec, G. Kasprian, D. Bettelheim, P.C. Brugger; Vienna/AT 
(daniela.prayer@meduniwien.ac.at) 
Diagnosis of pathologies of the fetal musculoskeletal system is regarded as a do-
main of ultrasound. Especially, 3D techniques allow detailed information on small 
details already in the early second trimester. Regarding these details, MRI is inferior 
to ultrasound even if the availability of echoplanar or gradient-echo sequences has 
improved its ability to visualize bone. However, skeletal malformations and deformi-
ties may be parts of complex syndromes, the prognosis of which depends on the 
presence or absence of additional pathology. In such cases, for instance in Chiari 
II syndrome, MRI may provide information that allows to estimate the prognosis 
more accurately. MRI can show the type of spinal dysraphism, and the extent of 
cerebral involvement. In syndromes like arthrogryposis that have a wide variety of 
etiologies, some of them may be proved or excluded. In case of a single anomaly, 
as for instance, a club foot, the question of presence or absence of a complex 
malformation or an underlying syndrome may be answered by MRI. Skeletal mal-
formations are often associated with thoracic deformities leading to a reduction of 
lung volumina. Lung volumetry and assessment of lung signals help to conclude 
on postnatal lung functionality. Malpositioned limbs may be the consequence of 
neuromuscular diseases. In such cases, MRI may find pathological signals in the 
muscles. It has also been described that MRI can demonstrate the developmental 
changes of the non-osseous parts of the metaphysis of the long bones. Whether 
this information will be usable for diagnostic purposes will have to be proved. 
Learning Objectives:
1. To understand which sequences demonstrate the fetal musculoskeletal 
system most adequately.
2. To learn the contribution of MRI in the workup of musculoskeletal 
pathologies.
3. To recognise characteristic features of such pathologies on US and MRI.
Panel discussion:  
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08:30 - 10:00 Room N/O 
Professional Challenges Session 
PC 3 
Teaching: Art, habit or science? 
Moderator:
J.E. Wildberger; Maastricht/NL 
A‑083 08:30 
Chairman’s introduction: Teaching and education - help yourself: 
Requirements for the future of radiology 
J.E. Wildberger; Maastricht/NL (j.wildberger@mumc.nl) 
Teaching and education in medicine is paid more and more attention, last but not 
least for the evident shortage of young academics. If students and young profes-
sionals are made enthusiastic by inspiring lectures and interactive seminars, it will 
be more likely that they are interested in becoming e.g. a radiologist. This session 
will provide different facets of lecturing and seminars. Standards, such as the 
European Training Charter for Clinical Radiology, form a good basis for a local 
adaptation. Core competencies and clinical expertise will always be required to 
present and communicate goals and objectives on a high level. In order to meet 
the miscellaneous expectations, learning objectives and the current level of knowl-
edge in the auditorium have to be considered. Improvements in teaching skills can 
be trained and reflected, e.g. by changing the perspective (teacher-learners), by 
receiving and providing feed-back, from independent evaluations, etc. to meet the 
ultimate goal, a higher level of educational effectiveness. Different approaches and 
perspectives will be presented: active participation can be combined with traditional 
interaction. Also, „new media“ such as e-learning will be discussed, which offer great 
opportunities for teaching and education, especially for our „visual“ and „digital“ 
discipline. These can also be incorporated into dedicated new teaching concepts, 
such as „problem-based learning“, where imaging is integrated rather than being 
a stand-alone discipline. Finally, we are looking forward to a vivid panel discussion 
on the different facets, opportunities and challenges in teaching and education. 
Session Objectives:
1. To review the specific features of teaching and education in radiology.
2. To understand the need of young radiologists in this context.
3. To learn about the current and future concepts for improving teaching and 
education.
A‑084 08:35 
Clinical teaching: Avoid the yawn 
R. Greif; Berne/CH (robert.greif@insel.ch) 
With a little effort, you, too, can deliver an exciting lecture or teaching session. 
As an expert in the field, your job is not just to know your topic by heart - it is to 
inspire your students, igniting the fire of learning rather than inspiring yawns. Ef-
fective clinical teaching requires involvement with your learners. Knowledge of their 
problems, views and visions of the topic influences the learning climate. Exciting 
clinical teachers are not born, they are trained. Get involved in CME seminars about 
teaching, or formal medical education training programs. Spend your limited time in 
seminars focusing on teaching skills that you might transfer to your clinical teaching 
environment. Interaction and emotions initiate learning on the neurophysiologic level 
via the hypothalamus. For this reason, inspiring your students intellectually will do 
more than a brilliant Powerpoint slide show. Communicate meaningful learning 
goals which are relevant for the students‘ clinical tasks and assignments. Give them 
experience by involving them actively in planning, conducting and assessment of 
teaching. Interactive participation provides intellectual stimulation, fostering under-
standing and retention of the subject matter, and motivates further engagement 
in the topic. You as a teacher modulate the learning climate by using a variety of 
teaching methods and learning materials and by adapting your teaching style to 
the learners‘ needs. Finally, recognize that improvement comes through feedback. 
Actively seek assessment of your performance from your peers and your students. 
Stimulate yourself to take on new learning and teaching experiences - and stay 
awake throughout your career. 
Learning Objectives:
1. To understand the need for intellectually inspiring lessons.
2. To learn options for exciting teaching.
3. To develop a practical approach to clinical teaching.
A‑085 08:50 
Clinical teaching: The young doctor’s perspective 
C. Nyhsen; Sunderland/UK (nyhsenc@doctors.net.uk) 
When preparing a teaching program, one usually thinks of the contents first and 
how to incorporate as much information as feasible into a relatively short period of 
time. Much effort goes into layout, making the sessions appealing and giving valu-
able advice. The learners‘ perspective is however often much different. Learning for 
the greater good is frequently replaced by „surviving“ in real life, such as passing 
the next exam or managing the next on-call successfully. It is, therefore, important 
that educators consider the learners‘ point of view. The better they understand the 
students‘ situation, the better the sessions will be received and the more motivated 
the students will become. Furthermore, considering the level of students one is 
teaching is important. Medical students vary greatly from junior medical doctors, 
and first year radiology trainees to more senior trainees. Therefore, a distinction has 
to be made between the very young, the young and the „more mature“ students, 
not only with respect of contents but also with respect of teaching methods used. 
This talk will introduce the Radiology Trainees Forum of the ESR with their role in 
representing the trainees‘ perspective and it is going to address questions such as: 
What are a young doctor‘s expectations? How can I get and maintain the student‘s 
interest? What are the worst mistakes to avoid? 
Learning Objectives:
1. To be aware of the special needs of teaching in radiology.
2. To provide an overview on current practical concepts: The young radiologist’s 
expectations.
3. To become familiar with the concept of the Radiology Trainees Forum (RTF).
A‑086 09:05 
e-Learning: Concept for the future? 
R. Fowler; Leeds/UK (richard.fowler@leedsth.nhs.uk) 
This short presentation will address the potential benefits of e-learning in radiology 
training. It is best utilised as a complementary resource to traditional work-place train-
ing, but can substitute for many of the repetitive instructional tasks allowing a more 
productive interface between learner and trainer. We will consider some of the current 
options with reference to the RCR Radiology Integrated Training Initiative (R-ITI). We 
will suggest how materials like these can best be integrated into radiology training. 
Learning Objectives:
1. To learn the benefits of e-learning in radiology. Is it a complement or a 
substitute to conventional learning?
2. To learn what the current e-options and models are.
3. To become familiar with the e-learning programme of the Royal College of 
Radiology.
A‑087 09:20 
Quality and outcome for teaching in radiology 
S. Kolkman; Amsterdam/NL (s.kolkman@amc.uva.nl) 
A doctor of the future should have a natural ability to use radiology for optimizing 
patient care. This doctor knows which investigation is the best for assessing pathol-
ogy, is aware of the ranking of different imaging modalities, from simple to complex; 
knows the indications for the different investigations and knows how to provide a 
radiologist with relevant information. He/she has practical knowledge of the basics 
of the most commonly used radiologic techniques and knows the risks of ionizing 
radiation. This doctor can identify normal anatomy in different radiological investiga-
tions and recognize pathology. At night, this doctor must recognize life-threatening 
disorders immediately. In every situation he/she must be able to explain his/her 
request to the imaging specialist in a succinct way. To reach this goal, a perfect 
educational radiology program during the medical curriculum is needed. Before 
developing an educational program, the final goal (s) must be clearly formulated. 
The contents should be in accordance with clinical issues. And for optimal results, 
the educational processes should be strictly controlled. In the AMC, Amsterdam, 
we developed a radiology educational program. Starting in the first year of medi-
cal school, different topics with increasing complexity are offered to the students 
throughout all years of the curriculum. The contents are developed by a radiologist 
in close cooperation with anatomists, pathologists and different clinicians, according 
to the subjects. For each part of the program, all students have to pass an exam. 
The programs are continuously evaluated and adapted when necessary, according 
to feed-back questionnaires. 
Learning Objectives:
1. To understand the special needs of teaching in radiology.
2. To be aware of quality criteria and standards in clinical education.
3. To learn how to implement quality control in your teaching practice.
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A‑088 09:35 
Teach the teacher 
M. Hofer; Düsseldorf/DE (matthias.hofer@uni‑duesseldorf.de) 
This presentation will present a short overview of three core competencies in 
order to provide effective lectures and seminars in radiology teaching sessions: 
a) Methods to communicate goals and objectives effectively, b) adequate use of 
questioning- and-answering techniques in interactions and c) effective slide design/
use of media to foster understanding and retention. The most common pitfalls in 
the design of lectures and small group seminars, which we experienced in over 
75 train-the-teacher workshops at six medical schools over the last five years will 
be demonstrated by short examples: • teacher-centered lecturing without active
involvement of the learners; • to much content per time uncoupling of listeners;
• unnecessary dark slide design fatiguing effects on learners; • inadequate use
and dosage of animation in PowerPoint-presentations; and • inadequate use of
assessment questioning. The influence of “psychological size” and the “threat of 
embarrassment”, especially in interactive teaching sessions on diagnostic imaging 
modalities, will be elaborated. Thus, we intend to enhance the teachers’ aware-
ness of these aspects of our interaction between us and our learners in UGME 
(UnderGraduate Medical Education) as well as in PGME (PostGraduate Medical 
Education). Finally, the predominant “blind spot” concerning our own teaching 
skills will be figured out and quantified, based upon previous and retrospective 
self-reflections of the trainees (colleagues) before and after their participation in 
teaching skills workshops. 
Learning Objectives:
1. To learn about the need to educate educators.
2. To understand the interaction between teachers and learners.
3. To develop a structured path on how to teach effectively.
Panel discussion:  
Teaching and education in radiology: Well-prepared for the future? 09:50 
08:30 - 10:00 Room P 
Cardiac 
RC 303 
Systematic approach to congenital heart disease (CHD) 
Moderator:
A. de Roos; Leiden/NL 
A‑089 08:30 
A. Echocardiography: The first line modality 
H. Abdul-Khaliq; Homburg a.d. Saar/DE (abdul‑khaliq@uks.eu) 
The prevalence of congenital heart disease in infancy is nearly 8/1000 and represents 
a heterogeneous spectrum of isolated or a combination of different malformations in 
the heart of connected vessels. Depending on the severity of congenital heart disease, 
immediate postnatal diagnosis is performed by transthoracal echocardiography in 
the majority of infants. Prenatal diagnosis in the majority of cardiovascular malfor-
mations or vessels is possible and may contribute to lower postnatal morbidity and 
mortality. Echocardiography is the first choice to diagnose structural and functional 
abnormalities in infants, children and adults before and after corrective surgery of 
congenital heart disease. Using 2D echocardiography, the intra cardiac and extra 
cardiac anatomy can be visualized in the majority of patients. Colour Doppler can 
be used to assess normal and abnormal intra- and extra-cardiac blood flow patterns. 
Doppler echocardiography provides quantitative information in blood velocity and 
the calculated pressure gradient. The introduction of new imaging modalities such 
as the tissue Doppler and speckle tracking enables quantification of myocardial 
wall movements and deformations providing information on the regional myocardial 
function. 3D echocardiography is not routinely used in assessment of structural heart 
abnormalities. However, the novel real time 3D echocardiography presents a reliable 
method for volumetric assessment of left and right ventricular function. Using these 
parameters, LV ejection fraction and dyssynchroneous contractile function can be 
assessed easily. In conclusion, the conventional and novel echocardiography methods 
provide a non-invasive and easy to perform method for evaluation of the morphology 
and function in the majority of congenital heart diseases. 
Learning Objectives:
1. To discuss differential indications for echocardiography.
2. To systematically analyse CHD.
3. To review cases with complex CHD.
A‑090 09:00 
B. MRI: Getting more specific 
P. Beerbaum1, S. Sarikouch2; 1London/UK, 2Hannover/DE 
Cardiac MR (CMR) has evolved as a diagnostic tool of key importance in the 
management of patients of all age with congenital heart disease (CHD). In clinical 
practice, CMR is considered an ideal adjunct to echocardiography in older children, 
adolescents and adults as reflected by class I-II recommendations for the clinical 
use of CMR by recent consensus panels. More recently, CMR is being increasingly 
used to image complex neonatal and infant CHD to plan surgical, interventional or 
hybrid repair, particularly during staged Fontan-type palliation of single ventricle 
physiology. The main reasons for its attractiveness include the unique abilities of 
CMR to: (1) non-invasively quantify blood flows and ventricular function and (2) 
provide detailed information on cardiovascular and airway morphology, particularly 
in complex CHD. Furthermore, hybrid systems of X-ray fluoroscopy combined with 
MRI scanners (“XMR systems”) allow for detailed investigation of pulmonary vas-
cular resistance using MR flow and invasive pressure recordings. There is active 
research to proceed towards MR-guided cardiovascular interventions in CHD as 
recent advances in the development of MR-safe guide wires and instrumentation 
allow for novel concepts of imaging during interventional procedures, using CMR as 
road map and pre-/post intervention assessment of procedural results. Large-scale 
clinical trials have utilized CMR for quantification of ventricular function in CHD and 
have much improved our understanding of prognostic factors for example in tetralogy 
of Fallot and Fontan circulation. Stress-CMR protocols using physical exercise or 
pharmacological stimulation are currently being investigated with respect to their 
potential role in diagnosing early ventricular failure. 
Learning Objectives:
1. To understand the advantages of MRI in CHD.
2. To use dedicated MRI techniques (e.g. flow measurements) in CHD.
3. To learn which MR parameters have a prognostic value in CHD.
A‑091 09:30 
C. MDCT: Filling the gap 
A. Küttner; Erlangen/DE 
In recent years a multitude of different examining techniques for cardiac CT 
have emerged. Retrospective gating, prospective triggering, Step and shoot and 
most recently the ultra high pitch technique (FLASH) have become available. 
All techniques have their distinctive advantage and disadvantages, which are to 
be discussed when and how to use them properly and how the patient needs to 
be prepared (beta-blocker, nitroglycerine). Furthermore different techniques for 
delivering contrast media are discussed. A special section will also address the 
issue of radiation dose and how to practically implement these considerations in 
daily examination routine. MRI and CT both can create images with high spatial 
and temporal resolution. In this course the advantages and disadvantages of both 
techniques are discussed as well as when to use them in regard to CHD, e.g. plaque 
imaging vs. scar tissue imaging (late enhancement). Coronary Heart disease has a 
wide spectrum, ranging from early plaque detection (“vulnerable plaque”), stenosing 
coronary heart disease (angina pectoris, chest pain protocol, triple-rule-out), acute 
phase imaging (vital myocardium vs. scar tissue), as well as follow up scan after 
stent placement or bypass surgery. The course is discussing different techniques 
how to image specific features and when to apply cardiac CT best.
Learning Objectives:
1. To learn how to examine CHD with MDCT.
2. To compare the advantages and limitations of MDCT in comparison to MRI.
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E. Kuligowska; Boston, MA/US 
A‑092 08:30 
A. “Functional imaging” of the ovary for everybody 
M. Weston; Leeds/UK (Michael.Weston@leedsth.nhs.uk) 
Ovarian morphology, as seen on ultrasound, provides information on the functional 
status of the ovary. The appearance changes as a woman progresses from child-
hood, through menarche and into her post-menopausal years. Furthermore, during 
her menstrual years, the ovary shows clear cyclical changes with each menstrual 
cycle. Intersex states can be suspected from the lack of normal ovarian morphol-
ogy, for example: androgen insensitivity may show a normal female phenotype 
but have intra-pelvic testes rather than ovaries. Chromosome anomalies such as 
Turner’s syndrome may also demonstrate altered ovarian morphology, typically 
‘streak’ ovarian stroma with no follicles. Polycystic ovary syndrome is a complex 
and heterogeneous condition, the cardinal features of which are hyperandrogenism, 
ovulatory dysfunction and polycystic ovary appearance (though this is not essential 
to the diagnosis). The polycystic ovary appearance requires 12 or more follicles of 
2 to 9 mm in size or a volume of greater than 10 mls. If there is a follicle of 10 mm 
or greater, then the scan should be repeated at a later date when the ovary is 
quiescent. Other features of increased stroma or increased stromal echogenicity 
are specific but are not needed for diagnosis. It is recognised that a stromal area 
to total area ratio may be predictive of hyperandrogenism. Assisted conception 
uses ultrasound to track development of follicles and aid timing and dosage of 
medication and egg retrieval. Hyperstimulated ovaries are a risk and need to be 
identified. 3D scans may offer advantages over 2D in follicle counts and tracking. 
Learning Objectives:
1. To review the different images associated with ovarian dysfunction such as 
polycystic disease, ovarian insufficiency, and chromosomic abnormalities.
2. To understand the role of the radiologist in preparation and management of 
ovarian stimulations.
A‑093 09:00 
B. Pelvic endometriosis: Why is it commonly overlooked? 
G. Restaino; Campobasso/IT (gennares@hotmail.com) 
Endometriosis is defined as the presence of endometrial-like tissue outside the 
uterus, which induces a chronic, inflammatory reaction. Subfertility is associated to 
endometriosis, with several proposed causal mechanisms: distorted pelvic anatomy, 
altered peritoneal, hormonal, and cell-mediated function, endocrine and ovulatory 
abnormalities, and impaired implantation. Imaging techniques currently used to 
diagnose endometriosis are ultrasound and magnetic resonance imaging (MRI). 
Sonographic features of endometriomas are low-level internal echos, multilocularity 
and parietal hyperchoic foci. At MRI, endometriomas appear hyperintense at T1- and 
T2-weighted sequences persisting at fat-suppressed T1-weighted images, often 
with loss of intraluminal signal on T2-weighted images, due to high concentrations 
of iron and protein. Common sites of endometriosis are: Douglas’ pouch, utero-
sacral ligaments, vagina, rectum and bladder. Rarer sites are: abdominal wall, fossa 
ischio-rectalis, round ligament, lymphnodes, vulva, liver, and chest. Presentation of 
endometriosis is protean and aspecific, with diagnostic delay up to 12 years. This is 
because endometriosis is not an organ pathology, but an abdomino-pelvic disease, 
heterogeneous for genetic background, pathogenesis, location, extent, severity, 
clinical manifestations, treatment requirement and outcome. Differential diagnoses of 
endometrioma include corpus luteum, teratoma, cystadenoma, fibroma, tubo-ovarian 
abscess and carcinoma. Neoplasm must be ruled out particularly in pregnant patients 
with decidualized endometriosis.A surgical procedure such as laparoscopy is required 
for definitive diagnosis of endometriosis. Transabdominal and transvaginal ultrasound 
represents the first-line imaging process for suspected endometriosis. MRI is the 
modality of choice to diagnose all lesion sites of endometriosis, and is performed in 
selected patients according to the results of ultrasound and the severity of symptoms. 
Learning Objectives:
1. To learn that pelvic endometriosis is a leading cause of infertility.
2. To review the typical and atypical appearance of endometriosis, to explain 
the diagnostic delay and potential differential diagnosis.
3. To understand the role of imaging in establishing treatment strategies.
A‑094 09:30 
C. Understanding gynecologic malformations 
F.M. Danza, A.L. Valentini; Rome/IT (fmdanza@rm.unicatt.it) 
The multiple embryologic steps of the urogenital system are reviewed to under-
stand the numerous malformations of the ginecological organs that are possible to 
observe during the radiological workup; pelvic or abdominal masses and infertility 
are usually the causes requiring a diagnostic study of these patients. Particular 
attention will be devoted to the diagnostic possibilities of radiological imaging in the 
anatomical demonstration of various clinical settings. Ultrasound and MRI are the 
methods of choice, owing to the absence of radiation risks, while CT is reserved 
only to particular case usually when the diagnostic orientation is confused or in 
emergency. Histerosalpingography is important when a fine anatomical detail of 
inner cavities are requested. Anyway, US and MRI, due to their capabilities to 
create series of multiplanar images and characterize tissues and liquids, are the 
main tools radiologists can use. A wide pictorial assay of the common and rare 
malformations of uterus, ovary and annexed bodies, in one with urologic associated 
conditions will be presented, as they appear on each imaging modalities, so that 
a correct diagnosis can be achieved. The differential diagnosis with other pelvic 
masses will be also displayed. 
Learning Objectives:
1. To understand the most common uterine and vaginal malformations, with 
regard to embryology.
2. To review the imaging appearance of uterine and vaginal malformations, with 
a special emphasis on US and MRI.
3. To be able to determine whether or not a malformation is the cause of 
infertility.
10:30 - 12:00 Room A 
ESR meets Poland 
EM 1 
Emergency radiology: The new frontiers, the old 
barriers
Presiding:
C.J. Herold; Vienna/AT 
M. Sasiadek; Wroclaw/PL 
M. Szczerbo‑Trojanowska; Lublin/PL 
A‑095 10:30 
Introduction 
M. Sasiadek; Wroclaw/PL (mareks@rad.am.wroc.pl) 
The history of Polish radiology started in 1896, just few months after Wilhelm 
Roentgen’s discovery, when the first X-ray image was performed in Cracow. Polish 
Medical Radiological Society (PMRS) was established in 1925. Currently, PMRS 
has 15 subspecialty sections, each of them organizes annual meetings and courses. 
The Congress of Polish Radiologists, which covers all fields of radiology, are held 
every third year. PMRS organizes every year a lot of postgraduate courses e.g. 
“Polish School of Radiology”, School of MRI, School of Multidetector CT, as well as 
subspecialty and regional courses. We also organize European Congresses and 
Courses, like European Society of Neuroradiology Congress (2008), European 
School of Radiology (ESOR) or Erasmus MRI Courses. The growing role of Polish 
radiology is reflected by fact, that the President of ECR 2010 is Prof. Malgorzata 
Szczerbo-Trojanowska from Lublin, Poland. Polish radiologists, especially those 
from academic centers, are active professionally and scientifically in all fields of 
modern radiology. In this session, we decided to present the selected topics of 
emergency radiology. The lecturers represent the younger generation of Polish 
radiologists and are considered to be the “rising stars”. The particular topics we 
have focused on are: stroke imaging, cardiac emergencies, management of aortic 
dissection and pulmonary embolism. The lecturers will present the updates in the 
fields mentioned above and propose the optimal management protocols in routine 
emergency setting. 
Session Objectives:
1. To outline the activities of the Polish Medical Society of Radiology.
2. To present the updates of the selected topics of emergency radiology.
3. To present the achievements of the rising stars of Polish radiology.
Postgraduate Educational Programme
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A‑096 10:35 
Modern emergency stroke imaging 
K. Sklinda; Warsaw/PL (katarzyna.sklinda@gmail.com) 
Stroke became one of the most common emergencies; however, very few patients 
arrive at ER departments within “time-window” which deprives some of them of 
r-tPA administration only because the limit of time has been exceeded. Allocation 
of treatment is still dominated by the 3-hour time-window but rising availability of 
neuroimaging techniques would enable refining the indication for thrombolysis and 
set a new tissue-window basing on the determination of the extent of the salvageable 
tissue. Non-contrast CT in stroke imaging is dedicated to exclude contraindications 
such as cerebral hemorrhage or marked early infarct signs. However, MRI has 
become more available recently allowing delineation of ischemia in DWI within 
minutes after onset and depicting hypoperfusion in PWI. PWI/DWI mismatch can 
be seen in about 80% of stroke patients in acute phase and quantitative PWI/TTP 
maps reduce risk of its overestimation. In clinical practice MR examination may 
not be available. Under such circumstances, CT could be the method of choice 
enabling fast quantitative evaluation of penumbra. In 256-detector row systems, it 
is possible to cover the whole brain and perform hemodynamic assessment at one 
bolus administration. It seems that CT can compete with MR in tissue - window 
imaging. The large number of patients arriving at ER-units with stroke-like symp-
toms and a relatively low sensitivity of CT in detection of cytotoxic/early vasogenic 
edema causes a need for developing a CAD system which would enable to exclude 
certain groups of patients from further diagnostics. Initial experience with this kind 
of software would be presented. 
Learning Objectives:
1. To consolidate knowledge of the methods already acknowledged.
2. To learn about CAD in stroke imaging.
3. To appreciate the value of CT.
A‑097 10:53 
Cardiac emergency imaging: Crossing frontiers, meeting barriers 
K. Gruszczynska; Katowice/PL (KJgruszczynska@gmail.com) 
Acute myocardial infarction (AMI) affects approximately one million Polish inhabit-
ants per year. The diagnosis of acute coronary syndrome (ACS) is not always 
straightforward, as the spectrum of clinical signs is wide. In Poland, ACSs account 
for 2/3 of patients hospitalized in intensive care units. Cross-sectional imaging 
may be most helpful in patients with atypical chest pain and non-diagnostic ECG. 
Computed tomography (CT) allows better definition of cardiovascular risk (coronary 
calcium score). CT coronary angiography can rule out significant coronary stenosis 
and identify non-cardiac causes of chest pain (triple rule-out). Imaging patients 
with acute ongoing chest pain may be challenging. Careful patient preparation 
and optimization of scan protocol are mandatory to optimize image quality and 
keep radiation exposure to a minimum. Due to recently reduced radiation expo-
sure cardiac CT become a viable option to study newborns with congenital heart 
disease before cardiac surgery. Cardiovascular magnetic resonance (CMR) may 
improve the triage of patients with ACS. It allows the diagnosis of several non-
coronary emergencies (myocarditis or cardiomiopathy). However, CMR requires 
prolonged patient cooperation. Moreover, coronary artery imaging by CMR is still 
technically challenging. Cardiac imaging with CT and CMR is established in a wide 
range of clinical indications. Many radiologists in Poland underwent training in this 
subspecialty and many practice it in elective, non-emergency settings. Cardiac 
emergency imaging represents ‚the next frontier’ for them. Proper training, an 
enthusiastic approach and tight cooperation with clinicians will hopefully allow 
young Polish radiologists to overcome the logistic barriers to non-invasive cardiac 
imaging in emergency settings. 
Learning Objectives:
1. To outline the clinical needs for cross-sectional imaging techniques such as 
CT and MR in cardiac emergencies.
2. To discuss the feasibility and the difficulties of performing CT and MR 
imaging in emergency cardiac clinical conditions.
3. To review successes and failures achieved by cardiac radiologists in Poland 
with CT and MR imaging in cardiac emergencies.
A‑098 11:11 
Dissection of descending aorta: Diagnosis and management of aortic or 
end-organ complications 
K. Milczarek; Warsaw/PL (krzys‑km@wp.pl) 
Acute aortic dissection is a life-threatening disease with aortic rupture as a main 
complication followed by end-organ ischemic complications resulting with multiorgan 
failure. Dissection of descending aorta is usually treated with aggressive medical 
therapy. However, complications of aortic dissection should be early diagnosed 
and treated promptly emphasizing the role of imaging modalities. Indications for 
intervention in an acute setting include: impending or contained rupture, malperfu-
sion syndrome, untreatable hypertension, persistent pain and early aneurysmal 
formation. The following treatment options are recognized: aortic stent-graft implan-
tation, aortic branch stenting or fenestration as a solitary methods or combined with 
SG placement. The main goal of thoracic endografting is to seal the primary tear, 
re-establish the collapsed true lumen and resolve end-organ ischemia if present. 
Some patients receiving only BMT require intervention. Analyses from different 
groups revealed several features that predict poor outcome including initial aortic 
diameter > 4 cm or partial thrombosis of the perfused false lumen. A resent consen-
sus statement considered following indications for endovascular repair in patients 
with chronic aortic dissection: aortic diameter > 5.5 cm, annual aortic expansion 
> 1 cm, resistant hypertension, recurrent pain and chronic malperfusion syndrome. 
However, despite successful endografting of the thoracic aorta, in some cases the 
problem of dissection remains on the abdominal level. To our knowledge, there is no 
overall clinical experience in endovascular repair of complicated aortic dissection 
in this region. We want to share experience of a leading center in Warsaw with the 
endovascular repair of descending aorta dissections, including the most challeng-
ing, abdominal region of aorta. 
Learning Objectives:
1. To present the most frequent complications of descending aorta dissection.
2. To define indications for intervention.
3. To review possible therapeutic strategies.
A‑099 11:29  
What you see is what you diagnose: Staging the severity of acute 
pulmonary embolism with computed tomography pulmonary angiography 
G. Staskiewicz; Lublin/PL (grzegorz.staskiewicz@gmail.com) 
Acute pulmonary embolism presents with a wide spectrum of clinical conditions, 
which range from clinically irrelevant isolated subsegmental embolism to a life-
threatening central embolism, resulting with hypotension and cardiogenic shock. 
Recent advances in the computed tomography have allowed a rapid progress in 
imaging of pulmonary embolism. Computed tomography pulmonary angiography 
(CTPA) makes it possible to visualize embolic material even in subsegmental 
arteries, and to assess pulmonary parenchyma and mediastinal structures at the 
same time. Furthermore, in large group of patients in whom PE has been excluded, 
CTPA allows for an alternative or additional diagnosis. CTPA allows an objective 
staging of obstruction of pulmonary arteries. It may also suggest the right ventricular 
dysfunction in the course of acute pulmonary embolism, as well as visualize the 
background of thrombotic event. 
Learning Objectives:
1. To summarise scoring systems used for objective staging of obstruction of 
pulmonary arteries.
2. To review CT signs of right ventricular dysfunction in the course of acute 
pulmonary embolism.
3. To become familiar with the range of alternative and additional diagnoses 
based of CT findings.
Panel discussion 11:47 
10:30 - 12:00 Room E2 




B. De Foer; Antwerp/BE 
A‑100 10:30 
A. External and middle ear 
A. Trojanowska; Lublin/PL (agnieszka30@yahoo.com) 
External and middle ear diseases are the second most frequent cause of visiting 
ENT specialist. With the introduction of multislice CT imaging and new MRI tech-
niques, excellent visualization of minute structures can be achieved. Therefore, 
accurate diagnosis of temporal bone diseases may be performed. In fact, the 
percentage of temporal bone imaging studies is growing fast. The critical condition 
for depiction any external and middle ear pathology is the profound knowledge of 
anatomy. Since not all pathological conditions require imaging, it is very important 
to know exactly which diseases will require radiological evaluation. Detailed indica-
tions for imaging and proper imaging techniques will be discussed. Although both 
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conditions. A detailed overview of common and most important external and 
middle ear diseases will be presented. These will include: EAC atresia, exostoses, 
osteoma, squamous cell carcinoma, congenital anomalies, post-traumatic changes, 
osteosclerosis, glomus tympanicum, middle ear schwannoma, inflammation and 
cholesteatoma. For each case, the most relevant clinical and radiological findings 
will be discussed together with differential diagnosis. 
Learning Objectives:
1. To review the relevant radiological anatomy of the external and middle ear.
2. To learn about the indications of imaging in external and middle ear disease.
3. To appreciate the relative value of CT and MRI in external and middle ear 
disease.
4. To become familiar with the imaging findings on CT and MRI in external and 
middle ear disease.
A‑101 11:15 
B. Inner ear and internal auditory canal 
B. Verbist; Leiden/NL (b.m.verbist@lumc.nl) 
Over the past years, there has been a growing interest in inner ear and cochlear 
nerve imaging due to advances in treatment of sensorineural hearing loss. Whereas 
in the past, hearing aids were the only option for amplification of sound, nowa-
days there is a possibility of direct stimulation of the cochlear nerve with cochlear 
implantation. In those cases, careful assessment of the cochleovestibular system 
and nerve provides crucial information for the surgeon. Abnormal development 
of the inner ear or cochleovestibular nerve, pathologies influencing the cochlear 
patency - such as labyrinthitis ossificans or abnormalities of bone metabolism - or 
the presence of retrocochlear pathology will influence patient management. Proper 
assessment of these structures requires high resolution CT or MR imaging. In this 
lecture, the normal anatomy of the inner ear and internal auditory canal will be 
illustrated and the imaging findings of congenital, infectious or inflammatory and 
tumoral pathology of the cochleovestibular system and nerve will be discussed. 
Learning Objectives:
1. To review the normal radiological anatomy of the inner ear and internal 
auditory canal.
2. To understand the importance of high-resolution imaging in evaluating inner 
ear and internal auditory canal pathology.
3. To become familiar with the imaging findings in inner ear and internal 
auditory canal disease.
12:15 - 12:45 Room A 
Plenary Session 
HL 1 
Wilhelm Conrad Röntgen - Honorary Lecture 
Presiding:
M. Szczerbo‑Trojanowska; Lublin/PL 
A‑102 12:15 
Diagnostic radiation and carcinogenesis: What do we know? 
M.N. Brant-Zawadzki; Newport Beach, CA/US (mbrant@hoaghospital.org) 
The lay media and even most radiologists assume that exposure to diagnostic 
radiation is carcinogenic. However, a review of the literature demonstrates that the 
state of knowledge of regarding carcinogenesis from diagnostic radiation is not at 
the level of scientific fact; indeed, it is at most a theory, and more likely the level 
of knowledge is at the stage of hypothesis, with evidence both for and against the 
null. This lecture will review that state of knowledge and provide a broad context 
for the concern regarding cancer production by diagnostic levels used in everyday 
radiologic procedures. Comparison of risk to other industries and actuarial risk 
of detriment will be discussed. The controversial concepts about the theory of 
hormesis or potential benefits of minimal doses of radiation in stimulating defence 
mechanisms potentially mitigating carcinogenesis will be explored. The purpose 
of the lecture is to stimulate discussion in this very controversial, yet somewhat 
misunderstood, area. All can agree that using the least amount of radiation nec-
essary for appropriate diagnosis is the ideal state; however, unnecessary fear of 
diagnostic radiation when it is appropriate should also be minimized. To these ends, 
a transparent review of the topic is worthwhile. 
Learning Objectives:
1. To comprehend the historical evidence for radiation induced carcinogenesis.
2. To understand the state of knowledge regarding low-dose induction of 
cancer, and controversy surrounding the “no threshold hypothesis”.
3. To become more familiar with the levels of risk posed by diagnostic radiation.
14:00 - 15:30 Room E2 
Foundation Course: Head and Neck Radiology 
E³ 520 
Nose and paranasal sinuses 
Moderator:
H. Eggesbø; Oslo/NO 
A‑103 14:00 
A. Inflammatory disease 
D. Farina; Brescia/IT (nappaje@yahoo.it) 
Anatomy is the key for a conceptual understanding of inflammatory disease of the 
paranasal sinuses; in particular, the complex network of infundibula and recesses 
that mark the pathway of mucus from the periphery (sinuses) to the centrum (nasal 
cavities). A vast number of variants complicate the interpretation of the anatomy: 
some are clinically irrelevant, some may predispose to rhinosinusitis, and some 
are potential sources of iatrogenic damage. Acute rhinosinusitis generally requires 
no imaging. Only on the onset of ocular or neurological sign and symptoms, cross-
sectional imaging (mainly MSCT) is urgently needed to identify complications. In 
patients affected by chronic rhinosinusitis, imaging must provide a roadmap for 
proper endoscopic surgery planning. In this setting, coronal MSCT is the standard 
for evaluation and represents a shared language that allows mutual understand-
ing between head and neck radiologists and surgeons. According to the drainage 
pathway (s) impaired, chronic rhinosinusitis can be classified in five patterns that, 
while simplifying the reporting process, also account for the pathophysiology of the 
disease. Among these, nasal polyposis is the most extensive and requires careful 
observation in order not to overlook benign or malignant neoplasms. Sagittal MPR 
reformations will be included in the protocol whenever the course and patency 
of the oblique frontal recess are to be demonstrated. MRI is inferior to MSCT in 
demonstrating the labyrinth of sinuses and drainage pathways. This technique 
will be used only in specific circumstances, such as when bone destruction (not 
necessarily over the midline) and orbital or deep soft tissue lesions are found. 
Learning Objectives:
1. To review the normal anatomical variants of the sinonasal cavities, and their 
importance.
2. To understand the indications for imaging in patients suffering sinusitis.
3. To learn how to adapt the imaging technique according to the clinical 
presentation.
4. To learn about the imaging findings in acute, chronic and complicated 
sinusitis.
A‑104 14:45 
B. Neoplastic disease 
T. Beale; London/UK (timothy.beale@royalfree.nhs.uk) 
The lecture will review the role of imaging in the diagnosis of sinonasal tumours, 
illustrating the diversity of tumours affecting this region. The patterns of local and 
distant spread of sinonasal neoplasia will be demonstrated and the respective 
roles of computed tomography and magnetic resonance imaging explained. Critical 
imaging review areas are discussed, in particular the assessment of orbital and 
intracranial involvement and perineural extension. The imaging features that aid in 
distinguishing inflammatory from neoplastic and benign from malignant sinonasal 
conditions will be discussed. The imaging protocol and follow-up imaging strategy 
undertaken at our institution will be explained. 
Learning Objectives:
1. To review the relevant anatomy in neoplastic disease of the sinonasal 
cavities.
2. To learn about the imaging findings in benign and malignant tumors of the 
sinonasal cavities.
3. To appreciate the relative value of CT and MRI in sinonasal tumors.
4. To understand the importance of imaging in determining the extension 
pattern of sinonasal tumors.
Postgraduate Educational Programme
S32 A B C D E F G
16:00 - 17:30 Room A 
New Horizons Session 
NH 6 
Functional imaging in CT: Optional or built-in? 
Moderator:
H. Alkadhi; Zurich/CH 
A‑105 16:00 
Chairman’s introduction 
H. Alkadhi; Zurich/CH (halkadhi@partners.org) 
In the past years, there has been a marked increase in attempts to image diseases 
with CT not only on a morphological but also on a functional basis. The reasons 
for these developments are manifold. One major reason is the known, inherent 
limitation of morphological imaging alone that may lack important information on 
function being of prognostic value or being relevant to gauge treatment efficacy. 
Another - simplistic though true - reason for these current attempts is a technical 
one: current CT scanners have undergone such tremendous technical developments 
with more and more gantry rotation speed and acquired slices as well as faster 
volume coverage that functional imaging with CT became feasible at a reasonable 
radiation dose. Currently, functional imaging with CT is emerging in a number of 
divergent fields, including the diagnosis and characterization of coronary heart 
disease and myocardial function as well as for the early prediction of treatment 
efficacy and identification of progressive disease in patients with cancer. This ses-
sion will deal with the technical requirements for functional imaging with CT and will 
introduce the various concepts including perfusion, dual- or multi-energy imaging. 
In addition, it will aim to highlight the added diagnostic value that can be extracted 
from this functional data for the ultimate goal to improve the care of our patients. 
Session Objectives:
1. To provide an overview on the technological developments that enable 
functional imaging with CT.
2. To learn the different types of algorithms for functional CT imaging.
3. To understand the added value of functional imaging with CT.
A‑106 16:03 
What functional CT requires: Speed, coverage, and many slices 
P. Rogalla; Berlin/DE (rogalla@charite.de) 
Functional CT is governed by many technical factors. Depending on the analytic 
model for data evaluation, fast sampling might represent the most important pa-
rameter for accurate capture of density changes over time. In order to ensure 
homogeneous sampling with time uniformity in the body area targeted for perfusion 
analysis, mechanical motion of the patient for larger Z-axis coverage should be 
applied with due caution. Alternative models are based on extended time coverage 
necessitating data sampling over more than 60 seconds. Longer scanning times 
result in proportional increase in radiation dose raising the need to implement low-
dose imaging techniques and data noise suppression. Motion correction poses an 
additional challenge independent of subsequent analysis techniques. Longitudinal 
tracing the volume of interest with rigid or elastic data warping surfaces the necessity 
of evading patient motion during scanning by either breath holding or - alternatively 
- shallow free breathing. Additionally, thin slice isotropic volume reconstruction plays 
a key role in data post-processing when elastic warping is deemed necessary for 
image registration. Overall, functional imaging poses tremendous technical chal-
lenges as to the optimal hardware selection, adequate scanning protocols, and 
post-processing algorithms. 
Learning Objectives:
1. To explain the technical prerequisites for functional CT.
2. To discuss the influence of reconstruction techniques, temporal resolution 
and temporal uniformity.
3. To outline the role of functional CT in view of risks and benefits.
A‑107 16:21 
Multi-energy: An approach to functional imaging with CT 
P. Stolzmann; Zurich/CH (paul.stolzmann@usz.ch) 
The ability of dual-source dual energy (DE) CT to simultaneously acquire two X-
ray spectra during the same phase of contrast enhancement excludes temporal 
changes in enhancement between acquisitions and spatial misregistration. Specific 
attenuation behaviours of different materials enable their differentiation which is 
caused by material-dependent Compton and photo-electric effects. DECT can 
thereby accurately measure elemental concentrations by using three-material 
decomposition algorithms. These algorithms are used to identify and quantify 
contrast materials allowing for the reconstruction of virtual non-enhanced (VNE) 
images and the assessment of perfusion or ventilation volumes. VNE data sets 
are a reasonable approximation of true non-enhanced image allowing for the re-
placement of non-enhanced acquisitions in the assessment of vascular disorders 
or enhancing masses. Data on contrast material distribution provide information 
that is complimentary to morphological CT. Regional alterations of lung perfusion 
are depicted by DECT in patients with predominant emphysema or pulmonary 
embolisms. Dynamic and static regional ventilation are displayed by ventilation 
DECT. Regarding cardiac imaging, DECT is promising for the integrative analysis 
of the coronary artery morphology and the myocardial blood supply. DE CT is an 
emerging technique that not only provides morphological but functional information. 
Learning Objectives:
1. To understand the principle and potential benefit of multi-energy and spectral 
imaging.
2. To learn how multi-energy CT may replace multi-phase imaging, giving rise 
to functional analyses.
3. To understand how multi-energy CT may be used for monitoring treatment 
and for simultaneous visualisation of morphology and function.
A‑108 16:39 
Functional cardiac imaging: The blessing of high spatial and temporal 
resolution 
C. Catalano, M. Francone; Rome/IT (Carlo.Catalano@uniroma1.it) 
Accurate and reproducible determination of cardiac function is essential for diagno-
sis, therapeutic management and follow-up of cardiac diseases. A variety of imaging 
techniques are used for the assessment of regional or global function however 
cardiac MRI has been widely adopted as the gold standard due to its unmatched 
temporal resolution and superior tissue contrast. Conversely, because of the ra-
diation exposure and poor temporal resolution of previous scanners, MDCT has 
been seldom used for functional cardiac imaging. Limited temporal resolution of the 
method hampered evaluation of both regional wall motion, which generally requires 
a resolution of 80 msec and the assessment of time-dependent parameters such 
as peak filling rate and peak ejection rate and led to systematic underestimation of 
ventricular volumes. Recent technical improvements of CT systems allowed to reach 
high temporal resolution (up to 83 msec) minimizing motion artefacts and leading 
to widespread diffusion of cardiac MDCT; accordingly, because information on any 
heart phase could be obtained using a retrospective ECG-gating, use of CT for 
functional analysis has started to be accepted and clinically applied. Combination 
of high spatial and temporal resolution yields another advantage, which is accurate 
depiction of cardiac valves and valvular leaflets motion can be analyzed, allowing 
to exclude stenoses or high-grade insufficiency and to quantify the orifice area. 
In conclusion, while the evaluation of coronary arteries remains primary clinical 
indication, the improved performances of last MDCT scanners allow simultaneous 
and accurate assessment of global functional parameters, regional wall motion and 
valvular function in a single scan. 
Learning Objectives:
1. To understand the advantages of recent CT technological developments in 
terms of spatial and temporal resolution.
2. To comprehend the importance of high spatial and temporal resolution in 
cardiac functional analysis, including assessment of regional and global wall 
motion and valvular function.
3. To emphasise the importance of quantitative and qualitative assessment of 
cardiac function for clinical diagnosis, risk stratification, patient management 
and prognosis.
A‑109 16:57 
Can CT perfusion monitor tumor therapy response? 
V.J. Goh; Northwood/UK (gohmcglone@hotmail.com) 
The use of imaging to monitor tumor therapy response has increased in recent 
years, both in the clinical setting and in clinical trials. With the increasing use of novel 
drugs, many of which are cytostatic, in combination with standard chemotherapy or 
radiotherapy to improve progression free survival, there is an increasing need for 
functional evaluation. Anti-angiogenic agents and vascular disruptive agents target 
the tumor vasculature, resulting in vascular pruning or vascular shutdown, and 
slowing of tumor growth. Kinetic modeling of tumor enhancement at Perfusion CT 
provides valuable information of tumor vascular physiology. Quantitative Perfusion 
CT parameters reflect in vivo perfusion, blood volume and vascular leakage may 
provide complementary information to standard assessment, and show promise as 
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anti-vascular effect, be used to define a biologically active dose, may provide insight 
into drug mechanism of action, and may aid treatment scheduling. The challenge for 
multicentre implementation of Perfusion CT to monitor tumor therapy response is to 
implement quality assurance, to standardize procedures and measurements, and to 
improve scan reproducibility, within a framework for imaging biomarker development. 
Learning Objectives:
1. To illustrate the methods that can be applied in clinical practice.
2. To give clinical examples of the application of CT for monitoring tumor 
therapy response.
3. To discuss the challenges and limitations of CT for monitoring therapy 
response.
Panel discussion:  
Functional imaging with CT: Ready for prime time? 17:15 
16:00 - 17:30 Room B 
Radiology of the Spine in 2010 
CC 616 
Discs: Old problems and new solutions 
Moderator:
A. Gouliamos; Athens/GR 
A‑110 16:00 
A. Spinal stenosis: How do you measure it? 
M. Gallucci; L’Aquila/IT (massimo.gallucci@cc.univaq.it) 
A small canal diameter has been associated with an increased risk of injury; 
however, there is a lack of reliable normative data on spinal canal diameters and 
several different proposals have been reported by researchers. Stenosis can be 
determined by several causes. Classically, congenital, acquired (degenerative) or 
mixed forms are distinguished. Moreover, central stenosis is distinguished from 
lateral, foraminal or concentric ones. Cervical stenosis is usually defined as a canal 
diameter of < 12 mm. An index often used on oplan X-ray film was the Torg ratio 
(canal vs body sagittal diameters. If less than 1= stenosis). A more modern concept 
is the SAC (space available for the cord). MRI permits to directly visualize the cord 
and the subarachnoid space. The mean diameter of the cervical cord is 7 mm and 
the SAC is therefore reduced when less than a 1 mm CSF layer is present around 
the cord, thus indicating a severe stenosis. At the lumbar level, congenital stenosis 
shows short pedicles, while acquired forms have their maximal expression at the 
level of the endplates. A mid sagittal diameter inferior to 14 mm is considered below 
normal limits. If inferior to 10 mm, it is severely below. Following both radiological 
and post-mortem studies, narrow canal appears to be very common. Therefore, 
radiographic finding should be closely correlated with clinical signs to make the 
diagnosis of stenosis and to make decision regarding treatment. Electromyography 
is strongly recommended to achieve the correct interpretation. 
Learning Objectives:
1. To be knowledgable about the normal mechanisms responsible for spinal 
stability.
2. To describe causes and imaging features of spinal stenosis.
3. To learn about measurements for assessment of spinal stenosis.
A‑111 16:30 
B. Degenerative disc disease 
L. van den Hauwe1, C. Venstermans2, F. De Belder2, M.H.J. Voormolen2, 
J.W.M. Van Goethem2, P.M. Parizel2; 1Brasschaat/BE, 2Antwerp/BE 
(lucvdhauwe@mac.com) 
The functional unit of the vertebral column consists of two adjacent vertebral bodies, 
an intervertebral disc and two facet joints. This unit is called the motion segment. It 
constitutes a three-joint-complex; degenerative changes of the intervertebral disc 
will, therefore, affect the normal anatomy and function of the facet joints. Plain X-ray 
films are of limited use in the assessment of DDD since early signs of degeneration 
cannot be seen. Multi-detector row computed tomography (MDCT) provides excel-
lent anatomic detail for the detection of disc herniation and nerve root compression. 
However, reporting disk contour changes has suffered greatly from incoherent and 
non-uniform nomenclature. Therefore, the Nomenclature Committee of the American 
Society of Spine Radiology has proposed a coherent and uniform nomenclature 
system, which has been widely accepted now among radiologists and physicians 
dealing with patients with DDD. Magnetic resonance imaging (MRI) is now con-
sidered the most sensitive imaging technique in DDD. Due to its superb soft tissue 
contrast discrimination, intrinsic disc changes may be observed early in DDD. MRI 
abnormalities in DDD include: disk height narrowing, T2 signal intensity changes, 
internal disk disruption, disk contour changes, spinal canal narrowing, associated 
changes in the vertebral endplates and posterior elements. Accurate interpretation 
of these findings remains a diagnostic challenge since not all imaging abnormalities 
are clinically relevant and may be encountered in the normal ageing population. 
The value of newer MRI techniques (diffusion-weighted imaging, T2-relaxometry, 
dynamic imaging) in patients with DDD are under evaluation. 
Learning Objectives:
1. To learn the current nomenclature for degenerative disc disease.
2. To be knowledgable about morphologic changes of the degenerated discs.
3. To introduce new MR imaging techniques for evaluation of the degenerative 
disc disease.
A‑112 17:00 
C. Minimally invasive therapies for discogenic disease 
M. Muto; Naples/IT (mario.muto@ospedalecardarelli.it) 
In the last 10 years, many types of percutaneous disk approach came out and have 
minimized the invasive nature of surgical techniques and avoid complications like 
infection linked to surgery. All those techniques try to decompress the disk and/or re-
duce the inflammatory reaction (oxygen-ozonetherapy) to improve clinical symptoms. 
There are emergency surgery indications for HNP that include: progressive foot droop, 
hyperalgic paralazyng sciatica, cono-cauda syndrome. All the other clinical symptoms 
can be treated by percutaneous disk treatment trying to avoid surgery. Nucleoptesis 
by oxygen-ozone mixture drying the nucleus with an oxygen-ozone mixture (O2-O3) 
uses a colourless irritant gas with a pungent odour which is unstable and has a 
strong anti-oxidizing power. The O2-O3 gas mixture produced can be injected into 
the intervertebral disc and root foramina, 3-4 ml into the disc and 15-20 ml into the 
neural foramen and root canal. The indications for O2-O3 treatment were extended to 
FBSS patients when it was understood that the ozone mechanisms of action could 
be exploited to treat the chronic inflammation and venous stasis present in FBSS. On 
the basis of our results and the assessment of our failures, we recommend selecting 
patients to avoid broadening the indications for treatment, thereby ensuring a high 
success rate. Accurate diagnosis of the lesion and the spinal level to be treated, ac-
curate technical execution under CT or fluoroscopic guidance in expert hands and 
patient follow-up by the neuroradiologist after treatment are key factors in ensuring 
the successful outcome of percutaneous treatment for this common condition. 
Learning Objectives:
1. To review the indications/patient selection criteria for percutaneous 
nucleoplasty.
2. To understand current nucleoplasty techniques.
3. To become familiar with the techniques and safety considerations associated 
with ozone therapy.
16:00 - 17:30 Room C 
ESR meets Neurologists 
EM 2 
Ischemic stroke: Diagnosis and treatment 
Presiding:
J.M. Ferro; Lisbon/PT 
C.J. Herold; Vienna/AT 
M. Szczerbo‑Trojanowska; Lublin/PL 
A‑113 16:00 
Introduction 
J.M. Ferro; Lisboa/PT (jmferro@fm.ul.pt) 
In a western population of 1 million inhabitants, 2,400 new strokes occur every year, 
of which 80% are ischemic in origin. One year later, less than 50% of patients will 
be independent, and many survivors will have residual deficits. At the acute stage 
of cerebral ischemia, the treatment consists of: (i) keeping biological parameters 
within normal limits and preventing complications; (ii) admission in a stroke unit; (iii) 
intravenous administration of rt-PA as soon as possible after admission up to 4.5 
hours; (iv) in patients who are not eligible for rt-PA, aspirin, and (v) decompressive 
surgery in patients with or at high risk to develop malignant infarct, Other measures 
such as intra-arterial pharmacological or mechanical thrombolysis in basilar artery 
occlusions or T occlusion of the end part of the internal carotid artery, or hypothermia 
in malignant infarcts are possible at the acute stage but, in the absence of clear 
proof of efficacy should be restricted to randomized trials or life salvage. Diagnostic 
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imaging of ischemic stroke should rule out other pathologies such as intracerebral 
bleeding but provide positive evidence for the ischemic event. This helps in case of 
unclear clinical presentations, provides prognostic and etiologic clues and serves 
to appreciate the location and extent of parenchymal damage Information on tissue 
at risk and the state of the extra- and intracerebral vessels would also be desirable 
as it can heavily influence therapeutic decision making. All imaging data should 
possibly be collected on one machine and as fast as possible. 
Session Objectives:
1. To define what information on stroke neurologists expect from radiologists.
2. To become familiar with the neuroimaging of acute stroke.
3. To be able to select the stroke patient for appropriate treatment.
A‑114 16:05 
What are the clinical requirements and expectations of diagnostic imaging 
F. Fazekas; Graz/AT (franz.fazekas@medunigraz.at) 
Ischemic stroke is quite variable in its presentation and aetiology, and the increasing 
possibilities of acute treatment further add to the complexity of its management. 
Ideally, diagnostic imaging should not only rule out other pathologies such as in-
tracerebral bleeding but also provide positive evidence for the ischemic event. This 
helps in case of unclear clinical presentations, provides prognostic and etiologic 
clues and serves to appreciate the location and extent of parenchymal damage 
which may influence the risk/benefit ratio of therapeutic interventions. Informa-
tion on tissue at risk and the state of the extra- and intracerebral vessels would 
also be desirable as it can greatly influence therapeutic decision making. Time 
is a critical factor in all situations of ischemic stroke; therefore, all imaging data 
should possibly be collected on one machine and as fast as possible. In addition 
to local options, it is always the patient’s clinical situation which ultimately defines 
the trade-off between the amount of information that would be desirable and that 
which is absolutely needed. Furthermore, planning image acquisition for ischemic 
stroke must also consider the possible need for medical support and supervision 
of the patient and problems which may be encountered because of co-morbidities, 
implants and inadequate patient collaboration. 
Learning Objectives:
1. To define what neurologists expect from diagnostic imaging.
2. To understand the importance of identifying the type and site of the lesion 
causing stroke and the location and extent of parenchymal ischemia.
3. To describe the minimal diagnostic imaging requirements for a stroke unit.
A‑115 16:23 
Diagnostic imaging of ischemic stroke 
M.M. Thurnher; Vienna/AT (majda.thurnher@meduniwien.ac.at) 
Ischemic penumbra was first defined by Astrup in 1981 as perfused brain tissue 
with the capacity to recover. Penumbra has become the focus of intense imaging 
research. Accurate detection of this ‘tissue at risk’ would identify patients who would 
benefit from thrombolysis. However, new insights in the stroke pathophysiology have 
shown that the concept of penumbra has some serious limitations and raised doubts 
on its clinical significance in acute stroke setting. It is now known that perfusion MR 
cannot identify tissue at risk, and signal abnormality on DWI does not represent 
only infracted tissue, it can also contain penumbra. The debate on CT and MRI as 
imaging modalities for stroke is still ongoing and the question is not answered yet. 
What is the best imaging modality for thrombolysis triage inside of three hours of 
stroke, and what is the best modality after three hours of stroke onset? The purpose 
of this lecture will be to describe neuroimaging modalities capable of identifying 
infarcted and penumbra tissue. Surrogate markers that could be used in ischemic 
stroke patients will be discussed also. 
Learning Objectives:
1. To demonstrate advantages and disadvantages of CT and MRI in 
assessment of ischemic stroke.
2. To explain DWI/PWI and CT perfusion “mismatch” and the concept of 
penumbra.
3. To give an overview of the past, present and future of stroke imaging.
A‑116 16:41 
Management of the acute stroke patient 
D. Leys; Lille/FR (DLEYS@CHRU‑LILLE.FR) 
Despite advances in prevention, the treatment of acute ischemic stroke remains 
essential to improve outcome and to lower mortality. At the acute stage of cerebral 
ischemia, the treatment consists of: (i) general non-specific rules, such as treating 
a vital emergency, keeping biological parameters within normal limits and prevent-
ing complications; (ii) admission in a stroke unit, to decrease mortality without 
increasing dependence or recurrence risks; (iii) intravenous administration of rt-PA 
as soon as possible after admission, and within 3 hours of stroke onset in eligible 
patients, with a possible extension up to 4.5 hours although the benefit decreases 
rapidly over time; (iv) in patients who are not eligible for rt-PA, aspirin (160 to 
300 mg) to reduce early recurrence risks and death, even in atrial fibrillation, and 
(v) decompressive surgery in patients with raised intracranial pressure or at high 
risk to develop malignant infarct because of a abnormality of more than 145 cm3 
on diffusion weighted images during the first 24 hours. Other measures are pos-
sible at the acute stage but, in the absence of clear proof of efficacy, should be 
restricted to randomized trials or tissue salvage: intra-arterial pharmacological or 
mechanical thrombolysis in basilar artery occlusions or T occlusion of the end part 
of the internal carotid artery, or hypothermia in malignant infarcts. Besides, early 
secondary prevention measures should be started as soon as possible at least in 
patients who have no large infarct. 
Learning Objectives:
1. To manage the flowchart of acute stroke treatment.
2. To learn who are the candidates for IV and IA thrombolysis.
3. To learn how to manage physiological parameters.
A‑117 16:59 
Endovascular treatment of the patient with ischemic stroke 
D. Vorwerk; Ingolstadt/DE (dierk.vorwerk@klinikum‑ingolstadt.de) 
Role of radiology in acute stroke was for a long time limited to imaging and exclu-
sion of differential diagnoses. CT and MRA now allow noninvasive localization of 
the occlusion level that may have rapid impact on the techniques of treatment. 
Although being used for only about 1% of all stroke patients, or of 10 % of all 
patients undergoing thrombolysis, intraarterial techniques further improved and 
play a significant role in the treatment of patients with occlusions of the basilary 
artery, the carotid T and the M1 segment. Furthermore, acute recanalization of 
the internal carotid artery in case of severe symptoms following thrombotic occlu-
sions or dissections are available. More and more mechanical systems are used 
alone or in combination with intraarterial thrombolysis. Close cooperation between 
neurologists and radiologists is required to determine the best additive treatment. 
Results from literature show that under these particular circumstances, patients 
benefit from an invasive approach in comparison to IV thrombolysis with/without 
ultrasound enhancement. 
Learning Objectives:
1. To learn about the role of interventional treatment in acute cerebral stroke.
2. To understand techniques of thrombolytic therapy and mechanical 
thrombectomy.
3. To understand parameters of acute success and long-tem outcome in 
interventionally treated patients.
Panel discussion 17:17 
16:00 - 17:30 Room D 
Abdominal and Gastrointestinal 
RC 601 
Tumor follow-up evaluation: Which modality for 
what? 
Moderator:
S. Terraz; Geneva/CH 
A‑118 16:00 
A. US and CEUS 
T. Rettenbacher; Innsbruck/AT (thomas.rettenbacher@i‑med.ac.at) 
Conventional US is the most frequently used liver imaging modality worldwide but 
has a lower sensitivity and specificity than contrast-enhanced CT and contrast-
enhanced MRI in the assessment of focal liver lesions. The introduction of US 
contrast agents has opened new diagnostic possibilities and markedly reduced the 
superiority of CT and MRI. In most cases, hepatic lesions have typical perfusion 
characteristics and enhancement patterns that allow definite differentiation. Due to 
the high spatial and time resolution of tumour vessel perfusion, contrast-enhanced 
ultrasound (CEUS) is very appropriate in the differentiation of uncharacteristic focal 
liver lesions detected at conventional US and is superior to CT or MRI. Conventional 
US and CEUS should also be used in cases of liver lesions appearing uncharacter-
istic on CT or MRI scans. Under good US and CEUS examination conditions, the 
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CT or contrast-enhanced MRI. But in general, conventional US and CEUS cannot 
replace the necessity of contrast-enhanced CT for tumour staging and tumour 
follow-up. On the other hand, conventional US and CEUS applied percutaneously 
and especially intraoperatively are able to detect additional small metastases not 
visible on CT or MRI. This is of impact for staging and follow-up of tumours in which 
the liver is an important organ for metastases like gastrointestinal, liver, bile duct, 
and pancreatic malignancies. CEUS can also be helpful for guiding liver tumour 
ablation. However, in the follow-up after tumour ablation, contrast-enhanced CT or 
contrast-enhanced MRI is more sensitive. 
Learning Objectives:
1. To learn about enhancement characteristics of the liver and the various focal 
liver lesions.
2. To understand in which situations US and CEUS is expected to be 
appropriate.
3. To discuss the role in comparison to CT and MRI.
A‑119 16:30 
B. CT and MRI perfusion 
F. Berger; Munich/DE (Frank.Berger@med.uni‑muenchen.de) 
At initiation, tumors in a pre-vascular phase are supplied by oxygen and nutrients 
that diffuse from pre-existing normal vessels. When the tumor reaches a critical 
size of approximately 1-4 mm diameter, the resultant ischemia leads to secretion 
of angiogenic factors. These factors, such as vascular endothelial growth factor 
(VEGF), recruit and maintain tumor vessels. „New“ vessels (neovasculature) exhibit 
increased blood volume and permeability compared with normal vessels. Various 
new specific therapies in oncology target tumor vasculature or tumor neoangiogen-
esis. It is not uncommon that these targeted therapies have pronounced cytostatic 
and not predominantly cytotoxic effects. This limits the usefulness of size based 
morphological tumor response assessments utilizing RECIST or WHO criteria. Of 
newer magnetic resonance imaging (MRI) modalities, perfusion MRI has emerged 
as a valid marker of tumor-induced blood vessels and their function. MRI perfusion 
measures the vascularity within a tumor, as well as its component heterogeneous 
parts. Of parameters which can be measured to date, blood volume and permeability 
are commonly applied in patient studies. Blood volume measures the aggregate size 
of the vascular space, while the permeability function informs about the integrity 
of vessels and their ‚leakiness‘ to contrast agents. We will describe the use of MR 
perfusion to monitor such new therapies and discuss its specific advantages and 
limitations in comparison to CT perfusion protocols. PET based strategies for tar-
geted treatment-monitoring in oncology will be briefly mentioned, with prospect on 
the significance of combined vascular and metabolic imaging for further optimizing 
non-invasive response assessment in specific anticancer therapies. 
Learning Objectives:
1. To learn about established morphological-based strategies for tumor 
response monitoring: RECIST and WHO criteria with its limitations in 
targeted treatment surveillance.
2. To learn about the latest antiangiogenic/antivascular treatment strategies in 
oncology.
3. To learn about perfusion imaging protocols, specific advantages and 
technical challenges when utilising CT or MRI.
4. To learn about the significance of CT or MR perfusion imaging in oncology, 
typical applications and future strategies for improvement of non-invasive 
treatment monitoring in oncology.
A‑120 17:00 
C. MR diffusion 
C. Della Pina; Pisa/IT (mclotilde@virgilio.it) 
The purpose of the lecture is to review the ability of diffusion-weighted magnetic 
resonance (MR) imaging in the assessment of loco-regional treatments of primary 
and secondary liver tumor. Guidance and monitoring local therapy, including radio-
frequency ablation (RFA) and transarterial chemoembolization (TACE), are crucial 
to evaluate the success and efficacy of therapy. A change in tumor size at computed 
tomography (CT) or MR imaging is the accepted criterion for assessing response 
after chemotherapy, according to RECIST criteria. In the early post-treatment period 
after loco-regional therapies, however, tumors may not change in size. Advances in 
MR imaging techniques, which include diffusion MR imaging and apparent diffusion 
coefficient (ADC) maps, can provide in vivo metabolic information. Recent studies 
demonstrated that water diffusion can be used to differentiate viable and cellular 
regions from necrotic area in the tumor. Viable tumors have intact cells that restrict 
the motion of water molecules, reducing ADC value; on the other hand, necrotic 
regions allow free diffusion of water molecules and increase ADC value. This ad-
ditional information may enhance the morphologic findings of baseline and dynamic 
MR study. Moreover, new classes of antitumor therapy have been developed that 
have an antiproliferative effect, inducing a delay in tumor shrinkage. Diffusion MR 
imaging can be promising in this clinical setting as a biomarker to predict early 
response to systemic chemotherapy. 
Learning Objectives:
1. To describe physical and technical principles of diffusion-weighted imaging 
in tumors.
2. To discuss the qualitative and quantitative information of the modality.
3. To review imaging findings after percutaneous and intra-arterial treatments of 
liver malignancies.
4. To address the clinical role of diffusion-weighted imaging in monitoring tumor 
response.
16:00 - 17:30 Room E1 
Musculoskeletal 
RC 610 
Metabolic bone diseases 
Moderator:
G. Guglielmi; Foggia/IT 
A‑121 16:00 
A. Latest advances in osteoporosis 
C.R. Krestan; Vienna/AT (christian.krestan@meduniwien.ac.at) 
Osteoporosis is of great socioeconomic impact, as approximately 30% of all 
postmenopausal women have osteoporosis in developed countries. Ageing of 
populations worldwide will be responsible for a major increase of the incidence 
of osteoporosis in postmenopausal women. In 1994, the WHO Working Group 
defined osteoporosis according to measurements of bone mineral density (BMD) 
using dual energy X-ray absorptiometry (DXA) as a bone density T score at or 
below 2.5 standard deviations (T score) below normal peak values for young 
adults. The relative risk of a fracture is between 1.3 and 1.6 for each unit decline 
in spine or total hip T score. Due to limitations of the T-score concept, a 10-year 
risk calculating tool has been developed by the WHO to determine intervention 
thresholds. Fragility fractures are however not only related to bone mineral density 
(BMD). Trabecular bone microarchitecture is a significant determinant of the bone’s 
mechanical properties and is thus of major clinical relevance in predicting fracture 
risk. Trabecular bone structure analysis can be based on images from multidetector 
computed tomography, high-resolution peripheral computed tomography, high-
resolution MRI and projection radiography. Advantages and disadvantages of the 
different methods depend on radiation, costs, availability and a reasonable time 
for in vivo scanning. Grading of vertebral fractures can be done by using a visual 
semiquantitative scoring method. Vertebral morphometry is based on radiographs 
or scans from DXA-machines calculating ratios of vertebral heights with normal 
values to identify vertebral fractures. 
Learning Objectives:
1. To describe what the radiologist ought to know about the WHO definition of 
osteoporosis and vertebral fracture risk.
2. To describe the standard techniques and newer diagnostic techniques that 
provide insights to the structure of trabecular bone.
3. To analyse the pros and cons of these techniques.
4. To describe methods of grading and quantitative morphometric assessment.
A‑122 16:30 
B. The many faces of Paget’s disease 
V.N. Cassar-Pullicino; Oswestry/UK (Victor.Pullicino@rjah.nhs.uk) 
Paget’s disease of bone can be monostotic or polyostotic in distribution. The pelvis, 
femur, spine and the sacrum in particular are commonly involved sites but any bone 
can be affected. The characteristic pathological process and its manifestation vary 
on conventional radiographs. The coarse enlarged trabeculae and consolidation 
of bone are particularly prominent along the cortical contours of long bones. The 
appearances differ depending on the ratio of cortex to trabecular bone. The appear-
ances vary from a predominantly lytic to very sclerotic radiographic features with a 
variable degree of expansion. In such instances, there is no need for further imag-
ing to make a diagnosis. Advanced imaging (scintigraphy, CT, MRI) is required in 
instances of diagnostic uncertainty and to exclude the development of complications 
secondary to Paget’s disease. In some instances, biopsy may also be necessary. 
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Learning Objectives:
1. To highlight the pathological mechanisms of Paget’s disease.
2. To discuss the radiological manifestations in the peripheral skeleton.
3. To stress the imaging characteristics of spinal involvement.
4. To review the benign and malignant complications that can arise in the 
disease.
A‑123 17:00 
C. Rickets and osteomalacia 
J.E. Adams; Manchester/UK (judith.adams@manchester.ac.uk) 
Metabolic diseases are caused by genetic, endocrine, nutritional or biochemical 
factors. Rickets in children (osteomalacia [OM] in adults) is a qualitative abnormality 
(reduced mineral/osteoid ratio), in contrast to osteoporosis which is a quantitative 
abnormality (too little bone). Aetiology: vitamin D and normal phosphate, alkaline 
phosphatase and serum pH are important requirements for normal mineralisation 
of bone. Rickets/osteomalacia is caused by vitamin D deficiency, end-organ resis-
tance to vitamin D, hypophosphataemia, hypophosphatasia and severe acidosis. 
Vitamin D deficiency results from lack of sunlight, dietary deficiency, malabsorp-
tion, chronic liver disease, chronic renal failure (CRF) and end-organ resistance 
(rare genetic disorders). Hypophosphataemia and phosphaturia result from renal 
tubular abnormalities including X-linked hypophosphataemic [XLH] and ‘oncogenic’ 
osteomalacia, in which a humoral factor is produced by the tumour (‘phosphatonin’). 
Candidates for phosphatonin include FGF-23 (fibroblast growth factor 23), PHEX 
(phosphate-regulating gene located on X-chromosome) and MEPE (matrix extracel-
lular phosphoglycoprotein). A large variety of tumours can cause oncogenic OM, 
which are often small and vascular (haemangiopericytoma); imaging is important in 
identification, as removal results in cure. Imaging: ricketic/osteomalacic bones are 
soft and bend (Harrison sulcus, bowed legs, knock knees, varus deformity proximal 
femur, tri-radiate pelvis). Abnormal endochondral ossification causes metaphyses 
to be cupped and poorly mineralized with widened growth plates. In adults, the 
pathognomonic feature is the Looser’s zone composed of unmineralized osteoid, 
typically found in medial femoral neck, pubic rami, lateral scapula and ribs. Some 
conditions (XLH) have other characteristic features (enthesopathy, extra-skeletal 
ossification, dense bones with coarse trabecular pattern). 
Learning Objectives:
1. To recognise the imaging features of rickets and osteomalacia.
2. To learn the various causes of vitamin D deficiency and other disorders that 
result in rickets and osteomalacia.
3. To appreciate the role of imaging in oncogenic and x-linked 
hypophosphataemic osteomalacia.
16:00 - 17:30 Room E2 
Foundation Course: Head and Neck Radiology 
E³ 620 
Oral cavity, oropharynx and nasopharynx 
Moderator:
V. Chong; Singapore/SG 
A‑124 16:00 
A. Oral cavity and oropharynx 
A. Borges; Lisbon/PT (borgalexandra@gmail.com) 
Although the oral cavity and oropharynx are in contiguity and affected by some of 
the same pathologic processes, they are anatomically and embriologically distinct 
and diseases affecting these regions differ in prognosis. Therefore, it is mandatory to 
recognize the boundaries between the two. The oral cavity is a space open anteriorly, 
very accessible to clinical inspection. It is separated from the oropharynx by the 
boundary between the hard and soft palate superiorly, the anterior faucial arches 
laterally and by the circunvallate papilla of the tongue, inferiorly. Lesions affecting 
the oral cavity and oropharynx may originate from the mucosa, readily available to 
clinical inspection, or may be submucosal and more difficult to characterize only on 
clinical grounds. The most common disease affecting these anatomic compartments 
is infection. In this setting, imaging is used in cases refractory to conventional treat-
ment and on patients with a more serious clinical condition (airway compromise). 
Squamous cell cancer is the most common neoplasm occurring in the oral cavity 
and oropharynx. Incidence decreases from anterior to posterior while the prognosis 
aggravates. Imaging is mandatory for tumor staging particularly in depicting deep 
extent. Tumors tend to grow along muscles and nerves and may invade bone. 
Disease extent dictates treatment modality and the extent of surgical resection, 
when surgery is the treatment option. Submucosal lesions span a wider gamut of 
pathologies including pseudomasses, infection, benign and malignant neoplasm. 
In this case, imaging is crucial to characterize the lesion and to provide a limited 
list of differential diagnoses. 
Learning Objectives:
1. To review the relevant anatomy of the oral cavity and oropharynx.
2. To learn about the imaging features of benign lesions occuring in this region.
3. To understand the extension patterns observed in malignant tumors of this 
region.




F. Dubrulle; Lille/FR (f‑dubrulle@chru‑lille.fr) 
The nasopharynx represents an intersection between the nasal choanae, the 
oropharynx, the deep facial spaces, the skull base and the intracranial cavity. 
Most nasopharyngeal neoplasms are malignant tumors showing aggressive local 
infiltration along well-defined routes. The primary role of imaging is accurate tumor 
mapping and detection of possible tumor extension, especially to the skull base and 
the deep facial spaces. The aim of this presentation is to illustrate these extension 
patterns of nasopharyngeal carcinomas on imaging and to show the particular 
implication of imaging in the correct staging of the lesion. 
Learning Objectives:
1. To review the relevant radiological anatomy of the nasopharynx and related 
spaces.
2. To learn about the imaging features of benign lesions occuring in this region.
3. To understand the extension patterns observed in malignant tumors of this 
region.
4. To appreciate the clinical impact of imaging findings in diseases of this 
region.
16:00 - 17:30 Room F1 
Genitourinary 
RC 607 
Imaging of the scrotum and penis 
Moderator:
B. Brkljacic; Zagreb/HR 
A‑126 16:00 
A. Acute scrotum 
L.E. Derchi; Genoa/IT (derchi@unige.it) 
Ultrasonography is the technique best suited to evaluate the acute scrotum, since 
modern transducers provide depiction of both fine anatomic details and intrates-
ticular vessels in all cases. It must be considered that causes of acute scrotum 
have different frequencies according to patient age. Torsion is more common in the 
pediatric age group; infections are more frequent in adults. In suspected testicular 
torsion, color Doppler evaluation of intratesticulr flow allows diagnostic sensitivity 
of 86%. However, flow signals can be seen in low-grade torsions and identification 
of high-resistance flow at spectral analysis may help avoid false negatives. Torsion 
of the testicular appendages may be recognized when a small nodule, adjacent to 
a normal-looking testis, with normal intratesticular flow, is encountered. Infection 
usually starts at the epidydimis and is diagnosed on clinical grounds; imaging is only 
rarely needed, but may be helpful in assessing testicular involvement. In patients 
with trauma, imaging plays a key role in assessing testicular integrity, since surgery 
is needed when there is testicular rupture. Other, less common, causes of acute 
scrotum involve the scrotal skin, vessels and spermatic cord. Additionally, in rare 
case, “non-scrotal” causes may produce acute scrotal symptoms. The most typical 
example is extension of pain to the scrotum during a renal colic. Other causes may 
be due to involvement of the scrotum from intrabdominal inflammatory or traumatic 
pathologic changes due to patency of the processus vaginalis. 
Learning Objectives:
1. To understand the role of imaging, especially US in testicular trauma.
2. To learn whether imaging is required for testicular torsion and what the 
imaging signs are.
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A‑127 16:30 
B. Incidentaloma in scrotal US 
L. Rocher; Le Kremlin‑Bicêtre/FR (laurence.rocher@bct.aphp.fr) 
The most frequent pseudotumoral lesion is the tubular ectasia of the rete testis: it 
is characterized by a group of numerous tiny cysts and/or tubular configurations. 
Multinodular echotexture (similar nodules with diffuse regular distribution) involving 
testis of normal size is usually bilateral and not malignant: it will be controlled. A 
medical evaluation in search of a granulomatous disease like sarcoidosis is rec-
ommended, especially if the epididymis is also pathological. Multinodular aspect 
(hypo or hyperechoic nodes) involving very small testis (less than 3 ml) suggests a 
Klinefelter disease. Nodules are small benign leydig cell tumors or hyperplasia. The 
hypoechoic nodules greater than 5 mm, within vessels, identified by color Doppler 
will generally be explored: Two main diagnoses are proposed: Seminoma and leydig 
cell tumor. Extemporaneous histologic analysis may be difficult. Hypoechoic areas, 
microlithiasis ou macrocalcification in the vincinity of the nodule, multifocal pattern, 
and very hypoechoic echotexture suggest malignity. A normal echotexture of the 
adjacent pulp, slight lobulate contours, a vascularity proportional to the size suggest 
a Leydig cell tumor. In this case, a peroperative ultrasound may help the surgeon 
to perform a tumorectomy. MRI does not help us to distinguish these pathologies. 
Small nodules of less than 5 mm incidentally found are generally controlled. We 
suggest monitoring by ultrasound at 3, 6 and 12 months the first year, and then 
annually for two years. The announcement of a potentially malignant unexpected 
lesion should be very prudent and appropriate. 
Learning Objectives:
1. To learn the various images that can be found incidentally on scrotal US, like 
masses, calcifications, parenchymal heterogeneity and ductal ectasies.
2. To determine which images may correspond to significant diseases and 
require follow-up or surgery.
A‑128 17:00 
C. Imaging of the penis 
M. Bertolotto; Trieste/IT (bertolot@univ.trieste.it) 
Ultrasonography (US) is the first-line imaging modality in patients with penile dis-
ease. Using high-end equipment after pharmacologically induced erection penile 
anatomy is well defined and virtually all clinically significant penile vessels can be 
evaluated in normal and in impotent men. The superior soft-tissue contrast resolution 
afforded by MR imaging provides an opportunity to advance imaging evaluation of 
the penis in selected cases. In the clinical practice, erectile dysfunction is the most 
frequent penile abnormality which is investigated with Doppler US. The clinical role 
of this evaluation, however, reduced after the introduction of oral medications for 
impotence. Differentiation among different forms of erectile dysfunction is mainly 
based on evaluation of Doppler waveform changes in the cavernosal arteries. 
Peyronie’s disease is the most frequent cause of penile induration. Imaging is often 
required to evaluate the extension of the plaques, involvement of the penile septum, 
and relationship between the plaques and penile vasculature. In patients with penile 
traumas, imaging allows accurate evaluation of albugineal tears, extra-albugineal 
and cavernosal hematomas, vascular lesions producing high flow priapism and 
other pathological changes. Compared with US, MR imaging has some advantages 
in identification of small albugineal tears, and is more accurate in identification of 
urethral or spongiosal involvement. Other situations in which penile imaging can 
be required are circumscribed or diffuse cavernosal fibrosis, tumors, priapism, 
severe inflammation, and evaluation of postsurgical complications. Most of these 
conditions are first investigated with US; MR imaging is optimal for tumor staging. 
Learning Objectives:
1. To learn the most frequent penile diseases that can be diagnosed by 
imaging.
2. To understand the respective roles of US and MRI and technical challenges 
of imaging.
3. To know how imaging influences treatment and follow-up.
16:00 - 17:30 Room F2 
Breast 
RC 602 
Breast MRI: Lesion characterisation 
Moderator:
K. Kinkel; Chêne‑Bougeries/CH 
A‑129 16:00 
A. Morphology and kinetics at CE dynamic imaging 
G. Esen; Istanbul/TR (gulesenicten@gmail.com) 
MRI is the most sensitive imaging modality for the detection of invasive breast 
carcinoma regardless of the fibroglandular composition of the breast. It is performed 
in prone position, in the axial, sagittal or coronal planes. Axial position is preferable 
because correlation with mammography and comparison with the opposite breast 
is possible. In order to detect small enhancing lesions reliably, fatty tissue signal is 
suppressed, either by active fat suppression or subtraction. Examinations should 
be performed in the second week of the menstrual cycle. Differential diagnosis 
is based on morphologic findings as well as contrast enhancement kinetics. It is 
important to have high resolution images while scanning as fast as possible so 
that the temporal data is not lost. On MRI, benign lesions usually demonstrate 
minimal and slow enhancement, whereas malignancies are expected to show rapid 
enhancement and then washout. Morphologic findings are described according 
to the MR BI-RADS lexicon for the standardization of reports and interpretation 
criteria. Masses with irregular or spiculated borders that show rim enhancement 
are highly suspicious for invasive tumors. Non-mass-like enhancement in the form 
of ductal or segmental clumped enhancement is also considered suspicious and 
can be detected in DCIS. While interpreting breast MRI examinations, morphologi-
cal and kinetic findings should be combined and correlated with mammographic 
and sonographic findings. Risk factors, if there are any, should also be taken into 
consideration. In this lecture, appropriate imaging techniques as well as findings 
that can be helpful in lesion characterization will be reviewed. 
Learning Objectives:
1. To know the protocols used in breast MRI.
2. To describe the different aspects of benign and malignant lesions.
3. To review the basics of kinetic behaviour of breast lesions.
A‑130 16:30 
B. Overdiagnosis by breast MRI 
F. Sardanelli; Milan/IT (f.sardanelli@grupposandonato.it) 
Overdiagnosis should be considered for MRI indications in which lesions are diag-
nosed which would have been undetected using only conventional imaging. This 
is intrinsically associated with screening MRI, recommended for high-risk women. 
However, high-risk cohort studies showed early stage of MRI-diagnosed cancers 
with a high rate of negative nodal status, which plays in favor of an outcome effect 
(using assumptions derived from mammographic screening in the general female 
population). Conversely, the relatively higher probability of triple negative cancers 
in these women (in particular BRCA1 mutation carriers) should be taken also into 
account. Meta-analyses showed that the risk of overdiagnosis is more important 
for preoperative MRI (pMRI) which changes 16.6% of surgical treatments: 9.2% 
increase of mastectomies due to 8.1% for true positives plus 1.1% for false positives; 
7.4% wider/additional excisions due to 3.0% plus 4.4%, respectively. Moreover, pMRI 
yields a 4.1% incremental detection rate of contralateral cancers (positive predic-
tive value 48%); 35% DCIS and 65% invasive (mainly node negative). To reduce 
overtreatment, we need needle sampling (including MRI guidance), reaching 13% 
of MRI-induced correct changes of surgical planning, to be compared with only 
about 1% annual risk of recurrences (but also with 20-40% rate of positive surgical 
margins). For contralateral cancers, needle biopsy can also reduce overtreatment, 
allowing excising contralateral cancers with simultaneous conservative surgery in 
4% of the women, to be compared with only 0.5-1% annual risk for contralateral 
cancer. pMRI has also been shown to detect extensive intraductal component, but 
with 11-28% overestimate and 17-28% underestimate. 
Learning Objectives:
1. To estimate overdiagnosis for preoperative MRI and for MRI screening of 
high risk women.
2. To evaluate the potential impact of overdiagnosis.
3. Possible ways to avoid overdiagnosis.
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A‑131 17:00 
C. How to improve specificity of breast MRI? 
J. Veltman; Nijmegen/NL (j.veltman@rad.umcn.nl) 
Breast MRI has shown diagnostic sensitivities of 94-99% for invasive breast cancer; 
however, specificities have been reported significantly lower with values between 
37 and 86%. The specificity of breast MRI is mainly based on the evaluation of 
morphologic features and relative “slow” dynamic characteristics of enhancing le-
sions. The only moderate specificity that is achieved using these characteristics can 
result in a significant number of false positive findings during for instance screening 
or pre-operative imaging. These findings will often require short term follow-up, 
target ultrasound with biopsy or even MRI guided biopsy. Fast dynamic imaging, 
spectroscopy and diffusion weighted imaging (DWI) have been described to have 
potential for improving the specificity of breast MRI. The use of fast dynamic imag-
ing sequences results in a more accurate evaluation of the initial enhancement of 
the lesion. In combination with pharmacokinetic modeling, this can result in a more 
quantitative evaluation of enhancement. In proton-MR Spectroscopy (MRS), the 
presence of a choline signal, a cell-membrane precursor, in breast lesions can be 
used to differentiate benign from malignant lesions. The specificity of MRS varies 
between 67 and 100% in literature (average 87%). DWI has also shown potential 
in differentiating between benign and malignant lesions, but, like with other tech-
niques, varying specificity values are reported ranging between 46 and 93%. In 
this presentation, the value of these techniques for improving the performance of 
breast MRI will be discussed. 
Learning Objectives:
1. To discuss literature on MRI specificity.
2. To discuss the value of ultrafast sequences.
3. To discuss the value of spectroscopy and diffusion-weighted imaging.
16:00 - 17:30 Room G/H 
State of the Art Symposium 
SA 6 
Adrenals: Small glands, big problems … and 
practical solutions
Moderator:
Y. Menu; Paris/FR 
A‑132 16:00 
Chairman’s introduction: Five good reasons for the radiologist to image 
the adrenals 
Y. Menu; Paris/FR (yves.menu@sat.aphp.fr) 
There are many reasons why adrenal imaging is meaningful. Five will summarize 
the objectives of this session: 1. Adrenal lesions including tumours are extremely 
common. It is likely that any radiologist will face these questions almost every day. 
2. The problem of the so-called «incidentalomas» is especially common, and is 
sometimes a very difficult situation in patients with known or suspected cancer. 3. 
Many imaging modalities, including ultrasound, CT, MR and nuclear medicine are 
useful in the detection, characterization, staging and follow-up of adrenal lesions. 
4. Imaging is powerful as long as precise protocols are applied, especially dynamic 
enhanced CT/MR and in-phase/opposed phase imaging. 5. Appropriate strategy, 
associating imaging and biology are sometimes poorly understood and should be 
clarified, because the radiologist is in most cases the person who discovers adrenal 
lesions. Therefore, he/she should orientate the strategy according to the likelihood 
of specific diseases, advising either a simple follow-up or even no further examina-
tion, or conversely prompting further clinical, biological or imaging investigations. 
This session will answer these questions and provide the attendance with solid 
knowledge, useful for everyday’s practice. 
Session Objectives:
1. It is a common clinical problem.
2. It is the role of the radiologist.
3. It is easy to manage.
4. It is helpful for the patient.
5. It saves anxiety and money.
A‑133 16:05 
What is normal, what is abnormal? 
M.-F. Bellin, S. Ferlicot, L. Rocher; Le Kremlin‑Bicêtre/FR 
(marie‑france.bellin@bct.aphp.fr) 
Because of the increasing use of cross-sectional imaging, adrenal masses are 
commonly detected, with reported frequency up to 5% at abdominal CT. Radiology 
plays a critical role in not only the detection of adrenal abnormalities but in charac-
terizing them as benign or malignant. Computed tomography continues to be the 
cornerstone of adrenal imaging and has become the study of choice to differentiate 
a benign adenoma from a metastasis in the oncology patient. An array of pulse 
sequences is now available that improves the image quality and diagnostic value 
of adrenal MR imaging. Adrenal masses can be classified into various groups on 
the basis of the presence of intracellular lipid, macroscopic fat, haemorrhage, cystic 
changes, vascularity and shape of the tumour. Recognition of the typical imaging 
features of adrenal lesions is important for radiologists because it often changes 
the treatment approach and may obviate surgery. 
Learning Objectives:
1. To explain the optimal techniques of MRI and CT for the examination of the 
adrenals.
2. To learn imaging landmarks of normal adrenal glands.
3. To understand the concept of adrenal hyperplasia.
4. To review the classification of adrenal tumours, benign and malignant, 
illustrated by radiopathological correlations.
5. To learn the clinical and radiological data in the most common diseases 
associated with adrenal insufficiency like TB, histoplasmosis, haemorrhage, etc.
A‑134 16:30 
What is abnormal and not a problem? 
G. Heinz-Peer; Vienna/AT (gertraud.heinz@meduniwien.ac.at) 
The widespread use of modern imaging techniques has significantly increased the 
number of incidentally detected adrenal masses. Adrenal incidentaloma is not so 
much a disease entity as a finding that may or may not represent a disease. Thus, 
incidental adrenal findings by their very nature pose a risk of over diagnosis and 
overtreatment. Although most adrenal incidentalomas are of no significance beyond 
the anxiety they produce indirectly. Some incidentalomas are clinically significant, 
and inadvertently leaving them alone might damage the patients´ health. Therefore, 
detection of an incidentaloma necessitates a conscious decision regarding its man-
agement. The past few years have seen an increasing reliance on semiquantitative 
techniques in imaging and characterization of adrenal masses. Evaluation of the 
mean percentage washout for adrenal masses on delayed enhanced CT series 
allows differentiating benign and malignant incidentaloma with high sensitivity 
and specificity. On MRI, dynamic gadolinium enhanced - and chemical shift (CSI) 
- techniques have become well-accepted diagnostic methods in the characteriza-
tion of adrenal masses. Additionally, nuclear medicine studies, and PET/CT have 
proved to be useful adjuncts in the whole assessment of adrenal lesions. All general 
approaches in managing adrenal incidentalomas involve hormonal screening. 
However, they vary both in extent and in the specific screening tests. In this lecture, 
an algorithm on the management of adrenal incidentalomas will be presented. 
Learning Objectives:
1. To understand the prevalence of adrenal incidentalomas.
2. To learn how radiology may help in differentiating benign and malignant 
incidentalomas.
3. To be able to advise adequate examinations, both biological and radiological, 
for the initial workup of adrenal incidentaloma.
4. To understand how to organise follow-up.
A‑135 16:55 
What is abnormal and a problem, and what are the solutions? 
U.G. Mueller-Lisse; Munich/DE (ullrich.mueller‑lisse@med.uni‑muenchen.de) 
Since the advent of cross-sectional imaging in clinical medicine, adrenal lesions 
are frequently diagnosed even in asymptomatic patients. The term «incidentaloma» 
has been coined for such lesions. However, while incidentalomas are frequently 
benign, finding an adrenal lesion may constitute a diagnostic problem when the 
patient has previously been diagnosed with malignant disease. Following lung, 
liver, and bone, the adrenal is the 4th most common site of malignant metastasis. 
Unenhanced CT and MRI with in-phase and out-of-phase GRE-sequences may 
help to characterize adrenal lesions as (non-functioning) adenoma when the 
lesion measures less than 4 cm, appears round and homogenous, and there is 
sufficient intracellular fat. Contrast-dynamic imaging recognizes adrenal adenoma 
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The majority of metastases are bright on T2-weighted and iso- or hypo-intense in 
liver on T1-weighted MR images. Desmoplastic reaction may render a metastasis 
dark at MRI. Frequently, adrenal metastases demonstrate the same or similar 
imaging characteristics as the primary malignancy. In some tumor entities, e.g., 
NSCLC, lymphoma, or melanoma, PET/CT may demonstrate adrenal metastasis 
with markedly increased specific-uptake-values for 18-FDG. However, tumors 
producing catecholamines, e.g., benign or malignant phaeochromocytomas or their 
metastases, may be characterized biochemically by means of MIBG- or octreotide 
szintigraphy (±SPECT), or Dota-Tate-PET/CT, and, in some instances, morphologi-
cally by their inhomogeneity and contents of calcification and haemorrhage. Risks of 
needle-tract-seeding, haemorrhage, and severe, acute hypertension are associated 
with adrenal biopsy. Localization and characterization of functional adrenal tumors 
may require adrenal venous blood sampling or orthostasis testing. 
Learning Objectives:
1. To learn the natural history and the usual and unusual appearance of 
primary cortical malignant tumors.
2. To identify adrenal metastases, and the specific appearance according to the 
primary site.
3. To understand the role of PET/CT in adrenal malignancies.
4. To be able to explain the advantages and limitations of percutaneous biopsy.
5. To understand the radiological appearance and staging strategy in case of 
symptomatic adenoma.
Epilogue: 
The practical role of the radiologist facing adrenal masses 17:20 
16:00 - 17:30 Room I 
Vascular 
RC 615 
Peripheral vascular malformations 
Moderator:
M. Sapoval; Paris/FR 
A‑136 16:00 
A. Pathology, correct anatomical classification and clinical work-up 
H. Kubiena; Vienna/AT (harald.kubiena@meduniwien.ac.at) 
Patients presenting with vascular malformations mostly are nomadic and hopeless 
individuals looking for help. Finally having reached a “multidisciplinary specialist-group” 
after a sometimes long and misleading trip throughout the ocean of “single-players” 
of different specialities, these patients do not ask for any more diagnostics - they 
strongly claim for therapy. Vascular malformations are congenital lesions, although 
merely seen at birth they become evident throughout the individual’s growth. These 
developmental errors can affect all components of the vascular tree in any area of 
the body. The therapeutic goal must be defined rather as “control” than “cure” of 
this disease. To make this point understandable for both patients and colleagues, 
a fundamental understanding of the pathogenesis and natural course must be cre-
ated. In special cases of complex vascular malformations, the precise diagnosis and 
the information about all potential side-effects as well as risk-factors of progression 
enables these patients to manage their daily life. Therefore, indications for treatment 
vary depending on the specific type of slow flow or high flow lesion, location, pain, 
functional and cosmetic impairments and general side-effects of each particular le-
sion. Since no single specialist has enough knowledge to diagnose or treat vascular 
anomalies beyond the border of his/her distinct specialty, multidisciplinary working-
groups have emerged at these interdisciplinary interfaces. Their common language 
in classifying and their overall understanding of pathogenesis, prognosis offers 
these mostly hopeless patients a costume-fit treatment addressing their symptoms. 
Learning Objectives:
1. To understand the difference between AVMs and hemangiomas.
2. To review the classification of arterio-venous malformations.
3. To understand the influence of AVM types on treatment selection.
A‑137 16:30 
B. Diagnostic approaches to AVM: How to image the dynamic 
S. Frevert; Copenhagen/DK (susanne.frevert@rh.regionh.dk) 
An arterio-venous malformation consists of a nidus made of micro- or macro fistulas 
and the feeding arteries and draining veins. The lesion is hemodynamically active 
with fast-flow and early venous shunting. AVMs are considered congenital but most 
become evident later in life. The ideal examination to evaluate arterio-venous mal-
formation must be safe, reliable and give answers to questions about the feeding 
arteries and draining veins as well as the nidus. The vessel supply and involvement 
of bones, muscles, subcutaneous tissues and organs have to be determined and 
finally the flow in the lesion must be addressed. Ultrasound combined with color 
Doppler examination is the primary diagnostic tool and documents the arterio-
venous shunting. The angioarchitecture of the lesion can be difficult to evaluate.
Contrast enhanced CT scanning is of limited value in arterio-venous malforma-
tions except in lesions involving the internal organs and the visceral vessels. The 
single most useful examination is MRI. The scanning has the distinct advantage to 
demonstrate the extent of the lesion. Contrast-enhanced MR angiography espe-
cially with time resolved sequences allow the flow characteristics to be assessed. 
Typical findings of AVM are dilated tortuous vessels with flow void corresponding 
to the fast flow in the arteries and veins. The black round holes are visible in most 
sequences. There is little if any soft tissue mass. The hypertrophied arteries and 
enlarged draining veins are depicted on contrast-enhanced MR angiography. 
Conventional angiography is indispensable for precise pre-therapeutic evaluation 
of the nidus and angioarchitecture. 
Learning Objectives:
1. To learn about techniques for dynamic non-invasive vascular imaging.
2. To demonstrate the imaging findings of different types of AVMs.
3. To understand potential pitfalls of imaging modalities.
A‑138 17:00 
C. Treatment of AVMs: Image-guided interventions: When and when not 
J.A. Reekers; Amsterdam/NL (J.A.Reekers@amc.uva.nl) 
Management of arterio-venous malformations (AVM) is still one of the most chal-
lenging interventional procedures. All AVMs are unique and need tailored treatment. 
The typical medical history of an increasing tumour, often already diagnosed in 
childhood, and the “trill” in a high-flow AVM already makes a diagnosis. The imag-
ing pathway is the same for all AVMs. MRI is the first choice diagnostic step. The 
typical appearance on T1 and T2 makes the diagnosis. The most important feature 
of the MRI is that it will show the extent of the lesion. The latter is important for pos-
sible treatment options. MRA does not contribute to the diagnosis and is therefore 
not necessary. After the diagnosis of a high-flow AVM, a treatment plan can be 
made. As an AVM is a benign disease, it is the patient’s complaints that lead to a 
treatment. Just having an AVM is not an indication for treatment. Pain, bleeding, 
physical constrain and sometimes cosmetic problems are the right indication for 
treatment. In high-flow lesions, the aim is to close the direct A_V fistulae. This can 
be done with several materials. Glue often gives the best results, but also coils or 
Onyx can be used. The outcome of treatment is not total cure (which is seldom 
reached) but improvement of QOL. 
Learning Objectives:
1. To learn about optimised treatment strategies.
2. To learn about risks and contraindications.
3. To discuss pros and cons of percutaneous and/or endovascular treatment.
16:00 - 17:30 Room K 




D. Bulja; Sarajevo/BA 
P.R. Kornaat; Leiden/NL 
A‑139 16:00 
Common pitfalls in MR mammography 
D. Djilas-Ivanovic; Sremska Kamenica/RS (draganadji@hotmail.com) 
Magnetic resonance imaging (MRI) of the breast is emerging as the most sensi-
tive modality available for the detection of primary or recurrent breast cancer. The 
published sensitivity ranges between 89 and 100%, with more variable specificity 
ranging between 20 and 100%. There are number of technical artifacts (motion 
artifacts, misregistration, magnetic susceptibility artifacts etc). and pitfalls (such as 
inadequate fat saturation at 3.0 T units) that can limit the interpretation of the images 
by masking or simulating disease. Both morphologic and kinetic features should 
be considered in the image interpretation. However, many diagnostic pitfalls must 
be considered. Both strong background enhancement and lack of enhancement 
of the lesion can lead to diagnostic mistakes. Lack of enhancement is strongly 
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predictive of benignity, with negative predictive value for invasive cancer of 94-
96%, but the absence of observed enhancement does not necessarily exclude a 
cancer. Morphologic criteria, such as margin characteristics of a focal lesion or the 
distribution of area enhancement, are considered the most important features for 
breast lesion diagnosis. 1H MR spectroscopy is a promising tool in the detection of 
breast malignancy, but there are many technical and interpretational pitfalls that 
one should be aware of. Correlation of breast MRI with other imaging modalities 
(mammography and ultrasound) improves the diagnostic specificity. If breast MRI 
reveals a lesion that was not detected with previous, standard procedures, the 
radiologist should try to localize the lesion using second-look ultrasound. 
Learning Objectives:
1. To learn about technical artifacts and pitfalls commonly encountered in 
breast MRI.
2. To become familiar with specific morphologic and kinetic features that should 
be considered in the image interpretation.
3. To appreciate the importance of correlation of breast MRI with other imaging 
modalities.
A‑140 16:30 
An easy approach to tackle neck imaging 
D. Farina; Brescia/IT (nappaje@yahoo.it) 
Essentially, two factors make neck imaging a demanding task: the challenge 
posed by motion artefacts and the understanding of the anatomy. First of all, neck 
imaging can be simplified if images of good quality are acquired. The routine use 
of multidetector CT equipments has noticeably decreased the impact of motion 
artefacts in CT imaging. Nonetheless, MRI should be preferred in the evaluation of 
soft tissue masses of the neck. Tailoring of the protocol to both patient and lesion 
is thus essential to obtain a correct diagnosis, by combining time decreasing tricks 
(such as parallel imaging), contrast improving sequences (fat saturation, above all) 
and high resolution acquisition (such as 3d-VIBE). Secondly, neck imaging can be 
simplified if the complex anatomy of this region is disassembled in spaces that are 
easily identified on cross-sectional scans, basically on axial plane (though also on 
coronal and sagittal images). These spaces are defined by the splitting of the three 
layers (superficial, middle, deep) of the deep cervical fascia. Nine spaces are thus 
defined, 4 located in the suprahyoid neck (parapharyngeal, masticator, parotid, 
pharyngeal mucosal), 1 in the infrahyoid neck (visceral) and 4 extending vertically 
on both sides of the hyoid bone (carotid, retropharyngeal, perivertebral, posterior 
cervical). This schematic classification helps to assign each lesion to a space of 
origin, and consequently, to narrow the list of differential diagnoses to a minimum. 
Moreover, this classification accounts for the need to scrutinize the neck along all 
its length when acute inflammatory processes are under investigation. 
Learning Objectives:
1. To become familiar with MSCT/MRI protocols for neck imaging.
2. To learn the tricks to improve the quality of images.
3. To understand the boundaries and vertical extension of the spaces of the 
neck.
4. To become familiar with the space-specific differential diagnosis.
A‑141 17:00 
Management in radiology 
L. Donoso; Barcelona/ES (ldonoso@clinic.ub.es) 
As the importance of imaging studies in the diagnosis and treatment of all kinds of 
patients continues to grow, professionals from many different backgrounds are gaining 
footholds in what was once the radiologist’s exclusive domain. Radiology departments 
need to adopt a proactive approach to ensure that radiologists will continue to lead the 
imaging revolution. Innovative proposals focused on maximizing client satisfaction and 
creating added value are the best way to keep a competitive edge. The management 
strategy of creating added value through innovation has been effective in many differ-
ent branches of industry, and the basic principles of this approach can be applied in 
radiology. This presentation will focus on different ways to become more competitive by 
creating added value in the services we provide. The future of radiology departments 
will depend largely on our willingness and ability to manage innovatively to ensure that 
we deliver added value to our clients. Innovative management begins with a critical 
evaluation of all the activities that make up the value chain. It is essential to review 
all the organization’s processes to determine which activities should be improved, 
reduced, or eliminated and to introduce new activities that create value for clients. Value 
curves make it possible to examine these activities in detail and to compare traditional 
approaches with innovations. Information and communication technologies are key to 
this strategy and this presentation will emphasize and illustrate their role in developing 
the radiology department’s business strategy. 
Learning Objectives:
1. To recognise the importance of innovative management in delivering 
radiological services.
2. To understand how innovative management creates added value for clients.
3. To appreciate the crucial role of information and communication 
technologies.
16:00 - 17:30 Room L/M 
Special Focus Session 
SF 6 
Imaging of cardiomyopathies 
Moderator:
V.E. Sinitsyn; Moscow/RU 
A‑142 16:00 
Chairman’s introduction 
V.E. Sinitsyn; Moscow/RU (vsini@mail.ru) 
Primary cardiomyopathies (CMP) are diseases of the myocardium of unknown 
origin, associated with cardiac dysfunction. There is a need for better detection and 
characterization of these diseases. Modern classification of CMP is quite complex. 
Thanks to progress of cardiac imaging, new types of CMP have been discovered. 
There is growing clinical interest in the use of cardiac MRI and MDCT in detection 
and characterization of CMP. Major tasks of cardiac imaging in CMP are: assess-
ment of cardiac morphology and function, quantification of blood flow and valve 
motion and myocardial characterization, e.g. identification of foci of inflammation 
and fibrosis. Both MRI and MDCT may detect major diagnostic features of CMP 
without limitations of echocardiography. MR with late gadolinium enhancement 
(LGE) has turned into one of the best modalities for myocardial characterization, 
competing with nuclear imaging. Recent clinical studies have suggested that the 
extent and pattern of LGE may have prognostic and therapeutic value in patients 
with CMP. CTA can reliably differentiate ischemic CMP from non-ischemic ones. New 
technologies of MDCT, such as dual energy CT, may be also used for myocardial 
characterization. It has been shown that MRI and MDCT can provide a valuable 
contribution to the diagnosis of CMP and contribute substantially to proper manage-
ment and treatment of patients with CMP. Current clinical recommendations list CMP 
as one of the major indications for cardiac MRI or CT. Broad and growing scope of 
indications for cardiac imaging requires corresponding competence of radiologists 
in diagnosis of non-coronary cardiac diseases, including CMP. 
Session Objectives:
1. To learn about the increasing incidence of cardiomyopathy, the various 
etiologies and the terminology.
2. To be aware of the natural history of cardiomyopathies.
3. To understand why the radiologist has an added value in the diagnosis, 
work-up and follow-up of cardiomyopathies, and how CT and MRI may play 
an important role in addition to echocardiography.
A‑143 16:03 
Imaging of cardiomyopathies: What is important for the cardiologist? 
J. Schulz-Menger; Berlin/DE (jeanette.schulz‑menger@charite.de) 
Cardiac Magnetic Resonance (CMR) has the capability to assess cardiac function, 
to visualize small myocardial lesions and to differentiate myocardial tissue changes. 
One of the most challenging tasks in cardiology is the differentiation of the underly-
ing cause of a wall motion abnormality, impaired myocardial function or causes for 
hypertrophy. In case of dilated cardiomyopathy, mainly the differentiation of ischemia 
and inflammatory reaction has to be elucidated. Beside characterization of tissue 
changes, CMR has the potential to differentiate prospectively between reversible 
and irreversible myocardial injuries. The changes can be monitored during follow-up. 
The broad clinical spectrum from subclinical disease to severe heart failure and 
a course of the disease from complete convalescence to dilated cardiomyopathy 
depends on the extent of the myocardial damage and its immediate detection. 
Therefore, an early non-invasive differentiation is warranted. Contrast-enhanced 
CMR and combined protocols has been used to detect myocardial inflammation 
for several years and for follow-up. In case of hypertrophic cardiomyopathy, CMR 
is superior in comparison to echocardiography in detecting small and uncommon 
localized hypertrophied regions. The high spatial resolution allows the visualiza-
tion of small abnormalities including findings affecting the papillary muscle. The 
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and provides some information regarding risk-assessment. Detection of myocardial 
tissue changes offers the opportunity to understand the development of disease 
and therefore the potential to optimize therapy. 
Learning Objectives:
1. To become familiar with classification and manifestations of 
cardiomyopathies.
2. To understand the major needs for imaging in cardiomyopathies.
3. To indicate the modern role of cardiac CT and MRI in the work-up of a 
patient with cardiomyopathy.
A‑144 16:15 
MRI and MDCT in dilated cardiomyopathy 
J. Bogaert; Leuven/BE (Jan.Bogaert@uz.kuleuven.ac.be) 
The role of non-invasive imaging techniques, in particular computed tomography 
(CT) and magnetic resonance imaging (MRI), is rapidly expanding in investigating 
patients with dilated ventricles. The etiology of uni- or biventricular enlargement is 
widely variable (e.g. idiopathic dilated, ischemic, toxic, metabolic, arrhythmogenic 
RV dysplasia, non-compaction cardiomyopathy), making straightforward diagnosis 
and treatment often challenging. Both CT and MRI provide volumetric data, and in 
combination with ECG triggering, ventricular volumes and volume changes of both 
ventricles throughout the cardiac cycle can be accurately quantified. The MRI, and 
CT to a lesser extent, can provide valuable information on the underlying cause and 
detect associated pathology (e.g. thrombus formation, valvular regurgitation). The 
presence and pattern of myocardial enhancement is informative about the type of myo-
cardial insult (e.g., ischemic versus inflammatory) and helpful in predicting response 
in cardiac resynchronization therapy (CRT). Angiographic CT/MRI techniques can 
be used to visualize the cardiac venous system, facilitating CRT lead placement. To 
conclude, the novel, not infrequently unique, information obtained by both techniques 
has been extremely helpful in better understanding the “dilated” heart. 
Learning Objectives:
1. To understand how to perform cardiac MRI and MDCT in order to assess 
cardiac morphology and function in patients with dilated cardiomyopathy.
2. To learn how imaging helps to differentiate dilated cardiomyopathy from 
ischemic cardiomyopathy and chronic myocarditis.
3. To compare MRI and MDCT with other imaging modalities in diagnosis of 
dilated cardiomyopathy and to show their contribution to treatment selection 
and patient outcome.
A‑145 16:35 
MRI and MDCT in hypertrophic cardiomyopathy 
M. Gutberlet; Leipzig/DE (matthias.gutberlet@herzzentrum‑leipzig.de) 
Hypertrophic cardiomyopathy (HCM) is a cardiomyopathy, which is characterized by an 
inappropriate myocardial hypertrophy in the absence of an obvious cause and is geneti-
cally transmitted in the majority of patients. It can occur with an obstruction (HOCM) 
of the left ventricular outflow tract (LVOT) and without (HCM). Magnetic Resonance 
imaging (MRI) as well as Multi Detector Computed Tomography (MDCT), i.e. in patients 
with contraindications for MRI, can assess left and right ventricular function and muscle 
mass. MRI with its possibilities of tissue characterization has improved the knowledge 
about different cardiomyopathies in the recent years so much. Especially, for the risk 
stratification of patients suffering from hypertrophic cardiomyopathy (HCM), MRI with 
the use of „late gadolinium enhancement“ (LGE) as a surrogate parameter for fibrosis 
or scar tissue seems to be of an additional value, because the areas of LGE can be 
seen as a potential arrhythmogenic region. Furthermore, MRI provides the unique 
possibility to quantify the LVOT-obstruction by the use of MR-flow measurements. 
Learning Objectives:
1. To become familiar with major forms of hypertrophic cardiomyopathy, clinical 
manifestations and complications of the disease.
2. To show the role of cardiac MRI and MDCT in the assessment of myocardial 
hypertrophy, flow and valvular disturbances in this form of cardiomyopathy.
3. To consolidate knowledge about possible links between imaging features of 
the disease, its complications and patient’s prognosis.
A‑146 16:55 
Uncharted waters: Unclassified and rare cardiomyopathies 
J.D. Dodd; Dublin/IE (J.Dodd@st‑vincents.ie) 
Cardiomyopathies are an important and heterogeneous group of diseases. They may 
be classified into primary and secondary etiologies. Primary cardiomyopathies are 
those solely/predominantly confined to heart muscle, whilst secondary cardiomyopa-
thies demonstrate myocardial involvement as part of a more generalized systemic 
multi-organ disease. The number of entities in both categories continues to rise as 
our definition and understanding of cardiomyopathies continues to evolve. In each 
broad category, what was once considered rare is becoming increasingly commonly 
recognized as our appreciation of the importance of genetic factors in combination 
with environmental influences continues to grow. The increasing availability of non-
invasive imaging modalities such as cardiac magnetic resonance imaging (CMRI) and 
echocardiography is playing an increasingly central role in the evaluation of patients 
suspected of cardiomyopathy. Rare primary cardiomyopathies include morphological 
and genetic variations of ARVD, non-compaction syndrome and glycogen storage 
disorders. Of the mixed cardiomyopathies, unusual infectious and toxic causes 
are being increasingly recognized. The evolving role of cardiomyopathies in the 
autoimmune and neuromuscular disease categories is of burgeoning interest. Our 
understanding of the acquired cardiomyopathies such as Tako-tsubo and peri-partum 
cardiomyopathies continue to develop. A number of secondary cardiomyopathies are 
now being characterized, such as those occurring as part of the connective tissue 
disorders. An overview of the clinical characteristics and potential etiologies of some 
of these rare cardiomyopathies and examples illustrated on CMRI will be provided. 
Learning Objectives:
1. To review the etiologies of the various unclassified/rare cardiomyopathies.
2. To learn about the clinical features and pathophysiology of the unclassified/
rare cardiomyopathies.
3. To acquire the latest knowledge of the appearances of the unclassified/rare 
cardiomyopathies on cardiac MRI.
Panel discussion:  
Imaging of cardiomyopathies: A wake-up call for the general 
radiologis 17:15 
16:00 - 17:30 Room N/O 
Contrast Media 
RC 606 
Organ-specific and future contrast media in MRI 
Moderator:
A.J. van der Molen; Leiden/NL 
A‑147 16:00 
A. Real added value of liver-specific contrast media 
O. Clément; Paris/FR (olivier.clement@inserm.fr) 
Liver specific contrast agents have been developed by pharmaceutical companies for 
almost 20 years, but what remains in 2010? A few specific indications. There are two 
major mechanisms for liver specific uptake: 1. A specific hepatobiliary uptake through a 
membrane transporter at the sinusoidal face of the hepatocyte (Multihance®, Primovist®) 
or through a non-specific mechanism for manganese (Teslascan®). 2. An uptake by the 
cells of the reticulo endothelial system for iron oxide particles (Resovist®, Endorem®). 
The resulting liver parenchymal enhancement will be a bright with gadolinium and 
manganese chelates (T1 effect) and dark with iron particles (T2 effect). On clinical 
routine for liver imaging, the initial dynamic arterial and portal phases are of paramount 
importance to detect and more to characterize lesions. With liver specific agents, another 
phase is added, the delayed parenchymal phase which adds information, especially 
for lesion detection. Clinical trials and marketing authorizations for liver specific agents 
concern either detection of metastasis or characterization of liver tumors. After so many 
years of market release, only few liver examinations are performed routinely, mainly 
in centers specialized in liver surgery. This can be explained because none of these 
agents offer both possibilities to have dynamic and delayed phases, and a good dynamic 
phase with a non-specific gadolinium chelate already answers a majority of the clinical 
questions. This course will detail the different clinical situations where a specific liver 
contrast agent is needed in routine liver imaging. 
Learning Objectives:
1. To know which liver-specific contrast media can be used in clinical practice.
2. To understand the respective working mechanisms.
3. To know the evidence for clinical applications and indications.
A‑148 16:30 
B. Contrast for atherosclerosis imaging 
J.H. Gillard; Cambridge/UK (jhg21@cam.ac.uk) 
Despite tremendous advances in the recognition and management of risk factors for 
atheromatous disease, it remains responsible for substantial morbidity and mortality 
in the Western world. Until recently, the risk of carotid disease in symptomatic pa-
tients was determined by simple luminal measurements. We are now able to image 
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individual plaque components including the fibrous cap, lipid core and haemorrhage. 
The current goal is to be better able to characterise plaque risk, whether it is in the 
carotid, coronary or peripheral vasculature. Our understanding of the natural history 
of atheroma development continues to grow. Whilst the assessment of risk is aided by 
the quantification of individual morphological components in plaque viewed with MR, 
it has been difficult to image true plaque function. Enticing studies of plaque activity 
demonstrated using FDG PET showed that it is possible to image inflammatory activ-
ity in humans. We now have MR contrast agents that are taken up by macrophages 
and are visible with high-resolution MR. We are also able to image not only individual 
plaque structure, but also function, allowing an improved understanding of why two 
patients will identical degrees of luminal stenosis may have completely different 
degrees of vulnerability. There have been tremendous advances in our ability to ac-
cess plaque instability using MR over the last few years, the most exciting being the 
ability to use cell specific markers of inflammation. The challenge is to validate these 
techniques in the carotid and assess their utility and effectiveness in clinical practice. 
Learning Objectives:
1. To understand the pathophysiology of the formation of the atherosclerotic 
plaque.
2. To understand how contrast agents can visualise plaques.
3. To know what the clinical applications and indications are.
A‑149 17:00 
C. CEST-type contrast media in MRI 
M.T. McMahon, A.A. Gilad, G. Liu, P.C.M. van Zijl, J.W.M. Bulte;
Baltimore, MD/US (jwmbulte@MRI.jhu.edu) 
A novel approach to generate MRI contrast without the use of metal-based contrast 
agents is to perform Chemical Exchange Saturation Transfer (CEST) imaging in 
the presence of agents with multiple exchangeable protons that are off-resonance. 
When irradiated with a saturation pulse at the specific off-resonance frequency, 
the protons lose their capability to create signal, with the signal loss transferred to 
bulk water (the source of MRI signal) through chemical exchange. Several types 
of CEST contrast agents have now been described, containing amide, amine, 
or hydroxyl protons as off-resonance exchangeable protons. By virtue of their 
frequency-specific resonance, it is possible to selectively saturate the proton group 
of choice, permitting a distinction of different polypeptides by assigning multiple 
colors. Some biological applications of CEST contrast agents include the cloning 
and expression of an amide-rich reporter gene for MRI cell tracking, their use as pH 
sensor, and lipoCEST agents for imaging of lymph nodes. As they are bio-organic 
and consist of naturally occurring compounds, the future clinical use of CEST 
agents may be facilitated. A closely related type of contrast media, PARACEST 
agents, works using a similar principle but uses metal ions to shift away the proton 
resonance from the water peak. Some examples of other groups developing these 
PARACEST agents will also be highlighted. 
Learning Objectives:
1. To understand the working mechanism of CEST-type imaging.
2. To introduce the potential clinical indications and applications.
16:00 - 17:30 Room P 
Chest 
RC 604 
Hot CT issues in clinical practice 
Moderator:
C. Schaefer‑Prokop; Amsterdam/NL 
A‑150 16:00 
A. How to manage incidentally found pulmonary nodules 
L. Bonomo; Rome/IT (lbonomo@rm.unicatt.it) 
Pulmonary nodules are small, focal, radiographic opacities that may be solitary or 
multiple. Solitary pulmonary nodule (SPN) is a single, round, well circumscribed 
radiographic opacity that measures < 3 cm in diameter and is surrounded completely 
by aerated lung. Small subcentimeter nodules measure < 8 to 10 mm in diameter and 
can be solitary or multiple. The improved technology in CT scanners has resulted in 
the detection of large number of small noncalcified pulmonary nodules (< 10 mm) 
on CT scans. In reported studies the frequency of detecting one or more SPN on 
a screening CT scan ranges from 5 to 60%. The clinical significance is unknown. 
Characterization of small pulmonary nodules is very difficult because detailed 
morphologic features often cannot be perceived. For small pulmonary nodules, 
CT morphology is quite non-specific, no typical feature of malignancy is defined, 
and considerable error is associated in the density measurement. The likelihood of 
malignancy depends on patient risk factors, nodule size and morphologic character-
istics; it is highest in current smokers and increases with age. A strong association 
between nodule diameter and the likelihood of malignancy has been reported. 
Regarding the morphology, the nodules may be characterized as solid, partly 
solid or pure ground glass opacities. In some studies, the likelihood of malignancy 
was high in ground glass opacities and in partly solid lesions but much lower in 
solid nodules. The optimal approach to the management of subcentimeter nodules 
remains problematic and the current guidelines are not in complete agreement. 
Learning Objectives:
1. To review the different risk situations for patients with pulmonary nodules.
2. To describe the rationale for choosing different management options in 
different patient populations.
3. To recommend management strategies for the individual patient.
A‑151 16:30 
B. Optimising and minimising radiation dose 
D. Tack; Baudour/BE (denis.tack@skynet.be) 
The radiation dose delivered by MDCT for a standard chest volumetric acquisition 
ranges between 10 and 100 times the one delivered for a chest radiograph. Nu-
merous recent technical improvements help limit the dose of volumetric CT. Using 
appropriate parameters, optimized MDCT of the chest delivers less than 10 times 
the dose of a chest radiograph while providing excellent diagnostic image quality. 
Low-dose chest MDCT with slightly reduced image quality may deliver a radiation 
dose in the range of that delivered for a radiographic examination. In this presenta-
tion, we will review the available reference diagnostic levels, and compare them to 
optimized dose and to low-dose levels. The reasons for inappropriate use of higher 
doses will be reviewed in addition to the most recent technological advances and 
research enabling further radiation dose reductions. 
Learning Objectives:
1. To review the latest technological advances for dose optimisation and 
minimisation.
2. To provide CTDIvol, DLP and effective dose values for state-of-the-art chest 
MDCT scanning.
3. To review radiation risks and benefits from perfusion and triple-rule-out 
MDCT studies of the chest.
A‑152 17:00 
C. Phenotyping and interventions in COPD 
P.A. Grenier; Paris/FR (philippe.grenier@psl.aphp.fr) 
Chronic obstructive pulmonary disease (COPD) is a slowly progressive airway 
obstructive disorder resulting from an exaggerated inflammatory response that 
ultimately destroys the lung parenchyma (emphysema) and induces irreversible 
reduction in the caliber of small airways (airway wall remodeling). Bronchial wall 
thickness and the extent of emphysema at CT in COPD patients have proven to 
be both the strongest independent determinants of the degree of airflow obstruc-
tion at pulmonary function tests. Using CT to define phenotypic abnormalities in 
COPD patients may serve to optimize treatment and assess response to potential 
therapeutic interventions. Although the different morphologic abnormalities seen 
on CT scans of COPD patients often overlap, two separate groups of patients can 
be identified, those with emphysema predominant disease and those with airway 
predominant disease due to chronic inflammation resulting in airway remodelling 
and narrowing. The former category can be further subdivided based on the type of 
emphysema present and further characterized by anatomic distribution and sever-
ity using visual assessment and volumetric quantitative CT techniques. Patients 
in the airway predominant category can also be characterized by CT as showing 
bronchial wall thickening, small airway inflammation, mosaic perfusion and air 
trapping expressing small airway narrowing, and expiratory bronchial collapse due 
to cartilage deficiency. Recent advances in automated airway segmentation and 
quantitative analysis have made measurements of airway dimensions feasible. In 
longitudinal studies, standardization of procedures and quality control are needed, 
particularly if quantitative CT outcomes are used as endpoint in clinical trials and 
ultimately in the clinical management of individual patients. 
Learning Objectives:
1. To know the classification of COPD phenotypes, and the key role of CT in 
determining the predominant phenotype in any given COPD patient.
2. To understand the methods used for CT quantitative assessment of 
emphysema and airway wall remodelling, and their limits.
3. To know the role of imaging in selecting candidates for interventions, and in 
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16:00 - 17:30 Room Q 
Interventional Radiology 
RC 609 
RF ablation beyond the liver 
Moderator:
R.D. García Mónaco; Buenos Aires/AR 
A‑153 16:00  
A. RF ablation in bone 
A.D. Kelekis; Athens/GR (akelekis@cc.uoa.gr) 
The purpose of this refresher course is to demonstrate techniques used in bone 
ablation in the spine and the appendicular skeleton. There is an active dilemma on 
which lesions to use thermal ablation and on which stabilization by bone augmentation 
techniques. We will review differences between lytic and blastic lesions and charac-
teristics of various ablation devices (such as monopolar, bipolar, single and multitined 
electrodes). Imaging techniques, including fluoroscopy, computed tomography and 
magnetic resonance will be addressed. Analgesia is being discussed. Complications 
are analyzed. By the end of this presentation, users of ablation techniques should be 
aware of the possible anatomical and positional landmarks, as well as the possible 
advantages and disadvantages of each device. Results of ablation will be discussed. 
Combination of the ablation technique with other methods will be presented. We will 
explore the possible advantages to standard osteoplasty. In conclusion, bone ablation 
is a valid technique, standing alone or in combination with other procedures. The 
purpose of this presentation is to allow the interventional radiologist to perform the 
ablation in a safe and efficient way. Knowing the limitations of the material at hand 
seems to be important for avoiding technical complications. 
Learning Objectives:
1. To discuss indications, patient selection and preprocedural imaging.
2. To descibe the technique.
3. To review the results and complications.
A‑154 16:30 
B. RF ablation in the kidney 
M.A. Farrell; Waterford/IE (michaela.farrell@hse.ie) 
Over the last two decades, open nephron sparing surgery has become the preferred 
surgical alternative to nephrectomy for treatment of patients with a single, small (< 5 cm) 
clearly localized renal mass and a normal contralateral kidney. Because 25-49% of newly 
diagnosed small renal masses are identified incidentally on cross sectional imaging, 
often in elderly patients, less invasive surgical nephron sparing alternatives have been 
advocated, including laproscopic partial nephrectomy and laproscopic cryoablation, 
for select tumors in an effort to reduce surgical mortality and morbidity while preserv-
ing renal function. Percutaneous image-guided ablation offers potential advantages 
over surgical methods including the minimally invasive nature of the procedure, less 
mortality and morbidity than surgery, shorter hospital stay, and quicker recovery. Local 
tumor control rates of up to 95% have been reported for small tumors. Central tumors 
and tumors greater than 3 cm in diameter are more difficult to successfully treat with 
local tumor progression occurring 25% of central tumors. Tumors larger than 3 cm in 
diameter typically require overlapping ablations and incomplete treatment can result 
from residual tumor at the ablation interfaces. While in some reports, local tumor pro-
gression occurred in up to 20% of tumors larger than 3 cm, in contrast, others have 
shown that all exophytic tumors, despite their size, can successfully be treated using 
multiple overlapping ablations and complete treatment may require more than one 
ablation session. The most clinically relevant and potentially avoidable complication is 
ureteral injury with resultant obstruction of the intrarenal collecting system. 
Learning Objectives:
1. To discuss indications and patient selection.
2. To describe currently available therapeutic alternatives.
3. To review the results of RF ablation compared with other treatments.
A‑155 17:00 
C. RF ablation in the chest 
I. Bargellini; Pisa/IT (irenebargellini@hotmail.com) 
In the past decade, percutaneous image-guided radiofrequency ablation (RFA) has 
been proposed as a safe and effective minimally invasive procedure in selected 
patients with unresectable or medically inoperable lung malignancies. When ad-
equately performed by experienced operators, the procedure is associated with 
up to 99% immediate technical success rate and low incidence of major (8-15%) 
and minor complications (20-40%). The most frequent complications are alveolar 
haemorrhage, pleural effusion and pneumothorax (9-52%), the latter requiring chest 
tube placement in a relatively low number of cases (3-5% of ablation sessions). 
Some studies have pointed out that, although these complications are unpredict-
able, there are some significant risks factors for pneumothorax, some of them being 
inevitable (such as patients’ age, emphysema, and tumor diameter and location), 
some others being avoidable, particularly when planning the needle access and 
track through the lung parenchyma. After RFA, sustained complete tumor response 
has been demonstrated in about 85-90% of the target lesions. These favourable 
figures are associated with promising survival rates. According to the RAPTURE 
study, the 2-year cancer-specific survival was 73% in patients with NSCLC, 68% 
in patients with colorectal metastases, and 67% in patients with other metastases, 
with corresponding overall survival rates of 48, 66 and 64%, respectively. These 
results can be obtained after proper patient selection by a multidisciplinary team. In 
particular, RFA can be useful in nodules smaller than 3 cm and in peripheral loca-
tion (possibly > 1 cm from the hilum). The association between RFA and chemo-/
radioteraphy should also be considered in selected patients. 
Learning Objectives:
1. To discuss indications and patient selection.
2. To describe the technique and complications.
3. To review the results of RF ablation to date.
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08:30 - 10:00 Room A 
Special Focus Session 
SF 7a 
Cardiac CT: Imaging beyond the coronaries 
Moderator:
K. Nikolaou; Munich/DE 
A‑156 08:30 
Chairman’s introduction 
K. Nikolaou; Munich/DE (konstantin.nikolaou@med.uni‑muenchen.de) 
While multislice CT (MSCT) has so far mainly been tested to detect obstructive coro-
nary artery disease (CAD), ongoing developments of scanner technology open up 
new diagnostic options and indications. With the improvement of temporal resolution, 
an accurate assessment of regional and global ventricular function, as well as of the 
cardiac valves, is becoming feasible. Regarding the assessment of the myocardium, new 
techniques such as myocardial perfusion imaging with CT or dual/multi energy imaging 
open up new horizons, depicting areas of ischemia and non-viable tissue. Finally, the 
ease and speed of CT - in conjunction with an improved radiation dose efficiency - have 
increased the number of CT acquisitions in cases of congenital heart disease, even in 
younger patients. While the evaluation of coronary artery stenoses will for now most 
probably remain the primary clinical indication for cardiac CT, these new applications 
are steadily under development and widening the options for cardiac CT imaging. 
Session Objectives:
1. To become familiar with the potential use and viability of CT for imaging of 
heart function.
2. To learn about indications and protocols for the use of CT in congenital heart 
disease.
3. To review dose reduction strategies for various protocols.
A‑157 08:36 
Myocardial and valvular function 
T.R.C. Johnson; Munich/DE (thorsten.johnson@med.uni‑muenchen.de) 
Dynamic CT with a muliphase coverage of the heart throughout the cardiac cycle 
requires restrictions in tube current modulation and implies a comparatively high ra-
diation exposure. Thus, the indication is restricted to elderly patients or individuals in 
whom echocardiography and MRI are not available as alternatives. However, dynamic 
information is also available as side information if the coronary arteries are of primary 
diagnostic interest. Practically it is easiest to perform a multiphase reconstruction of 
the entire data volume, e.g. in non-overlapping thin axial slices at 10% steps over the 
cardiac cycle. The evaluation of cardiac motion is best visualized in standard planes 
known from MRI and echocardiography, i.e. in long and short axis slices aligned parallel 
and perpendicular to the interventricular septum. New software tools also provide the 
option to automatically quantify parameters of global and regional volume, wall motion 
and ejection. These parameters can help to identify cardiomyopathy or areas of infarc-
tion. Dynamic reconstructions also make it possible to assess valvular function. The 
left ventricular valves are normally well visualized, while a long bolus or preferentially 
a mixed chaser bolus is necessary to opacify right atrial and ventricular volume suf-
ficiently to depict the pulmonary and especially the tricuspid valve. Aortic stenoses are 
usually quite obvious due to extensive calcification and lack of motion with small residual 
opening area. CT is far less sensitive to insufficiencies because a tiny gap between 
the leaflets can cause clinically relevant regurgitation, especially at the mitral valve. 
Learning Objectives:
1. To understand the technique and become acquainted with the practical 
evaluation of dynamic CT.
2. To become familiar with changes in myocardial wall motion and their 
diagnostic relevance. 
3. To recognise valvular disease and know the diagnostic accuracy in 
estimating the degree of changes.
A‑158 09:04 
Myocardial viability and perfusion 
J.-F. Paul; Le Plessis Robinson/FR (pauljf@ccml.fr) 
After an acute myocardial infarction (MI), myocardial damage varies within the 
ventricle wall. At first pass, myocardial ischemia is seen as a subendocardial 
hypodensity, more or less transmural and more or less persistent over time after 
injection of contrast medium. However, first pass imaging of cardiac muscle may 
be not accurate enough to assess ischemia. Additional delayed enhanced images 
may be also very useful to assess inflammatory changes within the cardiac muscle, 
either in case of myocardial infarction or myocarditis. Some clinical examples will 
be provided in case of unexplained severe chest pain, illustrating the great clini-
cal interest of MDCT based on delayed enhancement imaging. A comprehensive 
protocol in acute setting (including arterial phase and delayed acquisition) will be 
proposed for quick diagnosis of myocardial infarction. Very recently, MDCT delayed 
imaging has shown to be also useful for assessment of myocardial viability. MDCT 
may be then performed just after PCI, using intracoronary contrast injection required 
for stent placement. These histological changes are more or less severe resulting 
in a functional point of view from complete non-viability to complete recovery of the 
segmental contractility: transmural late enhancement is associated with non-viability. 
A dual-phase MDCT will be also detailed for assessment of viability in the first week 
after myocardial infarction. In summary, beyond coronary arteries, CT provides 
relevant information about cardiac perfusion and viability after myocardial infarction. 
Learning Objectives:
1. To understand the potential of CT for evaluating viability and perfusion.
2. To describe appropriate protocols for optimisation of late enhancement 
imaging.
3. To know how to use myocardial information in emergency settings.
A‑159 09:32 
Congenital heart disease 
S. Leschka; Zurich/CH (sebastian.leschka@kssg.ch) 
Various imaging modalities contribute diagnostic information in patients with 
congenital heart disease (CHD). Although echocardiography is the diagnostic 
method of choice, the development of multi-detector row computed tomography 
(CT) has increased its clinical application in evaluating patients with CHD. Because 
of increased scan speed, high spatial resolution, and simultaneous evaluation 
of cardiovascular structures and lung parenchyma, CT has become a helpful 
complementary imaging modality in pre- and post-surgical evaluation of patients 
with CHD. When coupled with electrocardiography-gating, CT can provide data on 
ventricular function and cardiac valves, and allows for accurate assessment of the 
coronary arteries. Expertise in morphology and terminology, profound knowledge 
in wide spectrum of surgical procedures, and dedicated imaging protocols for 
CT are required to comply with the altered flow conditions in patients with CHD. 
The sequential, segmental approach will be described for accurate morphologic 
interpretation of several CHD conditions. 
Learning Objectives:
1. To determine appropriate CT protocols for evaluating congenital heart 
disease (CHD).
2. To describe a sequential approach that may be used in interpreting CT 
images of CHD.
3. To provide typical case studies of congenital heart disease.
08:30 - 10:00 Room B 
Radiology of the Spine in 2010 
CC 716 
Spinal cord: Difficult but devastating diagnoses 
Moderator:
D. Balériaux; Brussels/BE 
A‑160 08:30 
A. Demyelinating diseases of the spinal cord 
A. Rovira-Cañellas; Barcelona/ES (alex.rovira@idi‑cat.org) 
The spinal cord is commonly affected in multiple sclerosis (MS) and other idiopathic 
inflammatory demyelinating diseases, such as acute demyelinating encephalomy-
elitis and neuromyelitis optica. The prevalence of cord abnormalities is as high as 
74 to 85% in established MS. In clinically isolated syndromes (CIS), the prevalence 
of asymptomatic cord lesions is lower, although they can be found in 30 to 40% of 
patients with this condition. MRI of the spinal cord can provide important diagnostic 
information in several clinical settings. Patients initially diagnosed with MS, but 
showing signs or symptoms of myelopathy, are typically evaluated by spinal cord 
MRI to exclude treatable lesions. Moreover, the presence of cord lesions may help 
to determine dissemination in space according to the 2005 McDonald diagnostic 
criteria, and can strengthen the diagnosis of MS in patients fitting the clinical criteria 
for MS, but with negative or inconclusive brain MRI findings. Similarly, diagnostic 
certainty can be increased in patients with non-specific brain findings, particularly 
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in MS, but are rare in other white matter diseases. Spinal cord abnormalities, as 
seen on conventional MRI scans, mainly reflect demyelination, but underestimate 
axonal damage, which is likely the reason why the relationship with disability is 
poor. The progressive refinement of modern quantitative techniques (e.g., diffu-
sion tensor imaging, MR spectroscopy, and magnetization transfer) should result 
in a more complete in vivo picture of spinal cord pathology in MS and, ultimately, 
a better relationship with the clinical picture. 
Learning Objectives:
1. To explain the mechanisms of demyelination.
2. To review the most common demyelinating diseases and their key imaging 
findings.
3. To comprehend the clinical criteria for diagnosing demyelinating diseases of 
the spinal cord.
A‑161 09:00 
B. Spinal cord tumors 
C. Mueller-Mang; Vienna/AT (christina.mueller‑mang@meduniwien.ac.at) 
Spinal cord tumors are uncommon, accounting for about 4 to 10% of all central 
nervous system tumors. Despite their rarity, these neoplasms are important to the 
radiologist because MR imaging provides essential information about the extent, 
location, and internal structure of spinal cord tumors, thus critically narrowing the 
differential diagnosis and guiding surgery. Most spinal cord tumors are malignant, 
and 90-95% are classified as gliomas. Astrocytoma is the most common spinal 
cord glioma in the pediatric age group, whereas spinal cord ependymoma is the 
most common type in adults. Both entities constitute up to 70% of all intramedullary 
neoplasms. Nonglial neoplasms are much less common and include hemangioblas-
tomas, paragangliomas, metastases, lymphoma, and primitive neuroectodermal 
tumors (PNETs). On MR imaging, intramedullary neoplasms cause enlargement 
of the spinal cord caused and almost always show contrast enhancement. They 
may be solid or associated with neoplastic cysts that are located within the tumor 
and result from necrosis and degeneration, or non-neoplastic cysts that are located 
at the cranial and caudal pole of the tumor and most probably represent reactive 
dilatation of the spinal canal. An optimal MR imaging study not only enables the 
correct differential diagnosis in the majority of spinal cord tumors preoperatively, but 
also allows the discrimination of tumor from these non-neoplastic cysts and edema, 
which is crucial for surgical planning. New MR techniques, such as diffusion tensor 
imaging (DTI) and fiber tracking (FT), may be helpful with further characterization 
of some spinal cord tumors and in better delineation of their margins. 
Learning Objectives:
1. To review the most common spinal cord tumors.
2. To summarise key imaging findings in different spinal cord neoplasms.
3. To discuss how to create the optimal MR imaging protocol for preoperative 
planning of spinal cord tumors.
A‑162 09:30 
C. Vascular disorders of the spinal cord 
T. Krings; Toronto, ON/CA (timo.krings@uhn.on.ca) 
Spinal vascular diseases are rare and constitute only 1-2% of all vascular neu-
rological pathologies. Since their clinical diagnosis is based mainly on magnetic 
resonance imaging (MRI) and digital subtraction angiography, the radiologist plays a 
major role in the diagnostic workup. In the lecture, the following vascular pathologies 
of the spine are described: spinal arterial infarcts, spinal cavernomas, and spinal 
arteriovenous shunting lesions and an overview about their imaging features both 
on MRI, MR angiography and digital subtraction angiography is given. Clinical dif-
ferential diagnoses, the neurological symptomatology and the potential therapeutic 
approaches of these diseases which might vary depending on the underlying 
pathology are presented. Although MRI including MRA constitutes the diagnostic 
modality of first choice in suspected spinal vascular malformation, a definite diag-
nosis of the disease and therefore the choice of suited therapeutic approach rests 
on selective spinal angiography, which should be performed at a specialized center. 
Learning Objectives:
1. To understand the pathophysiology of spinal vascular anomalies.
2. To describe imaging findings in different spinal vascular diseases.
3. To comprehend the concepts of CTA, MRA and angiography in evaluation of 
spinal vascular disorders.
08:30 - 10:00 Room C 
New Horizons Session 
NH 7 
Biomarkers: New word, new world, new work? 
Moderator:
A.R. Padhani; Northwood/UK 
A‑163 08:30 
Chairman’s introduction 
A.R. Padhani; Northwood/UK 
This introductory 90 min symposium focuses on clinical imaging biomarker develop-
ment with a view to meeting current challenges in clinical diagnosis and manage-
ment and of drug development. The lecturers will discuss via didactic talks the key 
biological hallmarks of cancers that are assessable by imaging techniques that 
are ready for clinical translation. For each imaging biomarker chosen, the biologi-
cal basis, quantification methods, validation and clinical use will be described by 
experts involved biomarker development. Emphasis will be placed on biomarker 
qualification processes. The approaches demonstrated will be relevant to other 
biomarkers and will be adaptable for diagnosing, assessment of tumour aggres-
siveness, therapy response and resistance and be relevant to the development of 
novel anti-cancer therapeutics. 
Session Objectives:
1. To understand the challenges of clinical diagnosis and management and of 
drug development.
2. To understand that cancers have unique hallmarks including cellular 
proliferation, tissue hypoxia and angiogenesis, many of which can be imaged 
and used for diagnosis, to assess therapy response and its outcome, as well 
as for drug development.
3. To review the biological basis and evidence for MRI and PET biomarkers that 
are ready for clinical translation.
4. To consider methods for predictive biomarker qualification.
A‑164 08:33 
Biomarkers: What are they? 
B. Van Beers; Clichy/FR (bernard.van‑beers@bjn.aphp.fr) 
Biomarkers are characteristics that are objectively measured as indicators of normal 
biological processes, pathological processes, or pharmaceutical responses to a 
therapeutic intervention. Compared with biochemical and histological biomarkers, 
imaging biomarkers have the advantage of remaining non-invasive and being 
spatially and temporally resolved. They are thus ideally suited for assessing the 
response to treatment. In new drug development, assessment of benefit and risk 
has to be done. The most reliable way to assess the clinical impact of a thera-
peutic intervention is through its effect on a clinical endpoint such as survival or 
disease-free survival. These standards may be impractical because long periods 
are required for these clinical endpoints to be achieved and trials with large number 
of patients are needed for their evaluation. Surrogate endpoints are biomarkers 
that are intended to substitute for a clinical endpoint. Anatomical, molecular, and 
functional characteristics can be used as imaging biomarkers. The RECIST crite-
ria are anatomical imaging biomarkers that are accepted surrogate endpoints in 
cancer treatment, but are limited in the assessment of some tumors. The use of 
molecular imaging biomarkers is limited by their narrow target specificity. Functional 
biomarkers are increasingly used with PET, contrast-enhanced CT, perfusion CT 
and MRI, diffusion-weighted MRI, MR elastography and spectroscopy. They have an 
important potential to help in selecting the patients and assessing the response to 
new treatments. However, important efforts of validation and standardization remain 
to be done before the wide use of functional biomarkers and their acceptance as 
surrogate endpoints. 
Learning Objectives:
1. To be able to distinguish biomarkers from surrogate markers.
2. To be able to give examples of the major classes of biomarkers (preclinical 
and clinical examples).
3. To know generally what needs to be done for any biomarkers to be useful in 
the clinic and for drug development.
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A‑165 08:51 
MRI biomarkers: Ready in abdomen? 
D.J. Lomas; Cambridge/UK (djl15@radiol.cam.ac.uk) 
Four quantitative MR biomarker examples will be presented including the basis for 
the observations, biological mechanisms, clinical context, analysis and evidence 
for their validation. These aspects will be discussed briefly along with what further 
development is required for their routine use in clinical practice. 1. Hepatic and cardiac 
iron measurements using R2 (*) methods, 2. Liver and spleen stiffness with elastog-
raphy, 3. Hepatic steatosis using MRI and MRS, and 4. Tumour response with DWI. 
Learning Objectives:
1. To be able to cite examples of MRI biomarkers that can be used to 
investigate abdominal disease.
2. To get to know the clinical context, biological basis, measurement and 
analysis methods of biomarkers of angiogenesis, hypoxia and fibrosis.
3. To become familiar with the clinical evidence for biomarker usage and 
limitations for each biomarker.
A‑166 09:09 
PET cancer biomarkers at the starting line 
E.O. Aboagye; London/UK (eric.aboagye@imperial.ac.uk) 
Positron emission tomography (PET) permits detection of molecular interactions and path-
ways non-invasively in living subjects. Of interest to cancer, PET molecular biomarkers are 
being adopted into the clinical research arena for studying tumour biology. Regional distribu-
tion and levels of both extracellular and intracellular targets can be measured. Presently, 
there are molecular probes for measuring the biochemistry of tumours including glucose 
metabolism proliferation, apoptosis, multi-drug resistance phenotype, hypoxia and angio-
genesis. With PET, unique information is present in both the spatial (limited) and temporal 
domains. Fusion of such molecular information with other imaging platforms that provide 
high anatomical resolution such as computed tomography (CT) provides improved detection 
and definition of lesions; improved quantification of ‘change’ results from this. A number of 
PET biomarkers including [18F]fluorodeoxyglucose and [18F]fluorothymidine have ‘matured’ 
are being used in drug development as pharmacodynamic and response markers. New 
imaging biomarkers have to be qualified/validated to enable their use for drug development 
and ultimately for patient management. This lecture will discuss the evidence for biomarker 
usage together with the potential and limitations of the methodologies. 
Learning Objectives:
1. To be able to provide examples of PET tracers that can be used to 
investigate tumor biology.
2. To get to know the clinical context, biological basis, measurement and 
analysis methods of PET biomarkers of angiogenesis, hypoxia, proliferation, 
apoptosis and multi-drug resistance of angiogenesis.
3. To become familiar with the clinical evidence for biomarker usage and 
limitations for each biomarker.
A‑167 09:27 
Biomarkers: An illustrated framework for development 
A.R. Padhani; Northwood/UK 
Development frameworks outlining the practical steps for the qualification of functional 
imaging as biomarkers for pharmaceutical drug development and clinical therapeutic 
efficacy assessments are urgently needed. The process is iterative involving several 
key steps which include: 1. Defining the key clinical/drug issues with reference to the 
tumour and therapy in question. 2. Biomarker selection process - linking the imaging 
biomarker to underlying pathophysiological processes or to changes induced by thera-
pies. 3. Initial feasibility studies - demonstrating in principle the link between the chosen 
biomarkers and therapy response. 4. Biomarker optimization before implementation 
of the biomarker into a generalised clinical trial setting. 5. Early efficacy studies docu-
menting test performance and for estimating group predictive values. 6. Determining 
the level of change of a biomarker that predicts response to therapy on an individual 
basis via measurement of error determinations. 7. Definitive clinical studies with efficacy 
endpoints beginning with demonstration of multisite working. 
Learning Objectives:
1. To understand how dynamic MRI has progressed as a method for 
personalised assessment of therapy response in breast cancer.
2. To be able to assess for any other biomarker the extent of development and 
so to be able define the next steps in development.
3. To discuss whether imaging biomarkers can realistically be developed for 
their intended purpose.
Panel discussion:  
How should we implement biomarkers in clinical practice? 09:45 
08:30 - 10:00 Room D 
Abdominal and Gastrointestinal 
RC 701 
Abdominal MRI: Protocols that work 
Moderator:
L. Grazioli; Brescia/IT 
A‑168 08:30 
A. Liver 
W. Schima; Vienna/AT (Wolfgang.Schima@khgh.at) 
Liver MRI is undertaken to study the liver parenchyma, vasculature, and biliary system. 
It is necessary to employ a variety of different MR pulse sequences to achieve lesion 
detection and characterization. A set of T1- and T2-w pulse sequences is standard for 
evaluation of fat and iron content and for lesion delineation. In-phase and opposed-
phase, T1-w GRE images show focal or diffuse fatty infiltration and focal sparing. 
For T2-w imaging, a TSE sequence with fat suppression (either breath-hold or with 
free breathing) is robust and provides high tumor contrast. The quite popular T2-w 
half-Fourier single-shot TSE (e.g., HASTE) pulse sequences show anatomic detail 
(including bile ducts), but lack lesion contrast because of the long echo train. In case 
of suspected iron overload (i.e., hemosiderosis and hemochromatosis), an additional 
T2*-w GRE is recommended because of the susceptibility. Administration of a contrast 
agent is mandatory in liver MRI because many focal lesions are only highlighted by 
enhanced pulse sequences. Dynamic gadolinium chelate-enhanced T1-w GRE pulse 
(preferably 3D interpolated) sequences are versatile and useful for lesion detection and 
characterization as well assessment of the vasculature (i.e., hepatic artery aneurysms, 
Budd-Chiari-S., portal vein thrombosis, etc). Both hepato-biliary and reticuloendothelial 
liver-specific contrast agents render excellent results for detection and differentiation 
between metastases and hemangiomas or FNH. Manganese- or superparamagnetic 
iron oxide liver-specific contrast agents can be administered in patients with renal insuf-
ficiency. The choice of contrast material should be based on availability, the specific 
clinical question, and the renal function of the patient. 
Learning Objectives:
1. To learn about the standard pulse sequences for liver imaging and the critical 
technical parameters.
2. To discuss the diagnostic value of non-specific gadolinium chelates and 
different liver-specific contrast agents depending on the clinical question.
3. To learn how to optimise pulse sequences and imaging protocols according 
to the scanner’s and the patient’s performance.
A‑169 09:00 
B. Small bowel and colon 
N. Papanikolaou; Iraklion/GR (npapan@med.uoc.gr) 
The advent of powerful gradient systems resulted in substantial improvement of im-
age quality in ultrafast magnetic resonance (MR) imaging and therefore novel clinical 
applications emerged including gastrointestinal tract imaging. Within this context, MR 
enteroclysis and MR colonography were developed, providing luminal, transmural and 
extramural diagnostic information at the same imaging session. Two different protocols 
have been developed for imaging the small bowel with MR. These include MR follow-
through and MR enteroclysis. MR follow-through is based on the oral ingestion of an 
adequate amount of contrast agent and acquisition of consecutive sequences. In a 
clinical setting, sufficient luminal distention that guarantees accurate individual lesion de-
tection can be achieved by MR enteroclysis. Two MR colonography protocols have been 
proposed. According to the first, termed as ‚bright lumen MRC’, a gadolinium-spiked 
water solution is administered endorectally to the patient who has previously undergone 
colonic cleansing to distend the colon, resulting in a homogeneous high-signal intensity 
on heavily T1-weighted 3D gradient echo images. Polyps are demonstrated as filling 
defects while air bubbles can be differentiated by performing the examination in both 
supine and prone positions. According to the second approach, termed as ‚dark lumen 
MRC’, dense barium or tapped water is used to distend the colon in conjunction with 
post-gadolinium 3D gradient echo with fat-saturation sequences. The colonic wall and 
the corresponding polyps exhibit high signal intensity as a result of gadolinium uptake 
while the colonic lumen presents with low signal intensity. 
Learning Objectives:
1. To review technical aspects of MR enteroclysis and MR colonography.
2. To review MR enteroclysis imaging features of Crohn’s disease.
3. To address the current clinical role of MR enteroclysis in patients with 
Crohn’s disease.
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A‑170 09:30 
C. Pancreas and bile ducts 
C. Matos; Brussels/BE (cmatos@ulb.ac.be) 
MR imaging of the pancreas and bile ducts relies upon a combination of T2-w and 
T1-w strategies in order to safely acquire anatomic, cross-sectional and functional 
information.Tissue-imaging strategies include free breathing T2-w imaging (obtained 
with echo-train spin-echo sequences with or without fat saturation) and breath-hold 
3D-gradient echo T1-w imaging (obtained with fat saturation) without gadolinium and 
in the capillary phase and in the interstitial phase post-gadolinium. This combination is 
valuable in the assessment of the full spectrum of pancreatic diseases and malignant 
bile duct obstruction. Hardware improvements (gradients) and the advent of more so-
phisticated phased-array coils and parallel imaging capabilities in modern MR scanners 
allowed increasing the spatial and temporal resolution of “conventional” T2-w and T1-w 
sequences. Furthermore, it provided the possibility of adding high-b-value diffusion 
weighted imaging (DWI) to our routine protocol in order to increase the sensitivity of 
MRI. To obtain conventional MRCP imaging, thick-slab heavily T2-w TSE sequences 
or 3D heavily T2-w TSE sequences may be used. Advantages and limitations of both 
sequences will be underlined. Functional bile duct imaging is obtained using contrast 
agents that are taken up by hepatocytes and excreted through the biliary system in 
combination with volumetric T1-w sequences. We use this technique in postoperative 
complications and to elucidate complex biliary anatomy. Functional imaging of the 
pancreas is obtained by combining MRCP along with hormonal stimulation with secretin. 
In addition, secretin improves anatomic delineation and allows MRI quantification of 
fluid production by the exocrine pancreas. 
Learning Objectives:
1. To describe the preferred imaging sequences for MRI/MRCP of the pancreas 
and bile ducts.
2. To describe the use of techniques/methods to improve image quality.
3. To propose imaging protocols for MRI/MRCP of the pancreas and bile ducts 
in different clinical settings.
08:30 - 10:00 Room E1 
Musculoskeletal 
RC 710 
Arthritis: Back to basics 
Moderator:
V. Jevtic; Ljubljana/SI 
A‑171 08:30 
A. Radiographic diagnosis 
A.J. Grainger; Leeds/UK (andrew.grainger@leedsth.nhs.uk) 
Despite the increasing availability of modern imaging techniques such as ultra-
sound (US) and MRI, conventional radiographs (CR) continue to be fundamental to 
rheumatological imaging, playing an important role in diagnosis and monitoring of 
the arthritides. Evaluation of plain films includes an assessment of the soft tissues 
for swelling and calcification. Soft tissue swelling can be extremely subtle but may 
be the first CR sign of joint disease. Joint space on CR reflects the thickness of 
articular cartilage and is typically lost as a result of arthropathy either symmetrically, 
as seen in the inflammatory arthritides, or asymmetrically as in osteoarthritis. In 
some arthritides, such as gout, joint space is preserved until subsequent stages in 
the disease process, while in other conditions bony ankylosis may occur. Evaluation 
of the periarticular bone usually reveals the presence of erosions, osteophytes, 
subchondral bone changes, such as cysts and sclerosis, and changes in bone den-
sity. Finally, plain films allow an assessment of joint alignment and also, in the case 
of hand and foot films, give an indication as to the distribution of disease. Despite 
the wide use of CR in the evaluation of the arthritides, it has the disadvantage in 
that it is relatively insensitive to the early changes of disease and changes occur 
relatively slowly. In the early stages of arthritis, when therapy may have the greatest 
role and where structural abnormalities may be reversible, radiographically defined 
joint damage is not a prominent feature. 
Learning Objectives:
1. To be able to recognise the range of the radiographic changes seen in 
arthropathy.
2. To be able to identify features on the radiograph that allow a specific 
diagnosis to be made.
3. To understand the role of radiographs in monitoring the progression of 
arthritis.
A‑172 09:00 
B. Imaging crystal arthritis 
A. Cotten; Lille/FR (acotten@chru‑lille.fr) 
Gouty arthritis, calcium pyrophosphate dihydrate crystal deposition disease and 
calcium apatite crystal deposition disease represent the three main crystal deposi-
tion disorders encountered in the clinical practice. If the clinical and radiological 
features are usually straightforward, some presentations may be misleading. This 
presentation will focus on the typical and atypical or unusual radiological features 
of these crystal deposition disorders. It will also present the potential usefulness 
and limitations of US, CT and MR imaging in the diagnosis of these diseases. 
Learning Objectives:
1. To present the main radiographic features of crystal deposition disorders.
2. To show the potential of US, CT and MRI in the diagnosis of these disorders.
3. To present some unusual radiological presentations of these disorders.
A‑173 09:30  
C. Imaging the spine in arthritis 
A. Jurik; Århus/DK (anne.jurik@aarhus.rm.dk) 
The spine can be involved as part of most inflammatory disorders, but most fre-
quent in rheumatoid arthritis (RA) and seronegative spondyloarthropathies (SpA). 
Involvement in RA is usually located to the cervical spine where erosive changes 
are predominantly seen in the atlanto-axial region. The diagnosis of cervical RA 
changes is important as they can cause instability potentially risking spinal cord 
injury. In RA patients with neck pain, radiography of the cervical spine including a 
lateral view during flexion is mandatory. Supplementary MRI or CT may be needed 
before treatment of instability and can sometimes reveal inflammatory changes in 
patients with normal radiography. According to the European classification criteria, 
seronegative spondyloarthropathies are divided into ankylosing spondylitis (AS), 
psoriatic arthropathy, reactive arthritis, arthritis associated with inflammatory bowel 
disorders (enteropatic arthropathy) and undifferentated spondyloarthropathy. Inflam-
matory changes at the sacroiliac joints always occur in AS and is part of most other 
forms of SpA. Spinal changes are also a feature of SpA, especially in late stages 
of AS. Manifest structural changes can be diagnosed at radiography. Vertebral 
squaring, syndesmophytes and ankylosis of apophyseal joints are characteristic of 
AS whereas more voluminous paravertebral new bone formation occur in psoriatic 
arthropathy and reactive arthritis. The features of enteropatic arthropathy often re-
semble those of AS. Detection of early inflammatory changes of the sacroiliac joint 
or the spine demands an MRI. MRI is also valuable for estimating and monitoring 
post-diagnostic disease activity. CT predominantly plays a role in the diagnosis of 
complicating fractures. 
Learning Objectives:
1. To become familiar with the radiographic features of spinal involvement in 
rheumatoid arthritis (RA) and seronegative spondyloarthropathy (SpA).
2. To know the MRI and CT features in RA and SpA.
3. To know the diagnostic advantages of MRI and CT.
08:30 - 10:00 Room E2 
Foundation Course: Head and Neck Radiology 
E³ 720a 
Larynx and hypopharynx 
Moderator:
M. Gödeny‑Polony; Budapest/HU 
A‑174 08:30 
A. Benign lesions 
R. Hermans; Leuven/BE (Robert.Hermans@uz.kuleuven.ac.be) 
The larynx and hypopharynx are anatomically very closely related. Essentially, the 
larynx consists of a supporting skeleton (made up of cartilages and fibrous bands), 
a mucosal surface, and in between a soft tissue layer containing fat, some ligaments 
and muscular structures. The larynx is divided into three regions: glottis (correspond-
ing to the level of the true vocal cords), subglottis and supraglottis. The hypopharynx 
is the portion of the pharynx that extends from the oropharynx to the esophageal 
verge. The larynx forms the anterior wall of the hypopharynx. The border between 
the hypopharynx and the oropharynx is at the level of the pharyngo-epiglottic folds, 
while the border with the esophagus is at the level of the inferior rim of the cricoid 
cartilage. The hypopharynx is divided into three regions: pyriform sinus (one on each 
side), post-cricoid region and posterior hypopharyngeal wall. On imaging studies, 
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the appearance of the laryngeal cartilages varies considerably, depending on the 
degree of ossification and the amount of fatty marrow in the ossified medullar space. 
The assessment of the intralaryngeal and intramural hypopharyngeal fat planes 
is essential in the workup of patients: obliteration of these fat planes may be the 
only sign of underlying pathology. Benign pathology of the larynx and hypopharynx 
requiring radiologic evaluation is uncommon. Laryngocele, traumatic pathology and 
vocal cord paralysis are the most frequent conditions imaged. Among the congenital 
lesions, thyroglossal duct cyst is most commonly seen. 
Learning Objectives:
1. To review the relevant anatomy of the larynx and hypopharynx.
2. To become familiar with some anatomical variants that may mimic disease.
3. To learn about the imaging findings in benign lesions of the larynx and 
hypopharynx.
A‑175 09:15 
B. Malignant lesions 
F.A. Pameijer; Utrecht/NL (f.a.pameijer@umcutrecht.nl) 
Imaging of the larynx is essentially the same as imaging of the hypopharynx because 
these structures are anatomically and functionally closely integrated. The presen-
tation will focus on squamous cell carcinoma, which is by far the most prevalent 
histology in laryngeal and hypopharyngeal cancer. The nature of malignancies in 
this region will be discussed with some epidemiological data. CT or MRI has become 
essential for the correct pretherapeutic staging of laryngeal and hypopharyngeal 
tumors. In this era of cost concern, it seems to be a good principle to do one cross-
sectional study that accurately answers the clinical questions. The relative value 
of CT and MRI in this aspect will be discussed. While the otolaryngologist uses 
endoscopy to evaluate the mucosal surface, it is the radiologist’s role to show the 
deep extent of a lesion. This effort becomes more effective if the radiologist is aware 
of the spread patterns observed in laryngeal and hypopharyngeal cancer. These 
typical spread patterns will be shown, using clinical examples from daily practice, 
in relation to the T-staging criteria for these tumors. 
Learning Objectives:
1. To learn about the nature of malignant lesions occuring in this region.
2. To understand the relative value of CT and MRI in evaluating malignant 
disease in this region.
3. To become familiar with the extension patterns observed in laryngeal and 
hypopharyngeal cancer.
08:30 - 10:00 Room F1 
Interactive Teaching Session 
E³ 720b 
Cancer of the uterus: Diagnosis, staging and 
follow-up 
Moderator:
H. Hricak; New York, NY/US 
A‑176 08:30 
Cancer of the uterus: Diagnosis, staging and follow-up 
B. Hamm1, P. Petrow2; 1Berlin/DE, 2Paris/FR (bernd.hamm@charite.de) 
MR imaging is the method of first choice for staging uterine malignancies. The main 
criterion for staging endometrial cancer is the depth of myometrial invasion. The 
diagnostic accuracy can be improved by performing a dynamic contrast-enhanced 
study in addition to T2-weighted imaging. The backbone of staging cervical cancer 
is T2-weighted imaging with a high spatial resolution performed in sagittal and 
transverse slice orientation. Invasion of the parametrium can thus be assessed with 
a high degree of accuracy. Especially in staging cervical cancer, MR imaging can 
replace numerous other diagnostic tests and thus improve pretherapeutic staging 
while at the same time reduce costs. In addition, MR imaging is used in planning 
radiotherapy and following-up patients having undergone irradiation. Lymph node 
staging still remains to be improved, for example, by a combination of MR lym-
phography and diffusion-weighted imaging. 
Learning Objectives:
1. To become familiar with imaging features in staging cervical and uterine 
cancer.
2. To understand the impact of imaging on modern patient treatment.
3. To understand the imaging findings on follow-up.
08:30 - 10:00 Room F2 





J. Cáceres; Barcelona/ES (josecac@gmail.com) 
Bronchogenic carcinoma is one of the main causes of mortality from cancer in 
the western world. Lung cancers are either suspected clinically or by the chest 
radiograph and confirmed with computed tomography. Lung biopsy corroborates 
the diagnosis and establishes the histological type. The cooperation with other 
clinical disciplines is crucial to obtain an adequate evaluation of the patient and to 
institute adequate therapy. 
Learning Objectives:
1. To optimise the use of diagnostic techniques in lung cancer.
2. To promote cooperation with other clinical disciplines in the management of 
lung cancer.
3. To emphasise the help of clinicians in image interpretation.
A‑178 08:35 
What the surgeon needs to know 
W. Weder; Zurich/CH (walter.weder@usz.ch) 
With increasing multidisciplinary efforts, accurate diagnostics and staging remains 
crucial in decision making for an individualized therapy at different stages of lung 
cancer patients. Radiologists are indispensably involved in each step of this pro-
cess. Using the TNM staging system CT scans, especially high resolution CTs, 
are still the gold standard of morphologic tumor assessment concerning primary 
tumor extension, signs of malignancy or relation to surrounding structures, which 
is essential for planning the surgical procedure. Furthermore, radiologists can help 
us to gather the initial diagnosis of undetermined pulmonary nodules by using CT 
guided fine needle aspiration techniques. For determining the N stage, contrast 
enhanced CT helps the surgeon to detect suspicious mediastinal lymphnodes and 
decide whether to go for primary surgery or further diagnostic with neoadjuvant 
therapy. In terms of mediastinal lymphnode and especially extrathoracic metastases, 
the combination of PET/CT has added a lot more value to the pure morphologic 
assessment of staging; the high negative predictive value has changed the ‚pre-
surgical‘ management of patients and has become a standard staging procedure 
for all stages in many institutions. For planning oncological resections, modern 
three-dimensional techniques are used more frequently. Also for evaluating the 
patients‘ response to neoadjuvant therapy or as postoperative control of recurrency 
or late metastatic disease, CT scans (or PET/CTs) are performed routinely. Finally, 
treatment regimens should be discussed in a multidisciplinary tumor board in the 
presence of an experienced radiologist in order to get the best information on the 
morphologic extent of the disease. 
Learning Objectives:
1. To know the local extension of the lesion as well as loco-regional metastasis.
2. To know the presence or absence of extrathoracic disease.
3. To determine the severity of co-morbidities on chest imaging such as 
emphysema, PH and others.
A‑179 08:55 
What the oncologist needs to know 
R. Pirker; Vienna/AT (robert.pirker@meduniwien.ac.at) 
Patients with lung cancer are treated based on histology and initial tumor stage. Clini-
cal tumor stage is crucial for both prognosis and optimal treatment. Staging should 
focus on size and location of primary tumor, mediastinal lymph node involvement 
and potential presence of distant metastasis. Other important information refers 
to tumor tissue accessible for diagnostic biopsies, tumor invasion of major vessels 
and tumor cavitation. CT of the lungs and upper abdomen is recommended for all 
patients but imaging of brain and bones depends on the clinical situation. Patients 
with resectable NSCLC will undergo surgery. Patients with pathological tumor stages 
II and III and selected patients with stage IB will receive adjuvant chemotherapy. 
Patients with incomplete tumor resection will receive adjuvant radiotherapy. With 
regard to stage III NSCLC, information on mediastinal lymph node involvement 
(single versus multiple levels, bulky) is required. Patients planned for curative 
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NSCLC are treated with chemoradiotherapy. Re-staging after chemoradiotherapy 
should particularly characterize patients with mediastinal down-staging who might 
benefit from additional surgery. Patients with advanced NSCLC receive palliative 
chemotherapy and, in case of progression, second-line therapy. Patients undergo 
radiological imaging usually every other cycle according to RECIST criteria and in 
case of clinical signs of progression. Patients with small cell lung cancer receive 
chemotherapy and, in case of limited disease, also local radiotherapy. Follow-up 
examinations in patients with lung cancer should focus on signs of progression and 
side effects of treatment such as infections and pneumonitis. 
Learning Objectives:
1. To present clinical guidelines for staging, prognosis and therapy in carcinoma 
of the lung.
2. To describe the criteria for adjuvant therapy in NSCLC.
3. To evaluate patients with NSCLC stage III.
4. To differentiate progression vs infection in advanced NSCLC.
A‑180 09:15 
Imaging in lung cancer 
J. Cáceres; Barcelona/ES (josecac@gmail.com) 
The initial examination in patients with lung carcinoma is the chest radiograph. Once 
the diagnosis is made, it is important to perform the proper radiological work-up 
to establish the stage and the adequate treatment. Staging is a key factor in lung 
cancer management and is important to select the proper imaging technique in 
individual cases. In treated patients, imaging is a main aspect of the follow-up. 
The radiologist must know how to evaluate signs of recurrence, which should be 
distinguished from related processes and post-radiotherapy changes. 
Learning Objectives:
1. To select appropriate imaging techniques in lung cancer.
2. To describe current tumor staging.
3. To learn to discover recurrences and complications post-treatment.
Panel discussion and case presentation 09:35 
08:30 - 10:00 Room G/H 
EFOMP Workshop
New technology in diagnostic radiology: Risk management, 
technology assessment and improved diagnosis 
EF 1 
Technology assessment for imaging equipment 
Moderators: 
A. Del Guerra; Pisa/IT 
K. Faulkner; Wallsend/UK 
Welcome address 08:30  
S. Christofides; Nicosia/CY 
M. Szczerbo‑Trojanowska; Lublin/PL
A‑181 08:40 
Introduction to EC initiatives in acceptability criteria for imaging 
equipment 
K. Faulkner1, J. Malone2, S. Christofides3, S. Lillicrap4; 1 Wallsend/UK, 2Dublin/IE, 
3Nicosia/CY, 4Bath/UK (keith.faulkner@nhs.net) 
In 1997, the European Commission published Radiation Protection 91: Criteria for 
acceptability of radiological (including radiotherapy) and nuclear medicine installa-
tions. This document specified minimum criteria for acceptability. It has been used 
to this effect in legislation, codes of practice and by individual professionals. Since 
the original publication, development of new radiological systems and technologies, 
as well as improvements in traditional technologies, has created circumstances 
where the acceptability criteria have been reviewed. In this lecture, the background 
to the development of the publication, and the implications on change in radiation 
protection/quality assurance philosophy for acceptability criteria and minimum 
performance standards for radiological, nuclear medicine and radiotherapy equip-
ment are described. Acceptability criteria have been produced consistent with the 
European Commission’s Medical Exposures Directive which requires that patient 
exposures are justified. Criteria were developed by a team drawn from a broad 
range of backgrounds including hospitals, industry, government bodies, regulators 
and standardisation organisations. Representatives were mainly from Europe, but 
individuals from the American Association of Medical Physics and International 
Atomic Energy Agency were included in the drafting process. 
Learning Objectives:
1. To understand the philosophy behind acceptability criteria.
2. To be aware of the implications of new acceptability criteria.
3. To discover the consensus based approach used in their development.
A‑182 09:05  
Technology assessment and radiological imaging 
S. Christofides; Nicosia/CY (cstelios@cytanet.com.cy) 
Technology Assessment (TA) in health care is a multidisciplinary field of policy 
analysis. It involves the study of the medical, social, ethical, and economic implica-
tions of development, diffusion, and use of health technology. Health Technology 
Assessment (HTA) is a multidisciplinary process that summarises information about 
the medical, social, economic and ethical issues related to the use of a health 
technology in a systematic, transparent, unbiased and robust manner. Its aim is to 
inform the formulation of safe, effective, health policies which are patient focused 
and seek to achieve best value. Despite its policy goals, HTA must always be firmly 
rooted in research and the scientific method. HTA is an approach to meet those 
challenges and apply the cost effectiveness in the selection of new technologies 
that are advancing rapidly and becoming highly sophisticated with time. It can help 
to meet the ever-increasing demands on competence, specialization and cost 
effectiveness that modern health care services are faced in today’s economically 
conscious world. The methodology developed by the EUnetHTA project will be 
used to demonstrate the value of HTA with particular emphasis in the evaluation 
of radiological imaging technologies. 
Learning Objectives:
1. To become familiar with the concepts of health technology assessment.
2. To understand the multidisciplinary nature of health technology assessment.
3. To appreciate the value of health technology assessment in providing cost 
effective and evidence based procedures for the benefit of the patient.
A‑183 09:30 
Acceptability criteria: A perspective from standards and equipment 
manufacturers 
R. Klausz; Buc/FR (remy.klausz@med.ge.com) 
In Europe, different systems exist to rule the design and performance of medical 
devices, in particular when they use ionising radiation. From one side, the European 
Council Directive 93/42/EEC (MDD) requires that medical devices are designed 
and manufactured so as to meet specified essential requirements. They should 
then be placed on the market or put into service within the territory of member 
states without any obstacle. The compliance with the Essential requirements can 
be reached by complying with harmonized standards, in particular, the EN60601 
series ruling Basic Safety and Essential Performances of Medical Devices. From 
another side, the Council Directive 97/43/Euratom requires that member states 
adopt specific criteria of acceptability for radiological installations in order to indicate 
when appropriate remedial action is necessary, including, if appropriate, taking the 
equipment out of service. The transposition of this directive in the regulation of the 
member states has resulted in methods and values for these criteria of acceptability, 
differing from country to country as well as from those driven by the MDD. It can, 
therefore, happen that a medical device is installed and put into service according 
to the MDD, and not authorized to be used following the national criteria of accept-
ability. To respect the policy set by the MDD which allows complying equipment to 
move freely within the Community and to be put into service in accordance with 
their intended purpose, the acceptability criteria throughout European Union should 
be harmonized, and fully compatible with the standardized criteria for design and 
manufacturing. 
Learning Objectives:
1. To identify the different standards and regulations applicable.
2. To understand the consequences of the acceptability criteria on the 
manufacturing and service of medical devices.
3. To understand the benefits for a standardisation of the acceptability criteria.
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08:30 - 10:00 Room I 
Vascular 
RC 715 
Vascular imaging: The diabetic patient 
Moderator:
J.H. Peregrin; Prague/CZ 
A‑184 08:30 
A. What the radiologist needs to know about the diabetic patient 
A. Raptis; Athens/GR (atraptis@med.uoa.gr) 
Diabetes mellitus (DM) is recognized as a major health - economic problem in the 
2 1st century. Ninety percent of the diabetic population is suffering from type 2 and 
the remaining 10% from type 1 and other types of DM. An epidemic of type 2 DM 
is occurring across the world and the number may increase from 100 to 200 mil-
lion over the next 15 years. As rates of childhood obesity escalate, type 2 DM has 
increasingly been diagnosed in children and adolescents. Duration of diabetes is 
an important factor in the pathogenesis of complications, but other risk factors - 
for example, hypertension, cigarette smoking, and hyperlipidaemia - interact with 
diabetes to affect the clinical course of microangiopathy and macroangiopathy. 
Cardiovascular disease (CVD) accounts for a great majority of deaths in patients 
with type 2 DM. According to the WHO, the prevalence of CVD in diabetic patients 
ranges from 26 to 36%. Fatality rate after myocardial infarction is greater in dia-
betic patients, and overall prognosis after coronary heart disease is worse. Based 
on these observations, it has been proposed that DM should be considered as a 
coronary heart disease risk equivalent. Atheromatous disease in the legs, as in the 
heart, tends to affect more distal vessels producing multiple, diffuse lesions that are 
less straightforward to bypass or dilate by angioplasty. The serious complications 
associated with DM make it essential for physicians to be aware of the risk factors 
and the screening guidelines, allowing for earlier patient diagnosis and treatment. 
Learning Objectives:
1. To learn about the prevalence, risk factors and prognosis of diabetic patients 
in the 2 1st century.
2. To understand the multimorbidity of diabetic patients.
3. To learn about the vascular manifestations of diabetes.
A‑185 09:00 
B. Imaging of the diabetic patient 
L.P. Lawler; Dublin/IE (llawler@mater.ie) 
Diabetes is a systemic disease with potential multi-organ dysfunction. Significant 
diabetic pathophysiology is linked to vasculopathy which can have distinctive features 
and patterns. We shall discuss how these vessels and territories may be optimally 
imaged, assessed and interpreted using current non-invasive and invasive imaging 
modalities. The particular challenges and limits to imaging diabetic vascular disease 
will be discussed. The latest changes in contrast/medication guidelines will be dis-
cussed. The particular patient risks from diabetes-related disease and medication 
and their management will be reviewed. Key elements of image acquisition and 
processing will be covered for 3D CTA, PET/CTA, MRA and DSA. The major arterial 
vascular territories including carotid-cerebral, coronary, aortic, mesenteric, renal and 
peripheral systems will be covered. Modern screening, diagnostic and therapeutic 
imaging strategies will be addressed. Novel imaging developments such as disease 
biomarkers, plaque imaging, and stem cell research will be considered. This lecture 
will provide the elements for comprehensive clinical assessment and problem solv-
ing as well as research potential in imaging the diabetic patient and vasculopathy. 
Learning Objectives:
1. To become familiar with the specific diagnostic requirements in diabetic 
vasculopathy.
2. To learn about specific risk factors for imaging and treatment in diabetic 
patients.
3. To discuss optimised imaging strategies in diabetic patients.
A‑186 09:30 
C. Cost-effective selection of the appropriate imaging technique 
R. Ouwendijk; Rotterdam/NL (r.ouwendijk@erasmusmc.nl) 
With the current constraints on health care resources and the emphasis on value for 
money, it is important to assess new technologies and demonstrate their value prior 
to their widespread use in day-to-day practice. To determine the optimal diagnostic 
imaging work-up for patients with peripheral arterial disease, we need to take into 
account not only the diagnostic accuracy of each test, but also the related effects 
of diagnostic imaging tests on treatment planning, functional improvement, qual-
ity of life and costs. Digital subtraction angiography is an invasive technique that 
requires post-procedural observation and, sometimes, hospitalization of the patient. 
DSA is associated with a higher complication rate and higher costs as compared 
with less invasive imaging techniques such as duplex ultrasound (DUS), computed 
tomographic angiography (CTA) and magnetic resonance angiography (MRA). DUS 
is an inexpensive non-invasive technique providing both anatomical and functional 
information. DUS, however, results in lower therapeutic confidence and more addi-
tional imaging compared to CTA and MRA. CTA and MRA are minimal invasive and 
can be performed as an outpatient procedure. Disadvantages of CTA are the use of 
radiation and impaired image interpretation in the presence of vessel wall calcifica-
tions. Disadvantages of MRA include the higher investment cost for equipment and 
venous overlay in the calf. Venous overlay and vessel wall calcifications are especially 
a problem in diabetic patients. During this presentation, the cost and effects of the 
different imaging techniques for peripheral arterial disease will be discussed including 
clinical utility, quality of life, functional patient outcomes and actual costs. 
Learning Objectives:
1. To understand the pros and cons of different diagnostic modalities with 
regard to cost effectiveness.
2. To provide cost-effective diagnostic algorithms in diabetic vasculopathy.
08:30 - 10:00 Room K 
Pediatric 
RC 712 
Imaging the GI/GU tracts 
Moderator:
G. del Pozo; Madrid/ES 
A‑187 08:30 
A. Is ultrasound enough for a comprehensive diagnosis? 
M. Riccabona; Graz/AT 
Paediatric US has emerged to a sophisticated technique allowing definite diagnosis 
of many paediatric GI and GU conditions. Restrictions have to be considered then 
indicating fluoroscopy or sectional imaging. The common GI queries where US has 
practically replaced other imaging are HPSt, volvolus, intussusception, IBD/appendicitis. 
In these, complementary imaging (usually fluoroscopy, sometimes MRI/CT) is rarely 
needed. Other queries need fluoroscopy (malrotation) or MRI/CT (tumours), some only 
radiographs (atresia, NEC), although US may offer some information. And US helps 
as a therapeutic option (US-guided hydrostatic reduction). GU tract US is even more 
important; indication for other studies (VCUG, MRU) heavily relies on US. A skilled 
and experienced technique by knowledgeable investigators applying age-adapted 
transducers is mandatory to exploit the vast US potential reducing/optimising additional 
imaging in many conditions. US is the primary imaging tool in HN, obstructive uropathy, 
urolithiasis, cyst and masses, and genital conditions (malformations, torsion). In signifi-
cant HN, additional reflux assessment and grading of obstructions is needed (VCUG, 
scintigarphy or MR-Urography). Childhood urolithiasis can usually be diagnosed by US, 
sometimes complemented by KUB, hardly adapted IVU or stone CT is necessary. In 
tumours, additional sectional imaging serves for imaging work-up/staging. In conclusion, 
modern US allows a comprehensive diagnosis in many paediatric GI and GU conditions 
obviating the need for additional, more invasive or radiating imaging. However, one 
needs to know US restrictions to then choose appropriate complementing imaging. 
Learning Objectives:
1. To learn about the technical requirements and potential of US in the GI/GU 
tracts.
2. To revisit important conditions that can be comprehensively assessed and 
partially treated by US.
3. To understand the limitations of US in the GI/GU tracts.
4. To learn about complementary imaging techniques when US is not enough.
A‑188 09:00 
B. Role of plain film, fluoroscopy, nuclear medicine and CT 
V. Donoghue; Dublin/IE (veronica.donoghue@cuh.ie) 
There have been many advances in cross-sectional imaging over the past years. 
Despite this, plain radiography still plays a significant role in the diagnosis of many 
abdominal conditions, particularly abnormalities of the gastrointestinal tract. Its 
role is particularly important in newborn infants in assessing the many causes 
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significantly in recent years; for example, many patients with inflammatory bowel 
disease are investigated using ultrasonography, MRI and CT and urocystosonog-
raphy has replaced the voiding cystourethrogram in many departments. However, 
fluoroscopy is still required for the diagnosis of many conditions, such as newborn 
bowel disorders and the assessment of feeding problems and is frequently used to 
guide the reduction of intussusception. In the paediatric population, it is important 
to keep the radiation dose to a minimum and some methods of fluoroscopic dose 
reduction will be addressed. Ultrasonography is the first choice in the investigation 
of most GI and GU disorders. However, CT is required in many instances such 
as in the assessment of abdominal tumours, the investigation of major trauma 
and occasionally in patients with acute appendicitis. The role played by nuclear 
medicine examinations will also be discussed particularly the role of Tc99m Mag3 
renography and Tc99m DMSA scans in assessing the many frequently encountered 
renal disorders in children. 
Learning Objectives:
1. To illustrate the continued usefulness of plain film radiography in children of 
all ages, in particular in the neonatal period.
2. To describe the current status of fluoroscopy and issues relating to dose 
reduction.
3. To discuss the uses and benefits of CT and the role played by nuclear 
medicine studies in specific GI and GU conditions.
A‑189 09:30 
C. MRI: Current state and new options 
W. Hirsch; Leipzig/DE (hirw@medizin.uni‑leipzig.de) 
Besides ultrasound, MRI is the imaging modality of choice of the abdomen in 
children and is equally important in paediatric radiology. Especially for children, 
3.0 Tesla MRI is gradually established in the daily routine alongside using 1.5 T. 
Fortunately, the shorter wave length of 3.0 T avoids typical artefacts especially in 
children because of their smaller body sizes in comparison to the higher incidence 
of these artefacts in adults with larger body sizes. The current state of paediatric 
abdominal imaging will be discussed by means of typical imaging examples us-
ing 1.5 T as well as 3.0 T MRI. MRCP has gained a new quality using higher field 
strength and contrast enhanced MRA has also improved significantly. Increasingly, 
paediatric radiology makes use of perfusion studies to characterise lesions of the 
liver as well as other parenchymatous organs. MR spectroscopy has not yet been 
established in abdominal examinations of children. An exception is the spectro-
scopic estimation of liver fat in children, which is however in an experimental stage. 
Learning Objectives:
1. To learn about typical indications and findings of abdominal MRI and how it 
compares with other imaging modalities.
2. To show the possibilities, advantages and disadvantages of standard and 
high field strength.
3. To show how we do it and how we try to avoid artefacts in imaging abdominal 
solid organs.





H. Ringertz; Linköping/SE 
C. Vandulek; Kaposvár/HU 
A‑190 08:30 
A. Investigation of occlusive peripheral arterial diseases: Role of CT, MR, 
US and DSA 
G. Pavlikovics; Miskolc/HU (gpavlikovics@gmail.com) 
Atherosclerosis is a generalized disease and contributes to cardiac death, stroke, 
limb loss and a range of other illnesses. Disease in the major arteries, including 
the infrarenal abdominal aorta, renal and internal iliac arteries, and peripheral 
vasculature, remains a major cause of morbidity and mortality. Traditional catheter-
based angiographic techniques are invasive and require arterial puncture. They 
also rely upon potentially nephrotoxic iodinated contrast agents; however, less 
invasive imaging techniques as US, CT and MRI have been developed. The ac-
curacy of these might approach the accepted standard of diagnostic X-ray based 
angiography. In this lecture: First, the clinical basics of peripheral arterial occlusive 
diseases (PAOD) with the anatomical fundamentals will be summarized; Second, an 
overview of the angiographic modalities will be presented; Finally, the methodology 
of peripheral MR angiography will be discussed with emphasis on: •Image quality
(Signal optimization, Contrast optimization, linear k-space reordering); •Timing (test
bolus, bolus trigger); •Contrast agent (extracellular (role of concentration!), and
blood-pool agents); •Instruments and patient preparation; •Contrast agent (Injection
protocols for different agents, minimizing the dose, role of renal function - NSF!!!,
blood-pool agents: steady-state imaging (perfusion?), pitfalls of blood-pool agents); 
•Sequences (first pass and steady-state).
Learning Objectives:
1. To consolidate knowledge about occlusive peripheral arterial diseases.
2. To appreciate the role of imaging modalities (CT, MR, DSA, US) in 
investigation and therapy planning with emphasis on bolus-chasing 
peripheral MRA and CTA.
3. To summarise the basics of contrast-enhanced MRA and CTA.
4. To learn about two kinds of MR contrast agents (extracellular and blood pool).
A‑191 09:15 
B. Practical approach to fMRI: Methods and cases 
P. Bogorodzki; Warsaw/PL (piotr@ire.pw.edu.pl) 
Magnetic resonance imaging (MRI) provides anatomic images of the human brain. 
Besides anatomy, recent scanners can provide physiological information, which is 
based on the blood oxygen level dependency (BOLD) effect. A technique called 
functional MRI (fMRI) allows us to detect the functional brain areas involved in 
various tasks: motor, hearing, language, etc. FMRI methodology involves several 
aspects: scanner settings, stimulation paradigm programming, subject preparation, 
subject’s performance monitoring and post processing software pipeline settings. 
Although not equally important, all these determine the final quality of fMRI. 
Moreover, fMRI studies require from clinical staff additional skills and knowledge 
about application of dedicated software for stimulating paradigms, application and 
maintenance of MR-compatible devices (headphones, display, response buttons) 
used for fMRI stimuli presentation, and application of statistical tools used for brain 
activations localization. All these aspects will be explored and illustrated with clinical 
and experimental examples from Bioimaging Research Center and collaborating 
institutions. Despite a large number of publications in medical imaging science, 
most of the recent developments in neuroimaging are not used in clinical routine. 
Many clinical radiologists consider these techniques as research tools and are not 
aware of their clinical applications. The main goal of this talk is therefore to promote 
this technique and translate fMRI imaging from bench to bedside. 
Learning Objectives:
1. To learn about the practical application of functional magnetic resonance 
imaging (fMRI) technique in terms of physics, instrumentation and 
experimental design.
2. To learn about critical factors determining repeatability and quality of fMRI, 
which will be illustrated using clinical examples.
3. To learn about the clinical use of fMRI.
08:30 - 10:00 Room N/O 
Special Focus Session 
SF 7b 
Present and future direction of ultrasound
Moderator:
L.E. Derchi; Genoa/IT 
A‑192 08:30 
Chairman’s introduction 
L.E. Derchi; Genoa/IT (derchi@unige.it) 
US is the most widely used and rapidly growing of all sectional imaging methods 
and constitutes a large part of the workload of many radiological departments. 
However, many radiologists seem to perceive it as a “mature” specialty, in which 
there are only few possibilities to advance and little chance to publish or present 
innovative studies. On the contrary, recent advances have significantly boosted 
the research horizons of US. This session will discuss the clinical applications and 
research relevance of three of the most important innovations in diagnostic US: 
contrast enhanced studies, volume US and elastography. Integration of these new 
US techniques into the activities of a busy radiological department needs efforts. It 
may be difficult to invest money into the new technologies, to have time to acquire 
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the necessary expertise and to maintain high patient throughput. The entire work-
flow of US studies should be adapted, possibly with shorter acquisition times and 
some marked time for the post-processing phases. Furthermore, the provocative 
title of the panel discussion will lead to evaluate the role of radiologists in US and, 
even in a situation in which many clinicians are using US as a “new stethoscope”, 
to maintain a strong position of our discipline in this field. 
Session Objectives:
1. To learn about technical advances in US.
2. To understand how new US techniques integrate into the activities of the 
radiology department.
3. To discuss the role of radiology in the future of US.
A‑193 08:35 
Clinical applications of US contrast media: Present guidelines 
M. Claudon; Vandoeuvre‑les‑Nancy/FR (m.claudon@chu‑nancy.fr) 
Ultrasound contrast agents (UCAs), in conjunction with contrast specific imaging 
techniques, are increasingly accepted in clinical use for diagnostic imaging and 
post-interventional workup in several organs. A first consensus document focused 
on focal liver lesions detection, characterization and follow-up was published by 
EFSUMB (European Federation of Societies for Ultrasound in Medicine and Biology; 
website: www.efsumb.org) in 2004. The first paper was updated and expanded in 
2008 to include recommendations for applications in the kidney, in vesico-ureteric 
reflux, in the pancreas, in trauma and in the cerebral circulation. Both papers were 
well received and are within the top 1%, according to their citation index. These 
guidelines and recommendations are based on comprehensive literature surveys 
including results from prospective clinical trials. On issues where no significant 
study data were available, evidence was obtained from expert committee reports 
or was based on the actual consensus of experts in the field of US and contrast 
enhanced ultrasound during consensus conferences. They provide general advice 
for the use of UCAs and are intended to create standard protocols for the use and 
administration of UCAs, and improve the management of patients. Beyond general 
recommendations, individual cases must be managed on the basis of all clinical 
data available for that specific case. These guidelines will be subject to change 
to reflect future advances in scientific knowledge and the rapidly evolving field of 
US technology. 
Learning Objectives:
1. To understand the basic principles of contrast enhanced US (CEUS).
2. To discuss appropriate technical settings and examination protocols.
3. To illustrate various examples of the main clinical applications of CEUS in 
adults and children.
A‑194 08:58 
Elastography: Clinical tool or toy? 
G. Rizzatto; Gorizia/IT (grizzatto@libero.it) 
The mechanical properties of biologic tissues depend on their constituents and 
their structural organization. Usually, tumors are stiffer than normal soft tissues and 
benign lesions. Sonoelastography is an ultrasound (US) technique that allows to 
estimate in vivo the mechanical properties of tissues; it mostly uses conventional 
ultrasound systems and customized software. The principle of elastography is 
based on slight tissue compression on the structures examined. It produces strain 
(displacement) within the tissue. Calculation of the strain profile along the axis of 
compression is converted into a real-time elastic modulus image. Basically, tissue 
elasticity US methods fall into two main groups: methods where a quasi-static 
external compression is applied to the tissue and the resulting components of 
displacement or of the strain tensor are estimated; transient elastography which 
relies on the observation of the propagation of a transient shear wave generated 
directly by the transducer to determine the viscoelastic properties of the tissues. 
Shear propagation imaging requires dedicated ultrafast scanners. A large number 
of reports show that US elastography is already a clinical tool in breast imaging. It 
mainly increases the specificity for benignity. Other proposed clinical applications 
include liver (diffuse and focal diseases), prostate (cancer detection), thyroid (benign 
nodules vs. carcinoma), lymph nodes (normal or reactive vs. metastatic), muscles 
and tendons (inflammations, traumas and tumors), and skin (abscesses). US 
elastography may be also part of more sophisticated applications (US endoscopy 
of pancreatic lesions, MRI and US fusion imaging of breast lesions, and monitoring 
of the efficacy of US guided therapies). 
Learning Objectives:
1. To describe the biomechanics that are the basis of tissue elastography.
2. To review the different methods of US tissue strain analysis.
3. To review the clinical and research results obtained in different areas.
A‑195 09:21 
Volume US in clinical practice for the radiologist 
S.T. Elliott; Newcastle upon Tyne/UK (simon.elliott@nuth.nhs.uk) 
The common perception of 3D ultrasound is of surface-rendered images, espe-
cially of the fetus. While these images are fascinating and appealing, they have 
little clinical application in the non-obstetric environment. However, the same 
equipment, enhanced by new transducer technology and software, can be used 
to take ultrasonography to another level, providing different image presentations, 
and working practices similar to those of CT and MR. This talk will describe the 
latest volume ultrasound technology and show new clinical applications, multi-
planar reconstruction, multislice imaging, and volumetric analysis. The proven 
and potential benefits, in terms of clinical accuracy, training, workflow and overall 
efficiency, will be discussed. 
Learning Objectives:
1. To learn about the indications and applications for volume US in non-
obstetric imaging.
2. To understand the technology involved in acquisition, manipulation and 
interpretation for volume US datasets.
3. To learn the benefits that can be gained by using volume US in terms of 
diagnosis and workflow efficiency.
Panel discussion:  
Will ultrasound remain only the stethoscope of the clinician? 09:44 
08:30 - 10:00 Room P 
Chest 
RC 704 
"Known" conditions revisited 
Moderator:
M.‑L. Storto; Chieti/IT 
A‑196 08:30 
A. An approach to cystic lung disease on HRCT 
A. Devaraj; Cambridge/UK 
Lung cysts are rounded areas of reduced attenuation usually surrounded by a 
thin wall and should be distinguished from lung cavities. The pathogenesis of 
multiple cysts in lung disease is mostly poorly understood. Offered explanations 
include focal necrosis, partial bronchiolar obstruction causing bronchial dilatation 
or retractile interstitial fibrosis. Disorders characterised by multiple lung cysts are, 
with the exception of centrilobular emphysema, rare conditions. In diseases such 
as lymphangioleiomyomatosis, LIP and langerhans cell histiocytosis, HRCT can 
provide useful diagnostic information by illustrating the distribution of disease and 
demonstrating other ancillary signs. In other instances (e.g. the rare disorder Birt-
Hogg-Dube syndrome), lung cysts are distributed randomly and CT does not show 
characteristic features. In this setting, a confident diagnosis requires lung biopsy. 
A more common occurrence is the identification of an occasional lung cyst on 
CT, with aetiologies including focal emphysema, pneumatocoeles, squamous cell 
metastatic disease and also as part of a normal phenomenon in elderly patients. 
Where possible, an explanation should always be sought when isolated lung cysts 
are identified, because simple lung cysts (equivalent to simple cysts in the kidney 
for example) are not typically seen in the lung. 
Learning Objectives:
1. To become familiar with a basic classification of cystic lung diseases.
2. To understand the pathogenesis of cystic air spaces in the lungs.
3. To learn about the spectrum of diseases characterised by pulmonary cysts.
4. To appreciate ancillary signs on HRCT that may refine the differential 
diagnosis.
A‑197 09:00 
B. Under-recognised infections in immune competent individuals 
T. Franquet; Barcelona/ES (tfranquet@santpau.cat) 
There have been increasing numbers of underdiagnosed emergent pulmonary infec-
tions in immunocompetent and immunocompromised adults. Necrotizing pneumoc-
cocal pneumonia, community-acquired methicillin-resistant Staphylococcus aureus 
(CA-MRSA), non-tuberculous mycobacterial infections and community-acquired 
respiratory viral infections are emerging pathogens that can cause severe infections 
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recognition with knowledge of the clinical setting is the best diagnostic approach to 
pulmonary infectious processes. When pulmonary infection is suspected, knowledge 
of the varied radiographic manifestations will narrow the differential diagnosis. 
Learning Objectives:
1. To understand the different clinical settings in patients with pulmonary 
infections.
2. To discuss the role of imaging methods in the management of patients with 
suspected pneumonia.
3. To become familiar with uncommon, but not rare, pulmonary infections.
4. To be aware of under-recognised pneumonias with unusual radiological 
features.
A‑198 09:30 
C. Imaging of thoracic tuberculosis 
I.E. Tyurin; Moscow/RU (igortyurin@gmail.com) 
Approximately 1.7 billion people worldwide are infected with Mycobacterium tu-
berculosis, of which 20 million are active cases. The reasons for resurgence of TB 
infection include the HIV epidemic, a rise in reactivation disease in the elderly, a 
growing migrant population and spread of drug resistant strains. In AIDS patients, 
the imaging features depend on the degree of immune suppression, TB is more 
often disseminated and more than half of patients have at least one extrapulmonary 
site of the disease. A pattern of postprimary TB is also usually seen among patients 
with decreased immunity due to alcoholism, renal failure, diabetes mellitus, ageing, 
malignancy, renal and cardiac transplantation. The development of the disease is a 
complex process closely related to the patents immunity and hypersensitivity. The 
pathologic form of the pulmonary infection depends on the sensitivity of the infected 
host and is classified as primary or postprimary. Primary TB pattern represents 
infection resulting from recent contact with the pathogen. Postprimary TB pattern 
results from reactivation of a dormant focus within the lungs or exogenous infection. 
Thoracic tuberculosis produces a broad spectrum of radiographic abnormalities. The 
radiological patterns had been described as parenchymal, airway, vascular, medi-
astinal, pleural, and chest wall lesions. Common causes of a missed diagnosis of 
thoracic tuberculosis are failure to recognize hilar and mediastinal lymphadenopathy 
as a manifestation of primary disease in adults, overlooking of minimal productive 
lesions or reporting them as inactive, and failure to recognize that an upper-lobe 
or superior segment of lower lobe mass might be tuberculosis. 
Learning Objectives:
1. To understand the radiologist’s role in diagnosis and management of thoracic 
tuberculosis.
2. To illustrate imaging features of thoracic tuberculosis and typical patterns of 
primary and post-primary infection, both at presentation and on follow-up.
3. To become familiar with the radiological patterns of multidrug-resistant 
tuberculosis and imaging features of thoracic tuberculosis in immune 
compromised patients.
08:30 - 10:00 Room Q 
Genitourinary 
RC 707 
CTU and MRU: Urinary tract imaging 
Moderator:
H.J. Michaely; Mannheim/DE 
A‑199 08:30 
A. CTU/MRU in acute obstruction 
T. Meindl, U.L. Mueller-Lisse, U.G. Mueller-Lisse; Munich/DE 
(thomas.meindl@med.uni‑muenchen.de) 
A variety of pathological processes that involve the upper urinary tract (UUT) may 
cause acute urinary obstruction: impacted calculi, neoplasms, intra- and extraluminal 
ureter compression, coagulopathy, fibrosis and surgery. Clinically acute obstruction 
leads to significant flanc pain and renal colic that urges the clinician to immediate 
diagnostic work-up and appropriate treatment. Radiological imaging procedures 
include ultrasonography, intravenous urography, computed tomography (CT) and 
magnetic resonance (MR) imaging. Among the cross-sectional examinations, multi-
detector CT is the modality of choice for clarifying the underlying cause of acute 
obstruction. Unenhanced (low-dose) CT is the new imaging standard for detec-
tion of calculi. Contrast-enhanced CT allows diagnosis of virtually all pathologies 
leading to obstructive nephropathy. After intravenous contrast media application, 
several contrast-phases can be imaged including the excretory phase for depiction 
of the UUT. Since radiation dose is a major drawback, imaging protocols have to 
be optimized and must be tailored to the clinical question. Magnetic resonance 
urography reveals the possibility of imaging the urinary tract without the need for 
contrast media by means of heavily T2-weighted sequences. These static urograms 
provide information about the grade and site of obstruction, independent of the 
excretory function of the kidneys. After injection of Gadolinium chelates, one or more 
urograms can be acquired during contrast media excretion. In the context of acute 
obstruction, MR urography is preferred in pediatric, young and pregnant patients. 
Patients with renal impairment are examined with T2-weighted sequences without 
the need for contrast media. Magnetic resonance urography is complementary to 
CT in challenging cases. 
Learning Objectives:
1. To learn the technical tips for MRU and CTU in acute obstruction.
2. To discuss the value of cross-sectional urography compared to IVP.
3. To review the appearance of major diseases like urinary stones, clots, etc.
4. To understand the drawbacks of each method and which one should be 
used first.
A‑200 09:00 
B. Chronic/intermittent obstruction 
M.-F. Bellin1, M. Claudon2, J. Ifergan1; 1Le Kremlin‑Bicêtre/FR, 
2Vandoeuvre les Nancy/FR (marie‑france.bellin@bct.aphp.fr) 
The recent technological advances of CTU and MRU have had an exceptional 
impact on the assessment of chronic/intermittent obstruction. Imaging studies 
should help answer the clinical questions raised concerning the presence, level, 
and cause of obstruction. In this session, the recommended techniques of CTU 
and MRU will be described and their relative merits and limitations reviewed. 3D 
CT images should be used as an adjunct to the transverse images, instead of a 
replacement, because volume-rendered images best depict the lumen and not the 
wall of the urinary tract. Thin-section reformatted CT images likely are as sensitive 
as transverse images in the detection of urinary tract abnormalities. MRU is being 
increasingly used because it provides excellent anatomic and functional imaging 
in a single setting. The relative advantages of static-fluid MRU and excretory MRU 
will be discussed. The main etiologies of chronic/intermittent obstruction will be 
illustrated. Bladder cancer, cervical cancer, and prostate cancer are relatively 
common causes of malignant ureteral obstruction. UPJ is the most common site 
of urinary tract obstruction in children. Vessels crossing a ureteropelvic junction 
obstruction contribute to the degree of hydronephrosis in up to 46% of these pa-
tients. Demonstration of these vessels and their location anterior or posterior to the 
obstruction facilitates surgical planning and limits potentially serious complications. 
Benign strictures of the ureter may complicate abdominal and pelvic inflammatory 
processes, infection, surgical or interventional procedures. At the end of the lecture, 
attendees will become familiar with moderate or severe urinary obstruction and 
their various features and causes. 
Learning Objectives:
1. To learn the technical tips for MRU and CTU in chronic obstruction.
2. To review the appearance of major diseases like PU junction, prostate 
masses, chronic inflammation and extrinsic compression.
3. To understand the advantages and disadvantages of each method.
A‑201 09:30 
C. Tumors: CTU/MRU 
N.C. Cowan; Oxford/UK (nccowan@gmail.com) 
1. Technological advances in both computed tomography (CT) and magnetic 
resonance (MR) imaging have improved diagnostic imaging of the urinary tract, 
surpassing ultrasound and the intravenous urogram. Multidetector computed to-
mography urography (CTU) is defined as CT examination of the kidneys, ureters 
and bladder with at least one imaging series acquired during the excretory phase 
of contrast enhancement. MR urography (MRU) can be performed by using heavily 
T2-weighted sequences without contrast material or T1 spoiled gradient- recalled 
echo sequences during the excretory phase after administration of gadolinium-
based contrast material. In adults, CTU or MRU is now the preferred examination. 
Technical aspects of image acquisition and processing will be explored and technical 
tips relating to protocol design given. 2. The typical and atypical appearances of 
upper urinary tract urothelial tumours and bladder cancers will be demonstrated. 
A method of fluoroscopic biopsy of upper tract tumours is described for validation 
of the imaging diagnosis. 3. Early and accurate diagnosis of urinary tract tumours 
helps optimise prognosis but conventional investigative pathways are complicated 
and lengthy, utilising multiple imaging tests and many diagnostic algorithms exist 
without rigorous evaluation. CTU offers a single imaging test of high diagnostic 
accuracy with the potential to replace multiple alternative imaging tests in the diag-
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nostic pathway, improve patient experience, improve diagnostic performance and 
accelerate diagnosis. MRU is a promising technique that may be used for the initial 
evaluation of patients at high risk for developing upper-tract urothelial carcinoma 
when CTU or intravenous urography is contraindicated. 
Learning Objectives:
1. To learn the technical tips for MRU and CTU in the detection of urothelial 
tumors.
2. To review the typical and atypical appearance of urothelial tumors.
3. To understand why CTU/MRU are complementary tools to other imaging 
methods.
10:30 - 12:00 Room B 
ESR meets Argentina 
EM 3 
Argentine radiology: Past, present and future 
Presiding:
A.E. Buzzi; Buenos Aires/AR 
C.J. Herold; Vienna/AT 
M. Szczerbo‑Trojanowska; Lublin/PL 
A‑202 10:30 
Introduction 
A.E. Buzzi; Buenos Aires/AR (alfredo.buzzi@diagnosticomedico.com) 
The Sociedad Argentina de Radiología (SAR) was founded on May 14th, 1917, 
in Buenos Aires, and has been the core of academic and social activity of the 
Argentinean radiological community. Many pioneers made original contributions to 
both diagnostic and therapeutic radiology that deserve a universal repercussion, 
as we will show. Since its origins, the SAR has carried out numerous activities 
among which we can highlight the publication of the “Revista Argentina de Radio-
logia” (edited since 1937), the dictation of the Course of Specialist in Diagnostic 
Imaging for more than 30 years (now in a virtual format), the organization of the 
Argentine Congress of Radiology for 55 years (with more than 2000 attendees), the 
organization of the Council of Professional Certification, and many services to its 
members. Since 2000, the SAR has the purpose of placing Argentinean radiology 
in the international radiological community, having signed scientific agreements with 
many radiological societies both in America and Europe that are very active. To keep 
the high academic level reached throughout the years, the SAR has maintained the 
ever-growing scientific, cultural and social activities, and has strongly worked in the 
formation of professionals. Despite the economic situation that Argentina and other 
Latin American are facing (that makes difficult for all our radiological community to 
accede to the top technology), there are many institutions with both medical level 
and equipment of the first level, as the speakers will demonstrate. 
Session Objectives:
1. To describe the original Argentinean contributions to clinical and 
technological radiology.
2. To describe the actual status of radiological practice in Argentina.
3. To share our vision of Argentinean radiology.
A‑203 10:35 
Pneumo esophageal MDCT: Its role in cancer presurgical characterisation 
and staging 
M. Ulla; Buenos Aires/AR (marina.ulla@hospitalitaliano.org.ar) 
Pre-surgical characterisation and staging of esophageal and gastro esophagic junc-
tion (GEJ) cancer with a sole imaging method could be useful for the therapeutic 
strategy since gastric invasion determines the scope of resection to be performed. 
Conventional CT scans have some limitations for hollow organ assessment in the 
absence of lumen distension, since the organ wall may be collapsed. Indeed, it 
is sometimes difficult to define wall thickening or to guarantee the presence of 
esophageal tumors with endoluminal growth. For these reasons, optimal esophageal 
distension has been considered useful to overcome these limitations. Although 
esophageal and gastric lumen distension has been performed with oral contrast 
agents, it is often suboptimal due to contrast rapid transit. Moreover, oral contrast 
enhancement may generate confusing images, with the same density as the tumor. 
This potential drawback is crucial at the level of the GEJ, a typically difficult region 
to evaluate, where depiction of the tumor anatomic location conditions the surgi-
cal strategy. To better evaluate the GEJ while staging the esophageal cancer, we 
develop a novel technique under MDCT in which CO2 is instilled into the esophagus 
to achieve maximum lumen distension. With this study, called pneumo esophageal 
MDCT, the thickened areas are highlighted in relation to the normal esophageal 
wall. The aim of this communication is to describe this technique, showing its results 
and imaging in correlation with surgical findings. 
Learning Objectives:
1. To learn about pneumo esophageal MDCT technique.
2. To understand its role in esophageal cancer presurgical characterisation and 
staging.
3. To appreciate the typical imaging findings.
4. To become familiar with the technique and interpretation.
5. To consolidate knowledge of esophagus tumor evaluation.
A‑204 10:53 
Cystic echinococcosis: Our experience in Patagonia 
S. Moguillansky; Cipolletti Rio Negro/AR (smoguil@speedy.com.ar) 
Human cystic echinococcosis (CE) or hydatidosis is a zoonotic infection caused 
by the larval stages of Echinococcus granulosus and its genetic variants. It is still 
endemic in Mediterranean countries, the Middle and Far East, and South America. 
One of the major endemic regions in Argentina is Patagonia, where the dominant 
strain of E. granulosus is the sheep-dog strain or G1. Humans become infected 
through accidental ingestion of contaminated water or vegetables or through 
contact with a definitive host. Imaging techniques represented a breakthrough in 
the diagnosis, treatment, and follow-up of patients with CE. Ultrasonography (US) 
is considered the gold standard for the diagnosis of hepatic hydatidosis (HH). 
US field surveys have been useful to reveal the natural history in asymptomatic 
individuals and allow improved epidemiologic evaluation. US is the method of 
choice to monitor response to treatment and guide surgical intervention. Its high 
sensitivity and specificity relegates immunodiagnosis as a complementary tool. Two 
classifications are widely used: the Gharbi and the WHO classification; however, 
controversy exists as to which better reflects the natural history and post-therapy 
changes. Different imaging signs have been described and are well known. This 
presentation emphasizes key features in differential diagnosis with other space-
occupying lesions of the liver. CT and MRI studies in the face of complications of 
HH will be reviewed. Therapeutic options are varied and far from uniform among 
different centers. They will be briefly mentioned and include: “watch and wait”, 
chemotherapy, surgery, and PAIR. 
Learning Objectives:
1. To illustrate national experience in mass screening approach.
2. To become familiar with the common imaging findings.
3. To understand how current classifications correlate with the natural history or 
treatment-induced changes of the cysts.
4. To appreciate how the imaging workup aids selection of optimal treatment.
A‑205 11:11  
Radioanatomy of the lower uterine arterial anastomoses 
R.D. García Mónaco; Buenos Aires/AR 
(ricardo.garciamonaco@hospitalitaliano.org.ar) 
The utero-ovarian anastomosis (upper or proximal uterine arterial anastomosis) are 
well described in the literature and have been related to hormonal alterations as a 
consequence of ovarian ischemia after uterine embolization (UAE).On the contrary, 
even though complications after UAE have been reported, the utero-vesical-vaginal 
anastomosis (lower or distal uterine arterial anastomosis) are less known and 
descriptions are scanty. Indeed, non-target embolizations (bladder,vaginal and 
vulvar) were reported after UAE. It has been often speculated that arterial reflux of 
the embolic agents might have been the cause. A better possible explanation could 
be the undesired passage of the embolic material from the uterine artery towards 
the vaginal or vesical arteries through the lower anastomotic plexus. Surgical or 
endovascular occlusion of both uterine arteries have proved to be inefficient in 
certain types of obstetric bleeding, probably due to collateral arterial supply from 
the lower uterine arterial anastomosis. These utero-vesical-vaginal anastomosis 
are constant, although hard to observe in normal clinical situations. They become 
angiographically evident in some hipervascular conditions such as pregnancy or 
placental infiltration, otherwise by forceful contrast injection in wedge catheter 
position. The lower uterine anastomotic system should be well recognized by 
interventional radiologists to avoid iatrogenic extrauterine ischemic complications 
or prevent symptomatic recurrence after embolization of obstetric hemorrhage. 
In this communication, we shall describe and illustrate the lower uterine arterial 
anastomosis, its angiographic and anatomical characteristics, with the aim of 
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Learning Objectives:
1. To learn about the uterine-vesical-vaginal arterial anastomoses.
2. To become familiar with arterial lower vascular supply.
3. To understand its clinical role in UAE and obstetric hemorrhage.
4. To appreciate its relation in placenta accreta diagnosis and management.
5. To avoid iatrogenic non-target UAE complications.
A‑206 11:29 
High-resolution MRI in rectal cancer 
A. Dieguez; Buenos Aires/AR (amdieguez@speedy.com.ar) 
High-resolution magnetic resonance has become an important tool in the staging of 
rectal cancer, directing the therapeutic strategy in the preoperative multidisciplinary 
team. MRI can clearly show the relevant anatomy for Total Mesorectal Excision, in 
particular the mesorectal fascia, assessing resectability. It can also identify patients 
with prognostic risk factors such as depth of invasion and status of the surgical 
circumferential resection margin. In this way, patients at highest risk can undergo 
preoperative adjuvant treatment, which has a better outcome and less toxicity than 
postoperative treatment. The report should include the T and N staging, the status 
of the circumferential resection margin, and the presence or absence of extramural 
vascular invasion. Knowing that the prognosis for low rectal cancer is different from 
that for upper and middle third level tumors, the analysis in this location deserves 
special attention. High-resolution magnetic resonance is reproducible and accurate 
in the selection of the proper preoperative treatment. We will describe the pertinent 
anatomy, the MRI technique, and the prognostic risk factors, and show our 5-year 
experience with a multidisciplinary team for the assessment of these patients. 
Learning Objectives:
1. To describe the high-resolution MRI state-of-the art technique and the data-
reporting form in patients with rectal cancer.
2. To describe the anatomic landmarks of relevance in Total Mesorectal 
Excision of the rectum.
3. To illustrate the use of high-resolution MRI in the identification of poor 
prognostic factors in rectal cancer.
4. To understand its role in selecting patients for preoperative neoadjuvant 
therapy.
Panel discussion 11:47 
10:30 - 12:00 Room E2 
Foundation Course: Head and Neck Radiology 
E³ 820 
Neck lymph nodes and glands 
Moderator:
S. Robinson; Vienna/AT 
A‑207 10:30 
A. Neck lymph nodes and salivary glands 
H.C. Thoeny; Berne/CH (harriet.thoeny@insel.ch) 
Involvement of lymph nodes in various pathologies of the head and neck is frequent 
not only in malignant diseases but also in inflammatory conditions. As size criteria 
are not sufficient to define a lymph node as malignant, other criteria such as shape, 
central necrosis and extracapsular spread are other helpful signs. However, micro-
metastases are still an unresolved problem although new imaging methods have 
already shown promising results. Typical imaging features of CT and MRI indicating 
extracapsular spread and carotid artery invasion will be discussed as these have 
therapeutic and prognostic implications. Although salivary gland pathologies are 
relatively rare, its large variety of differential diagnoses makes it challenging. In 
children and pregnant women, sonography is the first step, and CT is the method of 
choice in inflammatory disease. MRI is the first line examination in palpable salivary 
gland masses to assess the exact extent of tumours, the invasion of neighbouring 
structures, perineural spread and bone invasion. Differential diagnoses and imaging 
features of the most frequent tumour types will be discussed and an approach to 
differentiate between benign and malignant lesions will be provided. 
Learning Objectives:
1. To become familiar with the normal appearance of lymph nodes and salivary 
glands on imaging studies.
2. To review the imaging findings in common diseases affecting the neck lymph 
nodes.
3. To review the imaging findings in benign and malignant diseases of the 
salivary glands.
4. To appreciate the relative value of different imaging techniques in the 
evaluation of neck nodal and salivary gland disease.
A‑208 11:15 
B. Thyroid and parathyroid glands 
A.D. King; Hong Kong/CN (king2015@cuhk.edu.hk) 
Thyroid Gland: The normal appearance and developmental abnormalities of the 
thyroid are covered briefly, followed by a discussion of some of the more impor-
tant malignant and benign diseases of the thyroid. Imaging thyroid cancer will be 
illustrated with an emphasis on papillary carcinoma, which is the most common 
thyroid cancer. Diagnosis is obtained from ultrasound guided biopsy. Ultrasound 
is often sufficient to also stage early thyroid cancer in the neck, but MRI/(CT) is 
required for more advanced disease where there is extra-thyroidal primary tumour 
spread or extensive nodal disease. The impact of imaging on thyroid cancer man-
agement will be discussed. Benign thyroid nodules are common and ultrasound 
is used to distinguish these nodules from cancer; however, some nodules remain 
indeterminate on ultrasound and in these cases selection of criteria for biopsy is 
controversial. Finally, the imaging appearances in Graves’s thyrotoxoicosis and 
thyroiditis (Hashimoto’s, subacute and suppurative) will be illustrated. Parathyroid 
Glands: Imaging is used to localise the abnormal parathyroid gland (parathyroid 
adenoma, hyperplasia or rarely carcinoma) in hyperparathyroidism. There are 
usually four parathyroid glands located in the neck but supernumerary or ectopic 
glands may occur in the neck and mediastinum. Pre-operative localisation reduces 
operative time and allows minimally invasive forms of surgery to be performed. In 
this context, 99mTc- sestamibi scintigraphy and ultrasound are usually the first choice 
for localisation, while additional techniques such as MRI or CT are reserved for 
cases where the abnormal gland cannot be localised or there is persistent/recur-
rent disease after surgery. 
Learning Objectives:
1. To review the normal anatomy and imaging appearance of the thyroid and 
parathyroid glands.
2. To learn about the imaging findings in benign and malignant disease of these 
structures.
3. To understand the relative value of different imaging techniques to evaluate 
pathology of these structures.
4. To appreciate the impact of imaging findings on patient management.
10:30 - 12:00 Room G/H 
EFOMP Workshop
New technology in diagnostic radiology: Risk management, 
technology assessment and improved diagnosis 
EF 2 
Risk management and technology assessment 
Moderators: 
S. Christofides; Nicosia/CY 
A. Torresin; Milan/IT 
A‑209 10:30 
Acceptability criteria and radiography equipment, digital imaging and CT 
J. Malone; Dublin/IE (jifmal@gmail.com) 
In 2007, the EC commissioned a group of experts to undertake the revision of 
Report RP91 on “Criteria for Acceptability of Radiological (including Radiotherapy) 
and Nuclear Medicine Installations”. This paper introduces some of the concerns 
encountered in the diagnostic radiology section of the report and the approach 
adopted to establishing the criteria. It is expected that after a period of consultation, 
the report will be finalised by the European Commission and published. The group 
was particularly concerned to devise a set of criteria that applied to contemporary 
radiological equipment. Thus, all modalities including general film screen radiogra-
phy, CR, DR, fluoroscopy, interventional radiology, CT, dental radiography and DXA 
were reviewed. The group concentrated on identifying performance criteria which, if 
not met, would require equipment to be removed from service immediately. These 
were defined as suspension levels. The methodologies for assessing performance 
and the performance levels were, where possible, based on literature that com-
manded a high level of consensus. Where this was not available, the judgment 
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of the expert group, followed by peer review was employed. Where possible, the 
approach used has been consistent with the approach in international standards 
such as those issued by IEC. The paper will present the approach employed and 
some examples of the values recommended. 
Learning Objectives:
1. To comprehend the different meanings associated with terms like 
acceptance test, criteria for acceptability, and commissioning, as used with 
diagnostic imaging equipment.
2. To understand the status that will be afforded to criteria for acceptability 
for radiological equipment under the EU Medical Exposures Directive, and 
how this may influence the end users of equipment in hospitals/clinics and 
manufacturers/suppliers of equipment and services.
3. To become familiar with the bodies involved in the creation of standards and 
criteria for acceptability for diagnostic radiology imaging equipment.
4. To become familiar with the consultation process presently open with respect 
to the new draft criteria for the acceptability of equipment.
5. To examine examples of criteria for acceptability from the draft report.
A‑210 11:00 
Acceptability criteria and equipment for fluoroscopy and interventional 
radiology 
S. Balter; New York, NY/US 
Fluoroscopic systems can be highly flexible and are open to a wide range of ap-
plications. They may offer a multiplicity of modes (and sub-modes) of operation. 
Commissioning of newly installed equipment includes optimizing the equipment 
settings for its intended use. A representative subset of the most probable intended 
uses of the equipment should be identified for acceptability testing. For example, 
the main “cardiac mode (s)” and associated sub-modes might be tested in a unit 
whose intended application will be in the area of cardiac imaging. If the unit is later 
deployed for different purposes, the need for new commissioning and a new accept-
ability test will have to be considered by the practitioner and the MPE. Fluoroscopes 
intended for interventional use ought to have dose measurement capabilities such 
as Air Kerma Area Product and/or Accumulated Air Kerma at a reference point. 
Acceptability testing includes evaluating the accuracy of these instruments. In many 
cases, fluoroscopic systems are supplied as dedicated units suitable for cardiac, 
vascular, gastrointestinal or other specific applications. Powerful mobile units are 
available and are generally flexible. In all cases, the MPE will have to consider the 
intended application of the unit and the environment in which it will be installed and 
used. With respect to the X-Ray generator, many of the criteria of acceptability are 
similar to those prevailing for general radiographic systems. 
Learning Objectives:
1. To become familiar with the process of testing fluoroscopes for clinical 
acceptability.
2. To be aware of the need for optimizing the setting of a fluoroscope 
corresponding to its intended use.
A‑211 11:30 
Acceptability criteria and equipment for nuclear medicine 
S. Christofides1, L. Malone2, P. Horton3, S. Mattsson4; 1Nicosia/CY, 2Dublin/IE, 
3Newcastle upon Tyne/UK, 4Malmö/SE (soren.mattsson@med.lu.se) 
Purpose: To specify acceptable performance tolerance levels (suspension levels) 
for gamma camera and positron emission based procedures. Instruments needed 
for therapeutic procedures and intra-operative probes are also covered.
Methods and Materials: As shown in the preceding papers describing the revision 
of the EC RP91 criteria.
Results: This section considers equipment for: 1. Nuclear medicine therapeutic 
procedures. 2. Radiopharmacy quality assurance programme. 3. Gamma camera 
based diagnostic procedures. 4. Positron emission diagnostic procedures. 5. 
Hybrid diagnostic systems. 6. Intra-operative probes. Each part is comprised of 
a brief introduction and a list of equipment for which suspension levels are given. 
For each equipment, a table is given with the performance parameters and the 
suspension levels.
Conclusion: It is evident that there are few publications that give hard values for 
suspension levels, especially for new and evolving technologies in nuclear medi-
cine. Therefore, it was necessary to quote acceptable tolerance levels, which are 
related to the value used for acceptance testing/commissioning of the equipment 
and on values quoted by the manufacturer. It was also evident that case studies 
describing the suspension of equipment based on the characteristic parameters 
falling outside defined tolerance levels or hard parameter values were not identified 
in the published literature. It is recommended that such case studies should be 
published for future use in defining more solid suspension levels. Since technology 
is evolving continuously and new equipment is placed on the market with a rapid 
tempo, it is necessary with a regular review and updating of the recommended 
suspension levels. 
Learning Objectives:
1. To comprehend the background for and rational of the revised RP91 
acceptability criteria for nuclear medicine installations.
2. To understand when equipment no longer meets the required performance 
tolerance levels (suspension levels) and has to be withdrawn from use.
3. To become familiar with the revision of the EU RP91 document and 
with documents from IAEA, IEC and NEMA related to performance 
measurements and quality assurance for nuclear medicine equipment.
10:30 - 12:00 Room Z 
ESR Audit Session 
Clinical audit for radiologists: Why it is worth doing, 
and how to make it work 
Moderator:
E.J. Adam; London/UK 
A‑212 10:30 
Clinical audit: What is it and who should do it? 
E.J. Adam; London/UK (Jane.Adam@stgeorges.nhs.uk) 
This talk will focus on how radiologists can become involved in and carry out clinical 
audit, and what benefits it can bring. There are many definitions of clinical audit, 
some of which imply regulation or outside scrutiny, but clinical audit should be viewed 
as a professionally led method of improving patient care through the systematic 
examination of systems, processes and outcomes against chosen and agreed 
standards. It is a process that can readily be carried out by individuals, groups or 
whole departments. If properly conducted, with appropriate confidentiality and in a 
no-blame environment, clinical audit can be a professionally satisfying, productive 
and effective way of examining what we do to provide reassurance that all is well, or 
where necessary, find ways to improve and enhance the care we offer to patients. 
Learning Objectives:
1. To comprehend the definition of clinical audit.
2. To understand the methodology and scope of clinical audit.
3. To become familiar with the benefits of audit and how it can become part of 
our normal professional practice.
A‑213 10:50 
Clinical audit and accreditation: Intimidating or encouraging? 
Experience in Germany 
B. Ertl-Wagner; Munich/DE (Birgit.Ertl‑Wagner@med.uni‑muenchen.de) 
In Germany, quality management (QM) has been obtaining increasing attention in 
the medical arena, as the legislature now demands the introduction of a QM system 
both in the in- and out-patient settings. This has led to a steep increase in accredita-
tions in recent years, also in the field of radiology. A commonly used QM system in 
German hospitals is KTQ, a genuinely German system that can only be applied for 
entire hospitals and not for departments. In addition, ISO 9001:2008 is a prevalent 
system both for the in- and out-patient settings. Other QM and accreditation models 
include EFQM, Joint Commission International, proCum cert, and several models 
specifically designed for the out-patient practice setting. The introduction of QM to 
German medicine has caused a pronounced increase in both internal and external 
audits. These mechanisms have to be incorporated into the management system 
and organisational structure in order to ascertain continuous improvement of the 
department. Even though audit is oftentimes initially perceived as threatening, it 
can be an extremely rewarding and educational experience if conducted properly. 
Audit has the capability to identify potential weaknesses and to devise mechanisms 
to ameliorate or eradicate these. In a blame-free environment, this can lead to an 
improved and more content situation for patients, staff and referring physicians. 
Learning Objectives:
1. To become familiar with the various QM models commonly used in German 
medicine and radiology.
2. To become acquainted with the common processes of introducing a QM 
system to a radiological department.
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A‑214 11:10  
Clinical audit: Getting everyone involved! UK experience and the role of 
national audit projects 
S. Barter; Cambridge/UK (suebarter@btinternet.com) 
The Clinical Radiology Audit Sub-Committee (CRASC) of the Royal College of 
Radiologists (RCR) was established to co-ordinate national radiology audit activity. 
Its function is to promote and facilitate audit through nominated audit leads in each 
hospital trust, who act as a link between the RCR and their department, encouraging 
audit locally and participating in relevant RCR national audits. At least one national 
audit is carried out annually, with data collected via electronic submission and the 
anonymised results presented to audit leads at an annual Audit Forum. Individual 
departmental results are analysed using statistical process control (SPC) methodol-
ogy. This enables identification of departments underperforming against the national 
mean, and recommending corrective action, by redesigning the process being 
audited, or by identifying and eliminating specific root causes locally. Past National 
Audits include: 2006 - Audit of outcomes of Nephrostomy, 2007 - Audit of Effective 
Communication and 2008 - Audit of Accuracy of Staging of Uterine Cancer. The 
Committee has developed a web-based tool for facilitating local audit, “AuditLive”, a 
fully searchable collection of templates or “recipes” which can be downloaded and 
adapted. Fellows are also able to submit their own templates for audit for publica-
tion hence sharing best practice nationally. We encourage radiologists in training 
to participate in audit by holding Audit Poster competitions at National Radiology 
Scientific Meetings, and produce an audit newsletter, distributed to every member 
and Fellow of the RCR. Our experience leads us to believe that audit succeeds 
when relevant, locally owned and properly structured, and multi-professional, and 
our model encourages this. 
Learning Objectives:
1. To comprehend the role of clinical audit in radiology practice.
2. To understand how to facilitate clinical audit locally and nationally.
3. To become familiar with some of the systems developed in the UK by the 
Royal College of Radiologists.
A‑215 11:30 
Implementation of the EC guideline in practice 
S. Soimakallio; Tampere/FI (seppo.soimakallio@pshp.fi) 
Purpose: To introduce the new EC guideline of Clinical Audit (CA) and how it is to 
be implemented in practice of radiological department.
Methods and Materials: Guideline contains the terminology and practical matters 
of INTERNAL (annually) and EXTERNAL (within 5 years) AUDIT. Every radiological 
unit must have some kind of quality system with documented practice in quality 
manual. Motivation of staff is necessary to achieve the good quality of work and 
to prepare for the external inspection. Enough resources (time, costs, etc). must 
be reserved for updating of quality manual. Auditing organization can use only 
independent, experienced and educated auditors. The audited unit should change 
its own practice according to the recommendations given by auditors. National Ad-
visory Committee is useful to coordinate and to develop the national audit practice. 
Criteria of good practice should be developed in cooperation with national societies.
Results: The new guideline is supposed to give advice to every question concern-
ing clinical audit. In Finland, the most difficult thing was how to start the process. 
With two runs of CA, we will notice improved quality of diagnostics, reduced dose 
of radiation, effective use of resources and professional education. The number of 
recommendations has strongly diminished during two runs.
Conclusion: Guideline is the necessary tool to implement clinical audit in practice 
of radiology. National legislation and regulations should be taken into account in 
this process. 
Learning Objectives:
1. To comprehend the EC guideline.
2. To understand the whole process of clinical audit.
3. To become familiar with implementation of the guideline in radiology practice.
Discussion 11:50 
12:15 - 12:45 Room A 
Plenary Session 
HL 2 
Josef Lissner - Honorary Lecture 
Presiding:
M. Szczerbo‑Trojanowska; Lublin/PL 
A‑216 12:15 
The advance of musculoskeletal radiology and creating defining moments 
S.E. Anderson; Sydney/AU (andersonsembach@yahoo.com.au) 
Musculoskeletal radiology has experienced significant progress in clinical expertise, 
research and teaching. Technology has been, among others, a very positive driving 
force. However, medicine and radiology are still human centric disciplines. Teach-
ers, students and patients are important stakeholder groups. Their daily interaction 
on different levels sometimes blurs the key moments that might otherwise impact 
on individual choices in the long term. How do we leverage the human aspect in 
a more defined way? The speaker will discuss this topic and some ideas with the 
focus on teaching and cross-generational influence. 
Learning Objectives:
1. To have an appreciation of the advance of musculoskeletal radiology.
2. To appreciate the specific potential role of “defining moments” influencing 
education, teaching and to developing musculoskeletal radiology further.
12:30 - 13:30 Room I 
Joint Session of ESR and EC (European Commission)
eHealth: Legal and technical challenges for 
radiology 
Moderator:
I.W. McCall; Oswestry/UK 
A‑217 12:30 
Introduction on eHealth 
C. Dima; Brussels/BE 
European health systems are faced with challenges like citizens’ expectations for 
high-quality care, staff shortages, unequal territorial distribution and rising healthcare 
costs. eHealth and telemedicine in particular are tools which can help to address 
challenges, like contributing to deliver better quality of care, to increase accessibility 
to healthcare in remote geographical locations or to overcome shortages of health 
professionals in given situations. Recognising the potential benefits of ICT tools in 
this context, the European Commission has been supporting efforts in the field of ICT 
for Health for the last 20 years. EC instruments used for making eHealth a reality are 
a mix of research, policy and support to deployment activities. Research activities 
in three main areas (Personal Health Systems, Patient Safety, Virtual Physiological 
Human) are being financed under the Seventh Framework Programme for Research 
(FP7). Several policy actions have been adopted in order to support eHealth devel-
opment: Action Plan for a European eHealth Area (April 2004); Communication on 
lead markets (December 2007); Recommendation on cross border interoperability 
of EHR systems (July 2008); Proposal for a Directive on patient’s rights for cross 
border care (July 2008); Communication on “telemedicine and the benefit for patients, 
healthcare systems and society” (November 2008). Implementation, support to poli-
cies: Competitiveness Innovation Programme (CIP ICT PSP): Large Scale Pilot on 
Interoperability and Telemedicine + Thematic Networks. 
A‑218 12:40 
Legal aspects of eHealth related to medical imaging 
C. Dima; Brussels/BE 
The best illustration of an eHealth service in the field of medical imaging is tele-
radiology. Teleradiology is a telemedicine service which involves the electronic 
transmission of radiographic images from one geographical location to another 
for the purposes of interpretation and consultation. The Communication from the 
Commission to the European Parliament, the Council, the European Economic 
and Social Committee and the Committee of the Regions on telemedicine for 
the benefit of patients, healthcare systems and society [COM (2008) 0689 final] 
acknowledges the fact that teleradiology is currently the telemedicine service in 
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the most advanced stage of deployment. It is a way to optimize management of 
scarce resources. In the Communication the Commission undertook to publish, in 
cooperation with Member States, an analysis of the Community legal framework 
applicable to telemedicine services, including teleradiology. This was listed in the 
Communication as an action aimed to bring legal clarity to telemedicine. Several EU 
legal acts have been identified as being applicable to teleradiology. The challenge 
is to determine and clearly specify the scope, depth and borders of applicability 
of existing Community legal framework to teleradiology. It is both important and 
useful to analyse the case of teleradiology services by cross-reference to the 
relevant Community legislation in the main problematic areas, such as: freedom 
to provide telemedicine services, license/authorisation of health professionals 
providing telemedicine services, liability, personal data protection and jurisdiction. 
A‑219 12:55 
Radiology’s view on telemedicine communication 
L. Donoso; Barcelona/ES 
The European Society of Radiology (ESR) is closely monitoring EU legislation and 
EU affairs with a potential impact on medical imaging and has started to successfully 
build relations with relevant EU institutions and EU consulting and public affairs 
agencies. The ESR very much welcomes the Communication on Telemedicine 
issued by the European Commission as a document that brings to the attention of 
different stakeholders several important issues concerning telemedicine.
The ESR wants to make sure that: 1. Although staff shortages are expected in the 
future, a radiological act must always be defined as a medical act. 2. Standardised 
European training curricula and structures for all radiologists are established. 3. 
Reporting radiologists are registered, including adequate monitoring and accredita-
tion mechanisms. 4. Special attention is given to the challenges new technologies 
pose for the radiologist profession.
The ESR demands that a future legislation on Telemedicine shall provide the 
following: 1. Teleradiology has to be defined as medical act in its own right. 2. 
Establishment of accreditation criteria for teleradiology providers that are homog-
enous throughout the EU. 3. Emphasis on the importance of delivering high-quality 
healthcare to the patient. 4. International quality standards and careful monitoring 
of service providers. 5. Regulation of telemedicine and teleradiology should be the 
responsibility of the member state where the patient undergoes the imaging proce-
dure or telemedical referral. 6. Full information of patients and informed consent. 
A‑220 13:05 
eHealth: Technical aspects 
D. Caramella; Pisa/IT 
Broadband access and the ability of providers to enable full connectivity is a 
prerequisite for the deployment of teleradiology. However, the geographical areas 
that may be more in need of teleradiology (scarcely populated areas) usually 
have more difficult or limited access to the high-performance connections that are 
needed. Moreover, it is hard to underestimate the importance of interoperability and 
standardisation. In Radiology there has been formidable progress in this field with 
the development of DICOM and IHE. However, fine tuning of existing standards is 
still needed to cope with the specific issues that are relevant to teleradiology. For 
example, an EU wide consensus on specifications for transfer protocols, encryp-
tion, digital signatures and providing a Public Key Infrastructure service would 
improve the practical access to teleradiology and the interoperability between 
different partners in healthcare. Another important aspect is that interoperability 
has to include all information systems in which the remote radiologist may find the 
complete clinical information (images and data) that is necessary for the diagnosis. 
Therefore, access to prior imaging examinations as well as to the Electronic Patient 
Record must be available in teleradiology applications in order to ensure the same 
quality of radiological diagnosis that is obtainable in the HIS-PACS environment at 
the hospital level. Even if current state-of-the-art technology has reached a mature 
stage when it can really help to fulfil the aim of realising teleradiology, a serious 
deployment programme will never be possible unless other development points 
(namely legal and organizational issues) are tackled and fixed as well. 
Discussion 13:15 
16:00 - 17:30 Room A 
Radiology in Abdominal Emergencies 
CC 1017 
Missing perfusion: Abdominal ischemic disease 
Moderator:
N. Gourtsoyiannis; Iraklion/GR 
A‑221 16:00 
A. Mesenteric angiography: Diagnostic and therapeutic approach 
J. Lammer; Vienna/AT (johannes.lammer@akhwien.at) 
Acute abdominal organ ischemia may be caused by hypovolaemic shock, spasm 
(ergotism), embolization and aortic dissection. Embolization is the most common 
cause. It occurs typically in elderly patients with atrial fibrillation, after myocardial 
infarction or due to a thoracic aortic aneurysm (TAA). The primary diagnosis is made 
by CT with contrast enhancement which also can demonstrate cardiac thrombi or a 
TAA. Interventional treatment can be performed with a thrombectomy device or fibri-
nolysis with recombinant tissue plasminogen activator (rt-PA; 10 mg loading dose, 
5 mg/hr infusion dose). Acute aortic dissection may cause dynamic compression of 
the true lumen with occlusion of the ostium of the visceral arteries (floating visceral 
sign). The primary diagnosis is made by CT. Occlusion of the primary entry tear 
with a thoracic aortic stentgraft may decompress the true aortic lumen followed by 
reperfusion of the visceral arteries. Chronic abdominal ischemia in younger patients 
may be due to fibromuscular dysplasia, Takayasu arteritis or neurofibromatosis. 
In the elderly, it is usually caused by arteriosclerosis. The patient may have post 
prandial abdominal pain (angina abdominalis), diarrhea and/or weight loss. Due 
to the collateral circulation, symptoms usually occur only if more than one of the 
major arteries (celiac trunk, superior and inferior mesenteric artery) is narrowed. 
The diagnosis can be made by color Doppler ultrasound (CDUS), CT and MR with 
contrast enhancement. Endovascular treatment is done by PTA and stent placement. 
Learning Objectives:
1. To learn the different causes of ischemic abdominal emergencies and 
principles for treatment by interventional radiology.
2. To learn the causes and the optimal imaging strategy for preparing treatment.
3. To understand the principles, techniques and results of interventional 
radiology for the treatment of acute abdominal bleeding.
A‑222 16:30 
B. The black bowel 
P. Rogalla; Berlin/DE (rogalla@charite.de) 
Ischemic bowel disease represents a live threatening disease that requires immediate 
clinical attention once diagnosed. Expansion of cardiac surgery, surgical interven-
tions in elderly and high-risk patients have created an increasing demand for early 
diagnostic workup if bowel ischemia is clinically suspected. Multi-row detector CT with 
multiplanar refomations including further projection techniques plays a leading role in 
early detection of bowel ischemia if blood work and clinical presentation are equivocal 
or contradictory. Optimal sequencing of intravenous contrast media injection and the 
scanning delay represents a prerequisite for reliable diagnostic outcomes. Knowledge 
of typical patterns of the disease, early and late signs of ischemic bowel disease is 
mandatory for radiologist in charge. The course will help to understand physiological 
principles and causes of ischemic bowel disease. Diagnostic performance of cur-
rent imaging tests and how to integrate them into clinical practice will be discussed. 
Learning Objectives:
1. To understand the underlying physiological principles and causes of ischemic 
bowel disease.
2. To become familiar with typical signs of bowel ischemia and how to use 
them.
3. To discuss the diagnostic performance of current imaging tests and how to 
integrate them into clinical practice.
A‑223 17:00 
C. Clinical management: What you need to know 
D.E. Malone; Dublin/IE (dmalone@ucd.ie) 
Acute mesenteric insufficiency (AMI) is due to arterial or venous occlusion. Arterial 
AMI is an emergency. The typical patient is elderly, may have atrial fibrillation and has 
recent onset intense visceral pain disproportionate to clinical signs. CT is the mainstay 
of diagnosis and may be supplemented by CT angiography (CTA). Waste no time if 
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and symptom duration before therapy is an independent predictor of mortality. Age > 70 
years, metabolic acidosis and renal failure are other danger signs. Interrupt routine CT 
lists; ensure that these patients are scanned as soon as possible - neutral oral contrast 
and high-dose IV contrast are essential. CT appearances should be correlated with 
serum lactate as acute arterial occlusion without reperfusion may produce falsely 
'normal' bowel wall thickness. Early diagnosis and aggressive surgical intervention 
combining bowel resection with revascularisation offer the best prognosis. Venous AMI 
may present with a more chronic, intermittent course of pain, fever, abdominal tender-
ness and ascites. Therapy is bowel resection and anticoagulation. Ischaemic colitis 
occurs in elderly patients with atherosclerosis spontaneously or after aortic aneurysm 
repair. There are fewer systemic manifestations, bloody diarrhoea predominates; it may 
spontaneously resolve. CT or contrast enema is established imaging options. Chronic 
mesenteric ischaemia presents with 'intestinal angina' and weight loss. Doppler US, 
CTA/MRA are diagnostic. Surgical or interventional therapy is feasible; the correct choice 
varies with individual patient anatomic and comorbidity considerations. Endovascular 
therapy may have higher re-intervention rates, reducing cost-effectiveness. 
Learning Objectives:
1. To discuss the clinical signs of ischemic bowel disease.
2. To analyse the clinical management of patients with suspected bowel 
ischemia with focus on workflow.
3. To analyse cost-effectiveness and clinical outcome of early diagnosis and 
interventional treatment options.
16:00 - 17:30 Room B 
Radiology of the Spine in 2010 
CC 1016 
Bones: What you should know! 
Moderator:
V.G. Hadjidekov; Sofia/BG 
A‑224 16:00 
A. Primary and secondary tumors of the bony spine 
J.W.M. Van Goethem, L. van den Hauwe, C. Venstermans, F. De Belder, 
P.M. Parizel; Antwerp/BE (johan.vangoethem@ua.ac.be) 
Spinal tumors are uncommon lesions and affect only a minority of the population. 
However, these lesions can cause significant morbidity in terms of limb dysfunc-
tion and can be associated with mortality as well. In establishing the differential 
diagnosis for a spinal lesion, location is the most important feature. In general, 
extradural lesions are the most common (60% of all spinal tumors), with the major-
ity of lesions originating from the vertebrae. The most frequent extradural tumor is 
metastasis, while primary bone tumors are much less common. Solitary vertebral 
lesions are less common than tumors with multiple locations. Benign lesions are 
usually asymptomatic, incidentals findings, malignant vertebral tumors give back 
pain and sometimes manifest neurologic symptoms, especially in children. MR 
imaging is the best imaging modality, but bone scintigraphy is useful in detecting 
multiple lesions and distant metastases. CT is also important in imaging these 
lesions and sometimes shows typical patterns of bone destruction, sclerosis and/
or remodeling. The most frequent malignant extradural tumor is metastasis. Other 
malignant tumors include lymphoma - multiple myeloma, chordoma, Ewing sar-
coma and chondrosarcoma. The most frequent benign lesions are hemangioma, 
enostosis (simple bone island), osteoid osteoma - osteoblastoma, aneurismal bone 
cyst, giant cell tumor, eosinophilic granuloma (histiocytosis) and osteochondroma. 
Besides imaging findings, the age of the patient and the multiplicity and location of 
the lesion (s) are most important in the differential diagnosis. 
Learning Objectives:
1. To review the most common primary tumors of the bony spine.
2. To learn how to analyse imaging patterns of neoplastic bone lesions in the spine.
3. To re-evaluate the necessity of CT and/or MR in evaluation of tumors of the 
bony spine.
A‑225 16:30 
B. Traumatic bone injury 
M. Stajgis; Poznan/PL (stajgis@o2.pl) 
Traumatic bone injury of the spine presents a great clinical and social problem as 
it often affects young and previously healthy patients. The role of radiologist is to 
detect and precisely indicate the areas of the spine which have been affected by 
the trauma. The knowledge of normal anatomy of the spine and the most common 
anatomical variants are absolutely necessary to make the correct diagnosis. Also, 
the mechanism of injury is important - its understanding helps and simplifies the 
diagnostic pathwork. Crucial for the patient is to distinguish between stable and 
unstable fractures; this enables the optimal treatment (surgical vs. nonsurgical) - 
Denis concept of three columns of the spine is one of examples of common language 
between radiologist and neurosurgeon. Spinal injuries are divided into minor and 
major ones. Minor injuries include fractures of transverse and spinous processes, 
facets and interarticular parts. The most common major injuries are compression 
and burst fractures with anatomic dislocations. The role of radiograms will be 
presented. Without doubt, MDCT with reformats is the ‘gold standard’ method in 
evaluation of traumatic bone injury and must be implemented in routine protocol 
in every patient with neurological or other clinical symptoms. Also, MRI plays a 
very important role - it can detect the subtle injury symptoms like posttraumatic 
bone marrow oedema, evaluate the degree of spinal cord compression with its 
consequences and determine the injury of soft tissues (e.g. ligaments). Finally, 
the disadvantages and traps of different imaging modalities will be presented. 
Learning Objectives:
1. To understand the mechanisms of traumatic bone injury.
2. To learn about MR imaging findings in different traumatic abnormalities of 
the spine.
3. To become familiar with the advantages and disadvantages of different 
imaging techniques in spinal trauma.
A‑226 17:00 
C. Spinal infections: More common than expected? 
E.T. Tali; Ankara/TR (turgut.tali@gmail.com) 
Skeletal manifestations of TB remain a major problem in the world. The incidence is 
rising with increasing AIDS, immunosuppressive drugs or substance abuse. WHO de-
clared TB a global health emergency. Drug-resistant TB infections (multi-drug resistant 
TB (MDR-TB), which is defined as resistance to the two most effective first-line TB drugs: 
extensively drug-resistant TB (XDR-TB) and extremely drug-resistant TB (XXDR-TB) 
that have resistance to every anti-TB drug are also increasing recently. TB of the spine 
accounts for 1% of all TB infections and 25-60 of all bone and joint TB infections. It 
generally affects adults in the fourth and fifth decades. TB spondylitis is more indolent 
with a more gradual onset of symptoms over months to years. Lower thoracic and up-
per lumbar vertebrae are the most common sites. Multiple vertebral body involvement 
is the rule and skip lesions occur. Vertebral body is eventually destroyed with loss of 
cortical definition and fragmentation, large paravertebral abscess and epidural infection 
are frequently seen. Reactive sclerosis, vertebral body collapse, gibbous deformity and 
vertebral body fusion are findings of advanced cases. The incidence of TB meningitis 
with meningeal enhancement, adhesions, loculations and TB myelitis with focal cord 
swelling, edema, nodular lesions are low. Despite the advent of advanced diagnostic 
technology, neither clinical examination nor radiological findings may be reliable in 
differentiating atypical forms of spinal TB from other infections or from neoplasms. 
Generally, longer treatment with expensive drugs, with or without percutaneous spinal 
interventional procedures or surgical interventions, is required. 
Learning Objectives:
1. To review different forms of spinal infection.
2. To understand pathophysiology and imaging features of tuberculous 
spondylodiscitis.
3. To know about imaging findings in leptomeningeal and intramedullary 
infections.
16:00 - 17:30 Room C 
Special Focus Session 
SF 10a 
New insights in breast imaging 
Moderator:
E. Azavedo; Stockholm/SE 
A‑227 16:00 
Chairman’s introduction 
E. Azavedo; Stockholm/SE (edward.azavedo@ki.se) 
This Special Focus session will bring to you updated information in the field of breast 
imaging. During the last few decades, breast imaging has been the single most important 
contributor to decrease in breast cancer mortality. This, in turn, has been much due 
to our increased knowledge of image interpretation but also due to the tremendous 
improvements in the technology of breast imaging. In this session, we will learn about 
most of the new developments in the field of breast ultrasound, nuclear medicine, 
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physics behind the new technology etc. Each of the presenters will provide a thorough 
insight in their fields of expertise and time will be made available to discuss things that 
need clarification. We look forward to welcome you all to get an updated information 
about radiological information that could directly be implied in your clinical services. 
Session Objectives:
1. To update knowledge of new technologies.
2. To understand the physics and radiation dose of the new methods.
3. To understand the possible role of new techniques in clinical practice.
A‑228 16:05 
Tomosynthesis in breast imaging: Tomorrow’s mammography? 
K.C. Young; Guildford/UK (ken.young@nhs.net) 
The introduction of high quality digital full-field detectors for mammography has 
facilitated the development of digital breast tomosynthesis (DBT). Currently, a num-
ber of manufacturers have DBT systems either available for purchase or in clinical 
evaluation. However, there are significant variations in the approach adopted by each 
manufacturer. This presentation will review the underlying physics of tomosynthesis 
as well as discussing the differences between the approaches favoured by different 
manufacturers. A method of extending the current European dosimetry protocol 
for mammography to include DBT systems will be described and the current dose 
levels for DBT systems reviewed. While there is evidence that DBT may improve 
the detection of breast lesions, and particularly masses, some unresolved ques-
tions about how to use this new technology are discussed. These include whether 
DBT can replace 2D imaging or whether both are a needed. Does one still need 
two views with DBT? Is a narrow or wide tomo angle preferable? Are movement 
artefacts a significant problem? Is micro-calcification detection adequate in DBT? 
Learning Objectives:
1. To understand the physics of the method.
2. To appreciate its capabilities and limitations.
3. To learn about the radiation dose levels.
4. To become familiar with image interpretation.
A‑229 16:28 
Advances in breast ultrasound 
T.J. Popiela; Krakow/PL (msjpopie@cyf‑kr.edu.pl) 
Breast ultrasound (US) is a diagnostic tool complementary to mammography that 
increases the detection of malignant breast lesions. B-mode US is a method of choice 
for differentiating solid from cystic lesions. To make the examination more objective, 
the set of individual sonographic features used for US breast diagnosis together with 
US-BIRADS lexicon were implemented. Recent results of computer-aided diagnosis 
(CAD) are encouraging even though they can be used only to static images. Real-time 
compound imaging is the best technique for evaluation of the margin and internal 
echotexture of nodules, while tissue harmonic imaging has a significant role in the vi-
sualization of a lesion against a fatty background. Both techniques are complementary 
to B-mode imaging. To reliably evaluate tumor vascularization, a Doppler technique 
was implemented into breast US. Contrast agents with microbubbles used with this 
technique enhance signal from tumoral vessels in breast lesions. It helps to evalu-
ate benign and malignant breast masses and tumor response especially in patients 
receiving neoadjuvant chemotherapy. Three-dimensional real time US allows more 
reliable evaluation of breast lesion than standard 2D mode. It accurately assesses 
contours and interaction with surrounding tissue. It is helpful in guiding the biopsy 
needle, especially in small-size lesion. Breast cancer tissue is harder than surrounding 
healthy stroma, and this criterion is used in the analysis of US elasticity images that 
consist mainly of an image of strain in response to force. Breast mass elastography 
is another method with potential for enhancing the specificity of US cancer detection. 
Learning Objectives:
1. To be informed of the latest innovations including elastography, 3D and 
contrast enhanced US.
2. To understand how high resolution and “functional” US impacts on clinical 
practice.
3. To learn techniques that may improve users skill.
A‑230 16:51 
Breast specific gamma imaging: A novel, physiologic approach to breast 
cancer diagnosis 
R.F. Brem; Washington, DC/US (rbrem@mfa.gwu.edu) 
Breast specific gamma imaging is a novel, physiologic approach to molecular 
imaging of the breast which uses Tc sestamibi and a dedicated high resolution 
breast specific gamma camera for the diagnosis of breast cancer. This discussion 
will discuss the scientific basis for breast specific gamma imaging and will review 
the literature regarding the use of breast specific gamma imaging. Comparison of 
breast specific gamma imaging to other physiologic approaches to breast imag-
ing including MRI will be discussed. Approaches to integration of breast specific 
gamma imaging in clinical practice as well as proper use in clinical practice will 
be reviewed. Finally, ongoing research and developments using breast specific 
gamma imaging will be discussed including dedicated gamma guided minimally 
invasive breast biopsy. 
Learning Objectives:
1. To understand a new scintimammography method.
2. To learn to appreciate diagnostic information.
3. To learn about its position in relation to competing methods.
4. To learn about its possibilities and limitations.
Panel discussion:  
How should we integrate modern technology into our clinical diagnostic 
routines 17:14 
16:00 - 17:30 Room D 
Imaging in Lung Diseases 
CC 1018 
Beyond morphological analysis of lung tumors 
Moderator:
C. Beigelman; Paris/FR 
A‑231 16:00 
A. New therapeutic horizons: What do radiologists need to know? 
E.F. Patz, Jr.; Durham, NC/US (patz0002@mc.duke.edu) 
Radiology plays a fundamental role in every aspect of clinical oncology. Imaging 
tumors provides invaluable information in establishing a diagnosis and directing 
patient management. It is also used to suggest appropriate treatment, determine 
prognosis, assess disease status following therapy, and guide interventional 
procedures. The conventional imaging appearance of lung cancer has been well 
described, but does not correlate with the ultimate phenotype. Lung cancer cells 
result from abnormal genes, which generate a complex host response. This creates 
a primary mass consisting of a spectrum of cells including tumor cells, inflammatory 
cells, fibroblasts, macrophage, and hematopoietic progenitor cells. Therefore, if di-
agnostic imaging is to reflect tumor biology it must learn to incorporate fundamental 
molecular properties of the disease and move beyond traditional anatomic and 
morphologic descriptions. The genesis of a molecular imaging initiative occurred 
in the early 1990s, with the use of positron emission tomography (PET) imaging 
and the glucose analog probe, 18 F 2-fluoro-2-deoxy-D-glucose (FDG). FDG-PET 
imaging has become one of the most important tools to evaluate cancer patients. 
As a move toward molecular imaging continues, the development of new targets, 
techniques, and tumor-specific imaging probes should provide more accurate di-
agnostic information. In the future, imaging may be able to address many current, 
unresolved diagnostic issues in oncology. Imaging studies that elucidate basic 
molecular events would increase our understanding of malignancies, and ultimately 
influence clinical practice and outcomes. 
Learning Objectives:
1. To understand fundamental limitations in anatomical/morphological imaging 
of tumors.
2. To describe biological features of lung tumors.
3. To describe new approaches to imaging lung tumors.
A‑232 16:30 
B. Tumoral angiogenesis with CT 
N. Tacelli; Lille/FR (n‑tacelli@chru‑lille.fr) 
Highly vascularised tumours have been shown to be associated with a poor out-
come for many types of cancers, including lung carcinomas. In this latter group, 
the prognosis remains poor with a 5-year survival rate of only 15%. The necessity 
for new approaches in the assessment of this type of cancer has triggered major 
interest in biologic parameters among which angiogenesis factors that are known 
to play an important role in the process of tumor growth and metastasis dissemina-
tion. An in-vivo marker of angiogenesis, obtained through non-invasive imaging, 
can provide an independent indicator of prognosis, enabling risk stratification for 
patients with cancer. Following the advent of fast scanning technology, there has 
been a resurgence of interest in tumour perfusion analysis with CT, initially focused 
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examinations over a limited volume-of-interest. However, tumour vasculature exhibits 
both spatial and temporal heterogeneity that does not make perfusion assessment 
straightforward. Recent technological advances of perfusion analysis now allow 
quantifying spatial changes in blood flow but also in capillary permeability throughout 
the entire tumour height. The purpose of this lecture is to review the new trends in 
evaluating tumoral perfusion and to investigate the potential of functional MDCT 
technology to monitor the efficacy of newly introduced antiangiogenesis drugs. 
Learning Objectives:
1. To describe the CT parameters that enable characterisation of tumoral 
angiogenesis.
2. To learn about the current results of tumoral angiogenesis assessment with MDCT.
3. To describe the clinical impact of this novel evaluation of oncologic patients.
A‑233 17:00 
C. Nuclear imaging 
N. Howarth; Chêne‑Bougeries/CH (nigel.howarth@grangettes.ch) 
Integrated PET/CT imaging has an established role in the management of cancer 
patients and is now recommended for all patients with curative non-small cell 
lung cancer. PET/CT provides information essential for staging and prognosis, 
for choice of management and monitoring of treatment and for the detection of 
recurrence. Recent technical developments in PET/CT permit rapid examinations 
with improved resolution. Compared with standard CT or stand-alone PET, the 
added value of fused imaging is uncontested. The clinical influence of preoperative 
PET/CT is currently undergoing extensive evaluation. Radiologists should benefit 
from an understanding of important aspects of molecular imaging to improve their 
contribution to patient management. With the increasing use of PET/CT in the 
management of cancer patients, imaging pitfalls must be recognized to avoid both 
false-positive and false-negative interpretation. The principles and good practices 
of PET/CT will be explained. Normal distribution of FDG, pitfalls and normal vari-
ants will be presented. Specific examples will be discussed to demonstrate how 
the combined information of images of human anatomy upon which biological 
information within body structures is added improves delineation of disease, can 
guide surgical and radiation planning and biopsy. Advances in technology result in 
new training requirements for radiologists who should promote close collaboration 
with nuclear medicine specialists. 
Learning Objectives:
1. To understand how the combination of functional and morphologic data 
provides added value, helping patient management.
2. To learn the common pitfalls in PET/CT interpretation of lung cancer.
3. To emphasise the importance of a strong collaboration between nuclear 
medicine specialists and radiologists.
16:00 - 17:30 Room E1 
Musculoskeletal 
RC 1010 
Hip through the ages 
Moderator:
M. Padrón; Madrid/ES 
A‑234 16:00 
A. The pediatric hip 
D.J. Wilson; Oxford/UK (david.wilson@noc.anglox.nhs.uk) 
Depending on the age of the child, hip symptoms may predict a variety of diseases. 
In the infant, developmental dysplasia and infection should be considered. After 
the age of 4, irritable hip most commonly due to transient synovitis is the common-
est disease but infection is the more worrying condition. Perthes disease affects 
some and this condition overlaps into those over 8 who may have a slipped upper 
femoral epiphysis. Fractures and rare cases of osteonecrosis and chondrolysis are 
a concern in the adolescent. In the young and indeed in most cases, ultrasound 
provides a useful first line test. Aspiration of effusion may be both diagnostic and 
therapeutic. In the older child and, especially when SUFE is a risk, conventional 
radiographs with an external rotated “frog leg” view is very important. Despite 
the logistics problems in children, there is an important role for MRI especially in 
cases where the initial imaging does not explain the symptoms. I will review the 
imaging pathways and provide examples of common diseases. I will also discuss 
how to manage the difficult case and show recent audit data on detection rates 
and clinical management. 
Learning Objectives:
1. To understand the age-specific diseases of the hip in children.
2. To appreciate the strengths and weaknesses of each imaging method.
3. To understand how imaging is used in the management of children’s hip 
problems.
A‑235 16:30 
B. The hip in the young athlete 
C.W.A. Pfirrmann; Zurich/CH 
Femoroacetabular impingement (FAI) is a common condition in the young athlete. 
FAI refers to a conflict between the proximal femur and the acetabulum. Both an 
abnormal shape of the proximal femur (FAI of the „Cam-Type“: Aspheric femoral 
head and/or a waist deficiency of the femoral neck) and the acetabulum (FAI of 
the „Pincer-Type“: Acetabular retroversion or a deep acetabulum) or a combination 
of the two may be present. For a long period, the FAI may be asymptomatic and 
the only clinical finding will be an impaired internal rotation of the hip joint. Later 
cartilage damage (outside-in abrasion of acetabular cartilage/delamination) and 
labral tears occur. Labral tears are most common in the anterosuperior aspect of 
the acetabulum. Anatomic variants like a sulcus may be present and should be 
distinguished from tears. A sulcus is common at the junction of the labrum with the 
transverse ligament and is generally located beyond the equator of the hip joint. 
Insufficiency fractures about the hip commonly occur in the region of the femoral 
neck. Another site vulnerable to overuse is the symphysis pubis. Often, a bone 
marrow edema pattern around the symphysis pubis is observed. This reflects the 
stress reaction of bone. Injury to tendon attachments in the young athlete occurs 
frequently about the adductor tendons. A characteristic finding is the „secondary 
cleft sign“, which reflects a partial tear of the adductor tendon aponeurosis. Injury 
to other tendon attachments such as the abductor tendons may occur, but tend 
to be less common. 
Learning Objectives:
1. To understand the mechanisms of injury of the hip.
2. To recognise the imaging pattern of abnormalities of the hip.
3. To become familiar with femoroacetabular impingement.
4. To learn about the typical injuries to tendon attachments around the hip.
A‑236 17:00 
C. The ageing hip 
A.H. Karantanas; Iraklion/GR (akarantanas@gmail.com) 
Understanding age-related changes is essential for interpretation of imaging stud-
ies. Age is a risk factor strongly correlated with osteoarthritis (OA), which is the 
most common hip joint disease seen in adults. The diagnosis of OA is based on 
a combination of radiographic findings and characteristic subjective symptoms. 
The lack of a radiographic consensus definition has resulted in a variation of the 
published incidences and prevalence of OA. The progression of OA traditionally 
has been measured using radiographic joint space width (JSW). Weight-bearing 
radiographs centered on the hip are the most reproducible and reliable ones. The 
sequence of degeneration includes the following radiographic findings: joint space 
narrowing, osteophyte formation, subchondral sclerosis, and cyst formation. Cur-
rent definitions of radiological OA based on reduced JSW and osteophytes display 
predictive validity for clinical hip OA. Radiographs are also useful for assessing 
developmental dysplasia and other congenital disorders which may lead to early 
OA. There are cases though that radiographs show minor changes and the clini-
cal suspicion of early disease can be confirmed with more sophisticated imaging 
methods, such as CT and MRI. CT is helpful for additional measurements such as 
femoral and acetabular abnormal version which might lead to OA. Femoroacetabular 
impingement has been shown to cause labral and chondral lesions and leads to 
OA. Prompt recognition of abnormal head-neck junction on radiographs enables 
proper conservative or surgical treatment planning. MR arthrography is the method 
of choice for assessing the labra whereas CT arthrography might be used as an 
alternative for articular cartilage assessment. 
Learning Objectives:
1. To become familiar with the radiographic assessment of the ageing hip.
2. To discuss the MRI findings of degenerative hip disease.
3. To review the various disorders which predispose for early osteoarthritis.
4. To recognise the advantages and disadvantages of CT and MR arthrography 
of the ageing hip.
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16:00 - 17:30 Room E2 
Extremity Joint MRI 
MC 1025 
Lower extremity: Anatomy, variants and pitfalls 
Moderator:
M. Shahabpour; Brussels/BE 
A‑237 16:00 
A. Hip 
E. Llopis; Valencia/ES (ellopis@hospital‑ribera.com) 
Hip joint is designed for stability, supports the body weight and shifts mechanical loads 
during ambulation and activity to the lower extremities. Surrounded structures of the 
hip can be divided into static and dynamic and help to stability. The hip capsule, labrum 
and ligament, and primary iliofemoral ligament act as static stabilizers. The dynamic 
stabilizers are the surrounding muscles and their tendinous attachments, with the most 
significant group being the abductors. Hip musculature can be divided by anatomic 
location, quadrants (anterior, lateral, and posterior) or by functional groups (flexors, 
abductors, external rotators, and adductors). The hip has a ball and socket configu-
ration, where the sphere of the femoral head moves free in the round cavity of the 
acetabulum. When there is abnormal contact between the femur and the acetabulum, 
premature degenerative changes might develop. There are some anatomic normal 
structures that should not be confused with injuries, the acetabular notch, transverse 
ligament, ligament teres normal variants of the labrum absence or partial deficiency 
of the labrum, normal perilabral recess between the attachment of the capsule and 
the labrum and sublabral sulcus. Also, communication between the joint and ileopsoas 
bursa or less frequently to the obturador bursa is present in a small percentage of the 
normal population. However, there are other anatomical variants that have increased 
incidence on symptomatic patients or early degenerative disease, such as cystic 
changes in the femoral neck, os acetabuli or inverted labrum; these findings should 
be carefully correlated with other injuries and with patient’s symptoms. 
Learning Objectives:
1. To describe normal hip anatomy, bone, labral, and musculotendinous 
structures.
2. To understand pelvis alignment and basic hip biomechanics.
3. To provide helpful clues to distinguish pitfalls from pathological conditions.
4. To review normal anatomy variants and their relationships with symptoms 
and syndromes: Causes or consequences?
A‑238 16:30 
B. Knee 
B. Vande Berg; Brussels/BE (bruno.vandeberg@uclouvain.be) 
Knee MR imaging represents an everyday challenge to many radiologists: What is the 
importance of MR imaging in patient management? How can we avoid false positive 
diagnoses? How can we optimise lesion characterization? This lecture will focus on 
normal anatomy of the meniscus and on variants that may simulate surgical lesions. 
The importance of displaced meniscal fragment will be demonstrated and several le-
sions that may mimic fragments will be displayed. Common ligament variant will also be 
described. We will also provide in-depth analysis of incidental bone and marrow changes 
frequently observed on knee MR images (red marrow hyperplasia, bone islands, en-
chondroma); although they have less diagnostic importance, over-diagnosis may cause 
unnecessary anxiety to the patients. Finally, we will demonstrate the venous anatomy 
of the knee with implications on knee imaging. We will not describe muscle variants. 
Learning Objectives:
1. To provide an overview of the anatomy of the meniscus and ligaments with 
emphasis on variants that may simulate lesions.
2. To provide in-depth analysis of incidental bone and marrow changes 
frequently observed in knee MR images.
3. To demonstrate the venous anatomy of the knee with implications for knee 
imaging.
A‑239 17:00 
C. Foot and ankle 
N. Saupe; Zurich/CH (nadja.saupe@balgrist.ch) 
The purpose of this talk is to highlight anatomical variants of foot and ankle in the 
asymptomatic population as well as borderlands of normal and early pathological 
findings and also to discuss technical pitfalls in magnetic resonance imaging of foot 
and ankle. Special attention should be drawn to the complex ligament anatomy of 
the medial collateral ligaments (superficial tibionavicular ligament, tibiospring liga-
ment, tibicalcaneal ligament and the deep anterior and posterior tibiotalar ligaments) 
and the tendon insertion of anterior and posterior tibial tendons. Technical pitfalls 
such as the influence of foot positioning on prevalence of the magic angle artifact 
(MAE) in ankle tendons and inhomogeneous fat suppression will be discussed. Ad-
ditionally, various features of anatomic variants that are potentially associated with 
peroneal tendon disorders such as peroneus quartus muscle, low lying peroneus 
brevis muscle belly, size of peroneal tubercle and size of retrotrochlear eminentia 
as well as the shape of the fibular groove will be explained. The prevalence, pattern 
and size of bone marrow changes on short-tau inversion recovery (STIR) magnetic 
resonance images in asymptomatic feet and ankles such as cysts just inferior to the 
angle of Gissane and tiny bone marrow spots (vascular remnants) will be highlighted 
as well as plantar fat pad (PFP) signal intensity alterations under the metatarsal 
heads and their histological correspondence to fibrosis and adventitious bursae. 
This knowledge should prevent inaccurate interpretations and prevent unnecessary 
diagnostic work-up and treatment. 
Learning Objectives:
1. To become familiar with the anatomy of foot and ankle.
2. To know the prevalence of anatomic variants that can be associated with 
pathologic conditions in the foot and ankle.
3. To understand the influence of foot positioning on prevalence and site of the 
magic angle effect in ankle tendons.
16:00 - 17:30 Room F1 
Genitourinary 
RC 1007 
Kidney: Imaging and intervention 
Moderator:
R. Stern Padovan; Zagreb/HR 
A‑240 16:00 
A. Angiomyolipoma: A review 
N. Grenier; Bordeaux/FR (nicolas.grenier@chu‑bordeaux.fr) 
Angiomyolipomas (AML) are benign tumors derived from the perivascular epithelioid 
cell (PEC) characterized at pathological examination by expression of melanocytic 
marker HBM-45. They contain various proportions of the three components: vascular, 
fatty and muscular. An epithelioïd variant with a malignant potential is exceptional. 
80% are sporadic and 20% integrated to tuberous sclerosis. The association with a 
lymphangioleiomyomatosis is always possible: chest CT will be performed in TS and 
sporadic AML if large or associated with respiratory troubles. Characterization of AML is 
possible, based on identification of its fatty content mainly using CT. When microscopic, 
this component may be missed and biopsy is required with immunostaining. MR imag-
ing may be helpful using chemical-shift sequences but thresholds, to rule-out clear cell 
carcinoma, have to be better defined. Presence of necrosis or calcifications rules-out 
diagnosis of AML. AMLs must be treated if hemorrhagic, painful or if diameter exceeds 
4 cm. Embolization is the main nonsurgical method, using microparticles, alcool and/or 
coils but postembolization syndrome must be prevented. Volume regression may require 
all agents whereas aneurysm occlusion requires coiling. The effect on volume and on 
hemorrhagic risk is substantial making surgery as an alternative method for nephron 
sparing purposes. Secondary surgery is required in less than 10% of embolization. 
RF ablation is also possible but its efficacy is still under evaluation. 
Learning Objectives:
1. To learn the high frequency of angiomyolipoma, and the possibility of 
complication.
2. To review the imaging appearance of typical and atypical angiomyolipoma.
3. To understand the higher incidence of angiomyolipoma in certain 
phakomatoses.
4. To learn about the possibilities of intervention and to discuss the indications 
and results.
A‑241 16:30 
B. The (not so) rare malignant tumors of the kidney 
P. Hallscheidt; Heidelberg/DE (Peter.Hallscheidt@med.uni‑heidelberg.de) 
Caused by the hugh amount of ultrasound studies, by CT and MR scans many renal 
tumors are detected without symptoms. The radiologist has the duty to differentiate 
renal lesion and to diagnose malign tumours in adults and children. Modern imaging 
modalities like CT and MRI have the capability to differentiate renal tumours because 
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carcinoma, complex cysts, metastasis of other malignomas and lymphomas of the 
kidneys have to be differentiated. Whereas CT has very high spatial resolution and 
the capability to detect calcifications, MRI with its high soft tissue contrast showed 
to be superior in detection of complex cysts and delineation of tumor thrombus. 
The most common and not so common renal tumours are demonstrated and typi-
cal findings are discussed. 
Learning Objectives:
1. To review the malignant tumors of the kidney beyond renal cell carcinoma: 
Bellini duct carcinoma, chromophobe renal cell carcinoma, lymphoma, 
sarcoma, renal medullary carcinoma and metastases.
2. To learn how imaging can provide some clues for the diagnosis.
A‑242 17:00 
C. Radiofrequency and cryotherapy of renal tumors: Techniques, results 
and complications 
J.-M. Correas, M.-O. Timsit, A. Méjean, O. Hélénon; Paris/FR
(jean‑michel.correas@nck.aphp.fr) 
Conservative treatment is increasingly used for the treatment of small renal tumours 
in order to limit the renal function deterioration. The surgical procedure remains 
standard but minimally invasive therapy has been developed particularly for pa-
tients with multiple comorbidity factors (including age), hereditary renal cancer, 
chronic renal failure, and solitary functioning kidney. Multiple techniques can be 
applied including radiofrequency ablation, cryotherapy, microwave ablation and 
high-intensity focused ultrasound. Renal tumour ablation is facing some specific 
issues compared to the liver tumour ablation due to the high blood flow of both 
renal lesion and normal parenchyma, the limited amount of normal parenchyma for 
both preservation of the renal function and for the stabilization of the electrodes, 
and the sensitivity to heat of the collecting tubes in the renal sinus. The tumor size 
(over 4 cm) and the central position of the renal tumor seem to be the major limiting 
factors. The principles, indications and results of each technique will be discussed. 
Learning Objectives:
1. To learn the technique and results of radiofrequency ablation of renal tumors.
2. To learn principles, indications and results of cryotherapy, microwave ablation 
and high-intensity focused US (HIFU).
16:00 - 17:30 Room F2 
Special Focus Session 
SF 10b 
Breast cancer: How to evaluate response to 
treatment
Moderator:
T.H. Helbich; Vienna/AT 
A‑243 16:00 
Chairman’s introduction 
T.H. Helbich; Vienna/AT (Thomas.Helbich@meduniwien.ac.at) 
Neoadjuvant treatment has become a standard of care in locally advanced as well 
as in operable breast cancer. Response rates are high. There is, however, a lack 
of information on which modality is the best to evaluate response to treatment. 
Several modalities are offered such as imaging, blood probes, biological markers 
or a combination of all. The goal of this session is to discuss the value of imag-
ing techniques like mammography, ultrasound, MRI, PET and other non imaging 
modalities, which evaluate response to treatment in breast cancer. Participants 
will learn to apply these different modalities; in addition, they will get an overview 
about limitations as well as success rate with respect to the response rates during 
neoadjuvant treatment. We look forward to welcome you all to get updated informa-
tion, which could directly be implied in your clinical services. 
Session Objectives:
1. To give a basic understanding of how breast cancer responds to treatment.
2. To explain how to evaluate response to treatment from an oncologic/surgical 
perspective.
3. To show how response to treatment is assessed with imaging techniques.
A‑244 16:03 
From genes to surgical outcome 
M. Gnant; Vienna/AT (michael.gnant@meduniwien.ac.at) 
Surgical strategy in breast cancer treatment greatly depends on tumor size, patient’s 
anatomy, and breast tumor biology. Neoadjuvant treatment has become in standard 
of care in locally advanced cancer, but also in operable breast cancer where breast 
conservation may not be achievable without oncological or cosmetic compromises. 
Pre-treatment confirmation of malignancy is mandatory. Response rates are high, 
and overall response rates are usually reported between 60 and 90%. Complete 
pathological remission is optimal, and occurs between 3 and 60% of cases, greatly 
depending on tumor biology. Multimodality approaches require intense interaction 
between surgeons and diagnostic specialists. Both planning as well as definitive 
surgical strategy depend heavily on accurate response monitoring and assessment 
as well as localisation procedures. Breast conservation rates of 90% and more can 
be achieved in experienced interdisciplinary teams. 
Learning Objectives:
1. To stress the multidisciplinary approach to therapy.
2. To report the response rate to neoadjuvant therapy.
3. To demonstrate whether surgical strategy is affected by radiological 
monitoring of neoadjuvant treatment.
A‑245 16:21 
Mammography and ultrasound 
S. Delorme; Heidelberg/DE (s.delorme@dkfz‑heidelberg.de) 
Ultrasound and mammography are frequently used tools to follow-up breast cancer 
during neo-adjuvant chemotherapy. Although non-invasive and cost-effective, the 
results obtained with either method must be viewed with caution for several reasons: 
• Since necrotic cell death, rather than apoptosis, is the predominant mechanism
of tumour response, an early shrinkage of a lesion is unlikely, even in responders. 
Furthermore, persistent stroma may be difficult to discriminate from vital tumour. 
This is of particular concern with mammography, since the stromal reaction, which 
is often marked, contributes greatly to the imaging features of breast cancer. 
• Ultrasound is examiner-dependent and so are all measurements. Even with a
single examiner, the probe position may be impossible to be exactly reproduced. 
• With most probes being approximately 5 cm long, large or multicentric tumours
may be difficult to measure in toto. • After a tumour has partially responded to
chemotherapy, its overall size may be underestimated if isolated, small residual 
islets or intraductal components at its extremes are missed. Its size may be over-
estimated due to inflammatory changes or persistent stromal components. • In
studies comparing ultrasound, X-ray mammography, and contrast-enhanced MRI 
with the results of the histopathological workup, the sizes measured on MRI scans 
were best correlated with the diameter of the pathologic specimen. In summary, 
ultrasound or mammography may be used to identify early those patients whose 
disease progresses despite treatment, but for planning of breast-conserving surgery, 
an additional contrast-enhanced MRI should be considered. 
Learning Objectives:
1. To recognise treatment-induced changes.
2. To recognise the limitations of each method in assessing treatment 
response.
3. To understand the predictive value of US and mammography for the 
response to treatment.
A‑246 16:39 
MRI and more 
F. Sardanelli; Milan/IT (f.sardanelli@grupposandonato.it) 
A PubMed/Medline search found 59 original articles published from 06/1996 to 
06/2009 reporting MRI in the neoadjuvant chemotherapy (NAC) setting in 2,355 
patients. Of 40 studies (1,513 patients) on prediction of pathological response, 
36 (1,385 patients) concluded in favor of MRI with a good-to-excellent correlation 
between size of residual disease (RD) at MRI and pathology (r=0.65-0.98). However, 
MRI underestimation/overestimation of RD and false negatives were highlighted. 
Patients with mass lesions presenting concentric shrinkage are good candidates to 
conserving surgery while multifocal/multicentric cancers or unique masses present-
ing dendritic shrinkage or fragmentation should undergo mastectomy. For non-mass 
lesions, the probability of underestimating RD is higher than for mass-lesions. NAC 
type should be considered: RD was frequently underestimated in patients treated 
with taxanes and in HER-2 negative patients treated with bevacizumab. MRI early 
prediction of treatment efficacy was reported by studies resting on MRI volumetric 
changes and/or kinetic analysis. Importantly, initial experience was retrospectively 
described that when NAC is switched if the reduction in the largest diameter is 
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< 25% at MRI, > 70% of nonresponders show a favorable clinical response, increas-
ing the rate of conserving surgery. MRI is cost-effective if an early shift from an 
ineffective to a more effective NAC has a measurable benefit in the cure rate. MRI 
was also shown to predict disease-free and/or overall survival. Initial but promising 
results were shown using proton MR spectroscopy or diffusion weighted imaging. 
The ultimate benefit on survival in patients monitored with breast MRI in the NAC 
setting is not yet established. 
Learning Objectives:
1. To demonstrate the potential of CE-MRI for evaluating response to treatment.
2. To understand the predictive value of CE-MRI for the response to treatment.
3. To introduce non-contrast MR techniques for evaluating response to 
treatment: DWI and spectroscopy.
A‑247 16:57 
PET, PET/CT and more 
B. Sharma; Sutton/UK (bhuey.sharma@rmh.nhs.uk) 
Anatomical techniques including CT and MRI, together with bone scan are gener-
ally used for breast cancer metastatic disease evaluation and treatment response 
assessment. Functional imaging, particularly PET/CT, is a powerful modality in 
breast cancer, indeed being useful for early response evaluation, prognostication, 
response assessment at ‘difficult to image sites’ and bone response. This talk will 
detail the strengths and weaknesses of 18 FDG PET/CT compared with all other 
conventional and new (including MRI Diffusion) imaging techniques with regard to 
assessing all different body systems/organs. Bone response is an especially dif-
ficult and exciting area for functional imaging techniques; SUV analysis will also be 
discussed as will the relative sensitivities of PET compared to other techniques - this 
being an important aspect for clinicians to understand. Hormone, chemotherapy, 
radiotherapy, the new entities of both ‘pre and post liver Radiofrequency Ablation’ 
and ‘intracranial Gamma Knife’ response evaluation will all be discussed, with 
practical guidance regarding appropriate imaging in patients in order to enable 
optimal patient management. PET/CT providing patient prognostication regarding 
treatment regimens will be detailed. The use of novel targeted radiotracers, such 
as ER PET imaging, will also be addressed. 
Learning Objectives:
1. To understand the role of PET/CT relative to other modalities in staging 
primary and metastatic breast cancer.
2. To show the role of PET/CT in response evaluation (hormone and other 
treatments).
3. To focus on the strengths and weaknesses of PET/CT or other techniques 
(such as MRI/PET or optical imaging).
Panel discussion:  
Can we still trust oncologists‘ fingers? 17:15 
16:00 - 17:30 Room G/H 
Neuro 
RC 1011 
Focal brain lesions 
Moderator:
J. Walecki; Warsaw/PL 
A‑248 16:00 
A. Differential diagnosis of T2 hyperintense lesions 
A. Rovira-Cañellas; Barcelona/ES (alex.rovira@idi‑cat.org) 
Focal white matter T2 hyperintense lesions (THL) are commonly observed MRI 
abnormalities not only in the elderly, but also in middle age and young patients. In 
addition to physiological ageing brain changes, a large list of different disorders 
should be considered in patients presenting with THLs such as hypoxic-ischemic 
vasculopathies (atherosclerotic and hypertensive small vessel disease, CADASIL, 
Fabry’s disease, Susac’s syndrome), multiple sclerosis and variants, primary and 
systemic vasculitis, sarcoidosis, adult forms of leukoencephalopathies (meta-
chromatic leukodystrophy, globoid cell leukodystrophy, adrenomyeloneuropathy, 
mitochondrial disorders, vanishing white matter, and cerebrotendinous xanthoma-
tosis), trauma and radiochemotherapy, and acquired metabolic conditions (hepatic 
encephalopathy, alcoholism), among others. While it is recognized that a combi-
nation of findings from clinical history, physical examination, and laboratory tests 
is commonly required to correctly establish a firm and clear etiological diagnosis 
of THLs, a detailed analysis of different MRI features should also be considered 
essential: e.g. lesions shape, size, and distribution; contrast-uptake; associated 
structural lesions (microbleeds, infarcts, spinal cord, brainstem and cerebellar 
involvement, large-vessel disease). In addition to these conventional MRI-based 
features, non-conventional MR techniques (diffusion, MR spectroscopy, perfusion) 
may also provide in some cases useful diagnostic information. Knowledge of these 
features will assist the diagnostic work-up of patients presenting with THLs, and 
should be considered a first step to take full advantage of the potential of MRI, and 
in doing so should result in a reduced chance of misdiagnoses and facilitate the 
correct diagnosis of sometimes treatable disorders. 
Learning Objectives:
1. To be aware of the limited specificity of brain multifocal T2 abnormalities.
2. To learn about recognition patterns that might be helpful in suggesting the 
most likely etiology of brain multifocal T2 lesions.
3. To learn about the role of spinal cord imaging and advanced neuroimaging 
techniques in the differential diagnosis of brain T2 hyperintense lesions.
4. To be able to establish a neuroimaging diagnostic strategy in patients with 
multiple brain T2 lesions of unknown origin.
A‑249 16:30 
B. Neoplasm or not? Decision making in focal mass lesions of the brain 
Z. Rumboldt; Charleston, SC/US (rumbolz@musc.edu) 
A variety of diseases including neoplasms, but also infectious, inflammatory, 
vascular and traumatic processes, may present as focal intracranial mass lesions. 
Modern neuroimaging, primarily with MRI, enables differentiation of these entities 
allowing for accurate diagnosis in almost all cases. The requirements are appropriate 
image acquisition and detailed analysis of imaging findings, while pertinent clini-
cal information may be very helpful in certain cases. The distinction is frequently 
broad, between different disease processes, such as with tumefactive demyelin-
ation versus neoplasm, which is often sufficient for clinical decision making and 
patient management; at times this may be more specific, approaching histological 
diagnosis, such as with pilocytic astrocytoma versus medulloblastoma. This presen-
tation will go briefly over the imaging techniques and various disease processes, 
while heavily concentrating on the differentiating imaging features and decision 
making process. Helpful clinical information will also be mentioned and emergent 
conditions stressed. The emphasis will be on the key distinguishing features, such 
as presence or absence of vasogenic edema, intra or extra axial location, signal 
intensity characteristics, presence and pattern of contrast enhancement, as well 
as diffusion and perfusion features. A number of cases with intracranial masses 
will then be reviewed and analyzed, using a step by step approach, accentuating 
the most reliable distinguishing findings. 
Learning Objectives:
1. To list various pathologic processes that present as focal brain masses.
2. To define the differentiating imaging and clinical features of those processes.
3. To recapitulate the role of imaging techniques for differentiation of brain 
mass lesions.
A‑250 17:00 
C. Adult glioma: Advanced neuroimaging for treatment planning 
C. Calli; Izmir/TR (cemcalli@superonline.com) 
The role of MR imaging in gliomas consists of many steps. 1. Is there a lesion in 
the brain? 2. Is the lesion a tumor? 3. Is the tumor a glioma? 4. Is it a high- or low-
grade glioma? 5. If there is a suspicion and a biopsy is planned, which part of the 
tumor should be targeted at biopsy? 6. How should the surgery be performed to 
avoid injury to functional areas of the brain (e.g., motor cortex)? 7. If there is need 
for adjunctive radiotherapy, how should the extent of the tumor be defined to be 
targeted for radiation? 8. After radiotherapy, if a new enhancing lesion occurs, is it 
a recurrent glioma or radiation necrosis? Conventional anatomical MR imaging is 
not always powerful enough to answer these questions. However, with advanced 
MR imaging techniques like diffusion MR (including tractography), perfusion MR, 
MR spectroscopy and functional MRI (fMRI), we can answer the above questions 
reliably in most cases. 
Learning Objectives:
1. To emphasise different treatment protocols for different types of adult 
gliomas.
2. To give brief information about the advanced neuroimaging techniques, 
which may aid further pre-operative characterisation of adult gliomas.
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16:00 - 17:30 Room I 
Physics in Radiology 
RC 1013 
High field MRI: Beyond 3 T 
Moderators: 
E. Atalar; Ankara/TR 
H. Köstler; Würzburg/DE 
A‑251 16:00 
A. Challenges of high field MR 
M. Bock; Heidelberg/DE (m.bock@dkfz.de) 
Over the recent years the clinical MRI field strengths have gradually been increased 
to 3 Tesla; however, whole body MRI systems with higher fields of up to 9.4 Tesla have 
become available in experimental settings. Compared to clinical field strengths, MRI at 
very high magnetic fields has several advantages but also some unique challenges. 
With increasing field strength, the signal-to-noise ratio increases, which can be used 
to either increase the spatial resolution in the images, or to acquire the images more 
rapidly. Unfortunately, the energy deposited in the human body via the RF excitation 
scales quadratically with the field strength. Thus, the specific absorption rate (SAR) 
is a critical factor in all rapid imaging protocols and requires the design of RF pulses 
with low SAR, (e.g. VERSE pulses). Inhomogeneities of the RF field which are induced 
by standing wave phenomena have to be compensated, and make the design of 
efficient spin echo pulse sequences very difficult. At higher field also, the field inho-
mogeneities become larger and stronger imaging gradients are required to overcome 
the susceptibility-induced image distortion. Stronger gradient systems are difficult to 
manufacture, and the usable gradient slew rate is limited by peripheral nerve stimulation 
thresholds. Furthermore, stronger and faster gradients become very loud at high fields, 
and special measures for sound protection are required. Despite these limitations, high 
field MRI offers image with very high resolution, it provides unique contrasts, a better 
spectral separation of the resonance lines and high signal for non-proton applications. 
Learning Objectives:
1. To explain how the increased field strength affects exposure and image 
quality characteristics.
2. To describe MR imaging protocols developed for ultra-high field MRI.
3. To become familiar with technology for specific absorption rate reduction.
A‑252 16:30 
B. A complicated solution to a complicated problem: Transmit array 
K.P. Pruessmann; Zurich/CH (pruessmann@biomed.ee.ethz.ch)
Clinical MRI usually aims to depict anatomic regions of interest with uniform 
coverage and contrast behavior. To this end it is essential to use suitably homo-
geneous radiofrequency (RF) magnetic fields for spin excitation, refocusing, and 
saturation. Traditionally, such uniform transmit fields are generated by volume 
resonators based on quasi-stationary electrodynamics, which, however, gradually 
cease to apply as clinical MRI explores high field strengths of 3T and beyond. The 
concomitant increase in operating frequency entails shorter RF wavelength and 
increasing tissue interactions, which render the tayloring of RF fields substantially 
more complex and patient-dependent. One promising response to this challenge 
is to depart from volume resonators and perform RF transmission by multiple, 
individually fed transmitter elements. With such transmit arrays the effective RF 
field can be taylored on a per-patient and per-scan basis by adjusting the relative 
magnitude and phase of driving the elements (RF shimming). In advanced imple-
mentations the phase and magnitude relations are even varied during RF pulses. 
In combination with equally dynamic gradient waveforms such fully individual 
control permits particularly fast spatially taylored RF pulses (Transmit SENSE). 
Array transmission entails a generalization of RF pulse design, for which a range 
of efficient mathematical mehods have been developed. One important challenge 
that remains, however, is the need to calibrate array transmitters in terms of the 
individual channels’ RF field contributions, both magnetic and electric. The latter, 
in particular, underlie power deposition in the tissue and hence need to be closely 
controlled to enforce strict SAR limits. 
Learning Objectives:
1. To learn about the need to control radio-frequency fields, particularly at high B0.
2. To understand the principles of doing so by multiple-channel transmission.
3. To get acquainted with the methods of obtaining uniform and tailored 
excitation within SAR limits.
A‑253 17:00 
C. Is 7T ready for clinical use? 
R.W. Bowtell; Nottingham/UK (richard.bowtell@nottingham.ac.uk) 
The availability of magnetic resonance (MR) scanners operating at 7T and above 
has already proved beneficial for MR imaging and spectroscopy of the human 
brain and promises similar benefits in the human body. These advantages result 
from the increases with the magnetic field of the intrinsic signal-to-noise ratio, 
blood oxygenation level dependent (BOLD) contrast, which forms the basis of 
the vast majority of functional MR imaging (MRI) experiments, and chemical shift 
dispersion. These gains can be exploited in improving the spatial and/or temporal 
resolution of anatomical and functional MRI experiments and in increasing the 
spectral resolution in volume selective spectroscopy or chemical shift imaging. 
Operation at the increased magnetic field also offers easier access to T2
*-contrast 
and improved implementation of susceptibility-weighted imaging (SWI) in which 
the phase of gradient echo images provides information about local variation of 
magnetic susceptibility. In the brain, such variation appears to be dominated by 
differences in iron concentration and myelin content, so that high-field SWI may 
provide useful information about the progression of neurodegenerative disease. 
The elevated T1- relaxation times at 7 T also offer benefits for arterial spin labelling 
and time of flight angiography. Current and potential future applications of high-field 
MRI in clinical and pre-clinical studies in a number of areas will be discussed in this 
presentation, along with the barriers to wider usage of 7 T systems in clinical studies. 
Learning Objectives:
1. To categorise the advantages that 7T provides for magnetic resonance 
imaging and spectroscopy.
2. To identify the areas of clinical application where 7T already offers significant 
benefits over lower fields.
3. To highlight the barriers to clinical usage of 7T.
4. To recognise the technical developments that will help to overcome these 
barriers and allow wider clinical usage of 7T.





K. Åhlström Riklund; Umeå/SE 
S. Braico; Rome/IT 
A‑254 16:00 
A. Lean project at OUH 
L. Tarp; Odense/DK (lene.tarp@ouh.regionsyddanmark.dk) 
Purpose: We will illuminate how lean can be used in a Department of Radiology 
and how we can optimize patient journey and decrease non-value-added waste with 
existing resources. The main goal is to create a high quality system by eliminate waste 
and increase patient safety and worker satisfaction in order to make a lean culture. 
The first goal is to comply with the department’s targets for waiting time for the patient 
journey within our whole working process. The second goal is to optimize the daily 
production to reduce the wasting time and waiting time for every patient journey. A 
third goal is to get the staff involved and make better working environment for them.
Methods and Materials: We have meetings in every team on a weekly basis to 
discuss measurement and development in the team. We made analysis of patient 
journey in every team and we made analysis of working - to reduce/eliminate waste 
and increase efficiency.
Results: 1. Optimization of patient journey; Waiting time can now be met on the examination. 
2. Optimization of production, better workflow gives organized and more efficient rooms. 
3. Working environment for staff, time for training and development of staff was found.
Conclusion: Creating a lean culture will increase production, improve the patient 
journey and make better working environment for staff. It will change the organiza-
tion by allowing the basis staff to get involved in organizing their part of the work 
within the team and also to put the focus on the patient’s expectation for service. 
Learning Objectives:
1. To learn about lean thinking and how lean tools can be used in a radiology 
department.
2. To understand how different lean tools can improve the patient journey.
3. To learn about improving the working environment for staff.
4. To understand how a lean culture can increase job satisfaction.
5. To understand the challenges of how to get people involved.
Postgraduate Educational Programme
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A‑255 16:45 
B. Lean project at the NHS Lothian Edinburgh 
L. Hudson; Edinburgh/UK (lorraine.hudson@luht.scot.nhs.uk) 
NHS Lothian required improvement in its capacity and capability by significant 
service redesign. A Lean programme was implemented in 2006.The initial project 
was to reduce CT waiting times for cancer patients. The CT service consisted of 6 
scanners spread across 4 sites in Lothian. Each department worked as a stand-
alone service with little collaboration. Administration processes and waiting times 
varied in each department. The longest wait for an appointment was 21 weeks. 
A large, multidisciplinary staff group worked together during a ‘Kaizen’ (Japanese 
for change for the better) week. A two month period of intense preparatory work 
gathering information and data from key staff was necessary prior to the event. Good 
communication with staff was essential through introductory meetings to alleviate 
fears and suspicion of change. Work practices were analysed through process 
mapping with an aim to reduce waste and increase value for patients and staff. 
Referral pathways were streamlined, reducing delays and inappropriate referrals. 
Information was improved increasing the effectiveness of patient understanding of 
examination procedure and preparation. Waiting lists were pooled across Lothian 
with agreed protocols and scheduling. At the end of the Kaizen week, the booking 
turnaround time was reduced from 31 days to 24 hrs and the maximum waiting 
time reduced from 21 to 6 weeks, the average being 2-3 weeks. The commitment 
of time and support from senior management empowered staff to take ownership 
of the service they provided. Staff identified areas for improvement and found their 
own solutions, achieving dramatic and sustained benefits for patients. 
Learning Objectives:
1. To learn how we identified diverse practices across the 4 CT sites within 
Lothian.
2. To gain knowledge on how we improved waiting times, communication and 
identified and removed waste in our systems by using 5 Sigma, Kaizen, and 
Work Out.
3. To understand the obstacles to the implementation of change due to diverse 
personalities and processes across our radiology departments.
4. To appreciate the importance of communication and support of our Health 
Board and Executive management team and the requirement to involve the 
whole multidisciplinary team.
16:00 - 17:30 Room N/O 




C. Czerny; Vienna/AT 
A‑256 16:00 
A. Neck spaces: What you need to know 
S. Bisdas; Tübingen/DE (sotirios.bisdas@med.uni‑tuebingen.de) 
The rational analysis of the masses and pathologies arising in the suprahyoidal 
neck necessitates an exact localization. There is a certain overlap, sometimes 
resulting in confusion, between the anatomical and surgical borders and defini-
tions of the neck spaces. It is necessary for the clinical radiologist to elucidate the 
complex anatomical relationships from a radiological point of view and to present 
the critical contents of each space. Thus, a space-orientated differential diagnosis 
may be facilitated. According to the localization and the typical CT and MR imaging 
appearance of various lesions, the differential diagnosis may be narrowed down 
to specific pathologies. Common pathologies in the vicinity of the critical contents 
as well as pathologies extending beyond one anatomical space are also of major 
interest for the radiologist and crucial for the patient‘s treatment. Therefore, CT and 
MR surveys should be meticulously read for such imaging findings. 
Learning Objectives:
1. To identify the CT and MR imaging landmarks of the suprahyoid neck 
spaces.
2. To identify the common diseases and their typical appearance in each 
suprahyoid neck space.
3. To use the neck spaces as a basis for differential diagnosis in the suprahyoid 
neck.
A‑257 16:30 
B. How to ruin or improve your head and neck study 
V. Chong; Singapore/SG (dnrcfhv@nus.edu.sg) 
The anatomy of the suprahyoid neck is complex and the spectrum of diseases 
is wide. To improve studies of the neck, radiologists should become increasingly 
more familiar with the anatomy and expected pathology in the various spaces. 
This familiarity provides crucial information required for the selection of treatment 
options and therapeutic planning. In addition, radiologists should be aware of 
situations when diagnostic inaccuracies may lead to serious consequences and 
complications. For example, surgical approach to a deep lobe parotid tumour as 
though it is a parapharyngeal lesion will in all likelihood result in facial nerve injury. 
MRI artifacts such as complex flow-induced increase in signals may be mistaken 
as a lesion prompting an unnecessary operation. An awareness of such pitfalls 
helps to improve the quality of imaging studies. This presentation highlights some 
pertinent anatomical knowledge that may help improve the diagnostic accuracy of 
neck studies and at the same time explain the existence of pitfalls that may ruin 
imaging studies. 
Learning Objectives:
1. To learn the anatomic basis of imaging abnormalities.
2. To understand the pathologic basis of image interpretation.
3. To learn the potential pitfalls of radiologic diagnosis.
A‑258 17:00 
C. Tips and tricks in the parapharyngeal space 
A. Trojanowska; Lublin/PL (agnieszka30@yahoo.com) 
Parapharyngeal space (PPS) belongs to the deep spaces of the neck and it has a 
shape of inverted pyramid. The base of the pyramid is attached to the skull base and 
the apex reaches the level of hyoid bone. Primary neoplasms arising in this space 
are very rare, and parapharyngeal space becomes the most frequently invaded or 
displaced by processes growing in adjacent spaces. Based on the direction and 
pattern of PPS and its vessels’ displacement, a detailed differential diagnosis can 
be made. Both MRI and CT are frequently used for imaging of PPS pathological 
conditions, and the introduction of functional imaging has given also some benefits. 
Primary and secondary, benign and malignant processes of PPS will be discussed 
in detail. These will include: cysts, salivary gland tumors, schwannomas, paragan-
gliomas, squamous cell carcinomas, enlarged lymph nodes, lymphomas, vascular 
malformations, and inflammatory diseases. Since correct diagnosis requires close 
collaboration with ENT surgeons; clinical findings will be also discussed, together 
with principal information which should be included into report. 
Learning Objectives:
1. To become familiar with the anatomy and pathology of the parapharyngeal 
space.
2. To review the proper imaging technique to examine parapharyngeal space 
lesions.
3. To learn how to differentiate between benign and malignant lesions.
4. To provide a template of the ‘perfect’ report.
16:00 - 17:30 Room P 
Chest 
RC 1004 
Chest in the emergency room 
Moderator:
A.P. Parkar; Bergen/NO 
A‑259 16:00 
A. Can chest radiography tell you the whole truth? 
K. Malagari; Athens/GR (kmalag@otenet.gr) 
Chest radiography is the most frequently performed imaging examination performed 
in the emergency room. It allows a first assessment of the bony cage and lungs. 
Mediastinal emergencies are not feasible to appreciate; however, a normal chest 
X-ray has a high negative prognostic accuracy. Entities that may be missed will be 
discussed in this session. Positive intrathoracic findings include pleural effusion, 
diffuse or focused alveolar opacities, and signs of extraalveolar air. Fractures and 
dislocations are also feasible to recognise on the chest radiogram - but further 
evaluation is only possible with CT imaging. The signs of pleural effusion and ex-
traalveolar air in the supine and erect position are going to be discussed in detail. 
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frequently include aspiration, infection, atelectasis, contusion, and laceration. The 
differential diagnosis of these findings is going to be discussed thoroughly. At the 
end of the session, the audience will be able to take full advantage of the findings 
of chest X-ray and appreciate what is the best imaging algorithm to further proceed 
with the diagnosis. 
Learning Objectives:
1. To describe potential pitfalls of plain film in the emergency department.
2. To present the negative and positive predictive value of chest films in the 
emergency setting.
3. To become familiar with imaging features of the spectrum of emergency 
conditions.
A‑260 16:30 
B. Triple rule-out CT in atypical chest pain: Must or luxury? 
G. Savino; Rome/IT (gsavino@sirm.org) 
A variety of pathologies such as pneumonia, pneumothorax, pericarditis or more 
life-threatening conditions such as acute coronary syndrome, acute aortic syndrome 
or pulmonary emobolism may present with the same clinical condition: chest pain. 
It has been estimated that each year in the United States, approximately 5 million 
patients present to emergency department (ED) with acute chest pain and over 
more than 1.5 million are admitted after the standard diagnostic work-up. For most 
of these patients, no cardiac pathology is detected. Hospitalization is mandatory 
for patients with typical signs of myocardial ischemia, whereas those without risk 
factors for coronary heart disease, without typical cardiac chest pain and with a 
normal electrocardiogram, are usually discharged. Diagnostic uncertainty arises, 
however, for a substantial number of subjects who are usually subjected to further 
investigations, with the result of longer hospitalization and higher costs. The advent 
of 64-slice MDCT scanners has made it possible to perform a non-invasive high-
resolution study of the thorax, allowing evaluation of the coronary arteries, aorta 
and pulmonary arteries. The aim of this lecture is to discuss the utility of MDCT 
angiography of the thorax as triage tool in patients with acute chest pain and to 
examine the impact of this modality on patient and hospital management as well 
as in the clinical-decision making. The technical principles and the diagnostic 
algorithms for using a single ECG-gated 64-slice CT scan in ED for triple-rule-out 
of acute pulmonary embolism, aortic dissection, acute coronary syndromes and 
other diseases of the chest are discussed. 
Learning Objectives:
1. To learn how to perform a triple-rule-out scan by MDCT.
2. To understand how to select patients with typical chest pain.
3. To present clinical cases and to review the evidence data.
A‑261 17:00 
C. Imaging of chest trauma 
A. Oikonomou; Alexandroupolis/GR (aoikonom@med.duth.gr) 
Thoracic injury overall is the third most common cause of trauma following injury to 
the head and extremities. More specifically, penetrating thoracic injury is the cause 
of 4-15% of admission to major trauma centres. Blunt and penetrating thoracic 
trauma has a high morbidity and mortality accounting for approximately 25% of 
trauma-related deaths, second only to head trauma. More than 70% of cases of 
blunt thoracic trauma are due to motor vehicle collisions with the remaining caused 
by falls or blows from blunt objects. Penetrating thoracic injury is mainly caused by 
knives and handgun bullets. Mechanisms of injury are discussed and spectrum of 
abnormalities and radiologic findings encountered in blunt and penetrating thoracic 
trauma are categorized in injuries of pleural space (pneumothorax, hemothorax), 
lungs (pulmonary contusion, laceration, herniation), airways (tracheobronchial 
lacerations, Macklin effect), esophagus, heart, aorta and great vessels (injury to 
thoracic aorta, internal mammary artery and aortic arch branches), diaphragm and 
chest wall (rib, scapular, sternal fractures and sternoclavicular dislocations). The 
possible coexistence of multiple types of injury in a single patient is stressed and 
therefore systematic exclusion after thorough investigation of all types of injury is 
warranted. The superiority of CT over chest radiograph in diagnosing chest trauma 
is well documented. Moreover, with the advent of MDCT the time of scanning the 
trauma patient has significantly reduced to several seconds allowing more time 
for post-diagnosis appropriate care. Finally, high-quality multiplanar and volumetric 
reformatted CT images greatly improve detection of injury and enhance the under-
standing of mechanisms of trauma-related abnormalities. 
Learning Objectives:
1. To discuss epidemiology, mortality - morbidity, significance, pathophysiologic 
features and mechanisms of injury in blunt chest trauma.
2. To discuss the typical radiologic findings as well as pitfalls associated with 
the wide spectrum of types of injury in the thorax, including injury of the 
lung parenchyma, trachea and airways, aorta (and aortic vessels), heart 
and pericardium, esophagus, pleura, diaphragm and thoracic wall. Possible 
coexistence of multiple types of injury is stressed.
3. To review the advantages and diagnostic impact of CT/MDCT for selected 
injuries over other modalities and discuss recommended imaging protocols 
and algorithms.
16:00 - 17:30 Room Q 
Professional Challenges Session 
PC 10 
PET/CT in oncologic imaging 
Moderators:
E. Breatnach; Dublin/IE
A. Chiti; Milan/IT 
A‑262 16:00 
Chairmen’s introduction 
E. Breatnach1, A. Chiti2; 1Dublin/IE, 2Milan/IT 
This combined session from European Society of Radiology (ESR) and European 
Association of Nuclear Medicine (EANM) representatives is intended to illustrate 
the complementary role of techniques from both specialties in patient investigation, 
focussing on specific topics in oncologic PET/CT. The session will highight areas of 
knowledge which are necessary for good quality reporting of PET/CT, and where 
the benefits of knowledge of principles in the complementary specialty are illus-
trated. For the radiologist, updates on newer tracer elements and their application 
will be presented, and for the Nuclear Medicine physician and radiologist the CT 
correlates of benign processes which may mimic abnormality in oncologic patients 
on PET/CT will be illustrated. 
Session Objectives:
1. To familiarise radiologists and nuclear medicine physicians with the causes 
and imaging features of common false positive and false negative PET/CT 
findings.
2. To describe new possibilities to increase specificity and sensitivity of PET/CT.
3. To give a practical update on the development of newer tracers in PET/CT.
A‑263 16:05 
New probes to increase specificity and sensitivity of PET/CT in oncology 
W. Weber; Freiburg/DE 
PET is currently almost exclusively performed with the glucose analog fluorodeoxy-
glucose (FDG). While FDG allows a surprisingly sensitive and specific diagnosis 
of many human cancers, there is a clear need for a further characterization of 
malignant tumors and for even more sensitive and specific detection of metastases. 
Radiolabeled ligands binding to specific receptors on the surface of cancer cells 
offer the opportunity to improve the diagnostic accuracy of PET for these applica-
tions. PET with such radioligands can also identify patients who will benefit from 
radionuclide therapy targeting these receptors. The use of receptor PET is most 
advanced in the area of for neuroendocrine tumors (NETs) which frequently express 
somatostatin receptors (SSTRS). This receptor class can be targeted by a variety 
of radiolabeled octreotide derivatives such as tetraazacyclododecane-tetraacetic 
acid tyrosine octreotid (DOTATOC). PET with these radioligands allows highly 
accurate diagnosis of NETs, but is also used to select patients for treatment with 
Yttrium-90 DOTATOC. Ligands for the integrin alpha-v beta-3 can be used to as-
sess the expression and function of this integrin. These ligands (RGD peptides) are 
being tested in clinical studies for planning and monitoring of therapies targeting 
angiogenesis or tumor cell invasiveness. Another target being investigated is the 
GRP (gastrin releasing peptide) receptor, which is expressed on the majority of 
breast and prostate cancer cells. In conclusion, PET with receptor ligands provides 
a unique opportunity to improve the sensitivity and specificity of PET/CT. 
Learning Objectives:
1. To learn about receptors that are being studied as targets for PET imaging 
probes.
2. To understand the strengths and limitations of receptor PET imaging.
3. To appreciate the potential clinical applications of receptor PET.
4. To become familiar with the current status of research on PET ligands for 
somatostatin receptors, gastrin releasing peptide receptors and integrins.
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A‑264 16:23 
The added value of contrast-enhanced PET/CT 
T.F. Hany; Zurich/CH 
Anatomical information is an additional benefit in co-registered PET/CT imag-
ing and improves localization of pathological FDG uptake. Different CT systems 
(single or multi-slice spiral CT scanner) are used in hybrid PET/CT system. Since 
the application of contrast media is a standard procedure in CT, application of 
contrast has been also mandated in co-registered imaging. The beneficial use of 
intravenous contrast is dependent on tumor type, e.g. for certain indications like 
melanoma or lymphoma, intravenous contrast is not needed. For other malignan-
cies, especially abdominal malignancies, single - up to triple phase intravenous 
contrast enhanced CT protocols including arterial, portal venous and late phase 
imaging are implemented depending on the tumor type. Especially in the evalua-
tion of the liver in primary liver tumors like hepatocellular carcinoma or metastases 
from neuroendocrine carcinoma of the gastrointestinal tract (GIT) as well as in the 
evaluation of pancreatic cancer, arterial phase imaging is a standard procedure. 
Also in the ENT-tract, intravenous enhanced CT helps to delineate the primary 
tumor and especially necrotic, cystic lymph node metastases. Positive as well as 
negative oral contrast agents are used for delineation of the gastro-intestinal tract 
(GIT) from adjacent structures. Recently, liquid low density oral contrast agents as 
a mixture of locust bean gum and mannitol for CT have been demonstrated to be 
favorable in the use for PET/CT. Technical issues, indications and implications in 
the use of positive as well as negative oral contrast agents and intravenous contrast 
enhancement in PET/CT imaging are discussed. 
Learning Objectives:
1. To understand the technical application of contrast agents in PET/CT.
2. To know the indications and limitations for intravenous contrast enhanced 
PET/CT.
3. To learn new combined functional applications from CT imaging like CT-
perfusion imaging integrated into a PET/CT protocol.
A‑265 16:41 
Causes and imaging features of false positives/false negatives on PET/CT 
in oncologic imaging 
C. Smith; Dublin/IE
F18-FDG is a glucose analogue that is taken up and retained by a wide range of 
malignancies. F18-FDG PET/CT is now firmly established as an accurate method 
for the staging and restaging of various cancers. It is however well recognised that 
many false positive and false negative results can occur when interpreting oncology 
PET/CT scans. F18-FDG accumulates in normal tissue and other non-malignant 
conditions and some malignancies do not take up F18-FDG or have a low affinity 
for the tracer. PET/CT allows for the correlation of two separate imaging modalities, 
combining both morphological and metabolic information. The CT component is 
routinely used for attenuation purposes and to accurately locate the FDG uptake. 
We should however also use the CT to help interpret the PET findings. In this talk 
we will highlight specific false negative and false positive findings that would one 
should be aware of when interpreting staging scans for individual cancers. One 
such example is osteoblastic breast metastases, which can be PET negative. We 
aim to highlight specific conditions such as radiation changes, drug toxicities, thymic 
hyperplasia, flare response that are encountered routinely on restaging scans that 
can lead to false positive interpretations. We will emphasise the importance of using 
the CT component to help recognise these entities to allow improved diagnostic 
accuracy. In light of the increased use of PET/CT, it is important that nuclear 
medicine physicians and radiologists be aware of these conditions and correlate 
the PET and CT components to avoid misdiagnosis, over staging of disease and 
unnecessary biopsies. 
Learning Objectives:
1. To describe and discuss the common false positives and false negatives 
encountered by interpreting physicians on routine oncologic F18-FDG PET/CT.
2. To identify the pitfalls of F18-FDG PET/CT in imaging specific cancers.
3. To emphasise the importance of interpreting the PET images in conjunction 
with the CT images to give an accurate diagnosis.
A‑266 16:59 
New tracers in oncologic PET/CT 
H. Schoder; New York, NY/US 
New PET tracers in oncology can be characterized by their chemical structure, their 
mechanism of uptake and retention, and the “hallmark of cancer” they visualize. 
This presentation discusses some agents currently used in clinical trials. Choline 
(11C or 18F) uptake reflects choline kinase activity (enzyme up-regulated in cancer) 
and membrane synthesis. Accumulating data show promise for the imaging of brain 
tumors and recurrent prostate cancer (PSA relapse). 18F FLT is a marker of cellular 
proliferation. Its cellular uptake is proportional to thymidine kinase 1 activity. Since 
FLT uptake in most primary malignancies is low (lower than FDG uptake), it is not a 
suitable tracer for tumor staging. Instead, FLT may provide prognostic information, 
serve for treatment monitoring, and possibly differentiate radiation necrosis from 
recurrence in treated gliomas. Many current clinical trials incorporate FLT PET as an 
exploratory response measure. Antigens and receptors, expressed on the surface 
of tumor cells, can be targets for PET. Imaging of estrogen and Her2 receptors 
in breast cancer (18F FES; 68Ga/ 64Cu herceptin) may be useful in predicting and 
monitoring the response to hormonal therapy or trastuzumab. In prostate cancer, 
imaging of the androgen receptor (AR) with 18F FDHT provides insights into tumor 
biology. In contrast to widespread believe, AR is expressed and important for tumor 
growth and survival in all clinical states, including castrate-resistant metastatic 
disease. AR imaging appears useful in predicting and monitoring the response to 
novel anti prostate cancer drugs. 
Learning Objectives:
1. To briefly discuss new PET tracers already in clinical use and other tracers 
with likely clinical utility in the next 3-5 years for selected disease settings.
2. To discuss how new PET tracers can aid in moving the field of oncologic 
imaging from merely visualising the extent of disease to an improved 
understanding of tumor biology.
3. To provide examples of how new PET tracers can impact the clinical 
management of cancer patients.
Panel discussion 17:17 
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08:30 - 10:00 Room A 
Radiology in Abdominal Emergencies 
CC 1117 
The hole in the guts 
Moderator:
S.K. Puri; New Delhi/IN 
A‑267 08:30 
A. Wasting time with plain radiography? 
M. Laniado; Dresden/DE 
In recent years, continuing trends in radiology have diminished the importance of 
plain films of the abdomen significantly. Ultrasonography and MDCT are applied with 
enormous success to the investigation of many abdominal conditions in the emer-
gency setting. In the eyes of the radiologist, plain films, therefore, seem irrelevant in 
the presence of such powerful imaging procedures. Surprisingly, referring physicians, 
mostly surgeons, gastroenterologists and urologists, still request plain films although 
the potential of MDCT is obvious to them as well. In their perception, the plain film is 
either a definitive examination before initiation of treatment (e.g. stone at the uretero-
pelvic junction in US proven hydronephrosis) or a preliminary study prior to MDCT 
or surgery (exclusion of pneumoperitoneum or ileus). In the present climate of cost 
and radiation consciousness this trend may continue. Moreover, many surgeons, 
gastroenterologists, urologists, etc. have greater skills in reading plain films than in 
understanding MDCT. Therefore, the radiologist should be as much familiar as the 
referring physician with plain film appearances of many types of abdominal pathol-
ogy and established roentgen signs. The purpose of the presentation is to review 
remaining indications for abdominal plain films and to revisit common imaging findings. 
Learning Objectives:
1. To review the most common causes of hollow organ perforation.
2. To know the optimal technique for plain film of the abdomen in the 
emergency setting, signs of perforation.
3. To discuss if there are still indications for plain film of the abdomen in the era 
of US and CT.
A‑268 09:00 
B. Defining the role of US 
J.B.C.M. Puylaert; The Hague/NL (dr.jbcmpuylaert@wxs.nl) 
When a defect occurs in the bowel wall, air will appear within the peritoneal cavity, most 
frequently due to perforated peptic ulcer and perforated sigmoid diverticulitis. In most 
perforating gastrointestinal conditions, however, the -imminent- perforation is walled-off 
by neighboring bowel loops, mesentery and especially by the omentum, nick-named 
“policeman of the belly”. If this walling-off process occurs timely and effectively, no or 
only minimal free air will appear. The most important causes of walled-off gastrointestinal 
perforation are appendicitis, peptic ulcer disease, sigmoid diverticulitis, bowel malignancy, 
Crohn’s disease and - often underdiagnosed - accidently ingested sharp foreign bodies, as 
toothpicks, fish bones, chicken bones, etc. The extent to which the perforation is walled-off, 
determines the eventual course of the disease. The US hallmark of - imminent - perforation 
is inflamed fat around the involved bowel structure. Inflamed fat on US corresponds to 
what is often called “dirty fat” on CT scan: hypodense fat is interspersed with hyperdense 
streaks. This represents edema or cellular infiltration of the fatty mesentery and omentum, 
which have migrated towards the site of the imminent perforation in an attempt to seal it 
off. On US, inflamed fat is recognized as hyperechoic, non-compressible fatty tissue often 
interspersed with hypoechoic streaks. If fluid collections occur within the inflamed fat, this 
implies abscess formation. Inflamed fat is an important and valuable sign in perforating 
gastrointestinal conditions. If found in the absence of bowel pathology, the diagnosis is 
usually epiploic appendagitis or omental infarction. 
Learning Objectives:
1. To understand the strength of US as the primary imaging modality.
2. To know typical signs of bowel perforation.
3. To be aware of the limitations and pitfalls of US.
A‑269 09:30 
C. In search of the hole: CT 
A. Laghi; Latina/IT (andrea.laghi@uniroma1.it) 
MDCT is an extremely powerful tool when the search for a GI perforation is required. 
In fact, the high spatial and contrast resolutions, much higher than conventional X-
ray, make MDCT the most accurate imaging method to identify even small amount 
of free intraperitoneal air. There is general consensus about the acquisition of a 
contrast-enhanced scan acquired during the portal venous phase of enhancement 
(delay of around 60-70 sec). Controversies are still present in the literature about 
the utility of a pre-contrast scan as well as the need for a preliminary administra-
tion of an oral soluble iodinated cm or for an enema or gaseous distention of the 
distal GI tract. Image reviewing needs the use of a workstation since multiplanar 
reformations have been demonstrated to improve the detection of small amount 
of free air. An appropriate window setting (in particular the use of wide windows, 
i.e. lung window) is mandatory and it makes MDCT 100% accurate for identifica-
tion of free air and almost 90% accurate in the identification of the precise site of 
perforation. In fact, the aim of the examination is not only to assess the presence 
of free air, but also to detect the site of perforation: this is extremely useful clinical 
information especially if surgeons decide to perform a laparoscopic repair. Several 
CT signs have been described, able to guide the diagnosis and to differentiate 
between a perforation originating in the upper GI tract (stomach and duodenum), 
in the small bowel or in the colon. 
Learning Objectives:
1. To learn the appropriate imaging protocols in patients with suspected bowel 
perforation.
2. To learn useful signs for the detection and localisation of perforation.
3. To discuss imaging strategies in case of clinical suspicion of bowel 
perforation.
08:30 - 10:00 Room B 
Radiology of the Spine in 2010 
CC 1116 
Advanced imaging techniques in the spine 
Moderator:
M. Leonardi; Bologna/IT 
A‑270 08:30 
A. Benign vs malignant fracture in the spine 
A. Baur-Melnyk; Munich/DE (Andrea.Baur@med.uni‑muenchen.de) 
Vertebral collapse is common in the elderly population. The underlying condition 
is osteoporosis or metastases. Signal characteristics are the same for benign 
as well as for neoplastic disease, e.g. hypointense on T1 and hyperintense on 
STIR. Both show contrast uptake. Therefore, the knowledge of morphological 
signs are important to know to better discriminate these entities. New imaging 
techniques, such as diffusion and perfusion of the spine, can help in differential 
diagnosis. Diffusion-weighted imaging has been especially used for the differentia-
tion of benign and neoplastic vertebral collapse. Different sequences have been 
explored. Qualitative analysis can be done reliably with steady state free preces-
sion sequences (SSFP-Siemens, Erlangen). Hypointense or isointense signal is 
associated with benign edema, whereas tumor shows hyperintensity in contrast 
to normal surrounding marrow. Several studies applied quantitative DWI to normal 
and pathological vertebral bone marrow. Pathological bone marrow exhibits much 
higher diffusivities, ranging from about 0.7 to 1.0×10-3 mm2/s in metastases as well 
as malignant fractures. In acute osteoporotic and traumatic fractures ADCs of 1.0 
to 2.0×10-3 mm2/s were found. Although a certain overlap of ADC ranges can be 
seen, ADC measurements can be useful for the differentiation of benign vertebral 
fractures and metastatic lesions. Perfusion of vertebral fractures might also be a 
potential for the discrimination of acute benign and neoplastic fractures. In first 
studies, FDG PET/CT can help for the differentiation of benign and malignant 
conditions of spinal fractures. Increased FDG uptake (> 3-4 SUV) usually is seen 
in malignant fractures. 
Learning Objectives:
1. To understand the pathophysiological principles of vertebral body fractures.
2. To describe the use of diffusion-weighted MR imaging in differentiation of 
benign and malignant fractures.
3. To set up an optimal clinical MR protocol for evaluation of vertebral body 
fractures.
A‑271 09:00 
B. Imaging in low back pain 
A. Stäbler; Munich/DE (info@radiologie‑muenchen‑harlaching.de) 
Degenerative diseases of the spine include degeneration of the intervertebral discs 
and endplates as well as degenerations of the intervertebral joints. Degeneration 
of the intervertebral disc can result in anular tears and in disc herniation with com-
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as dislocation of nucleus pulposus material through a defect of the anulus fibrous 
(anular tear) bejond the outer part of the anulus fibrosus (non-contained disc) or 
as a dislocation of nucleus pulposus material inside the disc in areas of the anulus 
fibrosus with dislocation of the outer part of the anulus fibrous (contained disc). 
The location and morphology of the anular tear pedicts the direction of migration/
sequestration of a disc hernia. Dehydration and disintegration of the disc tissue 
leads to increased segmental mobility. Instability with symptomatic osteochondrosis 
named activated erosive intervertebral osteochondrosis can develop, character-
ized by bone marrow edema, disc vascularity and hyaline cartilage proliferations in 
erosions on MRI. Activated intervertebral or facet joint osteoarthrosis may become 
symptomatic due to synovitis and fibrovascular tissue. Facet joint osteoarthrosis 
can also be responsible for central spinal canal stenosis, stenosis of the recess 
or narrowing of the neuroforamen. Signs of symptomatic spinal stenosis on MRI 
are root redundancy and root edema with swelling. There exist mechanisms to 
recognize dynamic worsening of spinal canal stenosis by weight bearing on MRI 
in prone position. 
Learning Objectives:
1. To understand the aetiology and pathomechanisms of low back pain.
2. To identify key imaging findings in low back pain.
3. To describe the imaging protocol and strategy in patients with failed back 
surgery syndrome.
A‑272 09:30 
C. 3 T spinal imaging 
M. Law; Los Angeles, CA/US (meng.law@usc.edu) 
Image quality in spine MR imaging is dependent on five major factors: 1. Spatial 
Resolution, 2. Signal to Noise (SNR), 3. Contrast to Noise (CNR), 4. Temporal 
Resolution, and 5. Artifacts.
Artifacts: a) Susceptibility artifact and geometric distortion, b) Chemical shift 
artifact-from the existence of multiple resonance frequencies, c) CSF partial volume 
effects, d) Truncation artifact - insufficient phase-encoding sampling, e) B0- inho-
mogeneity of surrounding neck/airway structures, f) Physiologic motion- vascular/
CSF pulsation, respiratory, swallowing motion, g) Non physiologic motion - gross 
neck motion, h) Dielectric artifact, and i) Increased specific absorption rate (SAR). 
Most of these artifacts are in part dependent on magnetic field strength. There is 
substantial susceptibility and signal loss in the spine from signal dephasing at the 
tissue-bone and tissue-air interfaces. Similarly, increasing the TE to increase T2-
weighting for the cord, will result in increased CSF signal dephasing from pulsatile 
motion. These susceptibility effects can be decreased by using thinner sections as 
well as using multiple receiver coils with parallel imaging techniques. By the same 
token, combining phase array coil technology with higher field strengths can have 
a beneficial effect on other artifacts such as the dielectric effect and reducing the 
SAR. Modifying the shape of the RF pulse using a VariablE Rate Selective Excita-
tion (VERSE) pulse will also reduce SAR and improve image quality. Chemical 
shift effects are inversely proportional to received bandwidth. Hence, increasing 
the receiver bandwidth will decrease chemical shift; however, this comes at a cost 
of reducing SNR. 
Learning Objectives:
1. To learn about the factors affecting image quality for spine imaging at 3 T.
2. To become familiar with sequence and parameter choices for spine imaging 
at 3 T.
3. To understand artifacts and solutions in spine imaging at high field.





R. Siemund; Lund/SE 
A‑273 08:30  
A. CT or MRI in the acute ischemic stroke? 
G. Krumina; Riga/LV (gaida.krumina@apollo.lv) 
Early signs of hyperacute stroke on native CT are hypoattenuation of gray mat-
ter structures, hyperdense arteries, and mass effect. Insular ribbon sign reflects 
cytotoxic edema and relates to specificity of arterial anatomy. Two types of insular 
stroke with different functional outcomes have been distinguished: the minor and the 
major insular stroke. ASPECTS is a standardised quantitative CT grading system 
in acute anterior circulation ischemic stroke. Baseline ASPECTS value predicts 
response to intraarterial and intravenous thrombolysis functional outcome and 
incidence of secondary hemorrage within 3 and 6 hours of stroke onset. Hyperdense 
artery sign represents stasis of flow due to arterial thrombus. Proximal hyperdense 
MCA sign is associated with poor short and long-term prognosis; intravenous 
thrombolysis is ineffective. Distal hyperdense MCA sign does not implicate poor 
outcome; patients are applicable to thrombolytic therapy. Hyperdense PCA sign 
is associated with thalamic infarction, large PCA territory ischemia, more severe 
neurology and higher risk of hemorrhagic transformation. Hyperattenuating artery 
sign correlates positively with angiographic finding of occlusion. CTA is essential 
for evaluating of intra- and extracranial dissections, and intravascular thrombi. 
MRI protocol in acute stroke includes DWI, T1 SE, T2 FSE, FLAIR, T2* GE, PWI, 
MRA. DWI is most sensitive tool for detection of hyperacute stroke at first 6 hours. 
In patients with TIA, DWI has discriminative value in predicting risk of new TIA or 
future stroke. To correctly estimate the infarct age, it is important to examine DWI 
in comparison with ADC maps. 
Learning Objectives:
1. To learn how to recognise the early CT signs of hyperacute stroke.
2. To compare the sensitivity and specificity of CT and MRI for the diagnosis of 
acute stroke.
3. To discuss the practical aspects of the use of CT and MRI in the 
management of acute stroke patients.
A‑274 09:00 
B. DWI, CT/MR PWI, and/or CTA/MRA: What is necessary? 
A. Dörfler; Erlangen/DE (arnd.doerfler@uk‑erlangen.de) 
The goals of stroke imaging are to establish a diagnosis as early as possible to 
obtain accurate information about intracranial vasculature and brain perfusion to 
select the appropriate therapy. Comprehensive evaluation may be performed with a 
combination of CT or MRI. Unenhanced CT helps to rule out hemorrhage and may 
identify early signs of ischemic stroke, respectively. In addition, CT angiography and 
CT perfusion imaging may depict major vessel occlusion and perfusion disturbances 
indicating tissue at risk. Diffusion-weighted MR imaging is more sensitive in the 
detection of hyperacute ischemia. MR angiography reveals the status of extra- and 
intracranial vessels, and a mismatch between findings on diffusion and perfusion 
MR images may be pragmatically used to predict the presence of a penumbra. 
Regarding our own experience, “multimodal MR imaging” provides substantially 
greater information about brain ischemic pathophysiology and overall a more sensi-
tive diagnosis for acute stroke, especially in patients with an uncertain time window 
of symptom onset and vertebrobasilar ischemia. Thus, combining various imaging 
techniques may help to differentiate patients who may profit from intravenous or 
interventional therapy in an even extended time window from those who do not. 
Thus, we think that MRI should replace CT as the primary neuroimaging technique, 
at least in patients suspicious for vertebrobasilar ischemia or presenting in an 
extended time window. In our institution, we use a multimodal CT protocol when 
acute stroke patients present within 4.5 hours (ECASS III time window); patients 
presenting beyond this time window are examined with a multimodal MRI protocol. 
Learning Objectives:
1. To delineate the objectives of stroke imaging in the context of available 
stroke therapies.
2. To introduce the basic concepts of DWI, PWI, and MRA.
3. To discuss the strategies of multimodal CT and MR stroke imaging.
4. To discuss the differential diagnosis of stroke.
A‑275 09:30 
C. Nontraumatic intracranial hemorrhage 
L. van den Hauwe1, M.H.J. Voormolen2, C. Venstermans2, F. De Belder2, 
J.W.M. Van Goethem2, P.M. Parizel2; 1Brasschaat/BE, 2Antwerp/BE 
(lucvdhauwe@mac.com) 
Non-traumatic intracranial hemorrhage is a common cause of an acute neurologi-
cal deficit and represents up to 20% of patients presenting with stroke. Stroke is 
a medical emergency and CT should be performed as soon as possible to rule 
out intracranial hemorrhage and to exclude other intracranial pathology such as 
brain tumors. Once intracranial bleeding is ruled out, thrombolytic therapy may be 
considered. CT also allows to look for potential complications such as increased 
intracranial pressure and brain herniation. Intraparenchymal hemorrhage at the level 
of the basal ganglia is typically seen in older patients with hypertension, but may also 
be observed in younger patients with sinus thrombosis. Extra-axial hemorrhages 
may be found in the subarachnoid space as well as in the epidural and subdural 
compartments. Subdural hematomas are frequently observed in elderly people 
with brain atrophy and typically occur in patients taking anticoagulant medication 
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suffering a minor trauma. When CT demonstrates the presence of subarachnoid 
hemorrhage, CT angiography should be performed to rule out a cerebral aneurysm 
or vascular malformation, before going into catheter angiography. MRI, including T2* 
and Susceptibility Weighted Imaging (SWI), may be used to look for more subtle 
causes of bleeding such as cerebral amyloid angiopathy. 
Learning Objectives:
1. To review the different types of nontraumatic intracranial hemorrhage in 
patients presenting with stroke.
2. To discuss imaging strategies in the diagnostic work-up of hemorrhagic 
stroke.
3. To illustrate the optimal imaging techniques for the detection of nontraumatic 
intracranial hemorrhage.
08:30 - 10:00 Room D 




H. Trillaud; Bordeaux/FR 
A‑276 08:30 
A. Staging with US and CT 
A. Maier; Vienna/AT (andrea.maier@meduniwien.ac.at) 
For rectal cancer surgery, a variety of alternative operations are currently possible, 
including low anterior resection, total mesorectal excision and local, transanal 
resection. Furthermore, there is an increasing trend toward treating patients with 
radiotherapy before surgery to improve local control. The choice of operation and 
the decision whether to employ radiotherapy is based on preoperative staging. In 
patients with primary rectal cancer, accurate assessment of tumour extent within 
and beyond the rectal wall and the presence or absence of lymph node invasion 
are factors for determining prognosis and risk of tumour recurrence. Endorectal 
ultrasound (EUS) is effective for T-staging, although it is least accurate for T2 and 
T4 tumours. It has been recommended as the investigation of choice in the selection 
of potentially curative local excision. Distinguishing between T1 and T2 tumours 
may be a problem. Lymph node staging by this method is less precise than tumour 
staging. Initial reports of the use of CT for tumour staging were encouraging. How-
ever, studies which compare CT with EUS staging consistently show the latter to be 
more accurate for both tumour stage and lymph node stage. Thus, the usefulness 
of CT for rectal cancer is disappointing. Tumours within the rectal wall and slight 
invasion through the wall cannot be assessed. Accurate assessment of local spread 
can only be achieved in advanced tumours. The value of CT as an investigation 
tool for staging rectal cancer has to be seen in the detection of distant metastases. 
Learning Objectives:
1. To learn exam technique of endorectal US.
2. To describe morphology and staging of rectal cancer.
3. To understand the role of CT for local and distant staging.
A‑277 09:00 
B. Staging with MRI 
C. Hoeffel; Reims/FR (choeffel‑fornes@chu‑reims.fr) 
Advancements have been made in multiple aspects of diagnostic and therapeutic 
approaches to rectal cancer. Therapeutic advances include total mesorectal 
excision, transanal excision, and adjuvant treatments such as chemotherapeutic 
agents and refined radiotherapy techniques. The accurate identification of patients 
who are candidates for combined modality treatment depends on multidisciplinary 
approach and is particularly essential to optimize outcomes. The ability of MRI to 
accurately image the relevant structures of the mesorectum in rectal cancer has 
become increasingly evident. Advances in the method and technique for obtain-
ing these scans have resulted in improved image acquisition. Interpretation of 
preoperative MR images in patients with rectal cancer allows the identification 
of several prognostic factors that will enable better selection of patients who may 
benefit from more intensive treatment without subjecting those who will not to un-
necessary treatment. We will describe the MRI staging of rectal tumors, and how 
this information can be used to optimize management of these cancers, and will 
outline the added values of new techniques. 
Learning Objectives:
1. To demonstrate the techniques for accurate magnetic resonance imaging 
assessment of rectal tumors.
2. To understand the anatomy of the mesorectal margin in relation to total 
mesorectal excision surgery and the anatomy of the lower third of the 
rectum.
3. To understand the role of the radiologist in identifying prognostic factors 
preoperatively and preventing margin positive disease.




G. Brown; Sutton/UK (gina.brown@rmh.nhs.uk) 
Defining patterns of recurrence is crucial in the overall assessment of efficacy of 
treatment strategies. In particular, patterns of local recurrence can identify areas 
for locally directed therapy and the early detection of distant relapse is also es-
sential in enabling early and effective treatment of relapse. For the radiologist, 
knowledge of the patterns and outcomes from recurrence is essential for effective 
surveillance strategies and in this lecture the patterns of local relapse based on 
an understanding of their aetiology will be covered. At present, CT scanning of the 
thorax abdomen and pelvis remains the most common method of surveillance of 
patients following colorectal surgery. The majority of patients develop metastatic 
disease within the first two years of surgery and therefore six monthly post opera-
tive surveillance is common place for patients who are at a high risk of developing 
metastatic disease. In approximately 10% of cases, a cause for a rising CEA will 
not be found on conventional CT; in these circumstances, PET/CT can be helpful. 
Early detection of metastatic disease or recurrent disease in colorectal cancer 
has been shown to benefit patients and in up to 40% of patients resection of local 
or distant recurrence can result in long term cure. The following patterns of local 
recurrence will be discussed: • Marginal; • Pelvic side wall; • Peritoneal; • Perineal;
• Anastamotic; • Krukenberg; and Knowledge of the compartmental distribution of
recurrent disease will also enable planning for radical pelvic exenteration. 
Learning Objectives:
1. To understand the evidence base for follow-up of primary rectal cancer.
2. To understand the patterns of recurrent disease.
3. To review the guidelines for imaging of local and distant recurrent disease.





C. Masciocchi; L’Aquila/IT 
A‑279 08:30 
A. Rotator cuff and impingement 
J. Kramer; Linz/AT (kramer@ctmri.at) 
MR imaging findings of a normal shoulder joint, its variants and pathologic altera-
tions have to be known for enabling an exact diagnosis. Mostly rotator cuff lesions 
are observed in patients with more or less degenerated tendinous structures who 
had suffered not rarely a minor trauma only. In case the tendons basically are not 
degenerated, osseous lesions occur more likely. Especially long-standing impinge-
ment may cause rotator cuff lesions (degeneration/fraying of tendons, partial or 
full thickness tears). There are several forms of impingement: “Primary external 
impingement” is caused by subacromial or subcoracoid impingement (e.g. spurs, 
variations of the acromial morphology, etc). Chronic or long standing glenohumeral 
instability, mostly observed in athletes who participate in sports that require repeti-
tive overhead or throwing motions, may lead to “secondary external impingement”. 
In these cases, clinical symptoms may mask signs of underlying glenohumeral 
instability and point directly to rotator cuff lesions. “Internal impingement” is caused 
by abnormalities due to friction between the posterosuperior or anterosuperior 
labrum and glenoid, and rotator cuff. In this presentation, the different forms of 
impingement and MR imaging findings of rotator cuff pathology are demonstrated. 
Learning Objectives:
1. To become familiar with MRI of normal rotator cuff structures.
2. To understand the etiology of impingement.
3. To recognise imaging findings in different forms of impingement.
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A‑280 09:00 
B. Instability 
M. Reijnierse; Leiden/NL (m.reijnierse@lumc.nl) 
Stability of the glenohumeral joint is based on multiple factors. These include the 
rotator cuff, the glenoid labrum, the coracoacromial arch and the glenohumeral liga-
ments. Instability of the glenohumeral joint can be divided in two major categories: 
traumatic and atraumatic. Acute anterior dislocation is most frequently seen and 
often results in unidirectional instability of a shoulder. Atraumatic instability can 
be congenital or the result of repetitive microtrauma e.g. swimming and throwing. 
This instability is often multidirectional and may be bilateral. Three glenohumeral 
ligaments (GHL) have been described, the superior GHL, the middle GHL and 
the inferior GHL complex, formed by an anterior band, a posterior band and an 
axillary recess of the joint. The number of ligaments is variable in any person and 
their size varies considerably. The SGHL is present in 90-97% of shoulder studies 
and is variable in origin. The MGHL is present in 73-92% and the IGHL is pres-
ent almost 100% of shoulder studies. Ligamentous abnormalities can be seen in 
isolation; however, since stability is based on multiple factors, coexisting structural 
abnormalities are frequently found. For accurate assessment of the glenohumeral 
ligaments, the use of MR arthrography is essential. With joint distension, these 
intra-articular ligaments can be evaluated. MR arthrography is indicated to find 
additional abnormalities in case of clinical significant glenohumeral instability and 
is an essential part of presurgical planning. 
Learning Objectives:
1. To appreciate the role of MR imaging in glenohumeral instability.
2. To understand the anatomy and normal variations of the glenohumeral 
ligaments.
3. To recognise pathology due to instability.
A‑281 09:30 
C. The post-operative shoulder 
M. Zanetti; Zurich/CH (marco.zanetti@balgrist.ch) 
Standard radiographs are essential in the evaluation of the postoperative shoulder. 
Radiographs allow giving an overview of the position of humeral head and glenoid 
(acromiohumeral distance, anterior or posterior dislocation) in a physiologic upright 
standing position. Dislocation of metallic implants can be recognized on CT images. 
CT has its advantages in the assessment of extraanatomical glenoid reconstruc-
tions (Latarjet or Bristol procedures). Hidden fractures after shoulder prosthesis 
surgery at the coracoid process or acromion are often visible only on CT images. 
MR imaging after shoulder surgery is used to assess muscles and tendons. The 
direct MR arthrography is used to assess labrum or cartilage lesions. However, 
the diagnostic value of direct MR arthrography after rotator cuff reconstruction 
is limited by the fact that the rotator cuff is not watertight after surgery. Partial 
thickness rotator cuff tears cannot be discriminated from a normal postoperative 
scar. Therefore, standard MR imaging provides similar results. Ultrasound can be 
used alternatively for the postoperative assessment of the rotator cuff. Subacro-
mial bursitis diagnosed on MR STIR images is most commonly (98%) a normal 
postoperative finding. The postoperative MR protocol differs minimally (no gradient 
echo sequences, susceptibility artefact along the frequency direction, turbo spin 
echo instead spin-echo, short TE, large bandwidth, large echo train length, STIR 
instead fat sat) from the preoperative MR protocol. 
Learning Objectives:
1. To become familiar with surgical techniques in patients with impingement, 
instability-related disorders, and osteoarthritis.
2. To differentiate between normal and abnormal findings after shoulder 
surgery.
3. To learn about MRI after shoulder surgery.
08:30 - 10:00 Room E2 
Interactive Teaching Session 
E³ 1120 
Colorectal cancer: Diagnosis, staging and follow-up 
Moderator:
M. Marotti; Zagreb/HR 
A‑282 08:30 
Colorectal cancer: Diagnosis, staging and follow-up 
R.G.H. Beets-Tan1, A.H. Freeman2; 1Maastricht/NL, 2Cambridge/UK 
(r.beets.tan@mumc.nl) 
Colorectal cancer is common. Approximately 280,000 new cases occur each year 
in the 500 million population of the 27 states which comprise the EU. After lung, 
it is the second commonest cause of cancer death resulting in approximately 
140,000 deaths per annum. These relatively high mortality figures are a reflection 
of the fact that the disease is often advanced at the time of presentation. Efforts to 
reduce mortality, therefore, centre on early detection as well as accurate staging. 
The latter is particularly important in rectal cancer-the commonest site for colonic 
cancer. Detection depends on presentation, which is often protean or non-existent; 
hence, the introduction of screening programs. Typical diagnostic tools include the 
barium enema, optical colonoscopy and CT colonography. The limitations of the 
barium enema have been exposed by optical colonoscopy and it can no longer be 
advocated in this role. CT colonography, however, rivals optical colonoscopy in the 
detection of polyps and tumours, although of course has no therapeutic potential. 
Major advances in the treatment of rectal cancer include total mesorectal excision 
(TME) of the rectum as well as neo-adjuvant therapies such as chemo-radiation. 
Their use depends on highly accurate staging of the primary disease, which can 
only be achieved by MR examination, although of course CT or PET/CT is required 
for the assessment of more distant metastatic disease. Finally, once treated, it is 
essential that these patients are followed-up; usually by a regime of colonoscopy 
and CT. These issues will be discussed in an interactive lecture. 
Learning Objectives:
1. To review the genetic and environmental factors predisposing to colorectal 
cancer and to consider the significance of colorectal cancer in overall health 
terms.
2. To understand the rationale of screening and to discuss the role of CT 
colonography and its relation to other screening tests such as FOB test and 
colonoscopy.
3. To learn the principles and rationale for accurate preoperative imaging of 
rectal cancer.
08:30 - 10:00 Room F1 
Organs from A to Z: Liver 
MC 1119 
Anatomy and techniques 
Moderator:
S.C. Efremidis; Ioannina/GR 
A‑283 08:30 
A. Essentials of liver anatomy and multimodality display 
W. Schima; Vienna/AT (Wolfgang.Schima@khgh.at) 
Knowledge of the normal anatomy and of the most frequent variants and anoma-
lies of liver segments, vascular, and biliary anatomy is of major importance for 
hepato-biliary surgery and interventional procedures. Radiologic studies to evaluate 
anatomy include color Doppler ultrasound and contrast-enhanced MDCT and MRI. 
Analysis of 3D data sets obtained with MDCT or MRI is most helpful for evalua-
tion of complex anatomy. Radiologic classification of liver segments according to 
Couinaud can be reliably achieved with MDCT and MRI data sets with vascular 
opacification. Arterial-phase MDCT imaging is the best non-invasive technique 
to demonstrate variants of the hepatic artery, including accessory and replaced 
right and left hepatic arteries. For preoperative demonstration of biliary ductal 
variations and anomalies, MRCP has become the standard imaging technique. 
It reliably shows dystopic biliary radicles, which are at risk of inadvertently being 
clamped during surgery. The development of MRCP with liver-specific MR contrast 
agents has further increased the diagnostic yield to show normal-sized bile ducts. 
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Recently, multi-phasic MDCT with intravenous and biliary contrast agent has been 
shown to be a reliable tool for demonstration all aspects of surgically relevant liver 
anatomy in one-stop-shopping. Accurate assessment of liver segmental anatomy 
and vascular and biliary variants and anomalies is crucial to help pre-therapeutic 
planning and to avoid surgical complications. 
Learning Objectives:
1. To understand the segmental anatomy of the liver as seen with 
US, CT, and MRI.
2. To become familiar with vascular and biliary anatomy including anatomic 
variations.
3. To understand why US, CT and MRI are complementary and to learn the 
advantages of multimodality display.
A‑284 09:00 
B. The correct protocols for CT and MR 
B. Marincek; Zurich/CH (Borut.Marincek@bluewin.ch) 
Liver MDCT protocols are adapted to the clinical situation. Routine abdomen-pelvis 
scans are acquired during a portal-venous phase only and visualize hypovascular 
liver parenchyma lesions. In target-oriented liver scans, early arterial phase im-
ages provide a purely arterial road map. Dedicated triphasic protocols include 
a late arterial phase for the detection of hypervascular lesions, a portal-venous 
phase and an anytime between 2 and 5 minutes delayed phase for improving the 
demonstration of cholangiocarcinoma and cysts. Non-enhanced scans are help-
ful to depict intrahepatic biliary stones or to differentiate retained chemo-infused 
material from contrast enhancement. Tube current modulation techniques should 
be applied for dose reduction. In obese patients, 140 kV tube voltage is recom-
mended (standard: 120 kV). Liver MRI is mostly performed to evaluate focal disease. 
The protocol should include as a minimum precontrast T1w gradient echo (GE) 
in- and opposed-phase images to identify intracellular fat and T2w fat-suppressed 
spin echo sequences for the characterization of fluid-containing lesions (e.g. cyst, 
hemangioma). Non-specific extracellular Gd-chelates are routinely used for dynamic 
multiphase (late arterial, portal-venous, delayed phase) T1w fat-suppressed GE 
sequences. They are adequate for detection and characterization of the majority 
of focal lesions. Contrast agents with combined extracellular dynamic enhancing 
and hepatocyte-selective properties (hepatobiliary imaging window duration of 
60-120 minutes) are excreted into blind-ending bile ducts typical of FNH, but do 
not accumulate within an adenoma, HCC, or hypervascular metastases, facilitating 
differentiation. Reticuloendothelial system-specific contrast agents are taken up by 
functioning Kupffer cells, but lack dynamic enhancement information, reducing the 
ability to characterize lesions. 
Learning Objectives:
1. To learn about the MDCT protocols for detecting and characterising liver 
lesions.
2. To consolidate knowledge of standard MRI protocols for lesion detection and 
characterisation.
3. To become familiar with the use of contrast media for MRI, including liver-
specific agents.
A‑285 09:30 
C. Imaging the function and structure in clinical practice 
Y. Menu; Paris/FR (yves.menu@sat.aphp.fr) 
Beyond the traditional role of anatomical display, imaging extends now to functional 
and structural imaging. Because liver tumours, both primary and secondary, are so 
frequent, and because chronic liver disease is a real public health problem, liver 
imaging is a natural target for advances in organ evaluation. Perfusion studies can 
be made using US, CT and MRI after intra venous tracer injection. Bio-distribution 
of the tracer, either intra vascular or intra and extra vascular, should be understood, 
as well as main methods for extraction of parametric images anq quantitative pa-
rameters. The main role of perfusion studies is to evaluate angiogenesis and more 
over its evolution after administration of chemotherapy or targeted therapy in case 
of tumour. Hepatocyte uptake can be evaluated using specific tracers, providing 
functional information useful for tumour characterization. Structural analysis can 
be done using Diffusion Weighted MRI (DW-MRI). Advantages (fast acquisition, 
intra observer reproducibility, feasibility on virtually all installed machines) and 
drawbacks (absence of standardization, inter observer variability) should be fully 
understood. DW-MRI can be helpful in predicting and evaluating tumour response 
to treatment, as well as grading the severity of liver fibrosis. Other methods, like 
elastography, may play an increasing role in the evaluation of diffuse liver disease, 
and possibly of tumours. Spectroscopy is unlikely to become a routine clinical tool 
in the very near future. In this lecture, protocols for functional and structural ex-
aminations will be provided, and a tentative synthesis of their practical or potential 
role will be presented. 
Learning Objectives:
1. To understand how imaging can approach structure and function.
2. To learn the CT and MRI protocols for the exploration of liver structure and 
function.
3. To understand how diseases can impair structure and function and to learn 
the consequences on imaging.





R. Schulz‑Wendtland; Erlangen/DE 
A‑286 08:30 
A. US-guided core biopsy 
L. Apesteguía, L.J. Pina Insausti; Pamplona/ES 
US-NCB under local anaesthesia is nowadays the most widespread system of per-
cutaneous biopsy, because of the excellent control we can achieve with the needle 
and the ability to reach lesions located in difficult places such as axylla or near the 
nipple. It is a safe, comfortable and economical technique although it requires a no-
table level of experience. The length of needle and core can be selected according to 
lesion size, location, depth and other circumstances. The skin access point must be 
separated from the US probe because the needle must be orientated parallel to the 
chest wall. Three to five specimens are recommended to get the maximum accuracy 
and the lowest grade of infra-estimation. The number of samples should be greater 
for lesions with complex radiological features. The colour, consistence and grade of 
immersion of the cylinders in formaldehyde are useful criteria to know their suitability 
for diagnosis. This is the elective technique for BI-RADS-4-5 lesions properly identified 
by US. In particular situations, BI-RADS-3 lesions can be managed similarly. Only 
lesions not clearly seen by US should be punctured under stereotaxic or MR control. 
FNA-Cytology is reserved for special situations such as some BI-RADS-3 nodules 
or when the objective is evacuation. The extensive use of US-NCB has drastically 
reduced the number of surgical procedures due to false positive radiological findings. 
Correlating histological and radiological features is extremely important. In cases of 
disagreement, vacuum-assisted systems or surgical biopsy are recommended. All 
breast radiologists should be encouraged to get experience in US-NCB. 
Learning Objectives:
1. To review the principles of biopsy techniques.
2. To learn pros and cons of these interventions.
3. To update the indications in order to reduce false positives.
A‑287 09:00 
B. Stereotactic large core biopsy 
P.D. Britton; Cambridge/UK (peter.britton@addenbrookes.nhs.uk) 
Stereotactic breast biopsy has a long-established role in breast diagnosis for 
identifying lesions not detectable by ultrasound. Technical advances in ultrasound 
have meant that stereotactic biopsy is now almost exclusively performed on screen-
detected microcalcification and small parenchymal deformities. Such lesions present 
the greatest diagnostic challenges confronting the breast radiologist. Abnormalities 
are frequently small, hard to target and encompass most borderline and in-situ 
pathologies encountered. Compared with lesions targeted by ultrasound, diagnostic 
performance has lower sensitivity, higher false negative and cancer upgrade rates. 
To tackle these challenges, digital equipment is essential whether prone biopsy or 
upright. Fine needle aspiration cytology (FNAC) has been superseded by devices 
harvesting larger amounts of tissue such as core biopsy (CB) and vacuum-assisted 
biopsy (VAB). Are better results achieved with VAB, and if so, does it justify the 
considerable extra expense? Whatever targeting method or biopsy device is used, a 
meticulous approach to technique, adequate sampling and correlation with pathol-
ogy at multidisciplinary team meetings are essential for best and safe patient-care. 
Learning Objectives:
1. To understand the indications for stereotactic intervention.
2. To discuss different available systems.
3. To learn tricks and tips for needle and clip placement.
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A‑288 09:30 
C. An update on MR-guided wide excision biopsy 
S.H. Heywang-Köbrunner; Munich/DE 
Breast MRI is capable of visualizing lesions not visible by other methods. Depending 
on patient preselection, 20-30% of these lesions may be malignant. Indications: 
Lesions classified as BIRADS 4 or 5 which are visualized by MRI alone (as counter-
checked by retrospective ultrasound) need to be biopsied under MR guidance. Even 
though MR-guided percutaneous breast biopsy is the more demanding procedure, 
it should be preferred to wire localisation and surgery; among percutaneous breast 
biopsy methods, MR-guided vacuum-assisted breast biopsy appears the method of 
choice with proven accuracy and reporducibility (1). Techniques: Meanwhile, coils 
and software for MR-guided targerting are commercially available. An overview will 
be given of the procedure, available equipments and oneway material for MR-guided 
biopsy. Usefulness: MR guided interventions are indispensable to correctly assess 
lesions visible by MR alone. Following the European guidelines, minimal invasive 
breast biopsy should be performed for imaging detected lesions whenever possible 
(> 70%, optimum > 90% of the lesions). In case of benign lesions, unnecessary 
surgery can be avoided. In case of malignancy, treatment planning is optimized. 
An overview of existing literature data will be given. 
Learning Objectives:
1. To update the indications for this approach.
2. To learn basic techniques of present systems.
3. To explain its usefulness in multicentric cancers.
08:30 - 10:00 Room G/H 
New Horizons Session 
NH 11 
MRI of the lungs: Light at the end of the tunnel?
Moderator:
H.‑U. Kauczor; Heidelberg/DE 
A‑289 08:30 
Chairman’s introduction 
H.-U. Kauczor; Heidelberg/DE (hans‑ulrich.kauczor@med.uni‑heidelberg.de) 
MRI of the lung has experienced an impressive series of ground-breaking techno-
logical developments. Almost all of them are related to imaging speed, gating and 
signal enhancement. The potential of visualizing pulmonary vasculature, patho-
logical structures and probing pulmonary microstructure rivals CT. However, the 
capability of MRI to assess “function” in a broader sense is its biggest advantage 
over CT beyond the mere lack of ionizing radiation. Functional MRI of the lung 
includes: perfusion, ventilation, gas exchange, vascular permeability, flow, shunt, 
hemodynamics, right heart function, lung volumes and mechanics, motion. As such, 
the broad spectrum of functional MRI of the lung is capable to replace a series of 
different diagnostic procedures, such as pulmonary function tests, ventilation and 
perfusion scintigraphy, echocardiography, and fluoroscopy. Clinical indications for 
MRI of the lung are congenital cardiovascular and cardiopulmonary abnormalities; 
cystic fibrosis; pulmonary hypertension; lung cancer: differentiation between T3 
and T4 tumors; mediastinal tumors; and malignant pleural mesothelioma. Current 
recommendations for a standard protocol are focused on quality, workflow and 
speed, and allow for completing a MRI of the lung within less than 30 minutes. The 
structural and functional components of MRI of the lung can also be regarded as 
a part of whole body MRI, which gains more and more attention in diagnosis of 
congenital anomalies and diseases; thromboembolic disease; staging in oncology, 
and systemic inflammatory diseases, such as tuberculosis or COPD. 
Session Objectives:
1. To learn about indications of when to use MRI of the lung.
2. To understand the rationale of using MRI of the lung, especially with regard 
to CT.
3. To focus understanding of MRI techniques towards a clinical protocol.
A‑290 08:33 
Challenges for MRI of the lung 
J.M. Wild; Sheffield/UK (j.m.wild@sheffield.ac.uk) 
The talk will be primarily from a technical perspective, focusing on how best to 
image the lungs with MRI at present an how the speaker envisages improvements 
in the years to come. It will cover state-of-the-art imaging methods for 1H MRI of 
lung morphology including the role of parallel imaging. Review of current functional 
imaging methodology with 1H MRI will be given with an overview of pulse sequences 
for ventilation, oxygen enhancement, perfusion (CE and endogeneous) and lung 
dynamics. Discussion includes the role of hyperpolarised gas MRI - technical 
methods and functional sensitivity of 3He and 129Xe MRI in respiratory research. 
The talk will be illustrated with images from Sheffield and other leading lung MRI 
research groups. 
Learning Objectives:
1. To learn about state-of-the-art imaging methods for 1H MRI of lung 
morphology.
2. To understand functional imaging methodology with 1H MRI (ventilation, O2 
enhancement, perfusion (CE and endogeneous), lung dynamics).
3. To appreciate functional lung imaging methodology with hyperpolarised 
gases (3He, 129Xe).
A‑291 08:51 
MRI of neoplastic and inflammatory lung disease 
J. Biederer; Kiel/DE (juergen.biederer@rad.uni‑kiel.de) 
Combining fast breath-hold acquisitions with parallel imaging, shared echo-
technique and rotating phase encoding, MRI of the lung has overcome its former 
well-known limitations. Comprehensive protocols with fast sequences can be 
recommended for a number of indications including neoplastic and inflammatory 
lung disease. The non-contrast-enhanced basic protocol (in-room time 15 min). 
comprises a coronal T2w single-shot half-Fourier TSE (HASTE) sequence with 
a high sensitivity for infiltrates and a transversal T1w 3D-GRE (VIBE) sequence 
with a high sensitivity for small nodular lesions. A motion compensated T2w TSE 
improves depiction of masses with chest wall invasion. This is followed by a coronal 
steady-state free precession sequence (TrueFISP) in free breathing, which is highly 
sensitive for central pulmonary embolism and gross cardiac or respiratory dysfunc-
tion. A final multi-breath-hold transversal fat-saturated T2w-TSE visualizes enlarged 
lymph nodes and skeletal lesions. Unclear masses, consolidation or pleural effusion 
detected in the basic protocol warrant an additional contrast-enhanced fat-saturated 
3D-GRE (VIBE) sequence (plus 5 min). Detection rates for pulmonary infiltrates 
with the basic protocol match CT making it a valuable alternative in particular for 
children, young patients and pregnant women. The sensitivity for lung nodules 
reaches 80-90% for lesions > 4 mm (100% for > 8 mm). Both capacities are ap-
preciated in cystic fibrosis patients for follow-up using dedicated scores of the extent 
of disease. In lung cancer patients, MRI contributes to staging and radiotherapy 
planning by superior soft tissue contrast, e.g. to separate tumour from atelectasis. 
Administration of contrast material contributes to detect tumour necrosis, chest 
wall or mediastinal invasion and pleural reaction/carcinosis. 
Learning Objectives:
1. To outline a basic push-button protocol for 1H MRI of the lung with clinical 
1.5 T scanners.
2. To learn about the scope of MRI for solid and infiltrative lung disease using a 
standard protocol.
3. To become familiar with potential clinical applications and particular 
advantages compared to CT.
4. To observe limitations and pitfalls of 1H MRI.
A‑292 09:09 
MRI of pulmonary vascular disease 
S. Ley; Heidelberg/DE (ley@gmx.de) 
Visualization of the pulmonary arteries can be performed using steady-state free 
precession (SSFP) or contrast-enhanced 3D-GRE sequences (ce-MRA). SSFP 
techniques allow for evaluation of the main and lobar pulmonary arteries. Sensitivity 
on a lobar level was 79% in patients suffering from PE. As these sequences are 
performed in less than a minute, they should be used by default as initial sequences 
of a thoracic examination. High spatial resolution ce-MRA can be acquired in a 
breath-hold of less than 20 s with a spatial resolution in the range of 1.2-1.4 mm3. 
This allows for evaluation of the pulmonary arteries down to a segmental level. Even 
patients with mild to moderate shortness-of-breath are capable of breath-holding 
for this period of time. Therefore, this technique is well suited to rule out central PE 
or any other obstructive disease. One approach to reduce the breath-hold time is 
to acquire two sagittal image slabs (each 10-12 s), one for each lung. In patients 
with chronic thromboembolic disease, this technique showed more pathological 
findings than one coronal acquisition. Reducing the acquisition time to 1-1.5 s, a 3D 
perfusion-weighted (ce-perfusion) dataset can be acquired. Analysis can be done 
visually i.e. by image subtraction revealing perfusion deficits. Obvious perfusion 
defects, either focal or wedge-shaped, can be differentiated from a heterogeneous 
reduction. This basic analysis already allows for characterization of different vascular 
pathologies or diseases of parenchymal origin. Detailed functional information can 
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be gained from quantitative analysis of pulmonary blood flow, pulmonary blood 
volume and mean transit time. 
Learning Objectives:
1. To consolidate knowledge of state-of-the-art imaging methods for high-
spatial and temporal resolution, contrast-enhanced and non-contrast-
enhanced MR agiography of the pulmonary vasculature.
2. To become familiar with the clinical application of MRA of the pulmonary 
vasculature and its comparison to CTA.
3. To appreciate functional imaging of the pulmonary circulation using time-
resolved MRA.
A‑293 09:27 
MRI of ventilation and gas exchange in airway disease 
F. Molinari; Rome/IT (fmolinari@rm.unicatt.it) 
The management of patients with chronic airway disorders, such as asthma and 
COPD, is generally based on the assessment of clinical data and pulmonary func-
tion tests (PFTs). Although PFTs are recommended for diagnosing airway disease 
and grading airflow limitation, their use as a comprehensive tool for evaluating 
lung function has been debated. An individual susceptibility of airway response 
(i.e. inflammation) to external noxae is thought to influence the natural history of 
both asthma and COPD, leading to a considerable heterogeneity of clinical expres-
sion and patient outcome. Different pathogenetic and clinical phenotypes may be 
included in one single category of global lung function damage as determined by 
PFTs. CT and MRI show the regional pulmonary anatomy three-dimensionally. 
Quantitative data regarding lung structure and function can also be obtained 
from both modalities. The high spatial resolution of CT and intrinsic contrast dif-
ference between lung structures and air guarantees excellent definition of small 
changes of airways and lung parenchyma, such as bronchial wall thickening and 
obstruction, air-trapping and centrilobular emphysema. While limited in the ability 
to visualize small-scale lung anatomy, MRI has been used with gaseous contrasts 
to depict pulmonary airspaces and provide information on alveolar gas exchange. 
The possibility to perform longitudinal and interventional studies without radiation 
exposure has added to the understanding of the pathogenesis of asthma. Pulmo-
nary vasculature changes and respiratory muscle dysfunction have been studied 
in COPD using dynamic MRI techniques. All these imaging tools are available to 
identify new morphologic and functional patterns of alterations in airway diseases. 
Learning Objectives:
1. To summarise the clinical needs for imaging lung ventilation and gas 
exchange in airway disease.
2. To appreciate advantages and limitations of MRI in assessing changes of 
lung function related to airway obstruction.
3. To understand how CT and MRI can provide clinically relevant information in 
patients with airway disease.
Panel discussion:  
MRI of the lung: Can it beat CT? 09:45 
08:30 - 10:00 Room I 
Physics in Radiology 
RC 1113 
Diagnostic radiology and pregnancy 
Moderators: 
H. Bosmans; Leuven/BE 
E. Vaño; Madrid/ES 
A‑294 08:30 
A. Conceptus doses and risks from maternal diagnostic X-ray 
examinations 
J. Damilakis; Iraklion/GR (damilaki@med.uoc.gr) 
Whenever a diagnostic X-ray examination of a pregnant patient is considered to be 
necessary, conceptus dose estimation is an important step in assessing the risks 
to the unborn child. Accurate estimation of conceptus dose is also needed after 
inadvertent irradiation of a pregnant patient from a diagnostic X-ray procedure. 
Several methods have been developed to estimate conceptus dose from radiologic 
examinations. When the uterus is remote from the directly exposed tissues, the 
conceptus is exposed to scattered radiation and its dose is negligible (< 1 mGy). 
Examinations involving the abdomen-pelvis may deliver higher dose to the child. 
Variations in maternal body size and uterus position should be taken into account 
to obtain accurate conceptus dose estimation. Multidetector CT (MDCT) scanners 
have replaced conventional CT technology. Conceptus doses from abdominal MDCT 
range from about 11.0 mGy to about 27.0 mGy during the first post-conception 
weeks for a scan acquired at 120 kVp, 200 mAs with a pitch of 1.0, depending on 
maternal body size and uterine position. Multi-phase abdominal MDCT examinations 
may deliver relatively high doses to the unborn child. Doses to the conceptus below 
100 mGy should not be considered a reason for termination of pregnancy. The risk 
to the embryo/fetus for stochastic effects is assessed on the basis of dose using 
appropriate risk factors. Although these risks from a single diagnostic procedure 
are low for the majority of diagnostic X-ray examinations, it is important to ensure 
that doses are kept as low as reasonably achievable. 
Learning Objectives:
1. To learn how to manage and counsel pregnant patients in case of (a) 
intentional and (b) accidental exposure.
2. To learn how to estimate conceptus radiation dose from diagnostic X-ray 
examinations.
3. To learn how to assess the radiogenic risks to the embryo/fetus from 
diagnostic X-ray examinations.
A‑295 09:00 
B. X-ray imaging and pregnancy: Justification and optimisation of 
exposure
P. Vock; Berne/CH (peter.vock@insel.ch) 
As outside pregnancy, justification and optimisation are the main steps to be 
done when an imaging examination using ionising radiation is considered during 
pregnancy. However, the risk concerns the embryo/fetus in addition to the mother 
which means that justification has to be more critical whenever the uterine dose 
is not neglectable. The practical approach to an examination in any woman of 
child-bearing age starts by ruling out pregnancy, whether by history taking or by 
a laboratory test. When pregnancy cannot be ruled out, further steps will depend 
on the type of examination needed and the urgency of diagnostic clarification. 
Ultrasound is the alternative to be preferred when it can answer the clinical ques-
tion. But even among X-ray examinations, the uterine dose is varying widely which 
asks for a careful selection, optimisation and, maybe, for postponing the test. Once 
pregnancy is confirmed, the major question is whether the specific type of diagnostic 
examination will include the uterus in the primary radiation field. Examinations not 
involving the uterus by direct radiation, despite a potentially significant exposure by 
scattered radiation, can usually be performed without a relevant risk to the embryo/
fetus. The situation is more critical when the uterus is within the examination field 
and when therapeutic interventions are considered. The presentation will discuss 
the practical approach to these different situations, the influence of the stage of 
pregnancy, optimisation methods and the choice between alternative methods in 
some frequent clinical situations. 
Learning Objectives:
1. To become familiar with the radiologist’s practical approach to justification 
during pregnancy.
2. To learn how to optimise imaging protocols for X-ray examinations performed 
on pregnant patients.
3. To present the role of imaging modalities in the evaluation of pregnant 
patients.
A‑296 09:30  
C. Pregnancy and MRI: Risks to the unborn child 
J. De Wilde; Edinburgh/UK (jdewilde@staffmail.ed.ac.uk) 
This paper explores the risks to the fetus when Magnetic Resonance Imaging (MRI) 
is used. MRI uses three main components to produce images from inside the body, 
1. A static magnetic field, 2. Pulsed radio-frequency (RF) fields and 3. Time-varying 
gradient electromagnetic fields. The exact frequencies of these fields depend on 
the MRI system purchased, for example; a 0.5T scanner uses 21 MHz RF, a 1.5 T 
system uses 63 MHz and a 3 T system uses 127 MHz RF. There are a wide range 
of options for gradient strengths and slew rates to be considered as well. The 
overall exposure for the fetus depends ultimately on the imaging sequence used. 
This paper will discuss particular hazards that need to be addressed for pregnant 
women including biological effects of the static and time-varying magnetic fields, 
heating effects of the RF pulses and acoustic noise generated by the spatial encod-
ing gradients. The circumstances for fetal exposure in MRI will also be discussed 
including the following situations: the patient may not be aware she is pregnant, 
likely to be in the first trimester; the mother is referred for direct fetal imaging after 
ultrasound (normally 2nd or 3rd Trimester); the expectant mother may need diagnosis; 
research on pregnant volunteers. The exposure for pregnant staff working in MRI 
is also an essential consideration. Finally, how to minimise the exposure for the 
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Learning Objectives:
1. To understand the risks to the fetus in MRI from static and time-varying 
magnetic fields, with particular reference to the radiofrequency field.
2. To consider the exposure of the fetus to noise during MRI.
3. To understand how to minimise the exposure for the fetus during MR 
imaging.
08:30 - 10:00 Room K 
Pediatric 
RC 1112 
Advanced brain MR imaging: Why and when 
Moderator:
J.‑F. Chateil; Bordeaux/FR 
A‑297 08:30 
A. Diffusion tensor imaging 
A. Righini; Milan/IT (neurorad@icp.mi.it) 
Diffusion Tensor Imaging (DTI) studies demonstrate progressive Apparent Diffu-
sion Coefficient (ADC) decrease within gray and white matter areas starting from 
fetal life as sign of brain maturation; at the same time, Fractional Anisotropy (FA) 
increases in some white matter structures. Changes in FA and ADC, together with 
radial and axial diffusivity values, during cell proliferation-migration and during 
myelination, well correlate with modifications known from developmental histology 
studies. Acute ADC decrease (i.e. ischemia) can be detected already in fetal stroke 
and its measure is pivotal in monitoring neonatal hypoxic-ischemic encephalopathy. 
ADC calculation allows also to assess acute osmotic and metabolic anomalies in 
neonate (i.e. hypernatremia, hypoglycaemia, etc). Early FA decrease, with radial 
and axial diffusivity changes, is observed in white matter areas as sign or early 
wallerian degeneration after acute brain damage. Chronic regional white matter 
FA reduction is detectable in sequelae of periventricular leukomalacya or adjacent 
to malformative cortex, but also in older children with neurodevelopmental delay 
(mostly in statistical quantitative studies on autism, ADHD, dyslexia, etc). Finally, 
the building of Fiber Tracking and Color coded (RGB) maps from DTI data may 
help in better characterizing suspected structural anomalies on a single case basis 
(i.e., corpus callosum, hippocampal fornix, optic radiation, cerebellar peduncles 
malformations, etc). However, the potential of Fiber Tracking applications still needs 
to be fully exploited, especially in view of future higher spatial resolution acquisitions. 
Learning Objectives:
1. To learn about the correlation between ADC-FA values and structural 
characteristics of a normal developing brain.
2. To learn about pathology-tissular correlations with ADC-FA value changes in 
CNS pediatric diseases.




L. Astrakas; Ioannina/GR (astrakas@cs.uoi.gr) 
In vivo proton MR spectroscopy (MRS) is a non-invasive MR technique that is 
routinely used to assess a number of pediatric neurologic conditions. It is based 
on the fact that protons belonging to different metabolites have slightly different 
resonance frequencies (chemical shift). Using water suppression and volume 
localization techniques, we can obtain either one spectrum (single voxel) or mul-
tiple spectra (SI) containing metabolite peaks corresponding to predetermined 
anatomical site (s). In pediatrics, the majority of spectroscopy is performed in 
the brain and the metabolites detected usually are: N-acetyl aspartate, N-acetyl 
aspartyl glutamate, creatine and phosphocreatine, choline containing compounds 
(free choline, acetylcholine, phosphocholine, cytidine diphosphate choline, and 
glycerophosphocholine), Myoinositol, myoinositol monophosphate, and glycine, 
aminoacids (glutamine, glutamate, GABA), lactate, lipids and macromolecules. 
These metabolites participate in important metabolic pathways and their levels are 
being disturbed by various pathologies. Thus, MRS has a vast field of applications 
including tumors, infarction, hypoxia, ischemia, infection, inflammation, metabolic 
disorders, neurological disorders and trauma. In many cases, it can redirect or 
narrow differential diagnoses; in selected instances, it may provide the key finding 
that points to a final diagnosis. MR spectroscopy alone is usually not specific, but 
can be very helpful especially in combination with other clinical, diagnostic and 
other MR methods. Particular caution is needed in data evaluation because spec-
tral appearance and concentrations of the metabolites are affected by: a) proper 
selection of experimental and preprocessing factors and b) brain development. 
Learning Objectives:
1. To become familiar with the basic principles of proton MR spectroscopy.
2. To learn what proton MR spectroscopy can offer to the diagnosis and 
monitoring of various pediatric diseases.
3. To learn how MR spectroscopy combines with other MR techniques.
A‑299 09:30 
C. Functional MRI 
L. Hertz-Pannier; Gif sur Yvette/FR (lucie.hertz‑pannier@cea.fr) 
Functional MRI (fMRI) has become the tool of choice for studying the cerebral 
organization of children, due to its non-invasiveness allowing repeat unsuccessful 
studies in patients, and the study of healthy children (by contrast to radionuclide 
studies). However, several technical and physiological issues must be considered 
in order to use fMRI in the pediatric population, pertaining to the developing brain 
(cortical immaturity, ongoing myelination) and to the developmental age (adapted 
tasks, control of performance, reference state). The main difficulty remains to obtain 
the child’s cooperation and avoid head motion. When cooperation cannot be fully 
obtained, «passive» tasks can be used to test perceptual functions and receptive 
language. A comprehensive assessment of brain organization can thus be achieved 
through the combination of neuropsychology and MR techniques (anatomical MRI, 
diffusion tensor imaging and fMRI). Motor, language and visual fMRI paradigms are 
now being used successfully in children, which show activation patterns comparable 
to adults, with a trend toward more diffuse and scattered activation. The main clinical 
application is the assessment of reorganization (plasticity) of eloquent cortices in the 
presurgical workup of epileptic foci or brain tumors near the central or perisylvian 
regions and to tailor resections to avoid postoperative deficits. Nowadays, fMRI can 
replace the invasive Wada test in about 85% of epilepsy surgery patients and shows 
good colocalization of activated cortices when compared with electrical cortical 
stimulation. Further research is needed to outline the clinical contribution of fMRI 
to the management of developmental disorders with specific cognitive impairment. 
Learning Objectives:
1. To understand the basic mechanisms, advantages and limitations of fMRI in 
children.
2. To describe the anatomo-functional organisation and plasticity of the 
developing brain.
3. To describe the main clinical applications of fMRI in children.





P. Blackburn Andersen; Kolding/DK 
C. Garvey; Liverpool/UK 
A‑300 08:30 
A. Interaction between patient and radiographer during radiological 
examinations 
B.T. Andersson; Lund/SE (Bodil‑T.Andersson@med.lu.se) 
Aim: To examine the interaction in encounters in the course of radiographic 
examinations and to be able to understand advantages and difficulties involved.
Background: When a patient attends the hospital in order to undergo a radiographic 
examination he/she is in a need of professional care and support. For many patients 
within the context of diagnostic radiology, concern about the result and insecurity 
pertaining to what will come next can be a major issue. The radiographer has a 
central role as he/she meets the patient before, during and after the radiographic 
examination. It is of paramount importance that the radiographer is familiar with the 
problems involved and can give support during the entire radiographic procedure. 
Method: A descriptive design with a qualitative approach was chosen. Data were 
collected through interviews with radiographers and female patients.
Results: Four different types of encounters were expressed; the empowering, the 
empathetic, the mechanical and the neglectful. The empowering and the empathetic 
encounter gave rise to positive feelings within the patient while the mechanical 
and the neglectful engendered negative feelings. Radiographers’ competence was 
manifested by openness, active listening and by being present in the very short 
and intensive encounter with the patient.
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Conclusion: The quality of the interaction is of great importance to the whole 
radiographic procedure. The challenge for a radiographer in a diagnostic radiology 
department is to have knowledge of when the technology should be in focus and 
how to devote time to the patient and deal with the ambiguity and inseparability 
between them. 
Learning Objectives:
1. To gain knowledge about the interaction in the encounter.
2. To learn more about different types of encounters in the course of 
radiographic examinations.
3. To be able to understand advantages and difficulties involved in the 
interaction in the encounter.
A‑301 09:00 
B. The role of the radiographer in patient advocacy 
V. Challen; Lancaster/UK (val.challen@cumbria.ac.uk) 
Patient advocacy can be seen to be primarily concerned with both promoting and 
protecting the interests of patients; yet there is no single consistent definition of the 
term. A wide variety of patient advocacy models have been developed for the nursing 
profession and more recently five elements of advocacy have been identified as a 
guide for the radiography profession in the UK. Some radiographer job descriptions 
and quality benchmarks often refer to the requirement of the radiographer to act as 
patient advocate; yet often the reality is that the radiographer is not empowered to 
take on such a role either by the employing authority or through self motivation. A 
recent study has shown that advocacy is seen by the majority of radiographers as 
a professional requirement particularly in relation to radiation safety; however, most 
are unwilling to discuss potential radiation doses with patients despite requests 
from patients and carers. Championing ethical and social justice in the healthcare 
environment plus support for patients’ autonomy appears to be underdeveloped 
in many radiographers. These factors could be addressed through appropriate 
education and training in addition to the further development of assertiveness and 
communication skills. Advantages for both patient and radiographer in the undertak-
ing of such roles must be tempered by any perceived limitations whilst at the same 
time acknowledging the changing public expectations of healthcare professionals. 
Learning Objectives:
1. To understand the meaning of patient advocacy in its broadest term.
2. To appreciate the ethical and social factors involved in supporting the 
individual’s autonomy and championing patients’ rights.
3. To identify those factors that may influence and motivate radiographers in 
undertaking patient advocacy.
4. To analyse a number of scenarios involving an advocacy role and 
investigating the feelings and perceptions of radiographers undertaking such 
a role.
A‑302 09:30 
C. Measuring short and long-term consequences of a false-positive 
mammography among women attending breast cancer screening 
programmes 
A. Bolejko; Malmö/SE (anetta.bolejko@skane.se) 
Numerous studies have shown significant short-term negative psychological con-
sequences of a false-positive screening mammography. The consequences may 
for instance appear as increased anxiety, fear, and feeling certain about heaving 
breast cancer. The results regarding long-term psychological effects are, however, 
contradictory. The psychological consequences of a false-positive screening mam-
mography are difficult to measure. Up to now, generic instruments with additional ad 
hoc scales have been used. The generic questionnaires, although with established 
psychometric properties, are developed in general settings or patient populations, 
and as such they may not be sensitive enough to capture all psychological impact of 
a false-positive screening mammography. Results from studies using such measures 
can therefore be viewed as incomplete and remain tentative. Results from ad hoc 
scales are even more ambiguous, as these have not been tested regarding validity 
and reliability at all. The outcome measures conducted must be based on a model 
of the construct being measured, have high content validity, and the psychometric 
properties should be determined in the target population. Recently, a condition 
specific self-report instrument measuring consequences of a false-positive screen-
ing mammography has been established in Denmark. Initial evidence supports its 
reliability and validity, which provides an opportunity to measure such consequences 
in a more accurate and sensitive way. The questionnaire has just been adapted to a 
Swedish context and its content validity in a target population has been determined 
since the equivalence of content relevance and content coverage to the original 
version should be shown prior to use in another culture. 
Learning Objectives:
1. To learn about what is known so far from the literature about short and long-
term consequences of false-positive mammographic screening - truths and 
pitfalls.
2. To be aware of how to test, use and interpret available instruments 
for measuring short and long-term consequences of false-positive 
mammographic screening.
3. To be familiar with the field through examples from Sweden and Denmark.
08:30 - 10:00 Room N/O 




A.A.A. Abdel Razek; Mansoura/EG 
A‑303 08:30 
A. Hypopharyngeal cancer: What you need to know 
C.R. Habermann; Hamburg/DE (c.habermann@uke.uni‑hamburg.de) 
The hypopharynx, or laryngopharynx, is the most caudal portion of the pharynx that 
extent from the laryngeal surface of the epiglottis to the cricopharyngeus. Most authors 
divide the hypopharynx into the piriform sinuses, the posterior wall, and the postcricoid 
region. Occasionally, within the literature, a fourth area of the hypopharynx is described 
as the marginal area, represented by the lateral surface of the aryepiglottic folds. 
However, the larynx itself presents one of the true challenges of head and neck imag-
ing. Consequently, the diagnostic approach to the hypopharyngeal neck is based on 
a brief understanding of the complex anatomy and function of the larynx. Congenital, 
inflammatory, neoplastic, and traumatic abnormalities all affect the larynx. Due to 
endoscopy the clinician mainly has a decided idea of the clinical problem. Although, 
the endoscopist is limited in the ability to define the deep extent of a certain pathol-
ogy relative to precise landmarks. These landmarks determine whether the patient 
is a candidate for a pharyngolaryngectomy, a laryngectomy, a speech conservation 
therapy, or a radio- and/or chemotherapy. The exact knowledge of the different surgical 
approaches is mandatory for the radiologist to ascertain the necessary and most ap-
propriate therapeutic approach and to obtain the best result for the patient. Anatomic 
landmarks and the radiologic appearance in a non-pathologic neck and a pathologic 
involvement of these landmarks will be reviewed extensively in a coherent manner. 
Learning Objectives:
1. To understand the complex anatomy and function of the hypopharynx.
2. To become familiar with the TNM staging of hypopharyngeal neoplasm.
3. To recognise what the clinician needs to know for preoperative planning.
4. To provide a template for a valuable imaging report.
A‑304 09:00 
B. The suspected recurrence: How to deal with it 
R. Hermans; Leuven/BE (Robert.Hermans@uz.kuleuven.ac.be) 
Posttreatment imaging is done when a recurrent tumour is clinically suspected, 
and for confirmation and determining its extent. After radiation therapy, tumour 
recurrence appears on CT or MRI as a soft tissue mass at the primary site. After 
surgery, it appears as a mass along the resection margins. Imaging may also be 
used as a surveillance tool to try to detect recurrent tumour before it becomes clini-
cally evident, possibly with a better chance for successful salvage. Early tumour 
recurrence may be difficult to distinguish from treatment-induced tissue changes. An 
early follow-up CT or MR study, best obtained about 3-6 months after end of treat-
ment, documents treatment-caused changes. By comparing subsequent studies 
with this baseline study, tumour recurrences can be detected with more confidence, 
and often earlier than by clinical follow-up alone. Some authors recommend FDG-
PET as the initial baseline study. If performed 3-4 months after treatment, PET 
has a high negative predictive value, but relatively low positive predictive value. A 
positive posttreatment PET study should be correlated with clinical findings and 
results from other imaging modalities, and histological confirmation is desirable. 
Diffusion-weighted MRI provides information about cell density, cell integrity and 
vascularity, and is applicable in the head and neck region. This technique is very 
sensitive to structural changes in pathologic tissue, even during their very early 
stages of development. Ongoing research suggests that this non-invasive technique, 
not requiring an external contrast agent, may be more specific than FDG-PET in 
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Learning Objectives:
1. To review the expected tissue changes after therapy.
2. To learn the early signs of tumor recurrence.
3. To understand the value of post-treatment surveillance imaging.
4. To appreciate the relative value of different imaging modalities after therapy.
A‑305 09:30 
C. Lymph node imaging from A to Z 
R. Maroldi; Brescia/IT (maroldi@med.unibs.it) 
With the exception of distant metastases, the presence of cervical lymph node me-
tastases is the single most adverse independent prognostic factor in patients with 
head and neck squamous cell carcinoma (HNSCC). This implies that staging of neck 
metastasis is a crucial step in treatment planning. As the sensitivity of ultrasonography, 
CT and MRI in identifying small lymphatic metastases is inadequate, many of the 
patients with no detectable metastases will receive elective treatment of the neck. 
Nor PET/CT presently fully addresses this clinical question. In fact, its sensitivity is 
strictly dictated by the size of the metastasis: excellent when size is 8-9 mm or more, 
very low when diameter is less than 5 mm. Should ‘focused techniques’, like FNAC (or 
functional MR, ADC-based), be applied to the most probable nodal site (s), according 
to primary tumor location? Unfortunately, this strategy does not appear practical, as 
lymphatic drainage patterns from HNSCC are not highly predictable. Nuclear medicine 
techniques such as the sentinel lymph node biopsy may improve the detection rate 
of the lymph-borne target-node. Its role in staging and management of HNSCC is 
yet to be fully established. A second critical issue is the detection of tumor spreading 
beyond the lymphnode capsule (ECS). Its presence reduces survival to 25 to 30%, 
and it is a significant predictor of the development of distant metastasis. The imag-
ing features of ultrasonography, CT and MRI indicating extracapsular tumor spread, 
carotid and vertebral invasion should be well known to the radiologist because they 
have therapeutic and prognostic implications. 
Learning Objectives:
1. To understand the patterns of nodal spread.
2. To review the role of morphological imaging techniques.
3. To review the role of PET/CT.
08:30 - 10:00 Room P 
Chest 
RC 1104 
Bedside chest imaging 
Moderator:
J. Neuwirth; Prague/CZ 
A‑306 08:30 
A. Bedside chest radiography: Technical aspects and main results 
E. Eisenhuber; Vienna/AT (eisenhuber@gmail.com) 
Although bedside chest radiograph is one of the less elaborate imaging examina-
tions in our diagnostic armamentarium, it remains the most frequent radiologic 
procedure performed in intensive care patients. Despite its limitations, chest imag-
ing is an important tool in the management of the critically ill patient. Though the 
advent of digital radiography has vastly contributed to improved image quality of the 
bedside radiographs, optimal positioning and technique remain a real challenge for 
the performing technologist. Additionally, the interpretation of chest radiography in 
the critically ill patient poses a challenge for the radiologist, because findings are 
frequently unspecific and lung opacifications have similar appearances in a variety 
of different cardiopulmonary pathologies. Clinical information and an interdisciplinary 
approach are therefore crucial for optimal interpretation of these chest radiographs.
The American College of Radiology has established expert recommendations for the 
use of bedside chest radiography. Current recommendations suggest that routine 
daily chest radiographs should be reserved for patients with acute cardiopulmonary 
problems and in patients receiving mechanical ventilation. Acquisition of a portable 
chest radiograph is recommended after insertion of endotracheal tubes, central 
venous catheters, pulmonary artery catheters, chest tubes, and nasogastric tubes.
Therefore, knowledge of correct positioning of catheters, tubes, and monitoring 
devices and of various malpositions and associated complications is essential for 
the interpreting radiologist. 
Learning Objectives:
1. To review the technical requirements of portable chest units.
2. To recognise the main patterns of acute pulmonary diseases.
3. To be aware of the limitations of bedside chest radiography.
A‑307 09:00 
B. Role of bedside ultrasonography of the thorax 
K. Vidmar Kocijancic; Ljubljana/SI (ksenija.kocijancic@kclj.si) 
Chest ultrasonography (CHUS) is a useful imaging tool, but limited (because of 
ultrasound physics) to the thoracic soft tissues, pleural space and adjacent pro-
cesses in the lung parenchyma. This non-ionizing imaging method is unlike the 
radiography, CT or MRI, operator created and is very useful in patients at intensive 
care units because of its simplicity, reproducibility and being very useful for the clini-
cians, especially when performed by experts. The ICU patient can be examined in 
supine or sometimes in lateral or partly lateral position with the convex ultrasound 
(US) small radius probes using intercostal spaces as an acoustic window. Supine 
analysis of the anterior chest wall rules out pneumothorax, while lateral approach 
detects clinically relevant pleural effusion and parenchimal consolidations. CHUS is 
a method of choice in detection as well as in characterization and volume estimation 
of free and/or loculated pleural fluid. With CHUS, we can explore and characterize 
lung consolidations from the moment they reach the visceral pleura. They can be in 
contact with pleural line or can be observed through an effusion. Also, in the ques-
tion of pulmonary embolisms in critically ill patients, CHUS could be contributive. 
Sometimes, small pleural effusion can be visible with some peripheral lung tissue 
consolidations indicating minute pulmonary infarction. Typical pulmonary infarction 
is triangular tissue consolidation with air bronchogram and absence of Doppler 
blood flow signals within consolidated lungs. CHUS exploration of the diaphragm 
can reliably evaluate respiratory movements since pleural effusion, even substantial, 
does not affect the amplitude of diaphragmatic excursion. 
Learning Objectives:
1. To understand the role of US as a diagnostic tool in pleural and parenchymal 
diseases in critically ill patients.
2. To review the guidelines for estimation of pleural fluid volume.
3 To discuss the role of US as a guiding modality for bedside pleural/chest 
intervention.
A‑308 09:30 
C. Radiologic-guided bedside interventions of the thorax 
F. Gleeson; Oxford/UK (fergus.gleeson@nds.ox.ac.uk) 
This presentation will review the ultrasound appearances of pleural disease in ward 
and ITU based patients, and will discuss the indications for pleural procedures 
and the complications associated with them. The use of colour Doppler to aid the 
diagnosis of effusions will be discussed, as will the identification of septations 
and the need for intrapleural fibrinolytic therapy. The advantages of guided versus 
blind drain insertion will be presented, and the benefits of large versus small bore 
drains will also be discussed. 
Learning Objectives:
1. To learn when ultrasound-guided thoracic intervention should be performed.
2. To understand how intervention should be performed.
3. To be aware of the complications that may arise from ultrasound-guided 
thoracic intervention.





O.M. van Delden; Amsterdam/NL 
A‑309 08:30 
A. Which IVC filter? 
D.K. Tsetis; Iraklion/GR (tsetis@med.uoc.gr) 
Inferior vena caval (IVC) filters are effective devices for preventing pulmonary embo-
lism (PE). The incidence of fatal recurrent PE is 20%, despite adequate anticoagula-
tion, and typically occurs within the first 3 months after the initiation of anticoagulation 
therapy. The indications for IVC filtration are categorized as absolute, relative and 
prophylactic (absence of venous thromboembolism). Application of IVC filters has 
been expanded to include patients needing short-term IVC filtration. For this purpose, 
several types of optional, retrieval filters have been developed offering protection from 
long-term complications of permant filtratin such as IVC occlusion, caval penetration, 
filter migration or fracture. Conical type IVC filters are attractive designs, due to their 
ability able to trap large clots into the central part of the cava, allowing flow around 
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the periphery and thereby decreasing the chances of caval occlusion. In order to 
extend the retrieval window much longer than the initial recommendation of 10-14 
days, new filters have been designed to minimise effects of endothelialisation on their 
elements which contact the wall of the cava. The majority of these modern devices 
are designed with linear longitudinal struts which are able to slide out from under-
neath caval wall endothelium covering them. Unfortunately, there is little opportunity 
to compare efficacy and complication rates of different filter types, as new designs 
replacing older ones are continuously brought onto the market. 
Learning Objectives:
1. To know the principles of treatment and discuss the indications.
2. To learn about the different types of filters and their imaging appearances.
3. To discuss efficacy of different filters.
A‑310 09:00 
B. Complications of IVC filters and their management 
A. Nicholson; Leeds/UK (tonynick@tonynick.karoo.co.uk) 
Inferior vena cava (IVC) filtration devices were developed in the 1970s as an alter-
native to open caval ligation in patients perceived to be at high risk of pulmonary 
embolism (PE) where anticoagulation was contraindicated or ineffective. Despite 
over three decades of experience, the evidence for their efficacy is lacking, and 
is principally based on case control or observational studies; to date, there is only 
one randomized, controlled trial. Reported immediate complication rates for percu-
taneous filter insertion (and retrieval) are consistently low (in the region of 1%) but 
concerns relating to long-term IVC filtration persist, with reported IVC thrombosis 
rates of between 1 and 28%. There is evidence from the USA of increasing rates 
of IVC filter insertion over the last two decades, despite relatively stable rates of 
thromboembolic disease. Data from the US National Hospital Discharge Survey 
demonstrate increased filter use from 2000 insertions in 1979 to 49,000 in 1999. 
The development of smaller introduction systems and filters, which are potentially 
retrievable, has occurred contemporaneously with this increase. It is likely that the 
ease of insertion of percutaneous devices has reduced the perception of risk, driving 
increasing rates of filter insertion and a broadening of the categories of patients 
for whom a caval filter is considered. The development of retrievable devices may 
have reduced concerns relating to long term IVC filter safety and is likely to have 
contributed to increased rates of filter insertion in a similar manner. This has occurred 
despite evidence that only a proportion of retrievable filters are actually removed. 
Learning Objectives:
1. To review reported complications of filters.
2. To learn strategies to deal with the various complications.
3. To discuss how these may be avoided.
A‑311 09:30 
C. Central venous occlusions in the chest 
A. Basile; Catania/IT (antodoc@yahoo.com) 
Radiological approaches in the diagnostic pathway for central venous occlusion disease 
comprise mainly CT/MR pulmonary angiography and flebography for superior caval 
system. Looking at imaging modalities, angiography has long been considered the 
reference standard that all other techniques have to be measured against. Advantages 
include the option of inducing a therapy, local fibrinolysis-therapy via the angiographic 
catheter in place, angioplasty and stenting etc. Pulmonary embolism leads to right 
ventricular dysfunction and compromised hemodynamics of the cardiopulmonary 
system requires more aggressive treatment than anticoagulation because survival 
depends on rapid recanalization of the pulmonary arterial obstruction and reduction of 
the right ventricular afterload. Percutaneous catheter based treatment is an alternative 
to surgical embolectomy in high-risk patients or in patients with contraindications to 
thrombolytic drugs. Catheter-based thrombolysis accelerates clot lysis and hastens 
the rees-tablishment of normal pulmonary artery circulation, furthermore combined 
techniques with percutaneous thrombectomy including thrombus removal with aspira-
tion, extraction, or fragmentation, may enhance the efficacy. Symptomatic obstruction of 
the superior vena cava and innominate vein of the chest is a debilitating and potentially 
life-threatening condition. Conventional surgery and radiation therapy have a historical 
role in the management of patients with malignant superior vena cava obstruction. 
SVC stenting has become widely accepted in the management of SVCO and has 
also recently been advocated as the first line treatment option in patients with malig-
nant obstruction. Outcomes and complications compare very favorably with standard 
therapies such as chemotherapy and radiotherapy, and although recurrent obstruction 
may occur, most patients can be treated by re-intervention. 
Learning Objectives:
1. To review imaging modalities.
2. To discuss interventional radiological treatment options.
3. To learn about different indications and routes of treatment.
10:30 - 12:00 Room E2 
Interactive Teaching Session 
E³ 1220 
Lung cancer: From plain film to sectional imaging 
Moderator:
G.H. Mostbeck; Vienna/AT 
A‑312 10:30 
Lung cancer: From plain film to sectional imaging 
J. Cáceres1, J. Vilar2; 1Barcelona/ES, 2Valencia/ES (josecac@gmail.com) 
Bronchogenic carcinoma is a main cause of mortality from cancer in the western 
world. Lung cancers are commonly diagnosed in chest radiographs; while some 
are detected, many others are missed. Common and uncommon manifestations in 
the chest radiograph that suggest the diagnosis of lung cancer are thus important 
and must be recognized. Once the diagnosis is made, it is important to perform 
the proper radiological work-up to establish the stage and the adequate treatment. 
Staging is a key factor in lung cancer management and is important for selecting 
the proper imaging technique in individual cases. Finally, in treated patients, imag-
ing is a main aspect of the follow-up. The radiologist must know how to evaluate 
signs of recurrence, which should be distinguished from subclinical diseases and 
post-radiotherapy changes. 
Learning Objectives:
1. To optimise imaging procedures in diagnosing lung cancer.
2. To learn basic facts in staging lung cancer.
3. To detect complications and/or recurrence in treated lung cancer.
12:15 - 12:45 Room A 
Plenary Session 
HL 3 
Maria Sklodowska-Curie - Honorary Lecture
Presiding:
M. Szczerbo-Trojanowska; Lublin/PL 
A‑313 12:15 
Female urinary incontinence: 
Is there still a place for radiology/radiologists? 
A.P. Wieczorek; Lublin/PL (rtg@dsk.lublin.pl) 
Urinary incontinence is an involuntary leakage of the urine. This simple definition 
describes medical condition concerning more than 30% of female population, 
with the incidence increasing with age and parity. This embarrassing complaint 
significantly worsens the quality of life becoming a major society problem. Introduc-
tion of new surgical achievements such as implanting plastic tapes and meshes 
has opened new therapeutic opportunities. However, still between 15 and 30% 
of surgeries do not bring expected outcome. Among the causes of unsuccessful 
surgeries, multifactor background of the condition must be mentioned, as well as 
improper qualification for the operation, which often is based on patient history, 
clinical examination and urodynamics and sometimes additionally on insufficient 
imaging studies. Percentage of failures in surgical treatment of urinary incontinence 
could be decreased involving in the diagnostic process modern imaging tools such 
as MR or high frequency ultrasonography, which are not even mentioned in any 
urogynaecological and proctological guidelines for the management of urinary dys-
functions. Precise assessment of pelvic floor organs is nowadays possible despite 
their complex anatomy and function. This, however, requires close cooperation be-
tween radiologists and clinicians to define the role and place of imaging techniques 
in modern urogynaecology in order to better understand incontinence and provide 
clinically useful information for treatment of women with urinary incontinence. 
Learning Objectives:
1. To comprehend urinary incontinence in women as increasing social problem.
2. To understand the function of pelvic floor organs and modern imaging 
methods allowing their precise visualisation.
3. To become familiar with currently available imaging techniques in diagnostics 








A S83CB D E F G
14:00 - 15:30 Room A 
Extremity Joint MRI 
MC 1325 
Upper extremity: Anatomy, variants and pitfalls 
Moderator:
M. Rupreht; Maribor/SI 
A‑314 14:00 
A. Shoulder 
K. Wörtler; Munich/DE (woertler@roe.med.tum.de) 
The anatomy of the glenohumeral joint is not only complex but also highly variable. 
Anatomic variants are most frequently observed at the labral-bicipital complex 
(sublabral recess), the superior portion of the anterior glenoid labrum (sublabral 
hole, Buford complex), and the superior and middle glenohumeral ligaments (mor-
phologic variations, absence). On cross-sectional imaging, these variants might be 
misdiagnosed as sequels of previous trauma, such as SLAP lesions, injuries of the 
anteroinferior labro-ligamentous complex, or pulley lesions. Other anatomic variants, 
particularly those of the bony elements of the shoulder (abnormal glenoid version, 
glenoid dysplasia, os acromiale) and the long head of biceps tendon, might how-
ever be associated with shoulder pathology, such as glenohumeral instability and 
subacromial impingement. This course reviews the normal cross-sectional anatomy 
of the shoulder, important anatomic variants and typical pitfalls in interpretation. 
Practical guidelines that might prove useful in distinguishing morphologic variants 
and pathologic conditions on the basis of imaging features will be presented. 
Learning Objectives:
1. To become familiar with the anatomy of the shoulder joint.
2. To learn about anatomic variants of the labroligamentous complex, labral-
bicipital complex, and bony elements of the shoulder.
3. To avoid misinterpretations of anatomic variants as pathologic conditions.
4. To learn about useful imaging features in order to distinguish variants from 
labral tears, SLAP lesions and other shoulder pathologies.
A‑315 14:30 
B. Elbow 
M. Zanetti; Zurich/CH (marco.zanetti@balgrist.ch) 
The anatomy of the elbow joint is complex. The common flexor (associated with Golfer 
elbow) and extensor origins (Tennis elbow) dominate the soft tissue supporting struc-
tures medially and laterally. Biceps and brachioradialis anteriorly and triceps posteriorly 
make up the other significant muscles. Several anatomical variants are important for 
MRI interpretation. Extraarticular variants are divided into abnormal signal changes and 
anatomical variation in normal structures. Magic angle signal phenomenon on short 
TE sequences account for a high proportion of ‚normal’ signal variation. The biceps 
tendon and the flexor and extensor entheses are particularly prone. An increased sig-
nal in the ulnar nerve on fluid sensitive MR images is visible in 60% of asymptomatic 
elbows. The distal biceps tendon is commonly seen with two separate splits (-25%). 
Anatomical variations in ligaments are uncommon, though their anatomy is complex. 
The lateral collateral ligament is visible only in 85% of asymptomatic elbows but the 
other elbow ligaments are all visible. Three important nerves cross the elbow and all 
may be compressed by anatomical variants. The ulnar nerve may be compressed 
by an accessory anconeus epitrochlearis. The radial nerve may be compressed by 
fibrous bands, the vascular leash of Henry or between the two heads of supinator. The 
medial nerve may be compressed by an accessory supracondylar process or by the 
bicipital aponeurosis. Variants inside the elbow include joint surface pseudodefects, 
notably the capitellum and trochlea. Synovial folds (not thicker than 2 mm) are normal 
intraarticular structures. The posterolateral plica is seen in 98% asymptomatic elbows. 
Learning Objectives:
1. To review in detail the MRI anatomy of the elbow joint and its relevance to 
disease processes.
2. To consider imaging protocols and techniques directed to the clinical problem.
3. To review the small number of anatomical variants that may be encountered.
A‑316 15:00 
C. Wrist 
A.H. Karantanas; Iraklion/GR (akarantanas@gmail.com) 
MRI has become an important diagnostic tool in the evaluation of wrist pain and 
functional impairment. MRI is able to depict various disorders such as avascular 
necrosis, occult fractures, inflammation, neoplasms, infections, and injuries of the 
triangular fibrocartilage (TFC) and interosseous ligaments. Normal anatomy dem-
onstration by an optimized protocol is a prerequisite for depicting abnormalities. 
The increased SNR provided by high field MR systems (1.5-3.0 T) is important for 
obtaining high-resolution images. Patients should be placed in the prone position 
with the elbow extended overhead and the pronated hand in the center of a dedi-
cated surface or phased array coil placed in the isocenter. The imaging protocol may 
include the following sequences using FOV of 8-10 mm and slice thickness 2-3 mm: 
coronal and transverse T1-w SE and fat suppressed PD-w TSE, coronal STIR and 
3D-GRE and sagittal T1 and T2-w. Contrast-enhanced fat suppressed T1-w SE im-
ages are acquired in cases with clinical indication of inflammation, infections and 
neoplasia. The MR arthrogram is performed with fat suppressed T1-w SE (2 mm) 
in all three planes or with a transverse 3D-T1-w-GRE (1 mm) after intra-articular 
injection of Gd solution (1:200). Pitfalls of wrist MRI include inhomogenous fat sup-
pression, magic angle effect often seen in the abductor pollicis longus and extensor 
pollicis brevis tendons, high signal of ligamentous attachments on hyaline cartilage, 
susceptibility artifacts from previous operations and partial volume effects. Variants 
in the wrist include variable ulnar length, presence of accessory muscles and TFC 
age-related changes and tears in asymptomatic individuals. 
Learning Objectives:
1. To learn about a suggested updated MR technique for imaging the wrist.
2. To understand the normal imaging anatomy.
3. To become familiar with the most common pitfalls and variants that may 
simulate disease.





S. Matthews; Sheffield/UK 
A‑317 14:00 
A. Volume CT assessment of diffuse diseases of the airways 
G.R. Ferretti; Grenoble/FR (GFerretti@chu‑grenoble.fr) 
The diagnosis of airway disease is challenging for the clinician as it has no specific 
clinical or functional features. Volume CT has become the preeminent imaging 
modality for the assessment of the airways and is at the present time the radio-
logical method of choice for investigating a patient suspected of airway disease. 
Volumetric HRCT of the entire lung combining end inspiratory, end expiratory, and 
dynamic expiratory acquisitions demonstrates localized functional information. 
The addition of postprocessing techniques such as maximum intensity projection, 
minimum intensity projection, and multiplanar reformations enhance the diagnostic 
capabilities of CT in showing characteristic findings of airway diseases. Moreover, 
volumetric HRCT assesses the extent and severity of disease. It may be repeated 
for assessing the response to therapy, and often avoid the need for histological 
evaluations. In the presentation, we will review the role of volume CT in patients 
suspected of bronchiectasis, chronic bronchitis, asthma, tracheobronchomalacia, 
and small airway diseases. 
Learning Objectives:
1. To review the advantages of VCT for the diagnosis and characterisation of 
airway abnormalities.
2. To emphasise the post-processing techniques that may contribute to 
improving the visualisation of airway diseases.
3. To recognise the main patterns of small airway diseases on VHRCT.
A‑318 14:30 
B. Quantitative assessment of the airways 
F. Laurent; Pessac/FR (francois.laurent@chu‑bordeaux.fr) 
Methods for noninvasively measuring airway dimensions have been a challenge 
since the site and nature of airway obstruction in chronic airway diseases have been 
recognized. In this respect, the role of Computed Tomography has been essential 
and this course will focus on both the technical aspects and major results obtained 
using this technique. Taking the advantages of the three-dimensional evaluation of 
airways using multidetector CT, recent advances in computer algorithms have made 
possible to measure airway wall and lumen of any visible bronchus on CT images at 
each bronchial generation. Various methods of segmentation of airways have been 
proposed and developed. They will be presented with their respective advantages 
and drawbacks as well as the potential effects of CT technical and visualisation 
Postgraduate Educational Programme
S84 A B C D E F G
parameters and cardiovascular pulsations. So far, no consensus, however, has been 
found for establishing the most appropriate method for measuring airways. In addition, 
the limited spatial resolution of CT does not allow visualising and measuring small 
airways. Nevertheless, many investigators have compared morphometric bronchial 
parameters assessed by CT with functional and histological indexes in various 
chronic airway diseases, i.e. COPD, asthma and cystic fibrosis. Potential applications 
of these results are the definition of phenotypes, non-invasive assessment of airway 
remodeling and inflammation, evaluation of pharmacotherapy. During this course, 
these major features will be reviewed and their significance commented as well as 
discrepancies and contradictions amongst investigations. Finally, conditions of further 
developments including dynamic changes in airway caliber, a likely more appropriate 
method for assessing functional abnormalities, will be presented. 
Learning Objectives:
1. To know the technical requirements of MDCT for a quantitative evaluation of 
large and small airways.
2. To comprehend the various post-processing methods that are useful in 
quantitative evaluation of large and small airways.
3. To understand the potential applications in airway diseases.
A‑319 15:00 
C. CT quantification of pulmonary emphysema 
P.A. Gevenois; Brussels/BE (pierre.alain.gevenois@ulb.ac.be) 
Multi-Detector Row CT (MDCT) provides information on the overall lung structure as 
it relates to diffuse pulmonary diseases such as pulmonary emphysema, which is 
characterized by lung destruction and reduced tissue mass. These changes are as-
sociated with a shift of the attenuation distribution curve toward negative values. As a 
consequence, indexes derived from this distribution - such as the relative area of lung 
occupied by attenuation coefficients lower than a particular threshold and percentile 
of this distribution - can be used as measurements of the extent of pulmonary emphy-
sema. With MDCT, morphometrical comparisons have shown that the relative area 
of lung occupied by attenuation coefficients lower than -960 HU and the 1st percentile 
of the distribution curve are appropriate indexes to reflect both the macroscopic and 
microscopic extents of pulmonary emphysema but that indexes characterizing the size 
distribution of lung areas with attenuation lower than -960 and 1st percentile were not 
appropriate. In order to reduce radiation dose, the tube current-time product can be 
reduced (down to 20 mAs) but as the radiation dose has an effect on CT quantification, 
it should be kept constant in follow-up examination. For the same reason, slice thickness 
should also be kept constant. Based on quantification of pulmonary emphysema as 
part of COPD, MDCT makes now possible its phenotyping. 
Learning Objectives:
1. To understand the morphological features of pulmonary emphysema and the 
basis of CT quantification of pulmonary emphysema.
2. To become familiar with the different CT quantitative indexes and the 
influences of CT parameters on these indexes.
3. To understand the potential role of CT in phenotyping chronic obstructive 
pulmonary disease.
14:00 - 15:30 Room C 
State of the Art Symposium 
SA 13 
Lymph node imaging: Imaging is back! 
Moderator:
J.O. Barentsz; Nijmegen/NL 
A‑320 14:00 
Chairman’s introduction: Can US, CT and MRI challenge PET/CT? 
J.O. Barentsz; Nijmegen/NL (J.Barentsz@rad.umcn.nl) 
The proposed coursed will discuss the various aspects of nodal imaging pertinent to 
cancer staging in the abdomen and pelvis. The anatomical distribution of lymph nodes 
along with the imaging appearance of normal lymph nodes will be discussed along with 
pathways of metastatic nodal spread in various abdominal tumors. The use of state-of-the-
art imaging including US, MDCT, MRI, and PET-scanning for lymph nodes will be outlined. 
Recommendations for optimal imaging planes, optimal spatial resolution, appropriate 
use of contrast agents, and pitfalls will be made. The changing clinical role of imaging 
techniques in relation to nodal dissection will be assessed. Guidelines will be provided 
in which patient group nodal imaging should be performed and in the patients in whom 
imaging is less relevant. Finally, the increasing role of new techniques like multi detector 
high resolution CT, USPIO-MRI, advanced US, PET-scanning and 3D segmentation will 
be presented and discussed. Practical problems general radiologists may encounter using 
these new techniques will be addressed. After this course, the attendees will know where 
the various abdominal anatomical lymph nodes are located, how they can be found on 
cross-sectional images and, more in general, what the criteria are for metastatic nodes. 
They will be able to appropriately use cross-sectional techniques and will be aware of 
new developments and how they can potentially apply them. 
Session Objectives:
1. To appreciate the importance of nodal staging in cancer.
2. To understand the advantages and disadvantages of the various imaging 
techniques.
3. To show which imaging modality should be used for different cancers.
A‑321 14:05 
How and where to use US for nodal diagnosis 
L. Solbiati; Busto Arsizio/IT 
Nodal staging is of crucial importance in the diagnostic work-up and in the follow-up 
of the majority of neoplastic diseases. Sonography (US) plays a fundamental role in 
nodal staging when superficial nodal chains (neck, axilla, groin) are involved, while 
for deep abdominal and retroperitoneal nodal chains CT or MRI provide much higher 
detection rate. US allows to detect superficial adenopathies as small as 2-3 mm, with 
a detection rate higher than that of cross-sectional modalities, but, particularly for very 
small lymph nodes, the critical issue is the differentiation between immunoreactive and 
pathologic (either inflammatory or metastatic) nodes. For this purpose, morphological 
criteria - such as size, shape, echogenicity of the cortex, presence of the hyperechoic 
hilum, calcifications and intranodal necrotic or cystic changes - and vascular patterns 
assessed by color-power Doppler (hilar or peripheral vessel distribution, focal absence of 
perfusion, presence of subcapsular, displaced and/or burnt vessels, etc ..) are generally 
used, with reported sensitivity range of 80-85% and specificity of 85-90%. Recently, 
contrast-enhanced US (CEUS) has been applied to superficial lymph nodes and further 
findings have been described, particularly for the characterization of metastatic nodes, 
i.e. disruption of hilar vascularity, replaced by cortical hypervascularity with tortuous and 
aberrant feeding vessels and intranodal focal areas with early wash-out, representing 
deposits of neoplastic cells or necrotic changes. However, significant limitations in the 
characterization of small metastases in normal-sized or slightly enlarged nodes are still 
encountered, and fine-needle aspiration biopsy (FNAB) remains the main diagnostic 
modality for the final diagnosis in doubtful cases. US can enable more accurate selec-
tion of nodes to submit to FNAB, reducing the number of pathologic assessments and 
is the modality of choice for the guidance of FNAB in all cases. 
Learning Objectives:
1. To appreciate the importance of nodal staging in cancers.
2. To understand the potential and limitations of US in detecting lymph node 
metastases.
3. To show how nodes can be biopsied by US guidance.
A‑322 14:28 
Abdominal and pelvic nodes: Is morphological assessment using CT and 
MR useful? 
D.-M. Koh; Sutton/UK 
Nodal disease is an independent adverse prognostic factor in many cancers. 
Accurate nodal staging is important for treatment planning. Although nodal size 
measurement is still most frequently applied to distinguish between malignant and 
benign lymph nodes, there can be substantial overlap. As such, morphological 
assessment of lymph nodes using CT and/ or MR imaging can help to improve 
nodal staging. Morphological evaluation of nodal shape, nodal contour, presence of 
necrosis, nodal calcifications, nodal clustering, internal nodal heterogeneity, loss of 
fatty nodal hilum and nodal enhancement may improve the detection of malignant 
lymph nodes in patients with cancers prior to treatment. Nevertheless, the limitations 
and pitfalls of using these features for nodal assessment should be understood. Fol-
lowing chemotherapy, a change in nodal morphology may also suggest a response 
to treatment. Nodal assessment using nodal size and morphological appearances 
should be interpreted with the relevant clinical details, laboratory findings, as well 
as history of prior treatment. This combined approach can help to optimise nodal 
assessment using conventional CT and MR imaging. 
Learning Objectives:
1. To appreciate the importance of nodal staging in cancers.
2. To understand the criteria used to assess lymph nodes for malignancy on CT 
and MR.
3. To learn how knowledge of tumor markers, the pathological features of the 
primary malignancy and the pathways of nodal spread can contribute to 
nodal assessment.
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A‑323 14:51 
Nodal staging: MR and beyond? 
J.O. Barentsz; Nijmegen/NL (J.Barentsz@rad.umcn.nl) 
A macrophage-specific magnetic resonance (MR) contrast agent allows the detec-
tion of small and otherwise undetectable lymph node metastases in patients with 
cancer. This has an important clinical impact as the diagnosis will be more precise 
and less invasive to obtain. Subsequently, this will reduce morbidity and health 
care costs. However, thorough knowledge of sequence parameters and planes, 
lymph node anatomy, appearance of normal and abnormal nodes, patterns of 
spread, and pitfalls is essential when using this novel MR-technique. This will be 
elaborated in this presentation. 
Learning Objectives:
1. To show the value of MR imaging in detecting lymph node metastases.
2. To understand which new developments improve the recognition of 
pathologic nodes.
3. To compare the clinical prospects of these novel MRI techniques in relation 
to PET/CT.
Panel discussion:  
Choosing the right modality: Clinical cases 15:14 
14:00 - 15:30 Room D 
Imaging in Lung Diseases 
CC 1318 
Lung perfusion imaging: CT or MR? 
Moderator:
A. Larici; Rome/IT 
A‑324 14:00 
A. Technological basis for lung perfusion with CT 
B. Ghaye; Liège/BE (bghaye@chu.ulg.ac.be) 
Assessment of pulmonary perfusion could be useful in various clinical settings, i.e. 
pulmonary embolism. In this setting, CT pulmonary angiography (CTPA) is able to 
identify clots within distal pulmonary arteries with 95% specificity. The clinical impact 
of PE depends not only on the embolus size but also on the underlying factors, 
including vasoactive agents, vasoconstriction reflex, systemic arterial hypoxemia, 
sequelae of previous episodes of PE, or associated disorders, such as chronic 
obstructive pulmonary disease. Assessment of the impaired microcirculation may 
provide additional information that may be more important for patient treatment 
than the direct visualization of emboli. CT assessment of pulmonary perfusion has 
been attempted by various techniques, including dynamic CM enhancement or a 
dual-phase subtraction technique. Radiation dose is one of the main drawbacks 
precluding the use of repeating acquisitions with CT. With the introduction of dual 
energy CT (DECT), the pulmonary microcirculation can be assessed in a single 
acquisition at acceptable radiation dose. Nevertheless, DECT does not allow a 
true perfusion assessment as vascular iodine content can only be assessed at 
one time-point. However, compared to scintigraphy and MRI, it is the only imaging 
modality able to provide high-quality morphological and functional information on 
the pulmonary circulation from the same data set, justifying the moderate increase 
in the overall radiation dose compared to single-source CT. The aim of this lecture 
is to review the CT techniques to evaluate lung perfusion with special emphasis on 
DECT and to provide the technological basis to understand, perform and optimize 
multi-energy CT scanning. 
Learning Objectives:
1. To understand the technological basis of lung perfusion imaging with MDCT.
2. To describe the current protocols that enable lung perfusion imaging in 
routine clinical practice.
3. To review the various means of optimising image quality.
A‑325 14:30 
B. Clinical experience with CT 
F. Pontana; Lille/FR (fpontana@yahoo.fr) 
The assessment of the pulmonary microcirculation is clinically relevant in numerous 
thoracic disorders and is now accessible to CT. This new trend in evaluating the lung 
perfusion is driven by the technological developments of dual-source multidetector-row 
CT technology which offers the possibility to integrate the evaluation of the capillary 
level by means of dual energy CT (DECT). The analysis of the most distal portion of 
the pulmonary circulation is now available in routine clinical practice and requires, for 
proper interpretation of images, a basic knowledge of the lung perfusion physiology. 
With regard to the diagnosis of acute pulmonary embolism, DECT can detect perfu-
sion defects, well known from scintigraphic perfusion studies. It can also contribute 
to recognize ground glass opacities of vascular origin when a nonspecific pattern of 
ground glass attenuation is depicted on diagnostic images. Alterations in pulmonary 
perfusion can also be integrated in the CT assessment of small airways diseases like 
asthma or COPD. Lung perfusion quantification by DECT can also be considered in 
the preoperative assessment of postoperative pulmonary function in patients with 
severe emphysema or lung cancer. The major clinical impact of these new scanning 
protocols is that morphology and function can be obtained from the same data set, 
with no restriction on the diagnostic performance of high-resolution CT angiographic 
images and with radiation doses below the legally required levels. The purpose of this 
lecture is to review these physiological perspectives offered by DECT in 2010. 
Learning Objectives:
1. To learn about lung perfusion in normal subjects.
2. To describe the basic patterns of abnormal perfusion in clinically relevant 
situations.
3. To become familiar with the most frequently encountered interpretive pitfalls.
A‑326 15:00 
C. MR perfusion imaging 
S. Ley; Heidelberg/DE (ley@gmx.de) 
MRI of the chest is getting more and more accepted for the assessment of diseases of 
the lung parenchyma. Contrast enhanced pulmonary perfusion (ce-perfusion) is a key 
component of recommended MR examination protocols. Image acquisition is easy and 
can be rapidly performed. In principle volumetric datasets with a high-spatial resolution 
are acquired over time during a rapid injection of a contrast agent. These datasets can 
be reformatted as needed allowing for a good delineation of the lobar and segmental 
pulmonary anatomy. Analysis can be done visually i.e. by image subtraction revealing 
perfusion deficits. Obvious perfusion defects, either focal or wedge-shaped can be 
differentiated from a heterogeneous reduction. This basic analysis already allows for 
characterization of different vascular pathologies or diseases of parenchymal origin. 
Detailed functional information can be gained from quantitative analysis of pulmonary 
blood flow, pulmonary blood volume and mean transit time. These parameters show 
excellent agreement with perfusion scintigraphy and H (2)15O positron emission 
tomography (PET). Quantitative perfusion analysis should be applied in patients with 
pulmonary hypertension. Here, a good agreement with pressure measurements could 
be established. MRI of pulmonary perfusion is also well suited for follow-up examinations 
as this technique allows for regional and quantitative therapy monitoring. 
Learning Objectives:
1. To review the practical approach of perfusion imaging with MRI.
2. To become familiar with the functional parameters evaluated with MRI.
3. To describe the advantages and limitations of MRI in comparison with MDCT 
in evaluating lung perfusion.





M. Maas; Amsterdam/NL 
A‑327 14:00 
A. Menisci: Latest advances 
S.J. Eustace; Dublin/IE (seustace@iol.ie) 
This talk will review basic anatomy and function of meniscii and optimum imaging 
techniques using MRI. The talk will then review patterns of meniscal injury, types 
of meniscal tear, and review the concept of medical versus surgical meniscal injury. 
The talk will outline the role of radiology in the management of meniscal cysts and 
finally address current concepts in meniscal transplantation. 
Learning Objectives:
1. To review imaging protocols and anatomy of the menisci.
2. To review MR appearances of commonly encountered meniscal tears.
3. To review implications of imaging appearances on patient outcome and 
management.
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A‑328 14:30 
B. The posterior corners 
J. Hodler; Zurich/CH 
The posterolateral and posteromedial corners of the knee both consist of several 
structures which are important for stabilization. Unfortunately, they are not con-
sistently defined in the literature. Many descriptions of the posterolateral corner 
include the lateral collateral ligament, the popliteal tendon, the popliteofibular liga-
ment and the posterolateral capsule, which is reinforced by the arcuate ligament 
and the fabellofibular ligament. Descriptions of the posteromedial corner also vary. 
The superficial and deep medial collateral ligament as well as the posteromedial 
capsule serve as passive restraining structures. The popliteal oblique ligament may 
not be consistently found as an individual structure. If present, it has a close rela-
tionship with the posteromedial meniscus. The posteromedial corner has also been 
described as the “semimembranosus corner” because of the functional significance 
of the semimembranosus muscle. Up to five semimembranosus expansions have 
been described. Corner lesions are typically associated with injuries of the cruci-
ate ligaments and the menisci. In the acute phase, clinical findings can be difficult 
to interpret due to pain and swelling. Missed injuries of the posterior corners may 
lead to chronic instability, chronic pain, and, eventually, to secondary osteoarthritis. 
They may also adversely affect the outcome of knee surgery such as cruciate liga-
ment repair. MR imaging is the best diagnostic test in suspected corner lesions. It 
demonstrates corner injuries and associated lesions, including those that may be 
overlooked during clinical examination or arthroscopy. 
Learning Objectives:
1. To learn about the anatomy of the posterior corners.
2. To consolidate knowledge about injuries to the posterior corners.
3. To appreciate the role of imaging methods in the diagnosis of posterior 
abnormalities.
A‑329 15:00 
C. The post-operative knee 
C. Glaser; Munich/DE 
As meniscal, ligament and cartilage repair procedures are more and more commonly 
applied there is also a need for post-OP MRI in the knee. This requires knowledge 
from the radiologist regarding the basic principles of repair procedures, what are 
to be considered regular anatomy and normal imaging findings post-OP, how to 
differentiate these from pathologic post-OP evolution. Technically, the MR imaging 
approach has to cope with artifacts arising mostly from magnetic foreign particles 
introducing local field inhomogeneities. The overarching goal of repair procedures 
is to prevent future premature osteoarthritis. Principally, ligament repair aims at 
restoring a stable joint and at providing a quick return to activity. Meniscal surgery 
tries to preserve as much of a stable meniscal substance as possible because of 
the significant meniscal contribution to load bearing. Cartilage repair procedures 
target joint surface congruity. Technically, relaxation time dependent inversion 
recovery sequences provide a much more robust fat suppression than frequency 
based saturation techniques. As simple as it is, careful selection of frequency and 
phase encoding directions with respect to the location of foreign metallic objects 
versus the area of interest are indispensable to help avoid or at least greatly reduce 
artifacts. In addition, use of turbospinecho sequences with short echo spacing, 
short echo times in general, high spatial resolution, high bandwidth contribute to 
artifact suppression. Direct and indirect MR arthrography may be useful to detect 
recurrent/residual meniscal tears and fragmentation/early loosening after menis-
cal/cartilage surgery. 
Learning Objectives:
1. To review principles of repair procedures in the knee.
2. To appreciate technical aspects of imaging the post-operative knee.
3. To discuss normal and pathologic findings when imaging the post-operative knee.
14:00 - 15:30 Room E2 
Interactive Teaching Session 
E³ 1320 
Imaging in common clinical problems: 
Acute abdomen
Moderator:
F. Takis; Keratea/GR 
A‑330 14:00 
Imaging in common clinical problems: Acute abdomen 
A. Palkó1, P.-A. Poletti2; 1Szeged/HU, 2Geneva/CH (palkoand@gmail.com) 
In a general hospital, acute abdomen accounts for 30 to 40% of all emergency surgical 
admissions, and the abdomen is involved in approximately 25% of multi-trauma patients. 
Recent technological advancements have brought to the forefront the importance of 
imaging in the initial assessment and subsequent management of patients admitted 
with acute abdominal conditions. Thus, the role of clinical examination, laboratory 
data and imaging is constantly redefined in new management algorithms, in the strive 
to achieve the highest level of efficiency and to spare medical resources. Abdominal 
traumatic injuries, either isolated or part of more extensive trauma, require immediate 
and reliable imaging evaluation after stabilization of the patient’s condition in order to 
make fast therapeutic decision to reduce mortality to a minimal level. In both traumatic 
and non traumatic acute abdominal conditions, the routine diagnostic work-up scheme 
(plain abdominal X-ray + ultrasound) is more and more frequently replaced by abdominal 
multidetector CT examination extended to other regions if necessary. It is of utmost 
importance for an emergency radiologist to get familiar with the classical signs and 
pitfalls encountered in common traumatic and non-traumatic acute situations, as well as 
to understand the current role and diagnostic efficacy of the different imaging modalities. 
Learning Objectives:
1. To highlight the role of different imaging methods in the radiological work-up 
of patients with acute abdominal pain.
2. To discuss the radiological signs of the most frequently encountered acute 
abdominal pathologies.
3. To present pitfalls in imaging patients with acute abdominal pain.
14:00 - 15:30 Room F1 
Organs from A to Z: Liver 
MC 1319 
Diffuse liver diseases 
Moderator:
A. Besim; Ankara/TR 
A‑331 14:00  
A. Assessment of diffuse liver disease (including cirrhosis) 
L. Martí-Bonmatí; Valencia/ES (marti_lui@gva.es) 
The different MR approaches used to make a clear initial qualitative evaluation in 
diffuse liver disorders will be commented on and complemented with the implemen-
tation of imaging biomarkers to accurately quantify the degree of liver abnormalities. 
MR is unique in its ability to extract information on tissue components and functional 
status. This information has transformed the way imaging interacts in clinical sce-
narios of liver disorders. MR can accurate evaluate the degree of liver steatosis with 
the use of chemical shift and TSE fat suppression imaging. New tools (separation 
of water and fat signals with gradient asymmetric echo and spectroscopy) may be 
even more precise. Also, non-invasiveness iron concentration can be now calculated 
with multiecho T2* relaxometry techniques and even with simple monoexponential 
T2 decay signal intensity calculations. The degree of water in the parenchyma can 
be also inferred with the use of STIR images, thereby, allowing the diagnosis of 
steatohepatitis and grading the necroinflammatory infiltrate in cirrhosis. The pres-
ence of liver fibrosis directly affects the isotropy conditions of the water molecules, 
suffering from a higher restriction to movement. With IVIM, a restricted diffusion in 
patients with cirrhosis is mainly related to variations in the perfusion component 
as well as alterations in pure molecular water diffusion in cirrhotic livers. The liver 
perfusion characteristics may be also of interest in the evaluation of fibrosis and 
inflammation. MR Elastography and MR Spectroscopy with metabololomic quantita-
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Learning Objectives:
1. To learn the imaging features of cirrhotic diffuse liver disease.
2. To learn the imaging features of non-cirrhotic diffuse liver disease.
3. To learn how imaging can help in the quantification and follow-up of diffuse 
liver disease.
A‑332 14:30 
B. Infectious diseases of the liver 
O. Akhan; Ankara/TR (akhano@tr.net) 
Infectious diseases of the liver include pyogenic and amoebic abscesses, parasitic 
diseases such as hydatid diseases and schistosomiasis, fungal, viral and granulmat-
ous diseases such as tuberculosis. Infectious organisms may enter into the liver 
by hematogenous spread via the hepatic artery or portal vein, ascension of the 
infection from biliary tract or direct extension from penetrating trauma. The number 
of the patients with liver infections is increasing in the daily practice because of 
the increases in immigration and travel worldwide besides higher rate of immu-
nocompromised patients. Imaging modalities such as ultrasonography, computed 
tomography and Magnetic resonance imaging play important roles in the detection 
and differential diagnosis of liver infections. Features of imaging modalities with 
appropriate clinical information are needed to obtain the most likely diagnosis in 
most of the cases with liver infections. However, percutaneous biopsy is indicated 
to achieve the correct diagnosis in the others. Characteristic imaging features 
demonstrated in different liver infectious diseases may lead to early diagnosis, so 
that appropriate treatment can be performed accordingly. Besides the advances of 
the diagnosis, percutaneous treatment techniques under imaging guidance have 
already gained a major role in the treatment of liver abscesses and liver hydatid 
diseases. Percutaneous approach has already become the first choice in the treat-
ment of liver pyogenic abscesses and hydatid cysts. 
Learning Objectives:
1. To learn relevant epidemiology of infectious diseases of the liver.
2. To appreciate imaging findings of infectious disease in both 
immunocompromised and non-immunocompromised patients.
3. To understand the technique, indications and results of image-guided 
procedures in the management of infectious diseases of the liver.
A‑333 15:00 
C. Vascular diseases of the liver: Detection and role of transplantation 
V. Vilgrain; Clichy/FR (valerie.vilgrain@bjn.aphp.fr) 
There are three different vascular systems in the liver. Arterial diseases are uncom-
mon and mostly observed after transarterial chemo-embolisation or liver transplanta-
tion. These abnormalities will not be covered it this lecture. Portal venous obstruction 
may be due to tumoral obstruction mostly related to hepatocellular carcinoma or 
clotting (portal venous thrombosis). Risk factors for portal vein thrombosis (PVT) 
are liver cirrhosis, intra-abdominal infection, and thrombophilic disorders including 
myeloproliferative diseases. Diagnosis of PVT is based on imaging-studies and 
among them computed tomography plays an important role. Imaging is also helpful 
to differentiate acute stage from chronic stage and to evaluate the complications 
related to PVT including portal hypertension. Anticoagulation is strongly indicated 
in acute PVT as complete or partial repermeation can be achieved in most patients. 
Other treatments are exceptional. On the other hand, if extrahepatic PVT is pres-
ent, liver transplantation is much more complicated. The hepatic venous system 
extends from the central veins of the hepatic lobule, up to the hepatic vein ostia into 
the inferior vena cava. Most of the other disorders of the hepatic venous system 
eventually cause its obstruction. The so-called Budd-Chiari syndrome is the liver 
disease resulting from the hepatic venous outflow block. Primary BCS relates to 
the primary venous lesions including phlebitis, thrombosis or fibrosis. Diagnosis 
of PVT is based on imaging-studies and among them Doppler ultrasound and MR 
imaging play an important role. Anticoagulation and therapy for underlying disease 
are crucial. Portosystemic shunting and liver transplantation are discussed in 
symptomatic patients after anticoagulation. 
Learning Objectives:
1. To understand the imaging findings associated with vascular abnormalities 
within the liver.
2. To learn the indications of liver transplantation in vascular diseases.
3. To learn the importance of vascular assessment before liver transplantation 
and to recognise vascular abnormalities that may render difficult or even 
contra-indicate liver transplantation.
14:00 - 15:30 Room F2 
Breast 
RC 1302 
Screening programmes: New challenges 
Moderator:
S.B.G. Grover; New Delhi/IN 
A‑334 14:00 
A. Digital mammography screening 
M.J. Yaffe, R.A. Jong; Toronto, ON/CA (martin.yaffe@swri.ca) 
In the DMIST trial of mammography screening, conducted in North America, 
digital mammography was demonstrated to provide superior accuracy to screen 
film mammography, but only for certain overlapping subgroups, women with dense 
breasts and women under the age of 50. The performance of digital mammography 
is achieved through an interplay of new technology and image processing software, 
interfaced to a digital archiving system (PACS). The hardware consists of the X-ray 
detector system and the high-resolution computer image display. The software 
includes several types of image processing designed to facilitate interpretation 
of the examination and to improve performance at detection and characterization 
of lesions. Interestingly, unlike screen-film mammography, where the technology 
is fairly homogeneous, in digital mammography there is considerable diversity in 
the designs of the detector systems and variation in their physical performance 
characteristics including spatial resolution and noise. Most mammographic signs 
of cancer provide subtle contrast and in general digital mammography systems are 
designed to amplify these contrasts at the expense of spatial resolution. Depend-
ing on the technology used, they may also provide advantages in terms of dose 
reduction and improved throughput of imaging. In this presentation, some of the 
technical factors (detector, display, software and PACS) and their influence on the 
diagnostic performance and practicality of digital mammography in the context of 
screening will be discussed. 
Learning Objectives:
1. To describe conditions for digital screening.
2. To describe different systems.
3. To discuss the influence of digital screening on outcomes.
A‑335 14:30 
B. Are CAD systems of any help in screening? 
P.A.T. Baltzer; Jena/DE (pascal.baltzer@med.uni‑jena.de) 
The basic concept of “Computer Assisted Diagnosis” (CAD) in radiology is to 
simplify data analysis by use of computer techniques. The reader of a study is as-
sisted by semiautomated analyses, which can be detection or characterization of 
suspicious areas. Prospective use of statistical models derived from a previously 
analyzed representative case database or implementation of machine learning 
methods lead to the more sophisticated concept of “Computer Diagnosis”. In such 
a setting, the computer is able to detect lesions and calculate their respective 
probability of malignancy, acting as a second reader opinion. Up to now, only CAD 
systems are available commercially. The use of CAD in X-ray mammography is 
quite well analyzed. Most of these systems assist the reader by detecting suspi-
cious lesions or microcalcifications. A high computer sensitivity is controlled for 
specificity by a human reader. In MR-mammography, CAD systems so far focused 
on semiquantitative analysis of dynamic enhancement features. A threshold for 
initial enhancement is used to segment dynamic volume data. All image voxels 
passing the initial enhancement threshold are further differentiated by their en-
hancement characteristics. Parametric maps visualize results as a color-coded 
overlay. Furthermore, enhancement characteristics as well as lesion volumes can 
be assessed quantitatively. Results can be integrated into a BIRADS based report 
mask. The idea is to standardize and simplify reporting of MR-mammography and 
thus to improve the diagnostic workflow. This talk will discuss possibilities of CAD 
in clinical workflow considering different CAD concepts and critically evaluate the 
possible value of CAD in screening with MR-mammography. 
Learning Objectives:
1. To discuss CAD in clinical workflow.
2. To discuss different types of CAD in MRI.
3. To evaluate the value of CAD in screening with breast MRI.
Postgraduate Educational Programme
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A‑336 15:00 
C. Screening with MRI: The future? 
H. Dobson; Glasgow/UK (hilary.dobson@ggc.scot.nhs.uk) 
Population base screening for breast cancer with mammography has a strong evi-
dence base and is used widely throughout the world. Since its inception, refinements 
of the mammographic process e.g. with the introduction of digital mammography 
and extension of policy to include younger and older women from the initial cohort of 
50-74, have been introduced. In the U.K., recent mortality evaluations have shown 
generalised improvement, in part due to the contribution by screening as a result 
of the detection of “earlier” disease. More recently, MRI has an established role in 
improving cancer detection in populations deemed to be at high risk as a result of 
familial history/genetic mutation. This evidence base has resulted in a revision to 
the surveillance guidelines in the U.K. Conflicting evidence, however, exists with 
regard to the use of MRI “screening” of women recently diagnosed with breast 
cancer but being assessed for surgical conservation and a review of the literature 
(including ACRIN6667 and COMICE) will be presented. Evidence fails to show a 
cost effectiveness basis for the use of MRI as a “screening” modality undergoing 
follow-up following treatment for breast cancer. A recent study evaluating the use 
of MRI as a screening tool in young women have identified a potential increase in 
detection rate of ductal carcinoma in situ (DCIS) but further work is required. MRI 
screening of general population will be discussed in a cost effectiveness context. 
Learning Objectives:
1. To give an overview of where we are now.
2. To discuss the role of conventional imaging in screening together with MRI.
3. To discuss the future role of screening with MRI.







A. The new MS diagnostic criteria 
B. Góraj; Nijmegen/NL (B.Goraj@rad.umcn.nl) 
Multiple sclerosis (MS) is the most common demyelinating disease. It can affect relatively 
young people and progressively lead to a serious invalidation and even death. It has 
been first recognized and described as the clinical entity together with its histopathologi-
cal substrate in the end of the 19th century. From this time on, diverse variants and forms 
of the disease have been identified besides the classical MS. The clinical course of MS 
does not follow the uniform pattern; several possible forms have been distinguished. 
The diagnosis of MS relied for many years on the clinical assessment and then also on 
the presence of the CSF findings. Unfortunately, due to the frequently not unequivocal 
clinical manifestation, mimicking other disorders and to the low specificity of the CSF 
abnormalities, the diagnosis of MS remained difficult. The advent of MRI has changed 
this situation dramatically; the new tool has been found, able to depict directly the le-
sions in the brain. Visualisation of the demyelinated “plaques” has made it possible to 
diagnose MS on the basis of the presence and typical configuration of the lesions as 
seen on MRI scans of the brain and spinal cord. MRI techniques enable to document 
the dissemination of the lesions in space and time - essential for the definition of MS. 
The combination of clinical, laboratory and imaging parameters are being designed and 
constantly updated to serve as diagnostic criteria for the diagnosis of MS. 
Learning Objectives:
1. To understand the pathomechanisms which lead to different MRI 
manifestations of MS.
2. To become familiar with diverse forms and variants of MS.
3. To review the current diagnostic criteria for MS.
A‑338 14:30 
B. Early diagnosis and differential neuroimaging issues in dementia 
M.P. Wattjes; Amsterdam/NL (m.wattjes@vumc.nl) 
The diagnosis of dementia is based on clinical findings within a multidisciplinary 
diagnostic setting. Clinical neuroimaging is increasingly being used and has become 
one of the most important paraclinical tools in the diagnosis of dementia. According 
to current guidelines, neuroimaging should be performed at least once during the 
diagnostic work-up of patients with suspected or definite dementia. Initially, neuro-
imaging was used to identify or exclude potentially treatable causes of dementia 
which accounts only for a small proportion of all causes of dementia. Currently, the 
role of neuroimaging goes far beyond these purposes. Computed tomography (CT) 
and magnetic resonance imaging (MRI) are able to identify and quantify the amount 
regional/global cortical atrophy, hippocampus atrophy as well as detect vascular 
damage. On structural MRI or CT, we are able to identify certain atrophy patterns 
which can substantially aid diagnosis in dementia. Particularly in early disease 
stages, advanced imaging techniques such as positron emission tomography (PET) 
and single photon emission computed tomography (SPECT) can be valuable tools 
to further improve the ability to differentiate among different neurodegenerative dis-
eases. Using special tracers such as the Pittsburgh Compound -B (PIB) ligand, we 
are able to directly detect amyloid depositions in the brain which is helpful to narrow 
the differential diagnosis and to differentiate between Alzheimer pathology and other 
neurodegenerative diseases causing dementia. In addition to the role of neuroimaging 
for diagnostic purposes, MRI and other advanced imaging modalities have already 
become indispensable tools for treatment and safety monitoring in clinical trials. 
Learning Objectives:
1. To learn the additional value of clinical neuroimaging in dementia in terms of 
the exclusion of curable causes.
2. To discuss the key features of an imaging protocol for patients with dementia 
on MRI and MDCT.
3. To learn typical atrophy patterns and other imaging findings of 
neurodegenerative diseases.
4. To learn the diagnostic criteria and imaging findings in vascular dementia.
A‑339 15:00 
C. Neuroimaging in abnormal movement diseases 
B. Gómez-Ansón, E. Granell Moreno; Barcelona/ES (bgomeza@santpau.cat) 
Movement diseases including Parkinson´s disease, atypical Parkinsonisms, 
Huntington´s disease, Fragile X Chromosome Tremor Associated Ataxia Syndrome 
(FXTAS), essential tremor, and spinocerebellar ataxias, among others, have been tra-
ditionally described and classified on phenotypical (clinical) features. Recent advances 
on their underlying genetic, biochemical, pathological and neuroimaging features have 
produced the necessity for their reclassification. The association of cognitive decline to 
some of these conditions has produced the emergence of new concepts/entities, such 
as Parkinson´s Disease Dementia or cognitive decline associated to taupathies. Ad-
ditionally, novel treatment options, both pharmacological and in functional neurosurgery, 
have produced the necessity for improving early and precise diagnosis. Although neu-
roimaging features have been described in groups of patients having various abnormal 
movement disorders, a challenge still remains for neuroimaging to precisely characterize 
a single subject´s pathological condition. Neuroimaging methods, including modern 
postprocessing/anaylysis approaches, such as Voxel based Morphometry (VBM) or 
pattern recognition, may provide further insights in this regards in the very near future. 
For this, multicentric, large-scale efforts to create large databanks of multidisciplinary 
information, aiming at linking the different types, are needed. 
Learning Objectives:
1. To give an overview of the current classification of abnormal movement 
diseases, including clinical, biochemical, and genetic data.
2. To summarise the imaging findings described in these conditions.
3. To present the challenges for neuroimaging in the field for the very near 
future.
14:00 - 15:30 Room I 
Physics in Radiology 
RC 1313 
Radiation dose management 
Moderators: 
M. Koutalonis; London/UK 
J.N. Vassileva; Sofia/BG 
A‑340 14:00 
A. Justification in clinical practice 
J.R. Mayo; Vancouver, BC/CA (jmayo@vanhosp.bc.ca) 
Justification and dose optimization form the foundation of medical radiation dose 
management. Justification ensures that the benefit derived from the radiologic 
examination exceeds the risk imparted by: administered radiation, derived infor-
mation and societal cost. The justification decision can only be completed using 
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clinician’s differential diagnosis, experience, tolerance for diagnostic certainty; 
radiologist’s expertise, experience, tolerance for diagnostic certainty, knowledge 
of radiation risk; society’s provision of equipment, resource balancing perceived 
need. The weighting of any one factor may determine the final imaging decision. In 
majority of cases, the information available for the calculation of risk benefit is either; 
ignored, unrecognized, irrelevant, or nonexistent. Therefore, majority of imaging 
decisions are arbitrary. The increased utilization of expensive, high radiation dose 
imaging examinations is forcing the radiologic community to address this problem, 
with the poster child modality being CT. This review will provide an overview of the 
estimated extent of unjustified examinations and outline the currently implemented 
solution, clinical practice guidelines supported by clinical outcome data. The ultimate 
goal of justification is to provide all parties relevant risk and benefit information at 
the time of radiologic consultation. 
Learning Objectives:
1. To illustrate benefit-to-risk ratios for common CT examinations.
2. To review the evidence that suggests harm may be caused by the radiation 
dose delivered in medical imaging.
3. To outline a simple method of dose calculation for CT, the conversion of dose 
length product to effective dose.
A‑341 14:30 
B. Practical CT dose reduction strategies 
W.A. Kalender; Erlangen/DE (willi.kalender@imp.uni‑erlangen.de) 
It is generally known that dose depends on scan parameters such as tube voltage 
(kV) and time-current product (mAs); the basic relationships will be reviewed briefly. 
It is less well known and actually a very complex question how a desired image qual-
ity level, in particular a specific contrast-to-noise-ratio, can be achieved at minimal 
dose. Respective optimization efforts also have to take the imaging task into ac-
count, i.e. the question if soft tissue, contrast medium or bone is to be imaged. Tube 
current modulation and especially automatic exposure control which are available 
on modern CT scanners try and help the user with this task; respective concepts 
and technical implementations will be reviewed in detail. They allow working at a 
desired noise and resolution level by adapting the scan parameters automatically. 
Technical approaches, e.g. new image reconstruction approaches or detector 
materials, which may help to reduce dose further and which will likely become 
available routinely in the future, will be covered briefly to indicate their potential. 
Learning Objectives:
1. To understand how patient dose relates to the choices of standard scan 
parameters.
2. To understand the concepts of tube current modulation and automatic 
exposure control for CT.
3. To learn about new technical approaches to dose reduction.
A‑342 15:00 
C. Digital vs conventional radiography: What about the dose? 
J.R.G. Persliden; Örebro/SE (Jan.Persliden@orebroll.se) 
Digital radiography gives new possibilities to optimise the radiographic images. 
The radiation dose in digital radiography can often be substantially reduced. This, 
however, depends among other factors on the radiation detector used. Using CR 
(computed radiography), the doses have been shown in several studies to be ap-
proximately of the same magnitude as those in film screen radiography. Using flat 
panel detectors, the dose in some examinations have been reduced by up to 70% 
compared to the film screen dose. The new detectors dynamic range means that 
we no longer need to expose the image to the same density as before to avoid over 
or under exposure. We can now expose the image to the level where the noise no 
longer is disturbing the interpretation and let the computer adjust the grey scale 
level. Examples will be given on how to reduce the dose down to an acceptable 
noise level in lumbar spine and urography examinations. On the other hand, it is also 
possible to increase the dose without over exposing the image. An example will be 
given where the use of a digital fluoroscopy system substantially increased the dose. 
Using digital techniques, it is also possible to process the image, reduce the noise, 
enhance edges, etc. Factorial experiments have been performed to find optimal 
exposure and processing settings in, as an example, lumbar spine examinations. 
Learning Objectives:
1. To present radiation dose levels associated with digital radiography.
2. To become familiar with practical dose reduction methods in digital 
radiography.
3. To compare doses of conventional and digital radiography.





S. Ryan; Dublin/IE 
A‑343 14:00 
A. CT in children: Dose reduction strategies 
R.A.J. Nievelstein; Utrecht/NL (R.A.J.Nievelstein@umcutrecht.nl) 
The revolutionary development in multidetector CT (MDCT) technology during the 
past decade has contributed to a substantial increase in its diagnostic applications 
and accuracy in children. A major drawback of MDCT is the use of ionizing radiation 
with the risks of radiation induced side effects, of which the induction of secondary 
cancer is the most important. Therefore, justification and optimization of paediatric 
MDCT is of great importance in order to reduce these risks as much as possible 
(„As low as reasonably achievable“ principle). Optimization of paediatric MDCT 
starts with a solid understanding of all technical aspects of CT, including the most 
relevant scan parameters, dose reduction techniques and technique of IV contrast 
material administration. Furthermore, due to the smaller size and lack of visceral fat 
in young children, the interaction and absorption of radiation will be different which 
will influence the choice of the various technique and scan parameters. Although all 
these issues are pivotal for a successful CT examination, it may become worthless 
if the importance of pre-scan issues such as justification and patient preparation 
are ignored. After a short overview concerning the current knowledge on radiation 
related risks in children, this lecture will focus on several aspects relevant for MDCT 
optimization in children. Issues like justification, patient preparation, technique 
and scan parameters and contrast administration will be addressed. Finally, some 
guidelines for radiation dose level based CT protocols will be given. 
Learning Objectives:
1. To outline the current knowledge on radiation risks in children.
2. To discuss the CT scan and technique parameters that influence radiation 
dose.
3. To discuss dose reducing strategies in order to optimise CT in children.
A‑344 14:30 
B. Ensuring safety for infants undergoing MRI 
T.G. Maris; Iraklion/GR (tmaris@med.uoc.gr) 
Purpose: To present an overview of the safety hazards and safety protocols related 
to infants undergoing MRI examinations.
Methods and Materials: MRI infrastructure dependent safety hazards originating 
from: (a) static and fringe magnetic fields, (b) gradient subsystems, (c) radiofre-
quency subsystems and (d) acoustic noise sound pressure will be reviewed and 
discussed. Safety hazards related to upcoming technological issues and future 
trends concerning MRI will be presented. The current status of the organizations 
responsible to the problems of MR safety will be reviewed. An optimized protocol 
related to a variety of clinical MR sequences in reference to temperature measure-
ments, EMF measurements, SAR and acoustic noise figures using basic com-
mercially available infrastructure will be presented. 2D/3D TSE sequences with 
different ETLs, 2D/3D GRE, 2D/3D SSFP, SE/GRE EPI sequences with multi-(b) 
diffusion gradients and 3D TOF MR angiography sequences will be examined. In 
vitro measurements of SNR, spatial resolution and scan times will be performed 
for each clinical MR sequence.
Results: A comprehensive MRI equipment operational policy (optima: (ETL, TR, 
TE, b-value, EPI factor, SAR, SNR, Spatial Resolution, Scan time etc)) for a safety 
protocol for infants undergoing MRI is proposed. Recommendations for safe infant 
MRI examinations will be summarized and presented.
Conclusion: MRI equipment can operate safely for infant imaging but require 
policies and procedures beyond those required for standard diagnostic MRI 
examinations. 
Learning Objectives:
1. To present an overview of the three basic safety hazards related to infants 
undergoing MRI examinations.
2. To present safety hazards related to upcoming technological issues and 
future trends.
3. To present a safety protocol that could be applied in MRI examinations for 
infants.
Postgraduate Educational Programme
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A‑345 15:00 
C. Fetal MRI: Attitudes towards safety 
D. Price; London/UK (david.price@uclh.nhs.uk) 
With the development of ultra-fast imaging techniques such as EPI and HASTE, 
MRI has become a very important tool in the assessment of fetal abnormalities 
particularly in the brain. However, there a number of potential hazards associated 
with the use of this technique. The developing fetus will be exposed to both static 
and time-varying magnetic fields. There is also the potential for raised fetal tem-
peratures due to RF power deposition. Ultra fast MRI scans may also have high 
acoustic noise levels. Current evidence suggests that RF heating and acoustic noise 
are the most concerning issues. However, there is a great deal of uncertainty over 
any possible effects. At present, published follow-up studies of children exposed to 
MRI in-utero have not shown any strong evidence of detrimental effects. However, 
these studies have been on a small scale. Various national and international regu-
latory and advisory bodies have published guidance on MRI safety which include 
considerations of the pregnant patient and the fetus. Commercial MRI systems also 
operate to an IEC safety standard. In particular, this aims to restrict temperature 
rises within the patient through the use of specific absorption rate (SAR) limits. On 
the basis of our present knowledge, it is prudent to remain within the ‘normal’ mode 
of operation with regard to SAR exposure. It is also important, so far as possible, 
to reduce the maternal stress induced by the examination; for instance, through 
the provision of adequate hearing protection. 
Learning Objectives:
1. To understand the possible hazards to the fetus from MRI including RF 
power deposition and acoustic noise.
2. To achieve an awareness of the current evidence in the literature as to the 
extent of the hazards.
3. To achieve an awareness of the current guidance from safety advisory bodies.
4. To understand protective measures that may be considered as part of a risk-
benefit analysis for fetal imaging.





M. Golebiowski; Warsaw/PL 
D. Pekarovic; Ljubljana/SI 
A‑346 14:00 
A. CT of the GI system 
M. Leidner; Stockholm/SE (Madeleine@Leidner.se) 
CT of the small bowel and the colon is done in our department for many years now. 
As the technique gets better with the possibility to have thinner slices and shorter 
scan time, the exams are of course better today than when we started with CT of 
the GI tract. We started with a 4 slice scanner, then a 16 slice scanner and now 
with a 64 slice scanner we can really see the difference in images quality. The new 
technique also gives us nice reformatted images in other plans like coronal and 
sagital. At first, we used air for the colon and there had to be a doctor to insufflate 
the air; now we use carbon dioxide and with automated insufflations. This means that 
we get a much better colonic distention and it is easier for the patient. Now, we have 
some radiographers doing the examinations. For the small bowel we use negative 
contrast media, either Guaran (through a tube) or VoLumen to drink. The best is 
to administrate the contrast trough a nasogastric tube, but that means that there 
has to be a doctor to insert the tube. Both examinations need intravenous contrast 
media and we give 500 mg Iodine based on body weight. The delay for the colon 
is 70 seconds (venous phase) and for the small bowel 50 seconds (enteric phase) 
to see the enhancement in the bowel wall. We always scan the whole abdomen. 
Learning Objectives:
1. To learn about CT of the GI tract, especially the small bowel and colon.
2. To understand the MDCT technique and how to improve image quality using 
examples from 4, 16 and 64 slice scanners.
3. To become familiar with how to prepare the patient, the use of different 
contrast media, protocols for scanning and how to present the images for 
the doctor.
A‑347 14:45 
B. Introduction to PET/CT: Modalities and patient care 
K.J. Thomsen; Odense/DK 
In this presentation, the basics behind PET/CT will be presented giving an insight in the 
configuration of the scanner hardware and how the images are made. The technique 
is not as far away from X-rays as one should think. It is just turned a little upside down. 
The patient is the part emitting the radiation instead of the X-ray tube, and the PET 
crystal detects the radiation and converts it into useable images. The challenge in this 
process is the patient who becomes more or less radioactive. Rule number one: keeping 
distance very much applies here. And, of course, as little patient contact as possible. 
Lead is also used in protecting the staff but unfortunately the patient emits 511 KeV 
and so protective clothing made of lead is not an option. PET is a functional examina-
tion much like ultrasound and urography. PET shows metabolic active cells. However, 
it can be difficult to say exactly which organ is affected. This is where the CT comes in. 
When the two types of images are fused, it is easier to see which organs are involved 
and thereby making a more exact diagnosis which will be illustrated. 
Learning Objectives:
1. To understand the basics behind PET/CT scanning, hardware configuration etc.
2. To learn about the special problems/challenges when the patient is 
radioactive.
3. To learn about the advantages in diagnosing diseases with PET/CT.
14:00 - 15:30 Room N/O 
Genitourinary 
RC 1307 
Uterus: Imaging and intervention 
Moderator:
R. Forstner; Salzburg/AT 
A‑348 14:00 
A. Benign diseases 
T.M. Cunha; Lisbon/PT (tmargarida@netcabo.pt) 
Benign diseases of the uterus can be evaluated by US, MRI, hysterography, hystero-
sonography and hysteroscopy. Combined transabdominal and transvaginal US is the 
study of choice for the initial evaluation. The use of MRI appears to be cost-effective in 
the diagnosis of endometrial thickening following treatment by tamoxifen, selection of 
candidates for selective myomectomy and the follow-up of medically treated adenomyo-
sis. MRI is helpful in unexplained uterine bleeding with normal ultrasound, before and 
after embolization and in guiding focused ultrasound. CT has no role in the detection 
and characterization of benign uterine diseases. The most common diseases of the 
uterus are leiomyomas, adenomyosis and endometrial polyps. Leiomyomas may be 
solitary or multiple, and over 90% arise from the uterine corpus. Leiomyomas can be 
submucosal, intramural, subserosal, or pedunculated. Subserosal leiomyoma can grow 
to a large size indistinguishable from an adnexal lesion on US. On MRI, leiomyomas 
can be divided into two categories based on their histological characteristics: nonde-
generative and degenerative. Degenerative changes correspond to hyaline, myxoid, 
hemorrhagic and cystic degeneration, and calcification. Adenomyosis is characterized 
by the presence of ectopic endometrial glands and stroma within the myometrium, 
at least 2.5 mm from the endometrial basalis layer and is associated with reactive 
hypertrophy of the surrounding myometrial smooth muscle. Two forms of adenomyosis 
are known: a diffuse and a focal type, also known as adenomyoma. MRI is the most 
accurate noninvasive imaging test for differentiation of leiomyoma from adenomyosis. 
After imaging, detection of endometrial polyps should be always confirmed by hyster-
oscopy and pathological evaluation. 
Learning Objectives:
1. To recognise US and MRI findings and imaging pitfalls in benign uterine 
diseases.
2. To understand the indications for MRI.
3. To discuss the different types of uterine leiomyoma degeneration.
A‑349 14:30 
B. Malignant tumors 
J.A. Spencer; Leeds/UK (johnaspencer50@hotmail.com) 
A recent modification to the FIGO staging system for uterine cancer has been agreed 
and this will be discussed with emphasis on its implications for imaging. A staging 
system has been proposed for uterine sarcoma which has previously been staged 
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where size is an important local staging discriminator from endometrial stromal 
sarcoma and adenosarcoma where depth invasion is more relevant. Carcinosar-
coma is staged as for uterine carcinoma where now local stage is simply stage IA, 
inner half, all tumour grades vs outer half, stage IB. 
Learning Objectives:
1. To review MR imaging protocols and appearance of malignant uterine 
tumors.
2. To understand the role of MR imaging in staging malignant uterine tumors.
3. To understand current therapeutic strategies for malignant uterine tumors.
A‑350 15:00 
C. Ultrasound ablation and uterine artery embolisation for treatment of 
uterine leiomyomas 
T. Kroencke; Berlin/DE (thomas.kroencke@charite.de) 
Uterine artery embolisation (UAE) is a non-surgical intervention for treating 
symptomatic uterine leiomyomas and represents an alternative to surgical re-
moval (hysterectomy, moymectomy, hysteroscopic resection). The indication for 
uterine artery embolisation crucially relies on the pre-interventional assessment 
of symptomology and burden of disease. Especially the location, size, and number 
of leiomyomas are important to determine treatment options of patients. As a rule, 
both single and multiple fibroids can be treated by UAE. The number and location 
of the individual tumors (subserosal, intramural, transmural, submucosal) do not 
affect the approach, technique or outcome of UAE. MR guided high-intensity focused 
ultrasound (HIFUS) is a non-invasive treatment option for symptomatic leiomyomata. 
In contrast to UAE and surgery, it lacks the invasiveness of these procedures since 
the targeted leiomyoma are ablated by energy transmitted through the skin by 
focused ultrasound while exact delivery is monitored online by MR imaging. Size, 
location and number of fibroids are limiting factors for the application of HIFUS. 
Magnetic resonance imaging (MRI) is superior compared to ultrasound in delineating 
the extent of fibroid disease and excluding other pathologies or disease processes 
that may mimic fibroid-related complaints. Further advantages of MRI result from 
the use of MR angiography and contrast-enhanced imaging in assessing outcome 
and complications following UAE. This presentation summarizes the current role of 
UAE and ultrasound ablation (HIFUS) for uterine leiomyomata as well as the role 
of imaging before and after the procedure. 
Learning Objectives:
1. To understand basic principles, indications and contraindications of MR-
guided high-intensity focused US (HIFU) and uterine artery embolisation.
2. To understand the role of imaging in patient selection and follow-up.
3. To learn about the role of these treatment options and alternative surgical 
therapies in light of the current literature.
14:00 - 15:30 Room P 
Professional Challenges Session 
PC 13 
The radiologist of the future: 
Challenges and changes 
Moderator:
P.A. Grenier; Paris/FR 
A‑351 14:00 
Chairman’s introduction 
P.A. Grenier; Paris/FR (philippe.grenier@psl.ap‑hop‑paris.fr) 
From training to management, numerous challenges await radiologists in the future. 
It is necessary to update the curriculum for training in radiology, bearing in mind 
alarming demographic projections and the need for better representation of some 
subspecialties. In the face of constant evolution in medicine, the role that radiologists 
will play in innovative multidisciplinary fields, such as molecular imaging, needs to 
be discussed now. Although probably involved in the future translational and clini-
cal phases of development, radiologists must absolutely secure their place in the 
research teams as of today. Radiology could defend itself better in turf battles and 
to the authorities if it communicated more effectively and efficiently. Although numer-
ous challenges face imaging, there are reasons to be optimistic. Three international 
renowned experts will address their visions on training perspectives, investment in 
technologic innovations, and the role of management and communication to reinforce 
the position of radiology in healthcare systems. Different solutions will be debated 
during the session, and participants are extremely welcome to present their ideas. 
Session Objectives:
1. To become fully aware of the most important strategic issues for the future 
of radiology.
2. To know the visions of three renowned and highly estimated leaders to take 
up our professional challenges.
3. To be prepared to develop strategic plans in order to adapt our training 
programmes, develop new emerging areas of imaging, and improve our 
ability in management and communication.
A‑352 14:05 
How to train the radiologists of the 2 1st century 
I.W. McCall; Oswestry/UK (iainwmcc@aol.com) 
The quality of training is a key factor for the future of European radiology. The 
numbers of radiologists per national population varies across European, often 
with insufficient trainees to replace let alone expand the specialist work force. The 
increased percentage of female radiologists influences the available workforce and 
the working time directive increase the radiologist requirement for a 24/7 service. 
The training curriculum provides structure for all European training programmes 
and it must be regularly revised taking into account these demographic factors and 
future clinical demands reflecting future not past requirements. Developments that 
are limited to specialist centres or in advanced state of research will become main-
stream and new techniques incorporated. Trainees must understand both principles 
and practice. Techniques that are no longer required are removed. The curriculum 
must include an understanding of physiology and cell biology for molecular level 
imaging and function. Imaging is now too extensive for radiologists to be experts 
in all areas. Subspecialisation is therefore essential, but this must build on a core 
knowledge and ability to use all available equipment and to deal satisfactorily with all 
common diseases. The subsequent degree of subspecialisation will depend on the 
future role of the trainee. Subspecialisation curricula are also essential. Changing 
methods of delivering training will provide greater European uniformity. The use of 
computer based teaching programmes and internet access to quality interactive 
radiological case collections will also bring overall improvements and harmonisation 
combined with apprentice based experience monitored by a European organisation. 
Learning Objectives:
1. To review the demographic perspectives in radiology for the next 10 years.
2. To understand why and how the curriculum for training in radiology has to be 
updated regularly.
3. To know how to develop professional skills in subspecialties of radiology 
without leaving the common trunk.
A‑353 14:28 
Molecular imaging and therapy: Turf battle to lose or to win 
G.P. Krestin; Rotterdam/NL (g.p.krestin@erasmusmc.nl) 
Molecular imaging is expected to be pivotal to early diagnoses, patient stratifica-
tion, and early response assessment. Although at a first glance it may seem to 
be of little concern to radiologists, when looking beyond the pretty pictures and 
sometimes complex vocabulary of molecular imaging publications, it becomes clear 
that radiologists need to get involved in this emerging field, if they want to maintain 
their central role in health care. While molecular imaging used to be primarily linked 
to imaging modalities not commonly associated with radiology departments, i.e. 
optical imaging, PET and SPECT, technologies such as CT, MRI and ultrasound 
are becoming essential tools in the field, either as a single modality or in hybrid 
imaging approaches. It is the role of academic and research institutions to gather 
knowledge and dedicate resources in this field. The radiological community needs to 
invest in this future by education and participation in the molecular sciences and by 
creating relevant research facilities. But it is not only research. Clinical radiologists 
have to be aware of the ongoing innovations in our profession and support training 
and education of our next generations. Clearly, molecular imaging is the new frontier 
in diagnostic imaging, and therefore European radiologists have to be part in this 
development. But molecular imaging is and will remain a multidisciplinary effort for 
the years to come. Not only imaging specialists a related basic scientists but also 
other disciplines are and should be involved in the complex process of translation 
of fundamental innovation into the clinical environment. 
Learning Objectives:
1. To understand molecular imaging is a multidisciplinary field in medicine and 
science.
2. To make clear that radiologists must be involved in the development of 
molecular imaging.
3. To know the different steps and constraints in developing a molecular 
imaging programme in an academic centre.
Postgraduate Educational Programme
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A‑354 14:51 
Marketing in radiology: Evil or guardian angel 
M. Goyen; Hamburg/DE (goyen@uke.de) 
Marketing, public relations, customer communication - until recently the meaning 
of these concepts was unknown in European hospitals. With the incipient predatory 
competition and the increasing rivalry within the health market, a change of mind 
has resulted: the hospital on its way to becoming a patient-, quality- and employee-
oriented service provider. The process of informing and, not least, specifically 
addressing internal and external customers plays an important role in this change. 
This contribution offers an overview over health marketing as a marketing concept 
for the planning, coordination and control of market-oriented healthcare activities 
with the focus on radiology. 
Learning Objectives:
1. To understand why and how the crucial role of radiology in patient 
management and clinical outcomes must be more visible.
2. To know how to convince the authorities and healthcare decision makers 
about the strategic importance of investing in medical imaging innovations.
3. To acquire basic knowledge to improve our communication abilities with our 
partners and patients.
Panel discussion:  
Can we be optimistic? … Yes we can! 17:14 
14:00 - 15:30 Room Q 
Interventional Radiology 
RC 1309 
Infection and percutaneous drainage 
Moderator:
M. Bezzi; Rome/IT 
A‑355 14:00  
A. Empyema 
A.G. Ryan; Waterford/IE (jackoriain@yahoo.ca) 
Guided by the surgical axiom of: “Choose well, Cut well, Get well”, I will discuss: a) 
the diagnosis of empyema using radiographs, ultrasound and CT, b) the treatment 
options, including the use of adjunctive pharmaceuticals, c) the evidence supporting 
the optimal catheter and lytic and d) patient-related outcomes evidence for both 
interventional radiology and surgical techniques. 
Learning Objectives:
1. To discuss imaging and indications for drainage.
2. To review technical aspects of catheter drainage.
3. To discuss the use of urokinase.
4. To discuss results of percutaneous drainage.
A‑356 14:30 
B. Abdominal abscess 
V. Válek; Brno/CZ (vlvalek@med.muni.cz) 
With the new antimicrobial agents and advances in diagnostic imaging and imaging-
guided percutaneous procedures has been significantly improved management of 
pyogenic liver abscess. The advantages of the percutaneous approach include a 
marked decrease in the invasiveness and cost of abscess drainage. The classic triad 
of fever, upper right quadrant pain or fullness, and jaundice is rarely seen nowadays. 
Possible image-based exclusionary criteria for drainage included abscess size of 
less than 3 cm in diameter, fluid attenuation of more than 40 HU, absence of contrast 
material-enhanced margins, absence of trapped air in a fluid collection, absence of 
free intraperitoneal air, and presence of air without fluid in the abscess cavity. The 
most important is size of less than 3 cm. Possible clinical exclusionary criteria included 
normal white blood cell count, normal temperature, normal blood pressure, absence of 
peritoneal signs, lack of relevant medical history and do-not-resuscitate code status. 
Indications for percutaneous approach to abdominal abscess drainage are a clinical 
sign of inflammation and fluid collection (abscess) large than 3 cm. Contraindications 
are today only relative. Percutaneous needle aspiration or catheter drainage guided by 
CT of sonography, therefore, has become the therapy of choice for abdominal abscess. 
Learning Objectives:
1. To discuss common indications for drainage and appropriate imaging work-up.
2. To discuss image guidance, route planning and catheter placement.
3. To review follow-up strategies and results.
A‑357 15:00 
C. Pelvic abscess 
M.A. Funovics; Vienna/AT (martin.funovics@univie.ac.at) 
Pelvic abscess drainage may employ more difficult acces routes due to amatomic 
restrictions. The procedure may carry a higher risk of complications compared to 
simple abdominal drainage. To optimize patient preparation, correction of coagula-
tion deficits, optimization of antibiotic treatment, and sedation or anesthesia may be 
needed. The usual access routes for deep pelvic abscesses are the anterolateral and 
the posterior transgluteal approach. In selected cases, a transvaginal or transrectal 
approach may be the safer and more efficient option. Depending on the viscosity 
of the drained fluid, the presence of necrotic solid tissue and gas, different sizes of 
drainage material may be needed. Do not hesitate to employ large drainage catheters 
if indicated. An overview of the available material will be given. Intestinal laceration is a 
major complication which can be managed percutaneously in selected circumstances. 
The postinterventional management after percutaneous drainage is among the most 
important predictors of success, and most often neglected. It is advocated that the 
management is actively guided by the interventionalist who ensures that the drainage 
is properly handled, rinsed, and cleaned, that follow-up imaging is performed at the 
right intervals, and who ultimately indicates drain removal. 
Learning Objectives:
1. To discuss indications and imaging work-up.
2. To learn about transgluteal, endocavitary and other routes of drainage.
3. To review results and follow-up strategies.
16:00 - 17:30 Room A 
Radiology in Abdominal Emergencies 
CC 1417 
Inflammation and oedema 
Moderator:
J.‑M. Bruel; Montpellier/FR 
A‑358 16:00 
A. The three musketeers: Appendicitis, diverticulitis, colitis 
J. Stoker; Amsterdam/NL (j.stoker@amc.uva.nl) 
Appendicitis, diverticulitis and colitis are frequent causes of acute inflammatory bowel 
emergencies. In many patients, suspected for these conditions the diagnosis is not 
clear upfront. Imaging plays an important role in identifying the underlying cause. 
Ultrasound (US) and computed tomography (CT) are readily available and widely used 
imaging techniques for this work up. US comprises an examination of the abdomen 
with the graded compression technique. A transducer should be used optimized for 
the visualization of the bowel. The CT protocol includes the use of intravenous contrast 
medium, while oral contrast medium will not be routine in many institutions. Findings 
are bowel wall thickening (or enlarged appendiceal diameter), fat infiltration, free air 
and fluid collections. The present evidence on the role of imaging in appendicitis and 
diverticulitis is substantial and has been summarized in systematic reviews. Although 
US is accurate in diagnosing appendicitis and diverticulitis, CT is more accurate than 
US. Further advantages of CT are better identification of alternative diagnoses and 
better comparison between consecutive examinations. Thereby, CT is more helpful 
in communicating the diagnosis to the referring physician. Cost effectiveness of 
CT in acute appendicitis has been demonstrated as well as the positive impact on 
management. For colitis, the evidence is more limited and imaging has here more 
limitations. Drawback of CT is ionizing radiation exposure. An imaging strategy with 
initial US and CT only in inconclusive of negative US cases results in the highest 
sensitivity, reduces ionizing radiation exposure and is cost effective. 
Learning Objectives:
1. To know the pros and cons of ultrasound and computer tomography in 
appendicitis, diverticulitis and colitis.
2. To understand the imaging findings and results in appendicitis, diverticulitis 
and colitis.
3. To learn the role of imaging in acute inflammatory bowel emergencies.
A‑359 16:30 
B. Liver and biliary tree 
J.A. Soto; Boston, MA/US (jorgeasoto@aol.com) 
Acute inflammatory and infectious diseases of the liver and biliary tract are often 
suspected to be the cause of symptoms that require emergent attention. Thus, 
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patients presenting acutely. Additionally, the gallbladder and bile ducts are com-
monly found to be the unsuspected source of non-specific complaints, such as 
fever/malaise or alterations of laboratory tests, such as leukocytosis or elevated 
acute phase reactant levels. Acute hepato-biliary conditions encountered regularly 
include acute cholecystitis and its complications, acute biliary obstruction with 
ascending cholangitis and hepatic abscess. Although these diagnoses can be 
straightforward in patients with the classic combinations of specific symptoms, 
signs and abnormal test results, the clinical situation can be atypical, leading to 
delays in diagnosis with devastating consequences. Ultrasonography has been (and 
continues to be) the first imaging test used to evaluate the liver and biliary tract in 
the emergency setting. When sonographic findings confirm the clinically suspected 
disease, the diagnosis is established and specific therapy can be administered. 
However, due to the inherent limitations of ultrasonography in some instances and 
the non-specific clinical presentation of many patients, additional examinations are 
often acquired during the diagnostic investigation. These include CT, MR/MRCP, 
scintigraphy (HIDA scan), ERCP and EUS. This course reviews the imaging find-
ings on multiple modalities of these acute hepato-biliary inflammatory processes 
with reference to the various clinical contexts. Strengths and weaknesses of each 
modality are emphasized, with special attention placed on causes of false-negative 
and false-positive results. 
Learning Objectives:
1. To learn the etiology and clinical presentation of acute inflammatory liver 
diseases.
2. To understand imaging strategies using US, CT and MRI.
3. To know typical findings and the spectrum of differential diagnoses.
A‑360 17:00 
C. Pancreatitis: Common and critical 
P.R. Ros; Boston, MA/US (Pablo.Ros@UHhospitals.org) 
Pancreatitis is an abdominal condition potentially life threatening. Imaging plays a 
key role not only in the diagnosis but also in the staging and patient management of 
acute and chronic pancreatitis. Management of interstitial or edematous pancreatitis 
is supportive. On the other hand, severe or necrotizing pancreatitis requires intense 
monitoring, specific therapies and has a guarded prognosis, since it may lead to 
organ failure, infection, pseudocyst formation and extrapancreatic parenchymal and 
vascular complications. Pancreatic inflammation and necrosis can be easily identi-
fied by imaging methods and has prognostic implications. The clinical prognostic 
criteria in acute pancreatitis have been modified and are currently coupled with 
imaging criteria. CT plays a central role in the evaluation of patients with known or 
suspected pancreatitis. A CT based severity index is the main prognostic method 
to predict outcomes. In addition, MRI and MRCP play increasingly important roles 
in pancreatitis evaluation. Integrity of the pancreatic duct can be easily evaluated 
by this last method, particularly if coupled with the use of secretin. We discuss the 
modern imaging criteria for the diagnoses, staging and patient management in acute 
pancreatitis and review subtypes such as immunologic and groove pancreatitis. We 
additionally review the evidence based imaging utilization parameters and published 
appropriateness criteria for the use of CT and MRI in the setting of pancreatitis. 
Learning Objectives:
1. To learn epidemiology and clinical outcome of patients with pancreatitis.
2. To understand typical findings and diagnostic pitfalls.
3. To know the role of radiology in patients with acute and chronic pancreatitis.
16:00 - 17:30 Room B 
Special Focus Session 
SF 14 
Imaging in ENT emergencies 
Moderator:
B. Verbist; Leiden/NL 
A‑361 16:00 
Chairman‘s introduction 
B. Verbist; Leiden/NL (b.m.verbist@lumc.nl) 
Many ENT and craniofacial pathologies can be handled electively; however, there 
are otolaryngological emergencies, both traumatic and non-traumatic, for which 
proper initial assessment and management are crucial in preserving life and 
minimizing disabling or disfiguring sequelae. This session will highlight the diag-
nostic approach and critical imaging findings in patients with facial and temporal 
bone trauma and infectious or inflammatory disease of the paranasal sinus, neck, 
mastoid, middle and inner ear. 
Session Objectives:
1. To review indications for urgent imaging in head and neck radiology.
2. To provide appropriate imaging protocols for ENT emergencies.
3. To become familiar with imaging findings in acute head and neck pathology.
A‑362 16:05 
Emergencies of the sinonasal cavities and the anterior skull base 
J.W. Casselman; Bruges/BE (jan.casselman@azbrugge.be) 
Life-threatening emergencies are rare in the anterior skull base and sinonasal 
and orbital region. In trauma, even the most severe fractures or soft tissue lesions 
rarely require immediate life saving intervention. However, intracranial bleeding, 
brain concussion with swelling etc. require immediate care. Therefore, imaging 
should always include the intracranial structures. A major soft tissue bleeding can 
also put the patient’s life at risk and prompt action by the surgeon is then needed. 
Severe bleeding can also occur after surgery performed for other reasons (e.g. 
tumor surgery). Traumatic involvement of the eye and especially the optic nerve 
should be checked as fast decompression of the nerve is needed to preserve 
vision. Both CT and MR can play a role here. Infection, especially fungal sinus 
infection, can reach the orbital intra-conal structures or intracranial structures. This, 
then, becomes a real emergency and can have a fatal outcome in the absence 
of adequate treatment. Many other lesions present as “sub-acute” emergencies. 
Imaging is required to save normal function (e.g. vision, mastication, prevention or 
reparation of CSF leaks which often make normal daily life impossible etc). In most 
of the traumatic and bleeding emergencies, CT will be the technique of choice in the 
early post-traumatic period because of its availability, speed and access (monitoring 
etc). However, in some cases (e.g. optic nerve compression/edema), MR might be 
needed in an immediate second stage. Most of the above mentioned emergencies 
will be illustrated and discussed. 
Learning Objectives:
1. To know the traumatic and non-traumatic emergencies in the anterior skull 
base and orbit.
2. To learn which imaging techniques should be used in the different 
emergency situations.
3. To learn which information is most important for the clinician and must be 
reported.
A‑363 16:28 
Emergencies of the ear 
F. Veillon; Strasbourg/FR (Francis.Veillon@chru‑strasbourg.fr) 
The emergencies of the ear are represented by the acute infection of the middle 
ear with mastoiditis whose extension must be described by the radiologist to the 
otologist: peripheral abcess, osteitis, fistula of the otic capsule, thrombosis of the 
lateral sinus, extradural abcess, unique or multiple cerebral abcesses. Infections 
of the inner ear leading to ossifying labyrinthitis are regarded as an emergency in 
cases where cochlear implantation is considered. The traumatisms of the round 
and/or oval windows with or without fracture with a leakage of perilabyrinthine fluid 
are also discussed with the results of imaging leading, in most of the cases, to an 
immediate surgery. The fistulas of the inner ear with an important vertigo due to 
secondary or primitive cholesteatomas, histiocytosis, agranulocytosis, tuberculosis 
must be operated immediately. Finally, a precise knowledge of anatomy, a good 
technique of imaging and a close collaboration with the otologist are necessary. 
Learning Objectives:
1. To understand what the otologist wants to know from the radiologist in acute 
mastoiditis.
2. To learn about the different techniques of CT and MRI in emergencies of the ear.
3. To describe a practical approach to reading the images in emergencies of 
the ear.
A‑364 16:51 
Emergencies of the neck 
M. Becker; Geneva/CH (minerva.becker@hcuge.ch) 
The purpose of this lecture is to familiarize the radiologist with the most common 
types of traumatic and non- traumatic emergencies in the neck. A systematic review 
will include key radiologic features of laryngeal fractures, pharyngeal perforation, 
traumatic vascular injuries (dissection, occulusion, pseudoaneurysm, perforation 
and acute bleeding) and trauma of the brachial plexus (streching, avulsion, compres-
sion). The review will also focus on non-traumatic neck emergencies with a special 
emphasis on infectious lesions including suppurative lymphadenitis, cellulitis, neck 
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abscess, necrotizing fasciitis, pyolaryngoceles, osteomyelitis, septic thrombosis 
of the internal jugular vein and infected branchial cleft cysts. Typical associated 
infectious complications of the mediastinum and chest will be discussed with an 
emphasis on the early detection of lesions. The detection of foreign bodies as a 
cause of secondary infection will also be briefly addressed. Major emphasis will 
be put on what the clinician needs to know and on how to report the findings in a 
comprehensive way. 
Learning Objectives:
1. To become familiar with common presentations of traumatic and non-
traumatic emergencies of the neck.
2. To describe the pertinent radiologic findings and to identify related 
complications.
3. To be able to adapt the examination protocol depending on the type of lesion 
suspected.
4. To learn how to report the pertinent findings to the clinician.
Panel discussion:  
Good reasons for performing CT and MRI in emergencies 17:14 
16:00 - 17:30 Room C 
New Horizons Session 
NH 14 
Hybrid imaging: The radiologic/nuclear sandwich
Moderator:
T.F. Hany; Zurich/CH 
A‑365 16:00 
Chairman’s introduction 
T.F. Hany; Zurich/CH (thomas.hany@usz.ch) 
The science of medical imaging has various facets, especially function and morphol-
ogy, play a major role in oncology as well as non-oncological disease. Even though 
capable of detecting various functional impairments, radiology is regarded as the 
main diagnostic field in the detection of morphological pathologies, especially by 
cross-sectional imaging. Nuclear medicine, on the other hand, has been limited 
to a certain kind of pure functional studies. The introduction of positron-emission-
tomography (PET) at the end of the last decade by using different tracers, among 
which F-18 Fluorodeoxyglucose proved the most reliable substance for metabolic 
imaging, has rejuvenated nuclear medicine especially in the field of oncological 
imaging. Hampered by the lack of a morphological reference frame, addition of 
morphological cross-sectional image information of computed tomography (CT) 
to the so-called PET/CT has proved to be one of the most successful stories in 
medical imaging. This success has carried on further developments to combine 
different imaging modalities as well as nuclear medicine tracers/technologies like 
PET/MR or SPECT/CT in oncological imaging and other fields like cardiology or 
musculo-skeletal disease. This development has been driven by experts of each 
field; however, further efforts have to be invested to determine how/where to embed 
this technology and how to train our future users to satiate our ongoing hunger of 
knowledge, which a sandwich just cannot do. 
Session Objectives:
1. To learn technique and daily use of hybrid imaging technology.
2. To enhance the knowledge of new tracers used in hybrid imaging.
3. To have further insight in possible other hybrid imaging technology beyond 
PET/CT.
A‑366 16:05 
PET/CT: Lessons learned from a decade 
G. Antoch; Essen/DE (gerald.antoch@uni‑essen.de) 
Diagnostic potentials - as well as limitations - associated with morphological 
cross-sectional imaging on the one hand, and functional imaging on the other, are 
increasingly well understood. It has become obvious that in many cases both kinds 
of imaging complement one another. Therefore, hybrid PET/CT imaging must be 
considered one of the most important new developments in medical imaging in the 
past decade. However, some questions have to be raised and challenges have to 
be met to avoid overrating PET/CT in oncology and cardiology. In oncology, PET/
CT with [18 F]-2-Fluoro-2-deoxy-D-glucose (FDG) as a radioactive tracer has been 
reported to be more accurate than either imaging modality alone and sometimes 
even more accurate than CT and PET read side by side. However, the clinically 
important question after one decade of PET/CT imaging should rather be the fol-
lowing: Does this higher accuracy have an impact on patient management? Only 
recently have cardiac PET/CT applications have become feasible with integra-
tion of high-end CT systems within the PET/CT scanner. A „one-stop shopping 
approach“ when imaging a coronary artery stenosis with CT-angiography (CTA) 
and, simultaneously, imaging the corresponding functional effects of the affected 
myocardium must be considered desirable. However, visual correlation of CTA 
with PET or SPECT data sets acquired on separate scanners has been performed 
successfully for years. To address the topic „lessons learned from a decade“, this 
talk will provide an overview on current indications as well as limitations of PET/
CT in oncology and cardiology. 
Learning Objectives:
1. To become familiar with indications of PET/CT utilizing FDG and other 
radionuclides.
2. To understand the limitations of PET/CT as currently available in clinical 
routine.
3. To learn about tumor-specific PET/CT examination protocols.
A‑367 16:28 
New tracers in hybrid imaging 
S. Fanti; Bologna/IT (stefano.fanti@aosp.bo.it) 
Among molecular imaging procedures, Positron Emission Tomography (PET) is 
the most diffuse and rapidly growing, and at present it is routinely used in patients 
affected by a large variety of malignant neoplastic diseases. Many papers in the 
literature have already demonstrated the utility of this imaging technique whose 
capabilities have been furthermore developed by the introduction of hybrid scan-
ners, particularly PET/CT. The combination of functional data (given by PET) and 
anatomic details (by CT) allows to significantly increase diagnostic accuracy, es-
sentially due to a better specificity. The usefulness of PET relies on its capability 
of investigating molecular processes by means of specific radiotracers, with the 
most employed being 18 F-DeoxyGlucose (FDG). FDG PET scans give important 
information about tissues glucose consuption, usually very increased in the great 
majority of solid malignancies. Despite FDG scans representing more than 90% 
of all PET scans, other positron emitter tracers are available and each one may be 
specific for different neoplastic diseases. In fact, some malignancies do not show 
increase in glucose consumption and are almost invisible with FDG. Tracers already 
in clinical use include Choline (labelled with 11C or 18 F), a marker of cell membrane 
metabolism particularly useful for prostate cancer detection; 18 F-Tyrosine and 
11C-Methionine, which enable to study proteic metabolism and are successfully 
employed for CNS neoplastic diseases; 11C-Acetate, used for prostate cancer, 
hepatocellular carcinoma and other liver lesions; and 18 F-DOPA and 68Ga-DOTA-
NOC, useful in neuroendocrine tumors. Other PET tracers are currently undergoing 
trials to evaluate their potential usefulness in oncology and other fields. 
Learning Objectives:
1. To become familiar with new PET tracers beyond FDG recently introduced in 
hybrid imaging.
2. To understand the potential clinical applications of PET/CT using these new 
tracers.
3. To speculate on further development of hybrid imaging related to new tracers.
A‑368 16:51 
Hybrid imaging in 10 years 
T. Beyer; Essen/DE (thomas2@gmx.net) 
Since the 1990s, combinations of imaging systems have become available that 
allow the intrinsic combination of functional and anatomical imaging within a single 
exam. With the latest PET/MRI technology, this information can even be acquired 
simultaneously, thus opening the door to new insight into molecular pathways and to 
examinations that are affected less by motion artifacts. Though PET/MR is unlikely 
to replace PET/CT, or any other imaging technology as such in clinical routine, 
it has nonetheless aroused the interest of many researchers. PET/MR appears 
particularly appealing in neurology research and some oncology applications. 
In 10 years from now, we will see all existing dual-modality imaging systems in 
clinical routine, including PET/MR. These systems will offer patients a maximum 
accuracy in diagnosis, staging and follow-up. Research on PET/MR together with 
new advances in therapy strategies for neurodegenerative diseases may help 
push the importance of PET/MRI. We will witness ultra-fast, whole-body PET/CT 
staging becoming a modality-of-choice in oncology. SPECT/CT could evolve into 
a whole-body imaging modality with supplementary use in dosimetry applications. 
Although desirable, other combinations of imaging systems, such as SPECT and 
MRI, may have to wait another 10 years to turn into prototype systems for clinical 
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for first prototype adopters. As exciting as these new hybrid imaging systems, even 
triple-modality systems, sound we need to remember that these imaging systems 
need to be technologically feasible, applicable in clinical routine and cost-effective. 
Learning Objectives:
1. To review existing hybrid imaging technology in clinical practice 
(e.g. SPECT/CT, PET/CT, PET/MR).
2. To appreciate the potential of truly combined imaging technology 
(e.g. anatomical guidance of image reconstruction).
3. To speculate on hybrid imaging technology and applications in the near and 
distant future.
Panel discussion:  
Will all imaging become hybrid? 17:14 
16:00 - 17:30 Room D 
Imaging in Lung Diseases 
CC 1418 
Is volumetric CT the only way of scanning lung 
diseases? 
Moderator:
J. Rémy; Lille/FR 
A‑369 16:00 
A. Radiation dose and chest CT imaging 
D. Tack; Baudour/BE (denis.tack@skynet.be) 
X-rays delivered by diagnostic and interventional radiology are lower than 100 to 200 
mSv and belong to the low level radiation. As no direct carcinogenic effect of low level 
radiation has been definitely proven, the carcinogenic risk in the range of low-level 
radiation is calculated by linear extrapolation of the risk observed among atomic bomb 
survivors. CT is responsible for more than 50% of patient exposure for diagnostic imag-
ing because the number of examination and the dose per examination are both high. 
Chest is an anatomical region of high risk for radiation induced carcinogenesis because 
the radio sensitivity of its content is high, in particular in women because of the breast. 
Learning Objectives:
1. To understand the current debates on the radiation risks of medical imaging.
2. To describe the relative contribution of CT to radiation dose.
3. To review the relative radiosensitivity of chest organs and the subsequent 
practical considerations for chest CT imaging.
A‑370 16:30 
B. Optimisation of volumetric CT protocols 
M. Prokop; Nijmegen/NL (mathias.prokop@gmail.com) 
Volumetric CT protocols have become the de-facto standard for most body CT 
applications. The „scan thin-read thick“ paradigm is also valid for pulmonary CT: 
data are acquired with thin collimation (0.5 - 1 mm, depending on scanner type), 
reconstructed with slightly thicker overlapping sections (0.75 - 1.25 mm) to yield 
a „secondary raw data set“ from which, depending on the clinical question, thick 
axial, coronal and sagittal sections can be reconstructed using multiplanar reforma-
tions. For most clinical application, 5 mm thick sections reconstructed every 4 mm 
suffice. For lung embolism and high-resolution imaging of the lung parenchyma, 
however, thinner sections (1 - 2 mm) yield better results. For the lung parenchyma, 
in particular, special adaptations have to be considered: by using a 7682 or 10242 
matrix and a high-resolution kernel spatial resolution can be improved. By choos-
ing the reconstruction increment close to the relation “field of view/matrix size”, 
an isotropic data grid is produced that provides excellent quality in all imaging 
directions. Higher speed will reduce breathing artifacts. Minimum scan durations 
for the chest vary between 0.7 and 4 s, depending on the manufacturer. Without 
ECG-triggering, ultrafast scans may cover the heart in systole and suffer from severe 
cardiac motion artifacts also in the lung parenchyma. Prospective ECG-triggering 
of ultrafast spiral scans (“flash scanning”) is therefore advisable so that the heart is 
always covered in diastole. Retrospective gating is only useful in patients with lung 
disease if cardiac function or pulmonary artery pulsatility is to be evaluated as well. 
Learning Objectives:
1. To understand the “scan thin-read thick” paradigm of volumetric scanning.
2. To become familiar with the various techniques to optimise volumetric 
resolution.
3. To understand the effect of motion and learn about techniques to reduce 
motion artifacts.
A‑371 17:00 
C. Alternatives to volumetric CT 
S.R. Desai; London/UK (sujal.desai@kch.nhs.uk) 
Multidetector computed tomography (MDCT) of the lungs offers many advantages: 
the rapid acquisition significantly reduces or eliminates the movement artefacts 
that have plagued earlier generations of CT machines. Multiplanar images, once 
the ambit of magnetic resonance imaging, are now routinely available from MDCT 
acquisitions. Sophisticated post-processing techniques (including internal/external 
rendering and maximum/minimum intensity projections) and the ability to generate 
“high-resolution” images, that simulate conventional high-resolution CT (HRCT), 
are the other perceived benefits of MDCT technology. Nevertheless, advances in 
imaging often come at a price and must never be viewed uncritically: aside from 
the increased radiation burden, the real clinical impact of MDCT images has never 
been rigorously tested. Indeed, in specific clinical scenarios (for example, in the 
diagnosis of acute pulmonary embolism), MDCT images appear to offer no clinical 
or prognostic advantage over CT images acquired using single-slice technology. In 
many air space diseases, MDCT probably adds little to the diagnostic evaluation 
particularly after the findings on serial chest radiographs and the key clinical data 
have been considered. In diffuse interstitial lung diseases (DILD), it is noteworthy 
that the image quality of a “high-resolution” MDCT study may be inferior to con-
ventional HRCT. Furthermore, the added influence of the larger number of images 
generated in an MDCT examination on observer confidence and accuracy in DILD 
has been questioned. In this presentation, the value of volumetric MDCT in thoracic 
imaging will be critically evaluated. 
Learning Objectives:
1. To review the clinical situations in which alternatives to volumetric CT can be 
reasonably considered.
2. To describe the practical alternatives to volumetric CT.
3. To discuss the necessary collaboration between radiologists and clinicians to 
implement alternatives to volumetric CT in routine clinical practice.





K. Verstraete; Gent/BE 
A‑372 16:00 
A. Diagnosis: From radiographs to MRI 
K. Wörtler; Munich/DE (woertler@roe.med.tum.de) 
The diagnosis of a bone tumor is based on clinical findings, the age of the patient, 
the location of the lesion, its radiologic appearance, and, if imaging does not al-
low for a specific diagnosis, its histopathologic features. Radiography remains the 
initial imaging modality for evaluation of the localization of the lesion with respect 
to the longitudinal and axial planes of the involved bone, for the depiction of matrix 
mineralizations, and for estimation of biologic activity by analyzing the patterns of 
bone destruction and periosteal response. CT can add „radiographic“ information 
particularly in regions of complex skeletal anatomy such as the spine, pelvis and 
shoulder girdle. MR imaging has classically been used to determine the local ex-
tent of a bone tumor (local staging). In addition to radiography and/or CT, it can at 
times also be valuable in establishing the differential diagnosis, especially in cystic 
bone lesions and cartilaginous tumors. Whole-body applications have recently 
gained importance in demonstrating the presence and extent of bone (marrow) 
involvement in benign and malignant systemic/polyostotic tumorous diseases. This 
course reviews the basic principles of diagnosing bone tumors in a multimodality 
approach (with an emphasis on conventional radiography). The different steps of 
morphologic analysis as well as the advantages and disadvantages of the individual 
imaging techniques are illustrated on the basis of pathologically confirmed cases. 
Learning Objectives:
1. To become familiar with the basic principles of diagnosing bone tumors.
2. To learn how to determine the biologic activity of bone neoplasms and tumor-
like lesions on the basis of radiographic findings.
3. To understand the role of CT and MRI in the diagnosis of bone tumors.
4. To recognise imaging patterns on the basis of radiologic-pathologic 
correlation.
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A‑373 16:30 
B. Staging and intervention 
S. James; Birmingham/UK (steven.james@roh.nhs.uk) 
Primary bone tumours require both local staging and the identification of distant 
metastases to guide management. MR imaging is the modality of choice to determine 
local disease extent and allows excellent depiction of intra and extra-osseous disease. 
Chest CT enables pulmonary metastases to be identified and bone scintigraphy al-
lows evaluation of the presence of bone metastases. The roles of whole body MRI 
and PET/CT in the staging of bone tumours will also be discussed. Whilst imaging 
may allow a narrow differential diagnosis to be reached, histological confirmation 
of the nature of the lesion is required pre-operatively to plan appropriate treatment. 
Image guided biopsy may be performed using fluoroscopy, CT, MRI and occasionally 
ultrasound guidance. The relative values of each of these techniques will be covered. 
Percutaneous therapies are increasingly being utilised in the treatment of a number 
of primary bone tumours. Radiofrequency ablation is the method of choice for osteoid 
osteoma and is now used in the treatment of chondroblastoma. Alternatives include 
microwave therapy, cryotherapy and sclerotherapy. These percutaneous techniques 
may also be used for local disease control where disease recurrence is encountered. 
Learning Objectives:
1. To understand the role of radiographs, MRI, CT and bone scintigraphy in the 
staging of primary bone tumours.
2. To appreciate the principles and techniques of percutaneous bone biopsy.
3. To be aware of the indications, technique and outcome of percutaneous 
therapies in the treatment of bone tumors.
A‑374 17:00 
C. New techniques (including DWI) 
S. Pans; Leuven/BE (Steven.Pans@uz.kuleuven.ac.be) 
Magnetic resonance imaging (MRI) has evolved to become the most important diag-
nostic method for local staging of primary bone tumors and for detecting postoperative 
tumor relapse. It allows accurate preoperative staging of local tumor extent and helps 
to obtain adequate safety margins. MRI is a noninvasive technique that can be used to 
obtain information regarding tumor vascularization, metabolism, and pathophysiology, 
and allows early assessment of therapeutic effects of cancer drugs. One approach is 
dynamic contrast-enhanced (DCE) MRI, which measures tumor vascular characteristics 
after administration of a contrast medium. MRI enhanced with small-molecular-weight 
contrast agents is extensively used in the clinic to differentiate benign from malignant 
lesions, as well as to monitor tumor microvascular characteristics during treatment. 
Diffusion-weighted MRI (DWI) is a more recent technique and it allows noninvasive 
characterization of biologic tissues based on the random microscopic motion of water 
proton measurement. Several studies have shown that DWI allows early detection of 
tumor response to chemotherapy. The use of water diffusion is a surrogate marker used 
to distinguish highly cellular regions of tumor from acellular and necrotic regions. Whole 
body diffusion-weighted sequence (WB DWI) is a new promising technique feasible 
to evaluate multifocal disease. DWI has revealed great potential in the evaluation of 
patients with cancer or benign disease, as it supplies both quantitative and qualitative 
information of the whole body. This presentation will focus on the potential role of DWI 
in combination of DCE MRI in bone tumors as well as on the possibilities of WB DWI. 
Learning Objectives:
1. To learn about new techniques in diagnosis and follow-up of bone tumors.
2. To appreciate the integration of DWI in whole-body MRI.
3. To become familiar with diffusion-weighted imaging in bone tumors.
16:00 - 17:30 Room E2 
Interactive Teaching Session 
E³ 1420 
Lymphomas: Diagnosis, staging and follow-up 
Moderator:
J.A. Verschakelen; Leuven/BE 
A‑375 16:00 
Lymphomas: Diagnosis, staging and follow-up 
E. de Kerviler1, R.M. Mendelson2; 1Paris/FR, 2Perth/AU
(richard.mendelson@health.wa.gov.au) 
Lymphomas may be of nodal or extra-nodal origin and are broadly classified into 
Hodgkin‘s disease (HD) and Non-Hodgkin‘s lymphoma (NHL). Notwithstanding a 
sophisticated subclassification, the key issue for the radiologist is differentiating 
indolent and aggressive lymphomas. Protean imaging manifestations reflect the 
varied pathology of lymphomas. HD tends to progress contiguously and is limited 
to nodes and spleen until advanced. NHL often presents as disseminated extra-
nodal disease. Consequently, localized HD is often treated by a combination of 
chemotherapy and radiotherapy, whereas disseminated HD or NHLs are treated by 
intensive chemotherapy alone. Distinguishing localized and non-localized disease 
is therefore critical in HD. Examples of lymphoma in various organ systems will be 
demonstrated, with emphasis on gastrointestinal lymphomas. Imaging has roles in 
diagnosis, staging, and assessing treatment response. The advantages and limita-
tions of various modalities will be discussed. Imaging-directed core biopsy including 
specimen immunohistochemistry should obviate surgery. Relapse requires repeat 
biopsy to assess possible transformation. Staging, usually by the Ann Arbor clas-
sification (or modifications), is primarily by CT, which can also monitor therapeutic 
response. Other, organ-specific, imaging is performed when clinically indicated 
- for example, bone scintigraphy or MRI for bone pain; gastrointestinal studies for 
appropriate symptoms; MRI for suspected CNS lymphoma. 18F -PET or PET/CT 
are useful for showing occult advanced disease, assessing therapeutic response 
(by the International Harmonization Project revised response criteria), detecting 
relapse, and differentiating fibrosis/necrosis from viable tumour. Follow-up imag-
ing for Burkitt’s and aggressive lymphoma should be early to assess therapeutic 
efficiency, or after several chemotherapy courses for more indolent lymphomas. 
Learning Objectives:
1. To learn the protean appearances of lymphoma in relation to the organ 
systems involved.
2. To understand the radiologic-pathologic correlations of the different cell types 
of lymphoma.
3. To discuss the role of image-guided core needle biopsies in the definitive 
diagnosis of lymphoma at diagnosis and follow-up.
4. To discuss the roles of imaging in radiological and nuclear medicine 
techniques in staging, treatment and follow-up of lymphoma with emphasis 
on the new response criteria.
16:00 - 17:30 Room F1 
Molecular Imaging 
RC 1406 
Molecular imaging probes on your doorstep 
Moderator:
J.Å. Jakobsen; Oslo/NO 
A‑376 16:00 
A. SPIO and USPIO probes for inflammatory diseases 
N. Grenier; Bordeaux/FR (nicolas.grenier@chu‑bordeaux.fr) 
Superparamagnetic iron oxide particles will probably play a major role in future clini-
cal applications of imaging of inflammatory processes. Cardiovascular, neurological, 
renal and osseous inflammatory diseases are mainly concerned. First generation 
particles with a short circulating time (SPIO) will have limited applications because 
rapidly cleared from blood by phagocytosis. However, their incorporation ex vivo into 
cells is the most efficient for cell labeling and tracking, for example of macrophages. 
Following generations are smaller particles with longer circulating time (USPIO, 
MION, CLIO), better devoted to target inflammatory cells in vivo and to be used as 
molecular probes. Non-specific targeting of phagocytic cells as macrophages has 
been demonstrated in many experimental inflammatory models and, in humans, 
for characterizing vulnerable atherosclerotic plaques, active inflammatory renal 
diseases, and active plaques in multiple sclerosis. Mechanism of cell uptake is 
complex and its degree and speed depend on many factors as particle size and type 
of coating. Small particles can be targeted more specifically by attaching specific 
ligands of biological targets such as integrins overexpressed on surface of cells 
involved during inflammatory process as macrophages, leucocytes, smooth muscle 
cells, endothelial cells or activated platelets. Ex vivo labeling of macrophages has 
recently developed and incorporation of particles also depends on their physical 
characteristics. This method will make possible to track the macrophages to inflam-
matory sites and, in the future, could serve as cellular vectors for gene therapy. 
Learning Objectives:
1. To understand the working mechanism of SPIO and USPIO probes.
2. To understand how these probes can be used in visualisation of 
inflammatory diseases.
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A‑377 16:30 
B. Multi-functional MRI for assessing novel therapies: Decision tools or 
decorations? 
A.R. Padhani; Northwood/UK 
There is an increased opportunity to perform MR imaging using functional imag-
ing techniques at a variety of organ sites in a relatively short examination time 
acceptable to patients. These techniques yield quantitative information which 
reflects on specific aspects of the underlying tumour or tissue biology. Many of 
these techniques are used to provide unique information as surrogate biomark-
ers for tumour behaviour, including response of tumours to novel treatments. The 
multi-parametric approach combines the information from different function imaging 
techniques, which goes beyond what can be achieved using any single functional 
technique, thus allowing an improved understanding of the biological processes and 
the biological responses to therapeutic interventions. Multiparametric MR imaging 
has many potential clinical roles and is useful for pharmaceutical drug development 
and for predicting therapeutic efficacy. 
Learning Objectives:
1. To know that functional MRI bridges the gap between animal and humans in 
early drug development.
2. To realise that pharmacodynamic information has direct a influence on early 
drug development.
3. To know the biophysical basis and quantification of multifunctional MRI 
techniques that probe tumor processes of proliferation, hypoxia and 
angiogenesis.
4. To learn that imaging findings differ in their onset, duration and magnitude 
thus reflecting underlying pathophysiological changes and heterogeneity 
related to therapeutic effects.
A‑378 17:00 
C. MRI cell tracking 
J.W.M. Bulte; Baltimore, MD/US (jwmbulte@MRI.jhu.edu) 
The clinical development of novel immune and stem cell therapies calls for suitable 
methods that can follow the fate of cells non-invasively in humans at high resolu-
tion. Our lab has developed several methods to label cells magnetically (using tiny 
superparamagnetic iron oxide nanoparticles) in order to make them visible by MR 
imaging. Following years of extensive animal research, in 2005, this technology 
was introduced in the clinic using dendritic cell cancer vaccines. MRI cell tracking 
is further pursued in animal models of de- and dys-myelination, multiple sclerosis, 
brain tumors, spinal cord injury, stroke, and cardiovascular disease. Novel reporter 
genes are also being developed that can provide contrast on MRI scans. Artificial 
proteins are being designed, cloned, and expressed in mammalian cells that contain 
specific proton exchangable groups of which the proton signal can be manipulated. 
Instead of directly labeling cells, we have also shown that semi-permeable algi-
nate microcapsules can be loaded with multimodal contrast agents while offering 
simultaneous immunoprotection of cellular therapeutics. 
Learning Objectives:
1. To understand how cells can be labelled and thus tracked.
2. To introduce the potential clinical indications and applications.
16:00 - 17:30 Room F2 
Breast 
RC 1402 
Detection of ductal carcinoma in situ 
Moderator:
G. Forrai; Budapest/HU 
A‑379 16:00  
A. Mammography 
B. Brancato, R. Taschini; Florence/IT (b.brancato@ispo.toscana.it) 
Mammography is the leading method for the diagnosis of DCIS. As mammographic 
signs are sometimes rather subtle, their detection requires optimal technique and 
skilled radiologists. DCIS very often exhibit microcalcifications, due to either tumoral 
necrosis (typically, comedocarcinoma) or active cellular secretion; DCIS can also 
appear as a mass, due to epithelial proliferation, periductal fibrosis and elastosis. 
Microcalcifications are very often isolated (47% in our series). Less frequently, they 
are associated with mass (39%). Isolated masses are uncommon (4%). Digital 
mammography, as it betters conspicuity of microcalcifications, notably improves 
detection of DCIS. Although mammography is very powerful in detecting early 
signs of DCIS, it is less effective in differential diagnosis with benign lesions. Fine, 
linear, branching (casting) calcifications (BI-RADS 5) have the highest positive 
predictive value (PPV) for malignancy; amorphous, pleomorphic, and granular 
calcifications (BI-RADS 4) are of intermediate concern and needle core biopsy is 
always mandatory. Among masses, opacities with high density, irregular shape, 
spiculate margins have the highest PPV for malignancy, although DCIS usually 
exhibit low density masses, elongated, with indistinct margins. The PPV increases 
when a mass is associated with microcalcifications. The distinction is between 
DCIS and invasive carcinoma is very difficult as the signs are often similar and 
the two pathologies frequently associated (e.g. microinvasive carcinoma; invasive 
carcinoma with extensive intraductal component); DCIS is more likely in case of 
isolated microcalcifications without mass. 
Learning Objectives:
1. To review the signs in depicting DCIS.
2. To learn how we can reach this diagnosis with a low PPV.
3. To classify microcalcifications using BI-RADS categories.
A‑380 16:30 
B. Ultrasound 
C.F. Weismann; Salzburg/AT (christian.weismann@inode.at) 
What can US learn from mammography (MG) in DCIS? In up to 90%, DCIS is 
diagnosed by MG detecting pleomorphic and irregular clustered microcalcifications 
(MCs). The US investigator learns from MG the localisation and the distribution 
(group, linear, segmental, regional) of the MCs in the breast. Depending on mam-
mographical breast tissue density and on morphology of the DCIS, MG may show 
the combination of MCs embedded in a mass or in an enlarged tubular structure.
What are the US criteria of mammographically proven microcalcifications? US-
visualisation of the MCs depends on tissue contrast. The tissue contrast is influenced 
by the US-frequency used. The higher the frequency, the better the spatial resolution, 
although the tissue contrast may be reduced. Modern US technology permits to alter 
the frequency during the investigation to optimize the tissue contrast. The individual 
MC appears as a tiny echogenic dot or spot. It may show reverberations. Usually, 
acoustic shadowing is not produced by a single MC. Morphologic determination 
comparable to MG-features is currently beyond resolution. What are the US signs 
of calcified and non-calcified DCIS? Low echo lesions, well circumscribed with 
echogenic dots and spots (MCs) are the common type. Low echo lesions with an 
ill defined margin with or without echogenic dots, irregularly enlarged ducts filled 
with hypoechogenic structures with or without MCs, lesions in combination with a 
duct and intracystic solid lesions raise the suspicion of DCIS.
What helps to realize the problem? According to the above questions, some tips 
conclude the lecture. 
Learning Objectives:
1. To compare its value with mammography in DCIS.
2. To discuss diagnostic criteria for DCIS with and without microcalcifications.
3. To learn practical tips in problem solving.
A‑381 17:00 
C. MR imaging 
R.A. Kubik-Huch; Baden/CH (rahel.kubik@ksb.ch) 
Patients with ductal carcinoma in situ (DCIS) may develop invasive carcinoma in 
about 60% of cases over a period of 10 years. Therefore, it is important to diagnose 
and evaluate cases of DCIS properly for better patient management. Dynamic 
contrast-enhanced MRI of the breast has become a well established method for 
detecting and evaluating invasive breast carcinoma. There are less scientific data 
regarding the accuracy of MRI as compared to mammography for in situ carcinoma. 
In contrast to invasive carcinoma, DCIS usually displays linear of ductal clumped 
enhancement and focal branching pattern on dynamic contrast-enhanced se-
quences and delayed, persistent (i.e. benign) dynamics. Therefore, morphology is 
more reliable than kinetics. Overlap with benign disease, e.g. fibrocystic changes, 
does exist. MRI was shown to be significantly more sensitive than mammography 
or ultrasound for the detection of DCIS. The wide range of sensitivities for detection 
of DCIS published in the literature is in part likely to reflect variations in interpreta-
tions, imaging parameters and selections bias. DCIS are a highly heterogeneous 
group of tumors. Preliminary data indicate that the enhancement patterns may 
partly also depend on the grading and a normal MRI scan may potentially allow to 
exclude high grade DCIS. The role of MRI in DCIS is currently not fully established. 
MRI may play an increasing role in assessing the extent of disease in the breast 
in women with known or suspected DCIS in the future. 
Postgraduate Educational Programme
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Learning Objectives:
1. To learn about the morphological pattern and signal enhancement 
characteristics of ductal carcinoma in situ.
2. To discuss whether in situ carcinoma can be differentiated from invasive 
disease on MRI.
3. To review the current literature on MRI in ductal carcinoma in situ.
4. To discuss the potential impact of breast MRI on the treatment of DCIS.
16:00 - 17:30 Room G/H 
Neuro 
RC 1411 
Common disorders of the pediatric brain 
Moderator:
P. Eliás; Hradec Králové/CZ 
A‑382 16:00 
A. Fetal MR imaging: More than just T2-weighted images 
C. Hoffmann; Tel Hashomer/IL (chen.hoffmann@sheba.health.gov.il) 
The objective of this talk is to introduce other techniques than SS FSE T2 in use when 
scanning the fetal brain. The most frequent indications for MRI are ventriculomegaly, 
asymmetry of the ventricular system, brain malformations, infection and others. Most 
of the MR scan is done with Single Shot FSE T2 (SSFSET2); this is a sequence al-
lowing the acquisition of slice by slice of the brain, and thus minimizing the effect of 
fetal movement on the scan. Today, fast FRFSET2 are available; this is a very short 
T2 sequence in which the white and gray matter junction is visualized very well. T1 or 
FSPGR are used with limitations due to the fetal movements. It is necessary to perform 
T1 to demonstrate the myelination. DWI is a very important tool in the understanding the 
ischemic changes in the adult brain, allowing the diagnosis of acute infarcts. Ischemic 
insult can occur in fetuses with conditions such as TTTS in twin pregnancies and fetal 
demise. The living fetus can also suffer from abnormal blood supply to the CNS, and 
thus showing small or even large hemispheric infarcts. Other diffusion technique, DTI is 
also used to demonstrate the white matter formation of the fetal brain. MRS is also used 
in the evaluation of the fetal brain. The values of the NAA, choline and the existence of 
lactate are different than the values in the pediatric and adult brain. 
Learning Objectives:
1. To explore the new imaging techniques for the study of the fetal brain.
2. To study the use of diffusion-weighted imaging in the fetal brain.
3. To focus on an accurate use of T1-weighted sequences in the fetal brain.
4. To explore the possibilities of tractography in the fetal brain.
A‑383 16:30 
B. Normal findings and pitfalls in pediatric neuroimaging 
W. Chong; London/UK (ChongK@gosh.nhs.uk) 
Neuroimaging of the developing pediatric brain and spine requires the optimisation of 
imaging equipment and parameters. The radiologist is assisted by a good knowledge 
of embryology and normal variants as well as an understanding of pediatric disorders. 
However, even without a thorough knowledge of pediatrics, the application of sound 
radiological principles, including physics and anatomy, applied logically and rigorously, 
will allow the radiologist to provide clinically useful interpretations of the images. Pitfall 
may still occur, and the common ones are usually based on common misunderstand-
ings or even myths about pediatric normal anatomy or the presentation of disease as 
seen in adults. In a famous quote, ‘the child is not simply a small adult’. 
Learning Objectives:
1. To understand a different approach to neuroimaging in the developing 
pediatric brain and spine.
2. To appreciate that, despite the wide and potentially complex spectrum of 
diseases seen in neuropediatrics, most interpretations can be made through 
the thoughtful application of basic neuroradiological analytical techniques.
3. To be aware of certain areas where common pitfalls, myths and 
misunderstandings occur.
A‑384 17:00 
C. Neuroimaging in the acutely ill child 
E. Vázquez; Barcelona/ES (evazquez@vhebron.net) 
The ability to develop more aggressive treatments of acute neurological disorders 
in children is nowadays improving; however, infants and children are often uncoop-
erative, clinical signs are not always easily localized, and so diagnosis and therapy 
may be both delayed. Effective imaging of the central nervous system has assumed 
an increasingly important role in the evaluation of children with acute neurological 
disorders. This lecture will review the main indications to perform a neuroimaging 
procedure in children with a neurological emergency. With didactic purposes, these 
acute conditions will be classified in traumatic and non-traumatic conditions. In 
the no traumatic acute setting we will consider children presenting with headache 
(particularly with those symptoms and signs suggesting underlying neoplasm or 
haemorrhage), seizures (particular relevance to those cases that need urgent 
neuroimaging), coma, acute neurological deficits, or acute spinal cord syndrome. 
Practical algorithms with the preferential use of either CT or MRI (including diffu-
sion and spectroscopy) in each group of pathologies, such as cranial trauma, acute 
hypoxia, cerebral infarction, venous thrombosis, haemorrhage, shunt malfunction 
or encephalitis, will be presented following representative didactic cases selected 
from the daily routine in a paediatric tertiary hospital. 
Learning Objectives:
1. To learn the characteristic neuroimaging findings that may be useful in 
establishing differential diagnoses.
2. To understand the various neurological complications that can occur in the 
intensive care unit and to become familiar with their most typical imaging 
patterns.
3. To consolidate the best neuroimaging protocols for the acutely ill child 
and establish the main indications for the use of MR imaging, particularly 
diffusion and spectroscopy.
16:00 - 17:30 Room I 
Physics in Radiology 
RC 1413 
Clinical audit, accreditation and the role of the 
medical physicist 
Moderators: 
A. Del Guerra; Pisa/IT 
J. Geleijns; Leiden/NL 
A‑385 16:00 
A. European-wide perspective on clinical audit 
H. Jarvinen; Helsinki/FI (hannu.jarvinen@stuk.fi) 
The Council Directive 97/43/EURATOM introduced the concept of clinical audit to 
medical RADIOLOGICAL (diagnostic radiology, nuclear medicine and radiotherapy) 
procedures. Clinical audit is a systematic review of the procedures in order to im-
prove the quality and the outcome of patient care. According to the directive, clinical 
audits shall be implemented in accordance with national procedures. The review of 
its implementation in Europe has revealed a high variation of approaches and many 
practical problems. Therefore, the European Commission has published further guid-
ance on clinical audits in its Radiation Protection series. The purpose is to improve the 
implementation of clinical audits and to enable the member states to adopt the model 
of clinical audit with respect to their national legislation and administrative provisions. 
The guideline points out the importance of both internal and external assessments 
for clinical audit. It deals with all types and levels of clinical audit and gives practical 
guidance for application. It defines the list of topics which should be covered, while the 
actual criteria of good practice are discussed on generic levels only. The borderline 
between clinical audit and other quality assessments (accreditations, certifications, 
peer reviews) and regulatory inspections is also discussed. The guideline is ad-
dressed to all professional groups, hospital management, auditing organizations 
and regulatory bodies. It is important to recognize that the guideline is not a legal 
requirement. Through addressing technical, financial and clinical provision for high 
quality RADIOLOGICAL procedures, the main beneficiary is eventually the patient. 
Learning Objectives:
1. To describe the purpose and essential contents of the European commission 
guideline on clinical audit.
2. To describe a review of clinical audits in Europe.
A‑386 16:30 
B. National perspective: Clinical audit inspections 
S. Ebdon-Jackson; Didcot/UK (steve.ebdon‑jackson@hpa.org.uk) 
European Council Directive 97/43/Euratom requires under Article 6 (4) that “clinical 
audits are carried out in accordance with national procedures”. Implementation 
of this requirement across Europe has been varied. This paper will reflect on the 








A S99CB D E F G
taken in the UK by professional bodies and organisations. This will be contrasted 
with the role of the regulator and the aims of the inspection process with regard to 
compliance with the specific regulation addressing clinical audit and the remaining 
regulations addressing justification, optimisation etc. Examples will be provided of 
the type of audits undertaken within UK hospitals. A UK perspective of EC and 
IAEA initiatives in clinical audit will be provided. 
Learning Objectives:
1. To describe the approach taken by a national body to perform clinical audit.
2. To describe practical aspects of clinical audit inspections.
3. To describe lessons learned from inspection and suggestions for 
improvement.
A‑387 17:00 
C. Hospital perspective on clinical audit 
P. Gilligan; Dublin/IE (PGilligan@materprivate.ie) 
The demand from the public for greater accountability and standards has increased 
the importance of audit and accreditation in modern healthcare delivery. Success may 
determine whether the hospital can secure funding or even continue to offer certain 
services. Specifically, radiology departments participate in audits by a number of enti-
ties: 1. National bodies concerned with improving radiation safety particularly under 
EU 97/43 directives. 2. Hospital wide accreditation surveys from state and private 
accrediting organisations such as Joint Commission International and ISO. 3. Audit-
ing of standards from within professional bodies. 4. Investigation of specific incidents 
within radiology departments such as misdiagnosis or radiation concerns. 5. Modality 
specific standards. Although the specific requirements of the accrediting or auditing 
body may differ, the processes and practical aspects in demonstrating compliance with 
standards and quality improvement are similar. In addition to fulfilling basic regulatory 
requirements, the medical physicist is playing a role in developing performance indices 
particularly in radiation safety, clinical image quality and equipment management. 
The medical physicists experience in developing quality assurance programs has 
also proved useful throughout the whole hospital. The increasing role of the medical 
physicist in audit underpins the requirement for inclusion of audit and accreditation as 
part of their education. Recent experience of setting up and participating in EU 97/43 
directive based clinical audit in Ireland highlighted the critical need for clarity of roles 
and ownerships of processes to be communicated to those who are carrying out audit 
and those who are being audited in hospitals. 
Learning Objectives:
1. To describe practical aspects of complying with standards and undergoing audit.
2. To describe the outcomes of the audit.
3. To describe how to implement the results of the clinical audit.
16:00 - 17:30 Room K 
Pediatric 
RC 1412 
Imaging in non-accidental injury 
Moderator:
R.R. van Rijn; Amsterdam/NL 
A‑388 16:00 
A. CNS trauma 
P. Demaerel; Leuven/BE (philippe.demaerel@uz.kuleuven.ac.be) 
The presentation will focus on the role of the radiologist in non-accidental head 
injury. The common acute findings will be discussed as well as the long term imaging 
features on brain CT and MRI. An optimal imaging strategy will be defined. Particular 
attention will be paid to the role of skull X-ray and ultrasound, to the assessment of 
generalised brain edema on CT, to the estimation of timing hematoma on CT and 
MRI, to the role of diffusion weighted MRI, to the differential diagnosis with other 
entities and to the interaction with the forensic sciences in medico-legal situations. 
Non-accidental head injury is regularly encountered in large community hospitals 
and the role of the radiologist is crucial because the clinical presentation is often 
misleading. Therefore, all radiologists should be aware of the, sometimes subtle, 
imaging appearances. 
Learning Objectives:
1. To stress the role of CT in the assessment of non-accidental cranial injury.
2. To emphasise the contribution of MRI, including diffusion-weighted imaging, 
in the acute setting.
3. To describe controversies regarding the age of a subdural hematoma.
4. To give advice on how to report on a CNS non-accidental injury.
A‑389 16:30 
B. Skeletal trauma 
M. Alison, R. Azoulay, B. Tilea, G.-H. Sebag; Paris/FR
(guy.sebag@rdb.ap‑hop‑paris.fr) 
Imaging plays an important role in the detection and documentation of abuse, and 
failure to make a correct diagnosis may have serious consequences. Fractures are 
the second most common finding in child abuse after cutaneous findings and the 
skeletal survey is the cornerstone radiological examination in suspected physical 
abuse. The skeletal survey protocol should be performed according to the pub-
lished pediatric radiology guidelines and standards. Careful attention is needed 
with regard to the quality of the radiographs. Equivocal fractures at all sites should 
be evaluated with additional projections. The follow-up skeletal survey increases 
the sensitivity of initial radiographic examination and should be considered in all 
cases where abuse is strongly suspected. Bone scintigraphy may complement the 
skeletal survey notably in infants. Although estimation of fracture age should be 
approached with caution, it is important to differentiate recent from old fractures 
and when multiple fractures are present to state if the fractures are of similar or 
different ages. Careful interpretation by radiologists with experience in pediatric 
imaging is mandatory in order to distinguish abuse from accidental trauma, normal 
variants, metabolic bone diseases and skeletal dysplasias. 
Learning Objectives:
1. To describe the imaging strategy in skeletal non-accidental injury.
2. To determine the technical considerations including quality insurance.
3. To show the imaging features of inflicted skeletal injury.
4. To discuss the differential diagnosis.
A‑390 17:00 
C. Abdominal trauma 
M. Raissaki; Iraklion/GR (mraissaki@yahoo.gr) 
Child abuse accounts for 10% of all blunt abdominal traumas in patients younger than 
5 years. Abuse-related abdominal injuries carry a worse prognosis, with a mortality 
of up to 50%, due to the severity of injuries, the delay in seeking help and occasion-
ally the misleading provided history. A high index of suspicion should exist for any 
patient less than 3 years of age with a traumatised hollow or solid viscous especially 
when the history is not consistent with the clinical presentation or extent of injury. Any 
abdominal injury pattern may occur in child abuse, the commonest being duodenal 
or other hollow viscera’s hematoma and/or rupture, mesenteric trauma, pancreatic 
laceration, liver laceration, and adrenal hematomas. Multiple injured organs, combina-
tion of solid and hollow viscus injuries may also occur. Rib, pelvis and spinal fractures 
should be actively looked for. Indications for imaging the abdomen in suspected child 
abuse include elevated hepatic transaminases and amylase, abdominal bruising, 
distension, tenderness, bilious vomiting and hematuria. Abused children who have 
suffered massive trauma should be imaged with the same protocols as the ones fol-
lowing extensive accidental trauma. Following stabilization, CT is considered the test 
of choice for the identification and documentation of abdominal trauma in suspected 
child abuse. Ultrasonography is considered a reasonable preliminary study in stable 
children less than 1 year of age and extremely useful for the follow-up. An upper GI 
series is indicated for occult or resolving duodenal hematomas. 
Learning Objectives:
1. To understand differences between accidental and non-accidental abdominal 
trauma.
2. To describe the type of abdominal injuries that may indicate child abuse.
3. To discuss the appropriateness of imaging in suspected abdominal non-
accidental trauma.
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C. Balassy; Toronto, ON/CA 
P. Gerson; Paris/FR 
A‑391 16:00 
A. DR system: How to find the best hardware and software to achieve 
mininum dose and best images 
H. Precht, O. Gerke; Odense/DK (hepr@ucl.dk) 
Purpose: To develop knowledge for informed consideration of dose reduction 
and image quality in paediatric radiography and to reduce patient dose based on 
process heat algorithms in Canon’s DR system. Options for software optimiza-
tion were studied in relation to optimal image quality and follow-up examinations, 
to investigate when it may be possible to accept inferior image quality and thus 
comply with ALARA.
Methods and Materials: A quantitative experimental study based on experiments 
with technical and human phantoms. A technical CDRad phantom was used and 
the pictures were analyzed using CDRad software, giving results as objective IQF 
values. The human phantom was replaced with a lamb pelvis with femur, which 
offers absorption comparable to a 5-year-old child according to the report by NRPB. 
The human pictures were analyzed by 3 radiologists specializing in paediatric bone 
examinations using the relative VGA scale and the absolute VGA scale.
Results: Software impact on image quality was great, but the dose effect will 
always influence the experienced quality. CDRad analysis of the software base 
caused image quality factors, which are important in human images, to be impos-
sible to assess.
Conclusion: Optimal image quality is maintained at a dose reduction of 70%, 
but the images were diagnostically approved at a reduction of 97% on the basis 
of the reference value. Control recordings were possible at 0.5 mAs, all based on 
MLT (S)-optimized images. 
Learning Objectives:
1. To learn about possibilities for software processing optimisation in DR 
systems.
2. To become familiar with possibilities to grade dose and image quality in 
relation to the indication for the examination.
3. To report a study on the possibilities of improving image quality using 
different dose levels in pediatric femur examinations using Canons MLT (S) 
algorithm.
A‑392 16:45 
B. CT: Cardiac examinations in children 
T. Bock-Pedersen; Copenhagen/DK (tina.bock‑pedersen@toshscan.dk) 
We, at the University Hospital in Copenhagen, Denmark - Rigshospital, have gained 
experience with Cardiac CT, since 2005. We have a 64MSCT and a 320MSCT. We 
would like to share our considerations and show how we have set up our protocols 
for Cardiac CT imaging of the pediatric patient. One of the advantages with CT is 
examination speed, which allows us to perform most all pediatric CT scans without 
sedation or general anesthesia. Outpatient examination is possible, as it is a non-
invasive examination. Dose is a limiting factor, as children are much more sensitive 
to radiation. Therefore, when possible, non-ionizing modalities should be used 
(MRI or ECHO). What is essential when imaging a pediatric patient, especially in 
regards to heart imaging with congenital abnormalities? Triggering can be an issue 
and we prefer to trigger visually/manually. Continues bolus is made possible with 
the auto injector.Teamwork and preparation are the key factors! Before the patient
arrives, the radiologist/cardiologist and radiographer have to decide what is to be 
diagnosed, how to reach the diagnose and at what dose i.e. decide on the quality 
of the scan - can we do a ‚low dose‘ scan‘, arteriel phase, with ECG triggering? etc. 
Learning Objectives:
1. To learn how to perform a successful diagnostic CT on a pediatric patient.
2. To become familiar with the technical aspects of cardiac CT.
3. To learn about the difference between children and adults.
4. To learn about the importance of teamwork.
16:00 - 17:30 Room N/O 
Professional Challenges Session 
PC 14 
Radiology and the law 
Moderator:
E. Breatnach; Dublin/IE 
A‑393 16:00 
Chairman’s introduction 
E. Breatnach; Dublin/IE (ebreatnach@mater.ie) 
The modern radiologist needs to deal increasingly with European regulations 
which more and more impacts on every facet of his/her professional life. In addi-
tion, malpractice litigation is an increasing force. Many technologies have specific 
attendant legal issues, e.g. teleradiology, and the increasing workload of radiolo-
gists increases their vulnerability to individual malpractice claims. This session 
will address these topics and will highlight the extent of the problem both in the 
context of general regulations and individual risk areas. Three speakers represent-
ing North America, mainland Europe and the U.K. will present papers outlining the 
major issues involved. A final question and answer session will deal with specific 
medicolegal case scenarios and will be audience interactive. 
Session Objectives:
Using ‘real case’ material:
1. To familiarise radiologists with their vulnerability to litigation.
2. Steps to avoid being successfully sued.
3. Items of new European regulations and how they increasingly affect your 
radiology practice.
A‑394 16:05 
Radiologic communications: Dilemmas and pitfalls 
L. Berlin; Skokie, IL/US (lberlin@northshore.org) 
Communication is a two-way street. There is often a dispute between the radiologist, 
who argues that a report was transmitted, and the referring physician, who argues 
that the report was never received. Radiologists claim that a written report was 
sent and should have been sufficient. If the ordering physicians did not notice or 
read the report, then should not the radiologist be free of blame? Unfortunately, the 
answer is no. It is true that if the referring physician would promptly review written 
radiology reports, injuries to patients would not occur. Nevertheless, it is the radi-
ologist’s breach of the standard of radiologic care - failure to directly communicate 
significant unexpected findings to the referring physician - that initiates the chain of 
events that often leads to a patient’s injury or death. The radiologist is not relieved of 
liability. Communicating the results of radiologic examinations has become just as 
much the duty of radiologists as is the rendering of interpretations. The American 
courts and the American College of Radiology have clearly stated that radiologists 
must verbally communicate urgent or significant unexpected findings to referring 
physicians. There is now evolving in the American judicial system an expansion 
of the radiologist’s duty to include direct communication to patients as well as to 
referring physicians. Several companies now market direct communication products 
which may satisfy the requirements for direct communication. Radiologists may 
wish to investigate them to determine whether or not they would satisfy local needs. 
Learning Objectives:
1. To understand the radiologist’s responsibility in communication of acute and 
possibly life threatening radiologic abnormalities.
2. To recognise the radiologist’s responsibility in prompt communication of less 
acute findings.
3. To outline the principles of direct communication of radiological findings to 
patients.
A‑395 16:28 
Medical negligence: The lawyer’s perspective 
G. Loibner; Vienna/AT (anwalt@ra‑loibner.at) 
The basis of treatment of patients is the contract of treatment. Under such contract, 
the patient is not entitled to a specific result of the treatment but to treatment with 
due care. Due care is measured by the standard of medical skills and science. 
In case of damages suffered by the patient from lack of due care, the patient is 
entitled to compensation. The burden to prove the damage, the malpractice and 
the causality between malpractice and damage rests with the patient. The burden 
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concerning the missed finding of a malignant breast tumor will be presented. Beside 
malpractice, the lack of patient’s informed consent becomes an increasing source 
of physicians’ liability. Apart from treatment with due care, patients are entitled 
to information about the risks and consequences of treatment and alternatives 
thereto. Failure to adequately inform the patient can result in physician’s liability 
for damages resulting from treatment performed lege artis in case risks materialize 
the patient has not been duly informed of. Information by form sheet only is not 
considered sufficient. Extent and intensity of information depend on the urgency 
of treatment. The less urgent the treatment, the more intense information has to 
be. Proper documentation of information is essential for the avoidance of liability. 
Learning Objectives:
1. To learn about the general principles of liability for medical malpractice.
2. To understand the increasing risk of liability despite of lege artis treatment for 
lack of patient’s informed consent.
3. To appreciate the importance of proper documentation of patient’s 
information in order to minimise the risk of liability.
A‑396 16:51 
European legislation big brother: What the practitioner should know to 
avoid being sued and what to do if you are 
R. FitzGerald; Wolverhampton/UK (richard.fitzgerald@rwh‑tr.nhs.uk) 
1. European Working Time Directive (EWTD): The EWTD was passed in 1993. 
However there have been many delays in its full implementation by medical prac-
titioners, due to problems of staffing and service provision. Full implementation of 
EWTD is expected of all doctors in the EU from August 1st 2009. The legal climate 
will be more hostile for those doctors accused of negligence, with respect of a period 
of time when they have been in breach of the EWTD. There is increasing literature 
on the effect of fatigue on safe medical performance. 2. Patient Confidentiality: The 
European Court of Human Right ruled in 2008 that the Government of Finland 
had breached Article 8 of the European Convention on Human Rights (the right 
to privacy) by not securing the patient confidentiality of the plaintiff, a nurse. The 
Finnish Hospital had only been able to identify the five most recent individuals 
to access the patient’s electronic record and this was considered inadequate by 
the Court. The I versus Finland case alters the legal context for inadequate audit 
processes to assure patient confidentiality from inappropriate access to electronic 
patient records. 3. Medical Regulatory Requirements for Teleradiology Reporting 
for Patients in the EU: The Directive on the Application of Patient Rights in Cross-
Border Healthcare had a comfortable majority in its First Reading in the European 
Parliament in April 2009. It is now with EU Health Ministers and will go to the new 
MEPs in the autumn for a second reading. The current wording of Article 16 on 
e-Health includes provision to regulate telemedicine practitioners. 
Learning Objectives:
1. To appreciate the medico-legal consequences of failure to comply with the 
European Working Time Directive.
2. To understand the precedent set in I versus Finland for patient confidentiality 
with electronic patient records and PACS.
3. To be familiar with the current medical regulatory requirements for 
teleradiology reporting E.U./Worldwide.
Panel discussion:  
Illustrative cases on: 1. Medico-legal consequences of poor radiology 
communication. 2. What is an ‚acceptable‘ error rate for radiologists?  
3. Panel advice on how to reduce one‘s medico-legal vulnerability. 17:14 
16:00 - 17:30 Room P 
Cardiac 
RC 1403 
Valvular heart disease 
Moderator:
F. Cademartiri; Parma/IT 
A‑397 16:00 
A. Echocardiography: Clinical standard with limitations 
M.R. Rees; Gwynedd/UK (m.rees@bangor.ac.uk) 
Transthoracic echocardiography is routinely used in the office setting and acts 
as a first line diagnostic technique in cardiology. It is a portable, readily available 
modality but has its limitations. Among the diagnostic limitations of transthoracic 
echocardiography are diagnosis of the thickened, some types of cardiomyopathy 
and diseases of the cardiac apex, which is often not well seen. Details of valve mor-
phology and tranoesophageal echo are an invasive investigation where the patient 
has to swallow the echo probe. The patient often requires sedation for this but the 
investigation can be carried out as a day case. Trans-oesophageal echo provide 
greater detail of cardiac anatomy and function and is used frequently as an adjunct 
to cardiac surgery as an intra-operative procedure. Stress echo-cardiography is 
used for the diagnosis of myocardial ischaemia when accompanied by increasing 
doses of intravenous Dobutamine and for the diagnosis of myocardial viability. 
The principle of this test is that a low dose of Dobutamine will excite function in a 
non-functional area of myocardium which is viable. All types of echo can utilize the 
additional facilities of Doppler examination (pulsed and continuous wave) colour and 
echo contras to make physiological diagnoses. These tests remain more subjective 
than other competing image tests because of the need for operator experience 
and skill, patient-based factors and the more subjective nature of interpretation. 
Learning Objectives:
1. To discuss anatomy and clinical background.
2. To identify strengths and limitations.
3. To compare a transthoracic vs a transesophageal approach.
A‑398 16:30 
B. Computed tomography: More than calcification! 
A. Lembcke; Berlin/DE (Alexander.Lembcke@gmx.de) 
In cardiac surgery, heart valve diseases represent the second most common reason 
for an operation. Different modalities, (i.e. echocardiography, cardiac magnetic 
resonance imaging and cardiac catheterisation) are currently in use to assess 
patients with suspected heart valve disease. However, all examination techniques 
have their own strengths and limitations. Multislice computed tomography (MSCT) 
has recently emerged as an additional modality that permits functional 4D imaging 
of the cardiac valves. Beyond the quantification of calcifications, MSCT may allow 
for the detailed 3D visualisation of the valve morphology. This includes the detec-
tion of valvular vegetations and local complications (e.g. paravalvular abscess) 
in infective endocarditis. Furthermore, MSCT may provide useful information 
regarding disease severity in valve stenosis and insufficiency by planimetry of 
the valvular opening and regurgitant orifice area. The ability of MSCT to describe 
the 3D geometry of the entire aortic root is particularly helpful to plan aortic valve 
surgery and interventions (e.g. minimally invasive aortic valve replacement using 
either the transapical or transfemoral approach). Moreover, MSCT may allow for 
the simultaneous evaluation of the coronary arteries and myocardial function. This 
presentation will discuss the potential clinical role of MSCT for the evaluation of 
patients with heart valve disease, the advantages and disadvantages of current 
MSCT techniques and the differences between MSCT and established modalities 
used for evaluating heart valve disease (i.e. echocardiography, cardiac magnetic 
resonance imaging and cardiac catheterisation). 
Learning Objectives:
1. To optimise functional 4D-imaging.
2. To quantify valve insufficiency and stenosis with CT.
3. To plan surgery and percutaneous valve replacement, and to map 
calcification.
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A‑399 17:00 
C. Magnetic resonance: Value of flow measurements 
N.L. Kelekis; Athens/GR (kelnik@med.uoa.gr) 
Cardiac MRI has evolved into an alternative and complementary modality to ultra-
sonography in assessing patients with valvular heart disease. MRI on state-of-the-
art scanners using cine and velocity-encoded gradient echo sequences provides 
reliable qualitative and quantitative assessment of valvular dysfunction including 
stenosis and insufficiency. It can also quantify flow through the atrioventricular and 
ventriculoarterial valves, as well as virtually any vascular structure. MRI provides 
moreover morphological and functional assessment of both ventricles with objec-
tive volumetric measurements throughout the cardiac cycle. With the combination 
of the above volumetric and flow data, it can quantify stenosis and/or insufficiency 
in patients with simple or complex valvular disease, as well as Qp/Qs ratio and 
shunts. MRI is the only modality able to quantify the regurgitant volume, which is 
of importance in patients with aortic regurgitation or pulmonary insufficiency as in 
surgically corrected tetralogy of Fallot. The mathematical combination of pulmonary 
regurgitant and tricuspid flow reflects the diastolic function of the right ventricle. MRI 
is superior to ultrasonography in situations with poor acoustic windows such as 
postoperative or obese patients, conduits calcified or not, always providing objec-
tive anatomic and functional data. It is, however, a time-consuming and expensive 
modality and inferior to ultrasonography in the assessment of valve leaflets and 
small vegetations. Future perspectives include improved anatomic imaging at 3 T, 
efforts to adequately visualize valve leaflets, real-time velocity-encoded sequences, 
and whole-heart scanning with flow sequences encoded in the three directions. 
Learning Objectives:
1. To optimise imaging protocol.
2. To quantify valve insufficiency and stenosis with MRI.
3. To learn about pitfalls in MR flow measurements.
16:00 - 17:30 Room Q 
Interventional Radiology 
RC 1409 
Oncologic interventions in the liver 
Moderator:
J.‑I. Bilbao; Pamplona/ES 
A‑400 16:00 
A. RF ablation 
F. Deschamps; Villejuif/FR (Frederic.Deschamps@igr.fr) 
Percutaneous radiofrequency ablation (RFA) is a safe and effective treatment for 
well-selected patients with hepatic tumors such as hepatocellular carcinoma (HCC) 
and liver colorectal metastase (LCM). An appropriate selection is crucial. It is based 
on clinical and technical arguments. Clinically, surgical resection of the hepatic 
tumors remains the gold standard. Indeed, the survival data following RFA are not 
as good as surgical resection. The only exception seems to be the RFA of the very 
early HCC (≤2.0 cm) in cirrhosis that is not candidate for liver transplantation. Most 
often, the RFA offers an alternative for patients with medical comorbidities, poor 
liver function or prior hepatectomy. Technically, there are three decisive points for 
complete ablation. The first point is the good visualization of the tumor either under 
ultrasound or un-enhanced computed-tomography (CT) examination. Metallic coil 
placement, lipiodol tattoo and virtual CT sonography with magnetic navigation are 
technical tricks that allow the RFA of "invisible" tumors. The second point is the 
tumor size: in most series, a diameter less than 25-35 mm is commonly admitted 
as a prognostic factor. This is probably because the maximal ablation diameter is 
slightly larger than 40 mm with the electrode needles available now. RFA combined 
with trans-arterial chemo-embolization might improve the local control by increas-
ing the ablation diameter. The last point is the "heat-sink effect" that requires a 
temporary occlusion of a large vessel close to the tumor. The quality of follow-up 
imaging is a key factor for evaluation of the tumor destruction. 
Learning Objectives:
1. To discuss indications for RF ablation.
2. To learn about the technique and devices for RF ablation.
3. To discuss results and follow-up strategies.
A‑401 16:30 
B. New embolisation techniques 
F. Orsi; Milan/IT (franco.orsi@ieo.it) 
While liver resection is still the gold-standard for curative local treatment of liver 
lesions, several promising local approaches have been developed in the past three 
decades, such as intra-arterial treatments, percutaneous thermal ablation, stereo-
tactic radiotherapy and more recently high intensity focused ultrasound. There is no 
consensus on the best local therapy. However, intra-arterial therapies offer great 
promise based upon the premise that hepatic tumors are fed mainly, if not exclu-
sively, by arteries. Bland embolization, chemoembolization and radio-embolization 
are some of the most commonly performed local treatments for patients with liver 
cancers and several embolic agents have been specifically developed for that 
purpose. Both TACE and TAE may shut-down the arterial blood flow to the tumor, 
leading for tumor ischemia and, eventually, tumor cell death, if anoxia is induced. 
Association of local chemotherapy to the embolic effect represents the rationale for 
TACE. For this purpose, new embolic particles, which may precisely elute drugs, 
have been introduced. For radioembolization, micro-particles are injected into the 
feeding arteries as vehicles for delivering interstitial sources of radiation therapy. 
Small and precisely calibrated micro-particles have been introduced for a deeper 
a more effective TAE. Because hepatic tumors are supplied by several arterial 
feeders, complete tumor death may be obtained only if the entire vascular network 
supplying the tumor will be treated. If even small feeding arteries will be missed, 
tumor mass will be not completely treated and it will relapse. For this reason, the 
knowledge of possible vascular abnormality is mandatory for a better outcome. 
Learning Objectives:
1. To discuss the uses of drug eluting beads.
2. To review experience with selective internal radiation 
(yttrium-90, and others).
3. To review the role of hepaspheres in hepatic embolisation.
A‑402 17:00 
C. Future directions 
J. Kettenbach1, A. Melzer2; 1Berne/CH, 2Dundee/UK (joachim.kettenbach@insel.ch) 
Image-guidance and imaging fusion techniques represent an integral element in 
oncologic liver surgery. In addition, several liver planning techniques such as the 
Virtual Liver Surgery Planer enhance simulation of a proposed liver resection. Using 
roboter-assistance or navigational guidance, combined with classic tumor ablation 
techniques such as radiofrequency ablation, significantly enhances accuracy of ablation 
probe placement and efficacy of ablation necrosis. It has further shown that the local 
recurrence rate was considerable lower, and the amount of complete tumor ablation 
was significantly more likely as compared to other studies. Most recent, a European 
Union-funded project, lead by IMSaT, at the University of Dundee, collaborating with 
InSightec, Ltd and CapsuTech Ltd will integrate magnetic resonance imaging, focused 
ultrasound to deliver and activate nano-capsules carrying anti-cancer drugs to effectively 
target tumors. This project involves drugs being injected into the body in the form of 
tiny capsules, which are harmless until they are activated by a concentrated focused 
ultrasound ` blast‘, using devices developed in IMSaT‘s medical ultrasound laboratories 
as well as commercial systems. The MRI scanner will be used to track the passage of 
the drugs, visualize the target and monitor the delivery of the drug treatment. InSightec 
develops unique commercial MR-guided focused ultrasound systems, and CapsuTech 
deals with different aspects of a drug delivery platform based on targeted nano-capsules. 
All this innovative developments may contribute to improved patient outcome, less side 
effects, and reduced pain medication for patients, with otherwise unresectable tumors. 
Learning Objectives:
1. To review new ablation modalities.
2. To review research on targeted embolotherapy.
3. To discuss the use of combined therapies.
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Radiology in Abdominal Emergencies 
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A. The wrong twist: Mesenteric and omental torsion 
M. Macari; New York, NY/US (michael.macari@nyumc.org) 
There are numerous causes of acute abdominal pain. While the clinical history, 
physical examination, and laboratory results may be helpful in triaging patients with 
abdominal pain, MDCT has become one of the most important tools in the evaluation 
of these patients. Twisting of the mesentery is a relatively common cause of acute 
abdominal pain. This may be due to a primary volvulous, internal hernias through 
mesenteric rents, or around adhesions. Mesenteric torsion with small bowel volvu-
lous is most often caused by adhesions. Recognizing the CT findings of mesenteric 
volvulous with resultant closed loop intestinal obstruction and subsequent ischemic 
bowel are of utmost importance. Omental torsion is not as common as mesenteric 
torsion and the bowel is usually not affected. This lecture will review the imaging 
findings and clinical aspects of mesenteric and omental torsion. 
Learning Objectives:
1. To understand the pathophysiology of mesenteric and omental torsion.
2. To know the typical presentation on cross-sectional imaging modalities.
3. To learn imaging strategies with focus on MDCT.
A‑404 09:00 
B. Abdominal hernias 
G. Brancatelli; Palermo/IT (gbranca@yahoo.com) 
Abdominal hernias are common in daily practice and can be divided into: external or 
abdominal wall hernias, internal hernias; diaphragmatic hernias. External hernias typi-
cally involve protrusion of abdominal contents through a defect in the abdominal wall. 
Internal hernias involve protrusion of viscera through congenital or acquired defects in 
the mesentery or the peritoneum. Diaphragmatic hernias involve protrusion of abdominal 
contents into the chest. Among these conditions, the diagnosis of internal hernia is the 
most challenging. Bariatric surgery and liver transplantation with biliary-enteric anastomo-
sis, with the Roux-en-Y loop placed in a retrocolic position, are recognized predisposing 
factors for internal hernia development. Symptoms of hernia are nonspecific and vague, 
and clinical and radiologic diagnosis can sometimes be challenging. Immediate diagnosis 
is mandatory because misdiagnosis can be complicated by bowel obstruction, volvulus, 
strangulation, incarceration, or trauma. MDCT with its multiplanar capabilities is widely 
believed to facilitate this diagnosis, because it is able to delineate hernia type, location, 
size, and shape and is particularly useful to diagnose unsuspected hernias. It also allows 
distinguishing hernias from masses of the abdominal wall, such as tumors, hematomas, 
abscesses. As a result, knowledge of the CT findings of abdominal hernias may allow 
early and more accurate diagnosis, with a resultant decrease in the mortality rate. 
Learning Objectives:
1. To understand the predisposing factors, clinical presentation and 
complications of abdominal hernias.
2. To be able to recognise abdominal hernias on imaging through multiple 
examples with an emphasis on MDCT.
3. To illustrate the postsurgical anatomy underlying internal hernias.
A‑405 09:30 
C. Acute stages in neoplastic diseases 
J.A. Guthrie; Leeds/UK (Ashley.Guthrie@leedsth.nhs.uk) 
After the initial presentation, a patient with cancer enters a phase of active treatment 
(surgery, chemotherapy, or radiotherapy), and then remission/cure or palliative phases. 
An „acute abdomen“ may complicate any phase. The principle causes are obstruction, 
perforation, haemorrhage, ischaemia and sepsis. Tumours arising from the GI tract 
are leading causes but any tumour involving the abdominal cavity or haematological 
malignancy may be implicated. During treatment with chemotherapy or radiotherapy 
acute abdominal symptoms are common as a consequence of direct toxicity. Im-
aging must be used as an adjunct to clinical assessment. Patterns of abdominal 
involvement are often modified in the later phases of disease. GI tract obstruction 
may be due to progression or the mechanical consequences of prior surgery and 
is more commonly at multiple levels. Perforation or fistulation may occur with either 
progressive disease or tumour lysis in response to therapy. Cancer does not protect 
against the common inflammatory conditions but poor host response and the use of 
steroids may mask signs leading to extensive abnormality at diagnosis. Bone marrow 
suppression increases susceptibility to infection including neutropenic enterocolitis, 
and haemorrhage. Bone marrow transplantation and consequent graft versus host 
disease is a potent cause of acute abdominal symptoms. CT is the major imaging 
technique although MR has an increasing role particularly in the assessment of the 
female pelvis. Major determinants when considering the differential diagnosis include 
the nature and initial stage of the primary, any prior anatomical modification (surgery), 
the nature and relationship to current treatment and the bone marrow status. 
Learning Objectives:
1. To be able to list neoplastic diseases that may potentially lead to acute 
abdominal symptoms.
2. To appreciate the differences in causes and findings of the acute abdomen 
between the initial presentation with neoplasia and when undergoing 
treatment.
3. To understand typical CT findings and pitfalls, and the potential role of MRI.
08:30 - 10:00 Room B 
Special Focus Session 
SF 15a 
Acute aortic syndrome 
Moderator:
J. Lammer; Vienna/AT 
A‑406 08:30 
Chairman’s introduction 
J. Lammer; Vienna/AT (johannes.lammer@akhwien.at) 
The acute aortic syndrome is a life-threatening disease. Aortic dissection type A 
and B, intramural hematoma, penetrating aortic ulcer, traumatic transsection and 
the rupture of an aortic aneurysm may cause an acute aortic syndrome. Clinically, 
it usually causes severe chest pain. It can mimic myocardial infarction, pulmonary 
embolization and it may be followed by neurological symptoms such as hemiplegia 
or paraplegia. Rupture into the mediastinum and pleural space may cause shock 
or death. The primary diagnosis is made by contrast enhanced CT. ECG gated 
CT is mandatory for a detailed diagnosis. A triple rule out protocol is required in 
clinically unclear cases. The radiologist is the first to make the diagnosis and an 
important decision maker for the emergency treatment. Acute surgical treatment in 
type A dissections and endovascular treatment in complicated type B dissections, 
penetrating ulcers and traumatic dissections is the treatment of choice. Ruptured 
aortic aneurysms can be treated by open surgery and endovascular techniques. 
Session Objectives:
1. To learn about the clinical aspects of acute aortic syndrome.
2. To learn about imaging of acute aortic syndrome.
3. To learn about endovascular therapy of acute aortic syndrome.
A‑407 08:33 
Technique, advantages and limitations of CTA and MRA 
V. Bérczi; Budapest/HU (Berczi@hotmail.com) 
Technique, advantages, disadvantages of CTA and MRA will be explained. A brief com-
parison (indications, limitation, advantages, disadvantages) with other diagnostic tech-
niques, like X-ray, transesophageal echocardiography, and catheter angiography, will be 
presented. Preoperative and follow-up imaging of aortic dissection, intramural thrombus, 
and penetrating atherosclerotic aortic ulcer as well as aortic dissection, ruptured thoracic 
aortic aneurysms, and aortic injuries will be discussed. The triple rule-out CTA protocol 
to prove or exclude acute coronary syndrome, aortic dissection, or pulmonary embolism 
is crucial, since each year, approximately 6 million patients in the United States alone 
present to the emergency department with acute chest pain. CTA is considerably faster 
than MRA in this acute setting. It may exclude deadly causes of chest pain; the higher 
radiation dose delivered with current techniques is a valid clinical concern. Compared with 
the usual radiation dose of a standard 64-slice CCTA (10-23 mSv), the effective radia-
tion dose of a „triple rule-out” scan is often increased by 50% (25-40 mSv). However, a 
recent study demonstrates that the radiation can be a lot less (< 9 mSv) when using tube 
current modulation. Artery of Adamkiewicz is the largest anterior segmental medullary 
artery. It typically arises from a left posterior intercostal artery, which branches from the 
aorta, and supplies the lower two-thirds of the spinal cord via the anterior spinal artery. It 
can be important to identify the location of the artery before treating aorta diseases with 
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Learning Objectives:
1. To learn about the technique of CTA and MRA of the thoracic aorta.
2. To understand when to use CTA and when MRA is preferable.
3. To understand when not to use CTA and/or MRA.
A‑408 08:51 
Key imaging findings that allow distinction among the various aortic 
pathologies 
F. Fanelli; Rome/IT (fabrizio.fanelli@uniroma1.it) 
Different non-invasive imaging modalities: plain X-ray radiography, multidetector 
CT-angiography (MDCTA), MR-angiography (MRA), conventional digital subtraction 
angiography (DSA) and transesophageal echocardiography (TEE) are nowadays 
available for the evaluation of the acute aortic disease. At the level of the thoracic 
aorta also, a plain X-ray examination permits to evaluate abnormal findings in 88% of 
cases: widened mediastinum, abnormal aortic knob contour, tracheal or esophageal 
deviation, and ring sign with displacement of the aortic margin > 5 cm beyond the 
calcified aortic intima. An initial non-contrast MDCT scan should be performed to rule 
out intramural hematoma because intravenous contrast may obscure this diagnosis 
as a consequence of uniform opacification of luminal structures. Intramural hematoma 
may appear as a localized thickening of the aortic wall with internal displacement of 
intimal calcifications. MDCT enables clear visualization of the aortic wall to assess 
the presence of an inflammatory aortic aneurysm. Additionally, it facilitates accurate 
detection of aneurysm rupture or contained leakage. In patients with suspected acute 
aortic dissection, contrast-enhanced MDCT scanning of both the chest and abdomen 
should be performed because it is particularly useful in detecting intimal flap, the extent 
of aortic dissection, branch vessel involvement, patency of true and false lumens, 
potential pericardial effusion, and even the patency of the coronary arteries. MRA with 
axial images, acquired with "black-blood" sequences, allows a better evaluation of the 
aortic wall and of any dissection, ulcer or thrombus accumulation. This sequence takes 
advantage of the lack of signal from blood flowing perpendicular to the imaging plane. 
Learning Objectives:
1. To learn about the distinction between type A and type B dissection.
2. To understand the key imaging findings and the correct imaging protocol to 
diagnose an intramural hematoma.
3. To learn when an aortic ulcer is dangerous for the patient.
A‑409 09:09 
Endovascular management of acute type B dissection 
H. Rousseau; Toulouse/FR (rousseau.h@chu‑toulouse.fr) 
The life-threatening nature of aortic dissection requires that diagnosis and treat-
ment be rapid with the most reliable and least invasive technique possible. Imaging 
methods are essential with several objectives; accurate description of the lesions, 
topographical classification, investigation of the extent of the lesions to the supra-
aortic and visceral arteries or of involvement of adjacent structures. These extensive 
investigations provide an evaluation of the severity and potential for progression of 
the lesions and a guide to treatment. The CT scan is the best method of investigation 
in an emergency. Treatment and surveillance in the intensive care unit are essential 
in all cases. Besides medical therapy, schematically, in type B aortic dissection, 
surgery and endovascular procedures are reserved for complications, principally 
rupture and visceral ischaemia. In these cases, endovascular techniques have 
progressed because of their better tolerance. Exclusion of the proximal intimal tear 
by a stent-graft depressurises the false lumen and predisposes to its thrombosis. 
Remodelling with reduction of the aortic diameter is observed with reperfusion of 
the distal vessels. Endovascular fenestration is reserved for problems of perfusion 
due to a dynamic mechanism. The principle is to create a wide orifice between 
the true and false lumens in order to reduce pressure in the false lumen. The 
implantation of bare stents may be useful in the arteries of viscera with ischaemia 
by a static mechanism. In conclusion, aortic dissection may be treated effectively 
by endovascular techniques, either alone or as a complement to surgery of the 
ascending aorta. 
Learning Objectives:
1. To understand the indications for treatment of acute type B dissection.
2. To appreciate the difference between complicated and uncomplicated 
dissection.
3. To understand that the diagnosis of critical organ perfusion is important.
4. To learn about the technique of endovascular management of type B 
dissection.
A‑410 09:27 
Endovascular management of thoracic aortic rupture 
R. Morgan; London/UK (robert.morgan@stgeorges.nhs.uk) 
Rupture of the thoracic aorta is a catastrophic event leading to rapid death in the 
majority of cases. Standard therapy is by open surgical repair. However, many 
patients can be treated by the insertion of endografts into the aorta across the 
location of the rupture. Patients who survive initial resuscitation and the journey to 
hospital should undergo immediate imaging assessment for potential treatment. 
The optimal imaging strategy is a contrast enhanced CT scan with coverage from 
the neck to the groins. Suitability for treatment by endografts involves assessment 
of the images for satisfactory proximal and distal landing zones and iliac arteries 
of adequate calibre. If patients are deemed suitable for endografting, an endograft 
of suitable size is inserted across the site of the aortic tear. Generally, only a single 
endograft is required to cover the tear unless there is coexistent additional pathology 
(e.g. aneurysm, dissection). It is sensible to keep a supply of devices of appropri-
ate size in stock which may be used in emergency situations. Complications of 
endografting particular to trauma mainly relate to poor conformability of endografts 
in the aortic arch. Many patients presenting with aortic trauma are young. Current 
devices may not adequately conform around the curve of the aorta at the junc-
tion of the aortic arch and descending aorta, which is a common site of rupture. 
In extreme cases, poor endograft conformability may lead to device collapse and 
severe aortic pseudocoarctation, which may require open removal of the device. 
Learning Objectives:
1. To learn about the correct management of patients with aortic rupture.
2. To learn about imaging protocols of aortic rupture.
3. To learn about the technique of endovascular management of ruptured 
thoracic aortic aneurysms.
4. To become familiar with post-treatment complications in patients with aortic 
ruptures.
Panel discussion:  
When is it time for the diagnostic radiologist to call the interventionalist or 
surgeon urgently? 09:45 
08:30 - 10:00 Room C 
Abdominal and Gastrointestinal 
RC 1501 
CT colonography: All the relevant aspects 
Moderator:
A.K. Dixon; Cambridge/UK 
A‑411 08:30 
A. State-of-the-art technique 
F. Iafrate; Rome/IT (francoiafrate@gmail.com) 
In this lecture, the most important different technical aspects of CT colonography 
examination will be discussed. Bowel preparation represents a crucial point of a 
correct CTC study, necessary to cleanse the bowel of residual stool, which might 
simulate colonic lesions. Usually, the same preparation scheme as conventional 
colonoscopy or barium enema (i.e. polyethylene glycol 4000 electrolyte solution) is 
used. Different preparations (i.e. phospho-soda) have been investigated showing a 
significant reduction of residual fluids. However, due to patient discomfort, the goal 
for the next future is the avoidance of any bowel preparation, using a “fecal or fluid 
tagging” technique. Different approaches of tagging will be discussed. Choice of 
destending agent (Co2 versus room air) represents another crucial point of exam and 
will be discussed. Spasmolytics agents are routinely used by most investigators using 
CT colonography. The use of these drugs is still controversial as it was showed that 
glucagon administration does not improve colonic distention. The use of i.v. contrast 
agents is still questionable. Although it has been demonstrated a mild improvement 
in polyp detection if i.v. contrast agent is administered, its routine use strictly depends 
on clinical indications and using fecal or fluid tagging is still questionable. In fact, it is 
not feasible in a screening population due to higher costs as well as major complexity 
of the exam, whereas it is mandatory in case of staging neoplastic lesions and in 
patients undergoing follow-up for colo-rectal cancer. Finally, different formats used for 
image interpretation (primary 2D versus primary 3D) will be discussed. 
Learning Objectives:
1. To review current bowel preparation techniques for CTC from cathartic to 
“fecal/fluid tagging”.
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2. To review options for practical aspects and protocols used (distention, 
spasmolytic agents, use of I.V. contrast material…).
3. To describe principles of data acquisition at CTC.
4. To describe options for 2D and 3D image interpretation of CTC.
A‑412 09:00 
B. Avoiding traps or pitfalls 
P. Lefere, S. Gryspeerdt; Roeselare/BE (radiologie@skynet.be) 
Adequate interpretation of CT colonography (CTC) is directly related to the level 
of experience of the reporting radiologist. To reduce false negative and positive 
findings to a minimum, awareness and good knowledge of traps and pitfalls is 
invaluable. Pitfalls in CTC imaging may be related to the CTC technique used, the 
anatomy of colonic and pericolonic structures and the two- and three-dimensional 
imaging features. Technique related pitfalls are caused by the different steps of 
the CTC procedure: preparation, colonic distension and image acquisition. Diag-
nostic problems are frequently caused by retained stool, spasm, collapse, motion 
artefacts, and image noise. Anatomy related pitfalls are caused by prominent 
semi-lunar folds, deep haustrations with hidden zones, tortuosity with flexural 
pseudotumors, diverticulosis, the valves of Houston, the ileo-cecal valve. Pitfalls 
related to two- and three-dimensional imaging are caused by thickened folds, polyps 
close to a fold, polyps mimicking stool, flat lesions and by tagged or non-tagged 
retained colonic residue, diverticulosis, wall thickening, luminal narrowing, deep 
haustral folds, spasm v tumor, flat lesions, polyps v stool, flat lesions, respectively. 
Technique related pitfalls can be overcome by the application of state-of-the-art 
CTC technique performed by an experienced CTC-team. Anatomy related pitfalls 
can be avoided by detailed comparison between 2D and 3D images. Special 
care should be taken when inspecting blind ending structures as the cecum and 
the rectum. Experience with both two- and three-dimensional imaging aspects is 
required to adequately interpret CTC. Finally, ongoing quality assurance and¼ a 
good exam avoid a lot of errors. 
Learning Objectives:
1. To describe pitfalls in imaging related to CTC technique and colonic anatomy.
2. To describe typical pitfalls in imaging related to 2D and 3D imaging 
respectively.
3. To propose a flowchart for avoiding traps and pitfalls in imaging.
A‑413 09:30 
C. Evidence based results? 
S.A. Taylor; London/UK (csytaylor@yahoo.co.uk) 
It is over 15 years since the technique of CT colonography (“virtual colonoscopy”) 
was first described. Initial single center studies produced very promising results but 
early multi-center trials produced very mixed data. Sensitivity for 1 cm adenomas 
ranged from less than 60% to over 90% in these studies. Research then focused on 
identifying the reasons for this variability in diagnostic performance of CT colonogra-
phy. In particular, attention focused on optimum data acquisition parameters, bowel 
preparation, use of faecal tagging, reader training requirements and competence 
testing, and optimised visualisation techniques (notably primary 2D vs. primary 3D). 
Recent innovations now include computer assisted detection (CAD). Implementation 
of the findings from this body of research by the VC community has led to recent 
successful mutlicenter trial data from both the US and Europe. This presentation 
will summarise the main trial data reporting the diagnostic performance of CT 
colonography and highlight potential reasons for discrepancies between studies. 
In particular, reader training and data analysis methods will be reviewed and the 
potential role of CAD discussed. Based on the evidence to data, recommendations 
will be made to optimise CTC dissemination amongst the radiology community. 
Learning Objectives:
1. To review the latest CTC performance trial data.
2. To highlight inconsistencies in trial results and explore underlying reasons.
3. To review the evidence for optimised reader performance, focusing on 
reading technique and training.
08:30 - 10:00 Room D 
Imaging in Lung Diseases 
CC 1518 
New interactions between radiologists and 
endoscopists 
Moderator:
M. Boijsen; Gothenburg/SE 
A‑414 08:30 
A. Imaging of lymph nodes: We can do better 
C. Mueller-Mang; Vienna/AT (christina.mueller‑mang@meduniwien.ac.at) 
The accurate assessment of lymph node status is essential in selecting the optimal 
treatment strategy in patients with thoracic malignancies. To date, MDCT is still 
widely used for this purpose because it provides excellent anatomic information 
about the lymph nodes of the mediastinum. However, CT evaluation of the lymph 
nodes is limited by the fact that it yields only presumptive evidence of metastatic 
disease that is mainly based on size criteria, and studies have shown that it has a 
relatively low sensitivity for the detection of mediastinal nodal metastases between 
64 and 74%. PET imaging with FDG has been shown to be more accurate than 
CT in mediastinal nodal staging, but the highest accuracy for the differentiation 
of benign and malignant lymph nodes has been reported with integrated PET/CT 
(93%). Therefore, MDCT as a stand-alone imaging modality in mediastinal lymph 
node staging is declining in favor of integrated PET/CT. MR imaging of the chest 
is being performed more often, and recent studies have shown promising results 
in the detection of mediastinal nodal metastasis, based on signal intensity and 
morphologic characteristics, with an efficacy comparable to that of PET/CT. To 
assess the clinical utility of new MR techniques, such as diffusion-weighted MR 
imaging and MR imaging with ultrasmall iron oxide particles (USPIO), further stud-
ies are required. Considering the increasing concerns about radiation exposure, 
MR imaging could be a valuable alternative for PET/CT, especially in patients who 
require long-term follow-up imaging. 
Learning Objectives:
1. To consolidate knowledge on the various means of imaging lymph nodes.
2. To describe the current limitations of MDCT in lymph node evaluation.
3. To learn about recent developments in MR imaging of lymph nodes and their 
clinical impact.
A‑415 09:00 
B. Direct nodal sampling by echoendoscopy: The clinician’s expectations 
F.J.F. Herth; Heidelberg/DE (Felix.Herth@thoraxklinik‑heidelberg.de) 
Purpose: There is increasing awareness of minimally invasive endoscopic tech-
niques for mediastinal staging in lung cancer. Traditionally, cervical mediastinoscopy 
has been utilized. Endobronchial ultrasound-guided fine needle aspiration (EBUS) 
has recently emerged as a potential alternative.
Methods and Material: EBUS has sensitivity for lung cancer which is at least 
equivalent (if not superior) to cervical mediastinoscopy. The efficacy and technical 
aspects of endobronchial ultrasound (EBUS) are reviewed because this technol-
ogy promises to revolutionise bronchoscopy. Guided biopsies and real-time TBNA 
have been shown to increase the diagnostic yield over conventional bronchoscopic 
techniques.
Results: The pooled sensitivity of real-time EBUS-TBNA in lung cancer is 90% 
but the false negative rate is 20%. However, negative results need either further 
confirmatory testing or adequate clinical follow-up. Complications are rare with either 
EBUS modality and are usually related to the underlying biopsy procedure rather 
than the use of ultrasound. Procedure duration is short enough to be incorporated 
into an outpatient setting and can be performed under moderate sedation.
Summary: Currently, EBUS can be recommended for initial staging as a minimally 
invasive option provided negative results are followed by cervical mediastinoscopy. 
This would also allow cervical mediastinoscopy to be reserved for restaging. 
Conventional transbronchial needle aspiration has a limited role only as a firstline 
staging procedure but may aid diagnosis. In the future, EBUS may have a role in 
presurgical staging of the radiologically normal mediastinum and re-staging if prior 
staging is done by cervical mediastinoscopy. 
Learning Objectives:
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2. To review the lymph node sites accessible by echoendoscopy.
3. To learn about the tumoral and non-tumoral disorders that can benefit from 
this minimally invasive procedure.
A‑416 09:30 
C. Image-guided endoscopy and biopsy of lung nodules 
C.-H. Marquette; Nice/FR (marquette.ch@chu‑nice.fr) 
Transthoracic needle aspiration (TTNA) is the gold standard technique for peripheral 
lung lesions < 2 cm but the technique is associated with increased pneumothorax 
rates that range from 23 to 44%. The high diagnostic yield of this method (85%) 
derives from selected populations that fulfilled in advance clinical and radiologic 
criteria to undergo TTNA. Thus, in real life, many patients hardly can undergo TTNA 
due to medical comorbidities such as respiratory insufficiency. These reservations 
also apply to diagnostic surgery (via video-assisted thoracoscopic surgery or 
thoracotomy.). Diagnostic yield of blind transbronchial biopsies (TBB) via flexible 
bronchoscopy (FB) in this situation is very low (<20%) but novel technologies includ-
ing endobronchial ultrasound (EBUS) and electromagnetic navigation (EN) have 
been shown to be safe and effective imaging tool for TBB via FB. Not only will EN 
guidance improve the diagnostic yield of FB but one envision potential therapeutic 
approach to targeted lung lesions such as placement of fiducial markers for ste-
reotactic radiotherapy or placement flexible radiofrequency probes. 
Learning Objectives:
1. To review the principles of image-guided endoscopy and biopsy of lung 
nodules.
2. To describe the necessary interaction between radiologists and endoscopists 
for successful tissue sampling.
3. To learn about the advantages and limitations of this approach in comparison 
with alternative diagnostic tools.
08:30 - 10:00 Room E1 
Musculoskeletal 
RC 1510 
Elbow and wrist 
Moderator:
J.‑L. Drapé; Paris/FR 
A‑417 08:30 
A. Elbow and wrist trauma 
M.C. De Jonge; Amsterdam/NL (M.C.deJonge@amc.uva.nl) 
Trauma to the upper extremity is amongst the most common entities encountered 
in daily practice conventional radiography and should always be the first step to 
evaluate the patient followed by HRCT (High Resolution CT) for osseous lesions 
and MRI/US for the evaluation of soft tissues. Elbow: The supracondylar distal 
humerus fracture is one of the commonest and most feared fractures in children. 
Adults more often sustain an olecranon or radial head or neck fracture. Children often 
dislocate the radial head without fracture. Both adults and children can dislocate their 
elbow, which is almost always a posterior displacement of the ulna and radius. Soft 
tissue injuries around the elbow can be muscular, tendinous or ligamentous. The 
distal biceps tendon rupture is in adults probably the most common injury. Lower arm: 
Fractures of the mid lower arm are common in children but not in adults. The Galeazzi 
and Monteggia fracture-dislocation injuries are classic but in fact uncommon. Often 
in children, it is a ‘simple’ diaphyseal fracture of the radius and ulna whilst in adults 
we mostly see isolated injuries to the ulna (“nightstick” fracture). Wrist: Injuries to the 
wrist are ubiquitous in children, adolescents and adults. Usually, it involves the distal 
radius. Injuries to the carpal bones (scaphoid - triquetrum) are often seen in adults, 
but are uncommon in children. Fracture dislocations are not very uncommon but easily 
missed. Traumatic soft tissue injuries to the wrist usually involve ligamentous structures 
like the SL ligament or the TFCC. 
Learning Objectives:
1. To discuss the relevant anatomy.
2. To provide an overview of common acute injuries and relevant imaging.
3. To review the medicolegal implications of missed injuries.
A‑418 09:00 
B. Overuse of elbow and wrist 
E. Llopis; Valencia/ES (ellopis@hospital‑ribera.com) 
“Overuse may be defined as a level of repetitive microtrauma sufficient to overwhelm 
the tissues ability to adapt”. The purpose of this talk is to highlight the influence of 
repetive microtrauma causing injuries on the elbow and wrist. We will review the role 
of the different imaging techniques on diagnosis and management of these lesions. 
The lecture will be divided into: 1. Overuse tendon injuries of the elbow and wrist: a) 
lateral epicondylitis, extensor tendinosis, b) medial epicondylitis, flexor tendinosis, 
c) De Quervain tenosynovitis, d) intersection syndrome, e) extensor cubitus ulnaris 
tenosynovitis, f) tenosynovitis of the flexor carpi radialis; 2. Posterolateral elbow 
impingement, posterolateral plica and 3. Ulnar side impaction syndromes. Ulnar 
side impaction syndrome is a common source of pain and limitation of motion that 
results from repetitive forced impingement between the distal ulna and the carpal 
row and the surrounding structures. Depending on the impaction side can be divided 
into: Ulnar impaction syndrome, carpal-ulnar impaction; Ulnar impingement syn-
drome, ulna against distal radius; Ulnar styloid impaction syndrome, stylotriquetrum 
impaction; Hamato-lunate impaction syndrome or combined impaction syndrome. 
Learning Objectives:
1. To define the concept of overuse syndrome.
2. To understand anatomical and biomechanical influence on the development 
of overuse injuries.
3. To review the role of different imaging modalities, with emphasis on MRI and 
imaging-guided percutaneous treatments.
4. To describe characteristic imaging findings of specific overuse injuries.
A‑419 09:30 
C. Neuropathy 
C. Martinoli; Genoa/IT (carlo.martinoli@libero.it) 
A variety of peripheral neuropathies can be encountered about the elbow and wrist 
affecting the median, the radial and the ulnar nerve. Most are entrapment syndromes 
and include the supracondylar process syndrome, the pronator syndrome, the 
anterior interosseous neuropathy (Kiloh-Nevin syndrome) and the carpal tunnel 
syndrome for the median nerve; the posterior interosseous neuropathy and the 
Wartenberg syndrome for the radial nerve; the cubital tunnel and the Guyon tunnel 
syndrome for the ulnar nerve. Although clinical examination and nerve conduction 
studies are the mainstays of the diagnostic work-up of peripheral neuropathies, 
ultrasound (US) and magnetic resonance (MR) imaging may provide key informa-
tion about the exact anatomic location of a lesion and the nature of the constricting 
finding or may help narrow the differential diagnosis. In patients with peripheral 
neuropathies around the elbow and wrist, US and MR imaging may provide critical 
information for planning an adequate treatment strategy. A deep knowledge of the 
normal anatomy and of the possible causes, typical clinical findings, and imaging 
features of peripheral neuropathies that affect the median, radial, and ulnar nerves 
allows greater confidence in the diagnosis. Although US and MR imaging have fol-
lowed parallel paths for nerve imaging with little comparison of the two modalities, 
US seems to have some advantages over MR imaging, including higher spatial 
resolution, time effectiveness, the ability to explore long nerve segments in a single 
study and to examine tissues in both static and dynamic states. 
Learning Objectives:
1. To describe the spectrum of US and MR imaging findings of neuropathies 
around the elbow and wrist.
2. To emphasise the role of imaging in the management of entrapment 
neuropathies to delineate the nature and extent of the process.
3. To learn to recognise the main clinical picture of entrapment neuropathies.
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08:30 - 10:00 Room E2 
Interactive Teaching Session 
E³ 1520 
Common clinical problems: Cognitive decline  
and dementia 
Moderator:
A. Platkajis; Riga/LV 
A‑420 08:30 
Common clinical problems: Cognitive decline and dementia 
B. Gómez-Ansón1, F. Barkhof2; 1Barcelona/ES, 2Amsterdam/NL 
(bgomeza@santpau.cat) 
With advances in healthcare and age, the prevalence of dementia increases ex-
ponentially, with ~ 20% of subjects over 85 years becoming demented. While the 
guidelines differ by country, many recommend imaging at least once during the 
work-up of patients suspected of dementia. Beyond exclusion of surgically treatable 
disorders (e.g. tumour, subdural hematoma or hydrocephalus), imaging can now 
be used to positively determine the underlying disorder (e.g. hippocampal atrophy 
in Alzheimer’s disease). While MRI is the modality of choice, multislice CT with 
multiplanar reformats provides a robust and quick alternative to assess general 
cortical atrophy, hippocampal atrophy and vascular pathology. SPECT and PET 
should be reserved for second line investigation, e.g. suspicion of frontotemporal 
lobar degeneration (FLTD) lacking characteristic atrophy on structural imaging. The 
advent of amyloid imaging using PIB-PET provides a future tool to secure a diag-
nosis of Alzheimer through molecular imaging, but its value over CSF examination 
needs to be determined. Increasing insights are being gained into the aetiology, 
clinical features and imaging findings in other neurodegenerative diseases, e.g. 
Lewy-body dementia. Structural imaging plays an essential role in establishing the 
diagnosis of vascular dementia (VaD), and cases of mixed dementia. Serial MRI is 
very sensitive to the degenerative process underlying neurodegenerative disorders, 
providing insights into their pathogenesis and offers a possibility to determine the 
effects of putative new treatments in randomized clinical trials. 
Learning Objectives:
1. To learn about the usefulness of imaging in patients with dementia.
2. To be able to approach conventional CT and MRI examinations for patients 
with cognitive decline and dementia.
3. To become familiar with the most common types of dementia and their 
characteristic imaging findings.
4. To appreciate the role of imaging in early diagnosis of dementia and in 
differentiating the vascular and neurodegenerative disease dementia.
5. To become more familiar with the applications of imaging in research in 
dementia, especially in providing surrogate markers.
08:30 - 10:00 Room F1 
Organs from A to Z: Liver 
MC 1519 
Primary liver tumors 
Moderator:
B.I. Choi; Seoul/KR 
A‑421 08:30 
A. Benign liver tumors 
F. Caseiro-Alves; Coimbra/PT (caseiroalves@gmail.com) 
Imaging evaluation of focal liver lesions may be currently addressed by multiple 
techniques that may provide complementary diagnostic information in order to ac-
curately detect and characterize benign liver tumors. The ultimate goal of imaging 
is thus to be able to separate the “don’t touch me” lesion from those that should be 
managed more aggressively or by more or less close follow-up. The usual clinical 
context of benign liver tumors is the fortuitous discovery of a FLL especially by the 
widespread b-mode US scans. More in-depth analysis becomes necessary when 
classical radiological criteria are not entirely met or when we are dealing with a 
new or previously non-reported finding in an oncologic patient. Despite the vast 
array of benign liver tumors, we will discuss in more detail the imaging findings of 
cystic lesions, hemangioma, FNH and liver adenoma using current state-of-the-
art techniques such as CE sonography, cell-directed contrast agents for MRI and 
diffusion-weighted imaging. The new classification of liver cell adenoma as well 
its clinical implications will be also addressed. Finally, a strategy for the charac-
terization of the incidental liver lesion will be provided based on the concurrent or 
complementary information delivered by the different imaging techniques, focusing 
on their pros, cons and also, when applicable, the role of biopsy in order to secure 
the proper diagnosis. 
Learning Objectives:
1. To learn the classification and natural history of benign liver tumors.
2. To become familiar with the imaging findings with reference to tissue 
characterisation.
3. To learn about the imaging strategy in the assessment of an incidental focal 
liver lesion.
A‑422 09:00 
B. Imaging of hepatocellular carcinoma 
C. Bartolozzi; Pisa/IT 
In the setting of a cirrhotic patient, a solid nodular lesion found during ultrasound (US) 
surveillance has a high likelihood of being a hepatocelluar carcinoma (HCC). However, 
hystology demonstrates that many small nodules detected by US in cirrhotic livers 
do not necessary correspond to HCC. The differential diagnosis between small HCC 
and non-malignant hepatocellular lesions may be very challenging. Actually, nodules 
detected during US surveillance are further investigated with dynamic imaging tech-
niques, such as contrast enhanced US, contrast-enhanced multidetector computed 
tomography (MDCT), and contrast-enhanced magnetic resonance imaging (MRI). 
Dynamic imaging allows in fact detecting the major clue for suspecting malignant 
degeneration that is represented by the peculiar vascular supply. Through the progres-
sion from regenerative nodule, to low-grade up to high grade dysplastic nodule (DN), 
and finally to overt HCC, new arterial vessels, termed nontriadal arteries develops, 
and become the dominant nodular blood supply, with the decrease of portal venous 
flow. However, two further parallel processes take place during the carcinogenetic 
pathway: a) the progressive loss of biliary polarization of the hepatocyte and the 
derangement of the microscopic secretory structure, and b) the progressive nodular 
depletion of Kupffer cells. MRI, performed with hepatobiliary contrast media, may 
give an insight on this “grey area”, in which significant hystological changes already 
occurred, without an evident arterial supply: whereas moderately/poorly differenti-
ated lesions fail to take up the agents, appearing hypointense to liver on T1-weighted 
images, well-differentiated tumor may show as hyperintense, because of the uptake 
and trapping of the agent within neoplastic cells. 
Learning Objectives:
1. To understand the process of hepatocarcinogenesis.
2. To know how to differentiate dysplastic nodules and early-stage 
hepatocellular carcinoma, by means of different imaging modalities.
3. To learn the appropriate strategy in case of small nodules detected in a 
cirrhotic patient.
A‑423 09:30 
C. Other primary malignant liver tumors 
R. Manfredi; Verona/IT (rmanfredi@univr.it) 
Cholangiocarcinoma is a malignant tumor arising from the epithelium of the bile 
ducts. The relative incidence of cholangiocarcinoma among primary liver cancer 
reported in autopsy series ranges from 5 to 30%; it is, however, the most common 
primary malignancy of the biliary tree. Most of these tumors are adenocarcinomas. 
The Liver Cancer Study Group of Japan has proposed a new classification based 
on growth characteristics, with tumors being identified as mass-forming, periductal-
infiltrating, and intraductal- growing types. This classification is considered to be 
the most reasonable because it describes the gross appearance, growing char-
acteristics, biologic behavior, and prognostic implication for patients and because 
it is helpful for radiologic interpretation. The imaging evaluation of patients with 
hilar cholangiocarcinoma has traditionally included computed tomography and 
sonography or a combination of the two techniques for diagnosis and preoperative 
assessment of resectability. In recent years, MR imaging in conjunction with MR 
cholangiopancreatography (MRCP), has proved to be helpful in diagnosing hilar 
cholangiocarcinoma and in determining resectability. Cholangiocarcinoma appears 
as a moderately irregular thickening of the bile duct wall (> 5 mm), with symmetrical 
upstream dilation of the intrahepatic bile ducts. Sometimes, it may be difficult to 
differentiate the periductal-infiltrating type of cholangiocarcinoma, encompassing 
the bile duct confluence and the proximal segment of the common bile duct, from 
the intraductal-growing type, especially when the lesion is small. Less frequent 
primary liver neoplasms are represented by hepatoblastoma, fibrolamellar car-
cinoma, transitional cell tumor, embryonal sarcoma, angiosarcoma, hepithelioid 
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Learning Objectives:
1. To learn the spectrum of primary liver tumors, excluding HCC.
2. To learn about imaging findings in cholangiocarcinoma, and clues for staging 
and deciding treatment.
3. To become familiar with imaging findings of other less frequent, primary 
malignant tumors of the liver.
08:30 - 10:00 Room F2 
Special Focus Session 
SF 15b 
Diffusion-weighted imaging of the CNS  
beyond stroke
Moderator:
S. Sunaert; Leuven/BE 
A‑424 08:30 
Chairman’s introduction 
S. Sunaert; Leuven/BE (Stefan.Sunaert@uz.kuleuven.ac.be) 
Within this session, state-of-the-art diffusion-weighted MRI applications other than 
stroke will be reviewed. New developments, such as diffusion tensor imaging, will 
be covered. The benefits and challenges of DWI in the diagnosis of CNS pathol-
ogy will be compared to other imaging techniques. Finally, we will debate whether 
diffusion-weighted imaging provides a window on histology and pathophysiology. 
Session Objectives:
1. To review state-of-the-art diffusion-weighted MRI applications beyond stroke.
2. To evaluate the benefits and challenges of DWI in the diagnosis of CNS 
pathology in comparison to other imaging techniques.
3. To debate whether diffusion-weighted imaging provides a window on 
histology and pathophysiology.
A‑425 08:35 
DWI in focal non-ischemic brain lesions 
M. Law; Los Angeles, CA/US (meng.law@usc.edu) 
Diffusion weighted and diffusion tensor imaging is now widely utilized in the research and 
clinical settings beyond its clinical applications in stroke. In the clinical setting, qualitative, 
semi-quantitative and quantitative methods are being utilized to evaluate DWI and DTI 
data. There are a number of pitfalls with all of these approaches. The role of diffusion 
weighted and diffusion tensor imaging characterization of tumor biology and different 
pathologies will be reviewed. Differentiating between recurrent tumor and therapeutic 
necrosis is often a challenge. We will review the role of advanced imaging and also 
the effects of anti-angiogenic therapies on tumor microvasculature/microenvironment 
resulting in changes in diffusion, perfusion and MRS. As patients are being treated 
with new anti-angiogenic agents such as Bevacizumab (an anti-VEGF antibody), an 
entity called “pseudo-response” has also been described where patients demonstrate 
an MRI response. Lastly, to combine and apply these different imaging techniques in 
a complete imaging protocol and a multi-parametric algorithmic fashion in the clinical 
setting can be shown to increase our diagnostic specificity and confidence. 
Learning Objectives:
1. To apply diffusion-weighted imaging in the characterisation of focal non-
ischemic brain lesions.
2. To differentiate between tumoral and non-tumoral disease such as glioma, 
metastases, lymphoma, infection and demyelinating disease.
3. To differentiate recurrent tumor from therapeutic necrosis in the post-
therapeutic brain.
4. To combine DWI in a multi-parametric algorithmic fashion with other 
advanced MRI tools such as MR spectroscopy and perfusion/permeability 
imaging in the characterisation of focal brain lesions.
A‑426 08:58 
DWI in diffuse non-ischemic brain and spine pathology 
M. Mascalchi; Florence/IT (m.mascalchi@dfc.unifi.it) 
Hardware and software developments have determined an explosion of the clini-
cal applications of diffusion weighted (DW) and diffusion tensor (DT) MR imaging 
for assessment of diffuse diseases of the brain and spine. These applications are 
based on either simple visual assessment of tissue signal intensity in DW images 
or sophisticated quantitative analyses performed using ROI, histogram, tractogra-
phy or voxel-wise techniques on the maps of apparent diffusion coefficient, mean 
diffusivity or fractional anisotropy. Due to the sensitivity to extracellular edema or 
microstructural changes both determining increased proton diffusion, DWI and DTI 
are the techniques of choice for assessment of the diffuse white matter involve-
ment in inherited or acquired metabolic diseases and in age-related small vessel 
leukoencephalopathy. In particular, they enable detection of significant changes 
also in the normal appearing white matter which are closely correlated to the 
clinical and laboratory findings and can be used to monitor brain involvement or 
to serve as a surrogate marker of these diseases. DWI demonstration of areas of 
restricted diffusion in the cortical grey matter is a sensitive diagnostic feature of 
herpes encephalitis and Creutzfeld-Jakob disease. Finally, DWI and DTI have been 
increasingly used to map WM tract damage in neurodegenerative diseases of the 
gray matter such as movement disorders and dementias. The application of DWI 
and DTI to spinal pathology and, in particular, their potential contribution in the 
differential diagnosis between benign bone marrow edema and metastatic involve-
ment has been controversial. The adoption of lower b values (typically b=300-600 
s/mm2) are recommended for such a purpose. 
Learning Objectives:
1. To show the main results obtained in diffuse white matter and grey matter 
diseases of the CNS using DWI and DTI.
2. To illustrate the possible integration of DWI and DTI with other MR 
techniques providing structural and functional evaluation of the brain.
3. To appreciate the main results obtained with spinal DWI and DTI in spinal 
pathology.
A‑427 09:21 
DWI: Use of advanced diffusion markers in non-infarct lesions 
W. Van Hecke; Antwerp/BE (wim.vanhecke@ua.ac.be) 
Diffusion weighted imaging (DWI) is a relatively new method in which the image 
contrast is produced by the random microscopic motion of water molecules in dif-
ferent tissues. DWI consists of a DW image and an apparent diffusion coefficient 
(ADC) map. By acquiring at least 6 DW images in different spatial directions, a 
diffusion tensor (DT) can be estimated in every voxel. This DT describes the three 
dimensional diffusion process in that voxel can give an insight into the white matter 
fiber architecture. Local quantitative measures are derived from the diffusion ten-
sor, such as the fractional anisotropy (FA), which is a normalized measure for the 
degree of anisotropy, and the mean diffusivity (MD), i.e., the averaged diffusion. 
Recent DTI studies of different pathologies are starting to use these quantitative 
measurements, demonstrating the potential of this in vivo and noninvasive imaging 
technique for detecting microstructural pathological alterations. Quantitative DW 
and DT measures can give an insight into different non-infarct lesions of the brain, 
such as for example infectious, neoplastic and demyelinating diseases. 
Learning Objectives:
1. To become familiar with the different types of advanced diffusion markers 
calculated from DWI and DTI.
2. To become familiar with the visualisation and interpretation of diffusion 
tensor images.
3. To apply advanced diffusion (tensor) markers in non-infarct lesions.
Panel discussion:  
DWI: A window on histology and physiopathology? 09:44 





M. Forsting; Essen/DE 
A‑428 08:30 
A. Endovascular management of intracranial aneurysms 
A. Krajina; Hradec Králové/CZ (krajina@fnhk.cz) 
Endovascular therapy of intracranial aneurysms has become the first line treatment 
option, whenever this option is available. The neurointerventionalist performing the 
procedure should have appropriate radiographic equipment, training and regular 
workload of patients. This can be better accomplished in a high-volume neurovas-
cular center where appropriate neurosurgical care can be instituted promptly. There 
are two endovascular strategies to treat cerebral aneurysms. The first is occlusion 
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of the aneurysmal sac with metallic coils preserving the parent artery, and second 
is occlusion of the parent artery in order to exclude the otherwise untreatable 
aneurysms from the blood circulation. Controlled coil intrasaccular delivery is 
the prerequisite for their widespread and safe use. The technology allows for the 
withdrawal and exchange of incorrectly sized or unstable coils prior to deployment. 
The International Subarachnoid Aneurysms Trial was a large randomized, prospec-
tive study of endovascular coiling versus surgical clipping for a selected group of 
patients with bleeding aneurysms deemed suitable for both types of therapy. The 
study revealed an absolute risk of death or independency reduction 8.7% for coil-
ing over clipping in one year after treatment. Coiling is followed by annual delayed 
rebleeding rate of 1%. Permanent procedural complications occurred in 3.7%. 
The most frequent procedural complication was cerebral ischemia. Unruptured 
aneurysms are a heterogeneous entity with extreme variation in reported rupture 
risk. The critical size of the aneurysm is more than 7 mm. Posterior circulation 
location, multilobularity and aneurysms in young, hypertensive, smoking patients 
were found to be in increased risk of hemorrhage. 
Learning Objectives:
1. To review the principles and technique of endovascular management of 
intracranial aneurysms.
2. To review the results of endovascular treatment.
3. To learn about the management of treatment complications.
4. To discuss ruptured and unruptured aneurysm treatment strategies and 
follow-up.
A‑429 09:00 
B. Endovascular treatment of acute ischemic stroke 
L. Castellan; Genoa/IT (lucio.castellan@hsanmartino.it) 
In Europe, stroke represents the third cause of death and the first cause of disability, 
with an enormous social and economic impact. Prompt treatment with thrombolytic 
drugs can restore blood flow in occluded intracranial arteries before major brain 
damage has occurred. Over the past 2 decades, the management of stroke has 
progressed significantly due to intravenous and intraarterial trhombolysis. The ef-
ficacy of intravenous approach with tissue plasminogen activator within 4.5 hours 
since symptoms onset has been proven in large, well-designed studies. Intraarterial 
thrombolysis was first studied as an alternative to intravenous thrombolysis, with 
the particular intent to increase the time window, to rapidly deliver the thrombolytic 
agent with high concentration at the site of occlusion and to obtain mechanical clot 
disruption. The interventional treatment options available today are the intraarte-
rial administration of tissue plasminogen activator and newer antiplatelet agents, 
mechanical thrombectomy by means several different intravascular systems, and 
intracranial angioplasty and stent placement. These techniques should lead to 
improved recanalization and reduced hemorrhagic complications. Moreover, all the 
mechanical procedures could allow to bring the time window up to 8 hours or to 
try the recanalization also after unsuccessful intravenous thrombolysis. Neverthe-
less, because of the differences in stroke severity, time to treatment and occlusion 
locations, direct comparisons among different thrombolytic therapies have been 
difficult and currently many of these approaches have yet to prove their benefits in 
controlled clinical trials, although they offer new hope for a very large population 
of patients with stroke. 
Learning Objectives:
1. To point out patient selection criteria for new mechanical thrombectomy and 
other endovascular procedures of intracranial revascularisation.
2. To investigate the efficacy of intravenous thrombolysis.
3. To become familiar with the practical applications of mechanical 
embolectomy devices in the treatment of acute ischemic stroke.
4. To discuss integration of stroke centres of different levels in a territorial 
network of emergency care systems as well as the potential impact of well-
organised systems for stroke care.
A‑430 09:30 
C. Stent-based technologies in the treatment of intracranial aneurysms 
and atherosclerotic disease 
I. Szikora; Budapest/HU (h13424szi@helka.iif.hu) 
Stent technology is presently applied in the endovascular treatment of atheroscle-
rotic stenosis and that of aneurysms. For intracranial atherosclerotic disease, self 
and balloon expandable stents are used to decrease the incidence of procedural 
complications and to improve the long term results by reducing the incidence of 
restenosis. Recent studies demonstrate that the complication rate of intracranial 
angioplasty has been reduced from 15 to 3%. Up to now, significant restenosis 
rate remains as high as 28% and is symptomatic in 4.1%. For aneurysms, self-
expandable stents deployed across the aneurysm neck are used to make intrasac-
cular packing feasible or support tighter packing and to improve long-term results 
by promoting endothelial growth over the aneurysm orifice. More recently, high 
mesh density flow diverting devices became available that are capable of inducing 
aneurysm thrombosis without intrasaccular packing by significantly reducing flow 
across the orifice. Published results demonstrate that using coil supporting stents 
recanalization of completely occluded aneurysms can be reduced to 4.3% and 
progressive thrombosis in incompletely occluded lesions can be achieved in 14% 
of the cases. Using new generation flow diverting stents, complete, lasting occlusion 
of large, giant and broad neck aneurysms can be achieved in over 90% of cases. 
At present, stent angioplasty is an inherent part of the treatment of intracranial 
atherosclerotic disease. Intracranial stent implantation is an important adjunctive 
technique for some aneurysms and offers an entirely new avenue for the primary 
treatment of some previously difficult or impossible to treat lesions. 
Learning Objectives:
1. To understand the technical possibilities, limitations, potential complications, 
mid-term results and current indications of using stent-assisted angioplasty 
in atherosclerotic intracranial arterial stenosis and acute ischaemic stroke.
2. To understand the technical possibilities, limitations, potential complications 
mid-term results and current indications of using stent-assisted coil 
packing and stent-based flow modification in the treatment of ruptured and 
unruptured intracranial aneurysms.
08:30 - 10:00 Room I 
Physics in Radiology 
RC 1513 
Visualisation, perception and image processing 
Moderators: 
L. Donoso; Barcelona/ES 
W.J.M. van der Putten; Galway/IE 
A‑431 08:30 
A. Visualisation and perception 
A.G. Gale; Loughborough/UK (a.g.gale@lboro.ac.uk) 
Radiological interpretation always incurs some degree of error due to the nature 
of disease presentation coupled with the difficulty in diagnosis, especially where 
early signs of disease need to be identified such as in medical screening. Early 
research studies of radiologists’ performance concentrated upon the chest radio-
graph but more recent work has studied breast screening extensively, as well as 
MRI and CT. As radiology is now almost fully digital, research has also examined 
observer behaviour with a range of digital images, viewing conditions, and image 
display presentations. It is possible that radiological interpretation will never be 
accomplished without some errors occurring; however, it is important that steps 
are taken to minimise any causes of errors as far as possible. The reported error 
rates found in numerous investigations across different radiological domains will 
be reviewed and the reasons for these elucidated. Appropriate reporting conditions 
will be highlighted for different image viewing scenarios. A theoretical framework for 
understanding error causation, especially where abnormalities are missed, will be 
detailed. Furthermore, the underlying visual, perceptual and cognitive processes 
which lead to errors will be detailed and approaches to minimise error occurrence 
will then be proposed. The relationship between human perceptual and cognitive 
skills and computer imaging processing will be discussed and the usefulness of 
CAD systems outlined as how they can best aid the radiologist from the human 
performance viewpoint. 
Learning Objectives:
1. To review the basic principles of perception, detection and detectability.
2. To learn about specifics of perception in medical imaging.
3. To learn how image processing can help us with the perception process.
A‑432 09:00  
B. Image processing and perception 
B.M. ter Haar Romeny; Eindhoven/NL (B.M.terHaarRomeny@tue.nl) 
The need for quantitative image analysis in radiology is universal: computer-aided 
detection, segmentation for 3D volume visualization, image enhancement, pattern 
recognition etc. All need effective, robust and preferably generic (not ‘ad hoc’) algo-
rithms for the computer. How to design such algorithms? A good inspiration source 
is the functionality of the visual system; the best investigated brain structure today. 
In this talk, we will explain how we think the brain calculates features in images, 
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this in multi-scale analysis, and how we can learn to understand and exploit the 
Gestalt Laws. The visual system is strongly adaptive and self-learning. New optical 
recording techniques have given new insight in how the cells in the visual cortex 
are functioning. We will go through these functionalities step-by-step. What we 
discover is quite amazing. We recognize huge amounts of filter banks in the first 
stages of vision: many filters analyse each pixel of the incoming image at a range 
of scales, orientations, derivative order, for each colour, and also as a function of 
time. We programmed these filters into the computer and were able to build many 
interesting applications for (bio-) medical imaging: detection of catheters at seriously 
reduced levels of fluoroscopy X-ray radiation dose, automatic detection of polyps 
in the colon, quantitative analysis of ischemic heart ventricle deformation, breast 
cancer CAD, pulmonary emboli CAD and analysis of in-vivo microscopy images 
now so abundant in modern life-sciences research. 
Learning Objectives:
1. To gain insight into modern computer vision techniques for computer-aided 
diagnosis.
2. To learn how the first stages of human visual perception process information.
3. To learn a range of application areas of image processing techniques for 
medical imaging.
A‑433 09:30 
C. Clinical application of image processing 
A. Persson; Linköping/SE (anders.persson@cmiv.liu.se) 
The practice of medical image diagnosis is currently undergoing a fast transforma-
tion. Vast amounts of data can be generated in standard examination and focus is 
shifting from improving the collection of relevant data for diagnosis to development 
of effective methods to analyze, visualize, navigate, and interact with medical 
information. It is now becoming generally accepted in the medical community that 
one of the most important keys to manage the increasing information flow is the 
use of 3D and 4D applications. This talk will take its starting point in state-of-the-
art medical visualization and then discuss the need for a research agenda that 
focuses on the development of the next generation of medical visualization tools, 
emphasizing the fact that these tools must be based on medical user requirement 
and work flow studies as well as on new technical developments. 
Learning Objectives:
1. To learn how to use adequate reconstructions/image sequences in CT/MR.
2. To learn when to use transverse, sagittal and coronal displays.
3. To learn when to use 3D displays.
08:30 - 10:00 Room K 
Pediatric 
RC 1512 
Chest imaging: What to use and when to use it 
Moderator:
A.E. Healey; Liverpool/UK 
A‑434 08:30 
A. US: When and how? 
I. Gassner; Innsbruck/AT (i.gassner@i‑med.ac.at) 
Diseases of the chest are commonly evaluated by means of the three dominant 
imaging modalities: conventional chest radiographs, CT and MR. Thorax ultrasound 
is not often performed mainly because bone and air are traditionally considered 
natural barriers for the ultrasound beam. However, the unique thoracic anatomy 
of neonates and children as well as certain pathologic conditions provides many 
acoustic windows into the chest. Only little effort is needed to evaluate and diagnose 
a wide range of clinical problems in the thorax without the radiation exposure from 
frequent chest radiographs and CT, or the need for sedation often required for MR 
imaging. In particular, ultrasound is quickly implemented in the remote intensive 
care situation where patients can be examined in any given position and location 
minimising the need to move or transfer patients, who are on life support devices. 
Ultrasound is particularly useful in differentiating between pulmonary and pleural 
lesion, in visualising diseased parenchyma hidden by pleural effusion in chest radio-
graphs, to detect and characterise pleural fluid collections, to delineate anomalies 
of mediastinum and great vessels, and last but not least, to assess malposition 
and complications of central vein catheters. 
Learning Objectives:
1. To demonstrate imaging approaches to the mediastinum, pleura, diaphragm, 
and lung.
2. To review sonographic features of thoracic disorders.
3. To illustrate the use of chest US in neonatal intensive care.
A‑435 09:00 
B. CT: What you really need to know 
C. Owens; London/UK (owensc@gosh.nhs.uk) 
This presentation will discuss applications of CT in the evaluation of chest dis-
ease in children. The advent of fast acquisition thin collimation volumetric CT has 
revolutionized thoracic CT imaging in children. The majority of children requiring 
thoracic CT fall in to three basic categories; hence, three basic protocols suffice for 
most chest CT examinations in children. Metastatic disease, focal lung pathology 
or mediastinal mass/adenopathy allows scanning with thicker beam collimation 
and lower pitch factors preserving risk from inappropriate over dosage. Vascular 
or airways disease may require thinner collimation and higher pitches. MRI may, 
therefore, be more appropriate in these patients. In Diffuse lung disease, sequen-
tial scans with thin collimation and high spatial frequency reconstructions are the 
established optimal technique. Tube current (MA) and kilo voltage KV should be 
kept to the lowest allowing diagnostic quality images and depend on patient size 
and weight. Enabling automated dose modulation will override set parameters 
and so understanding of manufacturers’ settings is imperative. There are many 
controversial issues within applications of paediatric chest CT and it is vital that the 
radiologist is constantly questioning the added diagnostic role of CT over the other 
alternative non-ionizing examinations (e.g. MRI) when available and appropriate. 
The presentation will discuss areas of potential controversy within the assessment 
of children undergoing thoracic CT. 
Learning Objectives:
1. To discuss specific customised protocols used in pediatric chest CT imaging.
2. To discuss strategies for pediatric CT dose reduction.
3. To illustrate the strength of chest CT using case-based illustrations.
A‑436 09:30 
C. MRI: The icing on the cake. Are we really there yet? 
M.U. Puderbach; Heidelberg/DE (m.puderbach@dkfz.de) 
Diseases of the respiratory system are of great importance in paediatrics. Early 
detection and follow-up of infectious, congenital and environmental diseases in 
young patients is crucial for adequate treatment and improved outcome. Here, 
imaging techniques play an indispensable role. In the past, the interest was focused 
on morphological aspects of pulmonary tissue. Here, computed tomography (CT) 
serves as the gold standard. In the course of the development of MRI, MR imaging of 
the lung played a subordinate role. This was caused by several technical problems: 
1. low signal to noise ratio because of low proton density of the lung, 2. artefacts 
because of cardiac and breathing motion, 3. susceptibility artefacts because of air-
soft tissue transition. Despite these inherent difficulties of MRI of the lung, significant 
progress has been made recently. Although spatial resolution is lower than at CT, 
MRI allows for the visualisation of the lung parenchyma by using ultra short echo 
time (TE). Furthermore, MRI has the advantages to evaluate different tissue aspects 
(T1w, T2w, fat suppression) and to improve lesion characterization. Additionally, 
MRI is capable to assess lung function, e.g. perfusion, angiography, ventilation 
and respiratory mechanics. Using up to date scanner systems, a complete study 
of the chest including morphological and functional imaging can be performed in 
less than 30 minutes. Especially, diseases that go along with pulmonary structure 
augmentation and/or involve vascular structures can be studied by MRI. 
Learning Objectives:
1. To describe the various techniques available for MRI of the chest in children.
2. To illustrate specific clinical scenarios where MRI is helpful.
3. To illustrate the strengths and weaknesses of chest MRI with case-based 
illustrations.
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08:30 - 10:00 Room L/M 
Special Focus Session 
SF 15c 
Vascular ultrasound imaging: When and how
Moderator:
B. Brkljacic; Zagreb/HR 
A‑437 08:30 
Chairman’s introduction 
B. Brkljacic; Zagreb/HR (boris.brkljacic@zg.htnet.hr) 
Ultrasound has fundamentally transformed vascular medicine. It offered new 
and profound insight into vascular physiology, early detection became possible, 
and its high diagnostic accuracy permits optimal therapeutic management. US is 
unfortunately underused among radiologists; often, CTA and MRA are preferred 
even when they do not offer real advantages. Ultrasound is noninvasive, cheap, 
easily and widely available, provides morphologic and physiologic information, 
with direct hemodynamic data obtained at the site of pathologic lesion, and proxi-
mally and distally, and is highly accurate. It is also useful during many vascular 
interventional procedures. It requires experience, manual dexterity and is highly 
operator-dependent. In the session the role of US in the quantification of vascular 
disease will be described, with the emphasis on physiological measurements. 
State-of-the art performance and interpretation of carotid US examinations and 
the role of US and US contrast media for the characterization of plaque will be 
presented. The role and advantages of US over other imaging methods in planning 
of endovascular procedures and follow-up will be emphasized. Finally, deep venous 
thrombosis is a common and important condition potentially resulting in pulmonary 
embolism. US is the major imaging modality used for accurate diagnosis and to 
prevent thromboembolic complications; major aspects of US diagnosis of DVT will 
be presented. Additionally, alternative conditions that clinically mimic DVT and their 
US findings will be presented. Vascular ultrasound should be utilized by radiologists 
to complement CTA and MRA, since it provides a quick, inexpensive and accurate 
way to diagnose major arterial and venous diseases. 
Session Objectives:
1. To present the role of US in the evaluation of hemodynamics and 
quantification of vascular disease.
2. To describe the role of US in the planning and follow-up of endovascular 
procedures.
3. To discuss the role of US in the diagnosis of DVT and its mimics.
A‑438 08:33 
Not only imaging: A window on physiology
C. Deane; London/UK (colin.deane@kch.nhs.uk) 
Ultrasound is established in the diagnosis of arterial disease. The morphological 
information from B-mode, together with colour flow imaging of the residual arterial 
lumen, is complemented by Doppler measurement of arterial velocity and the flow 
waveform. This not only gives a measure of the geometrical severity of the lesion 
but is also indicative of the pressure changes through the stenosis and its effect 
on the local circulation. Changes to flow waveform show the effects proximal and 
distal vascular changes. The combination of local changes through a renal artery 
stenosis with flow waveform changes within the kidney is, for example, arguably 
valuable in assessing both the artery stenosis level and the intrarenal circulation. 
Ultrasound has an important role to play in the evaluation of early disease. It provides 
inexpensive screening for aortic aneurysm. Measurement of intimal thickening in the 
carotid arteries has been used as a predictor of increased cardiovascular disease. 
Ultrasound can also be used in the measurement of arterial stiffness which has 
shown to be an early indication of arterial disease. Lastly, transcranial Doppler is 
an inexpensive technique for examining cerebral haemodynamics. Clinically ef-
fective in, for example, screening children with sickle cell disease, it has extensive 
research applications. The use of TCD techniques to measure small microemboli 
has been shown to offer possibilities to identify patients at risk from stroke from 
carotid stenoses with the potential to enable refinement of treatment options. 
Learning Objectives:
1. To present the role of US in the quantification of vascular disease.
2. To provide an overview of US measurement techniques in vascular 
disease and flow measurement, the role of US in vascular physiological 
measurement including arterial compliance, and the use of transcranial 
Doppler techniques for cerebral hemodynamics and embolus detection.
A‑439 08:53  
Carotid stenosis and vulnerable plaque 
D. Gaitini; Haifa/IL (d_gaitini@rambam.health.gov.il) 
Identification of carotid stenosis and differentiation stenosis from occlusion may 
enable selection of the most appropriate candidates for endarterectomy or stent 
implantation. Carotid ultrasound (CUS) has become an important means to reach 
these goals thanks to advances in CUS performance and interpretation driven by 
technological improvements in gray scale, color and spectral Doppler. Intima-media 
thickness, plaque location and characterization, flow disturbance and flow velocities 
for the diagnosis of carotid stenosis are obtained by CUS. The degree of diameter 
stenosis of internal carotid artery is the main parameter used for therapeutic ap-
proaches. Plaque rupture is the most common type of plaque complications, ac-
counting for almost 70% of fatal acute myocardial infarctions and cerebral strokes. 
Microbubbles contrast media (CMUS) injection may demonstrate neovessels in the 
atherosclerotic plaque. A high density of neovascularization diagnosed by CMUS 
corresponds to a vulnerable plaque, with higher propensity to rupture and clinical 
manifestations. CUS is a unique imaging method for the investigation of carotid 
stenosis. Non-invasive, accurate and cost-effective, it provides morphological and 
functional information. It is increasingly becoming the first and often the sole im-
aging study before treatment, where costly and invasive procedures are reserved 
for special cases. State-of-the-art in the performance and interpretation of CUS 
examinations and the role of CMUS for plaque characterization are presented. 
Learning Objectives:
1. To describe the technique of US Doppler examination, correlation of US 
Doppler results with stenosis degree, and advantages and limitations 
compared to other imaging tests.
2. To present the patterns of atheroslcerotic plaques and the role of US 
contrast media in the characterisation of the vulnerable plaque.
A‑440 09:13  
Planning and follow-up of endovascular procedures 
Z. Morvay; Szeged/HU (mzita@radio.szote.u‑szeged.hu) 
Ultrasound is effective in imaging and measuring disease in large arteries although 
the skill and equipment required varies. For example, the abdominal aorta can easily 
be visualized but renal arteries require more skill and high specification equipment. 
Carotid, femoral, popliteal, brachial arteries are easily accessed and criteria for 
determining the severity of steno-occlusive disease are well-established. Small 
arteries in the arm and leg can be imaged although those in the leg may present 
difficulties, especially in diabetic patients with high prevalence of multiple lesions in 
tibioperoneal arteries. In this case, other image modalities are often required. Suc-
cessful imaging requires careful manipulation of colour flow and Doppler controls, 
gain, transmit frequency, PRF, beam steering and angle correction. It is important 
to be confident of flow direction and measures velocities; good scanning techniques 
can limit errors. Velocity criteria can be used to grade stenoses into categories. 
Absolute values are helpful although velocity ratios are useful to compensate for 
physiological variables; for example, in the peripheral circulation. Ultrasound is ef-
fective in determining the presence and extent of aneurysms, pseudoaneurysms, 
fistulas, dissections and has in important role in follow-up of surgical and radio-
logical vascular interventions. Fortunately, stents and grafts placed into vessel are 
“transparent” for ultrasound; after such procedures, the same measurements can 
be performed in vessels as for native vessels. Diagnostic criteria will be presented 
together with limitations as to their use in clinical scanning. 
Learning Objectives:
1. To describe indications, technique, pitfalls and general yield of Doppler US 
for the diagnosis of arterial stenosis.
2. To present the role and advantages of US over other diagnostic procedures 
in the diagnosis and therapy of post-procedural complications.
A‑441 09:33 
DVT diagnosis and mimics 
G. Ivanac; Zagreb/HR (gordana.augustan@zg.htnet.hr) 
Deep venous thrombosis (DVT) is extremely common and pulmonary embolism 
remains major killer of inpatients. Although the risk factors for DVT are known, 
prophylaxis is not universal. False diagnosis results in unnecessary anticoagulant 
therapy and the risk of bleeding. Clinical diagnosis of DVT alone is unreliable; only 
20-30% of those with symptoms have DVT and 90% of patients with fatal PE are 
asymptomatic for DVT. Accurate diagnosis and prompt therapy are essential to 
reduce risk of thromboembolic complications. Ultrasound is the major imaging 
method to diagnose DVT and follow-up the patient during and after the therapy. The 
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to evaluate the thrombus extent and characterize whether it is fresh or organized, 
free-floating or attached, partially or totally occlusive, and finally to establish 
the alternative diagnose to DVT in patients with similar symptoms. Examination 
technique and criteria to diagnose acute and chronic DVT will be presented. The 
role of US in the follow-up of patients will be discussed. Controversial and difficult 
issues will be discussed, regarding the selection of patients for imaging, screening 
of asymptomatic high-risk patients, imaging of isolated calf DVT, and the need to 
provide permanent hospital US service for suspected DVT. Clinical diagnosis of 
DVT is difficult, and the majority of thrombi are clinically silent; ultrasound enables 
recognition of alternative pathology with similar clinical symptoms in more than 15% 
of patients; many examples of alternative pathologic conditions will be presented. 
Learning Objectives:
1. To describe goals, technique, pitfalls and accuracy of Doppler US in 
diagnosis of DVT and post-thrombotic syndrome.
2. To discuss controversial issues and strategies to refine the selection of 
patients for imaging.
3. To present the advantages of US in diagnosing alternative conditions that 
clinically mimic DVT.
Panel discussion:  
Why is vascular US underutilised in radiology departments 09:53 
08:30 - 10:00 Room N/O 
Head and Neck 
RC 1508 
Common pains in the head and neck 
Moderator:
L. Akesson; Lund/SE 
A‑442 08:30 
A. Salivary colic 
T. Beale; London/UK (timothy.beale@royalfree.nhs.uk) 
This lecture will demonstrate a multimodality approach to the imaging of salivary 
colic. The relevant US and MRI salivary anatomy will be highlighted and the ultra-
sound, computed tomography and magnetic resonance appearances of salivary 
colic will be shown and techniques for optimising the imaging of salivary colic given. 
The use of US, CT, MRI, and both MRI and conventional sialography in the imaging 
of salivary colic will be discussed. The role of interventional sialography and mini-
mally invasive techniques in benign salivary gland obstruction will be demonstrated. 
Learning Objectives:
1. To review the role of imaging in the evaluation of salivary colic.
2. To understand the advantages and limitations of the different available 
imaging techniques.
3. To become familiar with MR sialography technique and how it compares with 
conventional sialography.
4. To learn the indications and limitations of interventional sialography.
A‑443 09:00 
B. Trigeminal neuralgia 
B.F. Schuknecht; Zurich/CH (image‑solution@ggaweb.ch) 
Trigeminal neuralgia is defined as recurrent episodes of intense lancinating pain 
most common in the second (V2) or third division (V3) of the trigeminal nerve. The 
pathogenesis is a neurovascular conflict by an artery or vein associated with fo-
cal demyelination of sensory fibers at the glia schwanncell junction. Apposition of 
demyelinated fibers induces abnormal generation and transmission of impulses. 
MR Imaging is based on high resolution sequences: CISS with coronal and sagittal 
oblique MPR and 3D TOF sequences with a thin MIP reconstruction to delineate 
the cisternal course of the trigmenial nerve, the root entry and glia schwanncell 
junction and the course of vessels along the trigeminal nerve. The brainstem and 
brain are assessed by T2, Flair and 3D isotropic Gd enhanced sequences, and the 
viscerocranium is examined by a noncontrast and coronal T1 Gd fat suppressed 
sequence. Analysis of images is focused on recognition of displacement and distor-
tion of the proximal trigeminal nerve by the SCA, rarely by the AICA, BA or petrosal 
vein. Inflammatory CNS disorders and peritrigeminal tumours are scrutinized as 
well as neoplastic or inflammatory lesions along the course of the V1 - V3 division 
from the root entry to the exit foramina. Correlation of the circumferential site of 
distortion at the root entry zone with the somatopic representation of fibers increases 
the in general low specificity of the neurovascular contact. Ruling our compressive 
tumours and delineating a marked neurovascular conflict may stratify patients in 
case of failure of antiepileptic medication to microvascular decompressive surgery. 
Learning Objectives:
1. To review the clinical diagnostic criteria and pathophysiology of trigeminal 
neuralgia.
2. To learn how to tailor MR imaging technique.
3. To become familiar with the most common causes.
4. To understand the value of imaging in patient management.
A‑444 09:30 
C. Painful swallowing 
M. Becker; Geneva/CH (minerva.becker@hcuge.ch) 
The purpose of this lecture is to provide an overview of the key imaging features of 
painful swallowing with or without associated mucosal pathology. In the presence of 
a mucosal lesion, painful swallowing is most often caused by infectious, neoplastic 
or traumatic lesions of the pharynx itself, whereas in the absence of mucosal al-
terations, painful swallowing is the result of functional disorders (dysfunction of the 
cricopharyngeus muscle), infectious, inflammatory or neoplastic diseases affecting 
adjacent neck spaces (retropharyngeal and paraphyrngeal space), neurologic 
impairment (glossopharyngeal neuralgia), carotidodynia and Eagle’s syndrome. 
The indications for CT, MRI, US and videofluoroscopy will be reviewed and their 
respective role in the detection and precise description of the underlying cause. 
Major emphasis will be placed on how to report the findings in a comprehensive way. 
Learning Objectives:
1. To recognise the most common causes of painful swallowing in patients with 
an abnormal pharynx at clinical examination.
2. To recognise the most common causes of painful swallowing in patients with 
a normal pharynx at clinical examination.
3. To review the role of different imaging techniques in the diagnosis and 
treatment of painful swallowing.
4. To review the key imaging features of the most common causes of painful 
swallowing as seen on the respective imaging techniques.
08:30 - 10:00 Room P 
Cardiac 
RC 1503 
Imaging coronary artery disease (CAD) 
Moderator:
G.H. Roditi; Glasgow/UK 
A‑445 08:30 
A. CT of coronary arteries: Luminography and beyond 
H. Alkadhi; Zurich/CH (halkadhi@partners.org) 
Coronary CT angiography has entered daily clinical practice. Increasing robustness 
for non-invasive coronary artery imaging could be achieved through the implemen-
tation of CT systems equipped with dual-source technology and/or providing a 
wider Z-axis coverage (128 slices and more). In addition, an increase in temporal 
resolution has diminished the dependency of image quality on the patients‘ heart 
rate. Cardiac CT is particularly useful in patients having an intermediate pre-test 
likelihood of coronary artery disease based on their history, cardiovascular risk 
factors, symptoms, and the results of ECG or stress tests. In these patients, CT is 
a clinically useful tool and may obviate the need for invasive diagnostic procedures. 
The contrast-enhanced CT scan for coronary angiography also includes qualitative 
information about the extent and composition of coronary plaques. These can be 
characterized by CT into calcified, non-calcified or mixed. Particularly, non-calcified 
plaques represent an early stage of atherosclerosis and mixed plaques carry some 
risk for rupture which makes their identification an important adjunct to a purely 
luminographic coronary artery assessment. Whereas MR continues to fall short of 
imaging the cororary arteries in a clinically robust manner, it has recently shown 
great promise in the detection and characterization of coronary artery plaques. 
This is mainly achieved through its excellent soft-tissue resolution that generally 
outperforms that obtained from CT. 
Learning Objectives:
1. To review the performance of CT for diagnosing CAD.
2. To highlight the importance of non-invasive imaging of coronary plaques.
3. To define the current and future role of CT for plaque imaging.
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A‑446 09:00 
B. MRI: What can it provide in CAD? 
L. Natale; Rome/IT (lnatale@rm.unicatt.it) 
MRI is a powerful tool in cardiac imaging, because of its morphological, functional 
and perfusion information, due to its high spatial, contrast and temporal resolu-
tions. In CAD, MRI has very strong clinical indications in ischemia detection, acute 
and chronic myocardial infarction assessment, and viability assessment. Many 
techniques can be employed: Fat sat T2 imaging is very useful in edema detection, 
first pass sequences can be used at rest and stress to detect perfusion defects 
and ischemia, delayed enhancement sequences are considered gold standard 
for necrosis and/or scar recognition and quantification and viability assessment. 
Furthermore, other information can be obtained by MRI; in treated and untreated 
acute myocardial infarction, microvascular obstruction presence represents a major 
prognostic factor. Different approaches can be used: Rest first pass imaging, so-
called early late enhancement, conventional late enhancement. Risk stratification is 
another important field where MRI can be employed. Ischemia presence/absence 
still remains a major prognostic factor in patients with suspected CAD. Rest and 
stress perfusion MRI is more feasible than rest and stress cine-MRI for ischemia 
recognition, with many advantages compared to nuclear perfusion imaging. More 
than important technical development, future of cardiac MRI can be represented 
by emergency room applications, such as T2 imaging in acute chest pain and 
perfusion imaging in atypical chest pain. 
Learning Objectives:
1. To review the scientific evidence of MRI in CAD.
2. To discuss various techniques for assessing function, perfusion and viability 
in CAD.
3. To define the current and future role of MRI in risk stratification of patients 
with CAD.
A‑447 09:30 
C. MRI and MDCT: Complementary or competitive? 
K. Nikolaou; Munich/DE (konstantin.nikolaou@med.uni‑muenchen.de) 
High-field-strength clinical magnets, high-performance gradient hardware, and ultra-
fast pulse sequence technology are rapidly making the vision of a comprehensive 
cardiac MR imaging examination a reality. This examination is poised to have a 
significant effect on the management of coronary artery disease by means of assess-
ment of myocardial function and regional wall motion with tagging and pharmacologic 
stress testing, evaluation of the coronary microvasculature with perfusion imaging, 
and with MRI having been established as the gold standard of myocardial viability 
analysis. On the other hand, the direct visualization of the coronary arteries has been 
the main clinical application for multislice CT. With ever faster multislice-CT scanners 
at hand and with growing indications for cardiac imaging and imaging in ischemic 
heart disease also using CT, the appropriate use of each imaging modality in patients 
with suspected and known coronary artery disease is under ongoing discussion. 
Learning Objectives:
1. To understand the strengths and weaknesses of MRI and MDCT.
2. To discuss clinical indications for both modalities.
3. To review CAD cases.
08:30 - 10:00 Room Q 
Interventional Radiology 
RC 1509 
Minimally invasive treatment of uterine fibroids 
Moderator:
R. Pietura; Lublin/PL 
A‑448 08:30 
A. Choice of embolic agent 
N. Hacking; Southampton/UK (nigel.hacking@virgin.net) 
1. To learn which embolic particles may be used for uterine fibroid embolisation 
(UFE): p-PVA, s-PVA: the longest use of any product for UFE, relatively cheap 
and effective in RCTs. Most commonly used embolic in UK and Canada. s-PVA 
introduced to allow deeper penetration and less clumping. Gelfoam: the cheapest 
embolic and effective, with long term studies showing safety and efficacy. Widely 
used in the Far East, UK, India and the Caribbean. Embospheres (ES), Beadblock 
(BB), Embozenes (EZ): three further spherical agents. Available in a wide range of 
sizes, colours and with different physical characteristics. Less catheter occlusions 
than with PVA. Easier to deliver through a micro-catheter. Agents of choice in the 
USA and much of Europe.
2. To discuss criteria for selection of particles: The ease of use, volume of embolic 
required, complication rates and cost all vary between embolic agents. Depth of 
penetration into the fibroid, the inflammatory response, uterine artery occlusion 
rates and fibroid infarction rates also show some variation. All the above agents have 
been used effectively and safely in UFE. The costs of the embolics vary significantly.
3. To review evidence for and against available embolic particles: Fibroid re-growth 
and recurrence of symptoms have been shown to be related to fibroid infarction 
rates and this is the most accurate way of predicting long term outcomes following 
UFE with differing embolic agents. Comparative fibroid infarction rates with these 
different agents will be presented. 
Learning Objectives:
1. To learn which embolic particles may be used for uterine fibroid 
embolisation (UFE).
2. To discuss criteria for selection of particles.
3. To review the evidence for and against available embolic particles.
A‑449 09:00 
B. Recurrence of fibroids after embolisation 
C. Binkert; Winterthur/CH (christoph.binkert@ksw.ch) 
Uterine fibroid embolisation (UFE) has shown a similar clinical outcome after two 
years compared to hysterectomy in the EMMY trial. However, there is a higher 
reported rate of re-intervention after UFE compared to hysterectomy. In the REST 
trial, the re-intervention rate was 20% for UFE vs. 2% for the hysterectomy population 
during a median follow-up of 32 months. MRI has become the modality of choice 
to assess the outcome after UFE. Youselfi et al. (JVIR 2006) showed that the large 
majority of recurrent fibroids occurs from re-growth after incomplete fibroid infarction 
and only a minority (12%) are new fibroids. Therefore, the key question is: what 
are the factors to prevent complete embolisation. Basically, the problem is that not 
enough particles get to the fibroids. One reason is an arterial supply other than 
the uterine arteries. The most common additional supply is the ovarian arteries. If 
parts of the fibroid are only supplied by the ovarian artery, a complete embolisation 
through the uterine arteries is not possible. Another reason is either the inability 
to catheterise the uterine artery or the impairment of flow before or during particu-
late embolisation such as spasms or dissection. In order to minimize incomplete 
fibroid infarction, the ovarian arteries should be assessed during UFE and in case 
of substantial supply to the fibroids embolised. Also, subtle catheter technique 
should be applied with the use of small catheters (4 F or microcatheters). Overall, 
it should not be forgotten that only symptomatic recurrences need further treatment. 
Learning Objectives:
1. To discuss factors affecting the incidence of fibroid recurrence.
2. To discuss methods of avoiding recurrence.
3. To review the current evidence regarding recurrence.
A‑450 09:30 
C. UAE and HIFUS: What the radiologist needs to know 
T. Kroencke; Berlin/DE (thomas.kroencke@charite.de) 
Uterine artery embolisation (UAE) and MR guided high-intensity focused ultrasound 
(HIFUS) are minimal-invasive therapies for treating symptomatic uterine leiomyo-
mas (fibroids) and represent alternatives to surgery (hysterectomy, moymectomy, 
hysteroscopic resection). The indication for treatment of uterine leiomyoma de-
pends heavily on symptomatology and burden of disease. Chronic fibroid related 
symptoms fall into three major categories: bleeding symptoms (hypermenorhea, 
dysmenorrhea), bulk-related symptoms (urinary frequency, obstipation, bloating, 
pelvic pain), and infertility. With the exception of infertility, patient expectations are 
centered on the efficacy of currently available treatment options regarding freedom 
of symptoms, quality-of-life and invasiveness of therapy. Validated questionnaires 
are available to assess symptom severity and impairment of quality-of-life in a 
standardized manner. The burden of disease is dependent on the location, size, and 
number of leiomyoma. However, as opposed to many malignant tumors, no unique 
classification system is available to date to determine the extent of disease and help 
to stratify treatment options. Non-invasive imaging such as transvaginal ultrasound 
(TVUS) and magnetic resonance imaging (MRI) play a crucial rule in detection of 
uterine leiomyoma and differentiation from other uterine and ovarian pathologies. 
This presentation summarizes current treatment options in the light of the current 
literature. Especially, the role of interventional radiological treatments like HIFUS 
and UAE for uterine leiomyoma is discussed in a case-based approach. The role 
of imaging with a focus on key information requested by the treating interventional 
radiologist, typical imaging features before and after these procedures as well as 
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Learning Objectives:
1. To discuss the role of HIFUS and UAE as an alternative to surgery.
2. To learn about the role of MR imaging prior to UAE and HIFUS.
3. To differentiate typical versus atypical findings after UAE and HIFUS.
10:30 - 12:00 Room E2 
Interactive Teaching Session 
E³ 1620 
Imaging in common clinical problems: Neck mass 
Moderator:
M.G. Mack; Frankfurt a. Main/DE 
A‑451 10:30 
A. Above hyoid 
S.J. Golding; Oxford/UK (stephen.golding@nds.ox.ac.uk) 
The face and neck offer some of the most complicated anatomy with which the 
radiologist has to deal, and also a particularly wide range of pathology, making 
cervicofacial imaging a complex area of clinical practice. Further, imaging signs in 
the face and neck can frequently be difficult to elicit. Many general radiologists prefer 
to avoid practicing in this area if possible but a basic knowledge of neck masses 
is fundamental to general radiology practice. A simple approach to the complexity 
of the suprahyoid neck may be taken on the basis of anatomical compartments. 
Knowledge of and ability to analyse these is fundamental to differential diagnosis 
and provide the radiologist with a useful guide to establishing the pathological basis 
of imaging signs. In this area, it is also important to correlate imaging with clinical 
examination, as lesions may have identical imaging signs but radically different 
pathophysiology. Imaging signs are rarely specific but provide a good guide to further 
clinical management, including local staging of both benign and malignant disease. 
In radiology generally, knowledge of the clinical treatment options is fundamental to 
providing a meaningful radiological report. This is particularly true of cervicofacial 
disease where therapeutic options are generally not well understood by radiologists, 
and where clinicoradiological liaison becomes paramount. 
Learning Objectives:
1. To learn about diagnostic imaging signs in the suprahyoid neck.
2. To appreciate the importance of correctly localising disease and how this 
helps in the differential diagnosis.
3. To understand the strengths and weaknesses of characterising suprahyoid 
lesions on the basis of imaging signals and characteristics.
4. To understand the importance to patient management of precise evaluation 
and staging by imaging.
A‑452 11:15  
B. Below hyoid 
N.J.M. Freling; Amsterdam/NL (n.j.freling@amc.uva.nl) 
The infrahyoid neck is an anatomical area between the oral cavity, the submandibular 
space and the entrance of the thoracic cage, which may serve as a highway, con-
necting different areas. It contains mainly longitudinal structures: muscles, blood 
vessels, nerves, esophagus and only a few horizontal structures, e.g. the hyoid 
bone, the thyroid gland, and the vocal cords. When examining this region at a digital 
workstation, it is important to use a rigid systematic analysis to avoid diagnostic 
failures: larynx - upper airways, hypopharynx - esophagus - blood vessels - lymph 
nodes - muscles - thyroid gland - spine - skin. Few clinical issues regarding the 
infrahyoid neck will involve this anatomic area only. For example, esophageal cancer 
of the cervical esophagus needs to be staged before treatment planning, including 
the neck nodes, chest and upper abdomen. Extension of a deep parapharyngeal 
neck abscess beyond the hyoid bone may involve the infrahyoid neck before 
extending into the mediastinum. But a lateral neck cyst is usually in an infrahyoid 
location. The choice of imaging depends on clinical information: should we use US, 
CT, MRI, PET/CT or shall the patient immediately be transported to the radiology 
intervention department? The radiologist should be aware of the acute (trauma, 
haemorrhage, vascular occlusion), semi-acute (infection) or non-acute situation 
(staging cancer, analysis slowly growing mass lesion). Pathology differs between 
children and adults and to know the incidence of the most common diseases in 
the infrahyoid neck is extremely rewarding in daily practice. 
Learning Objectives:
1. To learn what structures are located in the infrahyoid neck (excl. the larynx).
2. To know what a cystic lesion might represent in children and in adults.
3. To know how to diagnose a solid lesion and what its nature could be.
4. To learn how to recognise vascular lesions.
5. To understand how to use the best of different imaging modalities to obtain 
a diagnosis.
12:15 - 13:45 Room B 




C.J. Herold; Vienna/AT 
S.S.A. Lingawi; Jeddah/SA 
M. Szczerbo‑Trojanowska; Lublin/PL 
A‑453 12:15 
Introduction 
S.S.A. Lingawi; Jeddah/SA (dr_lingawi@yahoo.ca) 
The Radiological Society of Saudi Arabia (RSSA) is a young society. It was es-
tablished in January 2004 and is now in its 6th year. About 400 radiologists work 
in Saudi Arabia, a third of whom are Saudi nationals and the rest are expatriates 
from different nationalities including North America, Europe, North Africa, East 
Mediterranean counties and the Indian subcontinent. The ratio of women to men 
is almost 1:6. RSSA also servers radiographers, whose number is triple that of 
radiologists. As the field of radiology is evolving and the recognition of its importance 
is becoming a fact in all physicians’ minds, it is expected that the number of physi-
cians seeking radiology certification will increase. In our local training program, this 
has been noticed over the past five years with equal number of applicants among 
men and women. As the rest of the word, radiology in Saudi Arabia is met with 
the following main challenges: 1. High medical demand and shortage of enough 
qualified radiologists. 2. Need for high quality RIS/PACS systems at a national level. 
3. Need for reliable national and international Teleradiology systems. 4. Need for 
physician education to improve appropriate radiological investigation referral pattern. 
Certain endemic diseases are present in Saudi Arabia such as: tuberculosis and 
brucellosis, and parasitic infestations. Similarly, due to various genetic and social 
factors other diseases are prevalent such as congenital anomalies, diabetes mel-
litus, and sickle cell anaemia. Among the various oncological diseases, lymphoma 
seems to be prevalent. 
Session Objectives:
1. To introduce the practice of radiology in Saudi Arabia.
2. To highlight the role of the Radiological Society of Saudi Arabia.
3. To demonstrate some of the common health issues in Saudi Arabia.
A‑454 12:23  
Peculiar musculoskeletal infections and infestations 
M.E. Abd El Bagi; Riyadh/SA (drm_bagi@hotmail.com) 
Saudi Arabia emphatically surpassed hardship days, which left behind residual 
peculiar infections, to prosperity which provided accurate imaging facilities for 
diagnosing those infections. The most peculiar and most sinister is mycetoma. It 
is a mimicker of all bone diseases which may be misdiagnosed. Mycetoma can 
look like osteomyelitis, simple or aneurysmal bone cysts, fibrous dysplasia, en-
chondroma, osteosarcoma, Ewing’s tumour, osteoid osteoma or neurofibromatosis. 
Mycetoma is painless. It burrows deeply before it becomes clinically manifest and 
may require amputation or re-amputation. The bidirectional travel between tropical 
and temperate countries and the global warming may cause spreading of human 
parasites. No country is exempt. The musculoskeletal system could be the transit 
route or the graveyard of certain parasites. These include cysticercosis, hydatid 
disease, guinea worms and filariasis. Such parasites may be discovered acciden-
tally on radiographs as calcifications and may present with rheumatism or bizarre 
symptoms. Acute bone pain in sickle cell diseases patients is a common clinical 
dilemma with great morbidity. It could be due to an infection, an established infarct 
or a transient vasculopathy. Differentiation is difficult clinically and management is 
diverse. Plain films are usually negative. Ultrasound is neither sensitive nor specific. 
Radioisotopes may require multiple studies with technetium scan, WBC scan or 
colloid bone marrow scan with a significant radiation dose. MRI is the modality of 
choice but is expensive and may require heavy sedation for children. Future use of 
MR perfusion studies may help to differentiate among infection, infarct and transient 
vasculopathy to avoid invasive procedures. 
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Learning Objectives:
1. To summarise the peculiar infections of the musculoskeletal system.
2. To demonstrate the spectrum of the radiologic signs of peculiar 
musculoskeletal infections.
3. To describe how can these peculiar musculoskeletal infections mimic other 
bone diseases.
A‑455 12:46  
Brucellosis in Saudi Arabia from head to toe 
N.A. Al-Nakshabandi; Riyadh/SA (nizar.nakshabandi@ksu.edu.sa) 
Human brucellosis is notoriously a multisystem disease. Brucellosis is endemic in 
Saudi Arabia. Morbidity in humans in the Saudi population continues to be reported 
with increasing frequency from various regions of the country, particularly from the 
rural areas, and human infection is in the range of 1.6 - 2.6%. The disease presents 
in both sexes and in all ages with varied manifestations. It can involve any part 
of the body. In the brain, it can present with meningitis, encephalitis, MRI can be 
normal, abnormal enhancement of the meninges, from inflammation, white matter 
changes and vascular changes. Involvement of the spine can be diffuse or focal 
with most cases seen in the lumbar spine region. Erosions as well as sclerosis 
are in the endplates of the vertebra. Changes of inflammation can be seen on 
MRI. Osteomyelitis of adjacent vertebra is with or without involvement of the disc 
space and an epidural mass in diffuse spondolitic brucellosis. Sacroiliac joint is a 
favorite location for the disease. Most bone/joint involvement was normal on plain 
radiographs but evidence of osteomyelitis and septic arthritis was seen on MRI. 
In the body, there is hepatosplenomegaly and lymphadenopathy along with ileitis 
in rare cases. Colitis and spontaneous peritonitis have can be seen on CT scan. 
Sacular mycotic pseuoaneurysms of the aorta from direct extension of vertebral 
body osteomylitis can be seen on CT. Epididymo-orchitis is the most common 
genitourinary complication visualized on ultrasound. 
Learning Objectives:
1. To summarise the full extent of Brucella infection in various body systems.
2. To demonstrate the spectrum of the radiologic signs of Brucella infection.
3. To understand the importance of imaging in the diagnosis of Brucellosis.
A‑456 13:09 
Role of imaging in discovery and characterisation of genetic diseases 
I.A. Alorainy; Riyadh/SA (alorainy@ksu.edu.sa) 
Historically, imaging has significantly contributed in the discovery and understanding 
of many genetic diseases. With the recent imaging advances, the role of radiology 
and medical imaging is not any more limited to the study of gross alteration in 
structure, but rather extends to the study of microstructure and function of body 
organs, tissues, and cells. Today, there is a great opportunity for imaging to have 
stronger impact on knowledge about genetic diseases. In Saudi Arabia, genetic 
diseases are prevalent partly due to high percentage of consanguineous mar-
riages resulting in high frequency of autosomal recessive disorders and increased 
frequencies of homozygosity for autosomal dominant traits. Such genetic diseases 
are either rare by Western standards or are unknown. This presentation will address 
the role of imaging in the discovery and characterization of genetic diseases in 
Saudi Arabia with emphasis on neurological diseases. Examples of such diseases 
and syndromes include: HOXA1 mutation in Bosley-Salih-Alorainy syndrome, 
ROBO3 mutation in horizontal gaze palsy with progressive scoliosis (HGPPS), 
C2orf37 mutation in Woodhouse-Sakati syndrome, RELN mutations in autosomal 
recessive lissencephaly with cerebellar hypoplasia, CC2D2 A mutation in Joubert 
syndrome, intragenic deletion in the LARGE gene causes Walker-Warburg syn-
drome, TDP1 mutation in spinocerebellar ataxia with axonal neuropathy, MRE11 
mutation in ataxia telangiectasia-like disorder, and Dincsoy-Salih-Patel syndrome. 
From a local Saudi perspective, imaging had a pivotal role in the discovery and/
or characterization of these disorders, and with the advent of imaging techniques, 
including functional and molecular imaging, we expect to experience a further role 
of imaging in understanding genetic diseases. 
Learning Objectives:
1. To learn how imaging has contributed to the discovery and understanding of 
genetic diseases.
2. To appreciate the great opportunities for advanced imaging techniques 
to play a fundamental role in discovering new genetic diseases and 
characterising the existing ones.
3. To understand the importance of taking a lead position in multidisciplinary 
genetic research.
4. To recognise the importance of observation of structural or functional 
derangement in discovering and understanding diseases.
Panel discussion 13:32
14:00 - 15:30 Room E2 
Interactive Teaching Session 
E³ 1720 
Imaging in common clinical problems: Hemoptysis 
Moderator:
E. Castaner; Sabadell/ES 
A‑458 14:00 
Imaging in common clinical problems: Hemoptysis 
S. Diederich1, M.-L. Storto2; 1Düsseldorf/DE, 2Chieti/IT 
(s.diederich@marien‑hospital.de) 
Hemoptysis is a potentially life-threatening condition requiring an urgent and com-
prehensive evaluation of the lung parenchyma, airways, and vessels. Bronchiectasis, 
chronic bronchitis, malignancy, and chronic infections (particularly tuberculosis and 
aspergillosis) are well-known causes of hemoptysis. Less common causes include 
pulmonary embolism with infarct, vascular anomalies such as pulmonary arterio-
venous malformations and bronchial artery aneurysms, vasculitis, and iatrogenic 
conditions. “Cryptogenic” hemoptysis, a diagnosis of exclusion, should also be 
considered since it is responsible for 3-42.2% of episodes of hemoptysis, particularly 
in smokers. Standard diagnostic algorithms have been based on a combination of 
conventional radiography, bronchoscopy, CT, and thoracic angiography. In recent 
years, the development of multi-detector CT has introduced a comprehensive, 
noninvasive method of evaluating the entire thorax. Moreover, multi-detector CT 
can be used to detect bronchial arteries and, less frequently, nonbronchial systemic 
arteries causing hemoptysis. In this session, we will review different causes of he-
moptysis and illustrate typical cases using an interactive modality of presentation. 
We will also discuss the role of multi-detector CT and other imaging modalities 
in the evaluation and management of patients with hemoptysis together with a 
proposal of a diagnostic algorithm. 
Learning Objectives:
1. To describe the potential etiology of hemoptysis.
2. To understand the information provided by different imaging modalities in 
hemoptysis.
3. To demonstrate typical imaging findings in patients with hemoptysis from 
different etiologies.
16:00 - 17:30 Room A 
Radiology in Abdominal Emergencies 
CC 1817 
When time matters 
Moderator:
R.A. Novelline; Boston, MA/US 
A‑459 16:00 
A. Emergency room: When radiologists can save lives 
O. Chan; London/UK (zaideotto@blueyonder.co.uk) 
The advent of major new technological advances in radiology has dramatically 
changed the role of the ER radiologist. ER radiologists should now play a central role 
in delivering a comprehensive 24/7 service. ER radiologists should be key figures 
in The Emergency Team and have the opportunity to save lives - “stop imaging 
patients to death” and “stop examining patients to death”. In effect, the combination 
of early imaging, accurate and fast diagnosis and therefore avoiding unnecessary 
delays, will almost certainly lead to a reduction in the rate of unnecessary compli-
cations and deaths. In order to be able to effect change, ER radiologists will have 
to be central in the design of new Emergency departments, help to decide on new 
imaging strategies and protocols for different clinical scenarios and help to draw 
up the response to a major incident. 
Learning Objectives:
1. To know the radiologist’s task in the emergency room.
2. To understand examples of diseases in which fast-track imaging plays a role.
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A‑460 16:30 
B. Rupture of solid organs 
J. Cazejust; Paris/FR (julien.cazejust@sat.aphp.fr) 
In abdominal trauma, spleen and liver are the most frequently affected organs. Initial 
Ultrasonography is helpful in providing an overview of potential lesions, as proposed 
with the FAST-US. This is especially dedicated to patient with hemodynamic instabil-
ity, in which the presence of a massive hemoperitoneum prompts for surgery without 
any further examination. In other cases, the management of the patient is more 
and more conservative, associating supportive care and interventional radiology, 
while surgery is seldom performed. The severity of the injury is best assessed by 
multidetector CT. Hepatic or splenic lesions range from simple contusion or minor 
laceration to organ fracture (linear lesion> 3 cm) and vascular avulsion, according 
to the AAST classification. Grade V splenic lesion is "completely shattered spleen" 
or "hilar vascular injury which devascularized spleen", whereas "hepatic avulsion" 
is the most severe lesion (grade VI). MDCT can only be performed in a patient 
with controlled hemodynamic parameters. MDCT protocol should adapt to the 
Purpose: thin slices allow multiplanar reconstruction, especially dedicated to bone 
trauma, iodine injection provides detection of bleeding, as well as road mapping 
when intervention is necessary. Arterial phase is mandatory, although bleeding can 
sometimes be more conspicuous on venous phase. Intervention might be necessary 
shortly after CT when active bleeding is seen, and if the patient is hemodynamically 
unstable. However, detection of active bleeding does not mean that intervention 
is systematically done because some lesions may resolve spontaneously. In that 
case, a close follow-up is necessary, as well as multidisciplinary concertation with 
regard to potential recurrence. 
Learning Objectives:
1. To know organs at risk in typical trauma situations and to be able to quantify 
lesions and hierarchise the potential risk.
2. To learn imaging features and their diagnostic importance.
3. To understand potential pitfalls and limitations of US, CT and MRI.
A‑461 17:00 
C. Intestinal haemorrhage 
N. Elmas; Izmir/TR (nevraelmas@gmail.com) 
Gastrointestinal haemorrhage has been accepted as an important admission cause 
to emergency departments. Mortality and morbidity ranges due to gastrointestinal 
haemorhage point out high incidence potentially. Diagnostic and therapeutic ap-
proaches are different in upper and lower intestinal tract bleeding. Type of haemor-
rhage depends on the origin of the bleeding. Clinical examination with history is 
essential for the selection of investigation. Etiologic causes can be encountered 
as gastric ulcer, diverticulosis, inflammatory and ischemic bowel diseases, varices 
due to the portal hypertension, arteriovenous malformation, neoplastic changes 
etc. Endoscopic procedures have been used as primary examination modality in 
intestinal bleeding especially upper intestinal tract. However, endoscopic techniques 
may result with negative or failed examination in detection of bleeding source. 
Under these circumstances, additional examination techniques are necessary 
such as catheter angiography, radionuclide red cell labeling technique. These 
techniques have some disadvantages such as time-consuming, invasive and 
low sensitivity or specificity ranges. In recent years, computed tomography has 
become the first imaging technique with advances in speed, multiphasic imaging 
capacity, multiplanar visualization, angiographic ability and high spatial resolution 
in gastrointestinal bleeding. 
Learning Objectives:
1. To know the classification of intestinal haemorrhage types according to their 
location and causes.
2. To understand how to perform and interpret imaging in patients with acute 
and chronic intestinal bleeding.
3. To know the factors affecting therapeutic alternatives.
16:00 - 17:30 Room B 





R.G.H. Beets-Tan; Maastricht/NL (r.beets.tan@mumc.nl) 
This course is relevant for all radiologists who are dealing with CRC staging. The 
impact of imaging on treatment-stratification is significant. It is important to have 
in-depth knowledge of what clinicians want to know from imaging and how radi-
ologists can provide these answers. With the worldwide adoption of preoperative 
radiotherapy in rectal cancer surgery, primary-staging is necessary to accurately 
select patients who only need surgery from those who will have an unacceptably 
high risk for local failure unless aggressive neoadjuvant treatment is given. CT and 
MRI are being more widely used in local and distant staging, respectively. Their roles 
in primary staging will be discussed. The relevant surgical anatomy of the pelvis that 
will be useful for radiologists to better report MR pathology will be provided as well 
as the relevant biology of rectal cancer to understand local and distant recurrences 
and its prognostic-risk-factors. Imaging also influences tailoring of the radiotherapy 
fields that uses planar imaging for planning. To understand how your imaging find-
ings on tumor extent determine the radiation-treatment-volumes will be dealt with in 
this course. New treatment options like local excision or even wait and see to those 
who achieve a pathological good response (ypT1-2) or complete response (ypCR) 
following preoperative chemoradiotherapy have improved long-term outcomes in 
local control rates, independent of their initial TN-stage. Restaging with imaging 
may contribute in selecting these good responders. To understand how treatment 
decisions can be tailored according to the tumor responses after completion of 
radiotherapy, what conservative surgical treatments exist and what is the role of 
imaging in restaging are other important goals of this course. 
Learning Objectives:
1. To understand the increasingly important role of the radiologist in the 
multidisciplinary management of rectal cancer patients.
2. To understand the clinical background of different treatment options and its 
impact of imaging on treatment outcome.
A‑463 16:05 
What the surgeon needs to know 
G.L. Beets; Maastricht/NL (g.beets@ah.unimaas.nl) 
Rectal cancer treatment has changed from a monodisciplinary surgical disease 
to a disease that often requires a multidisciplinary approach. In different countries 
and institutions, different approaches are used, but the common theme is that in 
early disease surgery only is the preferred treatment, and in more advanced cases 
neoadjuvant radiotherapy or chemoradiation. Prognostic factors that can be used 
in these choices are: the T stage, the N stage, the distance of the tumour to the 
mesorectal fascia, and the distance of the tumour to the anorectal ring. The informa-
tion required in a particular institution is dictated by the treatment strategies that are 
used, and radiologists should be aware of this through a good communication and 
collaboration with the clinicians. Specific surgical questions that imaging can address 
are: the exact relation of the tumour to: 1) the mesorectal fascia 2) the surrounding 
organs and 3) the anal sphincter. Repeated staging after chemoradiation is not yet 
standardised, and the clinical relevance is again related to the change in strategy 
the clinicians are willing to make, such as: sphincter or organ saving surgery after 
a good response where this was not feasible before the chemoradiation or a local 
excision instead of a standard rectal resection in a good responder. This field is 
evolving, and no standard recommendations can be made. 
Learning Objectives:
1. To understand the anatomy that is relevant in treating patients with rectal 
cancer.
2. To understand the treatment options used in your institution, and how 
patients are selected.
3. To understand what surgeons will do with the images and information.
Postgraduate Educational Programme
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A‑464 16:25  
What the radiation oncologist needs to know 
V. Valentini; Rome/IT (vvalentini@rm.unicatt.it) 
With the worldwide adoption of preoperative radiotherapy in rectal cancer for pa-
tients who will have an unacceptably high risk for local failure, images contribute 
to tailor radiotherapy fields and treatment decisions according to tumor responses 
during and after completion of radiotherapy. Nowadays, innovative techniques 
using 3D conformal treatment planning are recommended for radiotherapy treat-
ment. The most important contribution of 3-D treatment planning was the ability 
to plan and localize tumour target and normal tissues at all levels of the treatment 
volume. Based on the predominant locations of local recurrences and the lymph 
node involvement, guidelines for definition and delineation of the pelvic volumes 
to irradiate in rectal cancer are proposed. The choice of pelvic volumes to irradiate 
take also into account the height of the tumour, the definition of the local tumour 
extent and the nodal status at clinical stage by imaging. Many series report that 
patients who achieve a pathological complete response (pCR) following preopera-
tive radiotherapy + concurrent chemotherapy have improved long-term outcomes 
in terms of excellent local control rates, independently of their initial clinical T and 
N stage. After treatment, imaging contributes to detect favourable patients who 
could be cured with less surgery. Sequential PET/CT data (before, during and after 
radiochemotherapy) in combination with clinical variables seem to increase the 
performance of prediction models for pathologic complete response significantly. 
Based on these imaging modalities, new early response modulated treatments can 
be tested in the following years. 
Learning Objectives:
1. To understand how your imaging findings on tumor extent determine the 
radiotherapy treatment volumes.
2. To understand how treatment decisions can be tailored according to the 
tumor responses during and after completion of preoperative radiotherapy.
A‑465 16:45 
Imaging in colorectal cancer 
R.G.H. Beets-Tan; Maastricht/NL (r.beets.tan@mumc.nl) 
The assessment of the local spread of the tumor includes the determination of the 
depth of tumor growth in the rectal wall, the circumferential resection margin at 
TME, the depth of tumor invasion in surrounding pelvic structures, and the nodal 
status. For superficial rectal cancer, that can be treated with surgery only (transanal 
resection or TME), endoluminal ultrasound is the most accurate staging method 
to assess tumor ingrowth in the muscular rectal wall. For the remaining mobile 
and fixed rectal cancer a high resolution MRI with a dedicated phased array coil 
is at present the most reliable technique to evaluate the mesorectal fascia and the 
circumferential resection margins. Despite the identification of lymph nodes even as 
small as 2-3 mm on high resolution imaging, reliable detection of nodal metastases 
is presently not possible, because planar imaging only rely on morphological criteria. 
However promising results have been reported with the use of LN MR contrast in 
MRI and new functional MRI techniques. State of the art imaging and the role of 
MRI as well as the relevant role of the radiologists in the multidisciplinary decision 
making team will be discussed. After preoperative chemoradiation most advanced 
tumors shows phenomenal response so new treatment dilemmas and new ques-
tions arises for MR of rectal cancer. The lecture will not only provides evidence in 
staging but also in restaging with imaging and will discuss the role of MRI as well 
as other modalities such as EUS and PET/CT. 
Learning Objectives:
1. To understand how imaging can identify low and high risk groups of rectal 
cancer patients and how it may influence the treatment choice.
2. To understand the evidence for the use of EUS, CT, MRI and PET/CT in local 
and distant staging of rectal cancer.
3. To know the right MR protocol, typical MR features and pitfalls when 
interpreting MRI.
Panel discussion and case presentation 17:05 
16:00 - 17:30 Room D 
Abdominal and Gastrointestinal 
RC 1801 
Crohn’s disease: Techniques and results 
Moderator:
F. Maccioni; Rome/IT 
A‑466 16:00 
A. Role of US 
V. Válek; Brno/CZ (vlvalek@med.muni.cz) 
The ultrasound examination (US) we do without any preparation; it is not neces-
sary to be empty. We examine patients in supine position, first small bowel, then 
mesentery and large bowel. We complete the examination in some cases with 
the application of the intravenous contrast (CEUS). CEUS is a useful method to 
assess the therapeutic effectiveness of specific medical anti-inflammatory treat-
ment in patients with Crohn’s disease. Using high-resolution linear transducer 
mural perfusion, changes in active Crohn’s disease can be appreciated applying 
contrast harmonic imaging with quantitative time intensity curve analysis. This 
technique could be an effective dynamic imaging modality for diagnosis and espe-
cially follow-up examination to monitor treatment in CD. At least four studies have 
prospectively compared the diagnostic accuracy of US with radiological studies, 
endoscopy or surgery in suspected Crohn’s disease at diagnosis. In these studies, 
the sensitivity of US ranged between 84 and 90% and its specificity reached 98 and 
100%. In our prospective study, we compared 102 patients with Crohn´s disease. 
The activity of the disease was assessed correctly in 91% patients by ultrasound. 
In the largest series, the overall sensitivity of US was 93% and the specificity was 
97%. US reach highest sensitivity (95%) when the disease involved the terminal 
ileum. US compares very well with radiological techniques and surgery, mainly in 
the detection of strictures and abscesses, while for fistulas data are more conflicting 
and less satisfactory, with sensitivity values ranging from 50 to 87% and specificity 
values from 90 to 95%. 
Learning Objectives:
1. To describe the strategy of small bowel US in Crohn’s disease.
2. To present keys for diagnosis and follow-up of US in Crohn’s disease.
3. To discuss the pros and cons of US including CEUS in Crohn’s disease.
4. To discuss the accuracy, objectivity and usefulness of US in Crohn’s disease.
A‑467 16:30 
B. MRI and MR-related tools 
S. Gourtsoyianni; Iraklion/GR (sgty76@gmail.com) 
Over the years, several different oral contrast agents have been tested for luminal 
distention of small bowel when assessing Crohn‘s disease with MRI. For consis-
tency of imaging findings, accurate wall thickness measurements and depiction of 
even subtle changes of bowel mucosa, MR Enteroclysis (MRE) performed after 
duodenal intubation and administration of a maximum amount of 2 lt of contrast 
agent, while the patient is lying prone inside the MR scanner were performed with 
excellent results. MRI examination protocol should include true FISP and HASTE 
sequences for anatomical delineation of mesenteries and bowel as well as post 
gadolinium 2D/3D T1 weighted fat saturated sequences for lesion characterization, 
lymph node enhancement measurements and evaluation of bowel wall enhance-
ment pattern. Normal intestinal wall exhibits moderate homogeneous enhancement 
while abnormal wall presents either with multilayered, in case of active Crohn‘s 
disease, inhomogeneous-diffuse, in case of chronic inflammation and fibrosis, or 
homogeneous marked, enhancement pattern in case of moderate inflammation. 
With the utilization of various MR-related tools such as multiple contrast mechanisms 
and cine true FISP sequences, accurate disease subtype classification may be 
achieved based on morphology and motility imaging features. MRI not only allows 
demonstration of transmural nature of disease but also „sees“ beyond obstructed 
bowel loops in contrast to direct examination methods such as capsule endoscopy. 
Stenotic lesions may be further characterized since differentiation between edema 
and fibrosis is possible with T2 weighted images in which fibrosis presents with 
a typical low signal intensity appearance, while inflammation or edema presents 
with high signal intensity. 
Learning Objectives:
1. To describe an advanced comprehensive MR examination protocol for 
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2. To discuss the potential of MR enteroclysis in characterising and 
differentiating inflammation from fibrosis in assessing Crohn’s disease 
activity and in defining different disease subtypes.
3. To review strengths and weaknesses of the application of MRE in view of 
other direct and indirect sensitive techniques available.
A‑468 17:00 
C. CT vs MRI 
M.A. Patak; Berne/CH (michael.patak@insel.ch) 
The aim of this lecture is to give an overview of the techniques and typical findings 
for imaging Crohn’s disease (CD) with either multirow detector computed tomog-
raphy (MDCT) or with magnetic resonance imaging (MRI) and compare the two 
different modalities. Optimal imaging of CD begins with the preparation phase. The 
small bowel has to be distended for a concise examination. This can be done either 
invasively, i.e. enteroclysis or orally, which is named enterography. There is much 
debate on which of these two preparation methods is better. For the administered 
intraluminal contrast, the best is water with some additives, which are neutral in CT 
and biphasic in MR. Imaging in MDCT is done 40 and 70 sec after IV administration 
of iodinated contrast with a thin collimation. All image data are reconstructed in 
axial, coronal and sagittal planes. The aim of imaging in CD should be to establish 
the following: 1) presence, severity, and extent of the disease; 2) its activity; and 
3) extra-intestinal complications. Both modalities have proven to be a good tool to 
evaluate the extent, the activity of the disease and the presence of extraluminal 
complications. Both are also able to identify the type of the disease, being the ac-
tive/inflammatory, the fistulizing /perforating, the fibrostenosing or the reparative/
regenerative type. The challenge for MRI is mostly the in-plane resolution of the 
image data whereas radiation dose is for CT. 
Learning Objectives:
1. To describe the possible techniques of CT in Crohn’s disease.
2. To consider the pros and cons of CT and MRI in Crohn’s disease.
3. To compare the diagnostic accuracy of CT versus MRI in Crohn’s disease.
4. To determine the role of CT and MRI in the radiological work-up for Crohn’s 
disease.
16:00 - 17:30 Room E1 
Special Focus Session 
SF 18 
Renal cancer: Old problems, new solutions
Moderator:
A. Magnusson; Uppsala/SE 
A‑469 16:00 
Chairman’s introduction 
A. Magnusson; Uppsala/SE (anders.magnusson@radiol.uu.se) 
Not many years ago, renal cancer was detected on excretory urography as a 
space occupying lesion. The further diagnostic work up included a few tools, fluo-
roscopically guided biopsies and renal angiography. Most tumours were large and 
symptomatic; often patients presented with the classic triad, including haematuria, 
flank pain and a palpable mass. The only tool, which was available for treatment, 
was radical nephrectomy. Today, a majority of renal tumours detected are incidental 
tumours. This is due to the increasing use of modern imaging techniques, CT, MRI 
and ultrasound. An incidental tumour is, by definition, discovered when the patient 
is investigated for symptoms not related to a renal tumour, it is asymptomatic and 
generally small in size and localized. In parallel, the tools which are available for 
diagnosis and treatment has expanded, CT- or ultrasound guided biopsy, nephron-
sparing surgery, either open, laparoscopic or robotic and ablative therapies, cryo- or 
radiofrequency ablation. The incidence of renal cell cancer, especially small renal 
tumours, is increasing and survival is improving. With an increasing number of small 
renal tumours, many of them benign lesions, a number of questions are raised: 
When to biopsy and can we trust the result? Which therapeutic strategy should be 
chosen, surgery or ablation? Are we overtreating some patients, or maybe a larger 
number should simply be followed? 
Session Objectives:
1. To review the imaging of renal cancer and the impact of new imaging 
methods.
2. To learn about the new developments in the staging of renal cancer on both 
CT and MRI.
3. To review the role of RF ablation in comparison with other treatments.
A‑470 16:05 
MDCT of renal cancer 
A. Cieszanowski; Warsaw/PL (andrzej.cieszanowski@wum.edu.pl) 
The superb spatial resolution of MDCT has resulted in higher detection rate of renal 
masses and better visualization of their morphology. MDCT allows discrimination 
between most of benign and malignant renal tumors, although its ability for correct 
characterization of some lesions is still limited (i.e. oncocytoma, low-fat angiomyo-
lipoma, fat-containing RCC, solitary renal lymphoma, focal inflammation). Accord-
ing to a revised Bosniak classification, cystic lesions can be divided into 5 types: 
simple cysts (I), minimally complicated cysts (II), minimally complicated cysts that 
need follow-up (IIF), possibly malignant cysts (III), and definite cystic neoplasms 
(IV). MDCT allows depiction of detailed morphology of cystic lesions (i.e. density, 
contrast enhancement, septa, calcification), allowing correct classification in majority 
of the cases. Recent classification of renal cell carcinoma includes the following 
histological subtypes: conventional (clear cell), papillary, chromophobe and collect-
ing duct carcinoma (with renal medullary carcinoma variant). Hypovascular tumors 
(i.e. papillary RCC) have better prognosis than hypervascular lesions (i.e. clear cell 
RCC). Involvement of collecting system, along with infiltrative growth, suggests the 
diagnosis of collecting duct carcinoma, which carries the worst prognosis of all RCC 
subtypes. MDCT also enables accurate staging of RCC, which has consequences 
for prognosis and therapy. Evaluation includes tumor relation to perinephric tissues, 
venous structures, adrenal s, Gerota’s fascia, as well as, involvement of regional 
lymph nodes and distant metastases. 
Learning Objectives:
1. To discuss the characterisation of cystic renal masses by CT.
2. To learn about pathologic subtypes of renal cell carcinoma and correlate 
them with CT findings.
3. To review the staging of renal cell carcinoma with CT.
A‑471 16:30 
US and MRI 
N. Grenier; Bordeaux/FR (nicolas.grenier@chu‑bordeaux.fr) 
US and MRI are useful tools to help in characterizing solid and cystic renal tumors. 
The main advantage of these techniques is their sensitivity to light contrast enhance-
ment when subtle or localized. Papillary carcinomas are often hypoperfused requir-
ing contrast-enhanced MRI or US, with delayed images, to detect their enhancement 
making it possible to separate solid and cystic tumors. Diffusion-weighted MR 
sequences can also help for that purpose. In cystic masses, the same is true for 
detection of enhancement of small areas as septas, capsule and small nodules, 
with an impact on Bosniak classification. The main indications of these techniques 
in that field are 2 F and non-classified cystic lesions. MRI may also show the fat 
and lipid contents of solid tumors by using chemical shift-weighted sequences 
(in-phase and opposed-phase), mainly to separate angiomyolipomas with small 
fat content and renal cell carcinoma. Unfortunately, no reliable threshold is able to 
accurately separate these two entities yet. Renal staging can also be performed 
with MRI, but with little advantages, when compared to CT. 
Learning Objectives:
1. To learn how to distinguish benign and solid lesions.
2. To review the Bosniak classification as it pertains to US and MRI.
3. To review the staging of renal cancer with MRI.
A‑472 16:55 
Tumor ablation 
A. Adam; London/UK (andy.adam@kcl.ac.uk) 
Radiofrequency ablation (RFA) is increasingly being used to treat small renal tu-
mours in patients who are not candidates for surgery. The main indications are renal 
insufficiency, a single kidney, multiple tumours and hereditary conditions associated 
with renal neoplasms. The procedure is usually guided by CT or ultrasound imaging 
and is tolerated well in most patients. Follow-up is mainly by imaging, the immediate 
goal of which is to assess whether complete necrosis has been achieved. Ultra-
sound does not usually provide useful information, as the echogenicity of fibrosis 
and neoplastic tissue overlap. Contrast enhanced-MRI and contrast enhanced-CT 
are capable of demonstrating residual viable tumour requiring treatment. Effective 
ablation is achieved in approximately 90% of patients in a single session of therapy. 
However, tumours larger than 3 cm in diameter are more difficult to eradicate at the 
first attempt, often requiring a second RFA session. Combining RFA with percutane-
ous ethanol injection (PEI) increases the area of coagulation. RFA is particularly 
helpful in patients with solitary kidneys and impairment of renal function. In such 
patients, partial nephrectomy can lead to renal failure and the need for dialysis in 
up to 10% of patients. RFA enables most patients to be treated with minimal loss 
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of function and avoids the need for dialysis in the vast majority. Combined PEI and 
RFA is a safe and effective alternative treatment for patients with renal tumours 
and is likely to replace partial nephrectomy in many patients with small neoplasms. 
Learning Objectives:
1. To review technical challenges and criteria for patient selection.
2. To discuss methods and results of tumor ablation as well as various imaging 
problems that may be encountered in patients previously treated either by 
percutaneous methods or by partial surgery.
3. To describe and compare tumor ablation and nephron sparing surgery and 
discuss how best to follow-up patients.
Panel discussion:  
1. How should we image and stage the patient with suspected renal 
cancer? 2. Is tumor ablation here to stay? 17:20 
16:00 - 17:30 Room E2 
Interactive Teaching Session 
E³ 1820a 
Imaging in common clinical problems: Acute chest pain 
Moderator:
G.A. Krombach; Aachen/DE 
A‑473 16:00 
A. Cardiac 
A. de Roos; Leiden/NL (A.de_Roos@lumc.nl) 
Cardiac and pericardiac causes for acute chest pain will be reviewed as shown 
by MDCT and MRI. MDCT is well suited to evaluate coronary artery disease by 
demonstrating stenoses and plaques. The utility of MDCT for assessing myocardial 
perfusion is currently under development. MRI is well accepted for imaging of isch-
emia and infarction. Pericardial disease can be depicted by both MDCT and MRI. 
MDCT is the preferred first-line technique for evaluation of large vessel disease, 
especially in the acute setting. Gated MDCT is advocated for imaging aortic dissec-
tion, especially when the ascending aorta is involved. There is a broad differential 
diagnosis in the setting of acute chest pain. Many of the possible diagnoses can 
be assessed by cross-sectional imaging. The capabilities of MDCT and MRI are 
getting more and more similar. The indications for MDCT and MRI are dependent 
on diagnostic performance, availability, expertise and local preference. 
Learning Objectives:
1. To learn CT and MRI methods for cardiac imaging.
2. To learn indications for acute cardiac disease evaluation.
3. To review acute cardiac disease presentations.
A‑474 16:45 
B. Non-cardiac 
L.R. Goodman; Milwaukee, WI/US (lgoodman@mcw.edu) 
Acute chest pain, whether traumatic or non-traumatic, involves multiple organ 
systems including the thorax, the pleura, the lung, the mediastinum, the pulmonary 
vessels, and the upper abdomen. Interactive cases will stress the radiographic 
diagnosis of many of these diseases: how to determine whether additional imaging 
is needed, and if so, which images? As time is often the essence in these patients, 
imaging efficiency will be stressed. Basic clinical parameters, such as onset of 
pain, duration of pain, distribution of pain, etc. will be integrated into the diagnostic 
approach. The primary emphasis will be emergency room and outpatient problems 
but inpatient problems will also be included. 
Learning Objectives:
1. To learn CT and MRI methods for evaluating acute chest pain.
2. To understand the appropriate indications for CT and MRI.
3. To review the most common pathologies in acute chest pain.
16:00 - 17:30 Room F1 
Interactive Teaching Session 
E³ 1820b 
Imaging in common clinical problems: Jaundice 
Moderator:
C. Roche; Galway/IE 
A‑475 16:00 
Imaging in common clinical problems: Jaundice 
C. Matos1, C. Becker2; 1Brussels/BE, 2Geneva/CH (cmatos@ulb.ac.be) 
In this interactive session, the authors will conduct the audience through the differ-
ent questions a radiologist needs to answer to choose the appropriate combination 
of imaging techniques when evaluating a patient with jaundice. Different clinical 
scenarios will be illustrated emphasizing the different steps to make a differential 
diagnosis between benign and malignant causes of jaundice. Guidelines for a 
multidisciplinary approach will be provided according to the likelihood of bile duct 
obstruction, to the accuracy of non-invasive and of invasive imaging modalities and 
to the therapeutic options available. 
Learning Objectives:
1. To describe the imaging techniques used for investigating a patient with 
jaundice.
2. To discuss key points of interpretation of benign and malignant causes of 
jaundice.
3. To provide imaging guidelines for investigating a patient with jaundice.
16:00 - 17:30 Room F2 




E. Vaño; Madrid/ES 
A‑476 16:00 
Chairman’s introduction 
E. Vaño; Madrid/ES (eliseov@med.ucm.es) 
Radiological Protection (RP) is a key topic in the modern radiology. Ionizing 
radiations are used for most of the diagnostic and interventional procedures and 
radiologists and other health professionals involved in these techniques should 
know the radiological risks to be able to make a good balance between benefit 
and risk when deciding the appropriateness of the examinations (justification) and 
the best way to perform the procedure (optimization). Several European Directives 
deal with RP, but two of them have significant regulatory impact in radiology: 97/43/
Euratom (on RP of patients) and Directive 96/29/Euratom (on RP of professionals). 
These directives (together with others) are now in a process of simplification and 
updating by the European Commission (EC) (“recast” process) to follow the 2007 
Recommendations of the International Commission on Radiological Protection 
(ICRP) and other International Organizations. It is expected that the new directive 
on “Basic Safety Standards” will improve the RP aspects in medical exposures and 
this will mean a professional challenge for the European radiologists and allied 
professionals. During the last three years, the EC has promoted many meetings 
and workshops to discuss and receive inputs from the scientific societies and from 
the Member States on the benefits and inconveniences of the existing Directives, 
to have the opportunity to improve the legislation. Several research programmes 
in the area of radiology and contracts (including networking) to help in the applica-
tions of the Directives have been funded by the EC. Contacts with the ESR are 
considered relevant in this process. 
Session Objectives:
1. To underline the importance of radiation protection in diagnostic and 
interventional radiology.
2. To inform on the work made by the European Commission and other 
International Organisations to improve radiation safety in medical exposure.
3. To introduce the networking work on radiation protection promoted in Europe 
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A‑477 16:05 
New European Directive on basic safety standards 
E. Vaño; Madrid/ES (eliseov@med.ucm.es) 
Several European Directives dealing with radiation protection (RP) are in a process 
of simplification and updating by the European Commission. The new Directive 
called “Basic Safety Standards” will improve the RP aspects in medical exposures 
now regulated by the Directives 97/43/Euratom (for patients) and 96/29/Euratom 
(for public and workers). “Protection of patients and other individuals submitted 
to medical exposure” will be Title VIII of the new Directive. The “medico-legal” 
exposures, now called “Non Medical Imaging Exposure” will not be considered 
a medical exposure. The course on radiation protection in medical and dental 
schools will be mandatory. Procedures on asymptomatic individuals, for early 
detection of disease but not as part of a health screening programme, will require 
specific justification. The radiation detriment of the medical radiological staff will 
be considered during justification and optimization of medical exposures. The use 
of Diagnostic Reference Levels will be also required for interventional procedures. 
Patient dose information for practitioner will be mandatory for interventional and 
CT procedures. Other radiodiagnostic equipment shall also have this information 
after the publication of the directive. Patient radiation dose will be part of the clinical 
report on the examinations. A registration and analysis system of events involv-
ing or potentially involving accidental or unintended exposures will be mandatory. 
All these changes will require member states, the radiology community and the 
industry, to adapt national regulations, quality assurance programmes and X-ray 
systems, to the new requirements. The goal will be a high standard of radiation 
safety in the European radiology. 
Learning Objectives:
1. To know that a new European Directive including aspects of radiation safety 
in medical exposures is in progress.
2. To become familiar with the changes in the new Directive in comparison to 
the 97/43/EURATOM.
3. To appreciate the potential impact of the new Directive on radiation safety 
aspects for patients and professionals in diagnostic and interventional 
radiology.
A‑478 16:28  
EMAN - The European Medical ALARA Network 
P. Vock; Berne/CH (peter.vock@insel.ch) 
New ICRP recommendations, basic safety standards, European Directives and 
national regulations, in order to become effective for the patient, have to be applied 
by the medical practitioners (radiographers, radiologists, and other medical doc-
tors) during their daily work. Building up a sustainable network among the different 
stakeholders is, therefore, an important step for an open discussion and exchange 
between different professionals trying to apply the ALARA principle in medicine. 
Seven partner organizations - among them the European Society of Radiology 
(ESR) and the European Federation of Radiographer Societies (EFRS) - have 
jointly founded the EMAN consortium to support the EC in promoting radiation 
safety in medical diagnostics and intervention. During the 3-year project, two 
working groups will concentrate on CT and interventional radiology, respectively, 
the most critical sources of individual patient and occupational exposure. One 
working group will specifically analyze and act on X-ray applications outside the 
department of radiology where training has historically been less well established. 
Dissemination of information and coordination will be enhanced by the EMAN 
website and a steering committee. Towards the end of the project, a European 
EMAN workshop will summarize the results and present them to the profession, 
and in parallel measures will be taken to maintain a sustainable EMAN rendering 
services to the medical practitioners and bringing feedback and suggestions to the 
EC regarding radiation protection in medicine. 
Learning Objectives:
1. To understand the importance of building a network on radiation protection 
for radiologists and radiographers.
2. To know the effort made by the European Commission to promote radiation 
safety in diagnostic and interventional radiology.
3. To recognise the objectives and workplan of the medical ALARA network.
A‑479 16:51 
Radiation protection training and practice: Bridging the gap 
M.M. Rehani; Vienna/AT (m.rehani@iaea.org) 
Not even a week passes without a paper getting published in peer reviewed jour-
nals on radiation protection in imaging technologies. Few years ago, the change in 
technology was faster than adoption of radiation dose management but currently 
even the development of dose reduction techniques is faster than its adoption. 
International organizations are seized with this issue and are working to cope 
with this challenge. Conventional training methodologies that deal with principles 
are inadequate as people are looking for specific information delivered to them at 
their desk or home on periodic basis. The amount of information currently avail-
able through internet is leading to “information pollution” and professionals look for 
information from authentic sources. International organizations such as International 
Commission on Radiological Protection (ICRP) and International Atomic Energy 
Agency (IAEA) are rising to the occasion to attend to the need and fill the gap. ICRP 
is an independent body that provides recommendations on radiological protection. 
IAEA develops safety standards and applies them in member states. The talk, while 
presenting the need, is going to create awareness about information that is avail-
able from ICRP and IAEA, the experience gained in making vast training material 
developed in collaboration with International Society of Radiology (ISR), Interna-
tional Society of Radiographers & Radiological Technologists (ISRRT), International 
Organization of medical Physics (IOMP) and WHO available free through website 
(http://rpop.iaea.org) and through CDs containing power point slides, conventional 
training courses and sending focused and condensed information from professional 
societies and academic publications through monthly emails. 
Learning Objectives:
1. To understand the need for good knowledge of radiation protection (RP) 
principles in the practice of diagnostic and interventional radiology.
2. To know the existence of recommendations issued by the International 
Commission on Radiological Protection.
3. To highlight the role and the existence of websites and training material for 
RP produced by different scientific societies and international organisations.
Panel discussion:  
What do radiologists need to know about the new recommendations of the 
ICRP and the new European Directive? 17:14 
16:00 - 17:30 Room G/H 
Neuro 
RC 1811 
Basic MR spectroscopy 
Moderator:
K.‑O. Løvblad; Geneva/CH 
A‑480 16:00 
A. MRS in daily practice made easy 
A. Urbanik; Krakow/PL (aurbanik@mp.pl) 
The presentation includes a discussion of magnetic resonance proton spectroscopy 
(HMRS). It shows the methods for MR signal acquisition and its processing. It 
presents technical as well as clinical factors which impact the quality of. An analysis 
includes a normal brain spectrum, as well as the function of specific metabolites. 
It lists examples of HMRS application in clinical procedures. 
Learning Objectives:
1. To present normal spectrum of the brain and meaning of the particular 
metabolites.
2. To explain the technical requirements and possibilities of MR spectroscopy 
of the brain.
3. To present the most common applications of MR spectroscopy of the brain.
A‑481 16:30 
B. MRS in metabolic CNS disorders 
P.C. Maly Sundgren; Lund/SE (pia.sundgren@med.lu.se) 
Neuroimaging might play an important role in the timely diagnosis of metabolic 
disorders and in some disease be helpful in therapeutic decision making such as ad-
renoleukodystrophy (ALD). Combined with conventional MRI, magnetic resonance 
spectroscopy (MRS) adds additional information and is considered helpful for the 
final diagnosis of some metabolic disorders. The interpretation of MR spectroscopy 
in children must be done with judgment. A range of factors can influence the profile of 
1H-MR spectrum including magnetic field uniformity, poor shimming that may result 
in reduced resolution, broadening of resonances and distorting metabolic ratios to 
inter-patient variability due to age and development. Relative ratios of detectable 
metabolites and the detection of metabolites normally not present in the pediatric 
spectral profile have shown to be valuable in the evaluation and work-up of metabolic 
disorders in children. For example, an abnormal elevation of NAA is classically seen 
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Therefore, electrocardiogram (ECG)-gated CT acquisitions are recommended for 
evaluation of AD, to eliminate the influence of motion artifact by cardiac pulsation. 
Furthermore, in ECG-gated CT acquisition, it is possible to obtain volume data at 
any cardiac phase and in four-dimensional images and, therefore, it is possible to 
differentiate between pulsating type and static type dissection; this evaluation is 
important because allows to show aortic motion and reduction of elasticity. Both 
of the phenomena lead to an increase of vessel wall shear stress, which is in turn 
considered to be the underlying biomechanical factor for intimal detachment and 
chronic aortic expansion. 
Learning Objectives:
1. To review the current classification of aortic dissections and their variants.
2. To learn about the respective roles of MRA and CTA.
3. To learn how to differentiate between dynamic and static dissection.
A‑484 16:30 
B. Imaging requirements prior to endovascular aneurysm repair 
T. Pfammatter; Zurich/CH 
While ten years ago endovascular aortic treatment planning relied on a combina-
tion of measuring catheter angiography and axial CT- or MR- images, nowadays 
multi-detector CT angiography (MDCT) is the default modality before treatment of 
both acute and chronic aortic conditions. MRA is a valuable alternative particularly 
for younger patients in order to reduce the cumulative radiation exposure as a fair 
number of these patients will require long-term postoperative imaging follow-up. 
As associated aortic pathologies occur in up to 25% of patients therefore the entire 
aorta, in addition to the iliac and femoral access arteries have to be included in 
the imaging volume. For diseases affecting the thoracic aorta the brachiocephalic 
branches (internal carotid disease, vertebral arteries before over-stentgrafting of 
left subclavian artery) have also to be imaged. Preoperative protocol generally 
include nonenhanced and first-pass arterial scans. 2D and 3D post processing 
algorithms such as multiplanar reformation (MPR), maximum intensity projections 
(MIP) and semi-automated center-line measurements on curved planar reforma-
tions allow anatomical patient selection for endovascular treatment and the choice 
of the appropriate stent-graft. Due to accordion and bow redundancy the in-situ 
length of the stentgraft tends to be underestimated on center-line measurements 
particularly in tortuous aortas or large aneurysms. Diameters, tortuosity and extent 
of calcification determine the choice of the insertion access. Evaluation of length, 
configuration and morphology of the stentgraft landing zones is very important as 
stent-graft fixation is crucial for short- and long-term exclusion of an aneurysm. 
Clinical relevance of time-resolved data acquisition (dynamic imaging, 4D-imaging) 
for endovascular treatment planning has not been proven yet. Automated mathemati-
cal analysis of CT data has been shown to be reliable for complex endovascular 
reconstructions (side-branched stent-grafts) and is likely to be adopted for these 
cases in the near future. 
Learning Objectives:
1. To learn about optimised imaging strategies prior to endovascular aortic 
aneurysm repair.
2. To become familiar with specific diagnostic requirements for treatment 
planning.
3. To discuss prognostic factors for successful endovascular aortic aneurysm 
repair.
A‑485 17:00 
C. Detection of complications after aortic stent grafting 
E. Brountzos; Athens/GR (ebrountz@med.uoa.gr) 
Lifelong surveillance after EVAR is recommended using imaging, focusing on 
three parameters: aortic diameter, endoleaks, and endograft’s integrity. The ideal 
follow-up modality should be inexpensive, widely available, reproducible, accurate, 
and without radiation exposure. Contrast medium-enhanced multidetector computer 
tomography angiography (MDCTA) is the most established follow-up modality for 
EVAR patients. The AAA diameter can be measured with 100% sensitivity and 
specificity, while MDCTA has a 92% sensitivity and 90% specificity for endoleak 
detection. Biphasic CTA is the most widely used technique, but there is no universal 
agreement on the ideal protocol. Magnetic resonance angiography (MRA) has 
a role in young patients. Aortic diameter measurement and endoleak detection 
are very accurate using MRA. MRA however, is not applicable for stainless steel 
endografts. Radiographs can detect structural abnormalities of the endograft. 
However, CTA can also provide sufficient information regarding the integrity of the 
endograft. Color Doppler ultrasonography (CDUS) performs poorly in the detec-
tion of endoleaks: pooled sensitivity rates were 66-69%. The recent introduction of 
contrast enhanced US (CEUS) significantly improved the detection of endoleaks: 
sensitivity (97.5 vs 62.5%), and specificity (81.8 vs 63.6%). Investigators have 
in Canavan’s disease, the absence or significant reduction of the creatine peak is 
the hallmark for different creatine deficiency diseases and a detectable presence 
of lactate in the basal ganglia supports the clinical and laboratory diagnosis of a 
mitochondrial disorder. The purpose of the present lecture is to describe the current 
MR spectroscopy techniques for evaluation of metabolic disorders, emphasizing 
key pathological metabolic spectra and typical brain MRI findings that can help 
in the diagnosis of some of the more common metabolic diseases, and to outline 
the strengths, weakness and applications of MR spectroscopy in the work-up and 
diagnosis of metabolic disorders. 
Learning Objectives:
1. To learn the imaging protocol for MRS in the study of metabolic disorders.
2. To discuss the clinical features of neurometabolic disease.
3. To discuss the MRS features of these disorders.
4. To discuss the differential diagnosis.
A‑482 17:00 
C. MRS in brain tumors 
M. Essig; Heidelberg/DE (m.essig@dkfz‑heidelberg.de) 
Proton magnetic resonance spectroscopy (MRS) and spectroscopic imaging (CSI) 
are becoming common clinical tools in neurooncology since they allow for functional 
tissue information. Spectroscopic characterization of brain abnormalities has relied 
mostly on the calculations of ratios between the main proton spectrum metabolites, 
notably N-acetylaspartate (NAA), a neuronal marker, choline-containing compounds 
(Cho), a marker of membrane turnover, and creatine-phosphocreatine (Cr), and 
on the presence of lipids and lactate. Brain tumors typically present with a loss of 
NAA and an increase in the Cho content. MRS has also been used to differentiate 
non-tumoral lesions like hamartomas from gliomas and to assess the grade and 
aggressiveness of a tumor. In several studies, it has been reported that hamartomas 
did not differ significantly from the normal brain, while gliomas had lower NAA/Cr, 
Cr/Cho, and NAA/Cho ratios. Follow-up assessment of cerebral tumors is another 
promising field for MRS and CSI. Increase in size and enhancement are typical 
findings for progression but also reflect therapy induced changes. Both techniques 
provide supplementary information about the possible extent and nature of changes 
on a routine MRI scan by analyzing the presence and/or ratio of the tissue metabo-
lites NAA, creatine, choline, and lactate. The ratio of choline to normal creatine 
level usually is significantly elevated in those areas consistent with tumor compared 
with those containing predominantly treatment effect. In fact, treatment effect is 
generally indicated by a marked depression of all the intracellular metabolites. CSI 
proved to be helpful in mixed histologic findings comprised of necrosis and tumor. 
Learning Objectives:
1. To present normal and tumorous spectra of the brain.
2. To learn how to use MR spectroscopy in the differential diagnostics of brain 
tumors.
3. To learn how MR spectroscopy can help to distinguish tumor progression or 
recurrence from therapy induced changes.





W. Cwikiel; Ann Arbor, MI/US 
A‑483 16:00 
A. Aortic dissections: New insights into an old disease 
F. De Cobelli; Milan/IT (francesco.decobelli@hsr.it) 
Aortic dissection (AD) is an emergency, critical and life-threatening disease. The 
mortality of this condition is high, with major complications including rupture and 
end-organ ischemia. The estimated mortality increases at the rate of 1% per 
hour once the diagnosis of aortic dissection is made. The DeBakey and Stanford 
classifications are usually adopted by radiologists to accurately classify AD using 
computed tomography (CT) or magnetic resonance imaging and angiography 
(MRI and MRA) and to indicate the appropriate therapeutic treatment. Both im-
aging techniques have different advantages and drawbacks in the evaluation of 
aortic dissection: usually, multidetector-CT is the preferable imaging technique in 
emergency condition such as in case of ascending aorta dissection. However, CT, 
usually involve acquisition of static images. Motion artifacts of ascending aorta itself 
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Learning Objectives:
1. To learn how to integrate teaching files into PACS (e.g. IHE TCE).
2. To know about differences in eLearning tools.
3. To know why structured reporting is important regarding eLearning.
A‑488 17:00 
C. What radiologists should know about the use of PACS in surgical 
procedures 
E. Neri; Pisa/IT (neri@med.unipi.it) 
Surgical procedures are more and more dependent on a deep pre-operative imaging 
assessment, and it is particularly evident in the planning of a minimally invasive 
surgical interventions. PACS (Picture Archiving and Communication System), de-
veloped in the Radiology Department, represents the natural working environment 
of the radiologist, but the strong demand of surgeons to access images for treat-
ment planning is pushing radiology to develop the proper image sharing strategies. 
Radiologists should be aware about which images are required to plan the surgical 
procedure (non-contrast, contrast-enhanced, arterial, portal phase or both), how 
many images (full datasets or only those obtained at the level of the surgical field?), 
how to provide the datasets (CDs, network) and finally they should know how to 
structure the report in the prevision of a surgical procedure. Do radiologists have 
enough knowledge about the above issues to be effective in the surgical planning? 
Probably most of them know the surgical demand, but are not yet aware about how 
to provide the information required. The presentation is aimed to cover these issues 
and provide to the radiologist an update on the surgical planning tools. 
Learning Objectives:
1. To learn about developments in planning therapy with imaging.
2. To know how these developments change PACS evolution.
3. To learn about consequences for diagnostic imaging.
4. To be familiar with the different therapeutic applications (e.g. planning, 
volumetry, registration, guidance, robotics, ...).
16:00 - 17:30 Room L/M 
Radiology of the Spine in 2010 
CC 1816 
Spinal intervention: A new level of success 
Moderator:
M. Serrallonga; Barcelona/ES 
A‑489 16:00 
A. Image-guided pain management 
B.A. Johnson; Minneapolis, MN/US (bjohnson@cdirad.com) 
Neck and back pain represents one of the most common and costly medical 
problems affecting developed nations. For example, low back pain currently affects 
up to 40% of adults in Western Europe, resulting in massive medical costs and 
lost productivity. Evaluating and treating these patients is challenging, due to the 
presence of a number of potential pain generators in the spine, multiple levels that 
can be responsible for pain, and the overlap of clinical symptoms that result from 
the various structures in the spine. The facet joints, vertebral bodies, nerve roots 
and local nociceptors represent potential sources of pain. The clinical evaluation of 
potential pain generators is mostly using physiologic tests to selectively anesthetize 
specific structures. A comprehensive history, targeted physical exam, and imaging 
studies help determine which structures are the best candidates for testing. In this 
session, we will review techniques for evaluating and treating spine-origin pain. 
Several techniques for the assessment and treatment of specific pathologic condi-
tions affecting the spine will be reviewed as an introduction to dedicated lectures 
on cement augmentation and other interventions. The benefits and disadvantages 
of these procedures will also be reviewed, in addition to the expanding role of 
neuroradiologists in pain management. 
Learning Objectives:
1. To understand the etiology and pathophysiology of spine-origin pain.
2. To review indications for image-guided, minimally invasive spine procedures.
3. To learn about equipment, materials and techniques utilised for spine 
procedures.
already suggested substituting CTA with CEUS for patients with low likelihood for 
complications. Current strategies and modalities for the follow-up of the patients 
after EVAR are far from satisfactory. The medical community is still on an ongoing 
quest for the ideal follow-up method. 
Learning Objectives:
1. To learn about typical findings after aortic stent grafting.
2. To become familiar with typical imaging pitfalls.
3. To learn about the most common complications.





J. Chabriais; Aurillac/FR 
A‑486 16:00  
A. How to improve PACS with open source software 
O. Ratib; Geneva/CH 
Open source software is a new paradigm in software development that has proven 
to be cost effective and successful in many general applications (Linux, Firefox, 
Joomla, etc). It is now penetrating vertical markets such as medical applications, 
and that is changing all the rules. It is particularly promising in advanced image 
display and analysis applications where the rapid increase in demand cannot be 
matched by traditional expensive commercial solutions. The evolution of radiology 
imaging modalities from 2D sectional acquisition to a 3D volumetric acquisition and 
even higher dimensions with functional data and the emergence of multimodality 
scanners such as PET/CT scanners calls for new and innovative display and visu-
alization tools. By combining multiple new technologies and open-source projects, 
it is today possible to develop a new generation of high-performance 3D DICOM 
viewers for personal computers. These 3D visualization tools were traditionally 
only accessible on expensive 3D workstations restricting their use to specialist 
radiologists. An example of such an Open Source project is the OSIRIX software 
for multimodality image analysis and processing. It provides the necessary tools for 
navigating and processing very large datasets of multimodality imaging. It can be 
implemented outside radiology departments and provide a solution for increasing 
needs and requirements of clinicians, surgeons and other specialists. It can also 
be easily integrated with existing PACS and RIS legacy systems. Open source 
component can provide cost effective and efficient ways for deploying advanced 
PACS workstations outside radiology in specialized clinical wards and conference 
rooms in large academic hospitals. 
Learning Objectives:
1. To learn why proprietary PACS solutions have advantages and restrictions.
2. To know how open source solutions could be implemented in PACS 
environment.
3. To learn about specific open source tools.
4. To understand legal aspects in clinical applications of open source software.
A‑487 16:30  
B. How PACS is useful for eLearning 
P. Pokieser; Vienna/AT (peter.pokieser@meduniwien.ac.at) 
The term “eLearning” includes all forms of learning, where digital media or com-
munication tools are involved in the presentation, distribution or communication of 
learning content. To be familiar with the spectrum of eLearning strategies enhanc-
ing radiological education with PACS, didactic basics of modern eLearning will 
be presented. A modern PACS without any additional tools can be used for many 
excellent eLearning strategies. Although, there are many different tools available, 
providing useful features for dedicated use. The lecture will focus on the integration 
of teaching files into PACS, explaining the use of IHE related tools (TCE), promising 
interoperability for sharing cases with other institutions. An overview of other useful 
features and some representative tools as examples will be discussed. One of the 
most important tasks of clinical radiology is the written report of a study. The various 
images and series of a study combined with a written report are the most fruitful 
basis for cultivating case based radiological eLearning. Structured reporting does 
not only facilitate communication of reports in daily routine; furthermore, it helps 
to transform routine work into teaching files easily. An example of a pertinent work 
flow will be presented; a demonstration of case series can be tested by participants 
of the ECR 2010 at the ePACS booth. 
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16:00 - 17:30 Room N/O 
Head and Neck 
RC 1808 
Reporting and staging head and neck tumors 
Moderator:
S.J. Golding; Oxford/UK 
A‑492 16:00 
A. Paranasal sinuses 
D. Farina; Brescia/IT (nappaje@yahoo.it) 
Sinonasal neoplasms encompass a large number of different histotypes, thus, 
accounting for the peculiar density of anatomical structures and tissues present 
in this restricted area. Adenocarcinoma, squamous cell carcinoma and olfactory 
neuroblastoma are more frequent, with the maxillary sinus (about 80%) largely 
prevailing on the ethmoid as the site of origin. MRI is generally regarded as the best 
imaging modality for its high contrast resolution. Characterization of the lesion is 
beyond the scope of imaging as substantial overlapping between different histotypes 
exists; yet, MRI proves helpful in separating the lesion from retained inflammatory 
secretions in blocked sinus cavities. Different TNM classifications are applied to 
maxillary sinus and nasal cavity/ethmoid tumors. Beyond TNM, correct treatment 
planning requires precise assessment of tumor spread towards three crucial areas, 
i.e. orbit, anterior cranial fossa and pterygopalatine fossa/masticator space. More-
over, detection of perineural spread is essential as this pattern of tumor growth can 
be clinically unsuspected whilst it conveys the tumor cells beyond the surgical and 
radiation fields of treatment. Thus, the FOV of any MRI study should encompass 
the cavernous sinus and Meckel’s cave and, if necessary - as may be the case in 
adenoid cystic carcinoma - follow perineural spread even further. Neck nodes are 
not routinely studied in sinonasal tumors although this issue needs thorough care 
when tumor extends to the skin or posteriorly to the pharynx. 
Learning Objectives:
1. To review the most common sinonasal malignancies.
2. To become familiar with the TNM staging of sinonasal neoplasms.
3. To understand the role of imaging in treatment planning.
4. To learn how to issue a valuable report.
A‑493 16:30 
B. Oral cavity 
F.A. Pameijer; Utrecht/NL (f.a.pameijer@umcutrecht.nl) 
Head and neck cancer commonly originates from the oral cavity as well as from 
the oropharynx. As in most head and neck sites, squamous cell carcinoma is by far 
the most prevalent histology. Correct pretherapeutic TNM-staging is an important 
factor in the treatment planning of oropharyngeal neoplasms. This is a multidisci-
plinary effort. While the otolaryngologist uses endoscopy to evaluate the mucosal 
surface, it is the radiologist’s role to show the deep extent of a lesion. CT or MRI 
has become essential for pre-therapeutic staging of oropharyngeal tumors. In this 
era of cost concern, it seems to be a good principle to do one cross-sectional study 
that accurately answers the clinical questions. The relative value of CT and MRI in 
this aspect will be discussed. To be an effective consultant, the radiologist’s report 
should contain information needed by the surgeon. To supply this information, it is 
helpful if the radiologist is aware of the spread patterns observed in oral cancer. The 
typical spread patterns from the various subsites in the oral cavity will be shown. 
Based on the imaging finding, it is (usually) possible to conclude the report with 
a ‘radiological’ TN (M)-stage. This approach will be demonstrated using clinical 
examples from daily practice. 
Learning Objectives:
1. To become familiar with the TNM staging of SCC.
2. To understand the advantages and limitations of available imaging 
techniques.
3. To learn what the surgeon needs to know for preoperative planning.
4. To provide a template for a valuable imaging report.
A‑494 17:00 
C. Larynx 
A.D. King; Hong Kong/CN (king2015@cuhk.edu.hk) 
Primary tumour (T Stage): MRI or CT is used to stage the primary; in general, MRI 
is slightly more sensitive to tumour spread but less specific and more likely to be 
degraded by motion. Mucosal tumour extent in the supraglottis, glottis and subglottis 
A‑490 16:30 
B. Cement augmentation: Patient and treatment selection 
G.H. Zoarski; Baltimore, MD/US (gzoarski@umm.edu) 
Appropriate patient selection is essential in achieving clinical success in perform-
ing any type of percutaneous vertebral augmentation. The primary indication for 
treatment is pain associated with a vertebral compression fracture caused by 
osteoporosis, hemangioma, or tumor invasion. Some argue that there may be a 
role for prophylactic treatment in patients at extremely high risk for compression 
fracture (e.g. patients with kyphosis due to prior osteoporotic compression fractures, 
or patients on chronic steroid treatment with sentinel pain or imaging findings). 
Prophylaxis, however, is not a generally accepted indication for vertebroplasty, and 
no controlled studies have been undertaken to substantiate the utility of performing 
vertebroplasty for prophylaxis. Best success is generally achieved with patients in 
whom pain and tenderness on palpation is localized to the level of radiographic 
compression fracture. In early published and unpublished treatment series, most 
patients had been allowed to fail conventional medical therapy of analgesics and 
bed rest prior to treatment. More recent series have advocated treatment as early 
as a few weeks, and even within days of the acute event. Late treatment (greater 
than six months) is less likely to be successful in relieving pain; however, numerous 
investigators have anecdotally reported symptomatic improvement with vertebral 
augmentation performed even years after the initial injury. 
Learning Objectives:
1. To learn about the benefits and risks of spinal height restoration.
2. To review the experience with cement augmentation.
3. To describe a safe approach for cement delivery systems into vertebral 
bodies.
A‑491 17:00 
C. Spinal interventions beyond vertebroplasty 
A. Gangi; Strasbourg/FR (gangi@rad6.u‑strasbg.fr) 
Interventional procedures of spine are performed under fluoroscopic, CT and MRI 
guidance. A combination of CT and fluoroscopy has been established in difficult 
spinal procedures. The MR imaging is used more and more in spinal interventions 
with the great advantage of absence of radiation, capacity of thermal monitoring, 
real time imaging, and multiplan capability. Spinal biopsy: biopsy of spinal lesions 
is one of the major indications in skeletal interventional radiology. Therapeutic joint 
injection: facet-joint injection in lumbar spine is a simple and safe procedure. Perira-
dicular infiltration consists of an injection of steroids and anaesthetic into the epidural 
space at the level of the pathological disk. Percutaneous laser and radiofrequency 
(RF) disk decompression: percutaneous laser and RF disk decompression are 
used to treat patients with radiculalgia caused by disk herniations. Percutaneous 
management of bone tumours: percutaneous thermal ablation of spinal tumours 
with radiofrequency, laser, and cryoablation is an efficient technique for ablation. 
The major indication is palliative treatment of spinal metastases and pain manage-
ment. Curative ablation is performed in some selected cases. Thermal ablation of 
bone metastases is promising in pain management. Osteoid osteoma is a benign 
neoplasm of bone. Curative treatment of these tumours by thermal ablation is well 
established and considered as standard treatment of this tumour. The interventional 
radiologist with an efficient imaging guided technique can increase the precision 
of the above described procedures allowing an improvement of the results and 
reduction of the complications. A multidisciplinary team work is mandatory for a 
successful practice. 
Learning Objectives:
1. To present an update of spinal interventions.
2. To understand the technique and the mechanism of action of percutaneous 
spinal tumor management.
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management of cancer patients, imaging pitfalls must be recognized to avoid both 
false-positive and false-negative interpretation. The principles and good practices 
of PET/CT will be explained. Normal distribution of FDG, pitfalls and normal vari-
ants will be presented. Specific examples will be discussed to demonstrate how 
the combined information of images of human anatomy upon which biological 
information within body structures is added improves delineation of disease, can 
guide surgical and radiation planning and biopsy. Advances in technology result in 
new training requirements for radiologists who should promote close collaboration 
with nuclear medicine specialists. 
Learning Objectives:
1. To understand how the combination of functional and morphologic data 
provides added-value, helping patient management.
2. To learn the common pitfalls important for PET/CT interpretation in lung 
cancer.
3. To emphasise the importance of a strong collaboration between nuclear 
medicine specialists and radiologists.
A‑497 17:00 
C. Radiofrequency ablation of NSCLC: Current status 
T. de Baère; Villejuif/FR (debaere@igr.fr) 
RFA provides 70 - 90% of complete ablation in small size lung tumors. The rate of 
complete ablation at 2 years for tumors less than 2 cm is 80 to 90% in most reports. 
The rate of complete ablation is highly dependent on the volume of ablation relative 
to the tumor. In 75 primary stage I NSCLC median survival was 29 months, with 
78, 36, and 27% at 1, 3, and 5 years, respectively. Better survival was reported 
for tumors 3 cm or smaller with a survival rate close to 50% at 5 years. Radiation 
therapy combined with RFA in 41 NSCLCC patients improved with 57% survival 
at 3 years. The survival was 34.6 ± 7 months for tumors > 3 cm and 44.4 ± 5.4 
months when ≤3 cm. CT follow-up induced some delayed discovery of incomplete 
treatment, 4 to 12 months (mean±SD = 7.66 ±2.77) after RFA in our experience. 
PET/CT appears promising to provide early evaluation of treatment response but 
timing of PET after ablation is a key factor because G6PD uptake is highly increased 
1 to 3 weeks after ablation with an SUV ratio of 5 and higher between RF ablation 
zone to muscle. After RFA, there is no changes in post-ablation respiratory test 
and, consequently, a major benefit of lung RFA to treatment of NSCLC is that it 
allows curative treatment in non-surgical early NSCLC. Moreover, this excellent 
tolerance allows safe treatment of single lung patients. 
Learning Objectives:
1. To be able to define the best candidates for lung radiofrequency ablation.
2. To know the results of radiofrequency ablation for primary tumours and lung 
metastases.
3. To know different imaging patterns of a radiofrequency ablated tumor.
16:00 - 17:30 Room Q 
Organs from A to Z: Liver 
MC 1819 
Liver tumors and management 
Moderator:
P.L. Pereira; Heilbronn/DE 
A‑498 16:00 
A. Liver metastases 
A. Palkó; Szeged/HU (palkoand@gmail.com) 
Metastasis is the spread of tumor cells via the lymph, blood, or body cavities to near 
or distant sites where new secondary tumors are formed. Most patients succumb to 
their metastatic disease; therefore, controlling the spread and growth of malignant 
cells at metastatic sites is an important challenge. Liver is the parenchymal organ 
most often affected by metastases, not only because of its rich, dual blood sup-
ply but also because of humoral factors that promote cell growth. Most common 
primary tumor sites are the colon, stomach, pancreas, breast and lung. 90% of the 
metastases are multifocal and can occur anywhere in the liver, their size ranges 
from macromorphologically undetectable seeds to several centimeters. Beyond this, 
the appearance of metastases depends on their homogeneity, vascularity, shape, 
contour, age of the filiae (presence and age of degenerative changes: necrosis, 
bleeding, calcification, scars) and tumour border (liver tissue surrounding the 
metastasis with compression, desmoplastic reaction, inflammatory changes). The 
role and responsibility of imaging diagnosis in detecting and characterizing these 
lesions is paramount. The task of this presentation is to summarize the techniques 
is assessed endoscopically (T1 and T2), aided by imaging in the subglottis. Deep 
tumour invasion into the pre and para-epiglottic spaces (T3), Extralaryngeal sites 
(T4) and cartilage (T3 or T4) is assessed by imaging. Treatment options vary widely 
and so the lecture will highlight some of the more important clinical implications of 
tumour spread into these (SPEC) sites. Nodal metastases (N Stage): Nodes are 
imaged by MRI or CT (according to modality for the primary) and may be supple-
mented by ultrasound. The sites of nodal spread are dependent on the primary 
tumour, being more common in supraglottic or deeply invasive tumours, and rare 
in early glottic tumours. Imaging identifies metastatic nodes and then stages the 
disease (single node ≤ 3 cm = N1, any node > 6 cm = N3, other combinations = 
N2). Patients without nodes (N0) who are candidates for surgery may undergo less 
extensive neck dissection or, in very selective cases, a conservative management 
approach. Distant metastases (M Stage). Distant metastases (M1) are uncommon 
in laryngeal cancer, patients being at greater risk from second primaries (espe-
cially lung). Chest radiograph is performed in all patients and thoracic CT in those 
at high risk. The role of FDG PET in distant metastases and second primaries is 
under investigation. 
Learning Objectives:
1. To become familiar with the TNM staging of laryngeal SCC.
2. To recognise the best imaging modality for staging.
3. To understand the required information to decide upon the best treatment 
option.
4. To provide a template for a valuable imaging report.
16:00 - 17:30 Room P 
Chest 
RC 1804 
Non-small cell lung cancer 
Moderator:
C.K. Atasoy; Ankara/TR 
A‑495 16:00 
A. Update in TNM classification 
S. Diederich; Düsseldorf/DE (s.diederich@marien‑hospital.de) 
The aim of precisely staging lung cancer with imaging techniques is to allow se-
lection of the optimum therapeutic strategy and avoid unnecessary therapies that 
cause harm to the patient or cost to the health system. As many other malignancies, 
lung cancer staging is performed using the T (Tumor)-, N (Node)- and M (Metas-
tasis)- classification to describe local tumor extent and the presence or absence 
of lymphatic or haematogenous metastases. According to potential therapeutic 
strategies, different combinations of TNM-categories are grouped in stages (stage 
I -IV). Radical surgery - if possible - is most likely to result in cure of the disease. 
Therefore, separation of resectable versus unresectable tumor manifestations by 
means of imaging studies is of utmost importance in order not to deny a potentially 
lifesaving operation to a resectable patient and simultaneously avoid unnecessary 
surgery in an unresectable patient. Using analysis of outcome in patients with dif-
ferent T-, N- and M-stages, the previous staging system has been modified recently. 
The aim of this course is to present the current staging system and give examples 
of different stages at imaging. 
Learning Objectives:
1. To understand the principles of T-, N- and M-classification in lung cancer.
2. To understand the effect on therapeutic strategies and prognosis of different 
tumor stages.
3. To understand the recent changes in the TNM-staging system in lung cancer.
A‑496 16:30 
B. PET/CT in lung cancer 
N. Howarth; Chêne‑Bougeries/CH (nigel.howarth@grangettes.ch) 
Integrated PET/CT imaging has an established role in the management of cancer 
patients and is now recommended for all patients with curative non-small cell 
lung cancer. PET/CT provides information essential for staging and prognosis, 
for choice of management and monitoring of treatment and for the detection of 
recurrence. Recent technical developments in PET/CT permit rapid examinations 
with improved resolution. Compared with standard CT or stand-alone PET, the 
added value of fused imaging is uncontested. The clinical influence of preoperative 
PET/CT is currently undergoing extensive evaluation. Radiologists should benefit 
from an understanding of important aspects of molecular imaging to improve their 
contribution to patient management. With the increasing use of PET/CT in the 
Postgraduate Educational Programme
S126 A B C D E F G
Learning Objectives:
1. To understand why tumor response evaluation is critical for the treatment 
strategy and to learn the different imaging criteria provided by international 
recommendations.
2. To understand which criteria are adapted for the evaluation of tumor 
response after ablation.
3. To learn about the latest developments in imaging assessment of tumor 
response.
and diagnostic algorithm of imaging modalities (with particular emphasize on the 
use of special MRI techniques), and to identify the typical imaging findings, but 
also the differential diagnostic difficulties encountered during the everyday activity 
of radiologists. 
Learning Objectives:
1. To understand the different consequences of the onset of liver metastases 
according to cancer type and clinical situations.
2. To appreciate the role of different imaging modalities and their respective 
accuracy for detection and characterisation.
3. To learn about the imaging criteria for assessing the response to systemic 
chemotherapies.
A‑499 16:30 
B. Staging of liver tumors and treatment planning: When and how to treat 
A.R. Gillams; London/UK (alliesorting@googlemail.com) 
The choice of therapy depends on tumour type, the number, size, location and 
distribution of liver tumours, the status of the background liver parenchyma, the 
patients overall status and the extent of disease elsewhere. Percutaneous ablation 
is indicated in patients with limited numbers of small-moderate sized tumours typi-
cally < 5 metastases, < 5 cm in diameter or in cirrhosis, 3 HCC nodules, < 3 cm 
or < 5 cm solitary HCC. In indolent neuroendocrine tumours, larger numbers of 
smaller tumours can be treated at sequential sessions. Ablation can be used in 
most parts of the liver, if appropriate imaging guidance is available. Vulnerable 
structures must be displaced away from the ablation to prevent collateral damage. 
Lesions next to the common bile duct should only be treated during intraductal 
cooling. Radiofrequency ablation is superior to percutaneous ethanol injection with 
the exception of exophytic HCC. In breast cancer, it is acceptable to treat patients 
with controlled extra-hepatic disease but generally, the best results are achieved 
in patients with liver-only disease. Percutaneous ablation is minimally invasive 
and well tolerated even in patients who are not sufficiently fit to undergo surgery. 
Percutaneous ablation is readily combined with other treatments e.g. resection 
or cyberknife. Chemoembolisation has a long track record in HCC and has been 
shown to improve survival in meta-analyses. Generally, chemoembolisation is used 
in conjunction with ablation or in patients who cannot undergo ablation. Chemo-
therapy is used to downsize patients who are not initially suitable for ablation or 
as an adjunctive treatment. 
Learning Objectives:
1. To learn about the spectrum of treatment options in liver tumors.
2. To appreciate the importance of tumor characteristics and spread for 
selecting the suitable treatment.
3. To understand indications, contraindications, and complications of intra-
arterial and percutaneous interventions in the treatment of primary and 
metastatic liver tumors.
A‑500 17:00 
C. Evaluation of tumor response to treatment 
T.K. Helmberger; Munich/DE (thomas.helmberger@kh‑bogenhausen.de) 
Staging and re-staging before and after therapy in malignancies are integral and 
crucial components of the comprehensive diagnostic and therapeutical concept 
of tumour treatment. For assessing tumor response to treatment, the WHO had 
established guidelines which were transformed in a more simplified evaluation 
system, the Response Evaluation Criteria in Solid Tumours (RECIST) now avail-
able in the even more simplified version 1.1. These criteria, which are primarily 
based on gathering data of presence and size of malignant lesions, are applied 
widely in oncology, and maybe reasonably meet the needs in follow-up of chemo-
therapy. However, with the advent and increasingly widespread use of multimodal 
therapy regimens including the huge variety of minimal invasive procedures and 
biologicals RECIST alone is not sufficient for evaluating treatment response. The 
often more complex tissue reaction to local or targeted treatment necessitates 
a more comprehensive assessment of response to cope with a specific therapy 
success. Therefore, extended criteria as type of perfusion of the index tumour (s), 
seemingly increased size of an ablation zone and its change over time, degree of 
uniformity or potential irregularity in the shape of an ablation zone, and changes 
in vascularisation, but also complications (e.g. bleeding, damage to biliary ducts) 
that might alter subsequent image interpretation) have to be incorporated into 
the response assessment. Modern cross-sectional imaging mainly by contrast-
enhanced CT and MRI, but also by ultrasound and PET/CT, offers beyond pure 
morphological evaluation a deep insight into changes of vascularization, fibrotic 
regression, residual or new tumor growth and complex concomitant phenomena. 
